Citrus Sinensis ID: 019905
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FHD7 | 487 | Probable serine/threonine | no | no | 0.955 | 0.655 | 0.777 | 1e-152 | |
| Q944A7 | 512 | Probable serine/threonine | no | no | 0.841 | 0.548 | 0.704 | 1e-121 | |
| Q7XJT7 | 465 | Probable inactive recepto | no | no | 0.790 | 0.567 | 0.485 | 3e-74 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.856 | 0.690 | 0.344 | 4e-37 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.829 | 0.672 | 0.334 | 4e-37 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.817 | 0.665 | 0.328 | 4e-37 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.859 | 0.726 | 0.319 | 4e-36 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.820 | 0.643 | 0.316 | 1e-35 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.835 | 0.654 | 0.308 | 1e-35 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.814 | 0.699 | 0.319 | 2e-35 |
| >sp|Q9FHD7|Y5126_ARATH Probable serine/threonine-protein kinase At5g41260 OS=Arabidopsis thaliana GN=At5g41260 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 536 bits (1382), Expect = e-152, Method: Compositional matrix adjust.
Identities = 252/324 (77%), Positives = 284/324 (87%), Gaps = 5/324 (1%)
Query: 1 MGIQCSKFTA-CCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG + SK +A CC + ++ PDV + + E + LP FREF++E ++NATSGF
Sbjct: 1 MGCEVSKLSALCCVSESGRSN----PDVTGLDEEGRGESNDLPQFREFSIETIRNATSGF 56
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
A ENIVSEHGE+APNVVYKGKLENQRRIAVKRFNR +WPD RQFLEEA++VGQLRN+R+
Sbjct: 57 AAENIVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMA 116
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NLLGCC E +ERLL+AE+MPNETLAKHLFHWE+ PMKWAMRLRV LH+AQALEYCTSKGR
Sbjct: 117 NLLGCCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGR 176
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYR+LFD+D NPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY
Sbjct: 177 ALYHDLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 236
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGTLLLDLLSGKHIPPSHALDLIRDRN+QML DS LEGQF+ DDGTEL+RLASRCLQYE
Sbjct: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYE 296
Query: 300 PRERPNPKSLVTALSPLQKETEFS 323
PRERPNPKSLV+A+ PLQK+ E +
Sbjct: 297 PRERPNPKSLVSAMIPLQKDLEIA 320
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q944A7|Y4523_ARATH Probable serine/threonine-protein kinase At4g35230 OS=Arabidopsis thaliana GN=At4g35230 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 198/281 (70%), Positives = 244/281 (86%)
Query: 41 LPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP 100
+PSF EF+ LK AT+ F+ +NIVSE GEKAPN+VYKG+L+N+R IAVK+F +MAWP+P
Sbjct: 55 IPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMAWPEP 114
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
+QF EEA VG+LR+NRL NL+G CC+GDERLLVAE+MPN+TLAKHLFHWE ++WAMR
Sbjct: 115 KQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIEWAMR 174
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220
LRV ++A+AL+YC+++GR LYHDLNAYR+LFDEDG+PRLS FGLMKNSRDGKSYSTNLA
Sbjct: 175 LRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYSTNLA 234
Query: 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280
+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +N+ +L DS LEG+F
Sbjct: 235 YTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHLEGKF 294
Query: 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ ++ T +V LAS+CLQYEPRERPN K LV L+PLQ +++
Sbjct: 295 STEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSD 335
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XJT7|SSP_ARATH Probable inactive receptor-like kinase SSP OS=Arabidopsis thaliana GN=SSP PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 136/280 (48%), Positives = 192/280 (68%), Gaps = 16/280 (5%)
Query: 42 PSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPR 101
P +F+ LK AT+ F+ ENIVS+ + +VV+KG+L+N +A+KRFN MAW DP+
Sbjct: 33 PPLTKFSFSALKTATNHFSPENIVSD---QTSDVVFKGRLQNGGFVAIKRFNNMAWSDPK 89
Query: 102 QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRL 161
FLEEA+ VG+LR+ RL NL+G CC+GD+R LVA++M N+TLAK LF + M W++RL
Sbjct: 90 LFLEEAQRVGKLRHKRLVNLIGYCCDGDKRFLVADFMANDTLAKRLFQRKYQTMDWSIRL 149
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF 221
RV +A+AL+YC + G A Y++L+AY++LFDEDG+ LS FGLMK + +
Sbjct: 150 RVAYFVAEALDYCNTAGFASYNNLSAYKVLFDEDGDACLSCFGLMKEINNDQ-------- 201
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
+ TG V PE+VIY FGT+L++LLSGK IPPSHA ++I +N+ L D L+G+F+
Sbjct: 202 -----ITTGSVNPENVIYRFGTVLVNLLSGKQIPPSHAPEMIHRKNVFKLMDPYLKGKFS 256
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
D+ + +LAS+CL+YE +E PN K +V L LQ TE
Sbjct: 257 IDEANVVYKLASQCLKYEGQESPNTKEIVATLETLQTRTE 296
|
Probable inactive protein kinase that activates the YODA MAP kinase cascade, regulating the asymmetric first division, and thus embryo polarity. Acts as an adapter at the plasma membrane, possibly recruiting an activator. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 111/322 (34%), Positives = 156/322 (48%), Gaps = 36/322 (11%)
Query: 32 NDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRI-AVK 90
NDE EV + + F+ +L AT F E ++ GE VYKGKLE I AVK
Sbjct: 52 NDEDKEVTNNIAAQTFSFRELATATKNFRQECLI---GEGGFGRVYKGKLEKTGMIVAVK 108
Query: 91 RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW 150
+ +R ++F+ E + L + L NL+G C +GD+RLLV EYM +L HL
Sbjct: 109 QLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDL 168
Query: 151 --ETHPMKWAMRLRVVLHLAQALEYCTSKGR--ALYHDLNAYRILFDEDGNPRLSTFGLM 206
+ P+ W R+R+ L A LEY K +Y DL A IL D + N +LS FGL
Sbjct: 169 TPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLA 228
Query: 207 KNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260
K G + + PEY RTG++T +S +YSFG +LL+L++G+ + +
Sbjct: 229 KLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRV-----I 283
Query: 261 DLIRDRNLQMLT-----------------DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
D R ++ Q L D LEG F + + V +A+ CLQ E R
Sbjct: 284 DTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVR 343
Query: 304 PNPKSLVTALSPLQKETEFSIS 325
P +VTAL L + SIS
Sbjct: 344 PLMSDVVTALGFLGTAPDGSIS 365
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 104/311 (33%), Positives = 166/311 (53%), Gaps = 34/311 (10%)
Query: 42 PSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR----------RIAVKR 91
P+ + FT +LK AT F ++++ E G + V+KG ++ Q IAVK+
Sbjct: 52 PNLKSFTFAELKAATRNFRPDSVLGEGGFGS---VFKGWIDEQTLTASKPGTGVVIAVKK 108
Query: 92 FNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWE 151
N+ W +++L E +GQ + L L+G C E + RLLV E+MP +L HLF
Sbjct: 109 LNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 168
Query: 152 TH--PMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
++ P+ W +RL+V L A+ L + ++ +Y D IL D + N +LS FGL K+
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKD 228
Query: 209 SRDG-KSY-STNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-----KHIPPS 257
G KS+ ST + + PEYL TG +T +S +YS+G +LL++LSG K+ PP
Sbjct: 229 GPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPG 288
Query: 258 H------ALDLIRD-RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
A L+ + R L + D+ L+ Q++ ++ ++ LA RCL +E + RPN +V
Sbjct: 289 EQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVV 348
Query: 311 TALSPLQKETE 321
+ L +Q E
Sbjct: 349 SHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 101/307 (32%), Positives = 163/307 (53%), Gaps = 34/307 (11%)
Query: 42 PSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR----------RIAVKR 91
P+ + F+ +LK+AT F ++++ GE V+KG ++ + IAVK+
Sbjct: 51 PNLKSFSFAELKSATRNFRPDSVL---GEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKK 107
Query: 92 FNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWE 151
N+ W +++L E +GQ + L L+G C E + RLLV E+MP +L HLF
Sbjct: 108 LNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 167
Query: 152 TH--PMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
+ P+ W +RL+V L A+ L + +S+ R +Y D IL D + N +LS FGL K+
Sbjct: 168 LYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKD 227
Query: 209 SRDG-KSY-STNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP----PSH 258
G KS+ ST + + PEYL TG +T +S +YSFG +LL+LLSG+ PS
Sbjct: 228 GPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSG 287
Query: 259 ALDLIR--------DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+L+ R + + D+ L+ Q++ ++ ++ L+ RCL E + RPN +V
Sbjct: 288 ERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVV 347
Query: 311 TALSPLQ 317
+ L +Q
Sbjct: 348 SHLEHIQ 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (384), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 103/322 (31%), Positives = 161/322 (50%), Gaps = 35/322 (10%)
Query: 27 VDAAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR- 85
V AA+ E + P + FT +LK AT F ++++ GE V+KG L+
Sbjct: 36 VAAAQKTEGEILSSTP-VKSFTFNELKLATRNFRPDSVI---GEGGFGCVFKGWLDESTL 91
Query: 86 ---------RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136
IAVK+ N+ + R++L E +GQL + L L+G C E + RLLV E
Sbjct: 92 TPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYE 151
Query: 137 YMPNETLAKHLFHWETH--PMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD 193
+M +L HLF + P+ W +R+ V L A+ L + S + +Y D+ A IL D
Sbjct: 152 FMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 211
Query: 194 EDGNPRLSTFGLMKNSRDGK-SYST-----NLAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
D N +LS FGL ++ G SY + + PEY+ +G + S +YSFG LLL+
Sbjct: 212 ADYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLE 271
Query: 248 LLSGK----HIPPSHALDLI--------RDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
+LSGK H P+ +L+ R + ++ D+ L+ Q+ ++ + +A +C
Sbjct: 272 ILSGKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQC 331
Query: 296 LQYEPRERPNPKSLVTALSPLQ 317
L +EP+ RP +V AL LQ
Sbjct: 332 LSFEPKSRPTMDQVVRALQQLQ 353
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (380), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 100/316 (31%), Positives = 154/316 (48%), Gaps = 42/316 (13%)
Query: 36 SEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR---------- 85
E+ P+ + FT +LKNAT F +N++ GE V+KG ++
Sbjct: 63 GEILSSPNLKAFTFNELKNATKNFRQDNLL---GEGGFGCVFKGWIDQTSLTASRPGSGI 119
Query: 86 RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK+ + +++L E +GQL + L L+G C EG+ RLLV E+MP +L
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 146 HLFHWETHPMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGNPRLSTFG 204
HLF P+ WA+R++V + A+ L + +K + +Y D A IL D D N +LS FG
Sbjct: 180 HLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 205 LMKN--SRDGKSYSTNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258
L K + D ST + + PEY+ TGR+T +S +YSFG +LL+L+SG+
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGR-----R 294
Query: 259 ALD-----------------LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
A+D L R L + D+ L GQ+ LA +CL + +
Sbjct: 295 AMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAK 354
Query: 302 ERPNPKSLVTALSPLQ 317
RP ++ L L+
Sbjct: 355 LRPKMSEVLVTLEQLE 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (379), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 96/311 (30%), Positives = 153/311 (49%), Gaps = 32/311 (10%)
Query: 36 SEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR---------- 85
E+ P+ + FT +LKNAT F ++++ E G V+KG ++
Sbjct: 60 GEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGF---GYVFKGWIDGTTLTASKPGSGI 116
Query: 86 RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK+ + +++L E +GQL + L L+G C EG+ RLLV E+MP +L
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 146 HLFHWETHPMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGNPRLSTFG 204
HLF P+ WA+R++V + A+ L + +K + +Y D A IL D + N +LS FG
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFG 236
Query: 205 LMKN--SRDGKSYSTNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258
L K + D ST + + PEY+ TGR+T +S +YSFG +LL+LLSG+
Sbjct: 237 LAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKS 296
Query: 259 ALDLIRD------------RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306
+ + + R L + D+ L GQ+ LA +CL + + RP
Sbjct: 297 KVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKM 356
Query: 307 KSLVTALSPLQ 317
++ L L+
Sbjct: 357 SEVLAKLDQLE 367
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (378), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 98/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 43 SFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR----------RIAVKRF 92
+ + F+ +LK AT F +++V GE V++G L+ IAVKR
Sbjct: 45 TVKSFSFNELKLATRNFRSDSVV---GEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRL 101
Query: 93 NRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF---H 149
N + R++L E +GQL + L L+G C E ++RLLV E+M +L HLF +
Sbjct: 102 NPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGN 161
Query: 150 WETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
+ P+ W +R++V L A+ L + S + +Y D+ A IL D D N +LS FGL ++
Sbjct: 162 KDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARD 221
Query: 209 SRDG-KSYST-----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK----HIPPSH 258
G +SY + + PEY+ TG + S +YSFG +LL+LL G+ H P+
Sbjct: 222 GPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAK 281
Query: 259 ALDLI--------RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+L+ R + ++ D+ L Q+ + L +A +CL +EP+ RP +V
Sbjct: 282 EQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVV 341
Query: 311 TALSPLQ 317
AL LQ
Sbjct: 342 RALVQLQ 348
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| 225454188 | 491 | PREDICTED: probable serine/threonine-pro | 0.952 | 0.647 | 0.900 | 1e-170 | |
| 356520418 | 491 | PREDICTED: probable serine/threonine-pro | 0.952 | 0.647 | 0.887 | 1e-169 | |
| 356504529 | 491 | PREDICTED: probable serine/threonine-pro | 0.952 | 0.647 | 0.884 | 1e-168 | |
| 224127648 | 491 | predicted protein [Populus trichocarpa] | 0.958 | 0.651 | 0.876 | 1e-167 | |
| 255541562 | 493 | receptor protein kinase, putative [Ricin | 0.955 | 0.647 | 0.872 | 1e-165 | |
| 224064025 | 491 | predicted protein [Populus trichocarpa] | 0.952 | 0.647 | 0.862 | 1e-163 | |
| 357507281 | 492 | hypothetical protein MTR_7g077150 [Medic | 0.955 | 0.648 | 0.857 | 1e-163 | |
| 225426412 | 488 | PREDICTED: probable serine/threonine-pro | 0.952 | 0.651 | 0.850 | 1e-162 | |
| 297814269 | 490 | kinase family protein [Arabidopsis lyrat | 0.952 | 0.648 | 0.847 | 1e-160 | |
| 22328189 | 489 | BR-signaling kinase 3 [Arabidopsis thali | 0.949 | 0.648 | 0.850 | 1e-160 |
| >gi|225454188|ref|XP_002272416.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297745267|emb|CBI40347.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1557), Expect = e-170, Method: Compositional matrix adjust.
Identities = 289/321 (90%), Positives = 299/321 (93%), Gaps = 3/321 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCSK CCW+SQFK +VLEAPDVD N E SEVD LP F E+T EQLKNATSGFA
Sbjct: 1 MGCQCSKLAPCCWDSQFKGSVLEAPDVD---NGEKSEVDYLPVFCEYTFEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNR+AWPD RQF EEAR+VGQLRN+RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRVAWPDARQFSEEARAVGQLRNHRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCE +ERLLVAEYMPNETLAKHLFHWET PMKWAMRLRVVLHLAQALEYCT +GRA
Sbjct: 118 LLGCCCEDNERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTGRGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFDEDGNPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRILFDEDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT+DDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTNDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPNPKSLV AL+PLQKETE
Sbjct: 298 RERPNPKSLVAALTPLQKETE 318
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520418|ref|XP_003528859.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1546), Expect = e-169, Method: Compositional matrix adjust.
Identities = 285/321 (88%), Positives = 299/321 (93%), Gaps = 3/321 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MGIQCS+ CC +SQ KA+V+E PD AE ++ SEV P+FRE+TLEQLKNATSGFA
Sbjct: 1 MGIQCSRLIPCCVDSQVKASVIETPD---AEIEDSSEVSNWPTFREYTLEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQ RIAVKRFNR AWPD RQFLEEARSVGQLRN RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEEARSVGQLRNQRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEG+ERLLVAEYMPNETLAKHLFHWET PMKWAMRLRVVLHLAQALEYCTSKGRA
Sbjct: 118 LLGCCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALD+IR RNLQMLTDSCLEGQF+DDDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPNPKSLV AL+PLQKETE
Sbjct: 298 RERPNPKSLVVALAPLQKETE 318
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504529|ref|XP_003521048.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1540), Expect = e-168, Method: Compositional matrix adjust.
Identities = 284/321 (88%), Positives = 298/321 (92%), Gaps = 3/321 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MGIQCS+ CC +SQ KA+V+E PD AE ++ SE P+FREFTLEQLKNATSGFA
Sbjct: 1 MGIQCSRLIPCCVDSQVKASVIETPD---AEIEDSSEASNWPTFREFTLEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQ RIAVKRFNR AWPD RQFLEE+RSVGQLRN RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEESRSVGQLRNQRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEG+ERLLVAEYMPNETLAKHLFHWET PMKWAMRLRVVLHLAQALEYCTSKGRA
Sbjct: 118 LLGCCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALD+IR RNLQMLTDSCLEGQF+DDDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPNPKSLV AL+PLQKETE
Sbjct: 298 RERPNPKSLVAALAPLQKETE 318
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127648|ref|XP_002320126.1| predicted protein [Populus trichocarpa] gi|222860899|gb|EEE98441.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 283/323 (87%), Positives = 300/323 (92%), Gaps = 3/323 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QC+K T CC +SQFKA V+E P V N+E SEV+ LP+FREFT EQLKNATSGFA
Sbjct: 1 MGSQCTKLTPCCLDSQFKAAVVEVPSVG---NEEKSEVNDLPTFREFTFEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD RQFLEEARSVGQLRNNRL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDARQFLEEARSVGQLRNNRLVN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET P+KWAMRLRVVLHLA+ALEYCTSKGRA
Sbjct: 118 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPIKWAMRLRVVLHLAEALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFDEDGNP+LS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRILFDEDGNPKLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLD LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF++DDGTELVRLASRCLQYE
Sbjct: 238 FGTLLLDHLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFSNDDGTELVRLASRCLQYEL 297
Query: 301 RERPNPKSLVTALSPLQKETEFS 323
RERP+ K LV AL+PLQKET+ +
Sbjct: 298 RERPSLKFLVAALTPLQKETDVA 320
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541562|ref|XP_002511845.1| receptor protein kinase, putative [Ricinus communis] gi|223549025|gb|EEF50514.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 281/322 (87%), Positives = 296/322 (91%), Gaps = 3/322 (0%)
Query: 1 MGIQCSKFTACCWNSQFKAT-VLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG CSKF CC +SQFKA V+E PD N+ SE+D LP+FREFT EQLKNATSGF
Sbjct: 1 MGSLCSKFIPCCLDSQFKAAAVVEVPDT--VGNEGKSEIDYLPAFREFTFEQLKNATSGF 58
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
AVENIVSEHGEKAPNVVYKGKLENQRRI VKRFNRMAWPD RQFLEEAR VGQLRN+RL
Sbjct: 59 AVENIVSEHGEKAPNVVYKGKLENQRRIVVKRFNRMAWPDARQFLEEARFVGQLRNHRLA 118
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NLLGCCCEGDERLLVAEY+PNETLAKHLFHWET PMKWAMRLRV LHLA+ALEYCTSKGR
Sbjct: 119 NLLGCCCEGDERLLVAEYLPNETLAKHLFHWETQPMKWAMRLRVALHLAEALEYCTSKGR 178
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYRILFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY
Sbjct: 179 ALYHDLNAYRILFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 238
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGTLL+DLLSGKHIPP+HALDLIRDRNLQMLTDSCLEGQF++DDGTELVRLASRCLQYE
Sbjct: 239 SFGTLLVDLLSGKHIPPNHALDLIRDRNLQMLTDSCLEGQFSNDDGTELVRLASRCLQYE 298
Query: 300 PRERPNPKSLVTALSPLQKETE 321
RERP+ KSLV AL+PLQKETE
Sbjct: 299 LRERPSSKSLVAALTPLQKETE 320
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064025|ref|XP_002301354.1| predicted protein [Populus trichocarpa] gi|222843080|gb|EEE80627.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1499), Expect = e-163, Method: Compositional matrix adjust.
Identities = 277/321 (86%), Positives = 298/321 (92%), Gaps = 3/321 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QC+K T CC +SQFKA V+E PDV N++ SEV+ LP+FREFTLEQLKNATSGFA
Sbjct: 1 MGSQCTKLTRCCVDSQFKAAVVEVPDVG---NEDKSEVNDLPTFREFTLEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
V+NIVSEHGEKAPNVVYKGKLENQRRIAVKRFN+MAWPD RQFLEEARSVGQLR++RL N
Sbjct: 58 VQNIVSEHGEKAPNVVYKGKLENQRRIAVKRFNKMAWPDARQFLEEARSVGQLRSHRLVN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLG CCEGDER+LVAE+M NETLAKHLFHWET P+KW MRLRVVLHLA+ALEYCTSKGRA
Sbjct: 118 LLGFCCEGDERVLVAEFMLNETLAKHLFHWETQPIKWPMRLRVVLHLAEALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFDEDGNP+LS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRILFDEDGNPKLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF+ DDGTELVRLASRCLQYE
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFSSDDGTELVRLASRCLQYEL 297
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERP+ KSLV AL+PLQKE +
Sbjct: 298 RERPSLKSLVAALTPLQKEND 318
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507281|ref|XP_003623929.1| hypothetical protein MTR_7g077150 [Medicago truncatula] gi|355498944|gb|AES80147.1| hypothetical protein MTR_7g077150 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1493), Expect = e-163, Method: Compositional matrix adjust.
Identities = 276/322 (85%), Positives = 291/322 (90%), Gaps = 3/322 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MGIQCS CC +SQ KA+V E PD AEN+ E + PSFREFTLEQL NATSGF
Sbjct: 1 MGIQCSSLVPCCVDSQVKASVPEVPD---AENENRIETNDGPSFREFTLEQLNNATSGFN 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGK+ENQ RI VKRFNR AWPD RQFLEEARSVGQLR+ RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKMENQTRIVVKRFNRSAWPDARQFLEEARSVGQLRSERLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCE DERLLVAEYMPNETLAKHLFHW++ PMKWAMRLRVVLHLA+ALEYCTS GRA
Sbjct: 118 LLGCCCEDDERLLVAEYMPNETLAKHLFHWDSQPMKWAMRLRVVLHLAEALEYCTSNGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRN+QMLTDSCLEGQF++DDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSEDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETEF 322
RERPN KSLV AL+PLQKETE
Sbjct: 298 RERPNTKSLVAALAPLQKETEV 319
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426412|ref|XP_002270065.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297742525|emb|CBI34674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1490), Expect = e-162, Method: Compositional matrix adjust.
Identities = 273/321 (85%), Positives = 294/321 (91%), Gaps = 3/321 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCSKF CCW+S+ K V+E P V EN+E SE D LP+F E+T++QL+ ATSGFA
Sbjct: 1 MGCQCSKFWVCCWDSEQKGLVVEPPSV---ENEENSEADDLPAFHEYTIDQLRMATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFN+ AWPD RQFLEEARSVGQLRN+RL N
Sbjct: 58 AENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNKSAWPDARQFLEEARSVGQLRNHRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCC EGDERLLVAE+MPN+TLAKHLFHWET PMKWAMRLRV L+LAQALEYCTSKGRA
Sbjct: 118 LLGCCSEGDERLLVAEFMPNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRI+FD+DG+PRLS FG+MKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV+YS
Sbjct: 178 LYHDLNAYRIVFDDDGDPRLSCFGMMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRN+QMLTDSCLEGQF+ DDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSSDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPNPKSLV AL PLQKETE
Sbjct: 298 RERPNPKSLVAALIPLQKETE 318
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814269|ref|XP_002875018.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297320855|gb|EFH51277.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1470), Expect = e-160, Method: Compositional matrix adjust.
Identities = 272/321 (84%), Positives = 290/321 (90%), Gaps = 3/321 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCS + CC NS K VLEAP VD N E SE+ +P+FRE+TLEQLK ATSGFA
Sbjct: 1 MGGQCSSLSQCCRNSSHKTAVLEAPYVD---NGESSEITDVPNFREYTLEQLKAATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VE IVSEHGEKAPNVVYKGKLENQ++IAVKRF RMAWPD RQFLEEARSVGQLR+ R+ N
Sbjct: 58 VEYIVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDARQFLEEARSVGQLRSERMAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET PMKW MRLRVVL+LAQALEYCTSKGR
Sbjct: 118 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRT 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+TPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQ LTDSCL+GQF+D DGTELVRLASRCLQYE
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEA 297
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPN KSLVTAL+PLQK+TE
Sbjct: 298 RERPNTKSLVTALTPLQKDTE 318
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22328189|ref|NP_191980.2| BR-signaling kinase 3 [Arabidopsis thaliana] gi|17064838|gb|AAL32573.1| Unknown protein [Arabidopsis thaliana] gi|20259854|gb|AAM13274.1| unknown protein [Arabidopsis thaliana] gi|332656524|gb|AEE81924.1| BR-signaling kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1468), Expect = e-160, Method: Compositional matrix adjust.
Identities = 273/321 (85%), Positives = 291/321 (90%), Gaps = 4/321 (1%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCS + CC N+ K VLEAPDVD N E SE+ +P+FRE+TLEQLK ATSGFA
Sbjct: 1 MGGQCSSLS-CCRNTSHKTAVLEAPDVD---NGESSEITDVPNFREYTLEQLKAATSGFA 56
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VE IVSEHGEKAPNVVYKGKLENQ++IAVKRF RMAWPD RQFLEEARSVGQLR+ R+ N
Sbjct: 57 VEYIVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDSRQFLEEARSVGQLRSERMAN 116
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET PMKW MRLRVVL+LAQALEYCTSKGR
Sbjct: 117 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRT 176
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+TPESVIYS
Sbjct: 177 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYS 236
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQ LTDSCL+GQF+D DGTELVRLASRCLQYE
Sbjct: 237 FGTLLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEA 296
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPN KSLVTAL+PLQKETE
Sbjct: 297 RERPNTKSLVTALTPLQKETE 317
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| TAIR|locus:2127118 | 489 | BSK3 "brassinosteroid-signalin | 0.949 | 0.648 | 0.850 | 2.8e-146 | |
| TAIR|locus:2155115 | 487 | BSK8 "brassinosteroid-signalin | 0.955 | 0.655 | 0.777 | 3.6e-137 | |
| TAIR|locus:2031279 | 487 | BSK7 "brassinosteroid-signalin | 0.952 | 0.652 | 0.791 | 4.6e-137 | |
| TAIR|locus:2198160 | 483 | BSK4 "brassinosteroid-signalin | 0.943 | 0.652 | 0.775 | 1.2e-131 | |
| TAIR|locus:2154538 | 489 | BSK5 "brassinosteroid-signalin | 0.940 | 0.642 | 0.750 | 7.3e-130 | |
| TAIR|locus:2084475 | 490 | BSK6 "brassinosteroid-signalin | 0.940 | 0.640 | 0.742 | 3.3e-127 | |
| TAIR|locus:2122058 | 512 | BSK1 "brassinosteroid-signalin | 0.844 | 0.550 | 0.705 | 3.3e-111 | |
| TAIR|locus:2083499 | 477 | BSK9 "brassinosteroid-signalin | 0.877 | 0.614 | 0.668 | 1.4e-105 | |
| TAIR|locus:2142315 | 489 | BSK2 "brassinosteroid-signalin | 0.889 | 0.607 | 0.634 | 2.8e-105 | |
| TAIR|locus:2150074 | 499 | BSK10 "brassinosteroid-signali | 0.949 | 0.635 | 0.595 | 4.9e-101 |
| TAIR|locus:2127118 BSK3 "brassinosteroid-signaling kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
Identities = 273/321 (85%), Positives = 291/321 (90%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCS + CC N+ K VLEAPDVD N E SE+ +P+FRE+TLEQLK ATSGFA
Sbjct: 1 MGGQCSSLS-CCRNTSHKTAVLEAPDVD---NGESSEITDVPNFREYTLEQLKAATSGFA 56
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VE IVSEHGEKAPNVVYKGKLENQ++IAVKRF RMAWPD RQFLEEARSVGQLR+ R+ N
Sbjct: 57 VEYIVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDSRQFLEEARSVGQLRSERMAN 116
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET PMKW MRLRVVL+LAQALEYCTSKGR
Sbjct: 117 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRT 176
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+TPESVIYS
Sbjct: 177 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYS 236
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQ LTDSCL+GQF+D DGTELVRLASRCLQYE
Sbjct: 237 FGTLLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEA 296
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPN KSLVTAL+PLQKETE
Sbjct: 297 RERPNTKSLVTALTPLQKETE 317
|
|
| TAIR|locus:2155115 BSK8 "brassinosteroid-signaling kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1343 (477.8 bits), Expect = 3.6e-137, P = 3.6e-137
Identities = 252/324 (77%), Positives = 284/324 (87%)
Query: 1 MGIQCSKFTA-CCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG + SK +A CC + ++ PDV + + E + LP FREF++E ++NATSGF
Sbjct: 1 MGCEVSKLSALCCVSESGRSN----PDVTGLDEEGRGESNDLPQFREFSIETIRNATSGF 56
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
A ENIVSEHGE+APNVVYKGKLENQRRIAVKRFNR +WPD RQFLEEA++VGQLRN+R+
Sbjct: 57 AAENIVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMA 116
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NLLGCC E +ERLL+AE+MPNETLAKHLFHWE+ PMKWAMRLRV LH+AQALEYCTSKGR
Sbjct: 117 NLLGCCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGR 176
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYR+LFD+D NPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY
Sbjct: 177 ALYHDLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 236
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGTLLLDLLSGKHIPPSHALDLIRDRN+QML DS LEGQF+ DDGTEL+RLASRCLQYE
Sbjct: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYE 296
Query: 300 PRERPNPKSLVTALSPLQKETEFS 323
PRERPNPKSLV+A+ PLQK+ E +
Sbjct: 297 PRERPNPKSLVSAMIPLQKDLEIA 320
|
|
| TAIR|locus:2031279 BSK7 "brassinosteroid-signaling kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1342 (477.5 bits), Expect = 4.6e-137, P = 4.6e-137
Identities = 254/321 (79%), Positives = 279/321 (86%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG + SK A C S + + V + D E + LP FREF++E L+NATSGFA
Sbjct: 1 MGCEVSKLCAFCCVSDPEGS---NHGVTGLDEDRRGEGNDLPQFREFSIETLRNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
ENIVSEHGEKAPNVVYKGKL+NQRRIAVKRFNR AWPD RQFLEEA++VGQLRN R+ N
Sbjct: 58 TENIVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRKAWPDSRQFLEEAKAVGQLRNYRMAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCC EG+ERLLVAE+MPNETLAKHLFHWE+ PMKWAMRLRV LH+AQALEYCT KGRA
Sbjct: 118 LLGCCYEGEERLLVAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTGKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFD+D NPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV+YS
Sbjct: 178 LYHDLNAYRVLFDDDSNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+GTLLLDLLSGKHIPPSHALDLIRDRN+QML DSCLEGQF+ DDGTEL+RLASRCLQYEP
Sbjct: 238 YGTLLLDLLSGKHIPPSHALDLIRDRNIQMLIDSCLEGQFSSDDGTELIRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPNPKSLVTA+ PLQK+ E
Sbjct: 298 RERPNPKSLVTAMIPLQKDLE 318
|
|
| TAIR|locus:2198160 BSK4 "brassinosteroid-signaling kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1291 (459.5 bits), Expect = 1.2e-131, P = 1.2e-131
Identities = 249/321 (77%), Positives = 275/321 (85%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG Q SK CC K T LEAPDV EN E EV+G+ SFRE++LEQLK ATS FA
Sbjct: 1 MGGQSSKIGTCC---SHKTTALEAPDV---ENKENGEVNGVHSFREYSLEQLKIATSCFA 54
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
+EN+VSEHGE APNVVY+GKLEN +IA+KRF+ AWPDPRQFLEEAR VGQLR+ R+ N
Sbjct: 55 LENVVSEHGETAPNVVYQGKLENHMKIAIKRFSGTAWPDPRQFLEEARLVGQLRSKRMAN 114
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLG CCEG ERLLVAE+MPNETLAKHLFHW+T PMKWAMRLRV L++++ALEYC++ G
Sbjct: 115 LLGYCCEGGERLLVAEFMPNETLAKHLFHWDTEPMKWAMRLRVALYISEALEYCSNNGHT 174
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+T ESVIYS
Sbjct: 175 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITAESVIYS 234
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLL+GKHIPPSHALDLIRDRNLQ LTDSCLEGQF+D DGTELVRL S CLQYE
Sbjct: 235 FGTLLLDLLTGKHIPPSHALDLIRDRNLQTLTDSCLEGQFSDSDGTELVRLTSCCLQYEA 294
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPN KSLVTAL LQK+TE
Sbjct: 295 RERPNIKSLVTALISLQKDTE 315
|
|
| TAIR|locus:2154538 BSK5 "brassinosteroid-signaling kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
Identities = 241/321 (75%), Positives = 276/321 (85%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG +CSK + C W + K+T EA D+D +D LPSF EF+ +QL+ AT GF+
Sbjct: 1 MGPRCSKLSLCWWPTHLKSTHNEASDLDNGTDD-------LPSFTEFSFDQLRAATCGFS 53
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
++IVSEHG KAPNVVYKG+LE+ R IAVKRFNR AWPD RQFLEEA++VGQLRN RL N
Sbjct: 54 TDSIVSEHGVKAPNVVYKGRLEDDRWIAVKRFNRSAWPDTRQFLEEAKAVGQLRNERLAN 113
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
L+G CCEGDERLLVAE+MP ETL+KHLFHW++ PMKW+MRLRV L+LAQALEYC+SKGRA
Sbjct: 114 LIGFCCEGDERLLVAEFMPFETLSKHLFHWDSQPMKWSMRLRVALYLAQALEYCSSKGRA 173
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFD+DGNPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRV PESV+YS
Sbjct: 174 LYHDLNAYRILFDQDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVIPESVVYS 233
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIR +N ML DSCL+G F++DDGT+LVRLASRCLQYE
Sbjct: 234 FGTLLLDLLSGKHIPPSHALDLIRGKNFLMLMDSCLDGHFSNDDGTDLVRLASRCLQYEA 293
Query: 301 RERPNPKSLVTALSPLQKETE 321
RERPN KSLV++L+PLQKET+
Sbjct: 294 RERPNVKSLVSSLAPLQKETD 314
|
|
| TAIR|locus:2084475 BSK6 "brassinosteroid-signaling kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1249 (444.7 bits), Expect = 3.3e-127, P = 3.3e-127
Identities = 239/322 (74%), Positives = 282/322 (87%)
Query: 1 MGIQCSKFTACCWNSQFK-ATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG +CSKF+ C + S FK A+VLE+PD+ EN +V P+F+EF LEQLK+AT GF
Sbjct: 1 MGARCSKFSFCLFPSHFKSASVLESPDI---ENG--GKV--WPTFKEFKLEQLKSATGGF 53
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
+ +NIVSEHGEKAPNVVY+G+L++ R IAVKRFNR+AW D RQFL+EA++VG LR++RL
Sbjct: 54 SSDNIVSEHGEKAPNVVYRGRLDDGRLIAVKRFNRLAWADHRQFLDEAKAVGSLRSDRLA 113
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NL+GCC EG+ERLLVAE+MP+ETLAKHLFHWE +PMKWAMRLRV L LAQALEYC++KGR
Sbjct: 114 NLIGCCFEGEERLLVAEFMPHETLAKHLFHWENNPMKWAMRLRVALCLAQALEYCSNKGR 173
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYR+LFD+DGNPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV++
Sbjct: 174 ALYHDLNAYRVLFDKDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVVF 233
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGT+LLDL+SGKHIPPSHALDLIR +N ML DS LEG F+++DGTELVRLA+RCLQYE
Sbjct: 234 SFGTVLLDLMSGKHIPPSHALDLIRGKNCAMLMDSALEGHFSNEDGTELVRLATRCLQYE 293
Query: 300 PRERPNPKSLVTALSPLQKETE 321
RERPN KSLVT+L LQKE++
Sbjct: 294 ARERPNVKSLVTSLVTLQKESD 315
|
|
| TAIR|locus:2122058 BSK1 "brassinosteroid-signaling kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
Identities = 199/282 (70%), Positives = 245/282 (86%)
Query: 40 GLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD 99
G+PSF EF+ LK AT+ F+ +NIVSE GEKAPN+VYKG+L+N+R IAVK+F +MAWP+
Sbjct: 54 GIPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMAWPE 113
Query: 100 PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAM 159
P+QF EEA VG+LR+NRL NL+G CC+GDERLLVAE+MPN+TLAKHLFHWE ++WAM
Sbjct: 114 PKQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIEWAM 173
Query: 160 RLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNL 219
RLRV ++A+AL+YC+++GR LYHDLNAYR+LFDEDG+PRLS FGLMKNSRDGKSYSTNL
Sbjct: 174 RLRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYSTNL 233
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279
A+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +N+ +L DS LEG+
Sbjct: 234 AYTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHLEGK 293
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
F+ ++ T +V LAS+CLQYEPRERPN K LV L+PLQ +++
Sbjct: 294 FSTEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSD 335
|
|
| TAIR|locus:2083499 BSK9 "brassinosteroid-signaling kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
Identities = 196/293 (66%), Positives = 234/293 (79%)
Query: 29 AAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIA 88
AA+N E E P+F EF+LEQL+ AT GF+ +NIVSEH E+ PN+VYKG+L + R+IA
Sbjct: 11 AADNKEEDEGSTCPNFLEFSLEQLRVATDGFSADNIVSEHNERVPNIVYKGQLNDGRKIA 70
Query: 89 VKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF 148
VKRF R++WPD +F+EEA++VG+ R+ + NL+GCC EG ERLLVAEYMPNETLAKHLF
Sbjct: 71 VKRFQRLSWPDSLEFIEEAQAVGRCRSEHMANLIGCCSEGHERLLVAEYMPNETLAKHLF 130
Query: 149 HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
HWE PMKW MRLRV LH A ALEYC G LYHDLN YRILFD+ GNPRLS FGLMK
Sbjct: 131 HWEKRPMKWEMRLRVALHTATALEYCNDWGIDLYHDLNTYRILFDKVGNPRLSCFGLMKC 190
Query: 209 SRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268
SR+GKSYSTNLAF PPEYLR G V PESV +SFGTLLLDL+SG+HIPP+HALDL R +N
Sbjct: 191 SREGKSYSTNLAFAPPEYLRLGTVIPESVTFSFGTLLLDLMSGRHIPPNHALDLFRGKNY 250
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
+L DS L+GQF+D+D TEL+ LASRCL+ EP ERP+ K L++ALS L+K E
Sbjct: 251 LVLMDSALDGQFSDEDRTELIHLASRCLRPEPDERPSIKFLMSALSRLEKRAE 303
|
|
| TAIR|locus:2142315 BSK2 "brassinosteroid-signaling kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 2.8e-105, P = 2.8e-105
Identities = 189/298 (63%), Positives = 245/298 (82%)
Query: 24 APDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLEN 83
AP+ + N + + + + +F+EF L +L+ AT+GF+ IVSE GEKAPNVVY+GKLE
Sbjct: 19 APNKPESVNGDQVDQE-IQNFKEFELNELRKATNGFSPSCIVSEGGEKAPNVVYRGKLEG 77
Query: 84 QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143
+A+KRF+R +WPD +QF+ EA VG+LRN R+ +L+GCC EGDERLLVAEYMPN+TL
Sbjct: 78 NHLVAIKRFSRQSWPDAQQFVVEATGVGKLRNKRIVSLIGCCAEGDERLLVAEYMPNDTL 137
Query: 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203
+KHLFHWE P+ W MR+R+ ++A+AL+YC + R +YHDLNAYRILFDE+G+PRLSTF
Sbjct: 138 SKHLFHWEKQPLPWDMRVRIADYIAEALDYCNIENRKIYHDLNAYRILFDEEGDPRLSTF 197
Query: 204 GLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI 263
GLMKNSRDGKSYSTNLA+TPPE+LRTGRV PESVI+S+GT+LLDLLSGKHIPPSHALD+I
Sbjct: 198 GLMKNSRDGKSYSTNLAYTPPEFLRTGRVIPESVIFSYGTILLDLLSGKHIPPSHALDII 257
Query: 264 RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
R +N +L DS LEGQ+ +DD T+LV LAS+CLQ E ++RP+ K L++A++PLQK+ E
Sbjct: 258 RGKNALLLMDSSLEGQYANDDATKLVDLASKCLQSEAKDRPDTKFLLSAVAPLQKQEE 315
|
|
| TAIR|locus:2150074 BSK10 "brassinosteroid-signaling kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
Identities = 194/326 (59%), Positives = 239/326 (73%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAEN--DEMSEVDG--LPS-FREFTLEQLKNA 55
MG C K W + + + +D EN + ++ DG P FREF+LEQL+ A
Sbjct: 1 MGCICFK----SWRRSSSSPSITSTVIDDLENVREYDADDDGGHYPLIFREFSLEQLRIA 56
Query: 56 TSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN 115
T GF+ NIVSEH + PN+VYKGKL + RRIAVKRF R++WPDP +F+ EA++VG+LR+
Sbjct: 57 TDGFSAGNIVSEHNDSVPNIVYKGKLGDGRRIAVKRFQRLSWPDPFEFINEAQAVGRLRS 116
Query: 116 NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT 175
+ NL+GCCC+ +ERLLVAEYMPN TLAKHLFHWE PMKW MRL+V LH A+ALEYC
Sbjct: 117 EHMANLIGCCCDDNERLLVAEYMPNGTLAKHLFHWEKRPMKWEMRLKVALHTARALEYCN 176
Query: 176 SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPE 235
KG LYHDLN YRI+FD+ G P+LS FGLMKNS +GK YSTNLAF PPEYLR G V E
Sbjct: 177 DKGIDLYHDLNPYRIMFDKTGIPKLSCFGLMKNSHEGKIYSTNLAFAPPEYLRLGTVIAE 236
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
SV +SFGTLLLDL+SG+HIPP+HALDL R +N +L DS L+GQF+D+D TEL+ +ASRC
Sbjct: 237 SVTFSFGTLLLDLMSGRHIPPNHALDLFRGKNYLVLMDSALDGQFSDEDRTELIHVASRC 296
Query: 296 LQYEPRERPNPKSLVTALSPLQKETE 321
+ EP ERP+ K L LS LQK +
Sbjct: 297 FKTEPEERPSIKFLKATLSRLQKRAK 322
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 334 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-22 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-09 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-07 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-04 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.001 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 0.001 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.001 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.001 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 0.002 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.003 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.004 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-30
Identities = 60/245 (24%), Positives = 95/245 (38%), Gaps = 49/245 (20%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
VY + + +++A+K + + L E + +L + + L G + +
Sbjct: 8 TVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLY 67
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
LV EY +L L E + LR++L + + LEY S G + H DL IL
Sbjct: 68 LVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENIL 124
Query: 192 FDED-GNPRLSTFGLMKNSRDGKSYST----NLAFTPPEYLR-TGRVTPESVIYSFGTLL 245
D D G +L+ FGL K KS A+ PE L G + +S I+S G +L
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184
Query: 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+L DLIR + LQ +P +RP+
Sbjct: 185 YEL--------PELKDLIR-----------------------------KMLQKDPEKRPS 207
Query: 306 PKSLV 310
K ++
Sbjct: 208 AKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-23
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 28/256 (10%)
Query: 75 VVYKGKL-----ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ ++V EYMP L +L + + L L +A+ +EY SK H DL A
Sbjct: 74 EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAA 131
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFG 242
L E+ ++S FGL ++ D Y + PE L+ G+ T +S ++SFG
Sbjct: 132 RNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFG 191
Query: 243 TLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
LL ++ + G+ + + L+ ++ +C EL +L +C
Sbjct: 192 VLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP---------ELYKLMLQCWA 242
Query: 298 YEPRERPNPKSLVTAL 313
+P +RP LV L
Sbjct: 243 EDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-22
Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 29/256 (11%)
Query: 75 VVYKGKLE-----NQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKGKL+ + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE 73
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ +V EYM L +L + + L L +A+ +EY SK H DL A
Sbjct: 74 EPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESKN--FIHRDLAA 130
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFG 242
L E+ ++S FGL ++ D Y + PE L+ G+ T +S ++SFG
Sbjct: 131 RNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFG 190
Query: 243 TLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
LL ++ + G+ + L+ +++ +C EL L +C
Sbjct: 191 VLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP---------ELYDLMLQCWA 241
Query: 298 YEPRERPNPKSLVTAL 313
+P +RP LV L
Sbjct: 242 EDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 20/249 (8%)
Query: 75 VVYKGKLEN-QRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VYK K + + +AVK + E R + +L + + L+ + D
Sbjct: 14 TVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHL 73
Query: 132 LLVAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
LV EY L +L P+ ++ L + + LEY S G + H DL
Sbjct: 74 YLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPEN 128
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGR-VTPESVIYSFGTL 244
IL DE+G +++ FGL K S T TP PE L G P+ ++S G +
Sbjct: 129 ILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 245 LLDLLSGKHI-PPSHALDLIR--DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
L +LL+GK + LD ++ R L + + E L +CL +P
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEF--DEPKWSSGSEEAKDLIKKCLNKDPS 246
Query: 302 ERPNPKSLV 310
+RP + ++
Sbjct: 247 KRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 9e-22
Identities = 73/258 (28%), Positives = 115/258 (44%), Gaps = 32/258 (12%)
Query: 75 VVYKGKL-----ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L + ++AVK A + R+ FLEEA + +L + + LLG C +G
Sbjct: 14 EVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ +V EYMP L L + L++ L +A+ +EY SK H DL A
Sbjct: 74 EPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAA 130
Query: 188 YRILFDEDGNPRLSTFGLMKN-SRDGKSYSTNLAFTP-----PEYLRTGRVTPESVIYSF 241
L E+ ++S FGL ++ D P PE L+ G+ T +S ++SF
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190
Query: 242 GTLLLDLLSG-----KHIPPSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRC 295
G LL ++ + + L+L+ D ++ ++C + EL L +C
Sbjct: 191 GVLLWEIFTLGEQPYPGMSNEEVLELLEDGY-RLPRPENCPD---------ELYELMLQC 240
Query: 296 LQYEPRERPNPKSLVTAL 313
Y+P +RP LV L
Sbjct: 241 WAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-21
Identities = 74/262 (28%), Positives = 111/262 (42%), Gaps = 33/262 (12%)
Query: 75 VVYKGKL----ENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VYKGKL +AVK A + R FL+EAR + +L + + LLG C E +
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE 69
Query: 130 ERLLVAEYMPNETLAKHL-------FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182
LV EYM L +L E + L + +A+ +EY SK + ++
Sbjct: 70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVH 128
Query: 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPES 236
DL A L ED ++S FGL ++ D Y + + PE L+ G T +S
Sbjct: 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188
Query: 237 VIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291
++SFG LL ++ + G + L+ +R + C + EL L
Sbjct: 189 DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD---------ELYEL 239
Query: 292 ASRCLQYEPRERPNPKSLVTAL 313
C Q +P +RP LV L
Sbjct: 240 MLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 8e-20
Identities = 56/248 (22%), Positives = 93/248 (37%), Gaps = 26/248 (10%)
Query: 75 VVYKGK-LENQRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
VY + + + +A+K + D + L E + + +L++ + L + D+
Sbjct: 14 KVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLY 73
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL---NAYR 189
LV EY L L A + + ALEY SKG ++ DL N
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSKGI-VHRDLKPEN--- 127
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESVIYSFGTLLL 246
IL DEDG+ +L+ FGL + G+ +T + PE L I+S G +L
Sbjct: 128 ILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILY 187
Query: 247 DLLSGK-----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+LL+GK I + +L+R + L +P
Sbjct: 188 ELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD----ISPEAKDLIR---KLLVKDPE 240
Query: 302 ERPNPKSL 309
+R +
Sbjct: 241 KRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 69/244 (28%), Positives = 107/244 (43%), Gaps = 29/244 (11%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VYKG L+ +AVK R P R+FL+EA + Q + + L+G C + +
Sbjct: 11 VYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYI 69
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
V E +P +L L + + + L++ L A +EY SK ++ DL A L
Sbjct: 70 VMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVG 127
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFGTLLL 246
E+ ++S FG M +G Y+ + + +T PE L GR T ES ++S+G LL
Sbjct: 128 ENNVLKISDFG-MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLW 186
Query: 247 DLLSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEP 300
+ S P + I + +M C E E+ RL +C Y+P
Sbjct: 187 ETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPE---------EIYRLMLQCWAYDP 236
Query: 301 RERP 304
RP
Sbjct: 237 ENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 16/244 (6%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V G Q+ +AVK + + FL EA + LR+ L LLG +G+ +V
Sbjct: 22 VMLGDYRGQK-VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L +L + A +L L + + +EY K ++ DL A +L ED
Sbjct: 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSED 138
Query: 196 GNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254
++S FGL K + G S + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 LVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 255 P-PSHALDLIRDR---NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
P P L + +M EG E+ ++ C + +P +RP K L
Sbjct: 199 PYPRIPLKDVVPHVEKGYRM---EAPEGC-----PPEVYKVMKDCWELDPAKRPTFKQLR 250
Query: 311 TALS 314
L+
Sbjct: 251 EQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 14/238 (5%)
Query: 76 VYKGKLE-NQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
V+ G+L + +AVK PD + +FL+EAR + Q + + L+G C + +
Sbjct: 11 VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
V E + L E +K +++V + A +EY SK ++ DL A L
Sbjct: 71 VMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVT 128
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
E ++S FG+ + DG ST + +T PE L GR + ES ++SFG LL +
Sbjct: 129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
S +P ++ + ++ + + + + + RL RC +Y+P +RP+
Sbjct: 189 AFSLGAVPYAN----LSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 76.3 bits (186), Expect = 2e-15
Identities = 64/292 (21%), Positives = 105/292 (35%), Gaps = 33/292 (11%)
Query: 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLR-NNRL 118
I+ + GE + VY + +++ +A+K + +FL E + + L +
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 119 TNLLGCCCEGDERLLVAEYMPNETLAKHL-FHWETHPMKWAMRLRVVLHLAQALEYCTSK 177
L + LV EY+ +L L P+ + L ++ + ALEY SK
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 178 GRALYHDLNAYRILFDEDGN-PRLSTFGLMKNSRDGKSYSTN----------LAFTPPEY 226
G ++ D+ IL D DG +L FGL K D S S+ + PE
Sbjct: 121 G-IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 227 LR---TGRVTPESVIYSFGTLLLDLLSGKH--------IPPSHALDLIRDRNLQMLTDSC 275
L + S I+S G L +LL+G S L +I + L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISPL 327
+ L + L +P+ R + S + L + S L
Sbjct: 240 SP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDL--SHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-15
Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 21/251 (8%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V+KG L+++ +AVK + + +FL EAR + Q + + L+G C + +V
Sbjct: 11 VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E +P L + +K ++ L A + Y SK ++ DL A L E
Sbjct: 71 MELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGE 128
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ ++S FG+ + DG S+ L +T PE L GR + ES ++S+G LL +
Sbjct: 129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188
Query: 250 SGKHIP-PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
S P P R++ + SC Q DD + ++ RC Y+P RP
Sbjct: 189 SLGVCPYPGMTNQQAREQVEKGYRMSC--PQKCPDD---VYKVMQRCWDYKPENRPK--- 240
Query: 309 LVTALSPLQKE 319
S LQKE
Sbjct: 241 ----FSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 23/257 (8%)
Query: 69 GEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
GE V +G+ Q+ +AVK N + FLEE + +L + L LLG
Sbjct: 15 GEGEFGAVLQGEYTGQK-VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH- 70
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
+ +V E M L L + L+ L +A+ +EY SK + ++ DL A
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAAR 129
Query: 189 RILFDEDGNPRLSTFGLMK-NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
IL EDG ++S FGL + S + + +T PE L+ + + +S ++S+G LL +
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
Query: 248 LLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE----LVRLASRCLQYEPRE 302
+ S G+ P +L +++ C+E + + + L + C + EP++
Sbjct: 190 VFSYGRAPYPKMSLKEVKE---------CVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 303 RPNPKSLVTALSPLQKE 319
RP+ L L+KE
Sbjct: 241 RPSFHKLR---EKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLL 122
+ E G VV+ GK + +A+K M+ D F+EEA+ + +L + L L
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLVQLY 65
Query: 123 GCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRA 180
G C + +V EYM N L +L K L + + +A+EY S G
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG-F 121
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPE 235
++ DL A L ED ++S FGL + D + S+ + + PPE R + +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD---GTELVRLA 292
S ++SFG L+ ++ S +P R N +++ +S G TE+ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYE------RFSNSEVV-ESVSAGYRLYRPKLAPTEVYTIM 234
Query: 293 SRCLQYEPRERPNPKSLVTAL 313
C +P +RP K L++ L
Sbjct: 235 YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 26/241 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++A+K + + P FL EA + QL++ RL L + + ++
Sbjct: 22 VWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIIT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM N +L L E + + + +A+ + + K ++ DL A IL E
Sbjct: 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSET 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE + G T +S ++SFG LL ++
Sbjct: 139 LCCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEI 196
Query: 249 LSGKHIP-PSHA-LDLIR--DRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++ IP P ++I+ +R +M D+C E EL L C + +P ER
Sbjct: 197 VTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE---------ELYELMRLCWKEKPEER 247
Query: 304 P 304
P
Sbjct: 248 P 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 77 YKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-LVA 135
Y+G ++AVK A + FL EA + QLR++ L LLG E L +V
Sbjct: 27 YRGN-----KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L +L + L+ L + +A+EY + ++ DL A +L ED
Sbjct: 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSED 138
Query: 196 GNPRLSTFGLMKNSRDGKSYST-NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254
++S FGL K + + + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 255 P 255
P
Sbjct: 199 P 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 21/223 (9%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL-FHWETHPMKWAMRL 161
F E A + QL + L G C GDE ++V EY+ +L +L + + W +L
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST--- 217
V LA AL + KG L H ++ A +L + + + +K S G S +
Sbjct: 104 EVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161
Query: 218 -----NLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML 271
+ + PPE + + ++ + +SFGT L ++ SG P S ALD + LQ
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS-ALD--SQKKLQFY 218
Query: 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
D Q TEL L ++C+ YEP RP+ ++++ L+
Sbjct: 219 ED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 67/266 (25%), Positives = 108/266 (40%), Gaps = 39/266 (14%)
Query: 76 VYKGKLENQR-----RIAVKRFNRMAWPDPRQFLEEARSVGQLRN---NRLTNLLGCCCE 127
V + + ++AVK N R E R + LR + G C +
Sbjct: 20 VELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE--REIEILRTLDHENIVKYKGVCEK 77
Query: 128 GDER--LLVAEYMPNETLAKHL-FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184
R L+ EY+P+ +L +L H + +K L + + ++Y S+ R ++ D
Sbjct: 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQ-RYIHRD 134
Query: 185 LNAYRILFDEDGNPRLSTFGLMK--NSRDGKSYSTNLAFTP-----PEYLRTGRVTPESV 237
L A IL + + ++S FGL K Y +P PE LRT + + S
Sbjct: 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASD 194
Query: 238 IYSFGTLLLDLLS-GKH--IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR---- 290
++SFG L +L + G PP+ L +I QM+ LE +G L R
Sbjct: 195 VWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE---LLKEGERLPRPPSC 251
Query: 291 ------LASRCLQYEPRERPNPKSLV 310
L C + EP++RP+ L+
Sbjct: 252 PDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 8/186 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK Q +A+K + + +F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM N L +L + L + + + + Y SK + ++ DL A L D+
Sbjct: 78 TEYMSNGCLLNYLREHGKRFQP-SQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDD 135
Query: 195 DGNPRLSTFGLMKNSRDGKSYST-----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G ++S FGL + D + S+ + ++PPE L + + +S +++FG L+ ++
Sbjct: 136 QGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195
Query: 250 SGKHIP 255
S +P
Sbjct: 196 SLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 21/245 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VYK + + +A+K + + + E + + + ++ + G + DE +
Sbjct: 15 EVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74
Query: 134 VAEYMPNETLAKHL-FHWETHPMKW-AMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
V E+ +L L +T A + +L + LEY S G ++ D+ A IL
Sbjct: 75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELL---KGLEYLHSNGI-IHRDIKAANIL 130
Query: 192 FDEDGNPRLSTFGL---MKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
DG +L FGL + +++ + + PE + ++ I+S G ++L
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG----TELVRLASRCLQYEPRERP 304
GK PP +L + L + G + E +CLQ P +RP
Sbjct: 191 AEGK--PPYS--ELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
Query: 305 NPKSL 309
+ L
Sbjct: 244 TAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGC 124
V E G +V+ G +R++A+K R F+EEA+ + +L + +L L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 125 CCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALY 182
C E LV E+M + L+ +L K++ L + L + + + Y S ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN-VIH 123
Query: 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESV 237
DL A L E+ ++S FG+ + D + S+ + ++ PE + + +S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 238 IYSFGTLLLDLLSGKHIP 255
++SFG L+ ++ S P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 32/255 (12%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV+ GK Q ++A+K N A + F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E+M N L +L + K M L + + + +EY ++ DL A L
Sbjct: 78 TEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEYLERNS-FIHRDLAARNCLVSS 135
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G ++S FG+ + D + S++ A ++PPE + + +S ++SFG L+ ++
Sbjct: 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR--LAS--------RCLQYE 299
+ +P + N +++ G L R LAS C +
Sbjct: 196 TEGKMP------FEKKSNYEVVEMI--------SRGFRLYRPKLASMTVYEVMYSCWHEK 241
Query: 300 PRERPNPKSLVTALS 314
P RP L+ A++
Sbjct: 242 PEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 25/241 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++AVK + P FL+EA+ + +LR+++L L C E + +V
Sbjct: 22 VWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L E ++ + + +A+ + Y S+ ++ DL A IL E+
Sbjct: 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGEN 139
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE GR T +S ++SFG LL ++
Sbjct: 140 LVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
Query: 249 LSGKHIP-PS-HALDLIR--DRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++ +P P +++ +R +M +C E EL L +C +P ER
Sbjct: 198 VTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPE---------ELYDLMLQCWDKDPEER 248
Query: 304 P 304
P
Sbjct: 249 P 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 24/247 (9%)
Query: 87 IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDER--LLVAEYMPNETL 143
+AVK R + +E + L + + GCC E + L+ EY+P +L
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203
+L H + A L + + + Y S+ ++ DL A +L D D ++ F
Sbjct: 96 RDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDF 151
Query: 204 GLMKNSRDGKSY-------STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS---GKH 253
GL K +G Y + + + E L+ + + S ++SFG L +LL+ K
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
Query: 254 IPPSHALDLIRDRNLQM----LTDSCLEGQ---FTDDDGTELVRLASRCLQYEPRERPNP 306
PP ++I + QM L + G + E+ L C + E + RP
Sbjct: 212 SPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271
Query: 307 KSLVTAL 313
+SL+ L
Sbjct: 272 RSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 21/249 (8%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V++G +N+ R+A+K + F +E +++ +LR+ L +L C G+ ++
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
E M +L L E + A + + +A+ + Y + +++ DL A IL ED
Sbjct: 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGED 140
Query: 196 GNPRLSTFGLMKNSRDG--KSYSTNLAF--TPPEYLRTGRVTPESVIYSFGTLLLDLLSG 251
+++ FGL + ++ S + + T PE G + +S ++SFG LL ++ +
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 252 KHIP-----PSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+P D I +M C + E+ ++ C EP +RP+
Sbjct: 201 GQVPYPGMNNHEVYDQI-TAGYRMPCPAKCPQ---------EIYKIMLECWAAEPEDRPS 250
Query: 306 PKSLVTALS 314
K+L L
Sbjct: 251 FKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 64 IVSEHGEKAPNVVYKGKLENQRR------IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNN 116
+ E GE A V+ G+ + +AVK A D R+ F EA + ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHL------------FHWETHPMKWAMRLRVV 164
+ G C EGD ++V EYM + L K L + + L++
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------ 218
+ +A + Y S+ ++ DL L D ++ FG+ SRD Y+T+
Sbjct: 129 VQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIGDFGM---SRD--VYTTDYYRVGG 182
Query: 219 -----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GK 252
+ + PPE + + T ES ++SFG +L ++ + GK
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 5e-11
Identities = 55/182 (30%), Positives = 77/182 (42%), Gaps = 18/182 (9%)
Query: 129 DERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+E+L LV EY P L HL + A + ALEY S G +Y DL
Sbjct: 65 EEKLYLVLEYAPGGELFSHLSKEGRFSEERA--RFYAAEIVLALEYLHSLG-IIYRDLKP 121
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL D DG+ +L+ FGL K S + TP PE L +S G
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ--FTDDDGTELVRLASRCLQYEPR 301
LL ++L+GK PP +A + + + + L+ F + E L S LQ +P
Sbjct: 182 LLYEMLTGK--PPFYA------EDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233
Query: 302 ER 303
+R
Sbjct: 234 KR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 52/284 (18%)
Query: 67 EHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLT 119
E GE A VYKG+L + +A+K A P +Q F +EA + L++ +
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETH--------------PMKWAMRLRVVL 165
LLG C + ++ EY+ + L + L H + + L + +
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 166 HLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------- 218
+A +EY +S ++ DL A L E ++S FGL SRD YS +
Sbjct: 132 QIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISDFGL---SRDI--YSADYYRVQSK 185
Query: 219 ----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQ 269
+ + PPE + G+ T ES I+SFG +L ++ S P +++IR R L
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL 245
Query: 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+ C + L C P RP K + T L
Sbjct: 246 PCPEDC---------PARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 36/273 (13%)
Query: 67 EHGEKAPNVVYKG------KLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLT 119
E G+ + +VY+G K E + R+A+K N A R +FL EA + + + +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHL----AQAL 171
LLG +G L++ E M L +L E +P++ L+ ++ + A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN------SRDGKSYSTNLAFTPPE 225
Y + + ++ DL A + ED ++ FG+ ++ R G + + PE
Sbjct: 133 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191
Query: 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQF 280
L+ G T S ++SFG +L ++ + P L + + L D+C + F
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF 251
Query: 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
EL+R+ C QY P+ RP+ +++++
Sbjct: 252 ------ELMRM---CWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 36/277 (12%)
Query: 63 NIVSEHGEKAPNVVYKG------KLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRN 115
++ E G+ + +VY+G K E + R+AVK N A R +FL EA +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 116 NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHL---- 167
+ + LLG +G L+V E M + L +L E +P + L+ ++ +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 168 AQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN------SRDGKSYSTNLAF 221
A + Y +K + ++ DL A + D ++ FG+ ++ R G + +
Sbjct: 129 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCL 276
PE L+ G T S ++SFG +L ++ S P L + D D+C
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 247
Query: 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
E + L C Q+ P+ RP +V L
Sbjct: 248 E---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 11/187 (5%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V++G N +AVK + DP+ FL EA+ + +LR+ +L L C + +V
Sbjct: 22 VWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
E M +L ++L +K + + +A + Y ++ ++ DL A +L E+
Sbjct: 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGEN 139
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE R + +S ++SFG LL ++
Sbjct: 140 NICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
Query: 249 LSGKHIP 255
++ +P
Sbjct: 198 VTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 26/241 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++A+K + P FL+EA+ + +LR+++L L E + +V
Sbjct: 22 VWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
E+M +L L + +K + + +A + Y + ++ DL A IL ++
Sbjct: 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY-IERMNYIHRDLRAANILVGDN 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R G + + +T PE GR T +S ++SFG LL +L
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++ +P L+ + +R +M C +G + EL++L C + +P ER
Sbjct: 197 VTKGRVPYPGMVNREVLEQV-ERGYRM---PCPQG--CPESLHELMKL---CWKKDPDER 247
Query: 304 P 304
P
Sbjct: 248 P 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 69/278 (24%), Positives = 127/278 (45%), Gaps = 36/278 (12%)
Query: 62 ENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
EN++S + A YKGK ++N + VK N + + + +G+L++ +
Sbjct: 695 ENVISRGKKGAS---YKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVK 747
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY--CTSKG 178
L+G C L+ EY+ + L++ L + W R ++ + +A+AL + C
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 179 RALYHDLNAYRILFDEDGNPRL--STFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPES 236
+ +L+ +I+ D P L S GL+ D K + ++ A+ PE T +T +S
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLRLSLPGLL--CTDTKCFISS-AYVAPETRETKDITEKS 859
Query: 237 VIYSFGTLLLDLLSGKHIPPSHA--------LDLIR----DRNLQMLTDSCLEGQFT--D 282
IY FG +L++LL+GK P+ A ++ R D +L M D + G +
Sbjct: 860 DIYGFGLILIELLTGKS--PADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
++ E++ LA C +P RP ++ L + +
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 18/237 (7%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++AVK + P FLEEA+ + +LR+++L L E + +V
Sbjct: 22 VWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L E +K + + +A + Y + ++ DL + IL +
Sbjct: 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY-IERMNYIHRDLRSANILVGDG 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R G + + +T PE GR T +S ++SFG LL +L
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 249 LSGKHIP-PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
++ +P P + +R + + D L L +C + +P ERP
Sbjct: 197 VTKGRVPYPG-----MNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 28/242 (11%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G R+A+K + P FL+EA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L ++ + + +A + Y + ++ DL A IL E+
Sbjct: 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGEN 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R G + + +T PE GR T +S ++SFG LL +L
Sbjct: 139 LVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLTDS-CLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ +P LD + +R +M C E L L +C + EP E
Sbjct: 197 TTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE---------SLHDLMCQCWRKEPEE 246
Query: 303 RP 304
RP
Sbjct: 247 RP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 44/160 (27%), Positives = 63/160 (39%), Gaps = 19/160 (11%)
Query: 161 LRVVLHLAQALEYC----TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS 216
R++ L AL C L+ DL I D + N +L FGL K S++
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 217 TNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272
TP PE L +S I+S G L+ +L + PP A RN L
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS--PPFTA------RNQLQLA 219
Query: 273 DSCLEGQFTDDDG---TELVRLASRCLQYEPRERPNPKSL 309
EG+F +EL + L +P +RP+ + L
Sbjct: 220 SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 48/284 (16%)
Query: 64 IVSEHGEKAPNVVYKGKLEN------QRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNN 116
++ E G+ + +VY+G + + R+A+K N + + +FL EA + + +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT- 175
+ LLG G L+V E M L +L P L + ++
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 176 -SKGRALYH-------DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------- 218
+ G A DL A + ED ++ FG+ +RD Y T+
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM---TRD--IYETDYYRKGGKGL 182
Query: 219 --LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP---PSH--ALDLIRDRNLQML 271
+ + PE L+ G T +S ++SFG +L ++ + P S+ L + D L
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242
Query: 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315
++C + +L+ L C QY P+ RP +V++L
Sbjct: 243 PENCPD---------KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 55/252 (21%), Positives = 108/252 (42%), Gaps = 19/252 (7%)
Query: 69 GEKAPNVVYKGKLENQRRI-AVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC 125
G+ + VV+K + +R+ A+K+ + +M + + ++EAR + +L ++ +
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68
Query: 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185
+ + +V EY N L K L P+ R + + L + SK + L+ D+
Sbjct: 69 LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDI 127
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSF 241
+ + D N ++ G+ K D +++ + TP PE +S +++
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187
Query: 242 GTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG---TELVRLASRCLQY 298
G +L + +GKH P A N L + G F +L +L +CL
Sbjct: 188 GVVLYECCTGKH--PFDA------NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239
Query: 299 EPRERPNPKSLV 310
+ R+RP+ L+
Sbjct: 240 DYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 66/279 (23%), Positives = 103/279 (36%), Gaps = 53/279 (18%)
Query: 63 NIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTN 120
++ G A VVY L N ++A+KR + + +E +++ Q + +
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRV--------VLH-LAQAL 171
GDE LV Y+ +L MK + VL + + L
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLL--------DIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG----LMKNSRDGKSYSTNLAFTP---- 223
EY S G+ ++ D+ A IL EDG+ +++ FG L + TP
Sbjct: 116 EYLHSNGQ-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 224 PEYLRTGRVTPESV-IYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLT----DS 274
PE + I+SFG ++L +G PP L MLT
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL---------MLTLQNDPP 225
Query: 275 CLEGQFTDDD----GTELVRLASRCLQYEPRERPNPKSL 309
LE T D ++ S CLQ +P +RP + L
Sbjct: 226 SLE---TGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 59/275 (21%), Positives = 108/275 (39%), Gaps = 37/275 (13%)
Query: 69 GEKAPNVVYKGKLE----NQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122
GE V +G+L +Q ++AVK + + + + +FL EA + + + L+
Sbjct: 8 GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLI 67
Query: 123 GCCCEGDER------LLVAEYMPNETLAKHLFH--WETHPMKWA--MRLRVVLHLAQALE 172
G C E +++ +M + L L + P K L+ ++ +A +E
Sbjct: 68 GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127
Query: 173 YCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPP------EY 226
Y +++ ++ DL A + ED ++ FGL K G Y P E
Sbjct: 128 YLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 227 LRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFT 281
L T +S +++FG + ++ + P D +R N + CL+
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD---- 242
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
EL L C + +P++RP L L +
Sbjct: 243 -----ELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G N ++AVK + + FLEEA + L++++L L + + ++
Sbjct: 22 VWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L E + + +A+ + Y K ++ DL A +L E
Sbjct: 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY-IHRDLRAANVLVSES 139
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE + G T +S ++SFG LL ++
Sbjct: 140 LMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLYEI 197
Query: 249 LSGKHIP 255
++ IP
Sbjct: 198 VTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 75 VVYKGKL--ENQRRI--AVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY G L + ++I AVK NR+ + QFL+E + + + +LLG C +
Sbjct: 10 CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE 69
Query: 130 -ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L+V YM + L ++ ETH + L +A+ +EY SK + ++ DL A
Sbjct: 70 GSPLVVLPYMKHGDL-RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAAR 127
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------LAFTPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + YS + + + E L+T + T +S ++S
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187
Query: 241 FGTLLLDLLSGKHIPPSHALD-------LIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
FG LL +L++ + PP +D L++ R L L+ ++ D L +
Sbjct: 188 FGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRL-------LQPEYCPD---PLYEVML 236
Query: 294 RCLQYEPRERPNPKSLVTALS 314
C +P RP LV+ +
Sbjct: 237 SCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 27/246 (10%)
Query: 76 VYKGKLENQ-RRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC--EGDE 130
VY ++ +AVK + + + E R + L++ + G E +
Sbjct: 16 VYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT 75
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLA----QALEYCTSKGRALYH-DL 185
+ EY+ +L+ L + V+ + L Y S G H D+
Sbjct: 76 LNIFLEYVSGGSLSSLL------KKFGKLPEPVIRKYTRQILEGLAYLHSNGIV--HRDI 127
Query: 186 NAYRILFDEDGNPRLSTFGLMK--NSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIY 239
IL D DG +L+ FG K + + ++ TP PE +R + I+
Sbjct: 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
S G ++++ +GK P S + + L + S + + E +CL+ +
Sbjct: 188 SLGCTVIEMATGKP-PWSELGNPM--AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244
Query: 300 PRERPN 305
P++RP
Sbjct: 245 PKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 26/225 (11%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLR 162
F E A + QL + L L G C DE ++V EY+ L L H E + + +L
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLHWKLD 105
Query: 163 VVLHLAQALEYCTSK--------GRALY---HDLNAYRILFDEDGNPRLSTFGLMKNSRD 211
V LA AL Y K G+ + + LN + F + +P + L + R
Sbjct: 106 VAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165
Query: 212 GKSYSTNLAFTPPEYLRTGRVTPESV--IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ 269
+ + PE +R G+ + +SFGT LL++ S P S L +
Sbjct: 166 ERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS---TLSSSEKER 217
Query: 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
D + D EL L ++C Y+P +RP+ ++++ L+
Sbjct: 218 FYQDQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 61/261 (23%), Positives = 106/261 (40%), Gaps = 42/261 (16%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146
+AVK + + F EA + L++ + G C EGD ++V EYM + L K
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 147 L--------FHWETHP---MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
L E + + + L + +A + Y S+ ++ DL L E+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGEN 156
Query: 196 GNPRLSTFGLMKNSRDGKSYSTN-----------LAFTPPEYLRTGRVTPESVIYSFGTL 244
++ FG+ SRD YST+ + + PPE + + T ES ++S G +
Sbjct: 157 LLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211
Query: 245 LLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
L ++ + GK + + ++ I + +C + E+ L C Q E
Sbjct: 212 LWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK---------EVYDLMLGCWQRE 262
Query: 300 PRERPNPKSLVTALSPLQKET 320
P R N K + + L L K +
Sbjct: 263 PHMRLNIKEIHSLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 61/264 (23%), Positives = 115/264 (43%), Gaps = 28/264 (10%)
Query: 67 EHGEKAPNVVYKGKLENQRR----IAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNL 121
E GE V +G+L+ + +A+K + R FL EA +GQ + + L
Sbjct: 16 EFGE-----VCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
G + +++ EYM N +L K L + + ++ +A ++Y + +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMN-YV 128
Query: 182 YHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-YSTN-----LAFTPPEYLRTGRVTPE 235
+ DL A IL + + ++S FGL + D ++ Y+T + +T PE + + T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA 188
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG---QFTDDDGTELVRLA 292
S ++SFG ++ +++S P D + Q + + +G D + L +L
Sbjct: 189 SDVWSFGIVMWEVMSYGERP-------YWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLM 241
Query: 293 SRCLQYEPRERPNPKSLVTALSPL 316
C Q + ERP +V+ L +
Sbjct: 242 LDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 48/284 (16%)
Query: 65 VSEHGEKAPNVVYKGKL-----ENQRRIAVKRF----NRMAWPDPRQFLEEARSVGQLRN 115
+ E GE A +YKG L ++ + +A+K N W + F +EA + +L +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---FQQEASLMAELHH 66
Query: 116 NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHP-----------MKWAMR---- 160
+ LLG + ++ EY+ L + L H +K ++
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-- 218
L + + +A +EY +S ++ DL A IL E + ++S GL + Y
Sbjct: 127 LHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 219 ----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQ 269
+ + PPE + G+ + +S I+SFG +L ++ S P ++++R R L
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL 245
Query: 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
++ C ++ L + C Q P RP K + T L
Sbjct: 246 PCSEDCPPRMYS---------LMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
R FL EA ++GQ ++ + L G G+ ++V EYM N L L E + A +
Sbjct: 51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV--AGQ 108
Query: 161 LRVVLH-LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN- 218
L +L LA ++Y + G ++ L A+++L + D ++S F ++ + Y+T
Sbjct: 109 LMGMLPGLASGMKYLSEMG-YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS 167
Query: 219 ----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
+ + PE ++ + S ++SFG ++ +++S
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 3e-08
Identities = 53/230 (23%), Positives = 101/230 (43%), Gaps = 11/230 (4%)
Query: 85 RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144
+ +A+K+ N P + E + +L+N + N L GDE +V EY+ +L
Sbjct: 45 QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104
Query: 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204
+ + A R L QALE+ + + ++ D+ + +L DG+ +L+ FG
Sbjct: 105 DVVTETCMDEAQIAAVCRECL---QALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFG 160
Query: 205 LMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260
+S + + TP PE + P+ I+S G + ++++ G+ PP
Sbjct: 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--PPYLNE 218
Query: 261 DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+ +R L + T+ E Q + +RCL+ + +R + K L+
Sbjct: 219 NPLRALYL-IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-08
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 12/247 (4%)
Query: 69 GEKAPNVVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + + A R L QALE+ S + ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSN-QVIHRDIKS 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ ++++ G+ PP + +R L + T+ E Q + +RCL + +R
Sbjct: 205 MAIEMIEGE--PPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 304 PNPKSLV 310
+ K L+
Sbjct: 262 GSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 12/247 (4%)
Query: 69 GEKAPNVVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+K+ N P + E + + +N + N L
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 87
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + + A R L QAL++ S + ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSN-QVIHRDIKS 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ ++++ G+ PP + +R L + T+ E Q + +RCL+ + R
Sbjct: 204 MAIEMVEGE--PPYLNENPLRALYL-IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 304 PNPKSLV 310
+ K L+
Sbjct: 261 GSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 31/228 (13%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDER------LLVAEYMPNETLAKHLFHWETHP-- 154
FL EA + + + + L+G C + E +++ +M + L L +
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106
Query: 155 --MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212
+ M ++ + +A +EY +SK ++ DL A + +E+ N ++ FGL K +G
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
Query: 213 KSYSTNLAFTPP------EYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALD 261
Y P E L T +S ++SFG + ++ + P S D
Sbjct: 166 DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
Query: 262 LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+R N CL+G L L S C P++RP+ ++L
Sbjct: 226 YLRQGNRLKQPPDCLDG---------LYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 51/236 (21%), Positives = 103/236 (43%), Gaps = 13/236 (5%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146
+AVK +FL+EA + ++++ L LLG C ++ E+M L +
Sbjct: 34 VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 147 LFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206
L + + L + ++ A+EY K ++ DL A L E+ +++ FGL
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLS 151
Query: 207 KNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260
+ G +Y+ + + +T PE L + + +S +++FG LL ++ + + P +
Sbjct: 152 RLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 209
Query: 261 DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
DL + L + + + ++ L C Q+ P +RP+ + A +
Sbjct: 210 DL---SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 52/223 (23%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLR 162
FL EA + L++++L L + + ++ E+M +L L E +
Sbjct: 48 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-------NSRDGKSY 215
+A+ + + + ++ DL A IL +++ FGL + +R+G +
Sbjct: 107 FSAQIAEGMAF-IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 165
Query: 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-PSHA-LDLIR--DRNLQM- 270
+ +T PE + G T +S ++SFG LL+++++ IP P + ++IR +R +M
Sbjct: 166 P--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
++C E EL + RC + P ERP + + + L
Sbjct: 224 RPENCPE---------ELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 52/264 (19%), Positives = 103/264 (39%), Gaps = 44/264 (16%)
Query: 87 IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL-- 143
+AVK A + R L E + Q+ + + L G C + LL+ EY +L
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 144 --------------------AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
+ +L + + + + +++ ++Y ++ + ++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQY-LAEMKLVHR 151
Query: 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESV 237
DL A +L E ++S FGL ++ + SY + + E L T +S
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211
Query: 238 IYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
++SFG LL ++++ G + I P +L++ ++C E E+ L
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSE---------EMYNLM 262
Query: 293 SRCLQYEPRERPNPKSLVTALSPL 316
C + EP +RP + L +
Sbjct: 263 LTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 50/225 (22%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 108 RSVGQLRNNRLTNLL---GCCCEGDER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLR 162
+ + LRN N++ G C E L+ E++P+ +L ++L + + +L+
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLK 113
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST----- 217
+ + + ++Y S+ + ++ DL A +L + + ++ FGL K K Y T
Sbjct: 114 YAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 218 --NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS---GKHIPPSHALDLIRDRNLQM-- 270
+ + PE L + S ++SFG L +LL+ + P + L +I + QM
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232
Query: 271 --LTDSCLEGQ---FTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
L EG+ + E+ +L +C +++P +R ++L+
Sbjct: 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 64/264 (24%), Positives = 103/264 (39%), Gaps = 45/264 (17%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146
+AVK + F EA + L++ + G C +GD ++V EYM + L K
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 147 LFHWETHPM----------KWAMRLRVVLH----LAQALEYCTSKGRALYHDLNAYRILF 192
L M K + L +LH +A + Y S+ ++ DL L
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLV 156
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTN-----------LAFTPPEYLRTGRVTPESVIYSF 241
G L G SRD YST+ + + PPE + + T ES ++SF
Sbjct: 157 ---GANLLVKIGDFGMSRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 242 GTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296
G +L ++ + GK + + ++ I + C + E+ + C
Sbjct: 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK---------EVYDIMLGCW 262
Query: 297 QYEPRERPNPKSLVTALSPLQKET 320
Q EP++R N K + L L K T
Sbjct: 263 QREPQQRLNIKEIYKILHALGKAT 286
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 27/259 (10%)
Query: 76 VYKG---KLENQR-RIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY+G EN++ +AVK P R+ FL+EA + Q + + L+G E +
Sbjct: 22 VYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
+V E P L +L + + A + L+ AL Y SK R ++ D+ A +
Sbjct: 81 VWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNV 138
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP-----PEYLRTGRVTPESVIYSFGTLL 245
L +L FGL + D Y + P PE + R T S ++ FG +
Sbjct: 139 LVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198
Query: 246 LDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
++L G + + + I + + +C L L ++C Y+P
Sbjct: 199 WEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC---------PPTLYSLMTKCWAYDP 249
Query: 301 RERPNPKSLVTALSPLQKE 319
+RP L LS + +E
Sbjct: 250 SKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-07
Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 23/245 (9%)
Query: 76 VYKGKLENQRR--IAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCEGDERL 132
VYKG ++N+ + +A+K + D + +++ +V Q + +T G +G +
Sbjct: 20 VYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY+ + L + P++ ++ + + L+Y S+ R ++ D+ A +L
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLL 134
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E G+ +L+ FG+ D + TP PE ++ ++ I+S G ++L
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
Query: 249 LSGKHIPPSHALDLIRDRNLQML---TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
G+ PP+ DL R L ++ + LEGQ++ CL +PR RP
Sbjct: 195 AKGE--PPNS--DLHPMRVLFLIPKNSPPTLEGQYS----KPFKEFVEACLNKDPRFRPT 246
Query: 306 PKSLV 310
K L+
Sbjct: 247 AKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 31/250 (12%)
Query: 75 VVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARS----VGQLRNNRLTNLLGCCCEGD 129
VVYKG LE +A+K+ + + L+ + L++ + +G D
Sbjct: 15 VVYKGLNLETGDFVAIKQISLEK--IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD 72
Query: 130 ERLLVAEYMPNETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
++ EY N +L + + + P A+ + VL Q L Y +G ++ D+ A
Sbjct: 73 SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLAYLHEQG-VIHRDIKAA 128
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTL 244
IL +DG +L+ FG+ D ++ TP PE + + S I+S G
Sbjct: 129 NILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCT 188
Query: 245 LLDLLSGKHIPPSHALDLIRDRN-----LQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+++LL+G PP + D N +++ D + EL +C Q +
Sbjct: 189 VIELLTGN--PPYY------DLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKD 238
Query: 300 PRERPNPKSL 309
P RP K L
Sbjct: 239 PNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 52/242 (21%), Positives = 94/242 (38%), Gaps = 26/242 (10%)
Query: 87 IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK D FL EA + + + + L+G E R ++ E M L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 146 HLFHWE---THPMKWAMR--LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR- 199
L P M+ L +A+ +Y ++ D+ A L G R
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRV 157
Query: 200 --LSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG 251
++ FG+ ++ Y + + PPE G T ++ ++SFG LL ++ S
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 252 KHIP-PSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRERPNPKS 308
++P P N +++ G+ G + R+ + C Q+ P +RPN +
Sbjct: 218 GYMPYPGR-------TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT 270
Query: 309 LV 310
++
Sbjct: 271 IL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 16/155 (10%)
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT 222
++ + LEY S + ++ D+ A IL +E+G +L+ FG+ D + + T
Sbjct: 104 ILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
Query: 223 P----PEYLRTGRVTPESVIYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDS 274
P PE ++ ++ I+S G +++ GK I P A+ +I ++ L+D
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP 222
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ E +CL +P ERP+ L
Sbjct: 223 -------EKWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 51/257 (19%)
Query: 87 IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK A + R FL+E + + +L++ + LLG C + D ++ EYM N L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 146 HLFH--------------WETHPM---KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L H + ++ L V L +A ++Y +S ++ DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRDLATR 167
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPP------EYLRTGRVTPESVIYSFG 242
L E+ +++ FG+ +N G Y P E + G+ T S +++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 243 TLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL---EGQFTDDDGTE------------ 287
L ++L L +++ LTD + G+F D G +
Sbjct: 228 VTLWEILM-----------LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQG 276
Query: 288 LVRLASRCLQYEPRERP 304
L L +C + RERP
Sbjct: 277 LYELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 19/200 (9%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCC 125
GE VVYK + +A+K+ + P+ L E + + +L + + LL
Sbjct: 8 GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF 67
Query: 126 CEGDERLLVAEYMPNETLAKHLFHWET----HPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
+ LV E+M + L K + + +K + L Q L +C S G L
Sbjct: 68 RHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL-----YQLLQGLAFCHSHG-IL 120
Query: 182 YHDLNAYRILFDEDGNPRLSTFGLMKNSR-DGKSYSTNLA---FTPPEYLRTGRVTPESV 237
+ DL +L + +G +L+ FGL ++ + Y+ + + PE L + V
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 238 -IYSFGTLLLDLLSGKHIPP 256
I+S G + +LLS + + P
Sbjct: 181 DIWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V E++ L + H + + A V L + +AL ++G ++ D+ +
Sbjct: 89 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQG-VIHRDIKS 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + PE I+S G
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 244 LLLDLLSGK----HIPPSHALDLIRD 265
++++++ G+ + PP A+ +IRD
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIRD 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 37/235 (15%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL---------FHWET-- 152
+E + +G+ +N + NLLG C + ++ EY L ++L + ++
Sbjct: 71 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 153 ---HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-- 207
M + + +A+ +EY S+ + ++ DL A +L E+ +++ FGL +
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 208 NSRDGKSYSTN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGK---HIPPSH 258
N+ D +TN + + PE L T +S ++SFG L+ ++ L G IP
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 259 ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L+++ + +C EL + C P RP K LV L
Sbjct: 248 LFKLLKEGHRMDKPANCT---------NELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 16/224 (7%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF-------HWETHPM 155
F E +L + + LLG C E + ++ EY L + L + P+
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 156 KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215
++ + +A +++ S R ++ DL A L ++S L K+ + + Y
Sbjct: 115 STKQKVALCTQIALGMDH-LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 216 STN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM 270
L + PE ++ + +S ++SFG L+ ++ + +P L + L
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY---GLSDEEVLNR 230
Query: 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
L LE + + L +L +RC P++RP+ LV+AL
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 53/235 (22%), Positives = 97/235 (41%), Gaps = 37/235 (15%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--- 160
+E + +G+ +N + NLLG C + ++ EY L ++L M ++
Sbjct: 68 MEMMKMIGKHKN--IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 161 -----------LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209
+ +A+ +EY S+ + ++ DL A +L ED +++ FGL ++
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 210 RDGKSY--STN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-----KHIPPSH 258
+ Y +TN + + PE L T +S ++SFG LL ++ + IP
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 259 ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L+++ + +C EL + C P +RP K LV L
Sbjct: 245 LFKLLKEGHRMDKPANCTH---------ELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETH-PMKWAMRL 161
F E A + Q+ + L + G C G E ++V E++ + L L + P+ W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 162 RVVLHLAQALEYCTSK----GRALYHDLNAYRILFDEDGNP--RLSTFGLMKNSRDGKSY 215
V LA AL Y K G ++ R+ E +P +LS G+ + +
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 216 STNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQ 269
+ + PE + G ++ + +SFGT LL++ +P PS + ++ +
Sbjct: 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYEKKHR 239
Query: 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
+ SC EL L S+CL YEP +RP+ ++++ L+
Sbjct: 240 LPEPSC----------KELATLISQCLTYEPTQRPSFRTILRDLT 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 43/260 (16%)
Query: 76 VYKGKL-------ENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCE 127
VY+G R+AVK + A + +FL+EA + + + LLG C
Sbjct: 11 VYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT-----SKGRALY 182
+ + ++ E M L +L + L + L L+ + ++
Sbjct: 71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLDVAKGCVYLEQMHFIH 129
Query: 183 HDLNAYRILFDEDGNPR-----LSTFGLMKNSRDGKSYST------NLAFTPPEYLRTGR 231
DL A L E G + FGL ++ Y + + PE L G+
Sbjct: 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189
Query: 232 VTPESVIYSFGTLLLDLLSGKHIP-PSHALDLIRDRNLQMLTDSCLEGQF------TDDD 284
T +S ++SFG L+ ++L+ P P+ N ++L G+ D
Sbjct: 190 FTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTAGGRLQKPENCPDK- 241
Query: 285 GTELVRLASRCLQYEPRERP 304
+ +L + C +P ERP
Sbjct: 242 ---IYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF-HWETHPMKWAMRL 161
F E A + Q+ + + L G C E ++V E++ L LF H ++ + +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKF 108
Query: 162 RVVLHLAQALEYCTSK----GRALYHDLNAYRILFDEDGNP--RLSTFGLMKNSRDGKSY 215
+V LA AL Y K G ++ R D + P +LS G+ +
Sbjct: 109 KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC 168
Query: 216 STNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS 274
+ + PE + + + + +SFGT L ++ IP ++D+ L +
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP-------LKDKTLAE-KER 220
Query: 275 CLEGQF--TDDDGTELVRLASRCLQYEPRERP 304
EGQ EL L + C+ Y+P +RP
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 57/248 (22%), Positives = 105/248 (42%), Gaps = 12/248 (4%)
Query: 69 GEKAPNVVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+K+ N P + E + + ++ + N L
Sbjct: 28 GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV 87
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + + A R L QALE+ S ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ ++++ G+ PP + +R L + T+ E Q + +RCL+ + +R
Sbjct: 204 MAIEMVEGE--PPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
Query: 304 PNPKSLVT 311
+ K L+
Sbjct: 261 GSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 23/198 (11%)
Query: 67 EHGEKAPNVVYKGKLENQRR----IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNL 121
E GE V++G L+ R +A+K RQ FL EA +GQ ++ + L
Sbjct: 17 EFGE-----VFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 122 LGCCCEGDERLLVAEYMPNETLAKHL--FHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
G + +++ EYM N L K+L E + LR +A ++Y S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKY-LSDMN 127
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--SYSTN-----LAFTPPEYLRTGRV 232
++ DL A IL + + ++S FGL + D +Y+T+ + +T PE + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 233 TPESVIYSFGTLLLDLLS 250
T S ++SFG ++ +++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 37/235 (15%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--- 160
+E + +G+ +N + NLLG C + ++ EY L ++L M++
Sbjct: 74 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 161 -----------LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209
+ +A+ +EY SK + ++ DL A +L ED +++ FGL ++
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 210 RDGKSY--STN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGKHIPPSHALD 261
Y +TN + + PE L T +S ++SFG LL ++ L G P +
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 262 LIRDRNLQMLTDSCLEGQFTDDDGT---ELVRLASRCLQYEPRERPNPKSLVTAL 313
L + +L EG D EL + C P +RP K LV L
Sbjct: 251 LFK-----LLK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 31/197 (15%)
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V E++ L + H + + A VL +AL + ++G ++ D+ +
Sbjct: 88 GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL---KALSFLHAQG-VIHRDIKS 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + E I+S G
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 244 LLLDLLSGK----HIPPSHALDLIRD------RNLQMLTDSCLEGQFTDDDGTELVRLAS 293
++++++ G+ + PP A+ IRD +NL ++ L
Sbjct: 204 MVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVS-------------PRLRSFLD 250
Query: 294 RCLQYEPRERPNPKSLV 310
R L +P +R L+
Sbjct: 251 RMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 47/276 (17%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGD 129
+AP ++ E +AVK A D + F EA + + + + LLG C G
Sbjct: 25 RAPGLL---PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81
Query: 130 ERLLVAEYMPNETLAKHLFHWETH--------------------PMKWAMRLRVVLHLAQ 169
L+ EYM L + L H P+ +L + +A
Sbjct: 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141
Query: 170 ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTP 223
+ Y S+ + ++ DL L E+ +++ FGL +N Y + + + P
Sbjct: 142 GMAY-LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMP 200
Query: 224 PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD------LIRDRNLQMLTDSCLE 277
PE + R T ES ++++G +L ++ S + P + + +RD N+ D+C
Sbjct: 201 PESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAHEEVIYYVRDGNVLSCPDNC-- 257
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
EL L C P +RP+ S+ L
Sbjct: 258 -------PLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------ 218
+ +A + Y SK R ++ DL A IL D ++ FGLM+ + +
Sbjct: 104 VQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 219 -LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-----GKHIPPSHALDLIRDRNLQMLT 272
A+ PE LRT + S ++ FG L ++ + + S L I D+ + L
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DKEGERLE 221
Query: 273 --DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
++C + ++ + +C + P +RP +L L
Sbjct: 222 RPEACPQ---------DIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSYS--TNLAFT 222
LA AL++ S G +Y DL IL DE+G+ +L+ FGL K S D K+YS + +
Sbjct: 107 LALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 165
Query: 223 PPEYLRTGRVTPESVIYSFGTLLLDLLSG 251
PE + T + +SFG L+ ++L+G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 112 QLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQAL 171
+L++ + LG + D + EY+P ++A L ++ + V + + L
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE--TLVRNFVRQILKGL 119
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK----NSRDGK------SYSTNLAF 221
Y ++G ++ D+ IL D G ++S FG+ K NS K S ++ +
Sbjct: 120 NYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH 253
PE ++ T ++ I+S G L++++L+GKH
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 76 VYKGK-LENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER- 131
VYK + + +A+K+ P + E + + +LR+ + L +
Sbjct: 15 VYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74
Query: 132 -LLVAEYMPNE---TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+V EYM ++ L + +K M+ L + L+Y S G L+ D+
Sbjct: 75 IYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-----QLLEGLQYLHSNG-ILHRDIKG 128
Query: 188 YRILFDEDGNPRLSTFGLMK--NSRDGKSYSTNLAFT----PPEYLRTG--RVTPESVIY 239
IL + DG +L+ FGL + R+ Y TN T PPE L G R PE ++
Sbjct: 129 SNILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPELL-LGATRYGPEVDMW 186
Query: 240 SFGTLLLDLLSGKHIPP----SHALDLI 263
S G +L +L GK I L+ I
Sbjct: 187 SVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VY K + +AVK + ++FL EA + QL + + L+G C +G+ +LV
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLV 73
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLH-LAQALEYCTSKGRALYHDLNAYRILFD 193
E P L K+L + L+ + H +A + Y SK ++ DL A +L
Sbjct: 74 MELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLV 129
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFGTLLL 246
++S FG+ + G Y L + PE + G+ + +S ++S+G L
Sbjct: 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
Query: 247 DLLS 250
+ S
Sbjct: 190 EAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 35/225 (15%)
Query: 114 RNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL--------------FHWETHPMKWAM 159
++ + NLLG C + ++ EY L + L + +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 160 RLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--ST 217
+ +A+ +EY S+ R ++ DL A +L ED +++ FGL + D Y ++
Sbjct: 136 LVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 218 N----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGKH---IPPSHALDLIRDRNL 268
N + + PE L T +S ++SFG L+ ++ L G IP L+R+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+C EL L C P +RP K LV AL
Sbjct: 255 MDKPSNCTH---------ELYMLMRECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 58/253 (22%), Positives = 105/253 (41%), Gaps = 24/253 (9%)
Query: 79 GKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138
G L N R + F+ P+Q V Q R +R G +L + +
Sbjct: 97 GNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIE------AGQASVLFSRFQ 150
Query: 139 PNETLAKHLFH-----WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
P+ + + + W++ P+ + +A+ +E+ S+ + ++ DL A IL
Sbjct: 151 PSTSGSTNPPQETDDLWKS-PLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLS 208
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
E+ ++ FGL ++ Y L + PE + T +S ++SFG LL +
Sbjct: 209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 268
Query: 248 LLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306
+ S G P ++ + Q L D + ++ E+ R+ C Q +P+ERP
Sbjct: 269 IFSLGASPYPGVQIN---EEFCQRLKDGT-RMRAPENATPEIYRIMLACWQGDPKERPTF 324
Query: 307 KSLVTALSPLQKE 319
+LV L L +E
Sbjct: 325 SALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 21/240 (8%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
KA +Y K +++R+ ++ +MA + ++ LE+ S R L E +
Sbjct: 15 KATGKMYACKKLDKKRLKKRKGEQMALNE-KKILEKVSS-------RFIVSLAYAFETKD 66
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYHDLN 186
L LV M L H+++ A R + + AQ LE+ + R +Y DL
Sbjct: 67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEA---RAIFYAAQIICGLEHLHQR-RIVYRDLK 122
Query: 187 AYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 243
+L D+ GN R+S GL +K + K + + PE L+ ++ G
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGC 182
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
L ++++G P + + L+ T + ++ D E L LQ +P +R
Sbjct: 183 TLYEMIAG-RSPFRQRKEKVEKEELKRRTLE-MAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 118 LTNLLGCCCEGDERLL-VAEYMPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCT 175
LT+L C + E L V EY+ L +FH ++ H + L++
Sbjct: 58 LTHLY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 176 SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGR 231
SKG +Y DL IL D DG+ +++ FG+ K + G + + TP PE L +
Sbjct: 114 SKG-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 232 VTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
+SFG LL ++L G+ P H D
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ--SPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 37/235 (15%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM--------------PNETLAKHLFH 149
+E + +G+ +N + NLLG C + +V EY P E +
Sbjct: 66 MEMMKMIGKHKN--IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 150 WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209
+ + +A+ +E+ SK + ++ DL A +L ED +++ FGL ++
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 210 RDGKSY--STN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGKHIP--PSHA 259
Y +TN + + PE L T +S ++SFG LL ++ L G P P
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 260 L-DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L L+++ +C + EL L C P +RP K LV L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQ---------ELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 44/250 (17%)
Query: 87 IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK R FL+E + + +L+N + LLG C D ++ EYM N L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 146 HLFHWETHP----------MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
L E + A L + + +A ++Y S ++ DL L
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGNH 165
Query: 196 GNPRLSTFGLMKNSRDGKSYSTNLAFTPP------EYLRTGRVTPESVIYSFGTLLLDLL 249
+++ FG+ +N G Y P E + G+ T S +++FG L ++
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCL---EGQFTDDDGTE------------LVRLASR 294
+ L +++ +L+D + G+F + G + + +L R
Sbjct: 226 T-----------LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR 274
Query: 295 CLQYEPRERP 304
C + ++RP
Sbjct: 275 CWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 58/286 (20%)
Query: 67 EHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
E GE A V+ + N + +AVK + + F EA + L++ +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETH----------------PMKWAMRLRVV 164
G C EG L+V EYM + L + L +H + L +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFL---RSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------ 218
+A + Y S ++ DL L + ++ FG+ SRD YST+
Sbjct: 129 SQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKIGDFGM---SRD--IYSTDYYRVGG 182
Query: 219 -----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GK----HIPPSHALDLI-RDRN 267
+ + PPE + + T ES I+SFG +L ++ + GK + + A++ I + R
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242
Query: 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L+ +C E+ + C Q EP++R K + + L
Sbjct: 243 LER-PRTC---------PPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 25/246 (10%)
Query: 76 VYKGKLEN--QRRIAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCEGDERL 132
V+KG ++N Q+ +A+K + D + +++ +V Q + +T G + +
Sbjct: 20 VFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 78
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY+ + L E P+ ++ + + L+Y S+ + ++ D+ A +L
Sbjct: 79 IIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLL 134
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E G +L+ FG+ D + TP PE ++ ++ I+S G ++L
Sbjct: 135 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
Query: 249 LSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
G+ + P L LI N LEG ++ L CL EP RP
Sbjct: 195 AKGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYS----KPLKEFVEACLNKEPSFRP 245
Query: 305 NPKSLV 310
K L+
Sbjct: 246 TAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 2e-05
Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 28/156 (17%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF----- 221
L AL+Y S+ + L+ D+ I +G +L FG+ K S+ +
Sbjct: 112 LCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGI------SKVLSSTVDLAKTVV 164
Query: 222 -TP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276
TP PE + +S I+S G +L +L + KH P NL L L
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH--PFEG------ENLLELALKIL 216
Query: 277 EGQFTDDD---GTELVRLASRCLQYEPRERPNPKSL 309
+GQ+ +EL L S LQ +P ERP+ +
Sbjct: 217 KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLL-VAEYMPNETLAKHLFHWETHPMKWAMRLR 162
+ E R + RN+ L CC + +RL V E++ L +FH + R R
Sbjct: 43 MTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARAR 99
Query: 163 V-VLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS-RDGKSYSTNLA 220
+ AL + KG +Y DL +L D +G+ +L+ FG+ K +GK+ ST
Sbjct: 100 FYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FC 157
Query: 221 FTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP 255
TP PE L+ P ++ G LL ++L G H P
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 42/281 (14%)
Query: 65 VSEHGEKAPNVVYKGKL------ENQRRIAVKRF-NRMAWPDPRQFLEEARSVGQLRNNR 117
+ E GE VYKG L E + +A+K ++ P +F EA +L++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHP----------MKWAMR----LRV 163
+ LLG + ++ Y + L + L H +K + + +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 164 VLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST------ 217
V +A +E+ +S ++ DL +L + N ++S GL + Y
Sbjct: 130 VTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLT 272
+ + PE + G+ + +S I+S+G +L ++ S P +++IR+R +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248
Query: 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
D C +T L C P RP K + + L
Sbjct: 249 DDCPAWVYT---------LMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET----LAKHLFHWETHPMK 156
R FL EA +GQ + + +L G + ++V EYM N + L KH + +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109
Query: 157 WAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KS 214
+R +A ++Y + G ++ DL A IL + + ++S FGL + D +
Sbjct: 110 GMLR-----GIASGMKYLSDMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163
Query: 215 YSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
Y+T + +T PE + + T S ++S+G ++ +++S
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 32/126 (25%), Positives = 57/126 (45%), Gaps = 10/126 (7%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
L+ +Y+ L HL+ E H + +R+ + + AL+ + +Y D+ IL
Sbjct: 82 LILDYVNGGELFTHLYQRE-HFTESEVRV-YIAEIVLALD-HLHQLGIIYRDIKLENILL 138
Query: 193 DEDGNPRLSTFGLMK-----NSRDGKSYSTNLAFTPPEYLRTGRVTPESVI--YSFGTLL 245
D +G+ L+ FGL K S+ + + PE +R G + + +S G L
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 246 LDLLSG 251
+LL+G
Sbjct: 199 FELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 25/171 (14%)
Query: 159 MRLRVVLHLAQA----LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL---MKNSRD 211
+ + ++ +A A L Y + R ++ D+ IL + G +L FG+ + NS
Sbjct: 100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159
Query: 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK------------HIPPSHA 259
T+ + PE ++ G+ T +S ++S G +++L GK P
Sbjct: 160 DTFVGTS-TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 260 LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
LDL++ + +Q F +D L CL +P ERP P+ L
Sbjct: 219 LDLLQ-QIVQEPPPRLPSSDFPED----LRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 43/200 (21%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYHDLNAYR 189
LV EY+P LA L + + A +++A+ ALEY S G ++ DL
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA-----RIYIAEIVLALEYLHSNG-IIHRDLKPDN 123
Query: 190 ILFDEDGNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVI---- 238
IL D +G+ +L+ FGL K + + P+Y+ PE ++
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI-----APEVILGQGH 178
Query: 239 ------YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG--QFTDDDGT--EL 288
+S G +L + L G IPP H + + + L G ++ +D E
Sbjct: 179 SKTVDWWSLGCILYEFLVG--IPPFH------GETPEEIFQNILNGKIEWPEDVEVSDEA 230
Query: 289 VRLASRCLQYEPRERPNPKS 308
+ L S+ L +P +R KS
Sbjct: 231 IDLISKLLVPDPEKRLGAKS 250
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 12/146 (8%)
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V E++ L + H + + A V L + +AL Y ++G ++ D+ +
Sbjct: 91 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG-VIHRDIKS 146
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + E I+S G
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 244 LLLDLLSGK----HIPPSHALDLIRD 265
++++++ G+ + PP A+ IRD
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRD 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 171 LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEY 226
L++ SKG +Y DL ++ D DG+ +++ FG+ K + G + ++ TP PE
Sbjct: 109 LQFLHSKG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 227 LRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
L+ + T +SFG LL ++L G+ P H D
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 28/246 (11%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER--LLVAEYMPNETLA 144
+AVK+ R F E + L+++ + G C R LV EY+P +L
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 145 KHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLS 201
+L + H + R +++L+ +Q +EY SK R ++ DL IL + + ++
Sbjct: 96 DYL---QKHRERLDHR-KLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIG 150
Query: 202 TFGLMKNSRDGKSYST-------NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254
FGL K K Y + + PE L + + S ++SFG +L +L +
Sbjct: 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210
Query: 255 ---PPSHALDLI-RDRNLQMLTDSCLE-----GQFTDDDG--TELVRLASRCLQYEPRER 303
PP+ + ++ D+ QM+ +E G+ G E+ + C +P +R
Sbjct: 211 SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270
Query: 304 PNPKSL 309
P+ L
Sbjct: 271 PSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 21/253 (8%)
Query: 69 GEKAPNVVYKGKLENQ--RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC 126
GE A VYK + + +A+K+ R+ + + E + ++ + +
Sbjct: 28 GEGASGEVYKAT-DRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN 186
GDE +V EYM +L + M V + Q LEY S+ ++ D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFV-RMNEPQIAYVCREVLQGLEYLHSQNV-IHRDIK 143
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFG 242
+ IL +DG+ +L+ FG KS ++ TP PE ++ P+ I+S G
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG 203
Query: 243 TLLLDLLSGK--HI--PPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+ +++ G+ ++ PP AL LI + + L + + E ++CL
Sbjct: 204 IMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP-------EKWSPEFKDFLNKCLVK 256
Query: 299 EPRERPNPKSLVT 311
+P +RP+ + L+
Sbjct: 257 DPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-05
Identities = 53/243 (21%), Positives = 105/243 (43%), Gaps = 19/243 (7%)
Query: 76 VYKGKLEN--QRRIAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCEGDERL 132
V+KG ++N Q+ +A+K + D + +++ +V Q + +T G +G +
Sbjct: 20 VFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW 78
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY+ + L + A L+ +L + L+Y S+ + ++ D+ A +L
Sbjct: 79 IIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-KKIHRDIKAANVLL 134
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E G+ +L+ FG+ D + TP PE ++ ++ I+S G ++L
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIEL 194
Query: 249 LSGKHIPPSHALDLIRDR-NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
G+ PP+ + +R + L G+F+ CL +P RP K
Sbjct: 195 AKGE--PPNSDMHPMRVLFLIPKNNPPTLTGEFSKP----FKEFIDACLNKDPSFRPTAK 248
Query: 308 SLV 310
L+
Sbjct: 249 ELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 162 RVVLHLAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN 218
R + AQ LE+ + R +Y DL +L D DGN R+S GL +DG+S +
Sbjct: 98 RACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156
Query: 219 LAFTP----PEYLRTGRVTPESVIY-SFGTLLLDLLSGK 252
A TP PE L+ G SV Y + G L ++++ +
Sbjct: 157 YAGTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 55/193 (28%), Positives = 82/193 (42%), Gaps = 26/193 (13%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
K+ VY KL + +F + D F EE R + N+ L C + D+
Sbjct: 65 KSSQKVYAMKL-------LSKFEMIKRSDSAFFWEE-RDIMAFANSPWVVQLFCAFQDDK 116
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWA--MRLRVVLHLAQALEYCTSKGRALYHDLNA 187
L +V EYMP L + +++ P KWA VVL AL+ S G ++ D+
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVL----ALDAIHSMG-LIHRDVKP 170
Query: 188 YRILFDEDGNPRLSTFGL-MKNSRDGKSYSTNLAFTP----PEYLRT----GRVTPESVI 238
+L D+ G+ +L+ FG MK G TP PE L++ G E
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 239 YSFGTLLLDLLSG 251
+S G L ++L G
Sbjct: 231 WSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL--FHWETHPMKWA 158
+Q +E + +L++ + LG E D + E +P +LAK L + P+
Sbjct: 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVI-R 105
Query: 159 MRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS---RDGKSY 215
+ R +L LEY + ++ D+ IL D +G +L+ FG+ K KS+
Sbjct: 106 LYTRQIL---LGLEYLHDRN-TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF 161
Query: 216 STNLAFTPPEYL-RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI-------RDRN 267
+ + PE + + G + I+S G +L++ +GK PP L+ + R +
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVFKIGRSKE 219
Query: 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
L + D D+ + + CLQ +P RP L
Sbjct: 220 LPPIPDH------LSDEAKDFILK---CLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 34/135 (25%), Positives = 58/135 (42%), Gaps = 11/135 (8%)
Query: 128 GDERLLVAEYMPN---ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184
D LV EY+ +L K L P WA + + + +E +G ++ D
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLGGL---PEDWAKQY--IAEVVLGVEDLHQRG-IIHRD 122
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTL 244
+ +L D+ G+ +L+ FGL +N + K + + PE + S +S G +
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCV 182
Query: 245 LLDLLSGKHIPPSHA 259
+ + L G PP HA
Sbjct: 183 IFEFLFG--YPPFHA 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 57/246 (23%), Positives = 104/246 (42%), Gaps = 32/246 (13%)
Query: 86 RIAVKRFNRMAWPDPRQFL-EEARSVGQLRNN-RLTNLLGCCCEGDERLLVAEYMPNETL 143
++AVK A R+ L E + + L N+ + NLLG C G L++ EY L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 144 AKHLFHWETHPMKWAMRLRVVLH----LAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199
L + + L +L +A+ + + SK ++ DL A +L +
Sbjct: 127 LNFL-RRKRESF---LTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGKIVK 181
Query: 200 LSTFGLMKNSRDGKSY-STNLAFTP-----PEYLRTGRVTPESVIYSFGTLLLDLLS-GK 252
+ FGL ++ + +Y A P PE + T ES ++S+G LL ++ S G
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
Query: 253 HIPPSHALD-----LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
+ P +D LI++ +M + + + ++++ C +P +RP K
Sbjct: 242 NPYPGMPVDSKFYKLIKE-GYRMA-----QPEHAPAEIYDIMK---TCWDADPLKRPTFK 292
Query: 308 SLVTAL 313
+V +
Sbjct: 293 QIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 22/245 (8%)
Query: 75 VVYKG-KLENQRRIAVKRFNRMAWPDPRQFLE-EARSVGQLRNNRLTNLLGCCCEGDERL 132
VYK + +A+K + D + ++ E + + Q R+ +T G +G +
Sbjct: 16 EVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW 75
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY + L + A LR VL LEY +G+ ++ D+ A IL
Sbjct: 76 IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLL---GLEYLHEEGK-IHRDIKAANILL 131
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E+G+ +L+ FG+ S TP PE ++ ++ I+S G ++L
Sbjct: 132 SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIEL 191
Query: 249 LSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
G+ + P L LI N L + +F+ + V L CL +P+ERP
Sbjct: 192 AKGEPPLSDLHPMRVLFLIPKNNPPSLEGN----KFSKP-FKDFVSL---CLNKDPKERP 243
Query: 305 NPKSL 309
+ K L
Sbjct: 244 SAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 38/171 (22%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 87 IAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+A+K N P +F++EA + + + L LLG C + LV + MP+ L
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLD 97
Query: 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205
++ H + + L + +A+ + Y + R ++ DL A +L + +++ FGL
Sbjct: 98 YV-HEHKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGL 155
Query: 206 MK-NSRDGKSYSTNLAFTPPEYL-----RTGRVTPESVIYSFGTLLLDLLS 250
+ D K Y+ + P +++ + T +S ++S+G + +L++
Sbjct: 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSYSTNL 219
+V + + + L Y K + ++ D+ IL + G +L FG+ D S+
Sbjct: 107 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDLIRDRNLQMLTDSCLEG 278
++ PE L+ + +S I+S G L+++ G++ IPP A + L+++ +EG
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA------KELELMFGCPVEG 220
Query: 279 QFTDDDGTELVRLASRCL-QYEPRERP 304
+ + + R R L Y P RP
Sbjct: 221 DPAESETSPRPRPPGRPLSSYGPDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 54/237 (22%), Positives = 98/237 (41%), Gaps = 15/237 (6%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
+A +Y K ++RI ++ MA + +Q LE+ N+R L E +
Sbjct: 22 RATGKMYACKKLEKKRIKKRKGESMAL-NEKQILEKV-------NSRFVVSLAYAYETKD 73
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
L LV M L H++H + + + LE + R +Y DL
Sbjct: 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED-LHQERIVYRDLKPEN 132
Query: 190 ILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLL 246
IL D+ G+ R+S GL + +G K + + PE ++ R T ++ G LL
Sbjct: 133 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 192
Query: 247 DLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++++G+ P I+ ++ L E ++++ + L L +P+ER
Sbjct: 193 EMIAGQS-PFQQRKKKIKREEVERLVKEVQE-EYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 28/120 (23%)
Query: 170 ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT 229
ALEY SK +Y DL IL D++G+ +L+ FG K RD ++++ L T PEYL
Sbjct: 113 ALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT--LCGT-PEYL-- 165
Query: 230 GRVTPESV----------IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279
PE + ++ G L+ ++L G PP D N + + L G+
Sbjct: 166 ---APEVIQSKGHNKAVDWWALGILIYEMLVG--YPP------FFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 24/163 (14%)
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTN 218
R+ + + + L Y S + L+ D+ +L + G +L FG+ + NS K+Y
Sbjct: 99 RIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYVGT 156
Query: 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-----------HIPPSHALDLIRDRN 267
A+ PE + + S ++S G ++L G+ + P L I D +
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216
Query: 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+L GQF++ + V ++C++ +P+ERP P++L+
Sbjct: 217 PPVLPV----GQFSE----KFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 170 ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PE 225
L++ KG +Y DL +L D+DG+ +++ FG+ K + +G+ ++ TP PE
Sbjct: 108 GLQFLHKKG-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPE 166
Query: 226 YLRTGRVTPESV-IYSFGTLLLDLLSGKHIPPSHALD 261
L+ G+ ESV +SFG LL ++L G+ P H D
Sbjct: 167 ILK-GQKYNESVDWWSFGVLLYEMLIGQ--SPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 36/143 (25%), Positives = 61/143 (42%), Gaps = 15/143 (10%)
Query: 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEY 173
LT L C D V EY+ L + E H + +A + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---- 118
Query: 174 CTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDG---KSYSTNLAFTPPEYLRT 229
SKG +Y DL ++ D +G+ +++ FG+ K N DG K++ + PE +
Sbjct: 119 --SKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 230 GRVTPESVIYSFGTLLLDLLSGK 252
++FG LL ++L+G+
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 9/92 (9%)
Query: 169 QALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA------FT 222
+ L Y SKG L+ DL A +L D DG ++S FG+ K S D N++ +
Sbjct: 119 EGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 223 PPEYLRTGR--VTPESVIYSFGTLLLDLLSGK 252
PE + + + + I+S G ++L++ +G+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 7/99 (7%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP--- 223
+A AL Y S +Y DL IL D G+ L+ FGL K + ++ TP
Sbjct: 105 IASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 224 -PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
PE LR + G +L ++L G +PP ++ D
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 15/216 (6%)
Query: 105 EEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVV 164
+E R + +L + + +LG CE L E+M +++ HL + K A+ +
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVS-HLLS-KYGAFKEAVIINYT 109
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP-RLSTFGLM-----KNSRDGK---SY 215
L + L Y + ++ D+ +L D G R++ FG K + G+
Sbjct: 110 EQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275
+AF PE LR + ++S G +++++ + K PP +A L S
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK--PPWNAEKHSNHLALIFKIASA 226
Query: 276 LEGQFTDDDGTELVR-LASRCLQYEPRERPNPKSLV 310
+ + +R + RCL+ +P +RP + L+
Sbjct: 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 169 QALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSYSTNLAFTPPEY 226
+ L Y K + ++ D+ IL + G +L FG+ + K++ ++ PE
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPER 170
Query: 227 LRTGRVTPESVIYSFGTLLLDLLSGK------HIPPSHALDLIRDRNLQMLTDSCLEGQF 280
++ + +S I+S G L++L +G+ + PP +L+ + G+F
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-QYIVNEPPPRLPSGKF 229
Query: 281 TDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ D + CL +PRERP+ K L
Sbjct: 230 SPD----FQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 33/250 (13%)
Query: 76 VYKG-KLENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC---CEGD 129
VY L+ +AVK R DP+ E A + L + NL+ +
Sbjct: 16 VYTAVNLDTGELMAVKEIRIQD---NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE 72
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
+ + EY TL + L H + L L + L Y S G ++ D+
Sbjct: 73 KVYIFMEYCSGGTLEELLEHGRILDEH--VIRVYTLQLLEGLAYLHSHG-IVHRDIKPAN 129
Query: 190 ILFDEDGNPRLSTFG----LMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE--SV-I 238
I D +G +L FG L N+ +LA TP PE + G+ + I
Sbjct: 130 IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189
Query: 239 YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL----VRLASR 294
+S G ++L++ +GK P LD Q++ + D +L R
Sbjct: 190 WSLGCVVLEMATGK--RPWSELD----NEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDR 243
Query: 295 CLQYEPRERP 304
CL+ +P++RP
Sbjct: 244 CLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 28/250 (11%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDP--RQFLEEARSVGQLRNNRLTNLL--- 122
G A VY+GK + R +A+K N + PD E + QLR ++ N+
Sbjct: 10 GRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 123 GCCCEGDERLLVAEYMPN---ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
G +G ++ EY TL K E + ++ +R VL AL+Y G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI---SVIIREVL---VALKYIHKVG- 121
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE 235
++ D+ A IL GN +L FG+ S + TP PE + G+
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181
Query: 236 SV-IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR-LAS 293
I+S G + ++ +G PP +D R ML + D+ ++L+R +
Sbjct: 182 KADIWSLGITIYEMATGN--PPYSDVDAFR---AMMLIPKSKPPRLEDNGYSKLLREFVA 236
Query: 294 RCLQYEPRER 303
CL EP+ER
Sbjct: 237 ACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 44/211 (20%), Positives = 75/211 (35%), Gaps = 54/211 (25%)
Query: 129 DERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYH- 183
+E L V EY PN L +++ + + K + A+ ALEY SKG + H
Sbjct: 74 EENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAEILLALEYLHSKG--IIHR 126
Query: 184 DLNAYRILFDEDGNPRLSTFG--------LMKNSRDGKSYSTNLA--------------- 220
DL IL D+D + +++ FG S G + + +
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186
Query: 221 -FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA------LDLIRDRNLQMLTD 273
+ PE L S +++ G ++ +L+GK PP I
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNEYLTFQKILKLEYSFP-- 242
Query: 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
D +L+ + L +P++R
Sbjct: 243 -----PNFPPDAKDLIE---KLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETH--PMKWA 158
R FL EA +GQ + + +L G + +++ E+M N L L + ++
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV 109
Query: 159 MRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS---Y 215
LR +A ++Y S+ ++ DL A IL + + ++S FGL + D S Y
Sbjct: 110 GMLR---GIAAGMKY-LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 216 STNLA------FTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
+++L +T PE + + T S ++S+G ++ +++S
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 17/132 (12%)
Query: 133 LVAEYMPNE---TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
LV EYM ++ L L H+ +K M+ L + L YC K L+ D+
Sbjct: 93 LVFEYMDHDLMGLLESGLVHFSEDHIKSFMK-----QLLEGLNYCHKKN-FLHRDIKCSN 146
Query: 190 ILFDEDGNPRLSTFGLMK--NSRDGKSYSTN----LAFTPPEYLR-TGRVTPESVIYSFG 242
IL + G +L+ FGL + NS + + Y TN L + PPE L R P ++S G
Sbjct: 147 ILLNNKGQIKLADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCG 205
Query: 243 TLLLDLLSGKHI 254
+L +L + K I
Sbjct: 206 CILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 3/104 (2%)
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSYSTNL 219
+V + + + L Y K + ++ D+ IL + G +L FG+ D S+
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDL 262
++ PE L+ + +S I+S G L++L G++ IPP A +L
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 15/115 (13%)
Query: 161 LRVVLH-LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL-MKNSRDGKSYSTN 218
+R V + +AL + S + ++ DL A IL DG+ +L+ FG+ KN + T
Sbjct: 105 IRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163
Query: 219 LAFTP----PEYL--RTGRVTP---ESVIYSFGTLLLDLLSGKHIPPSHALDLIR 264
+ TP PE + T + P ++ I+S G L++L + PP H L+ +R
Sbjct: 164 IG-TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME--PPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 16/197 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
+VY + L Q RIA+K + EE L++ + LG E +
Sbjct: 23 IVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALE---YCTSKGRALYHDLNAYRI 190
E +P +L+ L + P+K ++ + Q LE Y + ++ D+ +
Sbjct: 83 FMEQVPGGSLSA-LLRSKWGPLK-DNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNV 139
Query: 191 LFDE-DGNPRLSTFGLMKN----SRDGKSYSTNLAFTPPEYLRTGR--VTPESVIYSFGT 243
L + G ++S FG K + ++++ L + PE + G + I+S G
Sbjct: 140 LVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGC 199
Query: 244 LLLDLLSGKHIPPSHAL 260
++++ +GK PP L
Sbjct: 200 TIVEMATGK--PPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 14/160 (8%)
Query: 122 LGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
L C + RL LV EY+ L H+ P + A R + AL + +G
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA-RFYAA-EICIALNFLHERG-I 117
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNS-RDGKSYSTNLA---FTPPEYLRTGRVTPES 236
+Y DL +L D DG+ +L+ +G+ K G + ST + PE LR
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 237 VIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276
++ G L+ ++++G+ D+I D N M T+ L
Sbjct: 178 DWWALGVLMFEMMAGR-----SPFDIITD-NPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.002
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 11/207 (5%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
R L E R + +L + L NL + + LV + + L HL + ++
Sbjct: 45 RNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVK 103
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---SYST 217
+ + ALEY SKG ++ D+ IL DE G+ ++ F + S S
Sbjct: 104 FWIC-EIVLALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG 161
Query: 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD-RNLQMLTDSCL 276
+ PE L + +S G + L GK H+ + R Q D
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV-- 219
Query: 277 EGQFTDDDGTELVRLASRCLQYEPRER 303
+ TE + ++ L+ +P++R
Sbjct: 220 --LYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220
+R ++ +A +EY +SK ++ DL A + +E+ ++ FGL K G Y A
Sbjct: 116 VRFMIDIASGMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 221 FTPP------EYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD------LIRDRNL 268
P E L T S +++FG + ++++ P + + LI+ L
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+ D CLE ++ L +C EP+ RP+ + L L
Sbjct: 235 KQPPD-CLE---------DVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 9/154 (5%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRV 163
L E+R + R+ LT+L D V EY+ L FH + R R
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRF 99
Query: 164 V-LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK----NSRDGKSYSTN 218
+ AL+Y S G+ +Y DL ++ D+DG+ +++ FGL K ++ K++
Sbjct: 100 YGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158
Query: 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK 252
+ PE L + G ++ +++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 21/154 (13%)
Query: 118 LTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALE 172
LT L C + +RL V EY+ L H+ E +A +VL L+
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--IVL----GLQ 110
Query: 173 YCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDGKSYSTNLAFTP----PEYL 227
+ +G +Y DL +L D +G+ +++ FG+ K G + ST TP PE L
Sbjct: 111 FLHERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEIL 168
Query: 228 RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
P ++ G LL ++L+G+ P D
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ--SPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 43/208 (20%), Positives = 77/208 (37%), Gaps = 24/208 (11%)
Query: 86 RIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144
R+ VK A PD + FL+E + +L + + LG C E LLV E+ P L
Sbjct: 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83
Query: 145 KHLFHWETHPMKWAMRLRVVLHLAQALE---YCTSKGRALYHDLNAYRILFDEDGNPRLS 201
+L + + V+ +A + + ++ DL D + ++
Sbjct: 84 NYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIG 142
Query: 202 TFGLMKNSRDGKSYSTN------LAFTPPEY-------LRTGRVTPESVIYSFGTLLLDL 248
+GL Y T L + PE L T +S I+S G + +L
Sbjct: 143 DYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 249 LSGKHIPPSHALDL------IRDRNLQM 270
+ P D +R++++++
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQDIKL 230
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 48/208 (23%), Positives = 79/208 (37%), Gaps = 60/208 (28%)
Query: 155 MKWAMRL------RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL--- 205
+K A R+ ++ + + + L Y K + ++ D+ IL + G +L FG+
Sbjct: 90 LKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149
Query: 206 ----MKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPP--- 256
M NS G +SY + PE L+ T +S I+S G L+++ G++ IPP
Sbjct: 150 LIDSMANSFVGTRSYMS------PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
Query: 257 ------------------------SHALDLIRDRNLQMLTDSCLE--------GQFTDDD 284
H D R + L D + G F+D
Sbjct: 204 KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSD-- 261
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTA 312
E +CL+ P+ER + K L
Sbjct: 262 --EFQDFVDKCLKKNPKERADLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 34/173 (19%)
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPP 224
+A+ +E+ S+ + ++ DL A IL E+ ++ FGL +RD + P
Sbjct: 180 FQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGL---ARD--------IYKDP 227
Query: 225 EYLRTGR-------VTPESV----------IYSFGTLLLDLLS-GKHIPPSHALDLIRDR 266
+Y+R G + PES+ ++SFG LL ++ S G P +D R
Sbjct: 228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
Query: 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319
L+ T T E+ + C P +RP LV L L +E
Sbjct: 288 RLKEGTRMRAPEYATP----EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 8/136 (5%)
Query: 122 LGCCCEGDERLL-VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
L C + + RL V EY+ L H+ P + A + LA L Y +G
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG-I 117
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPES 236
+Y DL +L D +G+ +L+ +G+ K ++ TP PE LR
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 237 VIYSFGTLLLDLLSGK 252
++ G L+ ++++G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 21/148 (14%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNN---RLTNL 121
GE VVYK + +A+K+ R+ D P + E + +L + RL ++
Sbjct: 8 GEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 122 LGCCCEGDERL-LVAEYMPNETLAKHLFHWETHP--MKWAMRLRVVLH-LAQALEYCTSK 177
+ + +L LV E++ + L K++ ++ P ++ L+ L Q + YC S
Sbjct: 67 VHS----ENKLYLVFEFL-DLDLKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 178 GRALYHDLNAYRILFDEDGNPRLSTFGL 205
R L+ DL +L D +G +L+ FGL
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.24 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.12 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.61 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.32 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.8 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.45 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.4 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.35 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.27 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.02 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.82 | |
| PLN02236 | 344 | choline kinase | 96.72 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.52 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.3 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.25 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.04 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.73 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.73 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.41 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.23 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.21 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.72 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=360.21 Aligned_cols=248 Identities=20% Similarity=0.278 Sum_probs=207.8
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCC-eeeEEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-ERLLVA 135 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 135 (334)
.++.+.++.||+|+.|+||++.++ +++.+|+|.+...... ..+++.+|+++++..+||+||.++|.|..++ ...++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 346677789999999999999975 5789999999644322 3568999999999999999999999999988 499999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||++|+|++.+. ..+.+++..+..++.+|++||.|||+ ++ |+||||||+|||++..|.|||||||.+....+.
T Consensus 158 EYMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~-IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 158 EYMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERK-IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred hhcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccC-eeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 9999999999996 34779999999999999999999996 65 999999999999999999999999998865543
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh--hHHhhhcccccccccccCCCCCch-hHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNLQMLTDSCLEGQFTDD-DGTELV 289 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~ 289 (334)
.+.+||..|||||.+.+..|+.++||||||++++|+.+|+.|+.... ...+.. ....+.+... ..+|.. +++++.
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-Ll~~Iv~~pp-P~lP~~~fS~ef~ 312 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-LLCAIVDEPP-PRLPEGEFSPEFR 312 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-HHHHHhcCCC-CCCCcccCCHHHH
Confidence 57889999999999999999999999999999999999998887641 111110 0111222111 234444 888999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+..||++||.+|||+.++++
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999984
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=365.05 Aligned_cols=274 Identities=36% Similarity=0.639 Sum_probs=234.0
Q ss_pred CccccCHHHHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCcccee
Q 019905 43 SFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122 (334)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 122 (334)
..+.|++.++.++|++|+..+++ |+|+||.||+|..+++..||||++.........+|.+|++++.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~i---g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLI---GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcce---ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence 57789999999999999999888 999999999999988899999988766543145699999999999999999999
Q ss_pred eeeeeCC-eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CceecccCCCCeeecCCCCee
Q 019905 123 GCCCEGD-ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG--RALYHDLNAYRILFDEDGNPR 199 (334)
Q Consensus 123 ~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dikp~Nili~~~~~~k 199 (334)
|+|.+.+ +.+||+||+++|+|.+++......+++|..+.+|+.++|+||+|||... +|+||||||+|||+|+++++|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999988 5999999999999999998633228899999999999999999999865 399999999999999999999
Q ss_pred EcCCCCCccCCC-CCcc----cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch-----------hhHHh
Q 019905 200 LSTFGLMKNSRD-GKSY----STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-----------ALDLI 263 (334)
Q Consensus 200 l~Dfg~a~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~-----------~~~~~ 263 (334)
|+|||+|..... .... .||.+|+|||++..+..+.++||||||++++|++||+.+.... ....+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999976554 3221 7899999999999888999999999999999999999765421 12233
Q ss_pred hhcccccccccccC-CCCCc-hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 264 RDRNLQMLTDSCLE-GQFTD-DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 264 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+.....+.++... ..++. .....+..+...|++.+|..||+|.++++.|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 44456677777765 44443 4566789999999999999999999999999776644
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-51 Score=362.47 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=213.5
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCC-eeeEEEecCCCC
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD-ERLLVAEYMPNE 141 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~ 141 (334)
...+|.|+||+||+|.+++...||+|.+......+ .+.|.+|+.++.+++|||||+++|++..+. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 34479999999999999776569999998655333 348999999999999999999999999877 799999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCC----CCccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD----GKSYS 216 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~----~~~~~ 216 (334)
+|.+++.......+++..+..++.+|+.||.|||++++||||||||+|||++.++ ++||+|||+++.... .....
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~ 205 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVA 205 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCC
Confidence 9999997533678999999999999999999999997689999999999999997 999999999975443 23468
Q ss_pred ccccccCccccc--CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 217 TNLAFTPPEYLR--TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 217 ~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
||+.|||||++. ...|+.|+||||||+++|||+||+.||.......+.... .....+...+...++.+..++..
T Consensus 206 GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v----~~~~~Rp~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 206 GTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV----VVGGLRPPIPKECPPHLSSLMER 281 (362)
T ss_pred CCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcCCCCCCCccCCHHHHHHHHH
Confidence 899999999999 558999999999999999999999998765543322222 11222333444567789999999
Q ss_pred hhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 295 CLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
||+.||..||++.+++..|+.+......
T Consensus 282 CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred hCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 9999999999999999999988774443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=355.07 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=215.5
Q ss_pred ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
++++++||+|-||.||+|.++....||+|.++... ...+.|.+|++++++|+|++||+++++|..++.++|||||++.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 45678999999999999999888899999998764 34577889999999999999999999999988999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCccc-----
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS----- 216 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~----- 216 (334)
+|.++++...+..+.....+.++.|||.|++||++++ +|||||-.+||||+++..+||+|||+|+...+.....
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~-~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN-YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC-ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 9999998766788999999999999999999999999 9999999999999999999999999999554433221
Q ss_pred ccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch-hhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 217 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
-...|+|||.+....++.+|||||||++|||++|.+..++.. ....+. ..++..-+-..|..++..++++|..|
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-----~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-----ELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-----HHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 246899999999999999999999999999999966555433 222221 22233334456777788999999999
Q ss_pred hhcCCCCCCCHHHHHHHhccccccC
Q 019905 296 LQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
|+.+|++|||++.+...|+++....
T Consensus 441 W~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred hhCCcccCCCHHHHHHHHHHhhhcc
Confidence 9999999999999999999887543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=343.15 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=203.4
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
...+|.+.++||.|+|++||+|+++ ++..||||.+.... ....+.+..|+.+|+.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3466778888999999999999964 57899999997653 33355678999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC------CCeeEcCCCCCcc
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED------GNPRLSTFGLMKN 208 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~------~~~kl~Dfg~a~~ 208 (334)
||||+||+|.++++ ..+.+++...+.++.|++.||++||+++ ||||||||+|||++.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~~-IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHENN-IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999997 4568999999999999999999999999 9999999999999854 4589999999998
Q ss_pred CCCCC---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 209 SRDGK---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 209 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
..+.. +..|++.|||||++....|+.|+|+||+|+++|+|++|+.||............... .......+...+
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~---~~~~~~~~~~~s 241 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG---NEIVPVLPAELS 241 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc---ccccCchhhhcc
Confidence 87753 568999999999999999999999999999999999999999876555544321110 011112233333
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
..+.+++...++.+|.+|-++.+..
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhh
Confidence 4566777777888888877666554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=334.42 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=210.5
Q ss_pred CCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceee-eeeeCCe-eeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLG-CCCEGDE-RLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~l 133 (334)
..+|++++++|.|.||.||++. ..+|..+|.|.++-...+. .+.+..|+.+|++|+|||||++++ .+..+.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4567888899999999999998 5678999999998443322 356889999999999999999999 4555555 899
Q ss_pred EEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 134 VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTS---KGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
+|||+..|+|...+... ..+.+++..+|+++.|++.||..+|. .+.|+||||||.||+++.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999988642 45779999999999999999999998 23399999999999999999999999999998
Q ss_pred CCCCC----cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC-ch
Q 019905 209 SRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT-DD 283 (334)
Q Consensus 209 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 283 (334)
..... +.+||+.||+||.+.+.+|+.+|||||+||++|||+.-..||.+............. -...+| ..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-----d~~~~p~~~ 252 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-----DYPPLPDEH 252 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-----CCCCCcHHH
Confidence 76643 578999999999999999999999999999999999999999988655444332221 111233 56
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
.+.++..|+..|+..||..||+.-.++..+..
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 78899999999999999999997666655544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=354.49 Aligned_cols=243 Identities=18% Similarity=0.231 Sum_probs=213.8
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..|..-+.||+|+|+.+|.++. ++|+.||+|++...... ..+.+.+||++.+.|+|||||+++++|.+.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5577777889999999999996 88999999999764322 2467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
|+|..++|..++. ..+++++.+++.+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|......
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~-IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG-IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC-ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999887 6689999999999999999999999999 999999999999999999999999999876632
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.+..||+.|.|||++....++..+||||+||++|.|+.|++||.........+.... .....|...+.++.+|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~P~~ls~~A~dL 248 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSMPSHLSAEAKDL 248 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCcccccccCHHHHHH
Confidence 467899999999999988899999999999999999999999987765555433221 1223456777899999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
|.++|+.||.+|||+++||.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=342.63 Aligned_cols=248 Identities=20% Similarity=0.259 Sum_probs=202.7
Q ss_pred CCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCC-------hHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD-------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
++.|-+.+.||+|+||.|-+|. .++++.||||.+....... ...+.+|+++|++|+|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3447777899999999999998 4579999999997433222 2235799999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC---CCeeEcCCCCCc
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMK 207 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~---~~~kl~Dfg~a~ 207 (334)
.|+||||+.||+|.+.+. ..+.+.+..-..+++|++.|+.|||+.| |+||||||+|||++.+ ..+|++|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~G-I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQG-IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcC-cccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999987 5567888888999999999999999999 9999999999999855 779999999999
Q ss_pred cCCCC---CcccccccccCcccccCCC---CCCccchhhhHHHHHHHHhCCCCCCchhhHH-hhhcccccccccccCCCC
Q 019905 208 NSRDG---KSYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 208 ~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 280 (334)
..+.. ++..||+.|.|||++.+.. +..++|+||+||++|-+++|.+||.+..... ..+........ .....
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~--f~p~~ 405 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA--FGPLQ 405 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc--ccChh
Confidence 87653 5788999999999997765 3348899999999999999999997764433 11111110000 00112
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
-...+++..+||.+||..||++|||+.|+|+
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2446779999999999999999999999885
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=330.74 Aligned_cols=240 Identities=22% Similarity=0.276 Sum_probs=207.8
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.+..++++++.+|+|+||.||+++. ++++.+|+|+++..... ..+....|..+|.+++||.||+++..|++.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 3456677888889999999999985 55889999999765432 2456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC--
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-- 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~-- 210 (334)
+|+||++||.|..++. ..+.+++..+..++.+|+.||.|||+++ ||||||||+|||+|++|+++|+|||+++...
T Consensus 102 lVld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g-IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG-IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999997 5678999999999999999999999999 9999999999999999999999999998432
Q ss_pred --CCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 211 --DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 211 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...+..||+.|||||++.+..|+.++|.||||+++|+|++|..||.......+.+...... ....+.-.+.++
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----~~~~p~~ls~~a 253 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----LPLPPGYLSEEA 253 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----CCCCCccCCHHH
Confidence 2345789999999999999999999999999999999999999998877665554443322 112333467789
Q ss_pred HHHHHHhhhcCCCCCC
Q 019905 289 VRLASRCLQYEPRERP 304 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rp 304 (334)
.+++.++|+.||.+|.
T Consensus 254 rdll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHHHhccCHHHhc
Confidence 9999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=322.79 Aligned_cols=247 Identities=20% Similarity=0.298 Sum_probs=198.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|+.++++|+|+||+||+++.+ +|+.||||++.....+. .+-..+|+..|++++|+|+|.++.+|.....+++||||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4778889999999999999964 58999999997644211 24567999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC-CCC---
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-DGK--- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~-~~~--- 213 (334)
++..-|.+.-+ ....++...+.++++|++.|+.|+|+++ ++||||||+||||+.+|.+||||||+|+... ++.
T Consensus 83 ~dhTvL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~n-~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 83 CDHTVLHELER--YPNGVPSELVKKYLYQLLKAIHFCHKNN-CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred cchHHHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhhhcC-eecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 98665554433 5678999999999999999999999999 9999999999999999999999999999776 332
Q ss_pred cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh--------------------hccccc--
Q 019905 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR--------------------DRNLQM-- 270 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~--------------------~~~~~~-- 270 (334)
.++.|..|+|||.+.|. .|...+||||+||++.||++|.+.|++...-... +..+..
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 35678899999999984 5999999999999999999999988765221110 000000
Q ss_pred ccccc---cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 271 LTDSC---LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 271 ~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
++.+. .-+..-+..+.-+.+|+.+||+.||++|++-++++
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 00100 00111123445788999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=312.50 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=210.1
Q ss_pred cccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|..++++|+|+||+||+|. ..+|+.||||+++.....+ .....+|+..|+.++|+||+.++++|.+.+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 46677888999999999999 4679999999998765433 34678999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 213 (334)
++ .+|...++. +...++...+..++.++++|++|||++. |+||||||.|+|++++|.+|++|||+|+.+.+..
T Consensus 83 m~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~-IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 83 MP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW-ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh-hhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 97 899999976 6678999999999999999999999999 9999999999999999999999999999776532
Q ss_pred cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc---------------------
Q 019905 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------------------- 271 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------------------- 271 (334)
..+.|..|+|||.+.|.. |+..+||||.||++.||+-|.+.+++...-.........+
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 336788999999998876 9999999999999999999987666542221111111111
Q ss_pred -cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 272 -TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 272 -~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
........+....+.++.+|+.++|.+||.+|+|+.++++. ...++.+.+.+|
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~ 293 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPP 293 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCCh
Confidence 11111122334456688999999999999999999999853 233334444443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=328.68 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=200.5
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC--eeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 138 (334)
....+.+|+|+||+||++... +|...|+|.+........+.+.+|+.+|.+++|||||+++|...... .++++|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 444566799999999999964 48999999997654333567899999999999999999999855444 689999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCccCCC------
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRD------ 211 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~~~~~------ 211 (334)
++|+|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+|||++. ++.+||+|||.+.....
T Consensus 99 ~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g-~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG-IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC-EeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 99999999975333 7999999999999999999999999 999999999999999 79999999999876542
Q ss_pred -CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCch--hhHHhhhcccccccccccCCCCCchhHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSH--ALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
.....||+.|||||++..+. ...++|||||||++.||+||..||... ........ .... ....+|...+.+
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i----g~~~-~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI----GRED-SLPEIPDSLSDE 251 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH----hccC-CCCCCCcccCHH
Confidence 23567899999999999643 445999999999999999998887652 11111111 1111 112556677889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+.+|+.+|++.||.+||||+++|+..-
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 999999999999999999999997653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=339.64 Aligned_cols=245 Identities=20% Similarity=0.338 Sum_probs=212.6
Q ss_pred CCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
-..|....++|+|+.|.||.|. ..++..||||++........+-+.+|+.+++..+|+|||++++.|...+.+|.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4456677788999999999998 556889999999877766677899999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~ 213 (334)
+++|+|.+.+ ....+++.++..+++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..... ..
T Consensus 352 m~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~g-IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 352 MEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHARG-IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred cCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHhcc-eeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 9999999999 4566999999999999999999999999 99999999999999999999999999876554 34
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch-hhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
+.+||+.|||||++....|.++.||||||++++||+.|++||..+ ...... .........-..+...++.+.+|+
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly----LIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH----HHhhcCCCCcCCccccCHHHHHHH
Confidence 678999999999999999999999999999999999999988743 222111 222233333445667788999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||..|+.+|+++.|+|+
T Consensus 504 ~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHhhcchhcCCCHHHHhc
Confidence 9999999999999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=334.90 Aligned_cols=249 Identities=18% Similarity=0.271 Sum_probs=204.1
Q ss_pred CcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCC-CCCccceeeeeeeCC-eeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLR-NNRLTNLLGCCCEGD-ERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~ 135 (334)
..|.+++++|.|+||.||+|+ ..+++.||||+++..-... .-.-.+|+..|++++ ||||+++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 468889999999999999999 4568999999997644222 123468999999998 999999999999887 899999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
|||+ .+|.+.+..+ .+.|++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+...+.
T Consensus 90 E~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G-fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG-FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred Hhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC-cccccCChhheEecccceeEecccccccccccCCCc
Confidence 9996 8899999875 889999999999999999999999999 999999999999999999999999999976543
Q ss_pred CcccccccccCccccc-CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc------------------------
Q 019905 213 KSYSTNLAFTPPEYLR-TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------------ 267 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~------------------------ 267 (334)
..++.|..|+|||++. .+.|+.+.||||+||+++|+++-++.|++...-...-..
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 4678899999999985 455999999999999999999999888764211110000
Q ss_pred -cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 268 -LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 268 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.......... .+.+..+.++.++|.+|++.||.+||||.++++.
T Consensus 247 ~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 247 RFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111111 1123367899999999999999999999999964
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=323.63 Aligned_cols=255 Identities=19% Similarity=0.250 Sum_probs=208.1
Q ss_pred hcCCCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCCh-HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDP-RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
..+-+.|++...+|.|..++||+|. .+.++.||||++....+... ..+.+|++.++.++||||++++..|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 3455778888899999999999999 56789999999987765554 789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||.||.+||+.+.+...-...+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||........
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G-~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG-HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC-ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999998655677999999999999999999999999 999999999999999999999999976533221
Q ss_pred -------CcccccccccCcccccCC--CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc----ccccCCC
Q 019905 213 -------KSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT----DSCLEGQ 279 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~ 279 (334)
....||++|||||++... .|+.|+||||||++.+|+.+|..||..-..-.+.-......+ .......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence 455789999999996433 499999999999999999999998854322221111111111 1111111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
-....+..+.+++..||++||..|||++++++
T Consensus 261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 12224568999999999999999999999984
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=328.61 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=201.1
Q ss_pred CcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 134 (334)
+.|+.+++||+|+||.||+|+ ..+|+.||+|++..+... ...-..+||.+|++|+||||+++.+..... +.+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457888999999999999999 567999999999876532 345678999999999999999999998876 689999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
||||+ -+|.-++.. ..-.|++.++..++.|++.||.|+|.++ |+|||||.+|||||.+|.+||+|||+|..+....
T Consensus 197 FeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g-vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG-VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred Eeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC-eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99997 577777753 3457999999999999999999999999 9999999999999999999999999999665432
Q ss_pred ----cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-------------cccc--
Q 019905 214 ----SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-------------MLTD-- 273 (334)
Q Consensus 214 ----~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~-------------~~~~-- 273 (334)
..+.|..|+|||++.|.. |+.++|+||.||++.||++|++.+.+...-......+. .++.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 446689999999999877 99999999999999999999987765422111111100 0000
Q ss_pred -cccCCCC-------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 274 -SCLEGQF-------TDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 274 -~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
......+ ....+....+|+..+|..||..|.|+.++|+.
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0000001 12345678899999999999999999999853
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=330.26 Aligned_cols=259 Identities=20% Similarity=0.267 Sum_probs=216.2
Q ss_pred CCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCC---CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 133 (334)
-.++...+.+|+|+|++|++|+ .++++.+|||++..... ...+.+..|-++|.+| .||.|++++..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3456666777999999999999 45689999999964331 1234567888999999 89999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
|+||+++|+|.++|. +-+.|++...+.++.+|+.||.|||++| ||||||||+|||++++++++|.|||.|+...+.
T Consensus 152 vLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~G-IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNG-IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999999998 5578999999999999999999999999 999999999999999999999999998854321
Q ss_pred ----------------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccccc
Q 019905 213 ----------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 213 ----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
...+||..|.+||++.....++.+|+|+|||++|+|+.|.+||.......+....+. .
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~------l 302 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA------L 302 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH------h
Confidence 346899999999999999999999999999999999999999987655544433322 1
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh-------ccccccCCCCCCh
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL-------SPLQKETEFSISP 326 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L-------~~l~~~~~~~~~p 326 (334)
.-.++...++.+.+|+.++|..||.+|+|..+|.+-. +++.+.++.+..|
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~p 359 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQP 359 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccC
Confidence 2245666678999999999999999999998887532 4555555555544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=334.10 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=208.0
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+.+..+...||+|.||+||+|.|.++ ||||.++...... .+.|++|+..+++-+|.||+-+.|+|..++. .||+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 34455667889999999999999764 9999998766444 4579999999999999999999999998877 99999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
+|.|.+|..+++. ....|+......|+.||++|+.|||.++ |||||||.+||++.+++.|||+|||++..-.-
T Consensus 468 wCeGsSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK~-IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 468 WCEGSSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAKN-IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred hccCchhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhhh-hhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999999986 3467889999999999999999999999 99999999999999999999999999864221
Q ss_pred -CCcccccccccCcccccC---CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
-....+...|||||+++. .+|+..+||||||+|+|||++|..|+.....+.+.-..-..... ..........+.+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~-pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM-PDLSKIRSNCPKA 624 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC-ccchhhhccCHHH
Confidence 123456789999999963 35999999999999999999999988754433332111111000 0111233456679
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.+|+..||.+++++||.+.+|+..|+.++..
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 99999999999999999999999999888763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=317.72 Aligned_cols=263 Identities=17% Similarity=0.230 Sum_probs=210.7
Q ss_pred CCCCCccccCHHHHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCC
Q 019905 39 DGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRN 115 (334)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h 115 (334)
..+.+.+.++..++... .. ..+|+|+++.||+|.+ +|+.||+|.+....... .+.+.+|+.++++++|
T Consensus 7 ~~~~~~~~i~~~~i~~~-----~~---~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h 77 (283)
T PHA02988 7 SYINDIKCIESDDIDKY-----TS---VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDS 77 (283)
T ss_pred hhcCcceecCHHHcCCC-----CC---eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCC
Confidence 34455666777776221 11 2349999999999998 57899999997654333 3567799999999999
Q ss_pred CCccceeeeeee----CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCe
Q 019905 116 NRLTNLLGCCCE----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRI 190 (334)
Q Consensus 116 ~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Ni 190 (334)
|||+++++++.. ....+++|||+++|+|.+++. ..+.+++.....++.+++.||.|||+. + ++||||||+||
T Consensus 78 ~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~Hrdlkp~ni 154 (283)
T PHA02988 78 NNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTN-KPYKNLTSVSF 154 (283)
T ss_pred CCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhcCC-CCCCcCChhhE
Confidence 999999999876 346789999999999999997 445788999999999999999999985 6 89999999999
Q ss_pred eecCCCCeeEcCCCCCccCCCC-CcccccccccCcccccC--CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc
Q 019905 191 LFDEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267 (334)
Q Consensus 191 li~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~ 267 (334)
++++++.+||+|||++...... ....++..|+|||++.+ ..++.++||||||+++|||++|..||.......+....
T Consensus 155 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i 234 (283)
T PHA02988 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234 (283)
T ss_pred EECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999999999998754432 33457889999999976 56999999999999999999999998765433322211
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
. ........+...+..+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 235 ~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 235 I----NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred H----hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 111122233456678999999999999999999999999998876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=325.27 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=211.1
Q ss_pred CCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC----CC-CChHHHHHHHHHHhcCC-CCCccceeeeeeeCCe
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM----AW-PDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDE 130 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 130 (334)
....|.+.+.||+|+||+|++|.. .++..||+|.+... .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345688888899999999999985 46799999977653 11 23456778999999998 9999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-CCeeEcCCCCCccC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNS 209 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-~~~kl~Dfg~a~~~ 209 (334)
.++||||+.+|+|.+++. ..+.+.+.....++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~--~~g~l~E~~ar~~F~Qlisav~y~H~~g-i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV--NKGRLKEDEARKYFRQLISAVAYCHSRG-IVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHH--HcCCCChHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999997 3678899999999999999999999999 9999999999999998 99999999999877
Q ss_pred C----CCCcccccccccCcccccCCC-CC-CccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 210 R----DGKSYSTNLAFTPPEYLRTGR-VT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 210 ~----~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
. ......|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||............ ... .-.+|..
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki----~~~--~~~~p~~ 245 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI----RKG--EFKIPSY 245 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH----hcC--CccCCCC
Confidence 2 234678999999999999877 86 6899999999999999999999875444333321 111 1233444
Q ss_pred h-HHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 284 D-GTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 284 ~-~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
. +.++..|+.+||..||.+|+|+.+++ .-.-++.
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 4 78999999999999999999999999 5555554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=304.77 Aligned_cols=236 Identities=17% Similarity=0.216 Sum_probs=206.4
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+++.++.+|.|+||.|.+.+.+ ++..+|+|.+........ +...+|..+|+.+.||.++++++.+.+.+++++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 455677888899999999999954 578999999976543332 4567899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-C
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-K 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~ 213 (334)
|||++||.|.++++ +.+.++++..+.++.||+.||.|||+++ |++||+||+|||+|.+|.+|+.|||+|+..... -
T Consensus 123 meyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~-iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD-IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred EeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC-eeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 99999999999997 6678999999999999999999999999 999999999999999999999999999976654 3
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
+..||+.|+|||.++..+|..++|.||||+++|||+.|..||.......+.+.. .... -.+|.-.+.++.+|+.
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI----~~~~--v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI----LEGK--VKFPSYFSSDAKDLLK 273 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH----HhCc--ccCCcccCHHHHHHHH
Confidence 678999999999999999999999999999999999999999887654444332 2222 2467777889999999
Q ss_pred HhhhcCCCCC
Q 019905 294 RCLQYEPRER 303 (334)
Q Consensus 294 ~cl~~dp~~R 303 (334)
++|+.|-..|
T Consensus 274 ~LL~vD~t~R 283 (355)
T KOG0616|consen 274 KLLQVDLTKR 283 (355)
T ss_pred HHHhhhhHhh
Confidence 9999999999
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=306.23 Aligned_cols=267 Identities=19% Similarity=0.250 Sum_probs=211.6
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeee--CC
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE--GD 129 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 129 (334)
..++.++|+.+.+|++|+||.||+|+. ++++.||+|+++...... .-...+||.+|.+++|||||.+..+.+. -+
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 445667788999999999999999995 468999999998765332 2246789999999999999999998765 35
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..|+||||++ -+|.+.+.. -.++|...++.-++.|++.|+.|||.+. |+||||||+|+|++..|.+|++|||+|+.+
T Consensus 151 ~iy~VMe~~E-hDLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~w-ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVE-HDLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNW-ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHH-hhHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhce-eEecccchhheeeccCCcEEecccchhhhh
Confidence 6999999997 688888875 3478999999999999999999999999 999999999999999999999999999987
Q ss_pred CCC----CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc---------------
Q 019905 210 RDG----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--------------- 269 (334)
Q Consensus 210 ~~~----~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~--------------- 269 (334)
.+. ...+.|..|+|||.+.+.. |++++|+||+||++.|++++++.|++...-...+..+.
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 664 3567799999999998876 99999999999999999999988876532222111111
Q ss_pred ----------cccccccCCCCCch-hHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 270 ----------MLTDSCLEGQFTDD-DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 270 ----------~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
..+...++..+... .+....+|+..+|.+||..|.|+++.|+- ....+.+.+.+|
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P 373 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDP 373 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCCh
Confidence 11111111122222 45788899999999999999999999853 344444444433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=344.66 Aligned_cols=260 Identities=24% Similarity=0.310 Sum_probs=215.2
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.+....++||+|+||.||+|... ....||||.++..... ...+|++|++++..++|||||+++|+|..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34566789999999999999843 2468999999877644 3568999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccC--------CC----CCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeE
Q 019905 133 LVAEYMPNETLAKHLFHWE--------TH----PMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--------~~----~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl 200 (334)
+|+||+..|+|.++|+... .. +++..+.+.|+.||+.|+.||-++. +|||||-.+|+||.++..|||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-FVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-ccccchhhhhceeccceEEEe
Confidence 9999999999999997431 22 3888999999999999999999998 999999999999999999999
Q ss_pred cCCCCCccCCCCCc------ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCC-CCCCchhhHHhhhcccccccc
Q 019905 201 STFGLMKNSRDGKS------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-HIPPSHALDLIRDRNLQMLTD 273 (334)
Q Consensus 201 ~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~ 273 (334)
+|||+++....... ..-.++|||||.+..+.+|++|||||||+++||+++.+ .|+.+-+.+.+.........
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l- 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL- 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-
Confidence 99999986554332 22357999999999999999999999999999999955 45555444433322221111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCC
Q 019905 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSIS 325 (334)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~ 325 (334)
-..|..++.++++||..||+.+|.+||++.+|-..|++.-+..+.-++
T Consensus 724 ----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 724 ----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS 771 (774)
T ss_pred ----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence 245677778999999999999999999999999999998766555443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.44 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=200.3
Q ss_pred cccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeeeC-Cee
Q 019905 61 VENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEG-DER 131 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~ 131 (334)
+|++.+.||+|+||.||+|.+ .++..||+|.+....... ...+.+|+.++..+ +||||+++++++... +..
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 577788899999999999974 224689999997543222 35688999999999 899999999988764 457
Q ss_pred eEEEecCCCCCHHHhhcccC------------------------------------------------------------
Q 019905 132 LLVAEYMPNETLAKHLFHWE------------------------------------------------------------ 151 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~------------------------------------------------------------ 151 (334)
+++|||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 89999999999999886321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC------CcccccccccCcc
Q 019905 152 THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPE 225 (334)
Q Consensus 152 ~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE 225 (334)
..++++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ....++..|+|||
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 134778888999999999999999999 999999999999999999999999998754321 1223457899999
Q ss_pred cccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCC
Q 019905 226 YLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304 (334)
Q Consensus 226 ~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 304 (334)
++.+..++.++||||||+++|||++ |..||........... .+... .....+...++.+.+++.+||+.||.+||
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---RLKDG-TRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9998889999999999999999997 8877765322111000 00111 11122345567899999999999999999
Q ss_pred CHHHHHHHhcccccc
Q 019905 305 NPKSLVTALSPLQKE 319 (334)
Q Consensus 305 s~~~~l~~L~~l~~~ 319 (334)
|+.++++.|+.+..+
T Consensus 323 s~~el~~~l~~~~~~ 337 (338)
T cd05102 323 TFSALVEILGDLLQE 337 (338)
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=326.41 Aligned_cols=247 Identities=20% Similarity=0.314 Sum_probs=207.9
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
....|..+.-++.||+|+.|.||+|.+++ +.||||+++.-. ..+|.-|++|+|+||+.+.|+|....-++||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 33445555556788999999999999865 899999985322 3578889999999999999999998889999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
||||..|.|..+|+ ..+.+.......|..+|+.|+.|||.+. |||||||.-||||+.+..|||+|||-++.....
T Consensus 191 MEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK-IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK-IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred eeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh-HhhhccCCCceEeeccceEEeccccchHhhhhhhh
Confidence 99999999999997 6778999999999999999999999998 999999999999999999999999988765543
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
..+.||..|||||++.+.+.+.|+||||||+|||||+||..|+..-....+. -.+....+.-..|..++..+.-|
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----EeccCCcccccCcccCchHHHHH
Confidence 3578999999999999999999999999999999999999988654333222 22222222333455666689999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+++||+..|..|||+++++.-|+-.
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999999888654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=323.84 Aligned_cols=239 Identities=19% Similarity=0.267 Sum_probs=205.5
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|.+.+.+|+|.||+||+|+. .+.+.||+|.+...... +.+.+.+|+++++.++||||+.++++|....+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 44555669999999999994 45789999999754432 2456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----c
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 214 (334)
. |+|..++. ....+++..+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|+||||+|+...... .
T Consensus 84 ~-g~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~r-ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 84 V-GDLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNR-ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred h-hhHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcC-cccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 7 59999997 5578999999999999999999999999 9999999999999999999999999998766543 4
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..||+.|||||++.+.+|+..+|+||+||++||+++|++||........-...... + ...|...+..+..|+..
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~---v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P---VKPPSTASSSFVNFLQG 233 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C---CCCcccccHHHHHHHHH
Confidence 57899999999999999999999999999999999999999876554433222221 1 12345677899999999
Q ss_pred hhhcCCCCCCCHHHHH
Q 019905 295 CLQYEPRERPNPKSLV 310 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l 310 (334)
+|..||..|.|..+++
T Consensus 234 LL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLL 249 (808)
T ss_pred HhhcChhhcccHHHHh
Confidence 9999999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=319.45 Aligned_cols=249 Identities=16% Similarity=0.166 Sum_probs=205.0
Q ss_pred hcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
-...++++++..||+|+||.||+|+. ++|+.+|+|+++..... ..+.+..|-++|...++|+||+++..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34567888999999999999999994 56999999999865422 245678899999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC-
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR- 210 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~- 210 (334)
||||||+|||++..+|. ....|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+|||++.-..
T Consensus 217 YLiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g-yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG-YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC-cccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999986 5678999999999999999999999999 9999999999999999999999999964100
Q ss_pred -------------------------C-----C--------------------CcccccccccCcccccCCCCCCccchhh
Q 019905 211 -------------------------D-----G--------------------KSYSTNLAFTPPEYLRTGRVTPESVIYS 240 (334)
Q Consensus 211 -------------------------~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~s 240 (334)
+ . ...+||+.|+|||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 0 1236899999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 019905 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLV 310 (334)
Q Consensus 241 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l 310 (334)
|||++|||+.|-+||..+................ ...-....+.++.+||.+|+. ||..|.. ++||.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l--~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL--KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc--cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999999999998776555443332221111 111122334789999999999 9999965 55543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=313.17 Aligned_cols=240 Identities=24% Similarity=0.301 Sum_probs=192.9
Q ss_pred cccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC-----eeeEEEecC
Q 019905 65 VSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERLLVAEYM 138 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 138 (334)
.+.+|.|+||+||+|... +++.||||+...+. +.-.+|+++++.++|||||++..+|.... ...+||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 344599999999999964 46899999986543 34468999999999999999999886532 356999999
Q ss_pred CCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCccCCCC---
Q 019905 139 PNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 139 ~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~~~~~~--- 212 (334)
| .+|.++++.. .+..++.-.+.-+++||++||+|||+.+ |+||||||.|+|+|. .|.+||||||.|+....+
T Consensus 105 P-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 105 P-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG-ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred h-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC-cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 8 7898888632 3567778888999999999999999999 999999999999995 599999999999976543
Q ss_pred CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhh-----------------------ccc
Q 019905 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD-----------------------RNL 268 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~-----------------------~~~ 268 (334)
.++..+..|+|||.+.|.. |+.+.||||.||++.||+-|++.|+++....... ...
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~ 262 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKF 262 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccC
Confidence 4566789999999999876 9999999999999999999999888752222111 011
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
..+....+........++++.+|+.++|+++|.+|.++.+++
T Consensus 263 p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 263 PQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred cccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 222222332334556678999999999999999999999997
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=317.91 Aligned_cols=242 Identities=19% Similarity=0.287 Sum_probs=202.9
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
|..+..+|+|.||.||+|.. .+++.||+|.+......+ .+.+.+|+..|..++++||.++++.+..+..++++|||+.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 44456679999999999994 568899999998765443 5788999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~ 215 (334)
+|++.+.+. ....+.+..+.-++.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..... ..+.
T Consensus 95 gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~-kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 95 GGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK-KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred Ccchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc-eecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 999999995 3444588888899999999999999999 99999999999999999999999999875543 2577
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
+||+.|||||++.+..|+.++||||||++.+||.+|.+|+...-. .. ...+........+...+++.+.+|+..|
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----mr-vlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----MR-VLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----ce-EEEeccCCCCCccccccCHHHHHHHHHH
Confidence 899999999999988899999999999999999999987643321 11 1111111222233345677899999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 019905 296 LQYEPRERPNPKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~ 311 (334)
|++||+.||||.++|+
T Consensus 247 L~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLK 262 (467)
T ss_pred hhcCcccCcCHHHHhh
Confidence 9999999999999984
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.08 Aligned_cols=247 Identities=18% Similarity=0.203 Sum_probs=217.5
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCe-eeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE-RLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 135 (334)
+.|.+++.+|+|+||.+++..++ +++.+++|.+....... .+...+|+.++++++|||||.+.+.|..++. .+|+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788889999999999999854 46899999998665444 3467889999999999999999999999888 99999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
+|++||++.+.+.+.+...+++..+..|+.|++.|+.|||+++ |+|||||+.||+++.++.|+|+|||+|+...+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~-iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR-VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh-hhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999998767788999999999999999999999888 9999999999999999999999999999877653
Q ss_pred --cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 214 --SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
+..||+.||.||.+.+.+|..|+|||||||++|||++-+++|................. ...+..++.++..+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-----~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-----SPLPSMYSSELRSL 237 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-----CCCCccccHHHHHH
Confidence 57899999999999999999999999999999999999999887766555544444332 24566778899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~ 312 (334)
+..|++.+|..||++.++|..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=312.83 Aligned_cols=247 Identities=16% Similarity=0.228 Sum_probs=200.0
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|+.++.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++|++|+++.+++..++..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 34566779999999999985 5689999999864332 1234577899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Cc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KS 214 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~ 214 (334)
+++++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++...... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999998876434457899999999999999999999999 999999999999999999999999998765432 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..|+..|+|||++.+..++.++||||||+++|+|++|+.||.................. ....++...+.++.+|+.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHH
Confidence 46789999999999989999999999999999999999998654321111111111111 1123445566789999999
Q ss_pred hhhcCCCCCCC-----HHHHHH
Q 019905 295 CLQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps-----~~~~l~ 311 (334)
||+.||.+||+ ++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhc
Confidence 99999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=288.99 Aligned_cols=257 Identities=19% Similarity=0.205 Sum_probs=209.3
Q ss_pred CCCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC-----Cee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DER 131 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 131 (334)
|-..|++.+.+|+|+|+.||+++ ..+++.+|+|++.-...++.+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 44678899999999999999999 667899999999877767788899999999999999999999987543 348
Q ss_pred eEEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 132 LLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
|++++|...|||.+.+... ++..+++.+++.|+.++++||.+||+..+ ++||||||.|||+.+.+.+++.|||.+..
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999998753 34578999999999999999999999753 89999999999999999999999999865
Q ss_pred CCCC-------------CcccccccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc
Q 019905 209 SRDG-------------KSYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272 (334)
Q Consensus 209 ~~~~-------------~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 272 (334)
..-. .....|..|+|||.+. +...+.++|||||||++|.|+.|..||...-. ..+.....+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSlaLAv 255 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSLALAV 255 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeEEEee
Confidence 3321 1234688999999984 45588999999999999999999998864322 222211111
Q ss_pred cc-ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 273 DS-CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 273 ~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
.. ...-......++.+.+++.+|++.||.+||++.+++..++++.
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 1111112236789999999999999999999999999998875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=314.35 Aligned_cols=243 Identities=18% Similarity=0.190 Sum_probs=202.4
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4677788899999999999965 588999999864321 223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Ccc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~ 215 (334)
|+++++|.+++. ..+.+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 82 YVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 999999999986 4457899999999999999999999999 999999999999999999999999998765443 245
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.|++.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+..+.+++.+|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------KLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CcCCCccCCHHHHHHHHHH
Confidence 6889999999999888999999999999999999999998765433322221111 1123444566899999999
Q ss_pred hhcCCCCCCC-----HHHHHHH
Q 019905 296 LQYEPRERPN-----PKSLVTA 312 (334)
Q Consensus 296 l~~dp~~Rps-----~~~~l~~ 312 (334)
|+.||.+||+ +.++++-
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcC
Confidence 9999999995 8888743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=317.44 Aligned_cols=236 Identities=20% Similarity=0.243 Sum_probs=197.3
Q ss_pred cCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 469999999999985 4688999999975321 123456789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCccccc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYSTN 218 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~ 218 (334)
|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..... .....|+
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 82 LFFHLS--RERVFSEDRARFYGAEIVSALGYLHSCD-VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999886 4467899999999999999999999999 99999999999999999999999999875322 2235689
Q ss_pred ccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc
Q 019905 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (334)
Q Consensus 219 ~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (334)
+.|+|||++.+..++.++|||||||++|+|++|..||............... ...++...+.++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999888999999999999999999999998765443332221111 1123455677899999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 019905 299 EPRERP-----NPKSLVT 311 (334)
Q Consensus 299 dp~~Rp-----s~~~~l~ 311 (334)
||.+|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 233 DPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHcCCCCCCCHHHHHc
Confidence 999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=303.45 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=207.6
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..++++++++|+|++|.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45688889999999999999998788899999987543 23567889999999999999999999999888999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 213 (334)
++++|.+++.......+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 9999999987544567888999999999999999999998 9999999999999999999999999987654322
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||................ ........+.++.+++
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li 237 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-----RMPRMENCPDELYDIM 237 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCCHHHHHHH
Confidence 2234567999999988889999999999999999998 777776543332222111111 1112233456899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccc
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+||+.+|++||+++++++.|+++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.83 Aligned_cols=243 Identities=17% Similarity=0.202 Sum_probs=202.4
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
+.+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 456788888999999999999965 57899999986432 12345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-C
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-K 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~ 213 (334)
|||+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... .
T Consensus 97 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 97 LEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSKD-IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred EcCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999999986 3457889999999999999999999999 999999999999999999999999998765443 3
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...|++.|+|||++.+..++.++||||||+++|+|++|..||.............. . ...++...+..+.+|+.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA----G--RLKFPNWFDGRARDLVK 247 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc----C--CcCCCCCCCHHHHHHHH
Confidence 45688999999999998899999999999999999999999876543222211111 1 11233345568999999
Q ss_pred HhhhcCCCCCCC-----HHHHH
Q 019905 294 RCLQYEPRERPN-----PKSLV 310 (334)
Q Consensus 294 ~cl~~dp~~Rps-----~~~~l 310 (334)
+||+.||.+||+ +++++
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHh
Confidence 999999999987 57776
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=303.84 Aligned_cols=249 Identities=20% Similarity=0.326 Sum_probs=199.1
Q ss_pred cccCCCcCccEEEEEEe-CCCCEEEEEEecC--CCCCChHHHHHHHHHHhcCCCCCccceeeeeee-----CCeeeEEEe
Q 019905 65 VSEHGEKAPNVVYKGKL-ENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE-----GDERLLVAE 136 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 136 (334)
++.+|+|+||.|..+.. .+|+.||||++.. ....+.+...+|+.+|+.++|+||+.+.+++.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 56779999999999985 5689999999973 334456778899999999999999999999865 245899999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
++ +.+|...+. .++.++......+++|++.||.|+|+.+ |+|||+||.|+|++.+..+|++|||+|+....
T Consensus 107 lM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAn-ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 107 LM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSAN-VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred HH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhccc-ccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence 99 589999996 4556999999999999999999999999 99999999999999999999999999997742
Q ss_pred -CCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhH-------------------Hhhhc----
Q 019905 212 -GKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALD-------------------LIRDR---- 266 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~-------------------~~~~~---- 266 (334)
-...+.|..|.|||++... .|+.+.||||+||++.||++|+..|++...- .+...
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~ 262 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP 262 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence 1355678999999998654 4999999999999999999999888754111 11100
Q ss_pred c---cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhccccc
Q 019905 267 N---LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQK 318 (334)
Q Consensus 267 ~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~~ 318 (334)
. ........+.. ..+..++.+.+|+.+||..||.+|+|++++|. .|+.+-+
T Consensus 263 yi~slp~~p~~~f~~-~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 263 YIKSLPQIPKQPFSS-IFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHhCCCCCCCCHHH-HcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 0 11111111111 22356678999999999999999999999984 4555544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=304.10 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=202.3
Q ss_pred CcccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+++.+.||+|+||.||+|.++ .+..||+|.++...... ...+.+|+..++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45677788899999999999853 35689999997643222 34678899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~~-iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 85 TEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMG-YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999999999864 3457899999999999999999999999 9999999999999999999999999865432221
Q ss_pred ----cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 214 ----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...++..|+|||.+.+..++.++||||||+++|++++ |..||............... .....+...+..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 237 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-----FRLPAPRNCPNLL 237 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----CCCCCCCCCCHHH
Confidence 2234568999999998889999999999999999875 88777654332222111111 1112344556789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+++.+||+.+|.+||+++++++.|+++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=313.34 Aligned_cols=251 Identities=20% Similarity=0.232 Sum_probs=201.1
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.+|++++.||+|+||.||++... ++..+|+|.+...... ....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 56778888999999999999965 5788999998754321 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--Ccc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSY 215 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~ 215 (334)
+++++|.+++. ....+++..+..++.|++.||.|||+.+.++||||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 85 MDGGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 99999999986 34568899999999999999999998633999999999999999999999999998754332 345
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc-------------------------
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM------------------------- 270 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~------------------------- 270 (334)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||...............
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence 6889999999999888999999999999999999999988643222111000000
Q ss_pred -----------------ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 271 -----------------LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 271 -----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
+.............+.++.+|+.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000001112356789999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.07 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=201.6
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
+++++++.||+|+||.||++.++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4567788899999999999998887899999986443 335678899999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.. ....+++..+..++.+++.||.|||+++ ++|+||+|+||++++++.++|+|||.+....... .
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 83 NGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERNS-FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999998864 2346889999999999999999999999 9999999999999999999999999887543322 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++|+||||+++|++++ |+.|+............... .....+...+..+.+++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRLYRPKLASMTVYEVMY 235 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHHH
Confidence 234568999999988889999999999999999999 77776544322221111110 011123334568999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhc
Q 019905 294 RCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+||+.+|.+|||+.++++.|.
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHccCCcccCcCHHHHHHhhC
Confidence 999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=285.96 Aligned_cols=244 Identities=21% Similarity=0.249 Sum_probs=209.6
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
++++.+.||+|-||.||+|.. +++-.||+|++..... .-..++.+|+++-..|+||||++++++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 355667779999999999994 5577999999965431 224578899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--CCc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKS 214 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~ 214 (334)
|.+.|++...+.......+++...+.++.|++.||.|+|.++ |+||||||+|+|++..+.+|++|||.+...+. ..+
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~-VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~t 181 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKT 181 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC-cccCCCCHHHhccCCCCCeeccCCCceeecCCCCcee
Confidence 999999999998766778999999999999999999999999 99999999999999999999999999776543 346
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..||..|.+||...+..++..+|+|++|++.||++.|.+||.............. . .-.+|...+.++.++|.+
T Consensus 182 lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----~--~~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 182 LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----V--DLKFPSTISGGAADLISR 255 (281)
T ss_pred eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----c--cccCCcccChhHHHHHHH
Confidence 7899999999999999999999999999999999999999987654433322211 1 123456677799999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
|+..+|.+|.+..++++
T Consensus 256 ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMD 272 (281)
T ss_pred HhccCccccccHHHHhh
Confidence 99999999999999875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=302.21 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=209.3
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.+|.+++.+|.|++|.||+|...++..+++|.+..........+..|+.+++.++|+||+++++++......+++|||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34677888899999999999987789999999987665456778999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----cc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----SY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~ 215 (334)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~ 164 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccCcceEEEcCCceEEEccccchhhcCCccccccCC
Confidence 999999997655567899999999999999999999999 9999999999999999999999999987654321 22
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
.++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. ......+...+..+.+++.+
T Consensus 165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-----GYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-----CCcCCCCCCCCHHHHHHHHH
Confidence 34568999999988889999999999999999998 6777754432222211111 11112234556789999999
Q ss_pred hhhcCCCCCCCHHHHHHHhccc
Q 019905 295 CLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l 316 (334)
||+.||.+|||+.++++.|+.+
T Consensus 240 ~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 240 CWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=308.63 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=196.3
Q ss_pred CcccccccCCCcCccEEEEEEeCC-----------------CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-----------------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNL 121 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~ 121 (334)
..|.+.++||+|+||.||++.+++ +..||+|.+...... ....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 356677888999999999997532 336999998754322 23468899999999999999999
Q ss_pred eeeeeeCCeeeEEEecCCCCCHHHhhcccC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecc
Q 019905 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWE-----------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184 (334)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 184 (334)
++++...+..+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-ivH~d 163 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRD 163 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-ccccC
Confidence 999999889999999999999999885321 124677889999999999999999999 99999
Q ss_pred cCCCCeeecCCCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhC--CCCCC
Q 019905 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG--KHIPP 256 (334)
Q Consensus 185 ikp~Nili~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg--~~p~~ 256 (334)
|||+|||++.++.+||+|||++....... ...++..|+|||++.+..++.++||||||+++|+|+++ ..|+.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999987543321 22346789999999888899999999999999999875 34444
Q ss_pred chhhHHhhhcccccccc--cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 257 SHALDLIRDRNLQMLTD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 257 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
................. .......+...+..+.+++.+||+.||.+|||+.++.+.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 32222111111000000 00011123345668999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=320.52 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=211.7
Q ss_pred CcccccccCCCcCccEEEEEEeCC--C---CEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN--Q---RRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
++..+.++||+|+||.||+|.+.. + ..||+|...... ......+.+|+++++.++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445556889999999999999532 2 238999998633 22245688999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++|||+++||+|.+++.. ....++..++..++.+.+.||+|||+++ ++||||-.+|+|++.++.+|++|||++.....
T Consensus 237 ~ivmEl~~gGsL~~~L~k-~~~~v~~~ek~~~~~~AA~Gl~YLh~k~-~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKK-NKKSLPTLEKLRFCYDAARGLEYLHSKN-CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEEecCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHhHHHHHHHCC-CcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999999999985 3336999999999999999999999999 99999999999999999999999999875542
Q ss_pred CC----cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 212 GK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 212 ~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
.. ...-..+|+|||.+..+.|+.++||||||+++||+++ |..|+++.....++... .....+...+...+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI----~~~~~r~~~~~~~p~ 390 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI----VKNGYRMPIPSKTPK 390 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH----HhcCccCCCCCCCHH
Confidence 11 1124579999999999999999999999999999999 67777766554444322 122233344556777
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
++..++.+||..+|+.||||.++.+.|+.+.+....
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999998876554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.03 Aligned_cols=246 Identities=17% Similarity=0.204 Sum_probs=203.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC--CCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN--QRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.+..|++++.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 45568888899999999999998543 3689999986432 123456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++|+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999986 4457899999999999999999999999 999999999999999999999999998765432
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
....||+.|+|||++.+..++.++||||||+++|+|++|..||............... . ..++...+..+.++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~----~--~~~p~~~~~~~~~l 258 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG----I--IYFPKFLDNNCKHL 258 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC----C--CCCCCCCCHHHHHH
Confidence 3456899999999999888999999999999999999999998765433222221111 1 12344556689999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHHH
Q 019905 292 ASRCLQYEPRERP-----NPKSLVTA 312 (334)
Q Consensus 292 i~~cl~~dp~~Rp-----s~~~~l~~ 312 (334)
+.+||+.||.+|+ +++++++-
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999995 88888753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.77 Aligned_cols=241 Identities=20% Similarity=0.307 Sum_probs=207.2
Q ss_pred hcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCe
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 130 (334)
.-+..++++++.||+|.||+|+++..+ +++.+|||.++.... ++.+....|..++... +||.+++++..|++..+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345667888899999999999999965 578999999987652 3356677888888877 59999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
+|+||||+.||++..+. ..+.|++..+..++..|+.||+|||+++ |||||||.+|||+|.+|.+||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~-IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG-IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC-ceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999954444 5578999999999999999999999999 9999999999999999999999999998643
Q ss_pred ----CCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 211 ----DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 211 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
...+..||+.|||||++.+..|+.++|.||||+++|||+.|..||+++..+.+-+..... ...+|...+.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~~~yP~~ls~ 593 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSK 593 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------CCCCCCcccH
Confidence 235678999999999999999999999999999999999999999987666555433221 2246777888
Q ss_pred HHHHHHHHhhhcCCCCCCCH
Q 019905 287 ELVRLASRCLQYEPRERPNP 306 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~ 306 (334)
+..+++.++|..+|+.|.-+
T Consensus 594 ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHhccCcccccCC
Confidence 99999999999999999766
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=317.79 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=197.6
Q ss_pred cccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 61 VENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
++++.+.||+|+||.||+|.+ +++..||+|.+..... ...+.+.+|+.++..+ +||||+++++++...+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 466778889999999999973 2356899999975432 2345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccC-------------------------------------------------------------
Q 019905 133 LVAEYMPNETLAKHLFHWE------------------------------------------------------------- 151 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~------------------------------------------------------------- 151 (334)
+||||+++|+|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999885321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC------
Q 019905 152 ------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------ 213 (334)
Q Consensus 152 ------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~------ 213 (334)
...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 124678889999999999999999999 9999999999999999999999999987544322
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||............ .........+...+.++.+|+
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM----IKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH----HHhCccCCCCCCCCHHHHHHH
Confidence 1223467999999999899999999999999999998 66666443211100000 001111112233456899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccc
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+||+.||++|||+.++++.|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=300.11 Aligned_cols=250 Identities=21% Similarity=0.335 Sum_probs=205.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.++.+.+.+|+|++|.||+|... .++.||+|.+.... .....+.+|+++++.++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34667788899999999999964 47899999987543 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 213 (334)
++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||++++++.++|+|||.+.......
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9999999986544556899999999999999999999999 9999999999999999999999999987654322
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
....+..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. ......+...+..+.+++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----GYRMERPEGCPPKVYELM 238 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-----CCCCCCCCCCCHHHHHHH
Confidence 1223467999999998889999999999999999998 7777765433322211111 111233445567899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccc
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+||+.||++|||+.++++.|+.+
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=312.08 Aligned_cols=234 Identities=21% Similarity=0.229 Sum_probs=194.4
Q ss_pred CCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 599999999999964 57899999986432 22235677899999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccccc
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYSTNL 219 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~~ 219 (334)
.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... .....||+
T Consensus 81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKFN-VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99986 3457899999999999999999999999 99999999999999999999999999875322 22346889
Q ss_pred cccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcC
Q 019905 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (334)
Q Consensus 220 ~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (334)
.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+..+.+++.+||+.|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE------PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC------CCCCCCcCCHHHHHHHHHHcCCC
Confidence 999999999988999999999999999999999998765444333222111 11234456678999999999999
Q ss_pred CCCCCC---HHHHH
Q 019905 300 PRERPN---PKSLV 310 (334)
Q Consensus 300 p~~Rps---~~~~l 310 (334)
|.+||+ +.+++
T Consensus 232 p~~R~~~~~~~e~l 245 (312)
T cd05585 232 PTRRLGYNGAQEIK 245 (312)
T ss_pred HHHcCCCCCHHHHH
Confidence 999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=305.87 Aligned_cols=247 Identities=19% Similarity=0.209 Sum_probs=201.5
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--------------ChHHHHHHHHHHhcCCCCCccceee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--------------DPRQFLEEARSVGQLRNNRLTNLLG 123 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~iv~~~~ 123 (334)
...|+++.+||+|.||.|-+|.. .+++.||||.+....+. ..+.+.+||.++++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 45688889999999999999994 45889999999643211 1246889999999999999999999
Q ss_pred eeeeC--CeeeEEEecCCCCCHHHhhcccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeE
Q 019905 124 CCCEG--DERLLVAEYMPNETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (334)
Q Consensus 124 ~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl 200 (334)
+..+. +.+|+|+||+..|.+...- ..++ +++.++++++.+++.||.|||.++ |+||||||+|+|++++|++||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg-iiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG-IIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEEcCCCcEEe
Confidence 98764 5799999999988875433 3455 899999999999999999999999 999999999999999999999
Q ss_pred cCCCCCccCCCC---------CcccccccccCcccccCCC----CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc
Q 019905 201 STFGLMKNSRDG---------KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267 (334)
Q Consensus 201 ~Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~ 267 (334)
+|||.+.....+ ....||+.|+|||.+.++. .+.+.||||+|++||.|+.|+.||..+......+..
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 999998755221 2467999999999998743 456899999999999999999999887655554433
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 019905 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L 313 (334)
.. ..+...-.++..+++.+||.++|++||+.|.+..+|..-.
T Consensus 332 vn----~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 332 VN----DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred hc----CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 32 2222222335677999999999999999999999986554
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=313.87 Aligned_cols=249 Identities=17% Similarity=0.181 Sum_probs=203.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++++.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4677888899999999999965 57899999997432 1224567889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-CCcc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-GKSY 215 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~-~~~~ 215 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELG-YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 999999999996 4457889999999999999999999999 99999999999999999999999999876543 2345
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc--cccccccCCCCCchhHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--MLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
.|++.|+|||++.+..++.++||||||+++|+|++|..||.............. ...............+.++.+++.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 688999999999988999999999999999999999999875433322111100 001100000111234668999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~ 312 (334)
+||..+|.+||++.++++.
T Consensus 239 ~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhhChhhhcCCHHHHHhC
Confidence 9999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=318.67 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=200.8
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 131 (334)
.+|++.+.||+|+||.||++... ++..||+|.+....... ...+.+|+++++.+ +|+||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 35777888899999999998742 24579999997543222 34678899999999 899999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccC------------------------------------------------------------
Q 019905 132 LLVAEYMPNETLAKHLFHWE------------------------------------------------------------ 151 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~------------------------------------------------------------ 151 (334)
+++|||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999875311
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC------cccc
Q 019905 152 --------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYST 217 (334)
Q Consensus 152 --------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~------~~~~ 217 (334)
..++++..++.++.|++.||.|||+++ ++||||||+||++++++.++|+|||++....... ...+
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 124678889999999999999999999 9999999999999999999999999987543321 1223
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (334)
+..|+|||++.+..++.++||||||+++|+|++ |..||......... ............+...++++.+++.+||
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF----YKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH----HHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 467999999988889999999999999999997 88887654321111 0111111122223334578999999999
Q ss_pred hcCCCCCCCHHHHHHHhcccc
Q 019905 297 QYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 297 ~~dp~~Rps~~~~l~~L~~l~ 317 (334)
+.||.+|||+.++++.|+++.
T Consensus 353 ~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 353 NLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=298.38 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=205.5
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..+++.+.+|+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 3466778889999999999998778899999997644 345678899999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC--ccc-
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--SYS- 216 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~- 216 (334)
+++|.+++.......+++..+..++.+++.||.+||+++ ++||||||+||++++++.++|+|||++....... ...
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 999999996534456899999999999999999999999 9999999999999999999999999987654321 112
Q ss_pred --ccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 217 --TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 217 --~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
.+..|+|||.+.+..++.++||||||+++|+|++ |+.||............... .....+...+..+.+++.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-----YRMPCPPGCPKELYDIML 238 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcCCHHHHHHHH
Confidence 2357999999998889999999999999999999 77777554332222111111 111223345678999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+||+.+|.+||++.++++.|+.+
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=317.35 Aligned_cols=245 Identities=18% Similarity=0.257 Sum_probs=214.2
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
...+++.+.||.|+.|.|-+|++ .+|+.+|||.+.... ......+.+|+-+++.+.|||++++++++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45677888899999999999995 579999999997652 12245688999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
.||+++|.|.+++. ..+++++.+..++++||+.|+.|+|..+ |+|||+||+|+|++..+++||+|||+|....++.
T Consensus 91 lEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~-icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFN-ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhc-ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999997 6688999999999999999999999999 9999999999999999999999999998766553
Q ss_pred --cccccccccCcccccCCCCC-CccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 214 --SYSTNLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
+..|.+.|.+||++.|.+|. .++||||.|+++|.|++|..||.++.............. ..|...+.++.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------~MPs~Is~eaQd 241 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------EMPSNISSEAQD 241 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------cCCCcCCHHHHH
Confidence 56789999999999999975 589999999999999999999998776655544333222 345677789999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~ 312 (334)
|+.+|+..||..|.|+++|++-
T Consensus 242 LLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 242 LLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHhccCccccccHHHHhhC
Confidence 9999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=311.85 Aligned_cols=236 Identities=19% Similarity=0.244 Sum_probs=196.4
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
.||+|+||.||++... ++..||+|.+..... .....+.+|+.+++.++||||+++.+++...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 4699999999999954 588999999975421 223467789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCccccc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYSTN 218 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~ 218 (334)
|.+++. ....+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++..... .....|+
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 82 LFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 998886 3457899999999999999999999999 99999999999999999999999999875322 1234688
Q ss_pred ccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc
Q 019905 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (334)
Q Consensus 219 ~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (334)
+.|+|||.+.+..++.++||||||+++|+|++|..||.............. ....++...+.++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EDIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------CCccCCCCCCHHHHHHHHHHcCC
Confidence 999999999988899999999999999999999999865543332221111 01123455667899999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 019905 299 EPRERP-----NPKSLVT 311 (334)
Q Consensus 299 dp~~Rp-----s~~~~l~ 311 (334)
||.+|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=303.36 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=203.4
Q ss_pred CcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.++++++.||+|+||.||+|.... ...|++|.+....... ...+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 457788889999999999998533 2579999987543222 346789999999999999999999999888899
Q ss_pred EEEecCCCCCHHHhhcccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCe
Q 019905 133 LVAEYMPNETLAKHLFHWET--------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~ 198 (334)
++|||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccccceEEEcCCCcE
Confidence 99999999999999864211 45788899999999999999999999 9999999999999999999
Q ss_pred eEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccc
Q 019905 199 RLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQML 271 (334)
Q Consensus 199 kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 271 (334)
+|+|||++...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..............
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~-- 241 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS-- 241 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--
Confidence 99999998754322 12344678999999988889999999999999999998 8888765433322221111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
. .....+...+.++.+|+.+||+.||.+||++.++++.|+.+
T Consensus 242 --~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 242 --R-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --C-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 11123455677999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=295.73 Aligned_cols=256 Identities=20% Similarity=0.254 Sum_probs=201.5
Q ss_pred CCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCC-ccceeeeeeeCC-----
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNR-LTNLLGCCCEGD----- 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 129 (334)
...|..++++|+|+||+||+|. ..+|+.||+|++...... ......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3446667788999999999999 456889999999866532 2456789999999999999 999999998876
Q ss_pred -eeeEEEecCCCCCHHHhhcccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 130 -ERLLVAEYMPNETLAKHLFHWET--HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
.+++||||++ .+|..++..... ..++...+..+++||+.||+|||+++ |+||||||+||||+++|.+||+|||+|
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCcceEEECCCCcEeeeccchH
Confidence 7899999996 899999875332 46777889999999999999999999 999999999999999999999999999
Q ss_pred ccCCC----CCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc-------
Q 019905 207 KNSRD----GKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS------- 274 (334)
Q Consensus 207 ~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 274 (334)
+...- -...++|.-|+|||++.+. .|++..||||+||+++||++++..|++.............+..+
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 86542 2345678899999999887 49999999999999999999998887653322211111100000
Q ss_pred ---------ccCCCC-C-------chhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccc
Q 019905 275 ---------CLEGQF-T-------DDDGTELVRLASRCLQYEPRERPNPKSLVTA--LSPL 316 (334)
Q Consensus 275 ---------~~~~~~-~-------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--L~~l 316 (334)
...... + +...++..+++.+||+++|..|.|+..+++. +..+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 000000 1 1112488999999999999999999999864 4444
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=311.58 Aligned_cols=236 Identities=20% Similarity=0.253 Sum_probs=195.2
Q ss_pred cCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
.||+|+||.||++.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 469999999999995 4688999999975321 223456789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCccccc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYSTN 218 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~ 218 (334)
|..++. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..... .....|+
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 82 LFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 998886 3457899999999999999999999999 99999999999999999999999998765322 1234688
Q ss_pred ccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc
Q 019905 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (334)
Q Consensus 219 ~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (334)
+.|+|||.+.+..++.++||||||+++|+|++|+.||............... ...++...++++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999888999999999999999999999998655433222211111 1123445667899999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 019905 299 EPRERP-----NPKSLVT 311 (334)
Q Consensus 299 dp~~Rp-----s~~~~l~ 311 (334)
||.+|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 233 DPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHhCCCCCCCHHHHHc
Confidence 999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=301.87 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=202.9
Q ss_pred CcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..|.+++.+|+|+||.||+|...+ +..||+|.+...... ....+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346677888999999999998532 478999999765433 2457889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeE
Q 019905 133 LVAEYMPNETLAKHLFHWE------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl 200 (334)
++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-FVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eeccccccceEEEcCCCeEEE
Confidence 9999999999999986421 235778899999999999999999999 999999999999999999999
Q ss_pred cCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccc
Q 019905 201 STFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTD 273 (334)
Q Consensus 201 ~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 273 (334)
+|||.+...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...............
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--- 240 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--- 240 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---
Confidence 999998754321 22234678999999999899999999999999999998 88887654333222211111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
. ....+...+..+.+++.+||+.||++||++.++++.|++
T Consensus 241 -~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 241 -R-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -C-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 112233456689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=304.70 Aligned_cols=250 Identities=19% Similarity=0.276 Sum_probs=197.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
...|.+++.||.|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 456888899999999999999864 5789999999754322 23467789999999999999999999999889999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 84 YLD-SDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKRK-ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCC-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 997 589888853 3345788999999999999999999999 999999999999999999999999998754322
Q ss_pred CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc--------------------c
Q 019905 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------------------L 271 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------------------~ 271 (334)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 23456889999999876 45899999999999999999999888654322211100000 0
Q ss_pred cccccCC----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 TDSCLEG----QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 ~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+.... ......+.++.+|+.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 001234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=309.00 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=198.5
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|+++++||+|+||.||++... ++..+|+|.+...... ....+.+|+++++.++|+||+++++++..++..+++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 45778888999999999999965 5788999988654322 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--CCcc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSY 215 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~ 215 (334)
+++++|.+++. ....+++..+..++.+++.||.|||+.+.++|+||||+||+++.++.++|+|||++..... ....
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 85 MDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 99999999986 3456889999999999999999999752399999999999999999999999999875433 2334
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc---------------------------
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL--------------------------- 268 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~--------------------------- 268 (334)
.++..|+|||.+.+..++.++||||||+++|++++|+.||.............
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 67889999999998889999999999999999999999886432221110000
Q ss_pred -------------ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 -------------QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 -------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
................+.++.+|+.+||+.||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000000001123567899999999999999999999973
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=305.29 Aligned_cols=249 Identities=19% Similarity=0.226 Sum_probs=194.2
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 56788889999999999999965 5789999999754322 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~ 213 (334)
++ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... ..
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 96 788887754 3456888999999999999999999999 99999999999999999999999999864332 12
Q ss_pred cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhH--Hhhhccc----------------cccccc
Q 019905 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LIRDRNL----------------QMLTDS 274 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~--~~~~~~~----------------~~~~~~ 274 (334)
...++..|+|||++.+. .++.++||||||+++|+|++|..||...... ....... ......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 34568899999998764 4888999999999999999999988653111 0000000 000000
Q ss_pred ccCCCCC---------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 CLEGQFT---------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 ~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+ ...+.++.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 012357889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=303.97 Aligned_cols=248 Identities=19% Similarity=0.238 Sum_probs=196.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|++++.||+|+||.||++..+ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 4677888899999999999975 578999999975432 2245678899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
++++++..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99876665443 3457899999999999999999999999 999999999999999999999999998765432
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc---c-----------------cccc
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---L-----------------QMLT 272 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~---~-----------------~~~~ 272 (334)
....++..|+|||++.+..++.++||||||+++|+|++|+.||............ . ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 2345788999999999888999999999999999999999888654221110000 0 0000
Q ss_pred cccc------CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 DSCL------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+.. ........+.++.+|+.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00111224567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=295.93 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=201.8
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.++++++.+|+|++|.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577888899999999999998777789999987544 235678899999999999999999999998888999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 83 ~~~l~~~i~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 83 NGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESKQ-FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999864 2346899999999999999999999999 9999999999999999999999999987543322 1
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+................ ....+...+..+.+++.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-----RLYRPHLASEKVYAIMY 235 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-----CCCCCCCCCHHHHHHHH
Confidence 234567999999988889999999999999999998 777765433222221111111 11122334568999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhc
Q 019905 294 RCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+||+.||.+||++.+++..|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=305.81 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=191.9
Q ss_pred ccccCCCcCccEEEEEEeC-----CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 64 IVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+.+.||.|.||.||+|.+. .+..|+||.+...... ....+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4567799999999999976 2578999999653322 246789999999999999999999999988889999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
+++|+|.+++.......+++..+..|+.|++.||.|||+++ ++|++|+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN-IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT-EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 99999999998644678999999999999999999999998 999999999999999999999999998766221
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
........|+|||.+.+..++.++||||||+++||+++ |+.|+.......+.... .+. .....+...+..+.+
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL----KQG-QRLPIPDNCPKDIYS 236 (259)
T ss_dssp STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH----HTT-EETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccc-ccceeccchhHHHHH
Confidence 22345678999999988889999999999999999999 55666543222222111 111 111233445668999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 019905 291 LASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~L 313 (334)
++..||+.||.+|||+.++++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.35 Aligned_cols=247 Identities=17% Similarity=0.194 Sum_probs=202.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC-C-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-N-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+..|.+.+.+|+|++|.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 344788888899999999999853 3 57888998755443334467789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 137 YMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|+++++|.+++... ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999887532 3456889999999999999999999999 999999999999999999999999998865432
Q ss_pred ----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
....||+.|+|||++.+..++.++|||||||++|+|++|..||................. ...+...+.++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~ 299 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-----DPFPCPVSSGM 299 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCccCCHHH
Confidence 234588999999999988899999999999999999999999875543322221111111 11233455689
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 019905 289 VRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+++.+||+.||+.||++.+++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHh
Confidence 99999999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=301.79 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=206.0
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++.+.+.+|+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45667788899999999999742 345689999876554444678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCee
Q 019905 134 VAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~k 199 (334)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcEE
Confidence 999999999999986421 234788999999999999999999999 99999999999999999999
Q ss_pred EcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccccc
Q 019905 200 LSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLT 272 (334)
Q Consensus 200 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 272 (334)
|+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--- 240 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ--- 240 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC---
Confidence 9999998754332 22334678999999998889999999999999999999 7777654332222211111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
. .....+...+..+.+++.+||+.||.+|||+.++++.|+++.+.++
T Consensus 241 -~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 241 -G-RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred -C-CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 1 1111223345689999999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=312.88 Aligned_cols=246 Identities=17% Similarity=0.178 Sum_probs=194.6
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.+.+++.++.||+|+||.||++... +++.||||.+...... ....+.+|+++++.++|+||+++++++...+..++||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 4566777888999999999999964 5789999999654322 2356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
||+++++|.+.. ...+..+..++.||+.||.|||+++ ++||||||+|||+++++.+||+|||++......
T Consensus 152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH-IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999999986532 3567788899999999999999999 999999999999999999999999998764432
Q ss_pred -CcccccccccCcccccC-----CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....|+..|+|||.+.. ...+.++|||||||++|+|++|+.||.......+........ .......+...+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 302 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQPPEAPATASR 302 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccCCCCCCCccCH
Confidence 34568899999998843 224568999999999999999999886332211111000000 0011123345567
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
++.+|+.+||+.||++|||+.++++.
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999864
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.41 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=204.0
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..|+++++||+|+||.||+|..++++.||+|.+.... .....+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 3577888999999999999998888999999997544 34567889999999999999999999864 457899999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 999999986544567889999999999999999999999 9999999999999999999999999987554211 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|++++ |..||............... .....+...+.++.+++.
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-----YRMPRPDNCPEELYELMR 237 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-----CCCCCCCCCCHHHHHHHH
Confidence 234568999999988889999999999999999999 88777544322222111111 111223344568999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+||+.+|++||++++++..|+++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 238 LCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHccCChhhCCCHHHHHHHhhcC
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=307.47 Aligned_cols=237 Identities=20% Similarity=0.280 Sum_probs=195.1
Q ss_pred ccCCCcCccEEEEEEe----CCCCEEEEEEecCCC----CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 66 SEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5679999999999985 357899999986432 12234567899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~ 213 (334)
+++++|.+++. ....+.+..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... ..
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999886 3456788899999999999999999999 99999999999999999999999999864322 22
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...|++.|+|||++.+..++.++||||||+++|+|++|..||.............. . ....+...++++.+++.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~li~ 232 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK----G--KLNLPPYLTPEARDLLK 232 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHH
Confidence 34688999999999988899999999999999999999999876543322211111 1 11234455678999999
Q ss_pred HhhhcCCCCCC-----CHHHHHH
Q 019905 294 RCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rp-----s~~~~l~ 311 (334)
+||+.||.+|| +++++++
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhc
Confidence 99999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.06 Aligned_cols=251 Identities=18% Similarity=0.175 Sum_probs=210.4
Q ss_pred CcccccccCCCcCccEEEEEEeCCC-CEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeee-eee---C---Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQ-RRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGC-CCE---G---DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~---~---~~ 130 (334)
..+++.+.|.+|||+.||++....+ ..+|+|++...+..+.+.+.+||+++++|. |+|||.+++. ... . -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3456677789999999999997665 999999998777677788999999999996 9999999993 322 1 24
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
++|+||||.+|.|.++++.+....|++.++++|+.++++|+++||...+ |||||||-+||||+.++..||||||.|...
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 6899999999999999987777779999999999999999999998744 999999999999999999999999998743
Q ss_pred CCCC-------------cccccccccCcccc---cCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc
Q 019905 210 RDGK-------------SYSTNLAFTPPEYL---RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273 (334)
Q Consensus 210 ~~~~-------------~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 273 (334)
.... ....|+.|+|||++ .+.+++.|+|||||||+||-|+....||.......+.+..+..
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~--- 273 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSF--- 273 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccC---
Confidence 2211 22458999999988 5777999999999999999999999999877555454443331
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
...+..+..+.+||..||+.||.+||++.+++..+-.++.
T Consensus 274 -----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 274 -----PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -----CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1124677799999999999999999999999998877764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=296.51 Aligned_cols=255 Identities=18% Similarity=0.229 Sum_probs=205.1
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.+|++.+.+|+|+||.||+|.. .++..||+|.+....... ...+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4567778889999999999995 468899999886433222 245788999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 136 EYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
||+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999887532 2345788999999999999999999999 9999999999999999999999999987654322
Q ss_pred ----cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 214 ----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......... ...+.............+..+.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL--CQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH--HHHHhcCCCCCCChhhcCHHHH
Confidence 3457789999999988889999999999999999999999886543221110 0011111111112234556899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 290 RLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
+++.+||+.+|++||++.++++.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.73 Aligned_cols=246 Identities=21% Similarity=0.229 Sum_probs=201.6
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|.+++.||+|+||.||+|... +++.||+|.+..... .....+.+|++++..++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4677888899999999999965 588999999974321 234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g-iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKLG-FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999874 367899999999999999999999999 9999999999999999999999999987543322
Q ss_pred ------------------------------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHh
Q 019905 214 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI 263 (334)
Q Consensus 214 ------------------------------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~ 263 (334)
...||+.|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 34578999999999999999999999999999999999999876543322
Q ss_pred hhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 019905 264 RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN-PKSLVTA 312 (334)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~~l~~ 312 (334)
........ ...........++++.+++.+||. ||.+||+ +.++++.
T Consensus 239 ~~~i~~~~--~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWK--ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccC--CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 22111100 000111111246789999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=312.42 Aligned_cols=244 Identities=17% Similarity=0.169 Sum_probs=193.7
Q ss_pred CCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
....|++++.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 345688999999999999999995 457899999753 2346789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
++. ++|..++. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.....
T Consensus 164 ~~~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~~-IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 164 RYK-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHENR-IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred cCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 995 78888875 3456889999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh--------HH---hhhc--------------
Q 019905 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL--------DL---IRDR-------------- 266 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~--------~~---~~~~-------------- 266 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..|+..... .. +...
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 1235689999999999988899999999999999999999977653210 00 0000
Q ss_pred ----ccccccc--cccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 267 ----NLQMLTD--SCLEGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 267 ----~~~~~~~--~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
....... ....... ....+.++.+|+.+||+.||.+|||++++++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0000000 0123568999999999999999999999984
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=294.26 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=202.2
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
.+++++++|+|++|.||++...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 5677888999999999999988888899999976443 4567899999999999999999999875 4568999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----cc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----SY 215 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~~ 215 (334)
++|.+++.......+++..+..++.+++.||.|||+++ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 99999987544456899999999999999999999999 9999999999999999999999999987543321 12
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
.++..|+|||.+.+..++.++|+||||+++|++++ |..||............. .......+...+..+.+++.+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-----RGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCcCCHHHHHHHHH
Confidence 34567999999988889999999999999999999 676665433222221111 111122344556789999999
Q ss_pred hhhcCCCCCCCHHHHHHHhcc
Q 019905 295 CLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~ 315 (334)
||+.+|++|||+.++.+.|++
T Consensus 239 ~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 239 CWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=302.51 Aligned_cols=247 Identities=16% Similarity=0.217 Sum_probs=200.1
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|++++.||+|+||.||++... +++.||+|.+...... ....+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456677799999999999954 5789999999653322 224567899999999999999999999998999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---c
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---S 214 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~ 214 (334)
+++++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999998886434457899999999999999999999999 9999999999999999999999999987654322 3
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||++.+..++.++||||+|+++|++++|..||...............+.. ....++...+..+.+|+.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHH
Confidence 46788999999999888999999999999999999999988754322111111111111 1122344566789999999
Q ss_pred hhhcCCCCCC-----CHHHHHH
Q 019905 295 CLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rp-----s~~~~l~ 311 (334)
||+.||.+|| +++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhc
Confidence 9999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=300.63 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=203.6
Q ss_pred cccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.+.+.+.+|+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4566777899999999999742 2456899998755433345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCC
Q 019905 135 AEYMPNETLAKHLFHWE-----------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Df 203 (334)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+||
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcEEeccC
Confidence 99999999999886321 134889999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccccccccc
Q 019905 204 GLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 204 g~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
|++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.................
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~---- 240 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV---- 240 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc----
Confidence 9987543221 2233568999999998889999999999999999999 7776654433222211111110
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
...+...+.++.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus 241 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 241 -LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1122334568999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=300.57 Aligned_cols=249 Identities=20% Similarity=0.263 Sum_probs=192.0
Q ss_pred cccccccCCCcCccEEEEEEeC--CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcC---CCCCccceeeeeee-----C
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQL---RNNRLTNLLGCCCE-----G 128 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~ 128 (334)
.|++++.||+|+||.||+|... ++..||+|.+....... ...+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 4677888999999999999853 46789999987543222 23556677776665 69999999998852 3
Q ss_pred CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
...+++|||++ ++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 46899999996 78999886544566899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc--------------c
Q 019905 209 SRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------------L 271 (334)
Q Consensus 209 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------------~ 271 (334)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|..||............... .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 4432 2345788999999998888999999999999999999999888654221111110000 0
Q ss_pred ccccc----C---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 TDSCL----E---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 ~~~~~----~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..... . ....+..+..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0 0011234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=293.70 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=201.5
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..|++.+++|+|++|.||+|...++..||+|.+.... ...+.+.+|+++++.++|+||+++++.+. ....+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3477888999999999999998776789999997533 24567889999999999999999999874 456799999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.......+++..+..++.+++.||+|||+.+ ++|+||+|.||++++++.++|+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 999999997533456789999999999999999999999 9999999999999999999999999987544322 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||...+..++.++||||||+++|++++ |..||.............. ......+...+..+.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLMC 237 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-----CCCCCCccccCHHHHHHHH
Confidence 234567999999988889999999999999999999 6656644332222111111 0111223445678999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+||+.||.+||++.++++.|+.+
T Consensus 238 ~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 238 QCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=306.39 Aligned_cols=240 Identities=20% Similarity=0.287 Sum_probs=194.4
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHH---hcCCCCCccceeeeeeeCCeeeEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSV---GQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
|++++.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456778899999999999864 58899999997432 12234566666554 567899999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC---
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--- 211 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--- 211 (334)
|||+++++|...+. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENK-IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999998884 457899999999999999999999999 99999999999999999999999998764322
Q ss_pred -CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||............... ....+...+..+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~ 230 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSREAIS 230 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHH
Confidence 22356789999999999888999999999999999999999998765433332221111 11234455678999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHH
Q 019905 291 LASRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
++.+||+.||.+|| ++.++++
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 99999999999999 5666664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.35 Aligned_cols=236 Identities=22% Similarity=0.258 Sum_probs=195.2
Q ss_pred cCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
.||+|+||.||++.. .+++.||+|.+..... .....+.+|++++..++||||+++.+++...+..++||||+++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 469999999999985 4688999999975322 223456789999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
|.+++. ....+++..+..++.||+.||.|||+ ++ ++||||||+|||++.++.+||+|||++..... .....|
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~~-ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 82 LFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCC-EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 998886 34578999999999999999999997 67 99999999999999999999999999864322 123468
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
+..|+|||++.+..++.++||||||+++|+|++|..||............... ...++...++++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHhh
Confidence 89999999999888999999999999999999999998665433322211111 112344566789999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 019905 298 YEPRERP-----NPKSLVT 311 (334)
Q Consensus 298 ~dp~~Rp-----s~~~~l~ 311 (334)
.||.+|+ ++.++++
T Consensus 233 ~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred cCHHHhCCCCCCCHHHHhc
Confidence 9999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=314.04 Aligned_cols=245 Identities=16% Similarity=0.146 Sum_probs=196.8
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.||.|+||.||++... +++.||||++.... ......+.+|++++..++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 4677788899999999999964 58899999996432 1223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKLG-YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999986 3457899999999999999999999999 999999999999999999999999987643211
Q ss_pred --------------------------------------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCC
Q 019905 213 --------------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254 (334)
Q Consensus 213 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p 254 (334)
....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 013588999999999988899999999999999999999999
Q ss_pred CCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 019905 255 PPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLVT 311 (334)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~ 311 (334)
|................. ..........++++.+++.+|+. +|.+|++ +.++++
T Consensus 239 f~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDNPQETYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHHHHHHHHcCCC--ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 876543222211111000 00001111345689999999996 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.25 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=201.0
Q ss_pred CCcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
+..++++++||+|+||.||+|...+ +..||+|++....... .+.+.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4557788899999999999998532 4789999997543222 34578899999999999999999999998899
Q ss_pred eEEEecCCCCCHHHhhccc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC
Q 019905 132 LLVAEYMPNETLAKHLFHW--------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~ 197 (334)
++++||+++++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||.||++++++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhheEecCCCc
Confidence 9999999999999988421 1235788889999999999999999999 999999999999999999
Q ss_pred eeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 019905 198 PRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (334)
+||+|||++....... ...+++.|+|||.+.+..++.++||||||+++|||++ |..|+...............
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999977543221 2234578999999988889999999999999999998 55565443332222211111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
.....+...+..+.+++.+||+.+|.+||++.+++..|+.
T Consensus 243 -----~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 243 -----QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1112345567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=304.09 Aligned_cols=253 Identities=17% Similarity=0.249 Sum_probs=201.2
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCC----EEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.+|++++.||+|+||.||+|.+. ++. .||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45677788899999999999853 333 489999875432 2245688899999999999999999998764 5789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
+++|+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 86 v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 86 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999999874 3446888999999999999999999999 9999999999999999999999999998654322
Q ss_pred c------ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 214 S------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 214 ~------~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
. ..++..|+|||.+.+..++.++||||||+++|++++ |..|+............. .......+...+.
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 238 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQPPICTI 238 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----CCCCCCCCCCCCH
Confidence 1 223567999999998889999999999999999998 887776543332221110 1111112234456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
++.+++.+||+.||.+||++.+++..|.++.++.
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 8999999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.00 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=200.6
Q ss_pred CCcccccccCCCcCccEEEEEEe-----CCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
++.+++++.||+|+||.||+|.+ .++..+++|.+...... ....+.+|+++++.++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 45677888999999999999984 24578999999753322 2346788999999999999999999999989999
Q ss_pred EEEecCCCCCHHHhhcccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWE---------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~ 197 (334)
++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-eehhccccceEEEcCCCc
Confidence 9999999999999885211 234778889999999999999999999 999999999999999999
Q ss_pred eeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 019905 198 PRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (334)
++|+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......+.......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998754322 22334567999999988889999999999999999998 77676543322222111111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
. ....+...+..+.+++.+||+.||.+||++.++++.|..
T Consensus 243 ~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 243 Q-----LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred C-----cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 112233455689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.77 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=199.9
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.++++.+.+|+|++|.||++.++++..+|+|.+.... .....+.+|+++++.++|+||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3466778889999999999998777789999986543 234568889999999999999999999998889999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc-----
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS----- 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~----- 214 (334)
+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+....+...
T Consensus 83 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 83 NGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESNG-FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999864 2346889999999999999999999999 99999999999999999999999999875443221
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|++++ |..|+.............. ......+...+..+.+++.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-----GYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-----CCcCCCCCCCCHHHHHHHH
Confidence 122357999999998889999999999999999999 6666644322221111111 1111223445678999999
Q ss_pred HhhhcCCCCCCCHHHHHHHh
Q 019905 294 RCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L 313 (334)
+||..+|++|||+.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=312.05 Aligned_cols=240 Identities=22% Similarity=0.312 Sum_probs=202.6
Q ss_pred ccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
-++.||.|+||.||-|. ..+.+.||||++.-...... ..+.+|+..|++++|||++.+.|+|..+.+.|+|||||-
T Consensus 30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl 109 (948)
T KOG0577|consen 30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL 109 (948)
T ss_pred HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence 35677999999999998 45678999999975554443 468899999999999999999999999999999999995
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccccc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNL 219 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 219 (334)
|+-.|.+.- ..+++.+..+..|+.+.++||+|||+++ .||||||..|||+++.|.|||+|||.|....+..+++||+
T Consensus 110 -GSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~-~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTP 186 (948)
T KOG0577|consen 110 -GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN-RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTP 186 (948)
T ss_pred -ccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhh-HHhhhccccceEecCCCeeeeccccchhhcCchhcccCCc
Confidence 888887754 5678999999999999999999999999 9999999999999999999999999999999999999999
Q ss_pred cccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCc-hhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 220 AFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPS-HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 220 ~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.|||||++. .+.|+.++||||||+++.|+...++|.+. .+..... .+...-.+.+ ...+++..+..|+..|
T Consensus 187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY--HIAQNesPtL---qs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNESPTL---QSNEWSDYFRNFVDSC 261 (948)
T ss_pred cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH--HHHhcCCCCC---CCchhHHHHHHHHHHH
Confidence 999999995 45699999999999999999998876543 2222222 1111111111 2456778999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 019905 296 LQYEPRERPNPKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~ 311 (334)
|+.-|.+|||.++++.
T Consensus 262 LqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLK 277 (948)
T ss_pred HhhCcccCCcHHHHhh
Confidence 9999999999999875
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=312.82 Aligned_cols=246 Identities=18% Similarity=0.195 Sum_probs=195.4
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++++.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+++++.++|+||+++++++...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 466788889999999999985 45789999999653321 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
|+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKMG-FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999986 3456889999999999999999999999 99999999999999999999999998643210
Q ss_pred ----------------------------------------------CCcccccccccCcccccCCCCCCccchhhhHHHH
Q 019905 212 ----------------------------------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLL 245 (334)
Q Consensus 212 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 245 (334)
.....||..|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0123588999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH--hhhcCCCCCCCHHHHHH
Q 019905 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR--CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 246 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~Rps~~~~l~ 311 (334)
|||++|..||............... ............++++.+|+.+ |+..+|..||++.+++.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcc--ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999998654332221111110 0001111112345688999988 55666667999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=293.84 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=201.8
Q ss_pred cccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
++++.+.+|+|+||.||+|.+.. ...||+|.+....... ...+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 45566777999999999998642 4589999987544222 346788999999999999999999999988999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 85 EYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999864 3347899999999999999999999998 9999999999999999999999999988664211
Q ss_pred ----cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 214 ----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...++..|+|||.+.+..++.++||||||+++|++++ |..|+............... .....+...+..+
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l 237 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-----YRLPPPMDCPSAL 237 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHH
Confidence 1233568999999998889999999999999999998 88777544333222111111 1112233456789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.17 Aligned_cols=242 Identities=16% Similarity=0.221 Sum_probs=192.5
Q ss_pred CCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
||+|+||.||++..+ +++.+|+|.+...... ....+..|+++++.++||||+++.+++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 599999999999854 5899999998643211 223456799999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---ccccccc
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---SYSTNLA 220 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~ 220 (334)
.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ...++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC-EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 98886544556889999999999999999999999 9999999999999999999999999987654332 3457889
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCC
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 300 (334)
|+|||++.+..++.++||||||+++|+|++|..||...................... ......+.++.+++.+||+.||
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCH
Confidence 999999998889999999999999999999998886432111111111111111110 1112356689999999999999
Q ss_pred CCCCCHHHHHH
Q 019905 301 RERPNPKSLVT 311 (334)
Q Consensus 301 ~~Rps~~~~l~ 311 (334)
.+||++.++++
T Consensus 239 ~~R~~~~~~~~ 249 (277)
T cd05607 239 EDRLGSREKND 249 (277)
T ss_pred hhCCCCccchh
Confidence 99999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=297.52 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=199.2
Q ss_pred cccccccCCCcCccEEEEEEeC-----CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee--CCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 133 (334)
.+++++.+|+|+||.||++..+ ++..||+|.+........+.+.+|+++++.++||||+++.+++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4667788899999999999742 478999999876554445678899999999999999999998754 346789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
+|||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++.......
T Consensus 85 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 85 VMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999864 3346889999999999999999999999 9999999999999999999999999987654322
Q ss_pred c-------ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhh---cc--------cccccccc
Q 019905 214 S-------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD---RN--------LQMLTDSC 275 (334)
Q Consensus 214 ~-------~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~---~~--------~~~~~~~~ 275 (334)
. ..++..|+|||.+.+..++.++||||||+++|||++|..++.......... .. ........
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 1 122346999999988889999999999999999999876543322111110 00 00001111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.....+...+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122344567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.86 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=207.7
Q ss_pred CCcccccccCCCcCccEEEEEEeCC--C----CEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN--Q----RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
.........||+|+||.||.|...+ + -.||+|.+..... .....|.+|..+++.++||||++++|++......
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4456667888999999999999543 2 3489999986542 2346799999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWE-----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
++++|||.+|+|..+|++.. ...+....++.++.+|++|+.||++++ .|||||..+|+|+++...||++|||+|
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-CcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999998631 456888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcc------cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh-hHHhhhcccccccccccCCC
Q 019905 207 KNSRDGKSY------STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNLQMLTDSCLEGQ 279 (334)
Q Consensus 207 ~~~~~~~~~------~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 279 (334)
+.......+ .-...|||||.+..+.++.|+||||||+++||++|.+.+|++.. ...+.. ...... +-.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~----~~~~gg-RL~ 924 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL----DVLEGG-RLD 924 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH----HHHhCC-ccC
Confidence 954332211 12368999999999999999999999999999999776555432 222211 111111 334
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
.|..++..++++|.+||+.+|++||++..++++++++..
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 566777789999999999999999999999999887765
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=294.94 Aligned_cols=250 Identities=18% Similarity=0.191 Sum_probs=200.8
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..+|++++.+|+|+||.||+|.. .+++.||+|.+..........+.+|+.++.+++||||+++++++..++..+++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688889999999999999995 46789999999765544456688899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... .
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKG-KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999886 3457899999999999999999999999 999999999999999999999999998754322 2
Q ss_pred cccccccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc-cccccccccCCCCCchhHHHHH
Q 019905 214 SYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-LQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
...++..|+|||.+. ...++.++|+||||+++|+|++|+.|+............ ......... ......+..+.
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 242 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL--KDKTKWSSTFH 242 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC--ccccccCHHHH
Confidence 345778999999984 344788999999999999999999887543211111000 000010101 11223456899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHh
Q 019905 290 RLASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L 313 (334)
+++.+||+.+|++|||++++++.|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=291.75 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=202.4
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeee-eCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC-EGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 137 (334)
...+++.+.+|+|++|.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. .++..++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 456777888899999999999874 6789999986433 3457889999999999999999999764 45678999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-ccc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-SYS 216 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 216 (334)
+++++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 160 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccccchheEEEcCCCcEEecCCccceeccccCCCCc
Confidence 99999999987544446889999999999999999999999 9999999999999999999999999987544322 233
Q ss_pred ccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 217 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.+..|+|||.+.+..++.++||||||+++|+|++ |+.|+.............. ......+...+..+.+++.+|
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCCHHHHHHHHHH
Confidence 4568999999988889999999999999999998 7777765433322211111 111123345567899999999
Q ss_pred hhcCCCCCCCHHHHHHHhccc
Q 019905 296 LQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~~L~~l 316 (334)
|+.+|++|||+.++++.|+.+
T Consensus 236 l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 236 WHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred hcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=310.48 Aligned_cols=247 Identities=13% Similarity=0.110 Sum_probs=194.2
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.||+|+||+||++... +++.||+|.+..... .....+.+|+.++..++|+||+++++.+......++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 4667788899999999999854 578999999964321 123457789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~g-ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLG-FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999986 4467899999999999999999999999 999999999999999999999999998643210
Q ss_pred -----------------------------------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCc
Q 019905 213 -----------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPS 257 (334)
Q Consensus 213 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~ 257 (334)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 123688999999999998899999999999999999999999876
Q ss_pred hhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 019905 258 HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ--YEPRERPNPKSLVTA 312 (334)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~~~l~~ 312 (334)
..................... ....+.++.+++.+++. .++..||+++++++-
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 543322221111000000110 11235578888887553 233356899999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=311.32 Aligned_cols=250 Identities=16% Similarity=0.164 Sum_probs=201.0
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.+...|++++.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44567888889999999999999964 57899999996422 122345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++|+|.+++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~---~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999884 346888899999999999999999999 999999999999999999999999998764432
Q ss_pred -----CcccccccccCcccccCC----CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 213 -----KSYSTNLAFTPPEYLRTG----RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
....|++.|+|||.+.+. .++.++|||||||++|+|++|..||..................... .....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~ 273 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDIE 273 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC--CCcCC
Confidence 234688999999998653 3788999999999999999999998765443222221111111110 11123
Q ss_pred hHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 019905 284 DGTELVRLASRCLQYEPRE--RPNPKSLVTA 312 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~--Rps~~~~l~~ 312 (334)
.+.++.+++.+||+.+|.+ |+|+.++++-
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 5678999999999999987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=292.83 Aligned_cols=238 Identities=19% Similarity=0.337 Sum_probs=190.3
Q ss_pred cCCCcCccEEEEEEeCC-------------CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 67 EHGEKAPNVVYKGKLEN-------------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 56999999999998532 23589998876544444567889999999999999999999998888999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC-------eeEcCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN-------PRLSTFGLM 206 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~-------~kl~Dfg~a 206 (334)
+|||+++++|..++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++. ++++|||.+
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD-LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC-eECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999888753 3456899999999999999999999999 999999999999986654 899999998
Q ss_pred ccCCCCCcccccccccCccccc-CCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 207 KNSRDGKSYSTNLAFTPPEYLR-TGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 207 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
..........++..|+|||.+. +..++.++||||||+++|+|++ |..|+............ .... ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-----~~~~--~~~~~~ 232 (262)
T cd05077 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-----EGQC--MLVTPS 232 (262)
T ss_pred ccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-----hcCc--cCCCCC
Confidence 7665555667788999999986 4568999999999999999985 66655443222211100 0000 111223
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~~L 313 (334)
..++.+|+.+||+.||.+||++.++++.|
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 46799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.18 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=201.0
Q ss_pred CcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCC-CCCccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLR-NNRLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 131 (334)
..+.+.+.||+|+||.||+|.... +..||+|++....... .+.+.+|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 456777888999999999998521 3479999997543222 356889999999996 99999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccC------------------------------------------------------------
Q 019905 132 LLVAEYMPNETLAKHLFHWE------------------------------------------------------------ 151 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~------------------------------------------------------------ 151 (334)
++||||+++|+|.+++....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999999999998875311
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC
Q 019905 152 ----------------------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 152 ----------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~ 197 (334)
...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-CVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHhEEEeCCCE
Confidence 124677888999999999999999999 999999999999999999
Q ss_pred eeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 019905 198 PRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (334)
++|+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..|+............
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~--- 352 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK--- 352 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH---
Confidence 999999998754322 12234578999999998889999999999999999997 77777543221111000
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
.. .......+...+.++.+++.+||+.||++|||+.++.+.|+++.+
T Consensus 353 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IK-SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred Hh-cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00 011112234456789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.51 Aligned_cols=241 Identities=19% Similarity=0.258 Sum_probs=193.5
Q ss_pred CCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
||+|+||+||++... +++.+|+|.+...... ..+.+..|+++++.++|+||+++.+++......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 599999999999854 5789999998643322 224567899999999999999999999999999999999999999
Q ss_pred HHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Ccccc
Q 019905 144 AKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (334)
Q Consensus 144 ~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~ 217 (334)
.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+...... ....+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 8877431 3356899999999999999999999999 999999999999999999999999998754432 23467
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
+..|+|||.+.+..++.++||||||+++|+|++|+.||................... ....+...+..+.+++.+||+
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhc
Confidence 889999999999899999999999999999999999886532211111111111111 112344566789999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 019905 298 YEPRERP-----NPKSLVT 311 (334)
Q Consensus 298 ~dp~~Rp-----s~~~~l~ 311 (334)
.||.+|| +++++++
T Consensus 238 ~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 6777774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=304.91 Aligned_cols=231 Identities=21% Similarity=0.276 Sum_probs=190.9
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++..+ +++.||+|.+.... ......+..|..++..+ +||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 4699999999999964 57899999986432 12334567788888776 6999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~~-ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 82 DLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred hHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 9999886 4457899999999999999999999999 99999999999999999999999999765321 223468
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
++.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999998765443333222111 112334456789999999999
Q ss_pred cCCCCCCCH
Q 019905 298 YEPRERPNP 306 (334)
Q Consensus 298 ~dp~~Rps~ 306 (334)
.||.+||++
T Consensus 233 ~dP~~R~~~ 241 (320)
T cd05590 233 KNPTMRLGS 241 (320)
T ss_pred cCHHHCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=290.79 Aligned_cols=241 Identities=21% Similarity=0.264 Sum_probs=194.7
Q ss_pred cCCCcCccEEEEEEe---CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKL---ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~---~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
+||+|+||.||+|.+ .++..+|+|.+...... ..+.+.+|+.+++.++|+||+++++++. ....+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 579999999999975 35788999998654322 2356888999999999999999999875 45678999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-------c
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-------S 214 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-------~ 214 (334)
+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||.||++++++.++|+|||++....... .
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEETN-FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999986 3457899999999999999999999999 9999999999999999999999999987544322 1
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+....++.++|+||||+++|||++ |..||............. .......+...++++.++|.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-----SGERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----CCCCCCCCCCCCHHHHHHHH
Confidence 123468999999988889999999999999999998 887776543222211111 11112234456678999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+||+.||++||++.+|...|++.
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHhccCchhCcCHHHHHHHHhcc
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=307.81 Aligned_cols=245 Identities=18% Similarity=0.234 Sum_probs=195.0
Q ss_pred ccccccCCCcCccEEEEEEe----CCCCEEEEEEecCCC----CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 62 ENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
|++++.||+|+||.||++.. .+++.||+|.+.... ....+.+..|++++..+ +|++|+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 66778889999999999874 357899999986432 11234577899999999 5999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++++|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++......
T Consensus 82 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKLG-IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999886 4467899999999999999999999999 999999999999999999999999998754321
Q ss_pred -----CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....||..|+|||.+.+.. ++.++||||||+++|+|++|..||.................. ....++...+.
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCH
Confidence 2346889999999998754 788999999999999999999988532111000000000110 11123445567
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
.+.+++.+||+.||++|| +++++++
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 899999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=308.78 Aligned_cols=234 Identities=20% Similarity=0.230 Sum_probs=193.4
Q ss_pred ccCCCcCccEEEEEEe----CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 66 SEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
+.||+|+||.||++.. .++..+|+|.+...... ....+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4679999999999874 35789999999753321 23456789999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Ccc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~ 215 (334)
+++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... ...
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999886 3457899999999999999999999999 999999999999999999999999998754332 234
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.|+..|+|||.+.+..++.++||||||+++|+|++|+.||............... ....+...+.++.+++.+|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------KLGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHH
Confidence 6789999999999888999999999999999999999988654333222211111 1123445567899999999
Q ss_pred hhcCCCCCCCHHH
Q 019905 296 LQYEPRERPNPKS 308 (334)
Q Consensus 296 l~~dp~~Rps~~~ 308 (334)
|+.||.+||++.+
T Consensus 233 l~~~P~~R~~a~~ 245 (318)
T cd05582 233 FKRNPANRLGAGP 245 (318)
T ss_pred hhcCHhHcCCCCC
Confidence 9999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=291.21 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=206.0
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.++.+.+.+|.|++|.||+|..+++..+|+|.+.... .....+.+|+.++++++|+||+++++++......+++|||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4567778889999999999998778899999997544 345678999999999999999999999988888999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.......+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN-YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 999999997544457899999999999999999999999 9999999999999999999999999987654321 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...+..|+|||.+.+..++.++|+||||+++|++++ |+.||............... .....+...+.++.+++.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-----YRMPRPPNCPEELYDLML 238 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHHH
Confidence 223467999999998889999999999999999998 77777543322222111111 111223344668999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+||+.+|.+||++.++++.|+.+
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhcC
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=305.13 Aligned_cols=237 Identities=19% Similarity=0.254 Sum_probs=193.8
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCC-CccceeeeeeeCCeeeEEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 135 (334)
+|++++.||+|+||.||+|... +++.||+|.+.... ....+.+..|..++..++|+ +|+.+++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3667788899999999999965 46899999997432 22345677889999999765 5888999998889999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---- 211 (334)
||+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999999886 3456889999999999999999999999 99999999999999999999999999764321
Q ss_pred CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||............... ...++...+.++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~l 231 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------NVSYPKSLSKEAVSI 231 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHH
Confidence 22346889999999999988999999999999999999999998755433222221111 112344566789999
Q ss_pred HHHhhhcCCCCCCCH
Q 019905 292 ASRCLQYEPRERPNP 306 (334)
Q Consensus 292 i~~cl~~dp~~Rps~ 306 (334)
+.+||+.||.+|++.
T Consensus 232 i~~~l~~~P~~R~~~ 246 (324)
T cd05587 232 CKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHhhcCHHHcCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.90 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=200.7
Q ss_pred CCcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
+.++.+.+++|+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456777889999999999999632 35688999887655444567899999999999999999999999988999
Q ss_pred EEEecCCCCCHHHhhcccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCee
Q 019905 133 LVAEYMPNETLAKHLFHWET-------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~k 199 (334)
++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-eecccccHhhEEEcCCCCEE
Confidence 99999999999999864211 34788999999999999999999999 99999999999999999999
Q ss_pred EcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccccc
Q 019905 200 LSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLT 272 (334)
Q Consensus 200 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 272 (334)
|+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..............
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--- 239 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ--- 239 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc---
Confidence 9999998644322 12234578999999998889999999999999999998 7766644322211111111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
......+...+..+.+++.+||+.||.+||++.++++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 --GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 01112233455689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=290.18 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=194.2
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHH
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 144 (334)
.||+|+||.||+|... +++.+|+|.+..... .....+.+|+++++.++|+||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5699999999999964 688999998864332 12356889999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC------ccccc
Q 019905 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYSTN 218 (334)
Q Consensus 145 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~------~~~~~ 218 (334)
+++.. ....+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+....... ....+
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESKH-CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99864 3346889999999999999999999999 9999999999999999999999999987543321 11223
Q ss_pred ccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 219 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
..|+|||.+.+..++.++||||||+++|++++ |..|+.............. ......+...+..+.+++.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-----GVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-----CCCCCCcccCCHHHHHHHHHHcC
Confidence 56999999988889999999999999999998 6666543322222111111 11112334456689999999999
Q ss_pred cCCCCCCCHHHHHHHhc
Q 019905 298 YEPRERPNPKSLVTALS 314 (334)
Q Consensus 298 ~dp~~Rps~~~~l~~L~ 314 (334)
.+|++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.01 Aligned_cols=236 Identities=19% Similarity=0.258 Sum_probs=193.7
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||+|... +++.||+|.+.... ......+..|.+++..+ +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 4699999999999965 47899999997532 12234567788888866 7999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|...+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRHG-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9998886 4467889999999999999999999999 99999999999999999999999999875322 223457
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
+..|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------DVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHhc
Confidence 89999999999888999999999999999999999998765433332221111 112233456789999999999
Q ss_pred cCCCCCC-------CHHHHHH
Q 019905 298 YEPRERP-------NPKSLVT 311 (334)
Q Consensus 298 ~dp~~Rp-------s~~~~l~ 311 (334)
.||.+|| ++.++++
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhc
Confidence 9999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=290.70 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=200.3
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
.+++.++||+|++|.||++...++..+|+|.+.... ...+.+.+|+++++.++|+|++++++++. .+..+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 466778889999999999998777789999986543 23467889999999999999999999875 4568899999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----cc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----SY 215 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~~ 215 (334)
++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN-YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 99999997544456889999999999999999999999 9999999999999999999999999987543321 22
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
.++..|+|||...+..++.++||||||+++|++++ |..|+.............. ......+...+..+.+++.+
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-----GYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCcccCHHHHHHHHH
Confidence 34568999999988889999999999999999999 7777654332222111111 11112334556789999999
Q ss_pred hhhcCCCCCCCHHHHHHHhcc
Q 019905 295 CLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~ 315 (334)
||+.||.+||+++++++.|+.
T Consensus 239 ~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 239 CWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=294.75 Aligned_cols=242 Identities=18% Similarity=0.266 Sum_probs=208.4
Q ss_pred cccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChH---HHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPR---QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++.+.||+|+||.|-+|. ...|+.||||.++.+...+.+ .+.+|++++..|+||||+.++.+|...+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 47788899999999999998 467999999999877766544 57899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|..+|.|.+++. ..+.+++.+...+++||..|+.|+|+++ ++|||||.+|||+|.++++|++|||++..+....
T Consensus 134 YaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr-VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 134 YASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR-VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred ecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc-ceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 999999999997 5678999999999999999999999999 9999999999999999999999999988776653
Q ss_pred cccccccccCcccccCCCCC-CccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
++.|++-|.+||.+.|.+|. +.+|-||||+++|.|+.|..||.+.......... .....+ .+..+.++.-||
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI----s~GaYr---EP~~PSdA~gLI 283 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI----SRGAYR---EPETPSDASGLI 283 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh----hccccc---CCCCCchHHHHH
Confidence 67899999999999999874 6899999999999999999999876544332211 111111 122234688899
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~ 312 (334)
.+||-.||+.|.|.++|..-
T Consensus 284 RwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHHhcCcccchhHHHHhhh
Confidence 99999999999999998754
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=293.30 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=205.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.+|++.+.||.|++|.||++.. .++..+++|.+....... ...+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4567778889999999999995 468899999886533222 346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 136 EYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999988531 2356889999999999999999999999 999999999999999999999999987754432
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......... ...+.........+...+..+.
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH--hhhhhcCCCCCCCcccccHHHH
Confidence 23457789999999988889999999999999999999999886543221110 0111111111112234567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 290 RLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
+++.+||+.||.+|||+.+|++.++++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.81 Aligned_cols=249 Identities=19% Similarity=0.199 Sum_probs=207.7
Q ss_pred cCCCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
-++..+++++.||.|.-|+||++..++ +..+|+|++........ .++..|-+||..++||.++.++..|..+...+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 346678889999999999999999755 68999999976554333 35667999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC--
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-- 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~-- 210 (334)
++||||+||+|....+.+..+.+++..++.++.+++.||.|||-.| ||+|||||+||||-++|++.|+||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG-ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG-IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc-eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999998878889999999999999999999999999 9999999999999999999999998753100
Q ss_pred --------------------------------C-C-------------------------CcccccccccCcccccCCCC
Q 019905 211 --------------------------------D-G-------------------------KSYSTNLAFTPPEYLRTGRV 232 (334)
Q Consensus 211 --------------------------------~-~-------------------------~~~~~~~~y~aPE~~~~~~~ 232 (334)
. . ...+||-.|.|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 12357889999999999999
Q ss_pred CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC----HHH
Q 019905 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN----PKS 308 (334)
Q Consensus 233 ~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~ 308 (334)
+.++|.|+||+++|||+.|..||-+...+......... .+.-.-.+..+..+.+||+++|.+||.+|.. +.|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~----~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ----PLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC----CCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 99999999999999999999999876554443322221 1111112255678999999999999999988 777
Q ss_pred HH
Q 019905 309 LV 310 (334)
Q Consensus 309 ~l 310 (334)
|.
T Consensus 389 IK 390 (459)
T KOG0610|consen 389 IK 390 (459)
T ss_pred hh
Confidence 65
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.51 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=197.9
Q ss_pred cccccCCCcCccEEEEEEe-----CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeEE
Q 019905 63 NIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLV 134 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 134 (334)
++++.+|+|+||+||++.. .++..||+|.+..... .....+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778889999999988653 3577899999975432 2345678899999999999999999987653 357899
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||+++++|.+++. ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++.......
T Consensus 87 ~e~~~~~~l~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHH---HcCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999985 346899999999999999999999999 9999999999999999999999999987654321
Q ss_pred ------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH--hhhc--------ccccccccccC
Q 019905 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL--IRDR--------NLQMLTDSCLE 277 (334)
Q Consensus 214 ------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~--~~~~--------~~~~~~~~~~~ 277 (334)
...++..|+|||.+.+..++.++||||||+++|+|++|..|+....... .... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 1234567999999988889999999999999999999998764321110 0000 00001111111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
...+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1234455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=302.13 Aligned_cols=235 Identities=20% Similarity=0.285 Sum_probs=190.7
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||+|... +++.||+|.+.... ....+.+..|..++..+ +||||+++++++..++..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 4699999999999964 57899999997532 12234455666666654 8999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 82 DLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKKG-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 9999886 3457899999999999999999999999 99999999999999999999999999875322 223467
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
|..|+|||.+.+..++.++||||||+++|+|++|..||............... ...++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------RPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999998765433332221111 112344556789999999999
Q ss_pred cCCCCCCCHH-HHH
Q 019905 298 YEPRERPNPK-SLV 310 (334)
Q Consensus 298 ~dp~~Rps~~-~~l 310 (334)
.||.+||++. +++
T Consensus 233 ~~P~~R~~~~~~l~ 246 (316)
T cd05592 233 RDPTKRLGVDGDIR 246 (316)
T ss_pred CCHHHcCCChHHHH
Confidence 9999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=297.75 Aligned_cols=259 Identities=21% Similarity=0.267 Sum_probs=204.5
Q ss_pred CcccccccCCCcCccEEEEEEeCC-C--CEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-Q--RRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 134 (334)
++|++.+.||+|+||.||+|...+ + ..+++|.++.... ...+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 567778888999999999998643 3 3578888864321 2235688899999999 799999999999988899999
Q ss_pred EecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeE
Q 019905 135 AEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl 200 (334)
+||+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-FIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCcCCcceEEECCCCeEEE
Confidence 99999999999986321 135788999999999999999999999 999999999999999999999
Q ss_pred cCCCCCccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccccccccc
Q 019905 201 STFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 201 ~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
+|||++...... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-----~~ 235 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-----GY 235 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-----CC
Confidence 999998643221 11222457999999988889999999999999999997 8888765433322221111 11
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSI 324 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~ 324 (334)
....+...+..+.+|+.+||+.+|.+|||++++++.|+.+........
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 112233456689999999999999999999999999988876554443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=302.69 Aligned_cols=235 Identities=19% Similarity=0.246 Sum_probs=192.1
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++... +++.||+|.+.... .........|..++... +||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 4699999999999965 57899999997532 12334566777777654 8999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 82 DLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSKG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 9999886 3457889999999999999999999999 99999999999999999999999999864321 234567
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
+..|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------TPHYPRWITKESKDILEKLFE 232 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999889999999999999999999999998765433332221111 112334456789999999999
Q ss_pred cCCCCCCCHH-HHH
Q 019905 298 YEPRERPNPK-SLV 310 (334)
Q Consensus 298 ~dp~~Rps~~-~~l 310 (334)
.||.+||++. +++
T Consensus 233 ~dP~~R~~~~~~~~ 246 (316)
T cd05620 233 RDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHcCCChHHHH
Confidence 9999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=312.67 Aligned_cols=246 Identities=17% Similarity=0.180 Sum_probs=196.8
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++++.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++..++|+||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 577888999999999999995 458899999986432 1223567889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
|+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999986 3456888999999999999999999999 99999999999999999999999998742110
Q ss_pred ------------------------------------------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHH
Q 019905 212 ------------------------------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249 (334)
Q Consensus 212 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 249 (334)
.....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 01235889999999999988999999999999999999
Q ss_pred hCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 019905 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP---NPKSLVTA 312 (334)
Q Consensus 250 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~~l~~ 312 (334)
+|..||................ ...........+.++.+++.+|+ .+|.+|+ ++.++++-
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWE--TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccC--ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999987654332221111100 00111112234567889999977 5999999 88888743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.10 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=205.0
Q ss_pred hcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
......|++++.+|+|++|.||+|.. .++..|++|.+..........+.+|+.+++.++|+|++++++.+..+...++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 33445678888899999999999985 46789999999866655567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+......
T Consensus 96 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~g-i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999999984 346889999999999999999999999 999999999999999999999999987754332
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||............ ..........+...+..+.+
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHH
Confidence 2346778999999999888999999999999999999999988654322111100 01111111223445568999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||..||++|||+.++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhh
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.23 Aligned_cols=235 Identities=20% Similarity=0.264 Sum_probs=191.6
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||+|... +++.||+|.+.... .........|..++... +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 4699999999999965 47899999997532 12234566677777754 8999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 82 DLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSKG-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 9999986 3457889999999999999999999999 99999999999999999999999999874321 224567
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
|..|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHHHHHHHHHhc
Confidence 89999999999888999999999999999999999998655433222211110 112334456689999999999
Q ss_pred cCCCCCCCHH-HHH
Q 019905 298 YEPRERPNPK-SLV 310 (334)
Q Consensus 298 ~dp~~Rps~~-~~l 310 (334)
.||.+||++. +++
T Consensus 233 ~~P~~R~~~~~~l~ 246 (316)
T cd05619 233 REPERRLGVKGDIR 246 (316)
T ss_pred cCHhhcCCChHHHH
Confidence 9999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=311.75 Aligned_cols=246 Identities=16% Similarity=0.136 Sum_probs=194.9
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|.+++.||.|+||.||++.. .+++.||+|.+.... ......+.+|++++..++||||+++++++......++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 467788889999999999985 468899999986432 1123467789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKLG-FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999986 3467889999999999999999999999 999999999999999999999999998532110
Q ss_pred -----------------------------------------------CcccccccccCcccccCCCCCCccchhhhHHHH
Q 019905 213 -----------------------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLL 245 (334)
Q Consensus 213 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 245 (334)
....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 013588999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 019905 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER---PNPKSLVTA 312 (334)
Q Consensus 246 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~~l~~ 312 (334)
|||++|..||...................... -....+.++.+++.+|+. +|.+| +++.+++..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFP--DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999986543322211111100000000 011345689999999997 77765 599888754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=289.77 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=205.8
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..+++.+.+|.|++|.||+|... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45667788899999999999875 68999999976543 45678899999999999999999999988888999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-ccccc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-SYSTN 218 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 218 (334)
+++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+....... ....+
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN-FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 999999997544457899999999999999999999999 9999999999999999999999999987664322 22335
Q ss_pred ccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 219 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
..|+|||.+.+..++.++||||||+++|++++ |..|+............... .....+...++.+.+++.+||.
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-----YRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-----CCCCCccCCCHHHHHHHHHHhc
Confidence 67999999988889999999999999999997 88777655433322211111 1112234456789999999999
Q ss_pred cCCCCCCCHHHHHHHhccc
Q 019905 298 YEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 298 ~dp~~Rps~~~~l~~L~~l 316 (334)
.+|++|||+.+++..|+.+
T Consensus 238 ~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 238 LDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cChhhCcCHHHHHHHHhcC
Confidence 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=299.90 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=203.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCC--EEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQR--RIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
.+.++++.+.||+|+||.||+|.+. ++. .+++|.+..... .....+.+|++++.++ +|+||+++++++...+..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4566778888899999999999964 343 468887764322 2235678899999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCe
Q 019905 133 LVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~ 198 (334)
++|||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEecCCCcE
Confidence 9999999999999986321 135788999999999999999999999 9999999999999999999
Q ss_pred eEcCCCCCccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccccccc
Q 019905 199 RLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDS 274 (334)
Q Consensus 199 kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 274 (334)
+|+|||++...... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||............ ..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----~~- 238 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----PQ- 238 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH----hc-
Confidence 99999998643211 11223567999999988889999999999999999998 88777544322222111 11
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
......+...+.++.+++.+||+.+|++||++.+++..|+.+..+...
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 111112333456899999999999999999999999999887765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.69 Aligned_cols=246 Identities=20% Similarity=0.304 Sum_probs=190.9
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeC-----CeeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 133 (334)
|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 667788899999999999954 68999999987432 22344678899999999999999999987543 24799
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 82 v~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999995 78988886 3456899999999999999999999999 999999999999999999999999998753221
Q ss_pred ------CcccccccccCcccccC--CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh-------------------h
Q 019905 213 ------KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-------------------D 265 (334)
Q Consensus 213 ------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~-------------------~ 265 (334)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... .
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 23467889999999876 56899999999999999999999888643211100 0
Q ss_pred ccccccccc---ccC---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 266 RNLQMLTDS---CLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 266 ~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......... ... ....+..++.+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 000 0001123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=294.92 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=188.8
Q ss_pred cCCCcCccEEEEEEeCC-------------------------CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccce
Q 019905 67 EHGEKAPNVVYKGKLEN-------------------------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNL 121 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 121 (334)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 57999999999997421 24588999865443334567888999999999999999
Q ss_pred eeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-----
Q 019905 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----- 196 (334)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~----- 196 (334)
++++......++||||+++++|..++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKN-LVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC-ccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999999998864 3457889999999999999999999999 99999999999997543
Q ss_pred --CeeEcCCCCCccCCCCCcccccccccCcccccC-CCCCCccchhhhHHHHHHHH-hCCCCCCchhhHHhhhccccccc
Q 019905 197 --NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLL-SGKHIPPSHALDLIRDRNLQMLT 272 (334)
Q Consensus 197 --~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~ 272 (334)
.++++|||.+..........++..|+|||.+.+ ..++.++||||||+++||++ +|..|+............ ..
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~-- 236 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-EK-- 236 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-Hh--
Confidence 379999998865544445567788999999876 45899999999999999985 677666543222211110 00
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
....+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 237 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 237 ----KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ----ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 01122223457999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=295.85 Aligned_cols=256 Identities=17% Similarity=0.204 Sum_probs=205.3
Q ss_pred HHHHHhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC
Q 019905 51 QLKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129 (334)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 129 (334)
++.+.....+.|++++++|.|+||.||+|... ++..+++|.+..........+.+|+.+++.++|+|++++++.+..++
T Consensus 3 ~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 45555556677889999999999999999964 47899999997654444567888999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..++||||+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||.+...
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred eEEEEEecCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcCC-eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999887754 3457899999999999999999999998 999999999999999999999999987653
Q ss_pred CCC----CcccccccccCcccccC-----CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCC
Q 019905 210 RDG----KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 210 ~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (334)
... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+............... .......
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~ 237 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLSQ 237 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCccCCC
Confidence 322 23456789999999853 34788999999999999999999887543322111111110 0111122
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+...+.++.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 3445568999999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=302.77 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=198.5
Q ss_pred cccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeeeC-Cee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEG-DER 131 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~ 131 (334)
.|++++.||.|+||.||+|... +++.||+|.+....... ...+.+|++++.++ +|+||+++++++... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 5778889999999999999632 24789999987543221 34577899999999 799999999988654 567
Q ss_pred eEEEecCCCCCHHHhhcccC-----------------------------------------------------------C
Q 019905 132 LLVAEYMPNETLAKHLFHWE-----------------------------------------------------------T 152 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------~ 152 (334)
+++|||+++++|.+++.... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999885311 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC------CcccccccccCccc
Q 019905 153 HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEY 226 (334)
Q Consensus 153 ~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~ 226 (334)
..+++..+..++.||+.||.|||+++ |+||||||.||+++.++.++|+|||++...... ....++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~~-ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 26788999999999999999999999 999999999999999999999999998764322 12334568999999
Q ss_pred ccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC
Q 019905 227 LRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305 (334)
Q Consensus 227 ~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 305 (334)
+.+..++.++|||||||++|+|++ |..||............. ........+...+.++.+++.+||+.+|++||+
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL----KEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH----hccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999999999999998 887775422111100000 000111223345568999999999999999999
Q ss_pred HHHHHHHhccccc
Q 019905 306 PKSLVTALSPLQK 318 (334)
Q Consensus 306 ~~~~l~~L~~l~~ 318 (334)
+.++++.|+++..
T Consensus 323 ~~ell~~l~~~~~ 335 (337)
T cd05054 323 FSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=293.05 Aligned_cols=251 Identities=17% Similarity=0.228 Sum_probs=196.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCC----EEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++++++.||+|+||.||+|.+. ++. .+++|.+...... ....+..|+..+..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 34667788899999999999963 333 4788887543221 12456778888999999999999998754 45789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
++||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||.+......
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR-MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999964 3457899999999999999999999999 999999999999999999999999998754322
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....++..|+|||.+.+..++.++||||||+++||+++ |..|+.........+.. ........+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 238 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-----EKGERLAQPQICTI 238 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----HCCCcCCCCCCCCH
Confidence 12335678999999998889999999999999999998 88777654322221111 11011111223445
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
++.+++.+||..||.+|||+.++++.|..+..
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.10 Aligned_cols=236 Identities=19% Similarity=0.273 Sum_probs=194.1
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++... ++..||+|.+.... ......+..|..++..+ +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 4699999999999965 47899999997532 22334567788888877 7999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++..... .....+
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 82 DLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 9999886 3457899999999999999999999999 99999999999999999999999998864221 123457
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
+..|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+..+.+++.+||+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------EVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------CCCCCCcCCHHHHHHHHHHcc
Confidence 89999999999989999999999999999999999998755433322211111 112344456789999999999
Q ss_pred cCCCCCCCH-----HHHHH
Q 019905 298 YEPRERPNP-----KSLVT 311 (334)
Q Consensus 298 ~dp~~Rps~-----~~~l~ 311 (334)
.||.+|||+ .++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHcCCCCCCCHHHHhc
Confidence 999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.96 Aligned_cols=239 Identities=17% Similarity=0.257 Sum_probs=191.8
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++... +++.||+|.+..... .....+..|..++..+ +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999964 578999999975332 2234577899999888 7999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC----CCCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR----DGKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~----~~~~~~~ 217 (334)
+|.+++. ..+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.... ......|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9998886 4467999999999999999999999999 9999999999999999999999999986421 1224568
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-----hhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
|..|+|||++.+..++.++|+||||+++|+|++|+.||....... ............ ....+...+..+.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li 236 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 899999999999889999999999999999999999885321100 000000011111 1123445667899999
Q ss_pred HHhhhcCCCCCCC------HHHHH
Q 019905 293 SRCLQYEPRERPN------PKSLV 310 (334)
Q Consensus 293 ~~cl~~dp~~Rps------~~~~l 310 (334)
.+||+.||.+||+ +++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHh
Confidence 9999999999998 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=293.98 Aligned_cols=240 Identities=24% Similarity=0.369 Sum_probs=192.3
Q ss_pred cCCCcCccEEEEEEeCC--------CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 67 EHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.||.|+||.||+|.... ...+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 56999999999998532 2348888886544333456888999999999999999999999988999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC--------eeEcCCCCCccCC
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--------PRLSTFGLMKNSR 210 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~--------~kl~Dfg~a~~~~ 210 (334)
++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++. ++++|||.+....
T Consensus 82 ~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 82 KFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDKG-LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999864 2346889999999999999999999999 999999999999987664 6999999987766
Q ss_pred CCCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 211 DGKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 211 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
......++..|+|||++.+. .++.++||||||+++|++++|..++.............. .....+.....++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 233 (258)
T cd05078 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE------DRHQLPAPKWTELA 233 (258)
T ss_pred CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH------ccccCCCCCcHHHH
Confidence 66666788899999999874 489999999999999999999654433211111110000 01123334456899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 290 RLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+++.+||+.||++|||++++++.|+
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHhcC
Confidence 9999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=306.89 Aligned_cols=246 Identities=17% Similarity=0.164 Sum_probs=198.2
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++++.||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 4667788899999999999954 688999999975432 223457889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~-i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 82 YQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999864 2357899999999999999999999999 9999999999999999999999999987654322
Q ss_pred --cccccccccCccccc------CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 214 --SYSTNLAFTPPEYLR------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
...+++.|+|||++. +..++.++||||||+++|+|++|..||................ ...........+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 237 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ--RFLKFPEDPKVS 237 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC--CccCCCCCCCCC
Confidence 235789999999986 4457899999999999999999999986554332222111110 000001112345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.+|+.+||+ +|.+|||+.+++.
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 689999999998 9999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=299.34 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=201.9
Q ss_pred CcccccccCCCcCccEEEEEEeC--------CCCEEEEEEecCCC-CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 129 (334)
..+.+.+.+|+|+||.||++... ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 45667788899999999999731 23579999987533 22245688999999999 8999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
..+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Nili~~~ 173 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-CIHRDLAARNVLVTEN 173 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-eeecccccceEEEcCC
Confidence 9999999999999999986421 134678889999999999999999999 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccc
Q 019905 196 GNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 268 (334)
+.++|+|||.+....... ...++..|+|||.+.+..++.++||||||+++|++++ |..|+.............
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999999987654321 2234567999999988889999999999999999998 666665443333222111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
. ......+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus 254 ~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 254 E-----GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred c-----CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1 11112234456789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=302.77 Aligned_cols=237 Identities=19% Similarity=0.253 Sum_probs=193.8
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
+|++++.||+|+||.||+|... +++.||+|.+..... .....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3567788899999999999865 468999999875321 1233456677887777 5889999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---- 211 (334)
||+++|+|.+.+. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999999886 3456899999999999999999999999 99999999999999999999999999875321
Q ss_pred CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||............... ...++...+.++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~l 231 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------NVAYPKSMSKEAVAI 231 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCcCCHHHHHH
Confidence 22456789999999999999999999999999999999999998765433332221111 112344566789999
Q ss_pred HHHhhhcCCCCCCCH
Q 019905 292 ASRCLQYEPRERPNP 306 (334)
Q Consensus 292 i~~cl~~dp~~Rps~ 306 (334)
+.+||+.||.+|++.
T Consensus 232 i~~~l~~~p~~R~~~ 246 (323)
T cd05616 232 CKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHcccCHHhcCCC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.59 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=205.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++.+.+|+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+|++++++.+...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4667778899999999999965 7899999988643222 24568899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 137 YMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999988532 2356889999999999999999999999 999999999999999999999999998754332
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......... .................+..+.+
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH--HhhhhcCCCCCCChhhcCHHHHH
Confidence 23457788999999988889999999999999999999998875543221110 00011111111111245568999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 291 LASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
++.+||..+|++|||+.++++.|+.+.
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.99 Aligned_cols=245 Identities=18% Similarity=0.186 Sum_probs=194.0
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|.+++.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 366778889999999999995 4578999999864321 123467889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
|+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~al~~lH~~~-ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLI--RMGIFPEDLARFYIAELTCAVESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999886 3456889999999999999999999999 99999999999999999999999998642110
Q ss_pred ----------------------------------------------CCcccccccccCcccccCCCCCCccchhhhHHHH
Q 019905 212 ----------------------------------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLL 245 (334)
Q Consensus 212 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 245 (334)
.....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0123578999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 019905 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLVT 311 (334)
Q Consensus 246 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~ 311 (334)
|||++|..||................. ..........++++.+++.+++ .+|.+|++ +.++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQT--SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCC--CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999875432222111111000 0111112234568889998876 59999987 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.34 Aligned_cols=242 Identities=29% Similarity=0.408 Sum_probs=201.1
Q ss_pred cCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.+|+|+||.||+|.... +..+++|.+....... .+.+.+|++.++.++|+|++++++++......+++|||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 56999999999999643 7899999998655333 567889999999999999999999999988999999999999
Q ss_pred CHHHhhcccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 142 TLAKHLFHWE-------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 142 sL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
+|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-cccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999987421 367899999999999999999999999 999999999999999999999999998866542
Q ss_pred ----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhC-CCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
....++..|+|||.+.+..++.++||||||+++|+|+++ ..|+.............. ......+...+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 235 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----GYRLPKPEYCPDE 235 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccCChH
Confidence 234567889999999888899999999999999999994 766655433222221111 1122234455678
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+.+++.+||+.+|.+|||+.++++.|+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 236 LYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.15 Aligned_cols=245 Identities=19% Similarity=0.277 Sum_probs=201.9
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|.+.+.+|+|++|.||++... +++.|++|.+..... .....+.+|+++++.++|||++++++++...+..+++|||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 455667799999999999964 578999999865432 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----c
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 214 (334)
++++|.+++.......+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~-i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999997644567889999999999999999999999 9999999999999999999999999887554332 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||++.+..++.++|+||||+++|+|++|..|+................ ....+...+..+.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-----FPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCccccCHHHHHHHHH
Confidence 356788999999998889999999999999999999999886554322221111111 112233455689999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~ 312 (334)
||+.+|++||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 236 CLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HccCCcccCcCHHHHhhC
Confidence 999999999999999853
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=289.94 Aligned_cols=245 Identities=16% Similarity=0.209 Sum_probs=202.7
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
|++.+.+|.|+||.||++... ++..+|+|.+.... ....+.+.+|+.+++.++|+|++++++.+..++..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 567788899999999999954 57899999986432 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Ccc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~ 215 (334)
+++|.+++.......+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+...... ...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 999999886544566889999999999999999999999 999999999999999999999999998755432 234
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.++..|+|||++.+..++.++|+||||+++|+|++|..||.............. . .....+...+..+.+++.+|
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ----G-SYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc----C-CCCCCCcccCHHHHHHHHHH
Confidence 577889999999888899999999999999999999999876543322211111 1 11122344556899999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 019905 296 LQYEPRERPNPKSLVTA 312 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~~ 312 (334)
|+.||.+|||+.+++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=304.58 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=210.3
Q ss_pred ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh-HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP-RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
..++++||+|-||.|.++...++..||+|.++.....+. +.|.+|+.+|.+|+||||++++|+|..++.+++|+||+++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 456689999999999999998889999999998776665 7899999999999999999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCccc----
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS---- 216 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~---- 216 (334)
|+|..++.......+.-.....|+.||+.|++||.+.+ +|||||.++|+|+++++++|++|||+++....+....
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n-fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN-FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc-hhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 99999997543333455566789999999999999999 9999999999999999999999999999766554332
Q ss_pred --ccccccCcccccCCCCCCccchhhhHHHHHHHHh--CCCCCCchhhHHhhhcccccccccccC--CCCCchhHHHHHH
Q 019905 217 --TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS--GKHIPPSHALDLIRDRNLQMLTDSCLE--GQFTDDDGTELVR 290 (334)
Q Consensus 217 --~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 290 (334)
-..+|||||.+..+.+++++|+|+||+++||+++ ...|+..-..+.+-+.....+.++... ...|.-++..+++
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lye 778 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYE 778 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHH
Confidence 2489999999999999999999999999999865 556665544444433322222222211 1235566778999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 291 LASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+|..||..+..+|||++++...|+..
T Consensus 779 lml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 779 LMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 99999999999999999998887654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=296.43 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=201.9
Q ss_pred cccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
.|++.+.+|+|+||.||++... ....+|+|.+..... .....+.+|++++.++ +|+||+++++++..++..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 4667778899999999999853 236899999875432 1234578899999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHhhccc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCe
Q 019905 133 LVAEYMPNETLAKHLFHW--------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~ 198 (334)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-CIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-ccccccceeeEEEcCCCeE
Confidence 999999999999998531 2356888999999999999999999999 9999999999999999999
Q ss_pred eEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccc
Q 019905 199 RLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQML 271 (334)
Q Consensus 199 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 271 (334)
+|+|||.+....... ...++..|+|||.+.+..++.++||||||+++|++++ |..|+...............
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 250 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG- 250 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999987654321 1223567999999988889999999999999999997 77777654333322211111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
.....+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 251 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 251 ----YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111233445668999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=294.42 Aligned_cols=252 Identities=19% Similarity=0.330 Sum_probs=198.2
Q ss_pred ccccccCCCcCccEEEEEEe-----CCCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 133 (334)
|++++.+|+|+||.||++.. .++..||+|.+.... ......+.+|+++++.++|+|++++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 56778889999999999974 347899999987543 22235688999999999999999999998765 56889
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
+|||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~g-i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 86 IMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999864 2346889999999999999999999999 9999999999999999999999999987654321
Q ss_pred -------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh-----------hcccccccccc
Q 019905 214 -------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-----------DRNLQMLTDSC 275 (334)
Q Consensus 214 -------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~-----------~~~~~~~~~~~ 275 (334)
...++..|+|||.+.+..++.++||||||+++|+++++..|.......... ..........
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG- 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC-
Confidence 234556799999998888999999999999999999987554221100000 0000000000
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.....+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11122344567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=301.74 Aligned_cols=232 Identities=21% Similarity=0.248 Sum_probs=188.7
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHH-HHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||+|... +++.||+|.+..... .....+..|.. +++.++||||+++++.+...+..++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 4699999999999964 588999999964321 11233445544 567889999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g-ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 9999886 4467889999999999999999999999 99999999999999999999999999864322 223457
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
++.|+|||++.+..++.++||||||+++|+|++|..||................ ...+...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------LRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhh
Confidence 899999999998889999999999999999999999987654333322221111 11233446789999999999
Q ss_pred cCCCCCCCHH
Q 019905 298 YEPRERPNPK 307 (334)
Q Consensus 298 ~dp~~Rps~~ 307 (334)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (323)
T cd05575 233 KDRTKRLGAK 242 (323)
T ss_pred cCHHhCCCCC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=303.61 Aligned_cols=235 Identities=18% Similarity=0.259 Sum_probs=188.5
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++... +++.+|+|.+...... ....+.+|+.++.++ +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 4699999999999964 5789999999754322 234567888888776 7999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|..++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9998886 4467899999999999999999999999 99999999999999999999999999865321 223567
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-----hhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
+..|+|||++.+..++.++||||||+++|+|++|..||....... ........... .....+...+..+.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRSLSVKAASVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--CCCCCCCCCCHHHHHHH
Confidence 899999999999889999999999999999999999884211000 00000000111 11124555667899999
Q ss_pred HHhhhcCCCCCCCH
Q 019905 293 SRCLQYEPRERPNP 306 (334)
Q Consensus 293 ~~cl~~dp~~Rps~ 306 (334)
.+||+.||.+||++
T Consensus 237 ~~~L~~dP~~R~~~ 250 (329)
T cd05618 237 KSFLNKDPKERLGC 250 (329)
T ss_pred HHHhcCCHHHcCCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.74 Aligned_cols=241 Identities=28% Similarity=0.423 Sum_probs=197.3
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHH
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 145 (334)
.+|.|++|.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++......+++|||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 56999999999999766899999998765433 34578899999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc------ccccc
Q 019905 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS------YSTNL 219 (334)
Q Consensus 146 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~------~~~~~ 219 (334)
++.. ....++...+..++.+++.+|.|||+++ ++||||+|+||+++.++.++|+|||.+........ ...+.
T Consensus 82 ~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 82 FLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9864 3446788999999999999999999999 99999999999999999999999999876542211 12245
Q ss_pred cccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc
Q 019905 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (334)
Q Consensus 220 ~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (334)
.|+|||.+.+..++.++|+||||+++|+|++ |..|+.............. ......+...+.++.+++.+||..
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-----GYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-----CCCCCCCccCCHHHHHHHHHHhcc
Confidence 7999999988889999999999999999999 6666644332222211111 111123445567899999999999
Q ss_pred CCCCCCCHHHHHHHhc
Q 019905 299 EPRERPNPKSLVTALS 314 (334)
Q Consensus 299 dp~~Rps~~~~l~~L~ 314 (334)
+|.+|||+.++++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.96 Aligned_cols=252 Identities=17% Similarity=0.169 Sum_probs=199.2
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
.......|++++.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3334466888888999999999999965 57899999986422 1223457789999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||+++|+|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~~~-IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSMG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999984 346888999999999999999999999 9999999999999999999999999987654
Q ss_pred CC-----CcccccccccCcccccCCC----CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 211 DG-----KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 211 ~~-----~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
.. ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||..................... ...
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~ 271 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PED 271 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC--CCc
Confidence 32 2446899999999996543 788999999999999999999998765433222211111100000 111
Q ss_pred chhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 019905 282 DDDGTELVRLASRCLQYEPRE--RPNPKSLVTA 312 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~--Rps~~~~l~~ 312 (334)
...+..+.+++.+|+..++.. |+++.++++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 234668999999999855543 8899999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.16 Aligned_cols=242 Identities=19% Similarity=0.274 Sum_probs=194.5
Q ss_pred cCCCcCccEEEEEEeC---CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
.||+|+||.||+|.+. .+..||+|.+....... .+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3699999999999853 35579999997654222 3568899999999999999999998754 56899999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-------cc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-------SY 215 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-------~~ 215 (334)
|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN-FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcC-eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9998864 3457899999999999999999999999 9999999999999999999999999987543221 11
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
.++..|+|||.+.+..++.++||||||+++|++++ |..|+.......+.... ........+...++++.+++.+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-----EQGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-----HCCCCCCCCCCCCHHHHHHHHH
Confidence 22468999999988889999999999999999996 88777544322221111 1111123344556789999999
Q ss_pred hhhcCCCCCCCHHHHHHHhccc
Q 019905 295 CLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l 316 (334)
||..||++||++.++++.|+.+
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=293.02 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=196.1
Q ss_pred cccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.|++.+.+|+|++|.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 4667778899999999999753 246799999864321 123457889999999999999999999998889999
Q ss_pred EEecCCCCCHHHhhcccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 134 VAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCcchheEEEcCCCCEEECCCCC
Confidence 999999999999886321 124567888999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCC
Q 019905 206 MKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (334)
Q Consensus 206 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (334)
+....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. .. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~~-~~ 240 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----GG-LL 240 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----CC-cC
Confidence 86543221 2234678999999998889999999999999999999 5666654433222211111 00 11
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 223345568999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=315.77 Aligned_cols=246 Identities=18% Similarity=0.217 Sum_probs=200.3
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCC-------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------- 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 129 (334)
..|.+.+.||+|+||+||++.. .+++.||+|.+...... ....+.+|+..+..++|+|++++...+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4677778889999999999984 46899999999754322 2345778999999999999999888775432
Q ss_pred -eeeEEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 130 -ERLLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEeCCCCEEEEecccC
Confidence 367999999999999988642 2357889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCC------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCC
Q 019905 207 KNSRD------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 207 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (334)
+.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||................ ....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~ 265 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-----YDPL 265 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-----CCCC
Confidence 75432 234568899999999999889999999999999999999999987654433322221111 1123
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+...++++.+++.+||+.||.+||++.++++
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 4456678999999999999999999999975
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=291.44 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=200.6
Q ss_pred CcccccccCCCcCccEEEEEEeCC-C---CEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-Q---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+++.+.+|+|+||.||+|.... + ..||+|.+..... .....+..|+.+++.++||||+++.+++..+...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 456778888999999999999643 2 3699999875431 1245788999999999999999999999998899999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS 214 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 214 (334)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~g-~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 84 TEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999864 3456889999999999999999999999 99999999999999999999999998765432211
Q ss_pred -------cc--ccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 215 -------YS--TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 215 -------~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
.. .+..|+|||.+.+..++.++||||||+++||+++ |..||............... .....+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~ 236 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-----YRLPPPMDC 236 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-----CcCCCcccC
Confidence 11 1347999999998889999999999999999886 88777554332222211111 111123345
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 66899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=307.55 Aligned_cols=195 Identities=17% Similarity=0.205 Sum_probs=172.4
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CC-----CccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NN-----RLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~l 133 (334)
.|.+++.||+|+||.|-+|.. ++++.||||.++... .-..+...|+.+|..|+ |. |+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 567889999999999999994 568999999997644 23456678999999997 43 79999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC--CCCeeEcCCCCCccCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~--~~~~kl~Dfg~a~~~~~ 211 (334)
|+|.+. .+|.+++..+...+++...++.++.||+.||.+||+.+ |||+||||+|||+.+ ...+||+|||.+.....
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~-IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG-IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 999995 89999999888899999999999999999999999999 999999999999974 45799999999887655
Q ss_pred CC-cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch
Q 019905 212 GK-SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (334)
Q Consensus 212 ~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~ 258 (334)
.. .+..+..|+|||++.|.+|+.+.||||||||++||++|.+.|+++
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 32 566778999999999999999999999999999999998877654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=312.38 Aligned_cols=240 Identities=20% Similarity=0.302 Sum_probs=202.0
Q ss_pred cCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHH
Q 019905 67 EHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 145 (334)
.||+|+||+||.|+. ++...+|||.+........+.+.+|+.+.++|+|.|||+++|.+.+++++-|.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 469999999999995 4567899999987665566778999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCCCCCccC----CCCCccccc
Q 019905 146 HLFHWETHPM--KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNS----RDGKSYSTN 218 (334)
Q Consensus 146 ~l~~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~----~~~~~~~~~ 218 (334)
.++. +-+++ ++.+...+..||+.||.|||... |||||||-+||||+ -.|.+|++|||-++.. .-..+..||
T Consensus 662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~-IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENK-IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcc-eeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 9975 45666 78889999999999999999998 99999999999998 6789999999987653 335678899
Q ss_pred ccccCcccccCCC--CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhh
Q 019905 219 LAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (334)
Q Consensus 219 ~~y~aPE~~~~~~--~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (334)
.-|||||++..++ |..++|||||||++.||.||++||..-.......-..... ..-...|.+.+.++..+|.+|+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy---KvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY---KVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce---ecCCCCcHHHHHHHHHHHHHHc
Confidence 9999999997766 9999999999999999999999886432221111010000 1122467788899999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 019905 297 QYEPRERPNPKSLVT 311 (334)
Q Consensus 297 ~~dp~~Rps~~~~l~ 311 (334)
.+||..||++.++|.
T Consensus 817 epd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcccCccHHHhcc
Confidence 999999999999985
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=297.50 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=203.8
Q ss_pred CcccccccCCCcCccEEEEEEeC--------CCCEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 129 (334)
+.|.+.+.||+|+||.||++... +...+|+|.+..... .....+.+|++++..+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45778889999999999999742 235699999975432 2234677899999999 7999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.+
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~ 176 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTED 176 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHHheEEcCC
Confidence 9999999999999999996422 134788999999999999999999999 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccc
Q 019905 196 GNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 268 (334)
+.++|+|||.+....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 999999999987544321 1223467999999988889999999999999999998 666665443332221111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
. ......+...+.++.+++.+||+.+|.+|||+.++++.|+.+...+
T Consensus 257 ~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 257 E-----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred c-----CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111233445678999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=297.45 Aligned_cols=250 Identities=18% Similarity=0.302 Sum_probs=196.4
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
...|.++++||+|+||.||+|... ++..||+|.+...... ....+.+|++++++++|+||+++++++..++..+++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 356888899999999999999864 5788999998754322 23467789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLD-KDLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 997 588887754 3445788999999999999999999999 999999999999999999999999998754322
Q ss_pred CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc-----------c--------c
Q 019905 213 KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM-----------L--------T 272 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~-----------~--------~ 272 (334)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||............... . .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 234567899999998654 4889999999999999999999888654322111100000 0 0
Q ss_pred c-cccC----CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 D-SCLE----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~-~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. .... .......+.++.+++.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 0000 0011234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=284.96 Aligned_cols=241 Identities=25% Similarity=0.406 Sum_probs=196.6
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHH
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 145 (334)
.+|.|+||.||+|...++..+|+|.+....... ...+.+|+++++.++||||+++++++...+..+++|||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 469999999999998788899999987543221 2357889999999999999999999999899999999999999999
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----ccccccc
Q 019905 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----SYSTNLA 220 (334)
Q Consensus 146 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~ 220 (334)
++.. ....+++..+..++.+++.+|.|+|+++ ++|+||+|+||+++.++.++|+|||++....... ...++..
T Consensus 82 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 82 FLRK-KKDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 8864 3356789999999999999999999999 9999999999999999999999999986543321 1233567
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcC
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (334)
|+|||++.+..++.++||||||+++|++++ |..||.............. ......+...+..+.+++.+||+.+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-----GYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHHHHcccC
Confidence 999999988889999999999999999998 7777755432222211111 1111233445678999999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 019905 300 PRERPNPKSLVTALS 314 (334)
Q Consensus 300 p~~Rps~~~~l~~L~ 314 (334)
|++||++.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=295.96 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=205.5
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.......|.+++.+|.|++|.||++.. .++..||+|.+........+.+.+|+.+++.++|+|++++++++..++..++
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 344446788888999999999999995 4689999999976555555678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+......
T Consensus 94 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~-i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999999984 356888999999999999999999999 999999999999999999999999998754432
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....++..|+|||.+.+..++.++|+||||+++|++++|..||.......... ............+...+..+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eeccCCCCCCCCccccCHHHH
Confidence 23456789999999998889999999999999999999998886543211110 000111111122344556789
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+++.+||+.+|.+||++.++++
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.92 Aligned_cols=249 Identities=20% Similarity=0.307 Sum_probs=202.1
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..+++.+.+|+|+||.||++...++..+++|.+.... .....+.+|+++++.++|+||+++.+++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4577788889999999999997777889999887543 234578889999999999999999999877 67899999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.......+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 999999997544556788899999999999999999998 9999999999999999999999999987544321 1
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++|+||||+++|++++ |..|+............... .....+...+.++.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENCPEELYNIMM 237 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----CCCCCcccCCHHHHHHHH
Confidence 233467999999988889999999999999999999 77776544322222111111 111223445568999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+||+.+|++||++.++++.|+++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 238 RCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.23 Aligned_cols=242 Identities=21% Similarity=0.291 Sum_probs=196.2
Q ss_pred cCCCcCccEEEEEEeCC--C--CEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLEN--Q--RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.+|+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++|+||+++++++.. ...++++||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 56999999999998643 2 3689999987664 345678899999999999999999999888 8899999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-------Cc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-------KS 214 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-------~~ 214 (334)
+|.+++.......+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC-ccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 9999987533256899999999999999999999999 999999999999999999999999998765432 12
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. .......+...+..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK----EGERLERPEACPQDIYNVML 235 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCcCCCCccCCHHHHHHHH
Confidence 345678999999988889999999999999999998 8887754322222111111 01111123344568999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhc
Q 019905 294 RCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+||+.+|++|||+.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.41 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=201.0
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.++++.+.+|.|++|.||++.+.++..+|+|.+.... .....+.+|++++++++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4567778889999999999998777899999987543 235678899999999999999999999998889999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.. ....+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 83 HGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSN-VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999998864 3346789999999999999999999999 9999999999999999999999999887543321 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|++++ |..|+............... .....+...+..+.+|+.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-----FRLYKPRLASQSVYELMQ 235 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-----CCCCCCCCCCHHHHHHHH
Confidence 234568999999998889999999999999999998 77776544322222111110 011112334568999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhc
Q 019905 294 RCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+||+.+|++|||+.++++.|+
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHcccChhhCCCHHHHHHhhC
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=290.53 Aligned_cols=245 Identities=18% Similarity=0.246 Sum_probs=211.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.++++++||+|+||.||++.++ +|..+|||.+.... +.+++.+|+.++.+++.+++|+++|.|.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4678899999999999999964 58999999997644 68899999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~ 215 (334)
.|+..+.++. .++++.+.++..++...+.||.|||... -+|||||..|||++.+|..||+|||.|....+ ..+.
T Consensus 112 AGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~-KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK-KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH-HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 9999999876 6689999999999999999999999998 89999999999999999999999999887655 3567
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.||+.|||||++..-.|+.++||||||++..||..|++|+..-- .. +..+.....+......|...+.++.+++++|
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH--PM-RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH--PM-RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc--cc-ceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 89999999999999999999999999999999999998765321 01 1112222233333445677889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 019905 296 LQYEPRERPNPKSLVTA 312 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~~ 312 (334)
|-.+|++|.|+..+++-
T Consensus 267 LiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEH 283 (502)
T ss_pred hcCCHHHHHHHHHHhhh
Confidence 99999999999888753
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.87 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=201.1
Q ss_pred ccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
+++.+.+|+|+||.||+|... ....+++|.+...... ....+.+|+++++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 556778899999999999852 2357889888654321 235688899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhccc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee
Q 019905 135 AEYMPNETLAKHLFHW----------------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~----------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili 192 (334)
+||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~dikp~nill 160 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-LVHRDLAARNVLV 160 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-eehhhhhhheEEE
Confidence 9999999999987531 1135788899999999999999999999 9999999999999
Q ss_pred cCCCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhh
Q 019905 193 DEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRD 265 (334)
Q Consensus 193 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~ 265 (334)
++++.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.......+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999987543221 2234568999999988889999999999999999998 877776543332221
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
... .......+...+.++.+++.+||+.+|.+||++.++++.|+++..
T Consensus 241 ~~~-----~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 LLK-----TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHh-----CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111 111122344556789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.96 Aligned_cols=251 Identities=19% Similarity=0.251 Sum_probs=198.4
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCC----EEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++++++.||.|+||+||+|.+. ++. .||+|.+...... ....+.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 34667788899999999999853 343 4899998654322 23567889999999999999999999875 45789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
+++|+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||++++++.++|+|||++.......
T Consensus 86 ~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~-iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 86 VTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999999864 3456899999999999999999999999 9999999999999999999999999987554221
Q ss_pred ------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 214 ------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
...++..|+|||.+.+..++.++||||||+++||+++ |..|+.............. ......+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 238 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-----GERLPQPPICTI 238 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-----CCcCCCCccCCH
Confidence 1233568999999988889999999999999999998 7776654332222111111 011112334556
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
++.+++.+||+.||+.||++.++++.|+.+..
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 89999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=312.46 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=192.1
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC--------Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--------DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~ 130 (334)
..|++++.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|+||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 4578888899999999999996 467899999985422 3345799999999999999999876432 24
Q ss_pred eeEEEecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCc
Q 019905 131 RLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMK 207 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~ 207 (334)
.++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCcCHHHEEEcCCCCceeeeccccch
Confidence 678999997 577766642 13467889999999999999999999999 99999999999999654 79999999998
Q ss_pred cCCCC---CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc--------------
Q 019905 208 NSRDG---KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-------------- 269 (334)
Q Consensus 208 ~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~-------------- 269 (334)
..... ....+++.|+|||++.+. .++.++|||||||++|+|++|..||..............
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 65432 245678899999998765 589999999999999999999988865422111100000
Q ss_pred ---------cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH--HHhccc
Q 019905 270 ---------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV--TALSPL 316 (334)
Q Consensus 270 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l--~~L~~l 316 (334)
......+...++...+.++.+|+.+||++||.+|||+.+++ ..++.+
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00000111122334567899999999999999999999998 344443
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.47 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=200.2
Q ss_pred cccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
++.+.+.+|+|+||.||++... .+..||+|.+....... .+.+.+|+++++++ +|+||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 4666778899999999999741 24589999987543222 34678899999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
++|||+++++|.+++.......+++..+..++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 9999999999999986533345899999999999999999999999 999999999999999999999999998754332
Q ss_pred C------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 213 K------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 ~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
. ...++..|+|||.+.+..++.++||||||+++|++++ |..|+........... ..........+...+
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 270 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK----LIKEGYRMAQPEHAP 270 (302)
T ss_pred CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH----HHHcCCcCCCCCCCC
Confidence 1 2234578999999998889999999999999999998 7777654322111100 011111111233345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 6899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=294.39 Aligned_cols=246 Identities=17% Similarity=0.277 Sum_probs=197.7
Q ss_pred cccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+..+.||+|+||.||++... +++.+|+|.+....... ...+.+|+.+++.++|++++.+.+.+...+..+++|||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34456699999999999964 57899999986543222 235678999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---SY 215 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~ 215 (334)
++++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....... ..
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 9999999886444456899999999999999999999999 9999999999999999999999999987544322 34
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ........ .....+...+.++.+|+.+|
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-VQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh-hhhhcCccCCHHHHHHHHHH
Confidence 67899999999998889999999999999999999999886532111000 00001010 11123444566899999999
Q ss_pred hhcCCCCCCC-----HHHHHH
Q 019905 296 LQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rps-----~~~~l~ 311 (334)
|+.||.+||| ++++++
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCHHHccCCCCCchHHHHc
Confidence 9999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=286.78 Aligned_cols=244 Identities=18% Similarity=0.228 Sum_probs=198.3
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC-----ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
|++.+.+|+|++|.||.+.. .+++.+|+|.+...... ....+.+|++++++++||||+++++++..+...++++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 45566779999999999985 45889999998643311 1245778999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 84 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999886 3456889999999999999999999999 999999999999999999999999998654321
Q ss_pred ----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
....++..|+|||.+.+..++.++||||||+++|++++|+.||........... ..........+...+..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPDA 236 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHHH
Confidence 223466789999999988899999999999999999999988754322111111 111111223445566789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.+++.+||..+|.+|||+.+++..
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhC
Confidence 999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=292.40 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=205.3
Q ss_pred HHHhcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 53 KNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
......-..|++++.+|.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++......
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred HhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 33444445688888899999999999985 56889999999765545566788999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++|+||+++++|..++. ...+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~~-i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 99999999999999884 346899999999999999999999999 99999999999999999999999998775443
Q ss_pred C----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 212 G----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 212 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
. ....++..|+|||.+.+..++.++||||||+++|++++|..||.............. ........+...+..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 244 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSPI 244 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccCCHH
Confidence 2 234567899999999988899999999999999999999988865432211110000 001111123445668
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+++.+||..||.+|||+.++++
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhh
Confidence 999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=287.27 Aligned_cols=246 Identities=21% Similarity=0.247 Sum_probs=188.2
Q ss_pred cCCCcCccEEEEEEeCC---CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKLEN---QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
.||+|+||.||+|...+ +..+|+|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 57999999999998543 467999998754422 23468889999999999999999999998888999999999999
Q ss_pred HHHhhcccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC------C
Q 019905 143 LAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------K 213 (334)
Q Consensus 143 L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~------~ 213 (334)
|.+++.... ....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+...... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999986422 234567788899999999999999999 999999999999999999999999998653322 1
Q ss_pred cccccccccCcccccCC-------CCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 214 SYSTNLAFTPPEYLRTG-------RVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
...++..|+|||++.+. .++.++|+||||+++|+|++ |..||.............................+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 23456789999998642 35789999999999999996 88777543322211111111001111111222345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
..+.+++..|| .+|++|||+.+|+..|+
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 67889999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=306.86 Aligned_cols=245 Identities=13% Similarity=0.126 Sum_probs=194.6
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.||+|+||.||++... +++.||+|.+.... ......+..|+.++..++|++|+++++.+...+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4667788899999999999864 58899999996432 2224567789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~g-ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQLG-FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999986 4467899999999999999999999999 999999999999999999999999987643210
Q ss_pred -----------------------------------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCc
Q 019905 213 -----------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPS 257 (334)
Q Consensus 213 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~ 257 (334)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 123588999999999998999999999999999999999999876
Q ss_pred hhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 019905 258 HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLVT 311 (334)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~ 311 (334)
.................... .....+.++.+++.+++. ||.+|++ ++++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p--~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFP--PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCHHHHHHHHHcCCCceecC--CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 54333222111100000000 011245688999999774 9999985 566653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=293.21 Aligned_cols=246 Identities=18% Similarity=0.246 Sum_probs=197.5
Q ss_pred cccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 63 NIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+..+.||+|+||+||++.. .+++.+|+|.+...... ....+.+|+++++.++|+|++.+.+.+..++..+++|||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 3445669999999999986 45789999998654322 2345678999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Ccc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSY 215 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~ 215 (334)
++++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++...... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 9999998886534457999999999999999999999999 999999999999999999999999988654322 234
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.++..|+|||.+.+..++.++|+||||+++|++++|..||................... ...++...+.++.+|+..|
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHHHHHH
Confidence 67899999999998889999999999999999999999886543222111111111111 1123344566899999999
Q ss_pred hhcCCCCCCC-----HHHHHH
Q 019905 296 LQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rps-----~~~~l~ 311 (334)
|+.||.+||+ +.+++.
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCCHhHcCCCcccChHHHHc
Confidence 9999999999 667764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=287.65 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=193.5
Q ss_pred ccccCCCcCccEEEEEEeCCC---CEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeC------Ceee
Q 019905 64 IVSEHGEKAPNVVYKGKLENQ---RRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DERL 132 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~~---~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~ 132 (334)
+.+.+|+|+||.||+|.+..+ ..+|+|.+...... ..+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 456779999999999996543 26899998754322 245678899999999999999999987432 2468
Q ss_pred EEEecCCCCCHHHhhccc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 133 LVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++..
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-FIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhheEEcCCCCEEECCCCcccc
Confidence 999999999999887421 2345789999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 209 SRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 209 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
..... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. . .....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----~-~~~~~~ 236 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ----G-NRLKQP 236 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----C-CCCCCC
Confidence 54321 2234568999999998889999999999999999999 6666654332222111111 0 011123
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 34556799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.57 Aligned_cols=246 Identities=16% Similarity=0.193 Sum_probs=197.7
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
|++++.+|.|+||.||++... ++..+++|.+..........+.+|+++++.++|+|++++++++..++..++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788899999999999965 4678899998654433455688899999999999999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYS 216 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~ 216 (334)
++|..++.. ...++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ....
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999888753 3467899999999999999999999999 999999999999999999999999998654322 2345
Q ss_pred ccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 217 TNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 217 ~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
++..|+|||.+. +..++.++||||||+++|+|++|+.||................ ......+...+.++.++
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC---CCCCCCccccCHHHHHH
Confidence 788999999984 3447889999999999999999998876443221111111100 00111233455689999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~ 312 (334)
+.+||+.||.+||++.++++.
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.92 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=200.1
Q ss_pred CcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.++.+.+.+|+|+||.||+|.... +..||+|.+..... .....+.+|+.++..++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 356677888999999999998542 46899999865432 12346788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCC
Q 019905 133 LVAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg 204 (334)
++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999986321 224678899999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccC
Q 019905 205 LMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 205 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
++...... ....++..|+|||.+.+..++.++||||||+++|++++ |..|+............. . ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~-~~~ 239 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----D-GGH 239 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh----c-CCC
Confidence 98754322 22345678999999988889999999999999999998 777765433222221111 1 111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 12344456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.17 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=200.4
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCC-CCCccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLR-NNRLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 131 (334)
.++.+.+.||+|+||.||+|.++ .++.||+|++....... ...+.+|+.++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 34566788899999999999863 24689999997643222 346888999999997 99999999999998899
Q ss_pred eEEEecCCCCCHHHhhcccC------------------------------------------------------------
Q 019905 132 LLVAEYMPNETLAKHLFHWE------------------------------------------------------------ 151 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~------------------------------------------------------------ 151 (334)
++||||+++|+|.+++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999886321
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 152 ------------------------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 152 ------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
...+++..++.++.|++.||.|||+.+ ++||||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-CVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-cCcccCCcceEEEeCC
Confidence 123566778899999999999999998 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccc
Q 019905 196 GNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 268 (334)
+.++|+|||++...... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+............
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~- 354 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA- 354 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH-
Confidence 99999999998754321 12345678999999998889999999999999999998 77776543221111000
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
.........+...+.++.+++.+||..+|.+||++.++++.|+++.
T Consensus 355 ---~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 355 ---IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0011111234445678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=301.05 Aligned_cols=235 Identities=20% Similarity=0.223 Sum_probs=189.0
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHH-HHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEA-RSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++... +++.||+|.+..... .....+..|. .+++.++|+||+++++++...+..++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 4699999999999965 467899999864321 1123344444 4567889999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|.+++. ....+.+..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~g-iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 82 ELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 9999886 3456888889999999999999999999 99999999999999999999999999864322 234468
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
++.|+|||++.+..++.++||||||+++|+|++|..||............... . ...+...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~--~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----P--LQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC----C--cCCCCCCCHHHHHHHHHHcc
Confidence 89999999999988999999999999999999999998765433322221111 1 12233456689999999999
Q ss_pred cCCCCCCCHHHHH
Q 019905 298 YEPRERPNPKSLV 310 (334)
Q Consensus 298 ~dp~~Rps~~~~l 310 (334)
.||.+||++.+.+
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05602 233 KDRTKRLGAKDDF 245 (325)
T ss_pred cCHHHCCCCCCCH
Confidence 9999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=305.87 Aligned_cols=246 Identities=18% Similarity=0.233 Sum_probs=193.1
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCC-----eeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 133 (334)
+++++.||+|+||.||++.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++...+ ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 55677889999999999995 4689999999864321 22356889999999999999999999998766 7899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
|+||+. ++|.+.+. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 v~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG-ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 999996 67888775 4567899999999999999999999999 999999999999999999999999998754322
Q ss_pred ----CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc------------------
Q 019905 213 ----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------ 269 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------ 269 (334)
....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..............
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2235678899999998754 78999999999999999999988864422111100000
Q ss_pred -ccccccc-------CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 -MLTDSCL-------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 -~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+..... ........++++.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000 00122334568999999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=302.13 Aligned_cols=235 Identities=18% Similarity=0.208 Sum_probs=190.2
Q ss_pred cCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHH-HHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++.. .+++.+|+|.+..... .....+..|.. +++.++||||+++++.+...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 469999999999995 4588999999964321 12234455554 567789999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|..++. ....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~g-ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSIN-IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 9998886 4567899999999999999999999999 99999999999999999999999999864322 223468
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
+..|+|||++.+..++.++||||||+++|+|++|..||................ ...++..+..+.+++.+|++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------LVLRPGASLTAWSILEELLE 232 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------ccCCCCCCHHHHHHHHHHhc
Confidence 899999999999889999999999999999999999987654433322221111 11233455689999999999
Q ss_pred cCCCCCCCHHHHH
Q 019905 298 YEPRERPNPKSLV 310 (334)
Q Consensus 298 ~dp~~Rps~~~~l 310 (334)
.||.+||++.+.+
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05604 233 KDRQRRLGAKEDF 245 (325)
T ss_pred cCHHhcCCCCCCH
Confidence 9999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=294.38 Aligned_cols=249 Identities=18% Similarity=0.219 Sum_probs=198.2
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+|++++.||+|+||.||++... ++..+|+|.+...... ....+.+|++++.+++||||+++++++..++..+++|||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 4677888899999999999954 5788899988654321 2345788999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--CCcc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSY 215 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~ 215 (334)
++++|.+++. ....+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 82 ~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 82 DGGSLDQVLK--KAGRIPENILGKISIAVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC-EEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 9999999986 34678999999999999999999997 47 99999999999999999999999998865433 2345
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc---cccc--------------------
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL---QMLT-------------------- 272 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~---~~~~-------------------- 272 (334)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............. ....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence 67889999999988889999999999999999999998875432221111000 0000
Q ss_pred ---------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 273 ---------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 273 ---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
............+.++.+++.+||..||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000111245679999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=278.67 Aligned_cols=267 Identities=19% Similarity=0.216 Sum_probs=211.8
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC----Ch----HHHHHHHHHHhcC-CCCCccceeeeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP----DP----RQFLEEARSVGQL-RNNRLTNLLGCCC 126 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~----~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~ 126 (334)
..|..|..-+.+|.|..++|-++.+ .+++.+|+|++...... .. +.-.+|+.+|+++ .||+|+.+.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3344455555669999999988874 46889999998643311 12 2345799999999 5999999999999
Q ss_pred eCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
.+...++|+|.++.|.|.|++. +.-.+++.....|+.|+..|+.|||.++ |+|||+||+|||++++.+++|+|||++
T Consensus 94 s~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~-IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARN-IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhh-hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999997 5678999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC---cccccccccCcccccC------CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC
Q 019905 207 KNSRDGK---SYSTNLAFTPPEYLRT------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 207 ~~~~~~~---~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
....++. ...||++|+|||.+.. ..|+...|+|++|+++|.++.|.+||.-...-......+.....- .
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF--~ 248 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF--R 248 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc--C
Confidence 9887765 5689999999999842 348899999999999999999998886543333322222111111 1
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HhccccccCCCCCChhh
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQKETEFSISPLC 328 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~~~~~~~~~p~~ 328 (334)
..--.+.+....+||.+||+.||..|.|++|+|. .+.++..+....++|++
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~~ 301 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPVV 301 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCCCc
Confidence 1112345668999999999999999999999983 55556666666666654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.77 Aligned_cols=237 Identities=26% Similarity=0.384 Sum_probs=189.8
Q ss_pred cCCCcCccEEEEEEeCCCC-----------EEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 67 EHGEKAPNVVYKGKLENQR-----------RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 5699999999999975432 5788887654432 5678899999999999999999999887 7789999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-------CeeEcCCCCCcc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-------NPRLSTFGLMKN 208 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-------~~kl~Dfg~a~~ 208 (334)
||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .++|+|||++..
T Consensus 80 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 80 EYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDKK-LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhCC-eecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 99999999999864 2236889999999999999999999999 99999999999999887 799999999887
Q ss_pred CCCCCcccccccccCcccccCC--CCCCccchhhhHHHHHHHHhC-CCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 209 SRDGKSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 209 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
........++..|+|||.+.+. .++.++||||||+++|++++| ..|+............ . .....+....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~------~~~~~~~~~~ 230 (259)
T cd05037 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-Q------DQHRLPMPDC 230 (259)
T ss_pred cccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-h------cCCCCCCCCc
Confidence 6655555677889999999876 689999999999999999996 4444332211111110 0 0011112222
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 68999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.45 Aligned_cols=255 Identities=18% Similarity=0.255 Sum_probs=198.9
Q ss_pred CcccccccCCCcCccEEEEEEeCC-----------------CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-----------------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNL 121 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~ 121 (334)
..|++++.+|+|+||.||++.... +..||+|.+...... ..+.+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 357788999999999999988532 246899998754322 24568889999999999999999
Q ss_pred eeeeeeCCeeeEEEecCCCCCHHHhhcccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee
Q 019905 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWE---------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (334)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili 192 (334)
++++..++..+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||||+||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-i~H~dlkp~Nili 163 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-FVHRDLATRNCLV 163 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhceee
Confidence 999999899999999999999999986422 126889999999999999999999999 9999999999999
Q ss_pred cCCCCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh--CCCCCCchhhHHhh
Q 019905 193 DEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS--GKHIPPSHALDLIR 264 (334)
Q Consensus 193 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt--g~~p~~~~~~~~~~ 264 (334)
+.++.++|+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|++ +..|+.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 99999999999998754322 12334678999999988889999999999999999998 44455432222111
Q ss_pred hccccc--ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 265 DRNLQM--LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 265 ~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
...... ..........+...+.++.+++.+||+.||.+|||+.++++.|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111000 001111111233445789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=304.68 Aligned_cols=255 Identities=17% Similarity=0.169 Sum_probs=200.3
Q ss_pred HHHHhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeee
Q 019905 52 LKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127 (334)
Q Consensus 52 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 127 (334)
++........|++++.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4444445577888889999999999999965 57899999986422 1223457789999999999999999999999
Q ss_pred CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
++..++||||+++++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999884 346888899999999999999999999 9999999999999999999999999987
Q ss_pred cCCCC-----CcccccccccCcccccCCC----CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCC
Q 019905 208 NSRDG-----KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (334)
Q Consensus 208 ~~~~~-----~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (334)
..... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||................... ..
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~ 268 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--TF 268 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc--cC
Confidence 65432 2446899999999996543 7889999999999999999999987654332222211111110 11
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRE--RPNPKSLVTA 312 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~~l~~ 312 (334)
......+..+.+++.+|+..++.+ |+++.++++.
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 112345678999999999844433 6789888864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.04 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=200.8
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+..|++.+.+|.|+||.||++.. +++.+|+|.+.... ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 45677888889999999999975 56889999986532 345788999999999999999999998654 478999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Ccccc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYST 217 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~ 217 (334)
++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+...... .....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK-LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCC
Confidence 9999999997544456889999999999999999999999 999999999999999999999999998754432 22234
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (334)
+..|+|||.+.+..++.++|+||||+++|+|++ |..||.............. ......+...+..+.+++.+||
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-----GYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-----CCCCCCCCcCCHHHHHHHHHHc
Confidence 567999999988889999999999999999998 7777755433322221111 1111223445678999999999
Q ss_pred hcCCCCCCCHHHHHHHhcc
Q 019905 297 QYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 297 ~~dp~~Rps~~~~l~~L~~ 315 (334)
+.+|.+||++.++++.|++
T Consensus 235 ~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 235 ETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCChhhCcCHHHHHHHHcc
Confidence 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=281.93 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=206.8
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++-+.||+|.|+.||++.. .+|..+|+|.+.... ..+-+.+.+|+.+-+.|+||||+++.+.+...+..|+|+|++
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 55556779999999999984 568889988886432 234577899999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec---CCCCeeEcCCCCCccCCCCC--
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~---~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
.|++|..-+-. .--+++..+..++.||+.+|.|+|.++ |+|||+||+|+++. ...-+||+|||+|....++.
T Consensus 93 ~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n~-IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 93 TGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSNG-IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred cchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 99999876642 245778888999999999999999999 99999999999996 34458999999999877554
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...||++|||||++...+|+..+|||+.|+++|-++.|..||.++....+.++......+-. ...-+..++++.+|+
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~--~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP--SPEWDTVTPEAKSLI 247 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC--CcccCcCCHHHHHHH
Confidence 45789999999999999999999999999999999999999999877777666554443332 223345667899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||..||.+|.|+.|+|+
T Consensus 248 rrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHhccChhhhccHHHHhC
Confidence 9999999999999998874
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.49 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=202.0
Q ss_pred CcccccccCCCcCccEEEEEEeC-----CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeee--CCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 131 (334)
..+++++.+|+|+||.||++.+. ++..+|+|.+...... ....+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45667788899999999999853 3689999999765533 35678999999999999999999999877 5578
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
+++|||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 84 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQR-YIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999964 2335899999999999999999999999 99999999999999999999999999876553
Q ss_pred CC-------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh----------hccccccccc
Q 019905 212 GK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNLQMLTDS 274 (334)
Q Consensus 212 ~~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~ 274 (334)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|..|+......... ..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 21 123345699999998888999999999999999999999876543221110 0000001111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
......+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111112334456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=287.00 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=197.0
Q ss_pred cccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCe------
Q 019905 63 NIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE------ 130 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 130 (334)
++.+.+|+|+||.||+|.... +..||+|.+....... ...+.+|++.++.++|+||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456778999999999998532 3689999997543222 3468889999999999999999998865443
Q ss_pred eeEEEecCCCCCHHHhhccc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 131 RLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
.++++||+++++|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||.+
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-FIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchheEEECCCCeEEECCccce
Confidence 78999999999999887532 2246888999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCC
Q 019905 207 KNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (334)
Q Consensus 207 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (334)
....... ....+..|+|||.+.+..++.++||||||+++|||++ |..|+.............. . ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~----~-~~~~ 235 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH----G-NRLK 235 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----C-CCCC
Confidence 7544322 1223568999999988889999999999999999999 6666654332222211111 1 1112
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=289.34 Aligned_cols=246 Identities=17% Similarity=0.181 Sum_probs=197.3
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|.+.+.+|+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..+++|||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 566777889999999999985 4588999999876544444567889999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~ 215 (334)
+++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+..... ....
T Consensus 90 ~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 90 GGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKG-KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 999999886 4457899999999999999999999999 99999999999999999999999999765432 2344
Q ss_pred cccccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc-cccccccccCCCCCchhHHHHHHH
Q 019905 216 STNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-LQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 216 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.++..|+|||.+. ...++.++|+||||+++|+|++|..|+............ .......... .....+..+.++
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 244 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--DKMKWSNSFHHF 244 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--ccCCCCHHHHHH
Confidence 6788999999974 445888999999999999999999887543211111000 0000111110 111345579999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+||+.+|++|||+.++++
T Consensus 245 i~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHccCCchhCcCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.95 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=196.4
Q ss_pred cccccccCCCcCccEEEEEEeCC---------------CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLEN---------------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGC 124 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~ 124 (334)
.|++.+.||+|+||.||++...+ ...||+|.+...... ....+.+|++++.+++|+|+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 67788899999999999987532 235899998754322 23468899999999999999999999
Q ss_pred eeeCCeeeEEEecCCCCCHHHhhcccC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC
Q 019905 125 CCEGDERLLVAEYMPNETLAKHLFHWE----------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (334)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~ 194 (334)
+...+..+++|||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ ++|+||||+||++++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nill~~ 164 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGN 164 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-eeccccChhhEEEcC
Confidence 999999999999999999999885321 123678889999999999999999999 999999999999999
Q ss_pred CCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhC--CCCCCchhhHHhhhc
Q 019905 195 DGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG--KHIPPSHALDLIRDR 266 (334)
Q Consensus 195 ~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg--~~p~~~~~~~~~~~~ 266 (334)
++.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|+++ ..|+...........
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 244 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence 9999999999987543321 12335689999999888899999999999999999984 445543322221111
Q ss_pred cccccc--ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 267 NLQMLT--DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 267 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
...... ........+...+..+.+|+.+||+.||++|||+.++++.|+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 100000 0000111233445689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=287.80 Aligned_cols=246 Identities=20% Similarity=0.263 Sum_probs=186.4
Q ss_pred cCCCcCccEEEEEEeCC---CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKLEN---QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
+||+|+||.||+|...+ ...+++|.+...... ....+.+|+..++.++|+||+++++.+......+++|||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 57999999999997533 357888887643321 23457889999999999999999999999999999999999999
Q ss_pred HHHhhcccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC------C
Q 019905 143 LAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------K 213 (334)
Q Consensus 143 L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~------~ 213 (334)
|.+++.... ....++.....++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-EecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 999986422 233467788899999999999999999 999999999999999999999999998643221 2
Q ss_pred cccccccccCcccccC-------CCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 214 SYSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
...++..|+|||++.. ..++.++||||||+++|+|++ |..|+.........................+...+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 2234567999998743 347889999999999999999 55555443222111111111111111122334556
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
..+.+++..|| .||++|||+.++++.|.
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 67889999999 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=286.46 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=190.1
Q ss_pred cCCCcCccEEEEEEeC----CCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeee-eCCeeeEEEecCCC
Q 019905 67 EHGEKAPNVVYKGKLE----NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCC-EGDERLLVAEYMPN 140 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~ 140 (334)
.||+|+||.||+|.+. ....+|+|.+.... ......+.+|+.+++.++||||+++++++. .++..++++||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 4699999999999853 23579999985432 122456788999999999999999999775 45568899999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--------
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-------- 212 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-------- 212 (334)
++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 82 ~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 82 GDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASKK-FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999864 2344677788899999999999999998 999999999999999999999999998754321
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch-hhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+... .......... .. .....+...+..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~l 234 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----QG-RRLLQPEYCPDPLYEV 234 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----cC-CCCCCCCcCCHHHHHH
Confidence 1223456899999998888999999999999999999976554332 1111111110 00 0111122345689999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
+.+||+.+|++||++.++++.|+++..
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=292.42 Aligned_cols=248 Identities=17% Similarity=0.212 Sum_probs=190.9
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcC---CCCCccceeeeeee-----CCe
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQL---RNNRLTNLLGCCCE-----GDE 130 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~ 130 (334)
|++++.||+|+||.||+|... +++.||+|.+....... ...+.+|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 667788899999999999864 58899999987543222 23556777777665 69999999998764 245
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++|||++ ++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 789999997 58888886544456899999999999999999999999 9999999999999999999999999987654
Q ss_pred CC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc--------c------cc
Q 019905 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------L------TD 273 (334)
Q Consensus 211 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------~------~~ 273 (334)
.. ....++..|+|||++.+..++.++||||||+++|+|++|..||............... . ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 32 2345688999999999888999999999999999999999877543222111100000 0 00
Q ss_pred cccC-------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 SCLE-------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 ~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.... ....+..+..+.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0111234567899999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=299.08 Aligned_cols=232 Identities=21% Similarity=0.244 Sum_probs=188.4
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHH-HHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEA-RSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||+|... +++.||+|.+..... .....+..|. .+++.++||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 4699999999999964 578999999864321 1123344554 4678899999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|...+. ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++..... .....+
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9988886 3456888999999999999999999999 99999999999999999999999999875322 123457
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
++.|+|||.+.+..++.++||||||+++|+|++|..||............... ....+...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK------PLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999998765433333222111 112344556689999999999
Q ss_pred cCCCCCCCHH
Q 019905 298 YEPRERPNPK 307 (334)
Q Consensus 298 ~dp~~Rps~~ 307 (334)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (321)
T cd05603 233 KDQRRRLGAK 242 (321)
T ss_pred CCHhhcCCCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.27 Aligned_cols=245 Identities=19% Similarity=0.250 Sum_probs=194.9
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
++++++.||+|++|.||+|.. .++..||+|.+..... .....+.+|++++.+++||||+++++.+..++..+++|||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 456778889999999999985 4678999999865421 22346888999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--Cccc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSYS 216 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~ 216 (334)
++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... ....
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 999986543 4678889999999999999999999 999999999999999999999999998754432 3456
Q ss_pred ccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHh---hhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI---RDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 217 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .....................++++.+++.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 78899999999988899999999999999999999988754211000 000000001111111112234568999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~ 312 (334)
+||+.||.+||+++++++.
T Consensus 235 ~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 235 QCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhhCChhhCCCHHHHhcC
Confidence 9999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=320.97 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=202.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..|++++.||+|+||.||+|... +++.||+|++....... .+.+.+|+++++.++||||+++++++..++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46778888999999999999964 58899999997543222 346888999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 136 EYMPNETLAKHLFHWE---------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
||+++++|.+++.... ....++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-IIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-VLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999885311 123456778899999999999999999 999999999999999999999999998
Q ss_pred ccCCC----------------------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh
Q 019905 207 KNSRD----------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR 264 (334)
Q Consensus 207 ~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~ 264 (334)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 75411 01235889999999999999999999999999999999999988653322111
Q ss_pred hcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhcccccc
Q 019905 265 DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP-NPKSLVTALSPLQKE 319 (334)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~~l~~L~~l~~~ 319 (334)
.. .....+ .........++.+.+++.+||+.||++|| +++++++.|+.+.+.
T Consensus 241 ~~--~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 241 YR--DVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh--hhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 001110 00011124456799999999999999995 567778888777553
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=286.96 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=200.5
Q ss_pred CcccccccCCCcCccEEEEEEeC-C---CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-N---QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.+|++.+.+|+|+||.||+|... + +..+|+|.+...... ....+.+|+.+++.++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34667788899999999999853 2 347999998754322 235688899999999999999999999998999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS 214 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 214 (334)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+........
T Consensus 84 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 84 TEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999864 3356889999999999999999999999 99999999999999999999999999876543211
Q ss_pred -------ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 215 -------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 215 -------~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
...+..|+|||.+.+..++.++|+||||+++|++++ |..|+............... .....+...+.
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 236 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-----YRLPAPMDCPA 236 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----CcCCCCCCCCH
Confidence 112457999999998889999999999999999887 88877554322221111111 11112334566
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=287.26 Aligned_cols=248 Identities=21% Similarity=0.274 Sum_probs=198.7
Q ss_pred ccccccCCCcCccEEEEEEeCC-C---CEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKLEN-Q---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~-~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
++..+.+|+|++|.||+|.... + ..+++|.+..... ...+.+..|+++++.++|+|++++.+++...+..+++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 4455667999999999999642 2 3799999875432 224568889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc--
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-- 214 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 214 (334)
|+++++|.+++.. ....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 87 YMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMN-YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999864 3457889999999999999999999999 99999999999999999999999999875433211
Q ss_pred -----ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 215 -----YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 215 -----~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...+..|+|||.+.+..++.++||||||+++|++++ |..|+.............. ......+...+..+
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~ 239 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-----GFRLPAPMDCPSAV 239 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-----CCCCCCCCCCCHHH
Confidence 112357999999988889999999999999999997 8888755433222211111 11111223445689
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+++.+||+.+|++||++.++++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.89 Aligned_cols=236 Identities=17% Similarity=0.254 Sum_probs=191.9
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 136 (334)
++.++.||+|+||.||++... +++.||+|.+.... ....+.+..|..++..+. |++|+++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 345567799999999999854 58899999987432 122345677888888885 5678889999998899999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----C
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----G 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~ 212 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++..... .
T Consensus 82 y~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRRG-IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999999999886 4457899999999999999999999999 99999999999999999999999999875322 2
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
....|+..|+|||++.+..++.++||||||+++|+|++|..||.............. . ...++...+.++.+++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li 232 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME----H--NVSYPKSLSKEAVSIC 232 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCccCCHHHHHHH
Confidence 234588999999999988899999999999999999999998876543322222111 1 1123445567899999
Q ss_pred HHhhhcCCCCCCCH
Q 019905 293 SRCLQYEPRERPNP 306 (334)
Q Consensus 293 ~~cl~~dp~~Rps~ 306 (334)
.+||+.+|.+|++.
T Consensus 233 ~~~l~~~p~~R~~~ 246 (323)
T cd05615 233 KGLMTKHPSKRLGC 246 (323)
T ss_pred HHHcccCHhhCCCC
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.80 Aligned_cols=248 Identities=20% Similarity=0.298 Sum_probs=197.4
Q ss_pred cccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.+.+++.+|+|++|.||+|.+. .+..|++|.+....... ...+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 4666777899999999999964 35688999886443222 3458889999999999999999999988888999
Q ss_pred EEecCCCCCHHHhhcccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC---CeeEcCCCC
Q 019905 134 VAEYMPNETLAKHLFHWE-----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLSTFGL 205 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~---~~kl~Dfg~ 205 (334)
+|||+++++|.+++.... ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++ .++|+|||+
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-FIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchheEEEeccCCCcceEeccCcc
Confidence 999999999999986422 125888999999999999999999999 99999999999998654 589999999
Q ss_pred CccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCC
Q 019905 206 MKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (334)
Q Consensus 206 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (334)
+....... ....+..|+|||++.+..++.++||||||+++|+|++ |..||............. .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-----~~~~~ 240 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-----GGGRL 240 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----cCCcC
Confidence 87653221 1223467999999998889999999999999999997 777776543332222111 11112
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 234455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=295.96 Aligned_cols=252 Identities=17% Similarity=0.203 Sum_probs=192.9
Q ss_pred ccccCCCc--CccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 64 IVSEHGEK--APNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 64 ~~~~lg~G--~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+++.||+| +|++||++.. .+++.||+|.+....... .+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45667888 6789999985 568999999997543222 245778999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-------
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD------- 211 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~------- 211 (334)
++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999986434456899999999999999999999999 99999999999999999999999986432211
Q ss_pred ----CCcccccccccCcccccC--CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc----ccccccc-------
Q 019905 212 ----GKSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN----LQMLTDS------- 274 (334)
Q Consensus 212 ----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~----~~~~~~~------- 274 (334)
.....++..|+|||++.+ ..++.++||||||+++|+|++|..||............ .....+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 112245677999999976 35899999999999999999999988643211111000 0000000
Q ss_pred -----------------------------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhccc
Q 019905 275 -----------------------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPL 316 (334)
Q Consensus 275 -----------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l 316 (334)
..........++.+.+|+.+||+.||.+|||+.++++ .++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0000011234568999999999999999999999985 34443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=284.86 Aligned_cols=245 Identities=18% Similarity=0.222 Sum_probs=201.4
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|+.++.+|.|+||.||.+.. .++..+++|.+.... ......+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 56677789999999999984 457899999986543 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----c
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 214 (334)
++++|.+++.......+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999997543456899999999999999999999999 9999999999999999999999999987543322 3
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+.............. ... ...+...+.++.+++.+
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GNY-TPVVSVYSSELISLVHS 235 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CCC-CCCccccCHHHHHHHHH
Confidence 4578899999999888889999999999999999999988765433222211111 111 11223456689999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~ 312 (334)
||..+|.+||++.++++.
T Consensus 236 ~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcccCcccCCCHHHHhhC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.84 Aligned_cols=249 Identities=17% Similarity=0.222 Sum_probs=201.3
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.+.|++++.+|.|++|.||++... ++..+|+|.+........+.+.+|++++++++|+|++++++++..+...+++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999964 5789999999765444455788899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 84 ~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSHK-VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred cCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999999998864 3457899999999999999999999999 999999999999999999999999987644322 2
Q ss_pred cccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 214 SYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...++..|+|||.+. ...++.++|+||||+++|+|++|..|+............... .......+...+.++
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 238 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS---EPPTLDQPSKWSSSF 238 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC---CCCCcCCcccCCHHH
Confidence 345788999999985 334778999999999999999999887654222111111100 000111233455689
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.+++.+||+.+|.+||++.++++.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcC
Confidence 999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=288.84 Aligned_cols=254 Identities=18% Similarity=0.234 Sum_probs=202.1
Q ss_pred CcccccccCCCcCccEEEEEEeCC-----CCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeee-CCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 132 (334)
..|.+.+.+|+|+||.||+|.+.. +..|++|.+..... .....+.+|+.+++.++|+||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 345666778999999999999755 68899998864331 123567889999999999999999998766 46789
Q ss_pred EEEecCCCCCHHHhhcccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWET------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
++++|+++++|.+++..... ..+++..+..++.+++.||.|||+++ ++|+||+|+||++++++.++|+|||++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-VIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCHhhEEEcCCCcEEECCCCCc
Confidence 99999999999999864221 46889999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCC
Q 019905 207 KNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (334)
Q Consensus 207 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (334)
+...... ...++..|+|||.+.+..++.++||||||+++|++++ |+.|+............... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~ 239 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-----YRLA 239 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-----CCCC
Confidence 7543321 2334667999999988889999999999999999999 88777654322222111111 1111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+...+.++.+++.+||..||++|||+.++++.|+.+.+.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1233456899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=286.40 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=193.5
Q ss_pred cCCCcCccEEEEEEeCC-CC--EEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLEN-QR--RIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~-~~--~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.+|+|+||.||+|...+ +. .+++|.+..... ...+.+.+|++++.++ +||||+++++++...+..+++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 46999999999999644 33 568888874332 2245688899999999 7999999999999999999999999999
Q ss_pred CHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 142 TLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 142 sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccccceEEEcCCCeEEECCCCCcc
Confidence 9999986421 124788999999999999999999999 9999999999999999999999999975
Q ss_pred cCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 208 NSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 208 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
..... .....+..|+|||++.+..++.++||||||+++|+|++ |..||............ .. ......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~~-~~~~~~~~~ 235 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----PQ-GYRLEKPLN 235 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH----hC-CCCCCCCCc
Confidence 33211 11223467999999988889999999999999999997 88877543322211111 01 011112333
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
.+.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 4568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=283.86 Aligned_cols=247 Identities=17% Similarity=0.194 Sum_probs=201.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|++.+.+|.|++|.||++... +++.+++|.+........+.+.+|+++++.++||||+++++.+......+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4667788899999999999964 578899999986655556778999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Ccc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~ 215 (334)
+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...... ...
T Consensus 84 ~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 84 GGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHETG-KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred CCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 9999998864 2357899999999999999999999999 999999999999999999999999998754432 234
Q ss_pred cccccccCcccccCC---CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc-cccccccccCCCCCchhHHHHHHH
Q 019905 216 STNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-LQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.++..|+|||.+.+. .++.++|+||||+++|+|++|..|+............ ........ .......+.++.++
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 239 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK--LKDKEKWSPVFHDF 239 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc--ccchhhhhHHHHHH
Confidence 567889999999776 7889999999999999999999887653221111111 01001101 11223456789999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+||..+|.+|||+.+++.
T Consensus 240 i~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.06 Aligned_cols=247 Identities=16% Similarity=0.200 Sum_probs=191.6
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCC------
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 129 (334)
...|++++.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 35677888889999999999985 458899999996432 222456778999999999999999999986543
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..+++|||++ ++|...+. ..++...+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 100 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 4689999997 56666653 34788899999999999999999999 999999999999999999999999998754
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc------------------
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL------------------ 268 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~------------------ 268 (334)
... ....+|..|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 332 23467889999999999899999999999999999999999886432110000000
Q ss_pred cccccc-------ccC-----------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 QMLTDS-------CLE-----------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 ~~~~~~-------~~~-----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...... ... .......+..+.+|+.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000 0011123457899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=300.97 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=206.7
Q ss_pred cccCCCcCccEEEEEEeCC-----CCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 65 VSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
-+.||.|-||.||+|...+ .-.||||..+.+.. ++.+.|..|..+++.++||||++++|+|.+. ..|||||.+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~ 472 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELA 472 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecc
Confidence 3677999999999999432 34689999987553 3456799999999999999999999999765 579999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccc-
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST- 217 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~- 217 (334)
+.|.|..++.. +...++......+++||+.+|+|||+++ .|||||-.+|||+.+...|||+|||+++...+...+..
T Consensus 473 ~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkr-fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS 550 (974)
T KOG4257|consen 473 PLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKR-FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS 550 (974)
T ss_pred cchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhc-hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence 99999999976 5567888999999999999999999999 99999999999999999999999999987766543322
Q ss_pred ----cccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 218 ----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 218 ----~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
..-|||||.+.-..++.++|||-||+.+||+++ |..||.+- .+...-...+..-+..+|+.+++.++.|+
T Consensus 551 ~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv-----kNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 551 RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV-----KNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc-----cccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 367999999988889999999999999999977 55677543 23333333444455567888899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
.+||+++|.+||++.++...|..+..
T Consensus 626 skcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999988876654
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=293.20 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=200.7
Q ss_pred cccccccCCCcCccEEEEEEeC--------CCCEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 130 (334)
++.+.+.+|+|+||.||++... ....+|+|.+..... .....+.+|+++++.+ +||||+++++++...+.
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 4567788899999999999742 245789999875432 1234678899999999 69999999999998888
Q ss_pred eeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~ 196 (334)
.+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~~ 171 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-CIHRDLAARNVLVTEDN 171 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-eeeccccceeEEEcCCC
Confidence 999999999999999986421 235788899999999999999999999 99999999999999999
Q ss_pred CeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 019905 197 NPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQ 269 (334)
Q Consensus 197 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 269 (334)
.++|+|||.+....... ...++..|+|||.+.+..++.++||||||+++|++++ |..||..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 251 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987654321 1123357999999988889999999999999999999 6766654432222211111
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
......+...+.++.+++.+||+.+|++|||+.++++.|+++...
T Consensus 252 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 252 -----GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111122344556899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=286.45 Aligned_cols=244 Identities=14% Similarity=0.196 Sum_probs=194.2
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeC------CeeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG------DERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~l 133 (334)
|++.+.+|+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+|++++.+++... ...++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 455667799999999999864 57899999987543 3456788999999998 699999999998753 45789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-- 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~-- 211 (334)
+|||+++++|.+++.......+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 999999999999987544457899999999999999999999999 99999999999999999999999999875432
Q ss_pred --CCcccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 212 --GKSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 212 --~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
.....++..|+|||++. +..++.++||||||+++|+|++|+.|+........... ..............
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 241 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKW 241 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCCCc
Confidence 22346788999999986 33588899999999999999999988754322111110 01111111122334
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+..+.+|+.+||..||.+|||+.+++.
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 568999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=300.38 Aligned_cols=248 Identities=16% Similarity=0.219 Sum_probs=193.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeC------C
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG------D 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 129 (334)
...|++++.||+|+||.||++... .++.||+|.+...... ....+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 356778888899999999999854 5789999999754322 235677899999999999999999988643 2
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..+++|||++ +++.+.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~lv~e~~~-~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhc-ccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 4689999997 56766664 34788899999999999999999999 999999999999999999999999998765
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc----------------
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM---------------- 270 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~---------------- 270 (334)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 433 2356789999999999888999999999999999999999988653211110000000
Q ss_pred --cc----------------ccc--cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 271 --LT----------------DSC--LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 271 --~~----------------~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.. +.. .....+...+.++.+|+.+||+.||.+|||+.++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 000 0001112234578999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=296.10 Aligned_cols=243 Identities=12% Similarity=0.132 Sum_probs=188.7
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|++++.||+|+||.||+|... ++..||+|..... ....|+.++++++|+||+++++++......++|++++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 35778888899999999999965 4678999975322 2356899999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Ccc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSY 215 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~ 215 (334)
. ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||.+...... ...
T Consensus 140 ~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 S-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR-IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred C-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 5 788888764 4467899999999999999999999999 999999999999999999999999998753322 235
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH----H-------hhhccc-ccccccccC------
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD----L-------IRDRNL-QMLTDSCLE------ 277 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~----~-------~~~~~~-~~~~~~~~~------ 277 (334)
.||..|+|||++.+..++.++||||||+++|||+++..+++..... . ...... .........
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 6889999999999888999999999999999999976655321000 0 000000 000000000
Q ss_pred -------------CC-------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 278 -------------GQ-------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 278 -------------~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. .....+.++.+||.+||+.||.+|||+.++++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00 00122446778999999999999999999985
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=290.69 Aligned_cols=254 Identities=19% Similarity=0.278 Sum_probs=195.8
Q ss_pred cccccccCCCcCccEEEEEEeC-----------------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCcccee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-----------------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLL 122 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~ 122 (334)
+|++.+.||+|+||.||++... +...+|+|.+...... ....+.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4677788899999999998532 2346899998754322 245788999999999999999999
Q ss_pred eeeeeCCeeeEEEecCCCCCHHHhhcccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec
Q 019905 123 GCCCEGDERLLVAEYMPNETLAKHLFHWE---------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (334)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~ 193 (334)
+++..++..+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dlkp~Nili~ 164 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-FVHRDLATRNCLVG 164 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-eecccCChheEEEc
Confidence 99999999999999999999999886421 124667889999999999999999999 99999999999999
Q ss_pred CCCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh--CCCCCCchhhHHhhh
Q 019905 194 EDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS--GKHIPPSHALDLIRD 265 (334)
Q Consensus 194 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt--g~~p~~~~~~~~~~~ 265 (334)
.++.++|+|||++....... ...++..|+|||...+..++.++||||||+++|||++ |..|+..........
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999999987543321 1223568999999888889999999999999999998 555554332222111
Q ss_pred cccccccc--cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 266 RNLQMLTD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 266 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
........ .......+...+..+.+++.+||+.||.+||++.++++.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10000000 000011123345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=289.69 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.+|++++.+|.|+||.||++... ++..+|+|.+...... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 45777888899999999999853 4678999998754321 2356888999999999999999999999988999
Q ss_pred EEEecCCCCCHHHhhcccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee
Q 019905 133 LVAEYMPNETLAKHLFHWE--------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili 192 (334)
++|||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-i~H~dl~p~nil~ 163 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-FVHRDLATRNCLV 163 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-eecccccHhheEe
Confidence 9999999999999986321 124678889999999999999999999 9999999999999
Q ss_pred cCCCCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhh
Q 019905 193 DEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRD 265 (334)
Q Consensus 193 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~ 265 (334)
++++.++|+|||.+...... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998653322 12233567999999988889999999999999999998 666665433222211
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
... .... ...+...+.++.+++.+||+.||.+|||+.++++.|++
T Consensus 244 ~~~----~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 YVR----DGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHh----cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 110 0100 11233455689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.45 Aligned_cols=235 Identities=19% Similarity=0.258 Sum_probs=188.8
Q ss_pred cCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++.++ +|++|+.+++++...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 4699999999999954 578999999975432 1234577899998888 6999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~ 217 (334)
+|..++. ..+.+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 82 DLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHERG-IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9998885 3457999999999999999999999999 99999999999999999999999999874321 223568
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH---hhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL---IRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
++.|+|||++.+..++.++||||||+++|+|++|..||....... ............ ....+...+..+.+++.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 899999999999899999999999999999999999885321100 000000111111 112344556789999999
Q ss_pred hhhcCCCCCCCH
Q 019905 295 CLQYEPRERPNP 306 (334)
Q Consensus 295 cl~~dp~~Rps~ 306 (334)
||+.||.+|+++
T Consensus 237 ~L~~dP~~R~~~ 248 (327)
T cd05617 237 FLNKDPKERLGC 248 (327)
T ss_pred HhccCHHHcCCC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=296.64 Aligned_cols=249 Identities=19% Similarity=0.180 Sum_probs=194.2
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++..++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5778888899999999999954 57899999986421 1223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLG-YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999999999864 3456889999999999999999999999 9999999999999999999999999986543322
Q ss_pred --cccccccccCcccccC-----CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 214 --SYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
...|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...................... ......+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~ 238 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP-PDVTDVSE 238 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC-CccCCCCH
Confidence 2357899999999863 347889999999999999999999987654332221111100000000 11123466
Q ss_pred HHHHHHHHhhhcCCC--CCCCHHHHHHH
Q 019905 287 ELVRLASRCLQYEPR--ERPNPKSLVTA 312 (334)
Q Consensus 287 ~l~~li~~cl~~dp~--~Rps~~~~l~~ 312 (334)
.+.+++.+|+..++. .|++++++++-
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 899999998865443 37889888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=282.91 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=194.9
Q ss_pred ccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 66 SEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
++||+|+||.||+|.... +..+|+|.+...... ..+.+.+|+++++.++|+|++++++++. ....+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 357999999999998432 268999999765532 3456888999999999999999999875 4567999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc------
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS------ 214 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~------ 214 (334)
++|.+++.. ...+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESKH-FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcC-eeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 999999963 347899999999999999999999999 99999999999999999999999999875533221
Q ss_pred -ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 215 -YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 215 -~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
..++..|+|||.+.+..++.++||||||+++|++++ |..||............. .......+...+..+.+++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-----SGERLPRPEECPQEIYSIM 231 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-----cCCcCCCCCCCCHHHHHHH
Confidence 112357999999988889999999999999999998 777765432222111110 1111123444567899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
.+||..+|++||++.++++.|+++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=289.10 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=198.2
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..|++++.||+|+||.||+|..+ .+..||+|.+...... ....+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45777888999999999999743 2458999988644311 1235778999999999999999999999888999
Q ss_pred EEEecCCCCCHHHhhcccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCC
Q 019905 133 LVAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg 204 (334)
++|||+++++|.+++.... ...++...+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCCChheEEEcCCCcEEECcCC
Confidence 9999999999999996421 133456788899999999999999999 9999999999999999999999999
Q ss_pred CCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccC
Q 019905 205 LMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 205 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
++...... ....++..|+|||.+.+..++.++|+||||+++|++++ |..|+............. ... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----~~~-~ 239 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM----DGG-Y 239 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----cCC-C
Confidence 98754321 12234567999999998889999999999999999998 566665433322222111 110 1
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
...+...+..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1123344568999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=296.06 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=197.3
Q ss_pred CcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeC-Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG-DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 130 (334)
++|++++.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3577888999999999999973 24678999999754322 234578899999999 689999999988654 45
Q ss_pred eeEEEecCCCCCHHHhhcccC-----------------------------------------------------------
Q 019905 131 RLLVAEYMPNETLAKHLFHWE----------------------------------------------------------- 151 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------- 151 (334)
.+++|||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999885321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC------cccccc
Q 019905 152 ------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYSTNL 219 (334)
Q Consensus 152 ------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~------~~~~~~ 219 (334)
...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... ...++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 123677788899999999999999999 9999999999999999999999999987543221 123456
Q ss_pred cccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc
Q 019905 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (334)
Q Consensus 220 ~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (334)
.|+|||.+.+..++.++||||||+++|++++ |..|+............. ........+...++++.+++.+||+.
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----KEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH----hccCCCCCCCCCCHHHHHHHHHHccC
Confidence 7999999988889999999999999999997 777765432111100000 00011112223446799999999999
Q ss_pred CCCCCCCHHHHHHHhcccccc
Q 019905 299 EPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 299 dp~~Rps~~~~l~~L~~l~~~ 319 (334)
||.+|||+.++++.|+.+.+.
T Consensus 322 ~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 322 EPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=294.68 Aligned_cols=247 Identities=20% Similarity=0.206 Sum_probs=209.6
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCC---hHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPD---PRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 134 (334)
..|++.+.||.|.||.||++..+. |+.+|+|.+....... ...+.+|+.+|+++. ||||+.+.++|......++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 347777888999999999999655 8999999997655433 357899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC----CCCeeEcCCCCCccCC
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE----DGNPRLSTFGLMKNSR 210 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~----~~~~kl~Dfg~a~~~~ 210 (334)
||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ ++|||+||+|+|+.. ++.++++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g-vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG-VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999753 3999999999999999999999999 999999999999963 3579999999999877
Q ss_pred CC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 211 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
.. ....||+.|+|||++....|+..+||||+|+++|.|++|..||................. ......-+..+..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFTSEPWDDISES 268 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCCCCCccccCHH
Confidence 63 356789999999999999999999999999999999999999987654443332211111 2222334455779
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
+.+++..++..||..|+|+.++|+-
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999999999999999999984
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=288.89 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=201.5
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..+|++++.+|+|++|+||++... ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356778889999999999999954 578999998865432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--CC
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GK 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--~~ 213 (334)
|+++++|.+++. ..+.+++..+..++.+++.+|.|||+ ++ ++|+||+|+||++++++.++|+|||++..... ..
T Consensus 84 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred cCCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHhcC-eeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 999999999886 34578999999999999999999997 56 99999999999999999999999998765432 22
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH--------HhhhcccccccccccCCCCCchhH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD--------LIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
...++..|+|||.+.+..++.++|+||||+++|++++|+.||...... .+.. ..................+
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH-HHHHHhhccCCCCCchhcC
Confidence 346788999999998888999999999999999999999988653321 0000 0011111111111112255
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L 313 (334)
.++.+|+.+||+.||.+|||+.++++..
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 6899999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=299.89 Aligned_cols=247 Identities=15% Similarity=0.209 Sum_probs=192.6
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeC------C
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------D 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 129 (334)
...|++++.||+|+||.||++... .++.||||.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 356778888899999999999854 57899999997533 22245678899999999999999999987543 3
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 4799999996 57777664 34788899999999999999999999 999999999999999999999999999765
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc-------------
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD------------- 273 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 273 (334)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||..................
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 432 3346789999999999988999999999999999999999988653221111110000000
Q ss_pred -----c------------------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 -----S------------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 -----~------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. .............+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0000011112457899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=290.40 Aligned_cols=251 Identities=18% Similarity=0.287 Sum_probs=198.0
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.+..|.+++.||.|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4567889999999999999999864 5789999998754322 2346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 84 e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9997 688888764 3456889999999999999999999999 999999999999999999999999998754322
Q ss_pred -CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc-----------cccccc-----
Q 019905 213 -KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL-----------QMLTDS----- 274 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~-----------~~~~~~----- 274 (334)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||............. ......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 223457899999998764 47889999999999999999998886543221110000 000000
Q ss_pred -ccC-------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 -CLE-------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 -~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... .......+.++.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0011234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=282.89 Aligned_cols=244 Identities=16% Similarity=0.207 Sum_probs=199.0
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeee-CCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 137 (334)
|++++.+|.|++|.||++... +++.+|+|.+..... ...+.+.+|++++++++|+|++++.+.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 667788899999999999954 478899999965432 223467889999999999999999988764 4467899999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+++++|.+++.......+++..+..++.+++.||.+||+++ ++||||+|+||+++.++.++|+|||++...... .
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~-i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999987544567899999999999999999999999 999999999999999999999999998754322 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...+++.|+|||.+.+..++.++|+||||++++++++|+.||................ . ...+...+..+.+++.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~li~ 235 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK----L-PPMPKDYSPELGELIA 235 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----C-CCCccccCHHHHHHHH
Confidence 3456789999999998889999999999999999999998886543322221111111 1 1233456678999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.||.+|||+.+++.
T Consensus 236 ~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 236 TMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHhccCcccCCCHHHHhc
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=286.07 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=202.9
Q ss_pred CcccccccCCCcCccEEEEEEeCC-C----CEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-Q----RRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++++++.+|+|+||.||+|.... + ..+|+|.+...... ....+.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 346677888999999999998543 3 25899988755422 23567889999999999999999999877 78899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
++||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 86 ITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEKR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999864 3446899999999999999999999998 9999999999999999999999999987654322
Q ss_pred c------ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 214 S------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 214 ~------~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
. ..++..|+|||.+....++.++|+||||+++|++++ |..|+.......+....... .....+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 238 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-----ERLPQPPICTI 238 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-----CCCCCCCCCCH
Confidence 1 122467999999988889999999999999999998 88887665443333211111 11122334456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+.+++.+||..||..||++.++++.|+.+.+.
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.86 Aligned_cols=241 Identities=20% Similarity=0.316 Sum_probs=196.5
Q ss_pred cccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCCh---------HHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 63 NIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDP---------RQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.+.+.+|.|++|.||+|.. .++..+|+|.+........ +.+.+|++++++++||||+++++++...+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 3456679999999999985 4578999999875443221 35778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+++||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+......
T Consensus 83 lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~-ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 83 IFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHhcC-cccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999996 3467888999999999999999999999 999999999999999999999999998755421
Q ss_pred ----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 213 ----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 213 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~ 234 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF----KIGE-NASPEIPS 234 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH----HHhc-cCCCcCCc
Confidence 12346788999999998889999999999999999999999886532211110 0001 11122344
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 283 DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+..+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 55678999999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=285.42 Aligned_cols=242 Identities=18% Similarity=0.267 Sum_probs=199.1
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+|++++.+|.|++|.||+|... ++..+|+|.+.... ......+.+|+++++.++|+|++++.+++..+...++++||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4667778899999999999964 57899999987543 233456888999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...... ..
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 82 GGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEG-KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999999853 37899999999999999999999999 999999999999999999999999998765432 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch-hHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD-DGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|+|++|..|+............... .....+.. .+.++.+++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-----NPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-----CCCCCcccccCHHHHHHHH
Confidence 45678899999999888999999999999999999999887543221111111111 11111122 5568999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||..+|++|||++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 233 LCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.95 Aligned_cols=245 Identities=18% Similarity=0.230 Sum_probs=200.6
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.+|++.+.+|.|++|.||+|.... +..+++|.+..... ...+.+|++++++++|+||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 346677788999999999999754 78999999865432 567899999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----c
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 214 (334)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK-KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999999864 3467899999999999999999999999 9999999999999999999999999987654332 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||.+.+..++.++||||||+++|+|++|..|+.............. ........+...+..+.+++.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCCCCchhhcCHHHHHHHHH
Confidence 3467899999999888899999999999999999999988764322111110000 0001111223345689999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.||..|||+.+++.
T Consensus 236 ~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 236 CLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhcChhhCcCHHHHhc
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=288.47 Aligned_cols=248 Identities=18% Similarity=0.253 Sum_probs=199.5
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+|++++.+|+|+||.||++... ++..+|+|.+..... .....+.+|++++++++|+||+++++.+..++..+++|||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778889999999999999965 689999999865321 12356888999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--CCc
Q 019905 139 PNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~ 214 (334)
++++|..++.... ...+++..+..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+..... ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT 160 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC-EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcccc
Confidence 9999998886321 2478999999999999999999996 47 99999999999999999999999999875433 233
Q ss_pred ccccccccCcccccCCC------CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 215 YSTNLAFTPPEYLRTGR------VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|..||............ ...... .....+...+.++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~ 238 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-SAIVDG-DPPTLPSGYSDDA 238 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH-HHHhhc-CCCCCCcccCHHH
Confidence 45678999999985443 588999999999999999999988654332221111 111111 1122344567789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 019905 289 VRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+++.+||+.+|..||++.++++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhc
Confidence 99999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=300.89 Aligned_cols=243 Identities=16% Similarity=0.194 Sum_probs=193.7
Q ss_pred cccccccCCCcCccEEEEEEeC---CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|++++.||+|+||.||++... .+..||+|.+... ....+|+++++.++||||+++++++......+++||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 4888899999999999999753 3578999988542 2356899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
+. ++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 168 ~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g-ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 168 YK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG-IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred cC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 95 78888884 4567999999999999999999999999 999999999999999999999999998654332
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-------hhhcc---ccccc---------
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-------IRDRN---LQMLT--------- 272 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-------~~~~~---~~~~~--------- 272 (334)
....||..|+|||++.+..++.++|||||||++|+|++|+.||....... +.... .....
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 23468999999999998889999999999999999999999886532110 00000 00000
Q ss_pred -----ccccCC--CC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 273 -----DSCLEG--QF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 273 -----~~~~~~--~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
...... .. ....+.++.+++.+||..||.+|||+.+++..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00 11234578899999999999999999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=285.36 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=200.4
Q ss_pred CcccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+.+.+.+|.|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 345666788999999999998543 2478999987544 2234568899999999999999999998865 557899
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 85 MELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKR-FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEcCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999864 2346899999999999999999999999 9999999999999999999999999987543322
Q ss_pred ----cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 214 ----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...++..|+|||.+.+..++.++||||||+++|++++ |..||.............. ......+...+..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 237 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-----GERLPMPPNCPPTL 237 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----CCcCCCCCCCCHHH
Confidence 1223457999999988889999999999999999986 8888755432221111100 00112234456689
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+++.+||..+|.+|||+.++++.|+++..+
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=305.02 Aligned_cols=247 Identities=18% Similarity=0.210 Sum_probs=205.7
Q ss_pred CcccccccCCCcCccEEEEEEeCCC-CEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQ-RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+-.++++.||-|+||.||+|..+.. -..|.|++........+.|.-|++||..++||+|+++++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3456789999999999999996653 445688887766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~ 214 (334)
.||..+..+.+ ..+.+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+..... ...
T Consensus 112 ~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~-iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN-IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc-hhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 99999988876 6789999999999999999999999999 99999999999999999999999998654332 357
Q ss_pred ccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 215 YSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 215 ~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
+.||++|||||+.. ..+|+.++||||||+++.||..+.+|...-....+.-... ....+.-.-|..++..+.
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia---KSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh---hcCCCcccCcchhhhHHH
Confidence 88999999999874 4569999999999999999999997654433222221111 111122234667788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+++.+||..||..||++.++++
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhh
Confidence 9999999999999999999985
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.80 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=199.2
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.+++++..+|+|+||.||+|..+ +.+.+++|.+...... ....+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45667788899999999999854 2467999988654432 2356889999999999999999999998888999
Q ss_pred EEEecCCCCCHHHhhcccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWET-------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-FVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-cccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999864321 16899999999999999999999999 99999999999999999999999998
Q ss_pred CccCCCC-----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCC
Q 019905 206 MKNSRDG-----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (334)
Q Consensus 206 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (334)
+...... ....++..|+|||.+.+..++.++||||||+++|++++ |..||............. .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~----~~~~~~~ 239 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----AGKLELP 239 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH----cCCcCCC
Confidence 7643221 22345677999999988888999999999999999999 555654332222211111 1111112
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
.+...+..+.+++.+||+.+|.+|||+.++++.|.+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 233455689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=290.09 Aligned_cols=240 Identities=19% Similarity=0.262 Sum_probs=195.4
Q ss_pred ccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHH
Q 019905 66 SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 144 (334)
..||.|+||.||++.. .++..||||.+........+.+.+|+..++.++|+|++++++.+..++..+++|||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 4569999999999985 457899999986544444567889999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCccccccc
Q 019905 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYSTNLA 220 (334)
Q Consensus 145 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~ 220 (334)
+++. ...+++..+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||++..... .....++..
T Consensus 108 ~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 183 (292)
T cd06658 108 DIVT---HTRMNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCcc
Confidence 9884 356889999999999999999999999 99999999999999999999999998864332 123457889
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCC
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 300 (334)
|+|||.+.+..++.++|+||||+++|++++|..|+............... ...... .....+..+.+++.+||..||
T Consensus 184 y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-LPPRVK--DSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCccc--cccccCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999988654322211111110 111111 112345579999999999999
Q ss_pred CCCCCHHHHHHH
Q 019905 301 RERPNPKSLVTA 312 (334)
Q Consensus 301 ~~Rps~~~~l~~ 312 (334)
.+|||++++++.
T Consensus 261 ~~Rpt~~~il~~ 272 (292)
T cd06658 261 SQRATAQELLQH 272 (292)
T ss_pred hHCcCHHHHhhC
Confidence 999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=287.19 Aligned_cols=249 Identities=19% Similarity=0.235 Sum_probs=194.1
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+|++++.||+|++|.||+|... ++..||+|.+...... ....+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3667788899999999999964 5889999998654322 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 138 MPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 97 68888875422 357899999999999999999999999 999999999999999999999999998754322
Q ss_pred CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc--------------------ccc
Q 019905 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL--------------------QML 271 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~--------------------~~~ 271 (334)
....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||............. ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 2234578899999987644 7889999999999999999998876432111100000 000
Q ss_pred ccc---ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 TDS---CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 ~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... ..........++++.+++.+||+.||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000112234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.33 Aligned_cols=244 Identities=18% Similarity=0.242 Sum_probs=197.7
Q ss_pred ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC------hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
|.+.+.+|.|+||.||+|...++..+|+|.+....... ...+.+|+++++.++|+||+++.+++...+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 45667789999999999998788999999986543111 245788999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---- 211 (334)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHNNC-VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999986 3356889999999999999999999999 99999999999999999999999998764321
Q ss_pred ------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 212 ------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 212 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||........... ... ........+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~ 235 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IGA--HRGLMPRLPDSFS 235 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hhh--ccCCCCCCCCCCC
Confidence 1234577899999999988899999999999999999999988854321111000 000 0011112344566
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 78999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=284.73 Aligned_cols=249 Identities=17% Similarity=0.243 Sum_probs=196.5
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.+.++..... +|+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~~---lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVV---LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEE---EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4455555544 499999999999954 577899999876554455678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCccCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPM--KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSR 210 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~~~~ 210 (334)
++||+++++|.+++.. ....+ +...+..++.|++.||.|||+++ ++||||||+||+++. ++.++|+|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 83 FMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEecCCCCCHHHHHHH-hcccCCCcHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999864 22344 78888999999999999999999 999999999999986 6799999999886543
Q ss_pred CC----CcccccccccCcccccCCC--CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 211 DG----KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 211 ~~----~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
.. ....++..|+|||.+.+.. ++.++|+||||+++|++++|..|+............ ..........+...
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 237 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIHPEIPESL 237 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hhhhccCCCCCccc
Confidence 21 2345788999999986644 788999999999999999999887542211111000 00001112234456
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
++++.+++.+||+.+|.+|||+.+++.
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=300.61 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=217.3
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.++.+-.+||.|-||.||.|.|+. ...||||.++.+. ...++|.+|..+++.+.|||+|+++|+|..+..+|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345556789999999999999875 5689999998755 34688999999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc--cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS--YS 216 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~ 216 (334)
.+|+|.+++++-+...++.-.+++++.||..|+.||..++ +|||||-.+|+|+.++..||++|||+++.+..... ..
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn-FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 9999999998756667777888999999999999999998 99999999999999999999999999987665432 22
Q ss_pred c---cccccCcccccCCCCCCccchhhhHHHHHHHHhCC-CCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 217 T---NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 217 ~---~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
| .+-|+|||.+.-..++.++|||+||+++||+.|.+ .|+++-....+. .+.+...+..-|..+++.+++||
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-----~LLEkgyRM~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----GLLEKGYRMDGPEGCPPKVYELM 499 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-----HHHhccccccCCCCCCHHHHHHH
Confidence 2 46899999999999999999999999999999965 455554433332 33334444455777788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
..||+.+|.+||++.|+-+.++.|..+..+
T Consensus 500 raCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred HHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 999999999999999999999988765543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=282.00 Aligned_cols=246 Identities=17% Similarity=0.212 Sum_probs=184.9
Q ss_pred cCCCcCccEEEEEEeCCC---CEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKLENQ---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
+||+|+||.||+|...++ ..+++|.+..... ...+.+.+|+.+++.++||||+++++.+......+++|||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 579999999999975332 3566777654332 234578899999999999999999999999889999999999999
Q ss_pred HHHhhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC------CCc
Q 019905 143 LAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD------GKS 214 (334)
Q Consensus 143 L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~------~~~ 214 (334)
|.+++.... ....+...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-eeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999986421 234566778899999999999999998 99999999999999999999999998754221 123
Q ss_pred ccccccccCcccccC-------CCCCCccchhhhHHHHHHHHhCCC-CCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 215 YSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
..++..|+|||++.. ..++.++||||||+++|+|+++.. |+.............................+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 456788999999853 235789999999999999998654 443322211111111111111111222334566
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
.+.+++..|| .+|.+||+++++++.|.
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 8899999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.14 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=202.8
Q ss_pred cccccccCCCcCccEEEEEEeCC--------CCEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 130 (334)
.|++++.||+|+||.||++.... ...||+|.+..... .....+.+|+++++++ +|+||+++++++...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 46778889999999999997421 23689998874332 1245688999999999 79999999999999889
Q ss_pred eeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~ 196 (334)
.++++||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Nill~~~~ 171 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-CIHRDLAARNVLVTEDN 171 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceEEEcCCC
Confidence 999999999999999986421 234778889999999999999999999 99999999999999999
Q ss_pred CeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 019905 197 NPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQ 269 (334)
Q Consensus 197 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 269 (334)
.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 251 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999987554321 1223457999999998889999999999999999998 6666655433332221111
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
......+...+..+.+++.+||+.+|.+|||+.++++.|+++.....
T Consensus 252 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 252 -----GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11112233455689999999999999999999999999999886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=296.40 Aligned_cols=247 Identities=19% Similarity=0.272 Sum_probs=191.6
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeC------Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 130 (334)
..|++++.||.|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 4577778889999999999985 4678999999865331 1234577899999999999999999987543 34
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++++++ +++|.+++ ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIV---KCQKLSDEHVQFLIYQLLRGLKYIHSAG-IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 68999998 68998877 3457999999999999999999999999 9999999999999999999999999987654
Q ss_pred CC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (334)
.. ....++..|+|||++.+ ..++.++||||||+++|+|++|..||..............
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 43 34567899999999977 4589999999999999999999988865321111000000
Q ss_pred ccccc---ccC---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 MLTDS---CLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..... ... .......++.+.+|+.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000 0001123346889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.06 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=197.6
Q ss_pred cccccccCCCcCccEEEEEEeC-CCC----EEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
+++.++.||+|+||.||+|.+. ++. .+|+|.+....... ...+.+|+.+++.++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 3456677899999999999853 343 57899886543222 23678899999999999999999998654 46799
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
++|+++|+|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 87 TQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred ehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhcC-eeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999999864 3446889999999999999999999999 9999999999999999999999999987543221
Q ss_pred -----cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 214 -----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
...++..|+|||.+.+..++.++||||||+++|++++ |+.|+.............. ......+...+.+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 239 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-----GERLPQPPICTID 239 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-----CCCCCCCCCCCHH
Confidence 2234568999999998889999999999999999997 7777755432222211111 0011112334568
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.+++.+||..+|++||++.++++.|+.+...
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=289.19 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=196.7
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC--CCCCccceeeeeeeCC----eeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL--RNNRLTNLLGCCCEGD----ERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~l 133 (334)
.+.++++.+|+|.||+||+|.+++ +.||||.+.. .+.+.+.+|-++++.. +|+||+++++.-.... .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 444555666999999999999855 8999999964 3356788888877655 7999999999876554 7899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK--------GRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
|++|.+.|+|.+++ +...++|....+++..+++||+|||+. ..|+|||||++|||+.+++...|+|||+
T Consensus 286 Vt~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999 567899999999999999999999963 1299999999999999999999999999
Q ss_pred CccCCCCC------cccccccccCcccccCCC-CC-----CccchhhhHHHHHHHHhCCCCC-------C----------
Q 019905 206 MKNSRDGK------SYSTNLAFTPPEYLRTGR-VT-----PESVIYSFGTLLLDLLSGKHIP-------P---------- 256 (334)
Q Consensus 206 a~~~~~~~------~~~~~~~y~aPE~~~~~~-~~-----~~~Di~slG~~l~elltg~~p~-------~---------- 256 (334)
|....+.. ..+||.+|||||++.+.. +. .+.||||+|.|+||++++-.-. +
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98765432 468999999999997654 22 3689999999999999864211 1
Q ss_pred ----chhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 257 ----SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 257 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
++..+.+-...........+.. .....-+.+.+..||+.||+.|.|+.-+.+++..+..-.+.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111112111111111112221 13345789999999999999999999999999888876554
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.09 Aligned_cols=187 Identities=18% Similarity=0.258 Sum_probs=155.7
Q ss_pred ccCCCcCccEEEEEEeC---CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee--CCeeeEEEecCCC
Q 019905 66 SEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVAEYMPN 140 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 140 (334)
.+||+|+||.||+|... ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 47799999999999854 46789999986543 23457789999999999999999998854 456889999996
Q ss_pred CCHHHhhccc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee----cCCCCeeEcCCCCCccC
Q 019905 141 ETLAKHLFHW-------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 141 ~sL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili----~~~~~~kl~Dfg~a~~~ 209 (334)
++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+|||+ +..+.+||+|||++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 6787776421 1235888999999999999999999999 9999999999999 45678999999998754
Q ss_pred CCC-------CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCC
Q 019905 210 RDG-------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPP 256 (334)
Q Consensus 210 ~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~ 256 (334)
... ....+|..|+|||++.+. .++.++||||+||++|+|++|+.||.
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 322 234678899999999875 48999999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=280.17 Aligned_cols=245 Identities=28% Similarity=0.421 Sum_probs=197.7
Q ss_pred cccccCCCcCccEEEEEEeCC-----CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 63 NIVSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
++.+.+|.|+||.||++.... +..||+|.+...... ....+..|+..+..++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 355677999999999999653 388999999765533 45678899999999999999999999999899999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++++|.+++.......+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~-~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC-eeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999999986423223899999999999999999999999 9999999999999999999999999987554331
Q ss_pred --cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 214 --SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
...++..|+|||.+.+..++.++|+||||+++++|++ |..|+............... .....+...+.++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 235 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-----YRLPKPENCPPEIYK 235 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCCCcCCHHHHH
Confidence 1235678999999988889999999999999999998 55555433222221111110 111223335678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHh
Q 019905 291 LASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~L 313 (334)
++.+||..||.+|||+.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=281.57 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=199.7
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+|++.+.+|.|++|+||+|.. .++..+++|++..... .....+.+|++.++.++|+|++++++.+..+...++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 466778889999999999995 4578999999865432 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 139 PNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 139 ~~~sL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~-i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG-QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999864322 56899999999999999999999999 999999999999999999999999987654432
Q ss_pred ---CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
....++..|+|||.+... .++.++|+||||+++|+|++|..|+.............................+..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 223577899999999776 6899999999999999999999887644322111111111111111101112456789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 019905 289 VRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+++.+||+.||++|||+.+++.
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=304.87 Aligned_cols=243 Identities=19% Similarity=0.214 Sum_probs=189.9
Q ss_pred cccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|.+.+.||+|+||.||++.... +..||+|... ...+.+|++++++++|+||+++++++..++..+++|+++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 37778888999999999999654 7889999642 2345689999999999999999999999999999999995
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC------C
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------K 213 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~------~ 213 (334)
++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... .
T Consensus 244 -~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 -SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred -CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 788888754 3357999999999999999999999999 999999999999999999999999998754321 1
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh------------hHHhhhcccc--ccccc-----
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA------------LDLIRDRNLQ--MLTDS----- 274 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~------------~~~~~~~~~~--~~~~~----- 274 (334)
...||..|+|||++.+..++.++|||||||++|||++|..+++... ...+...... .....
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 2458999999999999889999999999999999999876543211 0011110000 00000
Q ss_pred ----------ccCCC--CC-----chhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 275 ----------CLEGQ--FT-----DDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 275 ----------~~~~~--~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
..... .+ .....++.+|+.+||+.||.+|||+.|+|+-
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00 0123478899999999999999999999863
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.24 Aligned_cols=244 Identities=16% Similarity=0.216 Sum_probs=201.2
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++++.+|.|+||.||++.. .+++.+|+|.+...... ....+.+|+.++++++|+||+++.+++...+..++++||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 56778889999999999985 45789999998653322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----c
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 214 (334)
++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999999886533446789999999999999999999999 9999999999999999999999999987654422 3
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||.+.+..++.++|+||||++++++++|..|+................ ....+...+.++.+++.+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-----YPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-----CCCCcccCCHHHHHHHHH
Confidence 356788999999988889999999999999999999998886543332221111111 112234456689999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.+|.+||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 236 LFKRNPRDRPSVNSILE 252 (256)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=283.05 Aligned_cols=247 Identities=19% Similarity=0.236 Sum_probs=194.4
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--C--------hHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--D--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
|.+.+.+|.|++|.||+|.. .+++.+|+|.+...... . .+.+.+|+.+++.++|+|++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 44556779999999999985 45889999988632211 0 1356789999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC-eeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999999863 357889999999999999999999999 9999999999999999999999999987543
Q ss_pred CC------CcccccccccCcccccCCC--CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 211 DG------KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 211 ~~------~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
.. ....++..|+|||.+.... ++.++|+||||+++|++++|..|+...........................
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 32 1235678999999987654 889999999999999999999887543221111111011111111111223
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 283 DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+..+.+++.+||+.+|..|||+.++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 34678999999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=289.60 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=196.8
Q ss_pred ccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChH--HHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPR--QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++++.||+|+||+||++.... ++.+|+|.+......... ...+|+.++++++|+||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677889999999999999655 568999999865532222 2345899999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC----CCCCc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS----RDGKS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~----~~~~~ 214 (334)
++++|.+++. ....+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~-i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG-IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT-EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc--cccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence 9889999996 3567899999999999999999999999 999999999999999999999999998642 12234
Q ss_pred ccccccccCccccc-CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc-ccccCCCCCchhHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLR-TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 215 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 292 (334)
..++..|+|||++. +..++.++||||||+++|+|++|..|+................. ...............+.+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 56788999999998 77899999999999999999999988876511111111100000 00000011111236899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||++|||+.++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=280.00 Aligned_cols=244 Identities=18% Similarity=0.217 Sum_probs=199.8
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|+.++.+|+|++|.||++.. .++..+|+|.+...... ....+.+|+++++.++|+|++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 56777889999999999985 45789999998754322 2456888999999999999999999998889999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-CCeeEcCCCCCccCCCC---Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSRDG---KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-~~~kl~Dfg~a~~~~~~---~~ 214 (334)
++++|.+++.......+++..+..++.+++.+|.|||+++ ++|+||+|+||+++.+ +.++|+|||.+...... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9999999997544556899999999999999999999999 9999999999999854 45799999998765433 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||.+.+..++.++||||||+++|+|++|..|+............... .....+...+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----TFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----CCCCCCCCcCHHHHHHHHH
Confidence 45678999999998888899999999999999999999888654332222111111 1112334456789999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.+|.+|||+.+++.
T Consensus 236 ~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 236 MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=284.80 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=195.2
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|++++.+|+|++|.||+|... +++.||+|++..... ...+.+.+|+++++.++|+|++++++++..+...+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4677788899999999999965 588999999864331 1235678899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 213 (334)
+++++|..++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 82 CDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN-CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred cCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99888877764 3456899999999999999999999999 9999999999999999999999999987654432
Q ss_pred cccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc---cc-----------------ccc
Q 019905 214 SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---LQ-----------------MLT 272 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~---~~-----------------~~~ 272 (334)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ .. ...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3456788999999876 44788999999999999999999887643211110000 00 000
Q ss_pred ccccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 DSCLEGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+..... .....+..+.+|+.+||+.+|++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 01233568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.13 Aligned_cols=243 Identities=18% Similarity=0.268 Sum_probs=199.7
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.|+.++.+|.|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4566778899999999999964 578999999875432 22356888999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
++++|.+++. ..++++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++++|||++...... ..
T Consensus 85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~~-ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSEK-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9999999884 356888999999999999999999998 999999999999999999999999998654432 22
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+............ ........+...+..+.+++.+
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----PKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----hcCCCCCCchhhhHHHHHHHHH
Confidence 35677899999998888999999999999999999999887644322111110 1111122344567789999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~ 312 (334)
||+.+|..||++.+++..
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 236 CLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HcccCcccCcCHHHHHhC
Confidence 999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.28 Aligned_cols=241 Identities=18% Similarity=0.289 Sum_probs=196.7
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
|..++.||+|+||.||+|... ++..||+|.+...... ....+.+|+++++.++|+||+++++++..+...++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455667799999999999854 5788999998744322 23468899999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----cc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----SY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~ 215 (334)
+++|.+++. ...+++..+..++.+++.|+.|||+++ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 86 ~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 86 GGSALDLLK---PGPLEETYIATILREILKGLDYLHSER-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC-eeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 999999884 457889999999999999999999999 9999999999999999999999999987544322 23
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.++..|+|||.+.+..++.++|+||||+++|+|++|..|+........... . ........+...+..+.+++.+|
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL----I-PKNSPPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh----h-hcCCCCCCCcccCHHHHHHHHHH
Confidence 467889999999988899999999999999999999988754322111110 0 00111122334556899999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 019905 296 LQYEPRERPNPKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~ 311 (334)
|+.+|.+||++.++++
T Consensus 237 l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 237 LNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.99 Aligned_cols=246 Identities=20% Similarity=0.205 Sum_probs=199.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++.+.+|+|++|.||++... +++.+|+|.+...... ..+.+..|+++++.++|+||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4667778899999999999965 4899999999765433 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+.+++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999986544567899999999999999999999999 999999999999999999999999987643211
Q ss_pred -----------------------------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHh
Q 019905 213 -----------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI 263 (334)
Q Consensus 213 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~ 263 (334)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 123467789999999988899999999999999999999998865432221
Q ss_pred hhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 019905 264 RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN----PKSLVT 311 (334)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~~l~ 311 (334)
..... ............+..+.+++.+||+.||++||| +++++.
T Consensus 241 ~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FSNIL----KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHh----cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11111 111111111124678999999999999999999 777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=294.14 Aligned_cols=248 Identities=18% Similarity=0.175 Sum_probs=194.1
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++|++|+++++++...+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5778888899999999999964 57889999986421 1123447788999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++|+|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 y~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~~-iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 82 YYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQLH-YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999999999964 2457889999999999999999999999 9999999999999999999999999987544321
Q ss_pred --cccccccccCcccccC-----CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 214 --SYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
...|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...................... ......+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~~~~ 238 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP-SHITDVSE 238 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC-CccccCCH
Confidence 2458899999999875 457889999999999999999999987543322221111110000001 11123467
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRE--RPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~--Rps~~~~l~ 311 (334)
++.+++.+|+..++.+ |++++++++
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 8999999999876544 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.73 Aligned_cols=242 Identities=19% Similarity=0.256 Sum_probs=197.3
Q ss_pred ccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 64 IVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
....+|+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|||++++++++..++..++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3446799999999999854 578999999976554455678899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cccccc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTN 218 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~ 218 (334)
|.+++. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ....++
T Consensus 105 L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 180 (297)
T cd06659 105 LTDIVS---QTRLNEEQIATVCESVLQALCYLHSQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180 (297)
T ss_pred HHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence 998773 456899999999999999999999999 999999999999999999999999988644322 234578
Q ss_pred ccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc
Q 019905 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (334)
Q Consensus 219 ~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (334)
..|+|||.+.+..++.++||||||+++|+|++|..||.............. .... ........+..+.+++.+||+.
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPP--KLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCC--CccccCCCCHHHHHHHHHHhcC
Confidence 899999999888899999999999999999999988764332211111100 0000 0111233456799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 019905 299 EPRERPNPKSLVTA 312 (334)
Q Consensus 299 dp~~Rps~~~~l~~ 312 (334)
+|.+||++.++++.
T Consensus 258 ~P~~Rps~~~ll~~ 271 (297)
T cd06659 258 EPQERATAQELLDH 271 (297)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=309.49 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=209.8
Q ss_pred ccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..+-+.||.|.||.|++|.++- ...||||.++....+. ...|..|+.|+.+++||||+++-|+........||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4455667999999999999642 4689999999776433 4579999999999999999999999999888999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-cc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-SY 215 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 215 (334)
||++|+|+.+|+.+ .+.|.+.++..+++.|+.|+.||-+.+ +|||||-.+|||++.+-.+|++|||+++...+.. ..
T Consensus 711 yMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm~-YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhcC-chhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 99999999999874 456999999999999999999999999 9999999999999999999999999998764433 11
Q ss_pred ----cc--cccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 216 ----ST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 216 ----~~--~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
.| ..+|+|||.+....++.+|||||+|+++||.++ |..|+-......+. ..++...+-..|.+++..|
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-----kaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-----KAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-----HHHHhccCCCCCCCCcHHH
Confidence 11 379999999999999999999999999999887 45555433322222 1222233445577888899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
++||..||++|-.+||.+.+|+..|++|..
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 999999999999999999999999999876
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=282.48 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=193.9
Q ss_pred cCCCcCccEEEEEEeCC-------CCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 67 EHGEKAPNVVYKGKLEN-------QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.+|.|+||.||+|...+ +..+|+|.+..... .....+.+|+++++.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 46999999999998642 25789998865432 23457889999999999999999999999888999999999
Q ss_pred CCCCHHHhhcccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-----CeeEcCCCCCcc
Q 019905 139 PNETLAKHLFHWE-----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-----NPRLSTFGLMKN 208 (334)
Q Consensus 139 ~~~sL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-----~~kl~Dfg~a~~ 208 (334)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-cccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999986421 234788999999999999999999998 99999999999999877 899999999865
Q ss_pred CCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 209 SRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 209 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
.... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-----~~~~~~~~~ 235 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-----TAGGRLQKP 235 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-----hcCCccCCc
Confidence 4322 12234578999999998889999999999999999998 88777543222211111 011111233
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
...+..+.+++.+||..+|.+||++.++++.|++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 4456789999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=295.89 Aligned_cols=236 Identities=19% Similarity=0.185 Sum_probs=186.1
Q ss_pred CCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcC---CCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQL---RNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
||+|+||+||+|... +++.||+|++....... ......|..++... +||||+.+++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 599999999999954 58899999986432111 22344566666555 699999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYS 216 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~ 216 (334)
++|.+++. ....+++..+..++.||+.||+|||+++ ++||||||+|||++.++.++|+|||++..... .....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKYD-IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99998886 4567899999999999999999999999 99999999999999999999999999865322 22456
Q ss_pred ccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 217 TNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 217 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
||..|+|||++.+.. ++.++||||||+++|+|++|..||................. . ......+.++.+++.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~---~~~~~~~~~~~~li~~~ 232 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--R---FPKNVLSDEGRQFVKGL 232 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--C---CCCccCCHHHHHHHHHH
Confidence 889999999997654 88999999999999999999999876543332221111100 0 01123456899999999
Q ss_pred hhcCCCCCC----CHHHHHH
Q 019905 296 LQYEPRERP----NPKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rp----s~~~~l~ 311 (334)
|+.||.+|| ++.++++
T Consensus 233 L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhc
Confidence 999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=293.10 Aligned_cols=249 Identities=18% Similarity=0.175 Sum_probs=194.7
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.||+|+||.||++..+ +++.+|+|.+.... ......+.+|+.++..++|++|+++++.+...+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 4677888899999999999965 46789999985321 1123347789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++|+|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 82 y~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~-iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999964 3457899999999999999999999999 999999999999999999999999998653321
Q ss_pred -CcccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....||+.|+|||++. ...++.++||||||+++|+|++|+.||..................... .......+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~~~s~ 238 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF-PAQVTDVSE 238 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC-CCccccCCH
Confidence 2246889999999986 345889999999999999999999998765433322221111100000 111234567
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 019905 287 ELVRLASRCLQYEPRE--RPNPKSLVTA 312 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~--Rps~~~~l~~ 312 (334)
++.+|+.+|+..++.. |+++.++++-
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 8999999998654444 6889888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=287.56 Aligned_cols=249 Identities=18% Similarity=0.158 Sum_probs=198.5
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+|++++.+|+|+||.||++... +++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4667788899999999999964 468999999875432 123467789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
|+++++|.+++. ....+++..+..++.+++.||.|||+.+ ++||||||.||+++.++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999996 3457889999999999999999999999 99999999999999999999999998763110
Q ss_pred --------------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC
Q 019905 212 --------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 212 --------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-- 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC--
Confidence 0113457789999999888899999999999999999999998875543332222111110000
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
......+.++.+++.+||+.||++||++.++++.|+.
T Consensus 237 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 237 -EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1112345689999999999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=284.91 Aligned_cols=246 Identities=20% Similarity=0.237 Sum_probs=197.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..|+.++.+|+|++|.||+|... +++.||+|.+....... ...+.+|+++++.++|||++++.+++..++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34666778899999999999964 58899999986443222 245788999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 215 (334)
||++ +++.+.+.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 95 e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~-i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~ 171 (307)
T cd06607 95 EYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHE-RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF 171 (307)
T ss_pred HhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence 9997 677776643 3456899999999999999999999999 999999999999999999999999998876666666
Q ss_pred cccccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 216 STNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 216 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
.++..|+|||.+. ...++.++||||||+++|+|++|..|+............. ........+...+..+.+++
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh----cCCCCCCCchhhCHHHHHHH
Confidence 7888999999884 3458899999999999999999998876433221111000 00111111233556899999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~ 312 (334)
.+||+.||++||++.+++..
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.23 Aligned_cols=248 Identities=20% Similarity=0.260 Sum_probs=201.3
Q ss_pred CCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
....|.+++.+|+|+||.||++.. .++..|++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 345677888889999999999985 4578999999875544445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++++|.+++. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~g-i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 97 YLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred cCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCC-EeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 999999999984 346789999999999999999999999 9999999999999999999999999876543322
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||.+.+..++.++|+||||+++|++++|..||........... ...........+...+..+.+++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhcCCCCCCCCccccCHHHHHHH
Confidence 23567889999999888899999999999999999999998865432111100 00011111112233456799999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~ 312 (334)
.+||+.+|.+||++.+++..
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=283.73 Aligned_cols=246 Identities=14% Similarity=0.204 Sum_probs=193.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeee------CCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCE------GDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~ 131 (334)
..|++++.+|.|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+|++++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 4556667779999999999996 457899999986543 2345678899999988 69999999999853 4568
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
+++|||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 99999999999999887544556888889999999999999999999 99999999999999999999999999875432
Q ss_pred ----CCcccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 212 ----GKSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 212 ----~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
.....++..|+|||.+. +..++.++|+||||+++|+|++|..||.......... .............
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~ 249 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPPPKLKSK 249 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----hHhhCCCCCCccc
Confidence 23355788999999986 3458889999999999999999998875432111110 0111111111123
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 283 DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+.++.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 45668999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.20 Aligned_cols=247 Identities=19% Similarity=0.222 Sum_probs=192.6
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++++.+|.|++|.||+|... +|+.+|+|.+...... ....+.+|++++++++|+||+++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 566778899999999999964 5889999998653321 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
+ ++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 82 ~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 82 D-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSHN-VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred C-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 7 678887753 3456899999999999999999999999 999999999999999999999999998754332 23
Q ss_pred ccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhccc--------------ccccccccC-
Q 019905 215 YSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNL--------------QMLTDSCLE- 277 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~--------------~~~~~~~~~- 277 (334)
..++..|+|||.+.+.. ++.++||||||+++|+|++|+.|+..... ........ ....+....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 35678899999987654 78999999999999999999988643211 10000000 000000000
Q ss_pred --------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 278 --------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 278 --------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.......++++.+++.+||+.||.+|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0112234578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=283.38 Aligned_cols=247 Identities=22% Similarity=0.326 Sum_probs=195.8
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++.+.+|.|++|.||+|... ++..|++|.+...... ....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 667788899999999999964 6889999999765422 2457889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~ 213 (334)
+++|.+++.. ....+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 82 -~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 82 -PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred -CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 9999998864 3467899999999999999999999999 999999999999999999999999998765432 2
Q ss_pred cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc-----------------cccc
Q 019905 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML-----------------TDSC 275 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~-----------------~~~~ 275 (334)
...++..|+|||.+.+.. ++.++||||||+++|+|++|..++................ ....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 345778999999987554 6889999999999999999976664432111100000000 0000
Q ss_pred cC-------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 276 LE-------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 276 ~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. .......+..+.+++.+||+.||.+|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0011234578999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=278.49 Aligned_cols=242 Identities=21% Similarity=0.240 Sum_probs=197.0
Q ss_pred cccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-----CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-----PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+..+.+|+|++|.||+|... ++..|++|.+..... ...+.+.+|+++++.++|+||+++++++..+...++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 34466799999999999965 688999999865332 123568889999999999999999999999899999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---C
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---K 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~ 213 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 83 LVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLHDRN-TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred ecCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 999999999986 3356889999999999999999999999 999999999999999999999999988754332 3
Q ss_pred cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||.+.... ++.++|+||||+++|++++|+.||............ .........+...++.+.+++
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI----GRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH----HhcccCCCcCCCcCHHHHHHH
Confidence 445778899999997766 899999999999999999999887554311111110 010111123445567899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.+|.+||++.+++.
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhhcCcccCcCHHHHhc
Confidence 9999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=283.85 Aligned_cols=241 Identities=20% Similarity=0.262 Sum_probs=199.6
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|.+++.||+|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++..+...+++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 4667788899999999999964 578999999865332 223567889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Ccc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~ 215 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 82 YVPGGELFSHLR--KSGRFPEPVARFYAAQVVLALEYLHSLD-IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred cCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 999999999986 3467899999999999999999999999 999999999999999999999999998765443 234
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.++..|+|||.+.+..++.++||||||+++|+|++|..|+............. .. ....+...+..+.+++.+|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~--~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL----EG--KVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cC--CccCCccCCHHHHHHHHHH
Confidence 57889999999988888999999999999999999998886544222221111 10 1123444567899999999
Q ss_pred hhcCCCCCC-----CHHHHH
Q 019905 296 LQYEPRERP-----NPKSLV 310 (334)
Q Consensus 296 l~~dp~~Rp-----s~~~~l 310 (334)
|+.||.+|+ ++++++
T Consensus 233 l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCHHHccCcccCCHHHHH
Confidence 999999998 777776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=283.62 Aligned_cols=240 Identities=19% Similarity=0.267 Sum_probs=195.7
Q ss_pred cccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 65 VSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
...||+|++|.||++.. .++..+++|.+........+.+.+|+.+++.++|+|++++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 34569999999999985 46789999998755444456688999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcccccc
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYSTNL 219 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~~ 219 (334)
.+++.. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+..... .....++.
T Consensus 104 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 179 (285)
T cd06648 104 TDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG-VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 179 (285)
T ss_pred HHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCc
Confidence 999853 56889999999999999999999999 99999999999999999999999998764332 12345788
Q ss_pred cccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcC
Q 019905 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (334)
Q Consensus 220 ~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (334)
.|+|||.+.+..++.++||||||+++|+|++|..|+............... .... ...+...+..+.+++.+||+.+
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~li~~~l~~~ 256 (285)
T cd06648 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK--LKNLHKVSPRLRSFLDRMLVRD 256 (285)
T ss_pred cccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC--CcccccCCHHHHHHHHHHcccC
Confidence 999999998888999999999999999999999887654322211111111 0001 1112224568999999999999
Q ss_pred CCCCCCHHHHHH
Q 019905 300 PRERPNPKSLVT 311 (334)
Q Consensus 300 p~~Rps~~~~l~ 311 (334)
|++|||+.++++
T Consensus 257 p~~Rpt~~~il~ 268 (285)
T cd06648 257 PAQRATAAELLN 268 (285)
T ss_pred hhhCcCHHHHcc
Confidence 999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=314.53 Aligned_cols=248 Identities=17% Similarity=0.208 Sum_probs=194.3
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeee--CCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 132 (334)
....|.+++.||.|+||+||++... ++..+|+|.+...... ....+..|+.++..++||||++++++|.. ...++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3567889999999999999999964 4678999998754322 23568889999999999999999998865 35689
Q ss_pred EEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHh-------CCCceecccCCCCeeecC---------
Q 019905 133 LVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTS-------KGRALYHDLNAYRILFDE--------- 194 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~-------~~~i~H~dikp~Nili~~--------- 194 (334)
+||||+++++|.+++... ....+++..++.|+.||+.||.|||+ ++ |+||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~-IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC-ceeccCcHHHeEeecCcccccccc
Confidence 999999999999988632 23578999999999999999999998 44 999999999999964
Q ss_pred --------CCCeeEcCCCCCccCCCC---CcccccccccCcccccCC--CCCCccchhhhHHHHHHHHhCCCCCCchhhH
Q 019905 195 --------DGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALD 261 (334)
Q Consensus 195 --------~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~elltg~~p~~~~~~~ 261 (334)
.+.+||+|||++...... ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 345899999998765432 234689999999998653 4889999999999999999999988643211
Q ss_pred HhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 262 LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
........... .......+.++.+||..||+.+|.+||++.++|.
T Consensus 250 ~qli~~lk~~p-----~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 SQLISELKRGP-----DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHhcCC-----CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11100011100 0111234568999999999999999999999983
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=277.40 Aligned_cols=243 Identities=20% Similarity=0.281 Sum_probs=197.3
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++.+.||+|++|.||+|... ++..+++|.+...... ..+.+.+|+++++.++|+||+++++++...+..++++||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 566778899999999999854 6789999999765543 3567889999999999999999999999889999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 213 (334)
++++|.+++. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHG-IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHh--hcCCCChHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999986 3345788999999999999999999999 9999999999999999999999999987654321
Q ss_pred ---cccccccccCcccccCCC---CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch--hH
Q 019905 214 ---SYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD--DG 285 (334)
Q Consensus 214 ---~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 285 (334)
...++..|+|||.+.+.. ++.++||||||+++|++++|+.||............... ......+.. .+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 234 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----GHKPPIPDSLQLS 234 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----CCCCCCCcccccC
Confidence 234678999999998766 889999999999999999999988543211111000000 011112222 36
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+.+++.+||+.+|.+|||+.+++.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 68899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=278.39 Aligned_cols=248 Identities=17% Similarity=0.272 Sum_probs=197.3
Q ss_pred ccccccCCCcCccEEEEEEeCC--CCEEEEEEecCCCCC----------ChHHHHHHHHHHhc-CCCCCccceeeeeeeC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLEN--QRRIAVKRFNRMAWP----------DPRQFLEEARSVGQ-LRNNRLTNLLGCCCEG 128 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~ 128 (334)
|.+.+.+|+|+||.||++.... ++.+|+|.+...... ....+..|+.++.+ ++|+||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5566778999999999999654 688999988643211 12346678887765 7999999999999999
Q ss_pred CeeeEEEecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 129 DERLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
+..+++|||+++++|.+++.. .....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||.
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc-eeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988743 134568899999999999999999996 66 99999999999999999999999999
Q ss_pred CccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 206 MKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 206 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
+...... ....++..|+|||.+.+..++.++|+||||+++|++++|..|+..................+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~ 236 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP----LPEG 236 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc----CCcc
Confidence 8765443 23457789999999998889999999999999999999998876543332222111111111 1112
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
..+..+.+++.+||+.||++||++.++...++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 34568999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.68 Aligned_cols=251 Identities=17% Similarity=0.189 Sum_probs=187.3
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCC------CCccceeeeeeeC-Cee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN------NRLTNLLGCCCEG-DER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~-~~~ 131 (334)
..|++++.||+|+||+||+|.. .+++.||||++.... ........|+++++.++| .+++++.+++... ...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 4577888889999999999985 457899999996432 123345667777776654 4578888888654 568
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCC--------------
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDG-------------- 196 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~-------------- 196 (334)
++||+++ +++|.+++. ....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~g-IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEecCCcccccccccccCCC
Confidence 8999998 688888886 34679999999999999999999998 48 99999999999998665
Q ss_pred --CeeEcCCCCCccCCC-CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc---ccc
Q 019905 197 --NPRLSTFGLMKNSRD-GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---LQM 270 (334)
Q Consensus 197 --~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~---~~~ 270 (334)
.+||+|||.+..... .....||..|+|||++.+..++.++|||||||++|||++|+.||............ ...
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence 499999998764432 33567899999999999999999999999999999999999988653211100000 000
Q ss_pred ----------------ccc------cccC---------CC--CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhcc
Q 019905 271 ----------------LTD------SCLE---------GQ--FTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSP 315 (334)
Q Consensus 271 ----------------~~~------~~~~---------~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~ 315 (334)
+.. .... .. ........+.+||.+||+.||.+|||++++++ .|.+
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 000 0000 00 00012356789999999999999999999996 4444
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=281.13 Aligned_cols=248 Identities=15% Similarity=0.173 Sum_probs=192.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeee-----eCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCC-----EGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~ 132 (334)
..|++++.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.+ +|+||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 34567777899999999999864 57899999886433 2245678899999999 6999999999874 345689
Q ss_pred EEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 133 LVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-ccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999999887531 3356888999999999999999999998 9999999999999999999999999987543
Q ss_pred CC----CcccccccccCcccccC-----CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 211 DG----KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 211 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
.. ....++..|+|||.+.. ..++.++||||||+++|+|++|+.|+............... .......+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 252 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---PPPTLHQP 252 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---CCCcccCC
Confidence 32 23457889999999853 34788999999999999999999887643221111000000 00111122
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
...+.++.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 3345679999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=280.65 Aligned_cols=246 Identities=19% Similarity=0.287 Sum_probs=196.5
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC------ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
|+..+.+|+|++|.||++.. .+++.+|+|.+...... ..+.+.+|+..+++++|+||+++++++...+..+++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34445669999999999984 56889999998643311 134678899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~~- 212 (334)
+||+++++|.+++. ...++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 82 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~~-i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999986 3457889999999999999999999999 99999999999998765 5999999998654432
Q ss_pred -------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....++..|+|||.+.+..++.++|+||+|++++++++|..|+........... .............+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCCCchhhC
Confidence 123567899999999888899999999999999999999988754322111110 011111111223445566
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+++.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 78999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=278.40 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=200.1
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC-CCChHHHHHHHHHHhcCC---CCCccceeeeeeeCCeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 136 (334)
|+.++.+|.|+||.||+|.. .++..+|+|.+.... ......+.+|+.+++.++ |||++++++++..+...+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 55667789999999999996 468899999987543 223456888999999886 9999999999999889999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++++|.+++.. ..+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 83 YAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG-VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred cCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999998853 47899999999999999999999999 999999999999999999999999988765432
Q ss_pred CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc-hhHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD-DDGTELVR 290 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~ 290 (334)
....++..|+|||.+.++ .++.++|+||||+++|+|++|..|+.............. ... ...+. ..+.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~ 233 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK----SKP-PRLEDNGYSKLLRE 233 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc----CCC-CCCCcccCCHHHHH
Confidence 234577889999998754 478899999999999999999988865432222111101 011 11111 25568999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCC
Q 019905 291 LASRCLQYEPRERPNPKSLVTALSPLQKETEFSIS 325 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~ 325 (334)
++.+||+.||++||++.+++. ..+.++......
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~--~~~~~~~~~~~~ 266 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLK--SKWIKAHSKTPV 266 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhh--ChHhhccccCch
Confidence 999999999999999999986 234444443333
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=280.31 Aligned_cols=240 Identities=23% Similarity=0.273 Sum_probs=200.0
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|++++.+|.|+||.||++... ++..+|+|.+...... ..+.+.+|++.+++++||||+++++.+..+...++++||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 567778899999999999965 5889999999754322 245788899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Cc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KS 214 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~ 214 (334)
+++++|.+++.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...... ..
T Consensus 82 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 82 LLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 999999999863 357899999999999999999999999 999999999999999999999999998765443 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh---HHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL---DLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
..++..|+|||.+.+..++.++|+||||+++|++++|..|+..... ...... ... .....+...+.++.++
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~--~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET--ADVLYPATWSTEAIDA 232 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc--ccccCcccCcHHHHHH
Confidence 4567889999999888899999999999999999999998875542 111111 110 2223445566799999
Q ss_pred HHHhhhcCCCCCCCH--HHHH
Q 019905 292 ASRCLQYEPRERPNP--KSLV 310 (334)
Q Consensus 292 i~~cl~~dp~~Rps~--~~~l 310 (334)
+.+||+.||.+||++ .+++
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHccCChhHcCCccHHHHh
Confidence 999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=280.99 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=199.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+++.++.+|.|++|.||++... +++.+++|.+...... ....+.+|++++++++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4566778899999999999975 5789999998765422 2456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--Ccc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSY 215 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~ 215 (334)
++++|.+++.. ....+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||.+...... ...
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~-i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 82 DGGSLDKILKE-VQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred CCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHcCCCC-eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 99999999864 22678899999999999999999999 88 999999999999999999999999987654321 225
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh--HHhhhcccccccccccCCCCCch-hHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNLQMLTDSCLEGQFTDD-DGTELVRLA 292 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li 292 (334)
.++..|+|||.+.+..++.++||||||+++|++++|..|+..... ..... ......... ....+.. .+.++.++|
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li 237 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNEP-PPRLPSGKFSPDFQDFV 237 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH-HHHHHhcCC-CCCCChhhcCHHHHHHH
Confidence 677899999999888899999999999999999999988764310 00000 001111111 1112222 566899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||..||.+|||+.+++.
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 238 NLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHcCCCchhCcCHHHHhh
Confidence 9999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.73 Aligned_cols=245 Identities=20% Similarity=0.283 Sum_probs=201.8
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
|.+.+.+|.|++|.||++... ++..+++|++..........+.+|++.++.++|+|++++.+++..+...++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 556677899999999999975 5789999999876544567789999999999999999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Ccccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYST 217 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~ 217 (334)
++|.+++.. ....+++..+..++.+++.+|.+||+.+ ++||||+|+||+++.++.++|+|||.+...... ....+
T Consensus 82 ~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 82 GSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSNG-IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred CcHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCC-EecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 999999864 2257899999999999999999999998 999999999999999999999999998766554 34567
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
+..|+|||.+.+..++.++|+||||++++++++|+.|+.............. ........+...+..+.+++.+||+
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHHHHHHHcc
Confidence 8899999999888899999999999999999999988765422111111111 0000001111225689999999999
Q ss_pred cCCCCCCCHHHHHH
Q 019905 298 YEPRERPNPKSLVT 311 (334)
Q Consensus 298 ~dp~~Rps~~~~l~ 311 (334)
.||++|||+.+++.
T Consensus 237 ~~p~~R~t~~~~l~ 250 (253)
T cd05122 237 KNPEKRPTAEQLLK 250 (253)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=278.35 Aligned_cols=242 Identities=18% Similarity=0.233 Sum_probs=191.2
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC-----ChHHHHHHHHHHhcCCCCCccceeeeeee--CCeeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 133 (334)
|+..+.+|+|+||.||++.. .++..|++|.+...... ....+.+|+.+++.++|+||+++++++.. ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 45566679999999999985 45889999998643321 12457789999999999999999998865 356889
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
++||+++++|.+++. ....+++...+.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~-i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 84 FMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999986 3456889999999999999999999998 999999999999999999999999998644321
Q ss_pred ------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 ------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 ------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....++..|+|||.+.+..++.++||||||+++|++++|+.||........... ..........+....+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHISE 236 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhcCH
Confidence 123467889999999988899999999999999999999988754322111111 1111112233444556
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+.+++ +||..+|++||++++++.
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhc
Confidence 788888 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=277.86 Aligned_cols=243 Identities=18% Similarity=0.189 Sum_probs=193.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--C---hHHHHHHHHHHhcCCCCCccceeeeeeeC--Ceee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--D---PRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 132 (334)
+|++.+.+|+|+||.||.+... ++..||+|.+...... . ...+.+|+.++++++|+||+++++++... ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 4556677799999999999864 5889999988643211 1 24677899999999999999999988663 4678
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
++|||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLHSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999999886 3356788899999999999999999999 99999999999999999999999998875432
Q ss_pred ------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 212 ------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 212 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
.....++..|+|||.+.+..++.++||||||+++|++++|+.||........... ..........+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 235 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPVLPPHVS 235 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCCCCCCCchhhC
Confidence 1234577899999999888899999999999999999999988754322211111 111111222344556
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+.+++.+||. +|++||+++++++
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 688999999994 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=283.39 Aligned_cols=248 Identities=20% Similarity=0.287 Sum_probs=194.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|++++.+|+|++|.||+|..+ +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..++..++++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4667788899999999999975 5889999998653322 245678899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+++++|..+.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 82 VDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99888887765 3345899999999999999999999999 999999999999999999999999998754332 2
Q ss_pred cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc---c-------------cc----c
Q 019905 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL---Q-------------ML----T 272 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~---~-------------~~----~ 272 (334)
...++..|+|||.+.+. .++.++||||||+++|+|++|..|+............. . .. .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 23467889999998754 47889999999999999999997775432111000000 0 00 0
Q ss_pred ccccC-----CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 DSCLE-----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..... ....+..+..+.+++.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 0012234568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=281.56 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=193.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
...|++++.+|+|++|.||+|..+ +++.||+|.+...... ....+.+|+++++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 456788888999999999999965 5789999998754322 23456789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----C
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----G 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~ 212 (334)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+..... .
T Consensus 84 ~~~-~~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLD-TDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQRR-VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCC-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 997 589988864 3347889999999999999999999999 99999999999999999999999998764322 1
Q ss_pred CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhh--HHhhhc----------cccccc-------
Q 019905 213 KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIRDR----------NLQMLT------- 272 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~--~~~~~~----------~~~~~~------- 272 (334)
....++..|+|||.+.+. .++.++||||+|+++|+|++|..||..... ...... ......
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 223457889999998764 488999999999999999999988754321 100000 000000
Q ss_pred -------ccccCCCC-CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 -------DSCLEGQF-TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 -------~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
........ ......++.+++.+||+.+|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0111267889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=283.02 Aligned_cols=250 Identities=18% Similarity=0.244 Sum_probs=196.2
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 133 (334)
...|++++.+|.|++|.||+|..+ +++.+++|.+....... ...+.+|++++++++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 456777888899999999999975 57899999997544222 23567899999999999999999998877 78999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
++||++ ++|.+.+.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 v~e~~~-~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVE-HDLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDNW-ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcC-cCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999997 589888764 3346899999999999999999999999 999999999999999999999999988765443
Q ss_pred ---CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc--------------------
Q 019905 213 ---KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL-------------------- 268 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~-------------------- 268 (334)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.............
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 2234678899999987654 6889999999999999999998876432211111000
Q ss_pred -----ccccccccCCCCCch-hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 -----QMLTDSCLEGQFTDD-DGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 -----~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...........++.. .++.+.+++.+||+.||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111122222 4678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=282.58 Aligned_cols=249 Identities=18% Similarity=0.236 Sum_probs=199.4
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|+.++.+|+|+||.||++.. .++..+|+|.+....... ...+.+|+++++.++|+|++++++++..+...+++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 44566779999999999995 457899999986543222 34678899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 217 (334)
++ ++|.+.+.. ...++++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..........+
T Consensus 107 ~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~-i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 107 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred CC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 97 577776643 3456899999999999999999999999 99999999999999999999999999877666666678
Q ss_pred cccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 218 NLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 218 ~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
+..|+|||.+. +..++.++||||||+++|+|++|..|+.............. ...........+..+.+++.+
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~ 259 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPTLQSNEWSDYFRNFVDS 259 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----ccCCCCCCccccHHHHHHHHH
Confidence 88999999984 34588999999999999999999988765422211111111 111111123445679999999
Q ss_pred hhhcCCCCCCCHHHHHHHhcccc
Q 019905 295 CLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
||+.+|.+||++.++++.+-.+.
T Consensus 260 ~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 260 CLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999998654444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=285.28 Aligned_cols=242 Identities=16% Similarity=0.248 Sum_probs=181.3
Q ss_pred ccCCCcCccEEEEEEeC---CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee--CCeeeEEEecCCC
Q 019905 66 SEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVAEYMPN 140 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 140 (334)
.+||+|+||.||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 46799999999999864 35789999986543 23467789999999999999999998854 456889999996
Q ss_pred CCHHHhhccc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee----cCCCCeeEcCCCCCccC
Q 019905 141 ETLAKHLFHW-------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 141 ~sL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili----~~~~~~kl~Dfg~a~~~ 209 (334)
++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 5777766421 1235788899999999999999999999 9999999999999 46678999999998754
Q ss_pred CCC-------CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHH-------------------
Q 019905 210 RDG-------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDL------------------- 262 (334)
Q Consensus 210 ~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~------------------- 262 (334)
... ....+|..|+|||.+.+. .++.++||||||+++|+|++|..||.....+.
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 332 234568899999999764 48899999999999999999998875321100
Q ss_pred ------hhhcc-cc---cccccccC------------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 263 ------IRDRN-LQ---MLTDSCLE------------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 263 ------~~~~~-~~---~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.... .. ........ ..........+.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00 00000000 0001112346888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.50 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=200.1
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
...|+....+|.|++|.||++..+ ++..+++|.+..... ....+.+|++.++.++|+|++++++.+......++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 344566677799999999999976 578999999976543 456788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 97 ~~~~~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~g-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 97 MDGGSLTDIITQN-FVRMNEPQIAYVCREVLQGLEYLHSQN-VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 9999999999742 237999999999999999999999999 999999999999999999999999987654332 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.................. ....+...+..+.+++.
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP---PLKNPEKWSPEFKDFLN 251 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---CCcchhhCCHHHHHHHH
Confidence 334678899999998888999999999999999999999887543322111111110000 01112224568999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.+|..|||+.+++.
T Consensus 252 ~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=281.60 Aligned_cols=248 Identities=20% Similarity=0.279 Sum_probs=194.0
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|+.++.+|.|++|.||+|... ++..||+|.+...... ....+.+|++++++++||||+++++++...+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 566777899999999999864 5889999998654321 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
+ ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 6 68988886544567899999999999999999999999 999999999999999999999999998754332 22
Q ss_pred ccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc---------------------c
Q 019905 215 YSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML---------------------T 272 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~---------------------~ 272 (334)
..++..|+|||.+.+.. ++.++||||||+++|+|++|+.||................ .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 34577899999987655 6889999999999999999998886543211110000000 0
Q ss_pred cccc--CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 DSCL--EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.... ........+.++.+++.+||+.||.+|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 00011234567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.88 Aligned_cols=263 Identities=18% Similarity=0.249 Sum_probs=202.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 134 (334)
+-..|+++++||+||.+.||++...+...+|+|++.....+. ...|.+|+..|.+|+ |.+|++++++-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 346789999999999999999997777788888876443222 456899999999995 99999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||=+ -+|..+|.........+ .+..++.||+.++.++|++| |||-||||.|+|+- .|.+||+|||+|......
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g-IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG-IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc-eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 99985 89999997543333334 78899999999999999999 99999999999987 579999999999876553
Q ss_pred ----CcccccccccCcccccCCC-----------CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC
Q 019905 213 ----KSYSTNLAFTPPEYLRTGR-----------VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
..++||..||+||.+.... .++++|||||||++|+|+.|+.||..-. ..+. .+..+.++...
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-n~~a--Kl~aI~~P~~~ 591 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-NQIA--KLHAITDPNHE 591 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-HHHH--HHHhhcCCCcc
Confidence 3678999999999985322 5689999999999999999998774322 1121 12333333332
Q ss_pred CCCCchhHH-HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCChhhh
Q 019905 278 GQFTDDDGT-ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISPLCR 329 (334)
Q Consensus 278 ~~~~~~~~~-~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p~~~ 329 (334)
-.++..-.. ++.+++..||+.||++|||..++|+.- +.+-.+++..++.+
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp--Fl~~~~i~~~~m~~ 642 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP--FLQIQPIPVEQMAK 642 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc--ccccccccchHHHH
Confidence 233332222 399999999999999999999998631 33222444444443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.23 Aligned_cols=243 Identities=19% Similarity=0.292 Sum_probs=201.4
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
++++++.+|.|++|.||++... +++.|++|.+..... .....+.+|+..+.+++|+|++++++++...+..++++||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 4566778899999999999965 489999999976543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 213 (334)
++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~~-~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 82 DGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccCC-CccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 99999999963 3678999999999999999999999 98 9999999999999999999999999987654332
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh---hHHhhhcccccccccccCCCCCch-hHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNLQMLTDSCLEGQFTDD-DGTELV 289 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~ 289 (334)
...++..|+|||.+.+..++.++|+||||+++|++++|..|+.... ......... ... ....+.. .+..+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~l~ 233 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGP-PPSLPAEEFSPEFR 233 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCC-CCCCCcccCCHHHH
Confidence 3356789999999988889999999999999999999998875542 111111111 111 1122233 567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+++.+||+.+|++|||+.++++
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHh
Confidence 9999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.49 Aligned_cols=260 Identities=21% Similarity=0.224 Sum_probs=198.7
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-----ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
|++++.+|.|++|.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++++......++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 556677899999999999964 5889999999765432 1245678999999999999999999999988999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
||+ +++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 999 89999998642 236899999999999999999999999 9999999999999999999999999987654321
Q ss_pred --cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc--------------ccccc-
Q 019905 214 --SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------------LTDSC- 275 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------------~~~~~- 275 (334)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..++............... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 23456789999998653 4788999999999999999997655432211100000000 00000
Q ss_pred -------cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 276 -------LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 276 -------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
.........+..+.+++.+||+.||++|||+.+++. ..+.++...+.+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~~~~~~ 294 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDPAPTPP 294 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCCCCCCC
Confidence 000111334578999999999999999999999997 3444444444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=276.23 Aligned_cols=246 Identities=15% Similarity=0.161 Sum_probs=191.6
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
-.+++..++.++ +|.|+||.||++.. .++..+|+|.+........ |+.....+ +|+|++++++.+...+..+
T Consensus 12 ~~~~~~~~~~~~-lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 12 FLKNCEIVKKLK-LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHhhcccccee-ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334444444443 59999999999995 4578899999865432211 22222222 6999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~ 211 (334)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++ .++|+|||.+.....
T Consensus 86 iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKHN-IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999999863 348999999999999999999999999 99999999999999888 999999999887766
Q ss_pred CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.....++..|+|||++.+..++.++||||||+++|+|++|..|+.................. .....+...++.+.++
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 163 PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--KKLPFIKNVSKNANDF 240 (267)
T ss_pred CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--ccCCcccccCHHHHHH
Confidence 66667889999999999888999999999999999999999888643222111011111111 1112333566789999
Q ss_pred HHHhhhcCCCCCCC-HHHHHH
Q 019905 292 ASRCLQYEPRERPN-PKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps-~~~~l~ 311 (334)
+.+||+.+|..||+ ++++++
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhccChhhCCchHHHHhc
Confidence 99999999999996 588873
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.93 Aligned_cols=243 Identities=18% Similarity=0.192 Sum_probs=191.5
Q ss_pred ccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCCh---HHHHHHHHH-HhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDP---RQFLEEARS-VGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~---~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
+.+|.|++|.||+|... +++.||+|.+........ ..+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45799999999999864 578999999865432111 223444444 4455899999999999998999999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCccccccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 220 (334)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..........++..
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQRG-IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcC
Confidence 99999986 3457889999999999999999999999 99999999999999999999999999876655555667889
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCC
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 300 (334)
|+|||.+.+..++.++||||||+++|++++|..|+.................. .........+.++.+++.+||+.+|
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCCcccccCCHHHHHHHHHHccCCH
Confidence 99999998888899999999999999999999988654333222111111100 1111223456789999999999999
Q ss_pred CCCCCHHHHHHHh
Q 019905 301 RERPNPKSLVTAL 313 (334)
Q Consensus 301 ~~Rps~~~~l~~L 313 (334)
++||++..+.+.|
T Consensus 237 ~~R~~~~~~~~~l 249 (260)
T cd05611 237 AKRLGANGYQEIK 249 (260)
T ss_pred HHccCCCcHHHHH
Confidence 9999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=275.41 Aligned_cols=248 Identities=20% Similarity=0.298 Sum_probs=192.8
Q ss_pred cccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCC------e
Q 019905 63 NIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 130 (334)
.+.+.+|+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+++++.++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45567799999999999853 3678999999754322 2346788999999999999999999886532 2
Q ss_pred eeEEEecCCCCCHHHhhccc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 131 RLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
.+++++|+++++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||.+
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccchhhEEEcCCCCEEECccccc
Confidence 46889999999998876421 1235788899999999999999999999 999999999999999999999999998
Q ss_pred ccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCC
Q 019905 207 KNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (334)
Q Consensus 207 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (334)
...... ....++..|++||.+.+..++.++||||||+++|++++ |..|+............... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~ 235 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-----NRLK 235 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-----CcCC
Confidence 754322 12234568999999988889999999999999999999 66665443322221111110 0111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2234556899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.30 Aligned_cols=249 Identities=17% Similarity=0.234 Sum_probs=195.7
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 136 (334)
.++.++.+|.|++|.||++... ++..+|+|.+...... ....+.+|+++++.++||||+++++++... +..+++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 3556677899999999999964 5789999998754322 245688999999999999999999988653 46899999
Q ss_pred cCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 137 YMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|+++++|.+++.. .....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 9999999887643 13456788999999999999999999999 999999999999999999999999998654332
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-----HHhhhcccccccccccCCCCC--chhH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-----DLIRDRNLQMLTDSCLEGQFT--DDDG 285 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~ 285 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|..|+..... ...... .............. ...+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEPGNGIKWS 239 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCCCCCCchH
Confidence 234567889999999988899999999999999999999988765411 001100 00000011111111 2345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+.+++.+||+.+|.+|||+.+++.
T Consensus 240 ~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 240 EEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 68999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=275.60 Aligned_cols=244 Identities=19% Similarity=0.259 Sum_probs=199.4
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeee--CCeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 136 (334)
|++++.+|.|++|.||++.. .++..+|+|.+....... .+.+..|+++++.++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 56778889999999999985 457899999987544322 3467789999999999999999998754 456789999
Q ss_pred cCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 137 YMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCT-----SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 137 ~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh-----~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
|+++++|.+++... ....+++..++.++.+++.||.||| +.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-ceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999988642 2467899999999999999999999 888 999999999999999999999999998865
Q ss_pred CCCC----cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 210 RDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 210 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
.... ...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.............. ......+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 235 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-----GKFRRIPYRYS 235 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-----CCCCCCccccC
Confidence 5432 34678899999999888899999999999999999999988865533222211111 11123344566
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhh
Confidence 78999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=277.10 Aligned_cols=241 Identities=18% Similarity=0.268 Sum_probs=197.8
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
|+.++.+|.|+||.||+|.. .++..+|+|.+...... ....+.+|+.++.+++|+||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 55677889999999999985 45789999998643322 23568889999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Ccc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~ 215 (334)
+++|.+++. ...+++..+..++.+++.++.+||+++ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 86 ~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 86 GGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccCC-eecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999884 356889999999999999999999999 999999999999999999999999988654432 123
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.++..|+|||.+.+..++.++|+||||+++|++++|..|+............. . ......+...+.++.+++.+|
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP----K-NNPPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh----c-CCCCCCCcccCHHHHHHHHHH
Confidence 56788999999988888999999999999999999998876433222111110 0 111123344567899999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 019905 296 LQYEPRERPNPKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~ 311 (334)
|+.+|..||++.+++.
T Consensus 237 l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 237 LNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCChhhCcCHHHHHh
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=278.26 Aligned_cols=241 Identities=17% Similarity=0.253 Sum_probs=192.8
Q ss_pred CCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
||+|+||+||++... +++.+|+|.+.... ......+..|+++++.++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 589999999999854 58899999986432 12234567899999999999999999999998999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Cccccccc
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLA 220 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~ 220 (334)
.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+...... ....++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR-IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 99987544457899999999999999999999999 999999999999999999999999988654322 23456778
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCC
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 300 (334)
|+|||.+.+..++.++||||||+++|+|++|+.||.................. .....+...++.+.+++.+||+.||
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999888543221111100011110 1112344456789999999999999
Q ss_pred CCCC-----CHHHHHH
Q 019905 301 RERP-----NPKSLVT 311 (334)
Q Consensus 301 ~~Rp-----s~~~~l~ 311 (334)
.+|| ++.+++.
T Consensus 238 ~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 238 EKRLGCRGGSADEVRE 253 (277)
T ss_pred hHccCCCcccHHHHHh
Confidence 9999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.18 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=195.5
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|++++.+|+|++|.||+|... +++.|++|.+.... ......+.+|+++++.++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 4677788899999999999965 57899999987533 22245788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 213 (334)
++++.+..+.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN-IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99766665553 3456899999999999999999999999 9999999999999999999999999987654332
Q ss_pred -cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhc--------------------ccc--
Q 019905 214 -SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR--------------------NLQ-- 269 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~--------------------~~~-- 269 (334)
...++..|+|||.+.+. .++.++||||||+++|+|++|..|+........... ...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34567889999999888 789999999999999999999987754321110000 000
Q ss_pred ccccc----ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 MLTDS----CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...+. .....++...+.++.+++.+||..+|++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0001122334678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=276.17 Aligned_cols=247 Identities=15% Similarity=0.203 Sum_probs=195.0
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCC------ee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD------ER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~ 131 (334)
..|++++.+|.|++|.||+|... ++..+++|.+..... ....+.+|+++++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45677788899999999999964 578899999875442 346788999999999 7999999999987543 48
Q ss_pred eEEEecCCCCCHHHhhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 132 LLVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEEccCCeEEECCCccceec
Confidence 99999999999999886422 467899999999999999999999999 999999999999999999999999998654
Q ss_pred CCC----CcccccccccCcccccCC-----CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCC
Q 019905 210 RDG----KSYSTNLAFTPPEYLRTG-----RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 210 ~~~----~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (334)
... ....++..|+|||.+... .++.++||||||+++|++++|..||.............. ........
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~ 240 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKS 240 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCc
Confidence 332 234577889999988532 377899999999999999999988864321111111111 11111111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+...+.++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2335668999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.75 Aligned_cols=247 Identities=19% Similarity=0.251 Sum_probs=191.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
++..++.||+|+||.||++... ++..+|+|.+...... ....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445567899999999999964 5789999998754322 2346788999999996 99999999999888889999999
Q ss_pred CCCCCHHHhh---cccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 138 MPNETLAKHL---FHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 138 ~~~~sL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
+. +++.++. .......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-eeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 86 5655533 222346789999999999999999999975 7 999999999999999999999999998654322
Q ss_pred --CcccccccccCcccccCC---CCCCccchhhhHHHHHHHHhCCCCCCchhh--HHhhhcccccccccccCCCCCchhH
Q 019905 213 --KSYSTNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ...... .. ...+......+...+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~ 240 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV-VK-GDPPILSNSEEREFS 240 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh-cC-CCCCcCCCcCCCccC
Confidence 234578899999999776 589999999999999999999988764321 111110 00 011111112223456
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.+|+.+||+.||.+|||+.+++.
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 78999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=274.26 Aligned_cols=244 Identities=17% Similarity=0.275 Sum_probs=198.4
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|.+.+.+|.|+||.||++..+ ++..+|+|.+..... ...+.+.+|+++++.++|+|++++++.+...+..++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 455667799999999999964 478999999865432 23456789999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCCCC----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDGK---- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~~~---- 213 (334)
++++|.+++.......+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 9999999987544446789999999999999999999998 99999999999999775 46999999887654432
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...++..|+|||.+.+..++.++|+||||+++|++++|..|+............... .. .......+.++.+++.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG----YF-APISPNFSRDLRSLIS 235 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc----cC-CCCCCCCCHHHHHHHH
Confidence 235778899999998888999999999999999999999888654332222111111 11 1123345568999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.+|++|||+.+++.
T Consensus 236 ~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 236 QLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=279.12 Aligned_cols=239 Identities=19% Similarity=0.269 Sum_probs=194.4
Q ss_pred ccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHH
Q 019905 66 SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 144 (334)
.++|+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4569999999999986 468899999986544334556888999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cccccccc
Q 019905 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTNLA 220 (334)
Q Consensus 145 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~ 220 (334)
+++. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++...... ....++..
T Consensus 106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~g-ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06657 106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence 9873 356889999999999999999999999 999999999999999999999999987654322 23457788
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCC
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 300 (334)
|+|||.+.+..++.++|+||+|+++|+|++|..|+.................. .. ......+..+.+++.+||+.+|
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KL--KNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-cc--CCcccCCHHHHHHHHHHHhCCc
Confidence 99999998888999999999999999999999887654322211111111111 10 1122345678999999999999
Q ss_pred CCCCCHHHHHH
Q 019905 301 RERPNPKSLVT 311 (334)
Q Consensus 301 ~~Rps~~~~l~ 311 (334)
.+||++.+++.
T Consensus 259 ~~R~~~~~ll~ 269 (292)
T cd06657 259 AQRATAAELLK 269 (292)
T ss_pred ccCcCHHHHhc
Confidence 99999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=279.42 Aligned_cols=257 Identities=16% Similarity=0.160 Sum_probs=197.1
Q ss_pred cCHHHHHHHhcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeee
Q 019905 47 FTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGC 124 (334)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 124 (334)
+++.++.... .+|.+++.+|+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +|||+++++++
T Consensus 12 ~~~~~~~~~~---~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 12 LGLESLGDPT---DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred hhcccCCCCC---CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 3344444444 4456667779999999999996 457899999986533 2345677899999998 79999999999
Q ss_pred eeeC-----CeeeEEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC
Q 019905 125 CCEG-----DERLLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 125 ~~~~-----~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~ 197 (334)
+... +..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCC
Confidence 8753 3589999999999999987531 3456889999999999999999999999 999999999999999999
Q ss_pred eeEcCCCCCccCCCC----CcccccccccCcccccCC-----CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc
Q 019905 198 PRLSTFGLMKNSRDG----KSYSTNLAFTPPEYLRTG-----RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~ 268 (334)
++|+|||.+...... ....++..|+|||.+... .++.++||||||+++|+|++|+.|+.............
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 999999998754322 234567889999998543 26889999999999999999998876532211111110
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. .......+...+..+.+++.+||+.+|++||++.++++
T Consensus 247 ~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RN---PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cC---CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00011112334567999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=282.65 Aligned_cols=244 Identities=18% Similarity=0.268 Sum_probs=206.7
Q ss_pred cccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
-|++-+.||+|-|..|-+|+ .=+|+.||||++.....+. ...+.+|+..++.++|||||++|.+...+..+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 35556677999999999998 3478999999998665444 35788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCCCCCccCCCCC---
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
-++|+|.+++-. ....+.+....+++.||+.|+.|+|+.. +|||||||+||.+. .-|-|||.|||++..+.+++
T Consensus 99 GD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqLH-VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 99 GDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQLH-VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred cCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhhh-hhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 999999999975 5578999999999999999999999997 99999999999887 67899999999998777764
Q ss_pred cccccccccCcccccCCCCCC-ccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTP-ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
+..|+..|-|||++.|..|+. ++||||||+++|-|++|+.||......... ..+++. ....|...+.+..+||
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----TmImDC--KYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----TMIMDC--KYTVPSHVSKECRDLI 250 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----hhhhcc--cccCchhhhHHHHHHH
Confidence 456889999999999999875 899999999999999999888654322221 122221 1245778889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~ 312 (334)
..||..||+.|.|.++|...
T Consensus 251 ~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHhcCchhhccHHHHhcc
Confidence 99999999999999999753
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=302.83 Aligned_cols=250 Identities=16% Similarity=0.180 Sum_probs=182.1
Q ss_pred CCcccccccCCCcCccEEEEEEeCC--CCEEEEE------------------EecCCCCCChHHHHHHHHHHhcCCCCCc
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN--QRRIAVK------------------RFNRMAWPDPRQFLEEARSVGQLRNNRL 118 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vaiK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i 118 (334)
...|+++++||+|+||.||++..+. +...+.| .+.. .......+.+|+.++++++|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence 3568899999999999999987532 2222222 1111 11123457789999999999999
Q ss_pred cceeeeeeeCCeeeEEEecCCCCCHHHhhcccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 119 TNLLGCCCEGDERLLVAEYMPNETLAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
+++++++...+..+++++++. ++|.+++.... ........+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-LIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCC
Confidence 999999999999999999995 67777664311 122335667889999999999999999 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCC-----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh----HHhhhc
Q 019905 196 GNPRLSTFGLMKNSRDG-----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDR 266 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~----~~~~~~ 266 (334)
+.+||+|||++...... ....|+..|+|||++.+..++.++|||||||++|||++|+.+|..... ......
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999999765432 234689999999999998899999999999999999999865432211 000000
Q ss_pred c------ccccccc-----------cc---CCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 267 N------LQMLTDS-----------CL---EGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 267 ~------~~~~~~~-----------~~---~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. .....+. .. .... ....+.++.+++.+||+.||.+|||+.+++.
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0000000 00 0000 0112346788899999999999999999985
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=278.71 Aligned_cols=244 Identities=18% Similarity=0.272 Sum_probs=190.6
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHH-HhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARS-VGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+|++++.+|+|+||.||++... +++.||+|++..... .....+..|+.. ++.++||||+++++++..++..+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 4667788899999999999964 589999999975432 223345556654 6667899999999999998999999999
Q ss_pred CCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 138 MPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
++ ++|.+++... ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-eecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 96 7887776532 235689999999999999999999997 7 999999999999999999999999998765432
Q ss_pred -CcccccccccCcccccC----CCCCCccchhhhHHHHHHHHhCCCCCCchhh--HHhhhcccccccccccCCCCCchhH
Q 019905 213 -KSYSTNLAFTPPEYLRT----GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.|+..... ..... ..............+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 234 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-----VVEEPSPQLPAEKFS 234 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-----HHhcCCCCCCccccC
Confidence 22457788999998865 3468899999999999999999988754211 11111 011111111122345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.+++.+||..+|.+||++.++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 68999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.57 Aligned_cols=237 Identities=19% Similarity=0.228 Sum_probs=194.8
Q ss_pred CCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
+|.|++|.||++... ++..+|+|.+...... ..+.+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 589999999999965 4789999999754322 235688999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Cccccccc
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLA 220 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~ 220 (334)
.+++. ....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....++..
T Consensus 81 ~~~l~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~-~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILR--DRGLFDEYTARFYIACVVLAFEYLHNRG-IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 99986 3356889999999999999999999999 999999999999999999999999998765443 23456789
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh--hHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (334)
|+|||.+.+..++.++|+||||+++|++++|..|+.... ....... ..........+...+.++.+++.+||+.
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND----ILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH----HhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 999999988889999999999999999999998886543 1111111 1111112223344467899999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 019905 299 EPRERPN-----PKSLVT 311 (334)
Q Consensus 299 dp~~Rps-----~~~~l~ 311 (334)
+|.+||+ +.++++
T Consensus 234 ~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 234 NPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ChhhCcCCcccCHHHHhc
Confidence 9999999 777775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=284.57 Aligned_cols=245 Identities=18% Similarity=0.240 Sum_probs=205.1
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
+.|..|+++ |+|+||.||-+.. .+|+.+|.|++.... ..+.....+|-.+|.+++.+.||.+-..|.+.+.++
T Consensus 185 n~F~~~Rvl---GkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 185 NTFRVYRVL---GKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cceeeeEEE---ecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 336667666 9999999999984 568999999885433 123345678999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+|+..|+||+|.-+|.......|+++....++.+|+.||.+||+.+ ||+||+||+|||+|+.|+++|+|+|+|.....+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~-iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR-IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc-eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999999998766678999999999999999999999999 999999999999999999999999999987665
Q ss_pred C---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 K---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
. ..+||.+|||||++.+..|+.+.|.|||||++|||+.|..||.......-....-.... .....++...++++.
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--EDPEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--cchhhcccccCHHHH
Confidence 4 45789999999999999999999999999999999999999976432222111111111 123356778889999
Q ss_pred HHHHHhhhcCCCCCCCHH
Q 019905 290 RLASRCLQYEPRERPNPK 307 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~ 307 (334)
++...+|+.||.+|...+
T Consensus 419 slc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHccCHHHhccCC
Confidence 999999999999996543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=271.63 Aligned_cols=268 Identities=16% Similarity=0.224 Sum_probs=201.2
Q ss_pred CCcccccccCCCcCccEEEEEEeC-C----CCEEEEEEecCCCC-CC-hHHHHHHHHHHhcCCCCCccceeeeeee-CCe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-N----QRRIAVKRFNRMAW-PD-PRQFLEEARSVGQLRNNRLTNLLGCCCE-GDE 130 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vaiK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 130 (334)
...|+.++++|+|+||.||+|+-. + ++.+|||.++.... .+ ....-+|+.+++.++|+|++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 345788899999999999999632 2 35789999986532 12 2457789999999999999999999877 778
Q ss_pred eeEEEecCCCCCHHHhhccc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC----CCeeEcCC
Q 019905 131 RLLVAEYMPNETLAKHLFHW---ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED----GNPRLSTF 203 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~----~~~kl~Df 203 (334)
.++++||.+ -+|...++.. ..+.++...+..|++||+.|++|||++. |+||||||.||++..+ |.||++||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999997 5788777532 3467889999999999999999999999 9999999999999877 99999999
Q ss_pred CCCccCCCC-------CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhh---------c
Q 019905 204 GLMKNSRDG-------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD---------R 266 (334)
Q Consensus 204 g~a~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~---------~ 266 (334)
|+++.+.+. ...+.|.-|+|||.+.|.. |+.+.||||.||++.||++-++.|.......... +
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999876543 3456789999999999877 9999999999999999999887664321110000 0
Q ss_pred ccc--------------------cccccccCCCCC-----------chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcc
Q 019905 267 NLQ--------------------MLTDSCLEGQFT-----------DDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (334)
Q Consensus 267 ~~~--------------------~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~ 315 (334)
.+. ..........+. ..-++...+|+.++|.+||..|.|++++++-.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-- 338 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-- 338 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc--
Confidence 000 000000000000 00123488999999999999999999998753
Q ss_pred ccccCCCCCChhhhh
Q 019905 316 LQKETEFSISPLCRF 330 (334)
Q Consensus 316 l~~~~~~~~~p~~~~ 330 (334)
+-.+-+.|..|+.+.
T Consensus 339 yF~~d~lpp~pt~~~ 353 (438)
T KOG0666|consen 339 YFTEDPLPPLPTSDN 353 (438)
T ss_pred ccccCCCCCCcccce
Confidence 444555555555443
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=270.98 Aligned_cols=244 Identities=20% Similarity=0.264 Sum_probs=203.5
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++++.+|.|++|.||++... ++..+++|++..... .....+.+|+++++.++|+|++++.+.+...+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 566777899999999999964 588999999976543 33456889999999999999999999999989999999999
Q ss_pred CCCCHHHhhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 139 PNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999987532 477899999999999999999999998 9999999999999999999999999987654432
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||.+.+..++.++|+||+|+++++|++|..|+................ ....+...+.++.+++
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i 235 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-----YPPIPSQYSSELRNLV 235 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----CCCCCCCCCHHHHHHH
Confidence 3456788999999988889999999999999999999998876554333322221111 1123345567899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||..+|++|||+.++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=278.15 Aligned_cols=243 Identities=20% Similarity=0.233 Sum_probs=194.1
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+....++|+|++|.||+|.. .++..|++|.+....... ...+.+|+++++.++|+|++++++++......+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 33445679999999999985 457899999986543222 24577899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 217 (334)
+. +++.+.+.. ...++++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..........+
T Consensus 103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~ 179 (313)
T cd06633 103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVG 179 (313)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccc
Confidence 96 677777653 3457899999999999999999999999 99999999999999999999999999876655556678
Q ss_pred cccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 218 NLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 218 ~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
+..|+|||.+. +..++.++||||||+++|+|++|..|+............... ..........+..+.+++.+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCccccCHHHHHHHHH
Confidence 88999999984 355888999999999999999999887654221111111100 01111122334579999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.+|.+||++.+++.
T Consensus 256 ~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 256 CLQKIPQERPASAELLR 272 (313)
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=278.58 Aligned_cols=246 Identities=20% Similarity=0.218 Sum_probs=196.2
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|..++.+|.|++|.||+|... ++..+|+|.+....... ...+.+|+++++.++|+|++++.+++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555677899999999999964 57889999986432222 34577899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 217 (334)
+. +++.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..........+
T Consensus 97 ~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (308)
T cd06634 97 CL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG 173 (308)
T ss_pred cC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHhEEECCCCcEEECCcccceeecCcccccC
Confidence 96 678777643 3456889999999999999999999998 99999999999999999999999999887666666678
Q ss_pred cccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 218 NLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 218 ~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
+..|+|||.+. ...++.++||||||+++|+|++|..|+.............. ...........+..+.+++.+
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh----cCCCCcCcccccHHHHHHHHH
Confidence 88999999985 34578899999999999999999988754322111110100 011111123455689999999
Q ss_pred hhhcCCCCCCCHHHHHHHhc
Q 019905 295 CLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~ 314 (334)
||+.+|.+||++.+++....
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HhhCCcccCCCHHHHhhCcc
Confidence 99999999999999986643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=276.20 Aligned_cols=248 Identities=20% Similarity=0.268 Sum_probs=193.7
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++++.+|.|++|.||+|... ++..||+|++...... ....+.+|++.++.++|+|++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456677899999999999864 6899999998754321 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
+ ++|.+++.......+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~-~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 5 78999886433346899999999999999999999998 999999999999999999999999998754322 22
Q ss_pred ccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc---------------------ccc
Q 019905 215 YSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ---------------------MLT 272 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~---------------------~~~ 272 (334)
..++..|+|||.+.+. .++.++|+||||+++|+|++|..||.............. ...
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 3457889999988664 478899999999999999999988754322110000000 000
Q ss_pred cc--ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 DS--CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. ..........+..+.+++.+||+.||.+|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0001112334568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=276.52 Aligned_cols=249 Identities=20% Similarity=0.214 Sum_probs=191.1
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|.+++.||+|+||.||+|.. .++..||+|.+....... ...+.+|+++++.++|+||+++.+++..++..+++|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 4577788889999999999985 457899999996543222 34577899999999999999999999998899999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~ 213 (334)
++ +++.+.+.. ....+.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..... ..
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 85 MH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQH-ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred cc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 96 677776643 3356778888999999999999999999 99999999999999999999999998865322 12
Q ss_pred cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhH--Hhhhcc----------------ccccccc
Q 019905 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LIRDRN----------------LQMLTDS 274 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~--~~~~~~----------------~~~~~~~ 274 (334)
...++..|+|||.+.+. .++.++||||||+++|+|++|..||...... ...... .......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 33467899999998764 4788999999999999999999887543211 000000 0000000
Q ss_pred ccCCCCC---------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 CLEGQFT---------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 ~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+ ...+..+.+++.+|++.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 012457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=276.70 Aligned_cols=250 Identities=19% Similarity=0.245 Sum_probs=193.0
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|++.+.||.|++|.||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 45778888899999999999964 5789999998654322 23567889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCccCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~~~~~~--- 212 (334)
|++ ++|.+++.......+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 996 68888775433444678888999999999999999999 999999999999985 567999999998754322
Q ss_pred -CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc---cccccc------------
Q 019905 213 -KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ---MLTDSC------------ 275 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~---~~~~~~------------ 275 (334)
....++..|+|||.+.+. .++.++||||||+++|+|++|..||.............. ......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 233567899999998764 478999999999999999999988754321111100000 000000
Q ss_pred ----cCC----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 276 ----LEG----QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 276 ----~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... ...+..++++.+++.+||+.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 012334567899999999999999999999985
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=276.07 Aligned_cols=247 Identities=22% Similarity=0.298 Sum_probs=193.6
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 136 (334)
|++++.+|.|++|.||+|... ++..+|+|.+.... ......+.+|+++++.++|+|++++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456778899999999999965 47899999998653 22345678899999999999999999999887 78999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~-~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMD-HDLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSNG-ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-ccHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 997 588888854 2357899999999999999999999999 9999999999999999999999999987654432
Q ss_pred --cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc---cc-------------
Q 019905 214 --SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT---DS------------- 274 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~---~~------------- 274 (334)
...++..|+|||.+.+. .++.++||||||+++|+|++|..|+................. ..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23456789999987654 478999999999999999999988765432211111000000 00
Q ss_pred ---------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 ---------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 ---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.....+....+..+.+++.+||+.+|.+||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000011112668999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=285.47 Aligned_cols=261 Identities=16% Similarity=0.257 Sum_probs=198.0
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeC-----Ceee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 132 (334)
..|++.+.+|+|++|.||+|.. .++..||+|.+..... .....+.+|+.+++.++|+||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 3467778889999999999985 4688999999864332 2234577899999999999999999987643 3478
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+++||+. ++|.+.+ ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 85 lv~e~~~-~~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELME-TDLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhcc-cCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 9999996 6888777 4467999999999999999999999999 999999999999999999999999998754322
Q ss_pred -------CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc-----------cc----
Q 019905 213 -------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------LQ---- 269 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~-----------~~---- 269 (334)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 12356788999998765 45889999999999999999999888543211100000 00
Q ss_pred ----cccc-cccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccccCCCCCC
Q 019905 270 ----MLTD-SCLEGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVTA--LSPLQKETEFSIS 325 (334)
Q Consensus 270 ----~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--L~~l~~~~~~~~~ 325 (334)
.... ...... ..+..+.++.+++.+||+.||.+|||+.++++. ++...+....+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~ 307 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVA 307 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccC
Confidence 0000 000000 012235679999999999999999999999975 7777665444444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=269.78 Aligned_cols=244 Identities=19% Similarity=0.240 Sum_probs=200.1
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 136 (334)
|.+.+.+|+|++|.||+|... ++..|++|.+..... ...+.+.+|++.+++++|+||+++++.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345566799999999999975 688999999875542 2356788999999999999999999999887 78999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++++|.+++.. ...+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG-IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999864 338899999999999999999999998 999999999999999999999999998765443
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....++..|+|||.+.+..++.++||||||++++++++|..|+.......... ............+...+..+.+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL---YKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HhccccCCCcCCCcccCHHHHH
Confidence 23456789999999988889999999999999999999998886543111100 1111111112334455678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||+.||.+||++.+++.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhh
Confidence 999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=292.23 Aligned_cols=241 Identities=20% Similarity=0.259 Sum_probs=201.1
Q ss_pred ccccCCCcCccEEEEEEeCC--C--CEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 64 IVSEHGEKAPNVVYKGKLEN--Q--RRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~--~--~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+.++||+|.||.|++|.|.. | -.||||++..+... ....|.+|+.++.+|+|+|++++||+..+ ...-+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 44677999999999999853 3 46899999876644 35689999999999999999999999876 4577999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS---- 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~---- 214 (334)
+.|+|.+.|+......|....+..++.||+.|+.||..++ +||||+-.+|+|+..-..|||+|||+.+-......
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr-lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR-LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh-hhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 9999999998755667888899999999999999999999 99999999999999999999999999886654331
Q ss_pred ---ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCC-CCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 215 ---YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 215 ---~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
......|+|||.+....++.++|||+||+++|||++++ .||.+..-..+. +.++..-+-..+..+++++++
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-----~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-----KNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-----HhccccccCCCCCCChHHHHH
Confidence 22346899999999999999999999999999999965 566554333332 223333333457778899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++..||+.+|.+|||+..|.+
T Consensus 347 imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHHHhccCCccccccHHHHHH
Confidence 999999999999999999963
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=292.11 Aligned_cols=238 Identities=18% Similarity=0.236 Sum_probs=191.0
Q ss_pred ccCCCcCccEEEEEEeC-CCCEEE---EEEecCC-CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCe--eeEEEecC
Q 019905 66 SEHGEKAPNVVYKGKLE-NQRRIA---VKRFNRM-AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE--RLLVAEYM 138 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~-~~~~va---iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~ 138 (334)
..||+|+|-+||+|... +|..|| +|.-... .....+.+..|+.+|+.|+|+||+++++++.+... ..+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 34699999999999863 466666 2222111 11224679999999999999999999999987654 88999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecccCCCCeeec-CCCCeeEcCCCCCccCCCC--Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDG--KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~~~~--~~ 214 (334)
..|+|..|+. +.+..+...+..|++||+.||.|||++.+ |+|||||-+||+|+ ..|.|||+|+|+|...... ..
T Consensus 126 TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks 203 (632)
T KOG0584|consen 126 TSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS 203 (632)
T ss_pred cCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce
Confidence 9999999997 56778889999999999999999998755 99999999999999 5689999999999865543 45
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..||+.|||||++. ..|+..+||||||++++||+|+.-|+..... ..+. .++........+..-..+++.+||.
T Consensus 204 vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY----KKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY----KKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH----HHHHcCCCHHHhhccCCHHHHHHHH
Confidence 68999999999998 6799999999999999999999988865422 1222 2333333333333333468999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+|+.. ..+|||+.|+|.
T Consensus 279 kCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHhcC-chhccCHHHHhh
Confidence 99999 899999999984
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=279.88 Aligned_cols=241 Identities=19% Similarity=0.227 Sum_probs=186.3
Q ss_pred CCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHH
Q 019905 69 GEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (334)
Q Consensus 69 g~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 145 (334)
|.|+||+||++... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++..++..++++||+++++|.+
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS 88 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence 45599999999964 68999999987543222 3567889999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----------CCc
Q 019905 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-----------GKS 214 (334)
Q Consensus 146 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~-----------~~~ 214 (334)
++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+..... ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (328)
T cd08226 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQNG-YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167 (328)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccc
Confidence 887544456889999999999999999999999 99999999999999999999999975432111 011
Q ss_pred ccccccccCcccccCC--CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-----------------------
Q 019905 215 YSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ----------------------- 269 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~----------------------- 269 (334)
..++..|+|||++.+. .++.++||||||+++|+|++|..||..............
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (328)
T cd08226 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQ 247 (328)
T ss_pred ccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccch
Confidence 2235679999999764 378999999999999999999988864321111000000
Q ss_pred ------------------cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 270 ------------------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 270 ------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
...............+..+.+|+.+||+.||.+|||+.+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 248 SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000011112234567899999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=274.09 Aligned_cols=238 Identities=18% Similarity=0.188 Sum_probs=186.0
Q ss_pred CCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHH---HhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 68 HGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARS---VGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 68 lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
||+|+||.||++.. .+++.+|+|.+....... ...+.+|... +...+|++++.+++.+..++..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 59999999999996 457899999986543221 1223444433 3344799999999999988899999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--Cccccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSYSTN 218 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~ 218 (334)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... ....++
T Consensus 82 ~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 82 GDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 99999886 3456899999999999999999999999 999999999999999999999999998654332 234678
Q ss_pred ccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhh
Q 019905 219 LAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (334)
Q Consensus 219 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (334)
..|+|||.+.+ ..++.++||||||+++|+|++|..||.............. ........+...+.++.+++.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hhcCCcCCccccCHHHHHHHHHHhc
Confidence 99999999864 4589999999999999999999998864321111100000 0011223345566789999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 019905 298 YEPRERP-----NPKSLVT 311 (334)
Q Consensus 298 ~dp~~Rp-----s~~~~l~ 311 (334)
.||.+|| |++++++
T Consensus 236 ~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CCHHHhcCCCCCCHHHHHh
Confidence 9999999 5998886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=271.93 Aligned_cols=237 Identities=23% Similarity=0.264 Sum_probs=193.0
Q ss_pred CCCcCccEEEEEEeCC-CCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 68 HGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
+|.|++|.||++.... ++.+++|.+..... .....+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 4899999999999764 89999999975543 2345688899999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----------
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----------- 212 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----------- 212 (334)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999863 347899999999999999999999999 999999999999999999999999987653322
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch--hHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD--DGTELV 289 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~ 289 (334)
....++..|+|||...+..++.++|+||||+++|++++|..|+................. ..+.. .+..+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 231 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI------EWPEDVEVSDEAI 231 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc------CCCccccCCHHHH
Confidence 123466789999999888899999999999999999999988865543332222111000 11112 256899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHh
Q 019905 290 RLASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L 313 (334)
+++.+||+.+|.+|||+..+.+.|
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHh
Confidence 999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=282.50 Aligned_cols=262 Identities=16% Similarity=0.262 Sum_probs=200.1
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeC-----Ceee
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 132 (334)
.|.+++.+|+|+||+||++.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 466677889999999999985 458999999987532 22344677899999999999999999987643 3479
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+++||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 78888886 4467899999999999999999999999 999999999999999999999999998765433
Q ss_pred ----CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh-------------------hccc
Q 019905 213 ----KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-------------------DRNL 268 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~-------------------~~~~ 268 (334)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 23456788999999865 45889999999999999999999887543211000 0000
Q ss_pred ccccc---cccC---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccccCCCCCCh
Q 019905 269 QMLTD---SCLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA--LSPLQKETEFSISP 326 (334)
Q Consensus 269 ~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--L~~l~~~~~~~~~p 326 (334)
..... .... .......+.++.+++.+||+.+|.+|||++++++. ++.+......++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~ 307 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQ 307 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCC
Confidence 00000 0000 00122456789999999999999999999999965 77666555544443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=277.60 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=193.5
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeC--Ceee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 132 (334)
+...|++++.||.|+||.||+|... ++..||+|.+....... ...+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3456788888899999999999964 58899999987543222 23466899999999999999999998754 4689
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+......
T Consensus 85 lv~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCE-QDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999996 588888754 3467899999999999999999999999 999999999999999999999999998765432
Q ss_pred ----CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc-----------c---
Q 019905 213 ----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT-----------D--- 273 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~-----------~--- 273 (334)
....++..|+|||.+.+. .++.++||||||+++|+|++|..||................. .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 122346789999998764 488999999999999999999988864432221111000000 0
Q ss_pred --c-ccC-CC------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 --S-CLE-GQ------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 --~-~~~-~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. ... .. .....++.+.+++.+||+.||.+|||+++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000 00 00123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.36 Aligned_cols=248 Identities=13% Similarity=0.095 Sum_probs=181.8
Q ss_pred CcccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCCh-H----------HHHHHHHHHhcCCCCCccceeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPDP-R----------QFLEEARSVGQLRNNRLTNLLGC 124 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~~-~----------~~~~e~~~l~~l~h~~iv~~~~~ 124 (334)
..|++.+.||+|+||.||+|...+ +..+|+|.......... + ....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 467788889999999999999654 34566665433221111 1 11223345567789999999997
Q ss_pred eeeCC----eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeE
Q 019905 125 CCEGD----ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (334)
Q Consensus 125 ~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl 200 (334)
+.... ..+++++++. .++.+.+.. ....++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCcEEE
Confidence 65543 3467888874 566666642 234678888999999999999999999 999999999999999999999
Q ss_pred cCCCCCccCCC-----------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-H-h---h
Q 019905 201 STFGLMKNSRD-----------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-L-I---R 264 (334)
Q Consensus 201 ~Dfg~a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~-~---~ 264 (334)
+|||++..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... . . .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99999875421 12245889999999999989999999999999999999999988654211 1 1 0
Q ss_pred hcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 265 DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
......+.... ......+..+.+++..||+.+|++||++.++++.|+
T Consensus 248 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111111111 112234568999999999999999999999998763
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=267.83 Aligned_cols=242 Identities=22% Similarity=0.298 Sum_probs=200.0
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|.+.+.+|+|++|.||++... +++.+++|.+..... .....+.+|++++++++|+|++++.+++..++..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 556677899999999999864 578999999976653 23456889999999999999999999999989999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----c
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 214 (334)
++++|.+++.. ...+++..+..++.|++.+|.+||+++ ++||||+|+||+++.++.++|+|||.+....... .
T Consensus 82 ~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 82 ENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQG-VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 99999999863 367899999999999999999999999 9999999999999999999999999987655433 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||...+..++.++|||+||+++|++++|..|+............. .......+...+..+.+++.+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----ccCCCCCCCCCCHHHHHHHHH
Confidence 456789999999988778999999999999999999998875432111111000 011122344556789999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||..+|++|||+.+++.
T Consensus 234 ~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 234 CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCChhhCcCHHHHhc
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=282.47 Aligned_cols=246 Identities=15% Similarity=0.204 Sum_probs=191.2
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeC------Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 130 (334)
..|++++.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 4567778889999999999995 468899999986432 22234677899999999999999999988643 34
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||+. ++|.+.+.. .++...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+....
T Consensus 96 ~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 699999996 688887742 2888999999999999999999999 9999999999999999999999999987654
Q ss_pred CC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc------------------
Q 019905 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------ 269 (334)
Q Consensus 211 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------ 269 (334)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 33 234567889999999998899999999999999999999988864321110000000
Q ss_pred ---------------cccccc----cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 ---------------MLTDSC----LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ---------------~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...... .....+...+..+.+++.+||+.||.+|||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 000012234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.19 Aligned_cols=246 Identities=19% Similarity=0.241 Sum_probs=188.8
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCC-CCCccceeeeeeeC--CeeeEEEe
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLR-NNRLTNLLGCCCEG--DERLLVAE 136 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 136 (334)
|++++.+|+|+||.||++... ++..+|+|.+...... ......+|+..+.++. |+|++++++++..+ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788899999999999954 5789999998754322 2233457888888885 99999999999887 88999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---C
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---K 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~ 213 (334)
|++ ++|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.++|+|||.+...... .
T Consensus 81 ~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRNG-IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCC-ccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 997 688887754 2357899999999999999999999999 999999999999999 99999999998765432 2
Q ss_pred cccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc-------c---------ccccccc
Q 019905 214 SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL-------Q---------MLTDSCL 276 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~-------~---------~~~~~~~ 276 (334)
...++..|+|||.+.. ..++.++||||||+++|+|++|..||............. . .......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 3456789999997754 457889999999999999999998886432111100000 0 0000000
Q ss_pred CC-------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 277 EG-------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 277 ~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. ......+..+.+++.+||+++|.+||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 011234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.44 Aligned_cols=239 Identities=21% Similarity=0.248 Sum_probs=184.4
Q ss_pred CccEEEEEEe-CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhc
Q 019905 72 APNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF 148 (334)
Q Consensus 72 ~~g~Vy~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~ 148 (334)
+++.||.+.. .+++.||+|++.... ......+.+|+++++.++|+||+++++++...+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 3445555552 268999999997542 2334678899999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----------Ccccc
Q 019905 149 HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----------KSYST 217 (334)
Q Consensus 149 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----------~~~~~ 217 (334)
......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++|||.+...... ....+
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~-ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKG-FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 544566889999999999999999999999 999999999999999999999999987643211 22345
Q ss_pred cccccCcccccCC--CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh-hc---cccccc-------------------
Q 019905 218 NLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-DR---NLQMLT------------------- 272 (334)
Q Consensus 218 ~~~y~aPE~~~~~--~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~-~~---~~~~~~------------------- 272 (334)
+..|+|||.+.+. .++.++|+||||+++|+|++|..||......... .. ......
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 6789999998763 4889999999999999999999988643211110 00 000000
Q ss_pred -----ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 -----DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 -----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
............+.++.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000011122334568899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=274.52 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=195.6
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++++.+|.|++|.||++... +++.+++|.+...... ....+.+|+++++.++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678899999999999864 6889999998765432 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----c
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 214 (334)
+ ++|.+++.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~-~~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 D-TDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSHG-ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred C-CCHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHCC-eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 7 588888764 3357899999999999999999999999 9999999999999999999999999887654432 3
Q ss_pred ccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc-----------ccc---------
Q 019905 215 YSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM-----------LTD--------- 273 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~-----------~~~--------- 273 (334)
..++..|+|||.+.+. .++.++|+||||+++|++++|+.||............... ...
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4467789999999877 6899999999999999999999887543321110000000 000
Q ss_pred --c--ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 --S--CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 --~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. ..........+.++.+++.+||+.||.+||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0000112234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=262.52 Aligned_cols=249 Identities=19% Similarity=0.253 Sum_probs=194.8
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC-CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..+.+.++.+|.|+.|.||++..+ +|...|||.+.... .+..+.+...++++... ++|+||+.+|+|..+...++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 344566788899999999999965 48899999997644 22334566667666555 5999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
|.+. .-++..+.. ..+++++..+-++...++.||.||..+..|+|||+||+|||+|+.|++||||||++-...+..
T Consensus 171 elMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 9994 555555543 567899999999999999999999876559999999999999999999999999987665543
Q ss_pred -cccccccccCcccccCC---CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
...|-+.|||||-+.-. .|+.++||||||++++||.||+.|+.....+..--.....-..+.+. .....++++.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~--~~~gFSp~F~ 326 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP--GHMGFSPDFQ 326 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC--cccCcCHHHH
Confidence 45677899999999543 48999999999999999999999998754433221111111111111 1223678999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+..||+.|+.+||.+.++|+
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhc
Confidence 9999999999999999999885
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=244.85 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=196.8
Q ss_pred cccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|+..++||+|+||+||+|+ +++++.||+|++..+..+ -.....+|+-+++.+.|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556788999999999999 556889999999765422 246789999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
|. -+|..+... -.+.++.+....++.|++.||.++|+++ ++|||+||+|.||+.+|.+||+|||+++-+.-. .
T Consensus 83 cd-qdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn-vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CD-QDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN-VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hh-HHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh-hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 95 778877754 4678899999999999999999999998 999999999999999999999999998865543 2
Q ss_pred cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCC-CCchhhHHhhhcc--------------cccccccccC
Q 019905 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRN--------------LQMLTDSCLE 277 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p-~~~~~~~~~~~~~--------------~~~~~~~~~~ 277 (334)
..+.|..|.+|.++.|.. |+++.|+||.||++.|+...+.| |++........+. +..+.+....
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 456789999999998877 99999999999999999875544 5544332222111 1122222222
Q ss_pred CCCCc---------hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 278 GQFTD---------DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 278 ~~~~~---------~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..++. .....-.+++.+.+.-+|.+|.+++++++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22221 22335678999999999999999999875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=274.27 Aligned_cols=249 Identities=19% Similarity=0.237 Sum_probs=189.8
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCC-CCCccceeeeeeeCCe-----e
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDE-----R 131 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----~ 131 (334)
.|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.+. |+||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4566777899999999999964 5889999998654322 2356788999999995 6999999999877655 7
Q ss_pred eEEEecCCCCCHHHhhcccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCc
Q 019905 132 LLVAEYMPNETLAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMK 207 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~ 207 (334)
+++|||++ ++|.+++.... ...+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.++|+|||.+.
T Consensus 82 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 82 YLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEecCCCeEEEeecccce
Confidence 99999998 57888775322 346899999999999999999999999 999999999999998 8899999999987
Q ss_pred cCCCC----CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc---ccc----
Q 019905 208 NSRDG----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT---DSC---- 275 (334)
Q Consensus 208 ~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~---~~~---- 275 (334)
..... ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...............+. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 223457789999988654 478999999999999999999988865322111100000000 000
Q ss_pred ---------------cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 276 ---------------LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 276 ---------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+..+..+.++|.+||+.||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000011234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.57 Aligned_cols=245 Identities=24% Similarity=0.428 Sum_probs=193.0
Q ss_pred ccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHH
Q 019905 66 SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 144 (334)
..+|+|+||.||+|.. .++..||+|++...... ...|++.+++++||||+++++++..+...++||||+++|+|.
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 3459999999999996 56889999998643321 235688999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccccccc
Q 019905 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCT---SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF 221 (334)
Q Consensus 145 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y 221 (334)
+++. .+++..+..++.|++.||+||| +.+ ++||||||+||+++.++..++. ||.+..........++..|
T Consensus 772 ~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y 844 (968)
T PLN00113 772 EVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPA-VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAY 844 (968)
T ss_pred HHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCC-eecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccc
Confidence 9994 3889999999999999999999 557 9999999999999988887775 5554433333344678999
Q ss_pred cCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh------HHhh----hcccccccccccCC--CCCchhHHHHH
Q 019905 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL------DLIR----DRNLQMLTDSCLEG--QFTDDDGTELV 289 (334)
Q Consensus 222 ~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~------~~~~----~~~~~~~~~~~~~~--~~~~~~~~~l~ 289 (334)
+|||++.+..++.++||||||+++|||++|+.|+..... ...+ ........++.... ..+.....++.
T Consensus 845 ~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (968)
T PLN00113 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924 (968)
T ss_pred cCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHH
Confidence 999999988899999999999999999999998743210 0000 01111112222211 12334456788
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 290 RLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
+++.+||+.||++|||++++++.|+++.+..+
T Consensus 925 ~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 925 NLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 99999999999999999999999999876443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=279.73 Aligned_cols=253 Identities=20% Similarity=0.320 Sum_probs=199.5
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCC-----eeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 133 (334)
|++.+.+|.|++|.||+|... +++.+|+|.+.... ....+.+.+|+.+++.++|+||+++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 566778899999999999964 48899999997643 223457889999999999999999999987764 6899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
+|+|++ ++|.+++. ....+++..++.++.+++.||.|||+++ ++||||||.||+++.++.++|+|||.+.......
T Consensus 82 v~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~g-i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSAN-VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999997 68888886 3448899999999999999999999999 9999999999999999999999999987654432
Q ss_pred -------cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc-------------
Q 019905 214 -------SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT------------- 272 (334)
Q Consensus 214 -------~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~------------- 272 (334)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.................
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 33467789999999887 789999999999999999999988865432221111000000
Q ss_pred ------c------cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhccccc
Q 019905 273 ------D------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQK 318 (334)
Q Consensus 273 ------~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~~ 318 (334)
. ...........+.++.+++.+||+.+|.+|||+++++. .++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 00000012234678999999999999999999999996 3555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.44 Aligned_cols=248 Identities=17% Similarity=0.245 Sum_probs=190.1
Q ss_pred ccccccCCCcCccEEEEEEeC---CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 133 (334)
|++++.+|+|++|.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 566778899999999999964 47899999997633 22345678899999999999999999999887 78999
Q ss_pred EEecCCCCCHHHhhccc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC----CCCeeEcCCCCC
Q 019905 134 VAEYMPNETLAKHLFHW---ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE----DGNPRLSTFGLM 206 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~----~~~~kl~Dfg~a 206 (334)
||||++ ++|.+.+... ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 999997 5677666421 1236889999999999999999999999 999999999999999 899999999998
Q ss_pred ccCCCC-------CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHH----------hh---h
Q 019905 207 KNSRDG-------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----------IR---D 265 (334)
Q Consensus 207 ~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~----------~~---~ 265 (334)
...... ....++..|+|||.+.+. .++.++||||||+++++|++|..|+....... .. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 754322 223567889999988764 48899999999999999999998875432111 00 0
Q ss_pred ----------------cccccccccccCCCCC-----------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 266 ----------------RNLQMLTDSCLEGQFT-----------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 266 ----------------~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...............+ ...+..+.+++.+||+.||++|||+.+++.
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000000111 134457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=267.39 Aligned_cols=243 Identities=19% Similarity=0.215 Sum_probs=195.0
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC-----CCChHHHHHHHHHHhcCCCCCccceeeeeeeC--Ceee
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA-----WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 132 (334)
+|++.+.+|+|++|.||+|.. .++..||+|.+.... ......+.+|++++++++|+||+++++++... ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 456677789999999999985 458899999885321 11234678899999999999999999998654 4578
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+++||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999886 3346888999999999999999999999 999999999999999999999999998754321
Q ss_pred -------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....++..|+|||.+.+..++.++|+||||+++|++++|+.||......... ............+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI----FKIATQPTKPMLPDGVS 235 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH----HHHHcCCCCCCCCcccC
Confidence 2345778999999999888999999999999999999999887543221111 11111122233556677
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+.+++.+||+ +|..||++.+++.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhc
Confidence 789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.95 Aligned_cols=248 Identities=19% Similarity=0.282 Sum_probs=193.8
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
|++++.+|.|++|.||+|... ++..||+|.+...... ....+.+|+++++.++|+||+++++++...+..+++|||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 567788899999999999964 5789999999765432 24567789999999999999999999999999999999997
Q ss_pred CCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 140 NETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 140 ~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+...... ..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 82 -KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred -ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 58888875422 346899999999999999999999999 999999999999999999999999998654322 23
Q ss_pred ccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc-----------ccc-cccCC---
Q 019905 215 YSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM-----------LTD-SCLEG--- 278 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~-----------~~~-~~~~~--- 278 (334)
..++..|++||.+.+. .++.++||||||+++|++++|..||............... ... .....
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 3457889999998664 4788999999999999999999887644322111110000 000 00000
Q ss_pred --------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 279 --------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 279 --------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...+..+..+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011233567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.19 Aligned_cols=244 Identities=18% Similarity=0.232 Sum_probs=200.2
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++.+.+|.|++|.||++... +++.+++|.+....... ...+.+|+++++.++|+||+++.+++......++++||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 566778899999999999854 57899999987543222 345678999999999999999999999989999999999
Q ss_pred CCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--Cc
Q 019905 139 PNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 214 (334)
++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 999999988642 2356889999999999999999999999 999999999999999999999999998765443 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||.+.+..++.++|+||||+++|++++|..|+............... .....+...+.++.+++.+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-----KYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----CCCCCchhhCHHHHHHHHH
Confidence 45678999999999888999999999999999999999888655433222211111 1112233556789999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.+|.+||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 236 MLQVKPKLRPNCDKILA 252 (256)
T ss_pred HcCCCcccCCCHHHHhc
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.76 Aligned_cols=245 Identities=18% Similarity=0.255 Sum_probs=193.2
Q ss_pred ccccccCCCcCccEEEEEEe----CCCCEEEEEEecCCCC----CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 62 ENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMAW----PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
|++.+.+|.|+||.||.+.. .++..||+|.+..... ...+.+.+|+.++..+ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56677889999999999985 3678999999875321 1235678899999999 5999999999999888999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+++||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLS--QRERFKEQEVQIYSGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999986 3456889999999999999999999999 999999999999999999999999998764432
Q ss_pred -----CcccccccccCcccccCC--CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 213 -----KSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....++..|+|||.+.+. .++.++||||||+++|++++|..|+................... ...++...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--CCCCCccCC
Confidence 134477899999998753 37789999999999999999998875321111000001111111 112344456
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
..+.+++.+||+.||++|| ++++++.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 7899999999999999997 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=278.56 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=193.9
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcC-CCCCccceeeeeeeC--CeeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG--DERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 134 (334)
.|.+.+.+|+|+||.||+|... ++..+|+|++.... ......+.+|+.+++++ +|+||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4566677799999999999965 57899999886432 22334567899999999 999999999988653 368999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||++ ++|..++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 88 ~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 88 FEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGN-VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99997 689888853 37888999999999999999999999 9999999999999999999999999987543221
Q ss_pred --------cccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc-----------------
Q 019905 214 --------SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN----------------- 267 (334)
Q Consensus 214 --------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~----------------- 267 (334)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 2356788999998865 44788999999999999999999887543211110000
Q ss_pred --ccccccc------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hccccccCC
Q 019905 268 --LQMLTDS------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA--LSPLQKETE 321 (334)
Q Consensus 268 --~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--L~~l~~~~~ 321 (334)
....... ..........+.++.+++.+||+.||.+|||+.++++. +.++....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~ 306 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD 306 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence 0000000 00001112246689999999999999999999999854 555544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=269.85 Aligned_cols=248 Identities=21% Similarity=0.255 Sum_probs=191.0
Q ss_pred ccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCC--hHHHHHHHHHHhcC---CCCCccceeeeeeeCCe-----
Q 019905 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPD--PRQFLEEARSVGQL---RNNRLTNLLGCCCEGDE----- 130 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 130 (334)
|++++.+|.|++|.||+|..+. ++.+|+|.+....... ...+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4566778999999999999764 8899999997543222 23455677776655 69999999999987766
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++|||++ ++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~-i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 899999997 58888886433446899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCC---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc----------------
Q 019905 211 DGK---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML---------------- 271 (334)
Q Consensus 211 ~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~---------------- 271 (334)
... ...++..|+|||.+.+..++.++|+||||+++|+|++|..|+................
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 322 2346778999999998889999999999999999999987776543221111110000
Q ss_pred --cccccC---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 --TDSCLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 --~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...... .......+..+.+++.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=271.56 Aligned_cols=248 Identities=18% Similarity=0.302 Sum_probs=192.6
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
|++.+.||.|++|.||+|... +++.|+||++...... ......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456678899999999999965 4789999998654321 2234567899999998 999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Ccc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSY 215 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~ 215 (334)
+++|.+++.......+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG-FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 789998887533457899999999999999999999999 999999999999999999999999998765442 234
Q ss_pred cccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc---------------------cccccc
Q 019905 216 STNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---------------------LQMLTD 273 (334)
Q Consensus 216 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~---------------------~~~~~~ 273 (334)
.++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||+........... ......
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 56788999998854 44789999999999999999999877543221110000 000000
Q ss_pred cccC---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 SCLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.... .......+.++.+++.+||+.||.+|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 0011122468999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=311.51 Aligned_cols=239 Identities=18% Similarity=0.232 Sum_probs=197.3
Q ss_pred ccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 66 SEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
-.+|.|.||.||-|. .++|+..|+|.+...... ....+.+|..++..++|||+|+++|+-.+....+|.||||.+|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 466999999999998 567899999998754422 23568899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--------Cc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--------KS 214 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--------~~ 214 (334)
|.+.+. .++..++....-+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|....+. +.
T Consensus 1321 La~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g-IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1321 LASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG-IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred HHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC-ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence 999986 4556777888889999999999999999 999999999999999999999999998765443 24
Q ss_pred ccccccccCcccccCCC---CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
..||+.|||||++.+.. ...+.||||||||+.||+||+.||..-..++..... +.-.....+|...+.+..+|
T Consensus 1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----V~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----VAAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH----HhccCCCCCchhhhHhHHHH
Confidence 57899999999997654 667999999999999999999998643322221111 11111224556688899999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+..||..||+.|-++.++++
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHH
Confidence 99999999999988877764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=268.59 Aligned_cols=235 Identities=20% Similarity=0.219 Sum_probs=186.6
Q ss_pred CCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHH---HHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 68 HGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEA---RSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 68 lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
||+|+||.||++.. .+++.||+|.+....... ...+..|. ..++...||+|+.+.+.+...+..++||||+++
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 59999999999985 457899999987543221 12233333 344556799999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--CCccccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSYSTN 218 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~ 218 (334)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++..... .....++
T Consensus 82 ~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (278)
T cd05606 82 GDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (278)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence 99998886 3457899999999999999999999999 99999999999999999999999999875432 2234678
Q ss_pred ccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchh---hHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 219 LAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 219 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..|+|||.+.+. .++.++||||+|+++|+|++|..||.... ......... ......+...+.++.+++.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh------ccCCCCCCcCCHHHHHHHHH
Confidence 999999999754 58999999999999999999999886541 111111110 01112334456789999999
Q ss_pred hhhcCCCCCC-----CHHHHHH
Q 019905 295 CLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rp-----s~~~~l~ 311 (334)
||..+|.+|| ++.++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHh
Confidence 9999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=273.89 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=188.8
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCC------
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 129 (334)
...|++++.+|+|++|.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 345778888999999999999964 5889999998644322 2335568999999999999999999986543
Q ss_pred --eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 130 --ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
..+++|||+. ++|.+.+.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNK-ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3599999996 688887753 3346899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCC--------cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc---ccccccc-
Q 019905 208 NSRDGK--------SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---LQMLTDS- 274 (334)
Q Consensus 208 ~~~~~~--------~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~---~~~~~~~- 274 (334)
...... ...++..|+|||.+.+.. ++.++||||||+++|+|++|..|+............ .......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 543221 234567899999987654 788999999999999999999877543221110000 0000000
Q ss_pred -------------ccCCC---------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 -------------CLEGQ---------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 -------------~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..... .+......+.+++.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 01112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=271.76 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=198.5
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC---CChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 135 (334)
+|.+.+.+|.|++|.||++... ++..||+|.+..... .....+.+|++++.+++ |+||+++++++..++..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 4667788899999999999964 688999999865322 12346788999999998 999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
||+++++|.+++. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~Lh~~~-~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALEYLHSKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999996 3457999999999999999999999999 9999999999999999999999999987543321
Q ss_pred ----------------------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc
Q 019905 214 ----------------------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML 271 (334)
Q Consensus 214 ----------------------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 271 (334)
...++..|+|||.+.+..++.++|+||||++++++++|+.|+.............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--- 235 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--- 235 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---
Confidence 2245688999999988889999999999999999999998876543222211111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 019905 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP----KSLVT 311 (334)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~~l~ 311 (334)
......+...++.+.+++.+||+.+|.+|||+ +++++
T Consensus 236 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 ---KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11123344556789999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=270.73 Aligned_cols=249 Identities=19% Similarity=0.277 Sum_probs=191.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 134 (334)
.+.++++++.+|+|++|.||+|..++ +..||+|.+...... ....+..|+.++.+. .|+||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34567788889999999999999764 889999999754322 233456677766666 599999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
|||+. +++.+.+.. ....+++..+..++.+++.||+|||+ .+ ++||||+|+||++++++.++|+|||++......
T Consensus 93 ~e~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCC-EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99995 577776653 34578999999999999999999997 57 999999999999999999999999998755432
Q ss_pred --CcccccccccCcccccCCC----CCCccchhhhHHHHHHHHhCCCCCCchhhH-HhhhcccccccccccCCCCCchhH
Q 019905 213 --KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .......... ..........+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 246 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE---PPSLPPNEGFS 246 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC---CCCCCCCCCCC
Confidence 2234667899999987553 788999999999999999999888642211 1111111100 00001111345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.++.+++.+||+.||.+||++.+++..
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 689999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.64 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=196.0
Q ss_pred ccccccCCCcCccEEEEEEe----CCCCEEEEEEecCCCC----CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 62 ENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMAW----PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
|++.+.||.|++|.||++.. .++..||+|.+..... .....+.+|++++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56677889999999999874 2468899999864321 1234577899999999 5999999999999988999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++++|.+++. ....+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~-~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999886 3456889999999999999999999998 999999999999999999999999988754332
Q ss_pred C-----cccccccccCcccccCCC--CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 213 K-----SYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 ~-----~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
. ...++..|+|||.+.+.. .+.++|+||||+++|+|++|..|+................... ....+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccC
Confidence 1 234678999999987655 7889999999999999999998875321110000000011111 112334455
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
..+.+++.+||+.||+.|||+.++...|+..
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 6899999999999999999988887766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.10 Aligned_cols=247 Identities=17% Similarity=0.262 Sum_probs=191.2
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeee----CCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 133 (334)
.|.+.+.||.|++|.||+|.. .++..||+|++..... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 455667779999999999995 4589999999875432 234567789999999999999999998753 346899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++......
T Consensus 86 v~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 86 VMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 999995 78988886 3456899999999999999999999999 999999999999999999999999998654321
Q ss_pred -------CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhh-------------------
Q 019905 213 -------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD------------------- 265 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~------------------- 265 (334)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 12356788999999866 458899999999999999999999886532111000
Q ss_pred ccccccccc-ccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 266 RNLQMLTDS-CLEGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 266 ~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......... ..... .....+.++.+++.+||+.+|.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000 00000 11234678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=271.85 Aligned_cols=249 Identities=21% Similarity=0.238 Sum_probs=189.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCC-------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------- 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 129 (334)
..|++.+.+|.|++|.||+|... +++.||+|.+..... .....+.+|+++++.++|||++++++++....
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 45666778899999999999975 578999999975432 22346778999999999999999999887644
Q ss_pred ---eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 130 ---ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
..++++||+++ ++...+.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999975 67776653 2457899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC-----cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-----------
Q 019905 207 KNSRDGK-----SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ----------- 269 (334)
Q Consensus 207 ~~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~----------- 269 (334)
....... ...++..|+|||.+.+. .++.++||||||+++|+|++|+.|+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 7544322 12346789999988654 478899999999999999999987754321111000000
Q ss_pred cccccccC-------------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 MLTDSCLE-------------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ~~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+...... .......+..+.+++.+||+.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 0001123568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=261.31 Aligned_cols=262 Identities=20% Similarity=0.202 Sum_probs=204.0
Q ss_pred ccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 66 SEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
+.||+|+++.|.-++ ..++..+|||++.....-....+.+|++++.+.+ |+||++++++|.++..+|||||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 355999999999998 6789999999998776556778999999999995 99999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC---CCeeEcCCCCCccCCC---------
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMKNSRD--------- 211 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~---~~~kl~Dfg~a~~~~~--------- 211 (334)
..++. ..+.|++.++..+..+|+.||.|||.+| |.|||+||+|||-.+- .-+|||||.+..-...
T Consensus 164 LshI~--~~~~F~E~EAs~vvkdia~aLdFlH~kg-IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 164 LSHIQ--KRKHFNEREASRVVKDIASALDFLHTKG-IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred HHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhcC-cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 99998 5678999999999999999999999999 9999999999998644 3489999988653221
Q ss_pred --CCcccccccccCccccc---C--CCCCCccchhhhHHHHHHHHhCCCCCCch--hhHHhhhcc-----cccccccccC
Q 019905 212 --GKSYSTNLAFTPPEYLR---T--GRVTPESVIYSFGTLLLDLLSGKHIPPSH--ALDLIRDRN-----LQMLTDSCLE 277 (334)
Q Consensus 212 --~~~~~~~~~y~aPE~~~---~--~~~~~~~Di~slG~~l~elltg~~p~~~~--~~~~~~~~~-----~~~~~~~~~~ 277 (334)
-.+..|+..|||||+.. + ..|+.+.|.||||+++|-|++|-.||.+. ....|..+. ...+......
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence 12446778999999873 2 23899999999999999999999998653 111111110 1111222211
Q ss_pred CC--CC----chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HhccccccCCCCCChhhhh
Q 019905 278 GQ--FT----DDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQKETEFSISPLCRF 330 (334)
Q Consensus 278 ~~--~~----~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~~~~~~~~~p~~~~ 330 (334)
+. +| ...+.+..++++.++..|+.+|.++..+++ -......+...|.+++-+-
T Consensus 321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~r 381 (463)
T KOG0607|consen 321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQR 381 (463)
T ss_pred cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccccc
Confidence 11 22 234678999999999999999999999987 3344444555666665443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=267.59 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=193.7
Q ss_pred cccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
+.++.+|+|++|.||+|... +++.+++|.+.... ....+.+..|+.+++.++|+|++++++++...+..++++||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 45567899999999999965 48999999998653 2224567889999999999999999999999899999999997
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----cc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----SY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~ 215 (334)
++|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||.+....... ..
T Consensus 82 -~~l~~~i~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 82 -MDLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAYCHSHR-ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred -cCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 689999864 2247899999999999999999999999 9999999999999999999999999987654322 23
Q ss_pred cccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc------------------------cc
Q 019905 216 STNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL------------------------QM 270 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~------------------------~~ 270 (334)
.++..|+|||.+.+. .++.++||||||+++|++++|..||............. ..
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 446789999999776 68999999999999999999988776543221110000 00
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
....... ...+..+..+.+++.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 239 FPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 011123568999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=269.08 Aligned_cols=251 Identities=18% Similarity=0.245 Sum_probs=194.8
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC--CCCCccceeeeeeeC----CeeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL--RNNRLTNLLGCCCEG----DERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv 134 (334)
...+++.+|+|.||.||+|.|+ |+.||||.+.. .+.+.+.+|.++++.+ +|+||+.+++.-..+ .+++||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 4567788899999999999995 58999999964 3467788999998866 899999999876543 358999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-------CCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-------KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-------~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.+|.++|||.|+| ...+++....++++.+++.||++||. +..|.|||||++|||+.+++...|+|+|+|.
T Consensus 288 TdYHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 288 TDYHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eecccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999 45789999999999999999999994 2229999999999999999999999999987
Q ss_pred cCCC--------CCcccccccccCcccccCCC----C-C-CccchhhhHHHHHHHHhC----C------CCCCc-----h
Q 019905 208 NSRD--------GKSYSTNLAFTPPEYLRTGR----V-T-PESVIYSFGTLLLDLLSG----K------HIPPS-----H 258 (334)
Q Consensus 208 ~~~~--------~~~~~~~~~y~aPE~~~~~~----~-~-~~~Di~slG~~l~elltg----~------~p~~~-----~ 258 (334)
.... ....+||.+|||||++.... + + ..+||||||+++||+.-. + .||.+ .
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 5432 34678999999999996432 2 2 268999999999998652 2 34432 1
Q ss_pred hhHHhhhcccc-cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 259 ALDLIRDRNLQ-MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 259 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
..+..+.-... .+.......-........+.++|+.||..||..|.|+-.+.+.|.++.+
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22222222211 1111122222234556788899999999999999999999999988874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=252.69 Aligned_cols=257 Identities=20% Similarity=0.262 Sum_probs=206.9
Q ss_pred ccCHHHHHHHhcCCCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceee
Q 019905 46 EFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLG 123 (334)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~ 123 (334)
-|.++.......+-++|++++++|+|.++.||.|. ..+++.++||.+++.. .+.+.+|+.+|+.|. ||||+.+++
T Consensus 24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhh
Confidence 36777766667788899999999999999999998 5678999999998644 567899999999997 999999999
Q ss_pred eeeeC--CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeE
Q 019905 124 CCCEG--DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRL 200 (334)
Q Consensus 124 ~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl 200 (334)
+..++ ....+++||+++.+..... ..++...+..++.+++.||.|+|+.| |+|||+||.|++|| +...++|
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G-ImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG-IMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC-cccccCCcceeeechhhceeee
Confidence 98765 3578999999998887766 46788899999999999999999999 99999999999999 5667999
Q ss_pred cCCCCCccCCCCCcc---cccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhH--------------H
Q 019905 201 STFGLMKNSRDGKSY---STNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALD--------------L 262 (334)
Q Consensus 201 ~Dfg~a~~~~~~~~~---~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~--------------~ 262 (334)
+|+|+|...+++... +.+..|..||.+...+ |+.+-|+|||||++..|+..+.||+-+..+ .
T Consensus 175 IDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred eecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 999999999887654 4467788999997665 899999999999999999999998643100 0
Q ss_pred ------------------hhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 263 ------------------IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 263 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+.................-.++++.+|+.++|.+|..+|||+.|++.
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0001111111111111112224578999999999999999999999873
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=278.16 Aligned_cols=247 Identities=17% Similarity=0.228 Sum_probs=189.6
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC----------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG---------- 128 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------- 128 (334)
..|.+++.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 4567778889999999999995 45889999999766555567788999999999999999999776543
Q ss_pred ----CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCC
Q 019905 129 ----DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTF 203 (334)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Df 203 (334)
...+++|||++ ++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++ +++.++|+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 68888874 356889999999999999999999999 99999999999998 5567899999
Q ss_pred CCCccCCCC-------CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc-------
Q 019905 204 GLMKNSRDG-------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL------- 268 (334)
Q Consensus 204 g~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~------- 268 (334)
|.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998754321 12345778999998754 458889999999999999999999885432111100000
Q ss_pred ------------ccccccccCC-----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 ------------QMLTDSCLEG-----QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 ------------~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.......... ......+.++.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000 011234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=274.99 Aligned_cols=242 Identities=19% Similarity=0.239 Sum_probs=188.4
Q ss_pred ccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--------------hHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--------------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
+.||.|+||+||+|... +++.||+|.+....... ...+.+|+++++.++|+||+++++++...+.
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 45799999999999954 58899999986543221 1246789999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++|||++ ++|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 95 ~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~~-i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred EEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHeEECCCCCEEECCccceeecc
Confidence 999999996 78998885 4456899999999999999999999999 9999999999999999999999999886543
Q ss_pred C------------------CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc
Q 019905 211 D------------------GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML 271 (334)
Q Consensus 211 ~------------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 271 (334)
. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~ 250 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 1 01223467899999997654 7889999999999999999998876543221111000000
Q ss_pred c---cc----------------ccC---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 T---DS----------------CLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 ~---~~----------------~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. .. ... .......+..+.+++.+||+.+|.+|||+++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 0 00 000 0011233567899999999999999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=260.68 Aligned_cols=241 Identities=15% Similarity=0.148 Sum_probs=192.7
Q ss_pred ccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeC----CeeeEEEecCC
Q 019905 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG----DERLLVAEYMP 139 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~ 139 (334)
+.||-|-.|.|-.+..+ +++.+|+|++.. .....+|+++.-.. .|||||.++++|... .-+.+|||.++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 45699999999999854 689999999853 44567888876555 699999999998652 23679999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec---CCCCeeEcCCCCCccCCCC---C
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG---K 213 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~---~~~~~kl~Dfg~a~~~~~~---~ 213 (334)
||.|.+.+.......|++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .+..+||+|||+|+..... .
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n-IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~ 221 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN-IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM 221 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc-hhhccCChhheeeecCCCCcceEecccccccccCCCcccc
Confidence 999999999877888999999999999999999999999 99999999999997 3556899999999976533 3
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccccc--CCCCCchhHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL--EGQFTDDDGTELVRL 291 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l 291 (334)
+..-|+.|.|||++....|+...|+||+|+++|-|++|-+||+..--..+.-+....+..... .+.--...+++..++
T Consensus 222 TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdl 301 (400)
T KOG0604|consen 222 TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDL 301 (400)
T ss_pred CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHH
Confidence 445689999999999888999999999999999999999999764222111111111111110 001113457899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~ 312 (334)
|+++|+.+|.+|.|++++++-
T Consensus 302 IR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 302 IRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHHHhcCCchhheeHHHhhcC
Confidence 999999999999999999854
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.65 Aligned_cols=232 Identities=23% Similarity=0.276 Sum_probs=192.3
Q ss_pred CCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
+|.|++|.||++... +++.+|+|.+...... ....+..|+++++.++|+|++++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 589999999999965 4889999998765432 234688899999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Ccccccc
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTNL 219 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~~ 219 (334)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....++.
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~~-~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999863 346899999999999999999999998 999999999999999999999999998765432 2345678
Q ss_pred cccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcC
Q 019905 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (334)
Q Consensus 220 ~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (334)
.|+|||.+.+...+.++|+||||+++|++++|..||.............. .....+...+..+.+++.+||..|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------DPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999888889999999999999999999988865433222211111 111234444668999999999999
Q ss_pred CCCCCCHHH
Q 019905 300 PRERPNPKS 308 (334)
Q Consensus 300 p~~Rps~~~ 308 (334)
|++||++.+
T Consensus 232 p~~R~~~~~ 240 (250)
T cd05123 232 PTKRLGSGG 240 (250)
T ss_pred HhhCCCccc
Confidence 999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=263.56 Aligned_cols=238 Identities=20% Similarity=0.238 Sum_probs=201.6
Q ss_pred CCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+++.++.||+|+||.|.+++ ..+++.+|+|.++....-.. ..-..|-.+|+..+||.+..+...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4556677788999999999998 45689999999986654333 3345688899999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC----
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR---- 210 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~---- 210 (334)
|||.+||.|.-++. ..+.+++...+.+...|+.||.|||+++ ||+||+|.+|.++|.+|++|+.|||+++..-
T Consensus 247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~-ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN-IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC-eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999998886 5678999999999999999999999998 9999999999999999999999999987422
Q ss_pred CCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 211 DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 211 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
...+..||+.|+|||++....|..++|.|.+|+++|||++|+.||+...-+....-... . .-.+|...++++..
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----e--d~kFPr~ls~eAkt 397 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----E--DLKFPRTLSPEAKT 397 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh----h--hccCCccCCHHHHH
Confidence 24578899999999999999999999999999999999999999986544333221111 1 12456777889999
Q ss_pred HHHHhhhcCCCCCCC
Q 019905 291 LASRCLQYEPRERPN 305 (334)
Q Consensus 291 li~~cl~~dp~~Rps 305 (334)
|+..+|..||.+|..
T Consensus 398 LLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLG 412 (516)
T ss_pred HHHHHhhcChHhhcC
Confidence 999999999999953
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.69 Aligned_cols=253 Identities=17% Similarity=0.241 Sum_probs=192.6
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCC------e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 130 (334)
..|.++..+|+|++|.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 4566777889999999999995 4689999999865321 12345788999999999999999999986542 4
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++++|+. .+|..+. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG-IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 689999996 5676654 236889999999999999999999999 9999999999999999999999999987653
Q ss_pred CC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (334)
.. ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 32 23456788999999876 4588999999999999999999998865432111100000
Q ss_pred cc---cccccCCC---CCchhHHHHHHHHHHhhhcCCCCCCCHHHHH--HHhccccc
Q 019905 270 ML---TDSCLEGQ---FTDDDGTELVRLASRCLQYEPRERPNPKSLV--TALSPLQK 318 (334)
Q Consensus 270 ~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l--~~L~~l~~ 318 (334)
.. ........ ..+..+..+.+++.+||+.||.+||++.+++ ..++.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 00000000 0122456789999999999999999999998 34665554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.85 Aligned_cols=247 Identities=17% Similarity=0.261 Sum_probs=191.2
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeee-CCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 136 (334)
.|++++.||.|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++.+++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 3666777799999999999854 68899999886432 2234567889999999999999999999865 457889999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Ccc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~ 215 (334)
|+ +++|.+++. ..+++...+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+...... ...
T Consensus 91 ~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~-iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (328)
T cd07856 91 LL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAG-VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY 165 (328)
T ss_pred hh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence 99 578988874 456888889999999999999999999 999999999999999999999999998754432 234
Q ss_pred cccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHh---------------hh----cccccc-ccc
Q 019905 216 STNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI---------------RD----RNLQML-TDS 274 (334)
Q Consensus 216 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~---------------~~----~~~~~~-~~~ 274 (334)
.++..|+|||.+.+ ..++.++||||||+++|++++|..||........ .. ...... ...
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 56788999999866 4589999999999999999999988754321100 00 000000 000
Q ss_pred ccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 275 CLEGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 275 ~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
..... .....+..+.+++.+||+.+|++|||+.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001 112345689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=277.12 Aligned_cols=248 Identities=21% Similarity=0.274 Sum_probs=210.0
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
..+.+..|.+++.||+|.|+.|.++.+ .++..||||.+....... ...+.+|++++..++|||||+++.+......+
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 345567788899999999999999995 468999999997655322 35688999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
|+||||+.+|.+.+++. +.....+.....++.|+..|++|||+++ |+|||||.+|||++.+.++||+|||++..+..
T Consensus 131 ylV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~-ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKN-IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcc-eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999999997 4445556888999999999999999999 99999999999999999999999999887665
Q ss_pred C---CcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 212 G---KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 212 ~---~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
. .+..|++.|.|||++.+..| .+.+|+||+|+++|.|+.|..||.+......+........ .++.-.+.+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~------rIp~~ms~d 281 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY------RIPFYMSCD 281 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee------cccceeech
Confidence 3 46789999999999998885 5699999999999999999999987765554433322211 223344558
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..++++++|-.+|..|++..++.+
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhh
Confidence 999999999999999999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=295.97 Aligned_cols=245 Identities=19% Similarity=0.256 Sum_probs=181.5
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeC--------
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-------- 128 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 128 (334)
+.+++.++.||+||||.||+++.+ +|+.+|||++.... ......+.+|+..|.+|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 344555666699999999999943 68999999998654 12234688999999999999999988532110
Q ss_pred --------------------------------------------------------------------------------
Q 019905 129 -------------------------------------------------------------------------------- 128 (334)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (334)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019905 129 -------------------------------DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK 177 (334)
Q Consensus 129 -------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 177 (334)
-.+||=||||+..++.+++..+... -.....++++++|+.||+|+|+.
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhC
Confidence 0125778999877777777532111 14678899999999999999999
Q ss_pred CCceecccCCCCeeecCCCCeeEcCCCCCccCC----------------------CCCcccccccccCcccccCCC---C
Q 019905 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR----------------------DGKSYSTNLAFTPPEYLRTGR---V 232 (334)
Q Consensus 178 ~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~~~y~aPE~~~~~~---~ 232 (334)
| +|||||||.||++++++.|||+|||+|.... +....+||.-|+|||++.+.. |
T Consensus 717 g-iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 G-IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred c-eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9 9999999999999999999999999987511 113457899999999997655 9
Q ss_pred CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC--CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE--GQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 233 ~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
+.|+|+||||++++||+. ||... .+.... ...+.+...+ ..+.....+.-..+|.++++.||.+||||.++|
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~Ts-MERa~i--L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTS-MERASI--LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCch-HHHHHH--HHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 999999999999999996 33322 222111 1111111111 222333344567899999999999999999998
Q ss_pred H
Q 019905 311 T 311 (334)
Q Consensus 311 ~ 311 (334)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 5
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=269.86 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=188.9
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeC-------
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG------- 128 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 128 (334)
...|++++.||.|++|.||+|... +++.+|+|.+......+ ...+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 456788888999999999999964 57899999986543222 24567899999999999999999987543
Q ss_pred -CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 129 -DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
...+++++|+. +++...+.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH-ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECcCccch
Confidence 24689999996 567776653 3457899999999999999999999999 9999999999999999999999999886
Q ss_pred cCCCCC---------------cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc---
Q 019905 208 NSRDGK---------------SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL--- 268 (334)
Q Consensus 208 ~~~~~~---------------~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~--- 268 (334)
...... ...++..|+|||.+.+. .++.++||||||+++|+|++|..||.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 543211 12346779999988664 48899999999999999999998875432211110000
Q ss_pred --------------ccccccccCCCCC-------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 --------------QMLTDSCLEGQFT-------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 --------------~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
............+ ....+.+.+++.+||+.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000001 122357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=272.58 Aligned_cols=260 Identities=17% Similarity=0.222 Sum_probs=195.6
Q ss_pred cccCHHHHHHHhcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccce
Q 019905 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNL 121 (334)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~ 121 (334)
+.....++...+.+ |.+++.||+|+||.||++.. .+++.||+|++..... ...+.+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~~~~~~~---y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 5 RQELNKTIWEVPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred hhhHHHHHhhccCc---eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 34445556666655 44566679999999999985 4688999999975321 123567789999999999999999
Q ss_pred eeeeeeC------CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 122 LGCCCEG------DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 122 ~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
++++... ...+++++++ +++|.+++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~ 156 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNED 156 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEcCC
Confidence 9988643 3367888887 789988774 346899999999999999999999999 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc------
Q 019905 196 GNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN------ 267 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~------ 267 (334)
+.++|+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 157 CELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred CCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999998765443 23467888999999876 45888999999999999999999887543211110000
Q ss_pred -----ccccc-----------ccccC---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 268 -----LQMLT-----------DSCLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 268 -----~~~~~-----------~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
..... ..... .......++++.+++.+||+.||.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 00000 00011235678999999999999999999999843
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.61 Aligned_cols=254 Identities=19% Similarity=0.181 Sum_probs=211.2
Q ss_pred HHHHHHhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeee
Q 019905 50 EQLKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCC 125 (334)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 125 (334)
..+++..-+-.+|.+++.||+|+||.|.+.+++ +++.+|+|++.... ..+..-|..|-+++..-+.+.|+.++..|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 455666666778889999999999999999965 47899999997532 22345678889999999999999999999
Q ss_pred eeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
.++.++|+||||++||+|...+.. ...+++..+..++..|+.||.-||+.| +|||||||+|||+|..|++||+|||.
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~mg-yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSMG-YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhcc-ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999999974 337999999999999999999999999 99999999999999999999999998
Q ss_pred CccCCC-C----CcccccccccCccccc----C-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccc
Q 019905 206 MKNSRD-G----KSYSTNLAFTPPEYLR----T-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275 (334)
Q Consensus 206 a~~~~~-~----~~~~~~~~y~aPE~~~----~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 275 (334)
+..... + ...+|||.|.+||++. + +.|...+|.||+|+++|||+.|..||+.+..-......+...
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---- 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---- 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence 776653 2 3568999999999994 2 449999999999999999999999999887665554443331
Q ss_pred cCCCCC--chhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 019905 276 LEGQFT--DDDGTELVRLASRCLQYEPRERPN---PKSLVT 311 (334)
Q Consensus 276 ~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~ 311 (334)
-.-.+| ...++++.+||.+.+ -+|..|.. ++++..
T Consensus 298 ~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 298 ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 112233 347789999999988 57888887 777753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=273.47 Aligned_cols=246 Identities=16% Similarity=0.225 Sum_probs=191.5
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCC------e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 130 (334)
..|++++.||+|++|.||++.. .++..||+|.+....... ...+.+|+++++.++|+||+++++++..+. .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 4477788889999999999984 468899999986433221 345778999999999999999999987543 3
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||+|+ +++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~g-i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 689988874 457899999999999999999999999 9999999999999999999999999987654
Q ss_pred CC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (334)
.. ....++..|+|||.+.+ ..++.++|+||||+++|++++|..||..............
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 33 23456789999999876 3488899999999999999999988864322111000000
Q ss_pred ccccccc---C---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 270 MLTDSCL---E---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 270 ~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
....... . .......+.++.+++.+|++.||.+|||+.+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000 0 001123456789999999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=261.59 Aligned_cols=243 Identities=16% Similarity=0.217 Sum_probs=191.9
Q ss_pred ccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCC-----CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW-----PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
|.+.+.+|+|+||.||++.... +..+++|.++.... .....+..|+.+++.++||||+++++++......++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5667788999999999998643 34455565543221 12335667899999999999999999999888899999
Q ss_pred ecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 136 EYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||.+......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-ccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999999988753 13457899999999999999999999999 999999999999975 56999999988754332
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....++..|+|||.+.+..++.++|+||||+++|++++|..|+.............. ......+...+.++.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 234 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-----GPTPSLPETYSRQLN 234 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-----CCCCCCcchhcHHHH
Confidence 234567889999999888889999999999999999999988865433222211111 111123445567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+++.+||+.+|++||++.++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhh
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=269.72 Aligned_cols=245 Identities=18% Similarity=0.244 Sum_probs=186.2
Q ss_pred ccccccCCCcCccEEEEEEeC-C--CCEEEEEEecCCCC--CChHHHHHHHHHHhcC-CCCCccceeeeeeeC----Cee
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-N--QRRIAVKRFNRMAW--PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG----DER 131 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~ 131 (334)
|++.+.||+|+||.||++... . +..||+|.+..... ...+.+.+|+++++++ +|+||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 556677899999999999954 3 67999999864321 1245677899999999 599999999875432 347
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
+++++|+. ++|.+.+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN-VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 88899985 78988885 4567899999999999999999999999 99999999999999999999999999875432
Q ss_pred C--------CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-----------cc
Q 019905 212 G--------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-----------ML 271 (334)
Q Consensus 212 ~--------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~-----------~~ 271 (334)
. ....++..|+|||.+.+ ..++.++||||||+++|++++|..||.............. .+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 1 12357889999998865 4589999999999999999999987754321111000000 00
Q ss_pred -----------ccc---ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 272 -----------TDS---CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 272 -----------~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
... ..........+..+.+++.+||+.||.+|||+.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 000011122356899999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=274.84 Aligned_cols=247 Identities=19% Similarity=0.262 Sum_probs=192.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCe------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE------ 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 130 (334)
..|++++.||+|++|.||+|... ++..||+|.+.... ......+.+|+.+++.++|+|++++.+++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 45777888899999999999964 57899999986432 1223557789999999999999999998765544
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++++||+ +++|.+++. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+....
T Consensus 95 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 95 VYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 579999884 357999999999999999999999999 9999999999999999999999999987654
Q ss_pred CC-CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc-----------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML----------------- 271 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------------- 271 (334)
.. ....++..|+|||.+.+. .++.++||||||+++|++++|+.||................
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 32 344567889999998653 57889999999999999999998886443221111100000
Q ss_pred --ccc---ccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 --TDS---CLEG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 --~~~---~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... .... ......+..+.+++.+||+.||.+|||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000 001123568999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=288.39 Aligned_cols=146 Identities=23% Similarity=0.284 Sum_probs=129.7
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
+..|.++++||+|+||.||+|... +++.||||++....... ...+..|+.++..++|+||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 456888899999999999999965 57899999997543222 25678899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
|||+++++|.+++. ....+++..++.++.||+.||.|||.++ |+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~--~~~~l~~~~~~~i~~qil~aL~yLH~~g-IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRHG-IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999986 3456889999999999999999999998 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=281.98 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=209.1
Q ss_pred ccccccCCCcCccEEEEEEe-CC----CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-EN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.+..++||.|+||+||+|.| .. ..+||||++...... .-.++..|+-++.+++|||+++++++|.... .-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457789999999999985 33 357899999765433 3467899999999999999999999998754 77999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 215 (334)
+|+++|+|.++++. ....+..+..+.|..||++||.|||.++ ++||||-.+|||+.+-..+|+.|||+++...+....
T Consensus 777 q~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qr-lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQR-LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcc-hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999987 6678899999999999999999999998 999999999999999999999999999876654321
Q ss_pred ------cccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 216 ------STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 216 ------~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...+.|||-|.+....|+.++||||||+++||++| |..|+.....+.+.+ +.....+-..|+..+.++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-----lle~geRLsqPpiCtiDV 929 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-----LLEKGERLSQPPICTIDV 929 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-----HHhccccCCCCCCccHHH
Confidence 23467999999999999999999999999999998 667776655554432 233333345677788899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.++.+||-.|+..||+++++...+..+.+.
T Consensus 930 y~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 9999999999999999999999998777653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=277.65 Aligned_cols=192 Identities=24% Similarity=0.308 Sum_probs=166.7
Q ss_pred ccCCCcCccEEEEEE-eCCCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCC------eeeEEEec
Q 019905 66 SEHGEKAPNVVYKGK-LENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ERLLVAEY 137 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~ 137 (334)
+.||+|+||.||+|+ ..+|+.||||.++... ....+..-+|++++++++|+|||+++++=.+.. ...++|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 456999999999999 4569999999998644 334567788999999999999999999865433 46899999
Q ss_pred CCCCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec--CCC--CeeEcCCCCCccCCCC
Q 019905 138 MPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDG--NPRLSTFGLMKNSRDG 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~--~~~--~~kl~Dfg~a~~~~~~ 212 (334)
|++|+|...+..+. ...+++.+++.++..++.||.|||+++ |+||||||.||++- ++| .-||+|||.|+...++
T Consensus 99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~-IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG-IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 99999999998653 468999999999999999999999999 99999999999984 334 3699999999987775
Q ss_pred C---cccccccccCccccc-CCCCCCccchhhhHHHHHHHHhCCCCCCch
Q 019905 213 K---SYSTNLAFTPPEYLR-TGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (334)
Q Consensus 213 ~---~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~elltg~~p~~~~ 258 (334)
. +..||..|.+||++. ...|+..+|.||||+++|+++||..||.+.
T Consensus 178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 4 568999999999998 477999999999999999999999998654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=254.76 Aligned_cols=219 Identities=19% Similarity=0.226 Sum_probs=176.3
Q ss_pred cCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcc
Q 019905 71 KAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFH 149 (334)
Q Consensus 71 G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 149 (334)
|.+|.||++.. .+++.+|+|.+.... ...+|...+....||||+++++++......+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 78899999995 457899999996543 233455555566799999999999999999999999999999998863
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-CcccccccccCccccc
Q 019905 150 WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLR 228 (334)
Q Consensus 150 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~ 228 (334)
...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++++|||.+...... ....++..|+|||.+.
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHREG-IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence 346899999999999999999999999 999999999999999999999999987654332 2334567799999998
Q ss_pred CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHH
Q 019905 229 TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307 (334)
Q Consensus 229 ~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 307 (334)
+..++.++|+||+|+++|++++|..|+....... . .......+...+..+.+++.+||+.||++||++.
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSGI-N---------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-c---------cccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 8889999999999999999999987654321110 0 0001123344567899999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=254.98 Aligned_cols=245 Identities=18% Similarity=0.228 Sum_probs=191.0
Q ss_pred ccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 64 IVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
-++.+|.|+||+|++-.+ ++|+..|||++..... ....++..|.+...+- +.||||+++|.+-.++..|+.||.++
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 356779999999999885 4689999999986653 3345688888765554 79999999999999999999999996
Q ss_pred CCHHHhhc---ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC---CCc
Q 019905 141 ETLAKHLF---HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---GKS 214 (334)
Q Consensus 141 ~sL~~~l~---~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---~~~ 214 (334)
.||+.+.. .-....++++.+-+|..-.+.||.||...-+|+|||+||+|||++..|.+||||||++-...+ ...
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence 78876543 223456888888999999999999998776699999999999999999999999999765433 234
Q ss_pred ccccccccCcccccC--CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCC---CchhHHHHH
Q 019905 215 YSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF---TDDDGTELV 289 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 289 (334)
..|-..|||||-+.. ..|+.+|||||||++++|+.||+.|+..+.. +.+............-.. ....+..+.
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~ 304 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSMV 304 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcccccccCHHHH
Confidence 567789999999953 3489999999999999999999977765432 222221111111111111 223567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.-|+.+|-..||.+.++++
T Consensus 305 ~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 305 RFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHhhcccccCcchhhhhc
Confidence 9999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=260.51 Aligned_cols=249 Identities=15% Similarity=0.159 Sum_probs=195.0
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-C-C----CccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-N-N----RLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~iv~~~~~~~~~~~~~ 132 (334)
..|.+++.+|+|+||.|-.+..+ .+..||||+++... .-.+...-|++.|.++. + | .++.+.++|...++.+
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 34778888899999999999854 46899999997543 12344567899999993 2 2 3788889999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC------------------
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE------------------ 194 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~------------------ 194 (334)
||+|.+ |.|+.+++..++-.+++...++.+++|++.++++||+.+ ++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k-l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK-LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc-eeecCCChheEEEeccceEEEeccCCccceecc
Confidence 999999 679999998877889999999999999999999999999 999999999999832
Q ss_pred --CCCeeEcCCCCCccCCCC-CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh-------hHHhh
Q 019905 195 --DGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-------LDLIR 264 (334)
Q Consensus 195 --~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~-------~~~~~ 264 (334)
+..++|.|||.|...+.. ...+.|..|+|||++.+-.++..+||||+||+|+|+++|...|.... .+.+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl 325 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL 325 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence 335899999999876654 45677999999999999999999999999999999999998775432 11111
Q ss_pred hccccccc------------ccccC---------------------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 265 DRNLQMLT------------DSCLE---------------------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 265 ~~~~~~~~------------~~~~~---------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+....... ...+. ....+....++.+|+.+||.+||.+|+|+.|+|+
T Consensus 326 Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 326 GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 00000000 00000 0112233457999999999999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=275.66 Aligned_cols=255 Identities=15% Similarity=0.238 Sum_probs=205.7
Q ss_pred CHHHHHHHhcCCCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeee
Q 019905 48 TLEQLKNATSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCC 125 (334)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 125 (334)
.++.+...+.-|..+ ..+|.|.+|.||+++ .+++..+|+|...... +..+++..|.++|+.. +|||++.++|+|
T Consensus 10 ~~~~lpdp~d~~ei~---evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 10 DLSSLPDPADIFEII---EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred chhhCCCCCCccEEE---EEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 333333344444444 455999999999999 5668889999887765 3456788899999988 699999999998
Q ss_pred ee-----CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeE
Q 019905 126 CE-----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (334)
Q Consensus 126 ~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl 200 (334)
.. ++++|||||||.+||..|++.......+.|..+..|++.++.||.+||++. ++|||||-.|||++.++.|||
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk-viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK-VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc-eeeecccCceEEEeccCcEEE
Confidence 64 578999999999999999998767788999999999999999999999998 999999999999999999999
Q ss_pred cCCCCCccCCC----CCcccccccccCcccccCC-----CCCCccchhhhHHHHHHHHhCCCCCCch-hhHHhhhccccc
Q 019905 201 STFGLMKNSRD----GKSYSTNLAFTPPEYLRTG-----RVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQM 270 (334)
Q Consensus 201 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~elltg~~p~~~~-~~~~~~~~~~~~ 270 (334)
+|||.+..... ..+..||+.|||||++... .|+..+|+||||++..||..|.+|+..- ... ..+..
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----aLF~I 240 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLI 240 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh----hhccC
Confidence 99999876544 3467889999999999643 3788999999999999999998765321 111 11122
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...+.+....+...++++.++|..||..|-..||++.++++
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 22333333446778899999999999999999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=267.61 Aligned_cols=238 Identities=20% Similarity=0.248 Sum_probs=197.2
Q ss_pred ccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 66 SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
+.||+|-||+||-|++ ++|+.||||++...... ...++.+|+.+|+.++||.||.+-..|.+.+..+.|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 4669999999999995 56999999999765432 34678999999999999999999999999999999999995 66
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccCCCC---Cccc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDG---KSYS 216 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~~~~---~~~~ 216 (334)
..+.+.....+.+++.....++.||+.||.|||.++ |+|.||||+|||+.+ ...+||||||+|+..... +..+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn-IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN-IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc-eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 666665556778999999999999999999999999 999999999999974 457999999999987763 5678
Q ss_pred ccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh--hHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 217 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
||+.|+|||++++..|..+-|+||.|+++|.-++|..||..+. .+.+++.... .+. ..-.+.++.+.+||..
T Consensus 728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yPp-----~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YPP-----NPWSEISPEAIDLINN 801 (888)
T ss_pred CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cCC-----CchhhcCHHHHHHHHH
Confidence 9999999999999999999999999999999999998886542 2222222111 111 1223456789999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
+|+..-..|.|....+.
T Consensus 802 LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHhcchHhhcc
Confidence 99999999999876553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=272.31 Aligned_cols=239 Identities=21% Similarity=0.246 Sum_probs=195.4
Q ss_pred CCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.+..|.....+|.|+|+.|-.+.. .++...++|.+.... .+..+|+.++... +||||+++.+++..+.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356688888999999999988884 567889999996542 2335677666666 7999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee-cCCCCeeEcCCCCCccCCCCC-
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF-DEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili-~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|.+.++-+.+.+. . .+.....+..|+.+|+.|+.|||.+| ++|||+||+|||+ ++.++++|+|||.+.......
T Consensus 396 e~l~g~ell~ri~--~-~~~~~~e~~~w~~~lv~Av~~LH~~g-vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 396 ELLDGGELLRRIR--S-KPEFCSEASQWAAELVSAVDYLHEQG-VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD 471 (612)
T ss_pred hhccccHHHHHHH--h-cchhHHHHHHHHHHHHHHHHHHHhcC-eeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence 9999998888775 2 23333777889999999999999999 9999999999999 588999999999998766652
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-HhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
+..-|..|.|||++....|+.++|+||||+++|+|++|..|+...... .+.. ......+....+..+.+|+
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~--------~i~~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT--------RIQMPKFSECVSDEAKDLL 543 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH--------hhcCCccccccCHHHHHHH
Confidence 334577899999999888999999999999999999999988665443 1111 1111222356677899999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~ 312 (334)
.+||+.||.+||++.++..-
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHhccCChhhCcChhhhccC
Confidence 99999999999999999753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=281.27 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=199.5
Q ss_pred ccCCCcCccEEEEEEeC--------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEE
Q 019905 66 SEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
+.+|+|+||.|++|... ....||+|.++..... ..+.+..|++++..+ .|+||+.++|+|...+..++|.
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 36799999999999842 1457999999865433 356788999999999 6999999999999989999999
Q ss_pred ecCCCCCHHHhhcccC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEc
Q 019905 136 EYMPNETLAKHLFHWE------T--------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLS 201 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~------~--------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~ 201 (334)
||+..|+|.++++... . ..+....++.+++||+.|+.||++.. ++|||+-.+|||+.++..+|++
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-~vHRDLAaRNVLi~~~~~~kIa 460 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-CVHRDLAARNVLITKNKVIKIA 460 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-ccchhhhhhhEEecCCCEEEEc
Confidence 9999999999997522 0 23888999999999999999999998 9999999999999999999999
Q ss_pred CCCCCccCCCCCcc-----c--ccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh--hHHhhhccccccc
Q 019905 202 TFGLMKNSRDGKSY-----S--TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNLQMLT 272 (334)
Q Consensus 202 Dfg~a~~~~~~~~~-----~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~--~~~~~~~~~~~~~ 272 (334)
|||+++...+.... . -...|||||.+....|+.++||||||+++||++|.+.+|+.+. ...+. . ..
T Consensus 461 DFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~----~-~l 535 (609)
T KOG0200|consen 461 DFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL----E-FL 535 (609)
T ss_pred cccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH----H-HH
Confidence 99999854443221 1 1346999999999889999999999999999999776555431 11111 1 22
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
....+...|..++.+++++|..||+.+|++||++.++.+.++.+.
T Consensus 536 ~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 536 KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 222233445666779999999999999999999999999998854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=244.51 Aligned_cols=233 Identities=22% Similarity=0.287 Sum_probs=191.6
Q ss_pred CccEEEEEEeC-CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcc
Q 019905 72 APNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFH 149 (334)
Q Consensus 72 ~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 149 (334)
+||.||+|... +++.+++|.+....... .+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 47899999975 48999999998765444 67889999999999999999999999998899999999998899999863
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---CcccccccccCccc
Q 019905 150 WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEY 226 (334)
Q Consensus 150 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~ 226 (334)
...++...++.++.+++.++.+||+.+ ++|+||+|+||++++++.++++|||.+...... ....++..|++||.
T Consensus 81 --~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 --RGRLSEDEARFYARQILSALEYLHSNG-IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 233889999999999999999999998 999999999999999999999999998866543 34567789999999
Q ss_pred ccCCCCCCccchhhhHHHHHHHHhCCCCCCc-hhhHHhhhcccccccccccCCCCCc-hhHHHHHHHHHHhhhcCCCCCC
Q 019905 227 LRTGRVTPESVIYSFGTLLLDLLSGKHIPPS-HALDLIRDRNLQMLTDSCLEGQFTD-DDGTELVRLASRCLQYEPRERP 304 (334)
Q Consensus 227 ~~~~~~~~~~Di~slG~~l~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rp 304 (334)
+.+..++.++||||||++++++++|..|+.. ............ ......... ..+.++.+++.+||..+|++||
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK----PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----cCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 9888889999999999999999999988765 222222211111 111101111 1456899999999999999999
Q ss_pred CHHHHHH
Q 019905 305 NPKSLVT 311 (334)
Q Consensus 305 s~~~~l~ 311 (334)
++.++++
T Consensus 234 ~~~~~~~ 240 (244)
T smart00220 234 TAEEALQ 240 (244)
T ss_pred CHHHHhh
Confidence 9999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.41 Aligned_cols=242 Identities=17% Similarity=0.198 Sum_probs=205.7
Q ss_pred cCCCcccccccCCCcCccEEEEEEeCCCC-EEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLENQR-RIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..+++.+++..||-|+||.|=+...++.. .+|+|.++.....+ .+.+..|-+++...+.|.||++|-.|.+..+.|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34567788899999999999999876543 48888887554333 456888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
++||-|-||.|+..++ ..+.|+..+...++.-++.|+.|||+++ ||+|||||+|.+++.+|-+||.|||+|+....+
T Consensus 497 mLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~-iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG-IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC-ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999997 6678999999999999999999999999 999999999999999999999999999987765
Q ss_pred C---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 K---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
. +..||+.|.|||++.+...+.++|.||||+++|||++|.+||.....-...+.. ....-.-.+|........
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I----LkGid~i~~Pr~I~k~a~ 649 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI----LKGIDKIEFPRRITKTAT 649 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH----HhhhhhhhcccccchhHH
Confidence 4 467999999999999999999999999999999999999998765433333222 222222244566667899
Q ss_pred HHHHHhhhcCCCCCCC
Q 019905 290 RLASRCLQYEPRERPN 305 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps 305 (334)
+||.++...+|.+|..
T Consensus 650 ~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 650 DLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHhcCcHhhhc
Confidence 9999999999999976
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=246.01 Aligned_cols=250 Identities=19% Similarity=0.266 Sum_probs=190.2
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeC--------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-------- 128 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 128 (334)
+.|..+.++|+|.||.||+|.. ++++.||+|++...+.. -.....+|+.+|..+.|+|++.++.+|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3456667889999999999995 45788998887653322 245678999999999999999999988642
Q ss_pred CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
..+++||.+|+ -+|...+.. ....++..++.+++.++..||.|+|+.. |+|||+|+.|+||+.+|.++|+|||+++.
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k-ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK-ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh-HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 34899999996 678887754 3357899999999999999999999998 99999999999999999999999999864
Q ss_pred CCCC--------CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhh---------------
Q 019905 209 SRDG--------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR--------------- 264 (334)
Q Consensus 209 ~~~~--------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~--------------- 264 (334)
+... ...+.|..|++||.+.|.. |+++.|||+.||++.||+++.+.+.+.......
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 3221 2334588999999998876 999999999999999999999777554222111
Q ss_pred -hcc---------cccccccccC----CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 265 -DRN---------LQMLTDSCLE----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 265 -~~~---------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
+.. ...+.....+ ...|..-..+..+|+.+++..||..|+++.++++-
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000 0000000000 00011112478899999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=253.95 Aligned_cols=238 Identities=19% Similarity=0.268 Sum_probs=198.6
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 133 (334)
..+++.+..||+|+||.|.+|..+ +.+.+|||+++.+..- +.+--..|-.+|... +-|.++++..+|++-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 355677788899999999999854 4678999999765421 222233456666666 47789999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC---
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR--- 210 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~--- 210 (334)
||||++||+|-.+++ .-+.+.++.+..++..|+-||-+||+++ |++||||.+||+++.+|++||+|||+++..-
T Consensus 428 VMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~kg-IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcCC-eeeeeccccceEeccCCceEeeecccccccccCC
Confidence 999999999999887 4467889999999999999999999999 9999999999999999999999999987532
Q ss_pred -CCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 211 -DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 211 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
..++..||+.|+|||.+.-.+|+.++|.||+|+++|||+.|+.||.++..+........ . .-.+|...+.++.
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e----h--nvsyPKslSkEAv 578 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME----H--NVSYPKSLSKEAV 578 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH----c--cCcCcccccHHHH
Confidence 23567899999999999999999999999999999999999999988765554433222 2 2357888899999
Q ss_pred HHHHHhhhcCCCCCCC
Q 019905 290 RLASRCLQYEPRERPN 305 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps 305 (334)
+++...|..+|..|..
T Consensus 579 ~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHhhcCCccccC
Confidence 9999999999999943
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=270.26 Aligned_cols=249 Identities=20% Similarity=0.229 Sum_probs=164.2
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-C----CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeee------ee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-N----QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGC------CC 126 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~ 126 (334)
...+|.+.+.||+|+||.||+|.+. + +..||+|++..... .+....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4567888889999999999999964 3 68999999864321 1111111 1222222222222221 23
Q ss_pred eCCeeeEEEecCCCCCHHHhhcccCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCC
Q 019905 127 EGDERLLVAEYMPNETLAKHLFHWETH------------------PMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188 (334)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~ 188 (334)
.+...++|+||+++++|.+++...... ......+..++.|++.||.|||+++ |+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-IiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-IVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-EEeCcCCHH
Confidence 456789999999999999988532100 0112345679999999999999999 999999999
Q ss_pred CeeecC-CCCeeEcCCCCCccCCC-----CCcccccccccCcccccCCC----------------------CCCccchhh
Q 019905 189 RILFDE-DGNPRLSTFGLMKNSRD-----GKSYSTNLAFTPPEYLRTGR----------------------VTPESVIYS 240 (334)
Q Consensus 189 Nili~~-~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~----------------------~~~~~Di~s 240 (334)
|||++. ++.+||+|||++..... .....+++.|+|||.+.... ++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 67999999999975432 23456788999999764322 334669999
Q ss_pred hHHHHHHHHhCCCCCCchhhHHhh---hcc--ccc---ccccccC------CCCCchhHHHHHHHHHHhhhcCCCCCCCH
Q 019905 241 FGTLLLDLLSGKHIPPSHALDLIR---DRN--LQM---LTDSCLE------GQFTDDDGTELVRLASRCLQYEPRERPNP 306 (334)
Q Consensus 241 lG~~l~elltg~~p~~~~~~~~~~---~~~--~~~---~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 306 (334)
|||++|||+++..++......... ... ... ....... ............+|+.+||+.||.+|||+
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999999977554432111110 000 000 0000000 00011122345689999999999999999
Q ss_pred HHHHH
Q 019905 307 KSLVT 311 (334)
Q Consensus 307 ~~~l~ 311 (334)
.++++
T Consensus 445 ~e~L~ 449 (566)
T PLN03225 445 KAALA 449 (566)
T ss_pred HHHhC
Confidence 99996
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=257.38 Aligned_cols=248 Identities=19% Similarity=0.219 Sum_probs=190.2
Q ss_pred HHHHHhcCCCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeee
Q 019905 51 QLKNATSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCC 126 (334)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~ 126 (334)
-++++.-.-+-+..++.||-|+||.|.++. .++...+|+|.+...+.-. ...++.|-+||...+.+.||+++..|.
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 344454444556678889999999999998 5667889999997654322 234678999999999999999999999
Q ss_pred eCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
+.+.+|+||+|++||++-.+|. .-+-|.+..++.++..+..|+.+.|..| +|||||||+|||||.+|++||.|||++
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkmG-FIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhcc-ceecccCccceEEccCCceeeeecccc
Confidence 9999999999999999999886 3456788888999999999999999999 999999999999999999999999997
Q ss_pred ccCC---------CC-------------------------------------CcccccccccCcccccCCCCCCccchhh
Q 019905 207 KNSR---------DG-------------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYS 240 (334)
Q Consensus 207 ~~~~---------~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~s 240 (334)
.-+. .+ ...+||..|+|||++....|+..+|.||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 5211 00 1336789999999999989999999999
Q ss_pred hHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCC
Q 019905 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304 (334)
Q Consensus 241 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 304 (334)
.|++||||+.|+.||-...-.......+. ....+.-.+....+.++.++|.++. -+++.|.
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 99999999999999865432211111100 1111111223345567777776654 3455564
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.40 Aligned_cols=238 Identities=23% Similarity=0.250 Sum_probs=181.7
Q ss_pred CCcccccccCCCcCccE-EEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNV-VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~-Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
|...+++ |.|+.|+ ||+|... ++.||||++.... ...+.+|+..|+.- +|||||++++.-.+..+.||..|
T Consensus 511 ~~~~eil---G~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEIL---GYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHc---ccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 4444445 6776655 7999984 5899999996533 34567999999988 59999999999988999999999
Q ss_pred cCCCCCHHHhhcccCCCCC---CHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---C--CCeeEcCCCCCcc
Q 019905 137 YMPNETLAKHLFHWETHPM---KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---D--GNPRLSTFGLMKN 208 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~---~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~--~~~kl~Dfg~a~~ 208 (334)
.|. .+|.+++... .... .....+..+.|++.||++||+.+ |+||||||+||||+. + .+++|+|||+++.
T Consensus 584 LC~-~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 584 LCA-CSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK-IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred Hhh-hhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc-cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 995 8999999642 1111 11345778899999999999998 999999999999975 3 4689999999986
Q ss_pred CCCC-------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 209 SRDG-------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 209 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
.... ....||.+|+|||++.+...+.++|||||||++|+.++|+..+++...+...+.......-..+. +
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~---~ 737 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLE---P 737 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeec---c
Confidence 5543 34578999999999999988889999999999999999976666554443222111100000000 1
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
.... ++.+||.+|++++|..||++.++|
T Consensus 738 ~~d~-eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 LPDC-EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred CchH-HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 799999999999999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=238.98 Aligned_cols=243 Identities=18% Similarity=0.267 Sum_probs=198.3
Q ss_pred CCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
+..++++++.||+|+|..|.++.+ ++.+.+|+|+++..- .++..-.+.|-.+..+. +||.+|-+..+|.++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 356788888999999999999985 457889999997533 23344566777777766 7999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC-C
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-D 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~-~ 211 (334)
+|.||++||+|--++. .++.++++.+..+...|+.||.|||+.| |++||+|.+|+|++..|++||.|+|+.+..- +
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg-iiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC-eeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999988886 5678999999999999999999999999 9999999999999999999999999987532 2
Q ss_pred ---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH----HhhhcccccccccccCCCCCchh
Q 019905 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD----LIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
..+..||+.|.|||.+++..|..++|.|+||++++||+.|+.||.--..+ ...+.....+.... -.+|...
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--iriprsl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPRSL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cccccee
Confidence 34678999999999999999999999999999999999999998632211 11222222222222 2345666
Q ss_pred HHHHHHHHHHhhhcCCCCCCC
Q 019905 285 GTELVRLASRCLQYEPRERPN 305 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps 305 (334)
+..+..+++..|.+||.+|..
T Consensus 483 svkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcC
Confidence 667888999999999999953
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=253.91 Aligned_cols=252 Identities=18% Similarity=0.225 Sum_probs=173.8
Q ss_pred CCcccccccCCCcCccEEEEEEe-----------------CCCCEEEEEEecCCCCCChHHH--------------HHHH
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-----------------ENQRRIAVKRFNRMAWPDPRQF--------------LEEA 107 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vaiK~~~~~~~~~~~~~--------------~~e~ 107 (334)
..+|++.++||+|+||+||+|.. ..++.||||++........+.+ ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 34677778889999999999963 2346799999875432222222 3366
Q ss_pred HHHhcCCCCC-----ccceeeeeee--------CCeeeEEEecCCCCCHHHhhcccC----------------------C
Q 019905 108 RSVGQLRNNR-----LTNLLGCCCE--------GDERLLVAEYMPNETLAKHLFHWE----------------------T 152 (334)
Q Consensus 108 ~~l~~l~h~~-----iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~----------------------~ 152 (334)
..+.+++|.+ +++++++|.. .+..++||||+++++|.+++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6667776554 3667777643 346799999999999999885311 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----cccccccccCcccc
Q 019905 153 HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----SYSTNLAFTPPEYL 227 (334)
Q Consensus 153 ~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~y~aPE~~ 227 (334)
..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++....... ...+++.|+|||.+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~-ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12456778899999999999999999 9999999999999999999999999986543321 12336899999998
Q ss_pred cCCC----------------------CCCccchhhhHHHHHHHHhCCCCCCchh--hHH-hh--hcccc---cccccccC
Q 019905 228 RTGR----------------------VTPESVIYSFGTLLLDLLSGKHIPPSHA--LDL-IR--DRNLQ---MLTDSCLE 277 (334)
Q Consensus 228 ~~~~----------------------~~~~~Di~slG~~l~elltg~~p~~~~~--~~~-~~--~~~~~---~~~~~~~~ 277 (334)
.... ...+.||||+||++++|+++..++.... ... .. ..... ........
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5432 1134799999999999999885332210 000 00 00000 00011111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 019905 278 GQFTDDDGTELVRLASRCLQYEP---RERPNPKSLVT 311 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~~l~ 311 (334)
.......+....+|+.++|..+| .+|+|+.++|+
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11223456789999999999866 68999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=221.13 Aligned_cols=201 Identities=17% Similarity=0.209 Sum_probs=165.4
Q ss_pred cccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCC
Q 019905 63 NIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..+..||+|++|.|-+-++ .+|...|+|++...-. ...++..+|+++..+. .+|.+|.++|.....+..++.||.++
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3456779999999877774 5789999999975432 1234567788776554 79999999999988999999999996
Q ss_pred CCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---c
Q 019905 140 NETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---S 214 (334)
Q Consensus 140 ~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~ 214 (334)
.||+.+... ..+...++..+-+|+.++..||.|||++-.++|||+||.||||+.+|+||+||||.+-...+.- .
T Consensus 129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 888877653 2567889999999999999999999998669999999999999999999999999987655432 2
Q ss_pred ccccccccCcccccC----CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh
Q 019905 215 YSTNLAFTPPEYLRT----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR 264 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~ 264 (334)
..|-..|||||.+.. ..|+.++||||||+++.||.+++.|++.+......
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q 261 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ 261 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence 456778999999843 25999999999999999999999998877655443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=243.74 Aligned_cols=247 Identities=22% Similarity=0.286 Sum_probs=190.7
Q ss_pred cccccccCCCcCccEEEEEE-eCCCCEEEEEEecCC-CCCCh------HHHHHHHHHHhcCCCCCccceeeeeeeC-Cee
Q 019905 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRM-AWPDP------RQFLEEARSVGQLRNNRLTNLLGCCCEG-DER 131 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~-~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 131 (334)
.|-++..||+|+|+.||+|. +...++||+|.-... +|.+. +..-+|..+.+.|+||.||+++++|..+ +.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 35566788999999999998 456789999987543 23332 2345789999999999999999999754 568
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CceecccCCCCeeec---CCCCeeEcCCCCCc
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD---EDGNPRLSTFGLMK 207 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dikp~Nili~---~~~~~kl~Dfg~a~ 207 (334)
+-|+|||+|.+|+-++. ..+.+++.++..|+.||+.||.||.... +|||-||||.|||+- .-|.+|+.|||+++
T Consensus 544 CTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 89999999999988886 4567899999999999999999998753 399999999999995 45789999999998
Q ss_pred cCCCC-----------CcccccccccCcccccCC----CCCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhcccccc
Q 019905 208 NSRDG-----------KSYSTNLAFTPPEYLRTG----RVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQML 271 (334)
Q Consensus 208 ~~~~~-----------~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~ 271 (334)
.+.+. ....||+.|++||.+.-+ ..+.++||||+|+++|.++.|+.||-..-. ..+.... ..+
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN-TIl 700 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN-TIL 700 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh-chh
Confidence 76542 234689999999998543 278899999999999999999999864322 2222111 111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
..........+..+.++..||.+||++.-++|....++.
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111122344567899999999999999998877765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=231.48 Aligned_cols=246 Identities=18% Similarity=0.268 Sum_probs=187.0
Q ss_pred ccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCC-----eeeEEE
Q 019905 64 IVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERLLVA 135 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ 135 (334)
.-+-||-|+||.||.... ++|+.||+|++...- ....+.+.+|+..|..++|.|++..+++..... ..|.++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 335669999999999985 568999999986432 223467889999999999999999998875432 357788
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
|.+. .+|...+. +.+.++...+.-+++||+.||.|||+.+ |+||||||.|.|++++..+|+||||+++......
T Consensus 137 ELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~-ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN-ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc-hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 8885 77888776 6788999999999999999999999999 9999999999999999999999999998655433
Q ss_pred ---cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchh----------------hHHhh---hccccc
Q 019905 214 ---SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHA----------------LDLIR---DRNLQM 270 (334)
Q Consensus 214 ---~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~----------------~~~~~---~~~~~~ 270 (334)
..+.|..|+|||.+.|.. |+.+.||||.||++.|++..+..|.... .+..+ ++....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 335578999999999877 9999999999999999998876663210 00000 000000
Q ss_pred cccccc-C------C--CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 019905 271 LTDSCL-E------G--QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 271 ~~~~~~-~------~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L 313 (334)
+..... . . ..+.....+...+..+++.+||..|.+.++++..+
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000000 0 0 01123344677899999999999999999887644
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=244.14 Aligned_cols=196 Identities=18% Similarity=0.188 Sum_probs=165.8
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC------CCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR------NNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~ 132 (334)
..|.+.+..|.|-|++|..|... .|..||||++...... .+.=.+|+++|++|+ --++++++-.|...+++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 35778888899999999999854 3679999999764422 233357999999995 237999999999999999
Q ss_pred EEEecCCCCCHHHhhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-CCeeEcCCCCCccCC
Q 019905 133 LVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSR 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-~~~kl~Dfg~a~~~~ 210 (334)
+|||-+ .-+|.+++... ..-.+....+..++.|++.||..|...+ |+|.||||+|||+++. ..+||||||.|....
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~-vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG-VLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC-eeecccCccceEeccCcceeeeccCccccccc
Confidence 999999 48899988742 3456888899999999999999999999 9999999999999965 568999999987665
Q ss_pred CCC--cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch
Q 019905 211 DGK--SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (334)
Q Consensus 211 ~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~ 258 (334)
... .+..+..|.|||++.|.+|+...|+||+||+||||+||+..|++.
T Consensus 589 eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 589 ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 433 445667899999999999999999999999999999999988765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-31 Score=218.33 Aligned_cols=206 Identities=27% Similarity=0.413 Sum_probs=181.7
Q ss_pred CCCcCccEEEEEEeCC-CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHH
Q 019905 68 HGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 145 (334)
+|+|.+|.||++...+ ++.+++|.+...... ....+.+|++.++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 5899999999999754 899999999865532 24678899999999999999999999999889999999999999999
Q ss_pred hhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCccCCCC----Cccccccc
Q 019905 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRDG----KSYSTNLA 220 (334)
Q Consensus 146 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~~~~~~----~~~~~~~~ 220 (334)
++... ...++...+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+...... ....+...
T Consensus 81 ~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKEN-EGKLSEDEILRILLQILEGLEYLHSNG-IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 98631 146889999999999999999999998 999999999999998 899999999998765543 33456788
Q ss_pred ccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcC
Q 019905 221 FTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (334)
Q Consensus 221 y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (334)
|++||.+... .++.++|+|++|++++++ ..+.+++.+|++.|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 9999999877 788999999999999999 37999999999999
Q ss_pred CCCCCCHHHHHHH
Q 019905 300 PRERPNPKSLVTA 312 (334)
Q Consensus 300 p~~Rps~~~~l~~ 312 (334)
|.+||++.++++.
T Consensus 202 p~~R~~~~~l~~~ 214 (215)
T cd00180 202 PEKRPSAKEILEH 214 (215)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=250.13 Aligned_cols=248 Identities=18% Similarity=0.196 Sum_probs=204.4
Q ss_pred CCcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
-.+|+++..+|+|++|-||+++ ..+++..|+|.++....++..-+..|+-+++..+|+||+.+++.+......++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3567888888999999999999 456899999999988777778888999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~ 213 (334)
+.+|+|.+..+ -..++++.++...++..++||+|||+.+ -+|||||-.||++++.|.+|++|||.+-.+.. .+
T Consensus 94 cgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g-k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 94 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG-KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred cCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC-cccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 99999999876 5678999999999999999999999999 99999999999999999999999998765443 46
Q ss_pred cccccccccCcccc---cCCCCCCccchhhhHHHHHHHHhCCCCCCch-hhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 214 SYSTNLAFTPPEYL---RTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 214 ~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
...||+.|||||+- +.+.|...+|||++|+...|+---+.|.+.. ......-.. ....++.. ..-+...++.+.
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-kS~~qpp~-lkDk~kws~~fh 248 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-KSGFQPPT-LKDKTKWSEFFH 248 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-ccCCCCCc-ccCCccchHHHH
Confidence 78899999999987 3456999999999999999997766554332 111111111 11111111 112344567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|++.++..+|+.||+++.+|+
T Consensus 249 ~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee
Confidence 9999999999999999988775
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=221.77 Aligned_cols=253 Identities=21% Similarity=0.228 Sum_probs=194.2
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeee-eeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGC-CCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e 136 (334)
+.|++.+.+|+|.||.+-++.++. ...+++|.+.... ...+.|.+|...--.| .|.||+.-+++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 346777888999999999999754 6789999987654 3467899999877777 58899987765 677788999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec--CCCCeeEcCCCCCccCCCCCc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGKS 214 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~--~~~~~kl~Dfg~a~~~~~~~~ 214 (334)
|+|.|+|.+-+ ....+.+.....++.|+++|+.|+|+++ +||||||.+||||. +.-++||||||.....+..-.
T Consensus 103 ~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHskn-lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 103 FAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSKN-LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred cCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhccc-hhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 99999999988 5567889999999999999999999999 99999999999995 455899999999765443322
Q ss_pred -ccccccccCcccccCC---C--CCCccchhhhHHHHHHHHhCCCCCCch--------hhHHhhhcccccccccccCCCC
Q 019905 215 -YSTNLAFTPPEYLRTG---R--VTPESVIYSFGTLLLDLLSGKHIPPSH--------ALDLIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 215 -~~~~~~y~aPE~~~~~---~--~~~~~Di~slG~~l~elltg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 280 (334)
..-+..|.+||++... . ..+.+|+|.||++++.+++|..|+.-. .+..+..+.....++.
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~------ 252 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK------ 252 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh------
Confidence 2234578999987432 2 678999999999999999999887522 2333333332222221
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
....++.+..+..+-+..++++|--..++.+....+..+..+.
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~ 295 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIK 295 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhc
Confidence 2234567889999999999999977777776666555544443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=232.06 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=191.2
Q ss_pred CcccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 134 (334)
..|..+.++|+|.|++||++... .++.||+|.+...+ ....+.+|++.|..+. +.||+++.+++..+++..+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 34777888899999999999842 46899999998755 4567899999999995 89999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCCCCCccC----
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNS---- 209 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~---- 209 (334)
+||+++....+++. .++...+..+++.++.||.++|.+| ||||||||.|+|.+ ..+.-.|.|||+|...
T Consensus 114 lp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G-IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG-IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC-ccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999999884 4778999999999999999999999 99999999999998 5677899999997610
Q ss_pred -------------CC--C-----------------------------CcccccccccCcccccCCC-CCCccchhhhHHH
Q 019905 210 -------------RD--G-----------------------------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTL 244 (334)
Q Consensus 210 -------------~~--~-----------------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~ 244 (334)
.+ + ....||++|.|||++...+ .++++||||.|++
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 0 0235789999999997665 8899999999999
Q ss_pred HHHHHhCCCCCCchhhH--------------Hhh------hc-------c----------cccc-cccccC--------C
Q 019905 245 LLDLLSGKHIPPSHALD--------------LIR------DR-------N----------LQML-TDSCLE--------G 278 (334)
Q Consensus 245 l~elltg~~p~~~~~~~--------------~~~------~~-------~----------~~~~-~~~~~~--------~ 278 (334)
++.++++..||+....+ .++ +. . ...+ ...+.. .
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999988532000 000 00 0 0000 000000 0
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+..+.+|+.+|+..||..|.|++++|.
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111223458999999999999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=222.23 Aligned_cols=243 Identities=18% Similarity=0.243 Sum_probs=185.9
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC--CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC------eee
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM--AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ERL 132 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~ 132 (334)
|.-+..+|.|+- .|-.+.. -.++.||+|++... .....+...+|...+..++|+||++++.+|.-.. ..|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 344455588876 4544442 24789999988543 2444567889999999999999999999986543 368
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+|||++. .+|...+. -.++-.++..+++|++.|+.|||+.+ |+||||||+||+++.++.+|+.|||+|......
T Consensus 98 ~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~-IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 98 LVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG-IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc-eeecccCcccceecchhheeeccchhhcccCcc
Confidence 9999995 88988875 34677889999999999999999999 999999999999999999999999999865443
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH---------------------------
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL--------------------------- 262 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~--------------------------- 262 (334)
...+.|..|.|||++.+..+...+||||+||++.||++|...|++...-.
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 34677889999999999999999999999999999999998776430000
Q ss_pred hhhc------c-cccccccccCC--CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 263 IRDR------N-LQMLTDSCLEG--QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 263 ~~~~------~-~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+... . ...+++..+.. ..++..+..+.+++.+||-.||++|.|++++|.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000 0 01111111111 112234567899999999999999999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=240.42 Aligned_cols=201 Identities=15% Similarity=0.207 Sum_probs=172.8
Q ss_pred HHHhcCCCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCC-----CCC---hHHHHHHHHHHhcCC---CCCccc
Q 019905 53 KNATSGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA-----WPD---PRQFLEEARSVGQLR---NNRLTN 120 (334)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~-----~~~---~~~~~~e~~~l~~l~---h~~iv~ 120 (334)
.....+|++|..++.+|+|+||.|++|.++. ...|+||.+.... |.. ...+..|++||..++ |+||++
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 3455778999999999999999999999654 6789999886433 111 123567999999997 999999
Q ss_pred eeeeeeeCCeeeEEEecCC-CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCee
Q 019905 121 LLGCCCEGDERLLVAEYMP-NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (334)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~k 199 (334)
++++|.+++++||+||... +-+|.+++. ....+++.....|+.|++.|+++||+.+ |+|||||-+|+.++.+|.+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~-ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQG-IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccC-ceecccccccEEEecCCeEE
Confidence 9999999999999999874 457888886 4467899999999999999999999999 99999999999999999999
Q ss_pred EcCCCCCccCCCC--CcccccccccCcccccCCCCCC-ccchhhhHHHHHHHHhCCCCCC
Q 019905 200 LSTFGLMKNSRDG--KSYSTNLAFTPPEYLRTGRVTP-ESVIYSFGTLLLDLLSGKHIPP 256 (334)
Q Consensus 200 l~Dfg~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~elltg~~p~~ 256 (334)
|+|||.+....++ ....||..|.|||++.|..|-- .-|||++|+++|.++....|++
T Consensus 711 lidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999998766554 5788999999999999988754 6899999999999998887765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=227.72 Aligned_cols=131 Identities=17% Similarity=0.186 Sum_probs=110.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-----CC---Cccceeeeeee---
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----NN---RLTNLLGCCCE--- 127 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~---~iv~~~~~~~~--- 127 (334)
..|.++++||.|-|++||++.. .+.+.||+|+.+... .-.+....||.+|++++ |+ .||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 4689999999999999999984 456899999987533 12345667999999883 33 59999999975
Q ss_pred -CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee
Q 019905 128 -GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (334)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili 192 (334)
+.+.++|+|++ |..|..+|....-+.++...+.+|++||+.||.|||.+-.|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 45789999999 78999999876778999999999999999999999987559999999999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=227.40 Aligned_cols=246 Identities=19% Similarity=0.215 Sum_probs=193.6
Q ss_pred ccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeC-CeeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-DERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l 133 (334)
.+....+-+|+||.||.|.|.+ .+.|.+|.++....+ ....+..|.-.+..+.|||+..+.+++..+ ...+.
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 4555566899999999997643 456677877654321 234577888889999999999999998764 56788
Q ss_pred EEecCCCCCHHHhhc-----cc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 134 VAEYMPNETLAKHLF-----HW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 134 v~e~~~~~sL~~~l~-----~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
++.+..-|+|..++. +. ..+.++..++..++.|++.|+.|||+++ ++|.||-.+|.+|++.-++||+|=.+++
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-VIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-cccchhhhhcceehhheeEEeccchhcc
Confidence 999999999999987 21 2356677788899999999999999999 9999999999999999999999988887
Q ss_pred cCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCC-CCCch----hhHHhhhccccccccccc
Q 019905 208 NSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSH----ALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 208 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~-p~~~~----~~~~~~~~~~~~~~~~~~ 276 (334)
...+. ........||+||.+.+..|+.++|+||||+++|||+|-+. |+..- .....+++.
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy--------- 515 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY--------- 515 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc---------
Confidence 65443 23445678999999999999999999999999999998554 44321 222222222
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
+-..|-+++.++..+|..||+.+|++||+++++..-|..+-
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 12234556669999999999999999999999998887654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-29 Score=211.45 Aligned_cols=192 Identities=25% Similarity=0.310 Sum_probs=167.9
Q ss_pred cccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCC
Q 019905 63 NIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
.+...+|.|++|.||++.... ++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 345667999999999999764 889999999866544 466788999999999999999999999888889999999998
Q ss_pred CCHHHhhcccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----Cc
Q 019905 141 ETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----KS 214 (334)
Q Consensus 141 ~sL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~~ 214 (334)
++|.+++.. ... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+...... ..
T Consensus 82 ~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRK--KGGKLSEEEARFYLRQILEALEYLHSLG-IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 899999863 233 889999999999999999999998 999999999999999999999999998766543 34
Q ss_pred ccccccccCcccc-cCCCCCCccchhhhHHHHHHHHhCCCCCCc
Q 019905 215 YSTNLAFTPPEYL-RTGRVTPESVIYSFGTLLLDLLSGKHIPPS 257 (334)
Q Consensus 215 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~elltg~~p~~~ 257 (334)
..++..|++||.+ ....++.++|+|+||++++++++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 5567889999998 566688899999999999999999998865
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=245.13 Aligned_cols=189 Identities=16% Similarity=0.179 Sum_probs=136.6
Q ss_pred CCC-CCccceeeee-------eeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecc
Q 019905 113 LRN-NRLTNLLGCC-------CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184 (334)
Q Consensus 113 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 184 (334)
++| +||++++++| .....+++++|++ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g-IvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQG-IVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCC-eeecc
Confidence 344 4677777766 2234577889988 5799999964 3456899999999999999999999999 99999
Q ss_pred cCCCCeeecC-------------------CCCeeEcCCCCCccCCC--------------------CCcccccccccCcc
Q 019905 185 LNAYRILFDE-------------------DGNPRLSTFGLMKNSRD--------------------GKSYSTNLAFTPPE 225 (334)
Q Consensus 185 ikp~Nili~~-------------------~~~~kl~Dfg~a~~~~~--------------------~~~~~~~~~y~aPE 225 (334)
|||+|||++. ++.+|++|||+++.... .....+|+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999954 44566777776653210 00124677899999
Q ss_pred cccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC
Q 019905 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305 (334)
Q Consensus 226 ~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 305 (334)
++.+..++.++|||||||++|||++|..|+..... ..... ....... .. .........++.+||+.+|.+||+
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~-~~~~~~~----~~-~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSL-RHRVLPP----QI-LLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHH-HHhhcCh----hh-hhcCHHHHHHHHHhCCCChhhCcC
Confidence 99999999999999999999999998866543211 11100 0011110 00 111235678899999999999999
Q ss_pred HHHHHH
Q 019905 306 PKSLVT 311 (334)
Q Consensus 306 ~~~~l~ 311 (334)
+.++++
T Consensus 259 ~~eil~ 264 (793)
T PLN00181 259 MSELLQ 264 (793)
T ss_pred hHHHhh
Confidence 999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=196.51 Aligned_cols=167 Identities=18% Similarity=0.147 Sum_probs=126.7
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCccccccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 220 (334)
|+|.+++.. ....+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+....... ..+++.
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~-------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g~~~ 69 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA-------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRVDPY 69 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcccEeEcCccceee--ccceEeecccc-CCCccc
Confidence 688888864 3467999999999999999999999986 999999999999999 99987654433 367899
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-HhhhcccccccccccC-CCCCchhHH--HHHHHHHHhh
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLE-GQFTDDDGT--ELVRLASRCL 296 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~--~l~~li~~cl 296 (334)
|+|||++.+..++.++||||||+++|||++|+.||...... ................ ...+..... .+.+++.+||
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 99999999999999999999999999999999887543211 1111111111111000 011222333 6999999999
Q ss_pred hcCCCCCCCHHHHHHHhccccc
Q 019905 297 QYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 297 ~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
+.||.+||++.++++.+..+..
T Consensus 150 ~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 150 SRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hcccccccCHHHHHHHHHHHHH
Confidence 9999999999999998866543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=195.97 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=199.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.++..+++.+|.+...|..|+|+|..+. ++.|.+....+.. .+.|..|.-.|+.+.||||..+++.|..+.+..++.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 3566677788899999999999997654 4557776544333 356888999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceec-ccCCCCeeecCCCCeeEcCCCCCccCCCCCc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKS 214 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~-dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 214 (334)
.|++.|+|...+++...--.+..+..+++.+++.|++|||+..+++-| -+++..++||++.+.+++ .+-+++......
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe~g 345 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG 345 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeeccc
Confidence 999999999999865555567788999999999999999998666554 889999999999888764 222222222233
Q ss_pred ccccccccCcccccCCC---CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
..-.+.||+||.++..+ --.++|+|||++++||+.|...||.....-..- .++.-..++..+|+..+..+..|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----mkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----MKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----hhhhhccccccCCCCccHHHHHH
Confidence 33467899999998766 345899999999999999999998654322111 11222234556788888899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
+.-|+..||.+||.+..++-.|++++
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-25 Score=197.66 Aligned_cols=257 Identities=16% Similarity=0.158 Sum_probs=196.2
Q ss_pred cccccccCCCcCccEEEEEEeCCC--CEEEEEEecCCCCCChHHHHHHHHHHhcCCC----CCccceeeee-eeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQ--RRIAVKRFNRMAWPDPRQFLEEARSVGQLRN----NRLTNLLGCC-CEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~l 133 (334)
.|.+.++||+|+||.||++...+. ..+|+|............+..|+.++..+.. .++..+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999996553 4788888876543333367788888888863 5788899988 47778899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-----CCeeEcCCCCCc-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-----GNPRLSTFGLMK- 207 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-----~~~kl~Dfg~a~- 207 (334)
||+.+ |.+|.++......+.++..+...++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G-~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG-FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC-cccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99999 799999875434578999999999999999999999999 9999999999999854 468999999998
Q ss_pred -cCC--------CC----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc
Q 019905 208 -NSR--------DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS 274 (334)
Q Consensus 208 -~~~--------~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 274 (334)
... .. ....||.+|.++....+...+.+.|+||++.++.+++.|..|+............ ......
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~-~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF-EKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH-HHHhhh
Confidence 311 11 1234899999999999999999999999999999999999887443211111100 000110
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
..........+..+.++...+-..+..++|.+..+...|+....+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1110022334457777877877789999999999999987766544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=187.49 Aligned_cols=252 Identities=16% Similarity=0.197 Sum_probs=198.6
Q ss_pred cccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.|++.++||+|+||.++.|+ +-++++||||.-...+ ...++..|...++.|. .++|...+.+...+-+-.+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 36778899999999999998 5578999999876543 4567888999998884 789999999888888889999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-----CCeeEcCCCCCccCCCC-
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-----GNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-----~~~kl~Dfg~a~~~~~~- 212 (334)
|.||.|+.. +..+.|+..+++.++.|++..+.|+|++. +|+|||||+|+||..- ..+.++|||+|+.+.+.
T Consensus 107 -GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~-LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 -GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD-LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred -CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc-eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 799999764 46789999999999999999999999998 9999999999999633 35889999999976543
Q ss_pred ----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc---ccCCC
Q 019905 213 ----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS---CLEGQ 279 (334)
Q Consensus 213 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 279 (334)
+...||.+||+=-...|...+.+-|+-|||-++++++-|..||.+-.....+.. +.++.+. ..-..
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-YeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-YEKIGETKRSTPIEV 262 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-HHHhccccccCCHHH
Confidence 456799999998888888899999999999999999999999876432222211 1111111 11112
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
+....+.++..-+...-..+-.+-|.++-+-..+.++..
T Consensus 263 Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 263 LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 233456678888888878888888998877666655543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=181.88 Aligned_cols=253 Identities=15% Similarity=0.152 Sum_probs=196.5
Q ss_pred CcccccccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|+++++||+|+||-+|+|. ..+|+.||||.-.... ...++..|..+++.|+ ...|..+..+..+..+-.+||+.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 468899999999999999999 6789999999865433 2346778999999997 45788888888888889999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec---CCCCeeEcCCCCCccCCC---
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRD--- 211 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~---~~~~~kl~Dfg~a~~~~~--- 211 (334)
+ |.||.+.... ..+.++..+++-++-|++..+.|+|.++ .+||||||+|+|.. .-..+.|+|||+++...+
T Consensus 93 L-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~-fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 93 L-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN-FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred c-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc-cccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 9 7999998764 5678999999999999999999999999 99999999999986 345689999999986543
Q ss_pred --------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhc--ccccccccccCCCCC
Q 019905 212 --------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR--NLQMLTDSCLEGQFT 281 (334)
Q Consensus 212 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 281 (334)
.....||.+|.+=-...+...+..-|+-|+|.++.++--|..||.+-........ .+....-....+.+.
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLC 249 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHh
Confidence 3456789999987777777789999999999999999999999876422211111 011111111112233
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
...+.++.-.+..|-..--++-|...-+-+.+.-|.
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 445667888888888888888888877766655444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=193.88 Aligned_cols=157 Identities=17% Similarity=0.057 Sum_probs=120.5
Q ss_pred CcccccccCCCcCccEEEEEEeC--CCCEEEEEEecCCCC---C--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMAW---P--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~~~~---~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..|.+.+.||+|+||+||+|.++ ++..+|||++..... . ....+.+|++++.+++|+|++..+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 34666777799999999999864 467789998753311 1 13468899999999999999853322 24579
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccc-CCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL-NAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~di-kp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
+||||+++++|.. +. . .. ...++.+++.+|.|||+++ |+|||| ||+|||++.++.++|+|||++.....
T Consensus 95 LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~g-IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 95 LVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAG-ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCC-CeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 9999999999863 21 1 11 1467899999999999999 999999 99999999999999999999885543
Q ss_pred CC------------cccccccccCcccccC
Q 019905 212 GK------------SYSTNLAFTPPEYLRT 229 (334)
Q Consensus 212 ~~------------~~~~~~~y~aPE~~~~ 229 (334)
.. ...++..|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 21 2345677999998853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-23 Score=182.72 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=192.0
Q ss_pred ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCC-CccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNN-RLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|.++..+|.|+|+.||++... ..+++|.+....... ...+.+|+..+..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 456677899999999999976 789999997655333 56788999999999988 799999999777778999999
Q ss_pred CCCCCHHHhhcccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCC----
Q 019905 138 MPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD---- 211 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~---- 211 (334)
+.++++.+++..... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~-~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG-IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999976653111 26889999999999999999999999 99999999999999888 799999999874432
Q ss_pred ------CCcccccccccCcccccC---CCCCCccchhhhHHHHHHHHhCCCCCCchhh----HHhhhcccccccccccCC
Q 019905 212 ------GKSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNLQMLTDSCLEG 278 (334)
Q Consensus 212 ------~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 278 (334)
.....++..|++||.+.+ ..++...|+|++|++++++++|..|+..... ........... ......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP-TPSLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC-Cccccc
Confidence 245578899999999987 5688999999999999999999988654432 11111111111 100000
Q ss_pred CCC----chhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 279 QFT----DDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 279 ~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
... ......+.+++..++..+|..|.+.......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 1123578899999999999999998877653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=168.89 Aligned_cols=139 Identities=15% Similarity=0.159 Sum_probs=108.7
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh--------------------------HHHHHHHHHHhcCCCCCc
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP--------------------------RQFLEEARSVGQLRNNRL 118 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~--------------------------~~~~~e~~~l~~l~h~~i 118 (334)
.+.||+|++|.||+|...+|+.||+|+++....... .....|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 457799999999999987899999999975432110 122348999999988776
Q ss_pred cceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCceecccCCCCeeecCCCC
Q 019905 119 TNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~i~H~dikp~Nili~~~~~ 197 (334)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.++ |+.+ ++||||||.||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g-iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR-LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEE-CCc
Confidence 44333322 22489999999877655432 345788999999999999999999 6888 99999999999998 478
Q ss_pred eeEcCCCCCccC
Q 019905 198 PRLSTFGLMKNS 209 (334)
Q Consensus 198 ~kl~Dfg~a~~~ 209 (334)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=171.62 Aligned_cols=169 Identities=12% Similarity=0.080 Sum_probs=129.5
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHH---------HHHHHHHHhcCCCCCccceeeeeeeC--
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQ---------FLEEARSVGQLRNNRLTNLLGCCCEG-- 128 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~-- 128 (334)
..|++++.+|.|+||.||+... ++..+|+|.+.+........ +.+|++.+.+++|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 3477777889999999999766 56789999997655333322 57899999999999999998886533
Q ss_pred ------CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcC
Q 019905 129 ------DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLST 202 (334)
Q Consensus 129 ------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~D 202 (334)
+..+++|||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||.||+++.++ ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g-i~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG-MVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC-CccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999987642 222 24569999999999999 99999999999999888 99999
Q ss_pred CCCCccCCCCCcccccccccCcccccCCCCCCccchhhhHHHHHHHH
Q 019905 203 FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249 (334)
Q Consensus 203 fg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 249 (334)
||............ -.+....+..++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~d--------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAKD--------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhHH--------HHHHHhHhcccccccceeEeehHHH
Confidence 99876543221110 0223334667999999999877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-24 Score=201.64 Aligned_cols=243 Identities=17% Similarity=0.130 Sum_probs=176.6
Q ss_pred cccCCCcCccEEEEEEe-CCCCEEEEEEecCC--CCCChH----HHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 65 VSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM--AWPDPR----QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~--~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
...+|.|++|.|+.... ...+..+.|.+... ...... .+..|+.+-..+.|+|++..+..+.+.....-.|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 34558999997777763 22344444443210 111111 255677777888999998888777665555555999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
+++ +|...+. ....+....+-.++.|++.|+.|+|..| +.|||+|++|++++.+|.+|++|||.+....-.
T Consensus 403 ~~~-Dlf~~~~--~~~~~~~~e~~c~fKqL~~Gv~y~h~~G-iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 403 CPY-DLFSLVM--SNGKLTPLEADCFFKQLLRGVKYLHSMG-LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred ccH-HHHHHHh--cccccchhhhhHHHHHHHHHHHHHHhcC-ceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 998 9999885 3346888889999999999999999999 999999999999999999999999987754321
Q ss_pred ---CcccccccccCcccccCCCCCC-ccchhhhHHHHHHHHhCCCCCCchhhHHhh---hcccccccccccCCCCCchhH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTP-ESVIYSFGTLLLDLLSGKHIPPSHALDLIR---DRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....|+..|+|||++.+..|++ ..||||.|+++..|++|+.||-........ ...........-...+....+
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 2456788999999999999887 689999999999999999777433222111 000111111111112234456
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..-..+|.++|+.||..|.|+++|++
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhh
Confidence 67889999999999999999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=199.51 Aligned_cols=244 Identities=17% Similarity=0.181 Sum_probs=176.6
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCC-CCChHHHHHHHHH--HhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA-WPDPRQFLEEARS--VGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
++...+.||++.|=.|.+|++++|. |+||++-... .-..+.+.+.++- ...+++||.+++.-+...+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788899999999999988875 8999986543 3334444443332 4555899999998887777778999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC---CCC-
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR---DGK- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~---~~~- 213 (334)
+. -+|.|.+. .+..+..-+..-|+.|++.||..+|..| |.|||||.+||||+..+.+.|+||...+... +..
T Consensus 103 vk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g-VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG-VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC-ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 95 68999884 2334456677778999999999999999 9999999999999999999999998765321 111
Q ss_pred -------cccccccccCcccccCC----------C-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccc
Q 019905 214 -------SYSTNLAFTPPEYLRTG----------R-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275 (334)
Q Consensus 214 -------~~~~~~~y~aPE~~~~~----------~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 275 (334)
+...-..|.|||-+-.. . .+++.||||+||+++|+++-+.|.+.-..-......-....+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 11223579999987431 2 67889999999999999887555544332222211111111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L 313 (334)
++. +. ...++.++..|++.||..|.|+++.|+.-
T Consensus 259 Le~-Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 259 LEK-IE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHh-Cc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 111 11 12689999999999999999999999873
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-22 Score=162.10 Aligned_cols=141 Identities=15% Similarity=0.193 Sum_probs=110.7
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC---------------------C-----hHHHHHHHHHHhcCCCCCc
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP---------------------D-----PRQFLEEARSVGQLRNNRL 118 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~~i 118 (334)
.+.||+|++|.||+|...+|+.||||.+...... . ......|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4677999999999999778999999999765311 0 0123578899999999987
Q ss_pred cceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCC
Q 019905 119 TNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~ 197 (334)
.....+... ..++||||++++++..... ....++......++.+++.++.++|+ .+ ++||||||.||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g-ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG-LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCChhhEEEE-CCC
Confidence 554444333 2489999998875544322 33467788899999999999999999 88 99999999999999 889
Q ss_pred eeEcCCCCCccCCC
Q 019905 198 PRLSTFGLMKNSRD 211 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~ 211 (334)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-23 Score=185.88 Aligned_cols=224 Identities=18% Similarity=0.202 Sum_probs=186.6
Q ss_pred CCCcCccEEEEEE----eCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecCCC
Q 019905 68 HGEKAPNVVYKGK----LENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 68 lg~G~~g~Vy~~~----~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
+|.|.+|.|++.. .+.+..+|+|.++...... ......|..++...+ ||.++++...+..++..+++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 5899999999775 3457888999887544222 124456788888886 99999999999999999999999999
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCccccccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 220 (334)
|.|...+. ....+.+.....+...++.++..+|+.+ ++|||+|++||+++.+|.+++.|||..+..-..+...||..
T Consensus 82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~-iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG-IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYE 158 (612)
T ss_pred chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH-HHHhcccccceeecccCccccCCchhhhHhHhhhhcccchh
Confidence 99988775 5567788888889999999999999999 99999999999999999999999999887766666689999
Q ss_pred ccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCC
Q 019905 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (334)
Q Consensus 221 y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 300 (334)
|||||++. ....++|.||||++.++|++|..||..+....+.. .....|......+.+++..++..+|
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~----------~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILK----------AELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhh----------hccCCchhhhHHHHHHHHHHHhhCH
Confidence 99999998 56889999999999999999999988733322221 1123466777889999999999999
Q ss_pred CCCCCH
Q 019905 301 RERPNP 306 (334)
Q Consensus 301 ~~Rps~ 306 (334)
..|.-.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 999655
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=171.66 Aligned_cols=229 Identities=20% Similarity=0.192 Sum_probs=147.8
Q ss_pred cccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcCCC----------CCccceeeeee--
Q 019905 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRN----------NRLTNLLGCCC-- 126 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h----------~~iv~~~~~~~-- 126 (334)
...+.||.|+++.||.+.+. +++.+|+|.+...... ..+++.+|.-.+..+.+ -.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34456799999999999964 5899999998654422 23556666655555432 12222222221
Q ss_pred -------eCC--------eeeEEEecCCCCCHHHhhcc---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecccC
Q 019905 127 -------EGD--------ERLLVAEYMPNETLAKHLFH---WETH--PMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN 186 (334)
Q Consensus 127 -------~~~--------~~~lv~e~~~~~sL~~~l~~---~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dik 186 (334)
... +.+++|+-+. ++|.+++.. .... .+....++.+..|+++.+++||..| ++|+||+
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-lVHgdi~ 172 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-LVHGDIK 172 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-EEEST-S
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-eEecccc
Confidence 111 2367888884 888887542 1111 2334556778899999999999999 9999999
Q ss_pred CCCeeecCCCCeeEcCCCCCccCCCCCc-ccccccccCcccccC--------CCCCCccchhhhHHHHHHHHhCCCCCCc
Q 019905 187 AYRILFDEDGNPRLSTFGLMKNSRDGKS-YSTNLAFTPPEYLRT--------GRVTPESVIYSFGTLLLDLLSGKHIPPS 257 (334)
Q Consensus 187 p~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~elltg~~p~~~ 257 (334)
|+|++++.+|.+.|+||+.....+.... ...+..|.|||.... ..++.+.|.|+||+++|.|+++..||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999988766554333 344577999997743 2378899999999999999999988865
Q ss_pred hhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCC
Q 019905 258 HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303 (334)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 303 (334)
......... .-..+. +.++.+..||..+|+.||.+|
T Consensus 253 ~~~~~~~~~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPEW---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSGG---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCccccccc---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 432222211 112344 677799999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=153.84 Aligned_cols=179 Identities=17% Similarity=0.157 Sum_probs=135.8
Q ss_pred ccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh----HHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecC
Q 019905 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP----RQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+...|++|+||+||.+.- .+..++.+.+....+... ..+.+|+++|+++. |+++++++++ +..+++|+|+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 445679999999997765 568888888876554222 24788999999995 5788888886 3468999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccc-CCCCeeecCCCCeeEcCCCCCccCCCCCcc--
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL-NAYRILFDEDGNPRLSTFGLMKNSRDGKSY-- 215 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~di-kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 215 (334)
.|.+|...+. . ....++.|++.+|.++|+.| |+|||| ||.||+++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~---~------~~~~~~~qi~~~L~~lH~~G-IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPP---R------GDLAYFRAARRLLQQLHRCG-VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhh---h------hhHHHHHHHHHHHHHHHHCc-CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9888865432 1 11357789999999999999 999999 799999999999999999999865543211
Q ss_pred ---------------cccccccCcccccCC-CCC-CccchhhhHHHHHHHHhCCCCCCc
Q 019905 216 ---------------STNLAFTPPEYLRTG-RVT-PESVIYSFGTLLLDLLSGKHIPPS 257 (334)
Q Consensus 216 ---------------~~~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~elltg~~p~~~ 257 (334)
..++.|++|+...-. ..+ ...+.++.|.-+|.++|++.+...
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 124566666654322 233 567899999999999999977644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=156.11 Aligned_cols=131 Identities=14% Similarity=0.119 Sum_probs=103.3
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-----CCCCccceeeeeeeCC---e-eeEEEe
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-----RNNRLTNLLGCCCEGD---E-RLLVAE 136 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e 136 (334)
..||+|++|.||. ++.....+||++........+.+.+|+.+++.+ +||||+++++++.++. . +.+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4559999999996 433334479998765444567899999999999 5799999999998863 4 337899
Q ss_pred c--CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCceecccCCCCeeecC----CCCeeEcCCC
Q 019905 137 Y--MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQAL-EYCTSKGRALYHDLNAYRILFDE----DGNPRLSTFG 204 (334)
Q Consensus 137 ~--~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~i~H~dikp~Nili~~----~~~~kl~Dfg 204 (334)
| .++++|.+++.. ..+++. ..++.+++.++ .|||+++ |+||||||+||+++. ++.++|+||+
T Consensus 86 ~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~-IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 86 FDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNR-IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred CCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 9 557999999953 345555 35678888888 9999999 999999999999973 3479999944
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=173.89 Aligned_cols=209 Identities=22% Similarity=0.328 Sum_probs=161.6
Q ss_pred HhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc-eecccCCC
Q 019905 110 VGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA-LYHDLNAY 188 (334)
Q Consensus 110 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i-~H~dikp~ 188 (334)
|+.+.|.|+.+++|.+..+...+.|.+|+..|+|.+.+.. ....+++.-...++++++.||.|||... + .|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccc
Confidence 4678999999999999999999999999999999999975 4567888888999999999999999986 5 99999999
Q ss_pred CeeecCCCCeeEcCCCCCccCCC------CCcccccccccCcccccCCC-------CCCccchhhhHHHHHHHHhCCCCC
Q 019905 189 RILFDEDGNPRLSTFGLMKNSRD------GKSYSTNLAFTPPEYLRTGR-------VTPESVIYSFGTLLLDLLSGKHIP 255 (334)
Q Consensus 189 Nili~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~elltg~~p~ 255 (334)
|.+++....+||.|||+...... ........-|.|||.+++.. .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999765532 11122346799999997642 356799999999999999999988
Q ss_pred CchhhHHhhhcccccccc---cccCCCCC-c-hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 256 PSHALDLIRDRNLQMLTD---SCLEGQFT-D-DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
...............+.+ ...+.... . ...+++..++.+||..+|..||+++.+-..++.+.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 653211111111111111 11111111 1 33447999999999999999999999999998887754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=162.42 Aligned_cols=191 Identities=16% Similarity=0.186 Sum_probs=141.8
Q ss_pred CCCCccceeeeeee---------------------------CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHH
Q 019905 114 RNNRLTNLLGCCCE---------------------------GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLH 166 (334)
Q Consensus 114 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~ 166 (334)
.|||||++.++|.+ +...|+||...+ -+|..++ ..+..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl---~~~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYL---WTRHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHH---hcCCCchHHHHHHHHH
Confidence 59999999987743 123589999886 6899988 4456677777889999
Q ss_pred HHHHHHHHHhCCCceecccCCCCeeec--CC--CCeeEcCCCCCccCCC----------CCcccccccccCcccccCCC-
Q 019905 167 LAQALEYCTSKGRALYHDLNAYRILFD--ED--GNPRLSTFGLMKNSRD----------GKSYSTNLAFTPPEYLRTGR- 231 (334)
Q Consensus 167 i~~~l~~lh~~~~i~H~dikp~Nili~--~~--~~~kl~Dfg~a~~~~~----------~~~~~~~~~y~aPE~~~~~~- 231 (334)
++.|+.|||+++ |.|||+|++|||+. ++ ..+.++|||.+--... .....|.-.-||||+....+
T Consensus 350 lLEav~hL~~hg-vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 350 LLEAVTHLHKHG-VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHcc-chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999 99999999999994 33 3578999997542221 11234566789999986433
Q ss_pred ----C-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCH
Q 019905 232 ----V-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306 (334)
Q Consensus 232 ----~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 306 (334)
. -.++|.|+.|.+.||+++...||+...........+..-.- ...+...++.+.+++...|+.||++|++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL----Palp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL----PALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC----CCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 2 24899999999999999999999874333332222221111 13455666789999999999999999998
Q ss_pred HHHHHHh
Q 019905 307 KSLVTAL 313 (334)
Q Consensus 307 ~~~l~~L 313 (334)
.-+.+.|
T Consensus 505 ~iAANvl 511 (598)
T KOG4158|consen 505 NIAANVL 511 (598)
T ss_pred cHHHhHH
Confidence 7666555
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=177.85 Aligned_cols=240 Identities=17% Similarity=0.139 Sum_probs=173.9
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC---CCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..+.+-+.+|+|+||.||.|...+++.||||.-++.....- .--.+++.+|+ -+.|..+...+...+..++|++
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 34556678899999999999988899999999887663331 11123333333 3456677777777777899999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-------CCCCeeEcCCCCCccC
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-------EDGNPRLSTFGLMKNS 209 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-------~~~~~kl~Dfg~a~~~ 209 (334)
|.+.|||.++++ ..+..++..+..+..|++..+..||..+ |||+||||+|+++. ....++|+|||.+..+
T Consensus 775 y~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~-IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 775 YSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG-IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred ccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc-eecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999999997 6677899999999999999999999999 99999999999994 2345899999988753
Q ss_pred C---CCC---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 210 R---DGK---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 210 ~---~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
. ++. ...+|-.+-.+|...|.++++.+|.|.|+.+++.|+.|+..= ..++....+... ++.-
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~~~~~~~-----~~Ry 919 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSSWMVKTN-----FPRY 919 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcceecccc-----chhh
Confidence 3 332 345678899999999999999999999999999999998210 112221111111 1111
Q ss_pred h-HHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 284 D-GTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 284 ~-~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
. ..-..+++..+|..|-..=|...++...|+...
T Consensus 920 ~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 920 WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 1 123456777777733333376666666665543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.2e-19 Score=147.20 Aligned_cols=134 Identities=18% Similarity=0.230 Sum_probs=111.8
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh--------HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP--------RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+.||+|++|.||+|.+ .+..+++|.......... ..+.+|+.++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4679999999999987 567899998764432211 2466799999999999988877777777788999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
++|++|.+.+.. . .. ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~--~---~~-~~~~i~~~i~~~l~~lH~~~-i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS--N---GM-EELELSREIGRLVGKLHSAG-IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh--c---cH-HHHHHHHHHHHHHHHHHhCC-cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998853 1 12 78899999999999999999 99999999999999 78899999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-19 Score=150.21 Aligned_cols=155 Identities=14% Similarity=0.115 Sum_probs=115.5
Q ss_pred HHHHHHHhcCCCcccccccCCCcCccEEEEEE--eCCCCEEEEEEecCCCCC-------------------C-----hHH
Q 019905 49 LEQLKNATSGFAVENIVSEHGEKAPNVVYKGK--LENQRRIAVKRFNRMAWP-------------------D-----PRQ 102 (334)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vaiK~~~~~~~~-------------------~-----~~~ 102 (334)
..++....+.-..|.+.+.||+|++|.||+|. ..+|..||+|.+...... . ...
T Consensus 17 ~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (237)
T smart00090 17 RLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLW 96 (237)
T ss_pred HHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHH
Confidence 33444444444467788889999999999998 567899999999754311 0 012
Q ss_pred HHHHHHHHhcCCCCC--ccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 019905 103 FLEEARSVGQLRNNR--LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180 (334)
Q Consensus 103 ~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i 180 (334)
+..|+.++.++.+.+ +.++++. ...++||||+++.+|..... ....+.......++.|++.++.+||+.+.+
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~g~i 170 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKEGEL 170 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence 467999999997533 3333332 23589999999888766542 233456666789999999999999998669
Q ss_pred eecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 181 ~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
+||||||+||+++ ++.++|+|||.+....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999876443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=144.17 Aligned_cols=129 Identities=18% Similarity=0.246 Sum_probs=105.4
Q ss_pred CCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--------hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 68 HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
||+|++|.||+|.+ ++..+++|......... ...+.+|++++..++|+++.....++......+++|||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 59999999999996 56789999875433211 1346689999999998876666666666677899999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
|++|.+.+.. . .. .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||.+..
T Consensus 81 g~~l~~~~~~--~-~~------~~~~~i~~~l~~lH~~g-i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEE--G-ND------ELLREIGRLVGKLHKAG-IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhh--c-HH------HHHHHHHHHHHHHHHCC-eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988742 1 11 78999999999999999 99999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=162.28 Aligned_cols=165 Identities=25% Similarity=0.375 Sum_probs=124.8
Q ss_pred eeeEEEecCCCCCHHHhhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 130 ERLLVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
..+|.|+++...+|.+++..+ .....++...+.++.|++.|+.| ++ .+|+|+||.||++..+..+||+|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~-~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG-LIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc-chhhhccccccccccchhhhhhhhhheee
Confidence 478999999999999999632 33456678889999999999999 77 99999999999999999999999999765
Q ss_pred CCCC----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhC-CCCCC-chhhHHhhhccccccccccc
Q 019905 209 SRDG----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-KHIPP-SHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 209 ~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg-~~p~~-~~~~~~~~~~~~~~~~~~~~ 276 (334)
.... ....||..||+||.+.+..|+.++||||||++++|++.- ...+. ..+...++++.+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip------- 478 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIP------- 478 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCC-------
Confidence 4332 356789999999999999999999999999999999972 11111 1111222222111
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHH
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPK 307 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 307 (334)
..+.. .-++-..|+.+++...|.+||++.
T Consensus 479 -~~~~~-d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 479 -PEFLQ-DYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred -hHHhh-cCcHHHHHHHHhcCCCcccCchHH
Confidence 01111 112456799999999999999443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=138.59 Aligned_cols=137 Identities=15% Similarity=0.155 Sum_probs=106.1
Q ss_pred ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC----------------------ChHHHHHHHHHHhcCCCCC--
Q 019905 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP----------------------DPRQFLEEARSVGQLRNNR-- 117 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~-- 117 (334)
|.+.+.||.|+||.||++...+|+.||||++...... ....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5566778999999999999888999999987643210 0112567888888887764
Q ss_pred ccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC
Q 019905 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~ 197 (334)
+...++ ....+++|||+++++|..... ......++.+++.++.++|+.+ ++||||+|.||++++++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~g-i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHG-IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCC-CCcCCCCcccEEEcCCCc
Confidence 333333 234589999999998876542 1345678899999999999999 999999999999999999
Q ss_pred eeEcCCCCCccCCC
Q 019905 198 PRLSTFGLMKNSRD 211 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~ 211 (334)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=166.65 Aligned_cols=204 Identities=19% Similarity=0.211 Sum_probs=144.7
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
++++.|+.+-.|++|.||...++. ...+|+ +++... -+.+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee-------------------
Confidence 456667777999999999998764 567888 443322 11111 33333344333
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC--------
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-------- 210 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~-------- 210 (334)
|+-...+. .-++++... +.++.|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+...
T Consensus 136 --gDc~tllk--~~g~lPvdm--------vla~Eylh~yg-ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 --GDCATLLK--NIGPLPVDM--------VLAVEYLHSYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred --chhhhhcc--cCCCCcchh--------hHHhHhhccCC-eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 33333332 223333322 77899999999 9999999999999999999999999876311
Q ss_pred -----------CCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCC
Q 019905 211 -----------DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (334)
Q Consensus 211 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (334)
..+...||+.|.|||++.-..|...+|.|++|+++|+++.|..||+++..+......+...+. +.+.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~--wpE~ 280 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--WPEE 280 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc--cccc
Confidence 113447899999999999999999999999999999999999999988666554443332221 1111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCH
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNP 306 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~ 306 (334)
....++++.+++.++|+.+|.+|.-.
T Consensus 281 -dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 281 -DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred -CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 34455689999999999999999443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=159.31 Aligned_cols=132 Identities=19% Similarity=0.201 Sum_probs=106.2
Q ss_pred ccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC--------ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP--------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..+.||+|+||.||+|.+.+.. +++|+....... ..+.+.+|++++..++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3466799999999999875543 444433211111 1235778999999999999988877777777789999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ +++.++|+|||++..
T Consensus 416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g-iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG-IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC-CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999998873 35678999999999999999 9999999999999 678999999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-17 Score=128.65 Aligned_cols=132 Identities=15% Similarity=0.044 Sum_probs=110.4
Q ss_pred ccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCC--CCccceeeeeeeCCeeeEEEecCCCC
Q 019905 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN--NRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
+++.+|.|.++.||++...+ ..+++|....... ...+.+|+.+++.+++ .++++++.+...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34667999999999999755 7899999865442 4578899999999976 58888888888778899999999877
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK---GRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
++... +......++.+++.++.++|.. + ++|+|++|.||++++.+.+++.|||.+..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~-i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLV-LCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceE-EEecCCCcceEEEECCcEEEEEecccccC
Confidence 66432 5566778899999999999984 5 99999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=130.13 Aligned_cols=138 Identities=15% Similarity=0.166 Sum_probs=96.7
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh--HH----------------------HHHHHHHHhcCCCCC--c
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP--RQ----------------------FLEEARSVGQLRNNR--L 118 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~~--i 118 (334)
.+.||+|+||.||+|...++..||||++........ .. ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 356799999999999987889999999875432111 11 124555555554332 3
Q ss_pred cceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCC
Q 019905 119 TNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~ 197 (334)
.+.++. ...+++|||++++++..... ..... ......++.+++.++.++|. .+ ++|+||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l--~~~~~-~~~~~~~~~~~~~~l~~lh~~~~-ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRL--KDVRL-LEDPEELYDQILELMRKLYREAG-LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhh--hhhhh-cccHHHHHHHHHHHHHHHhhccC-cCcCCCChhhEEEE-CCc
Confidence 333332 24589999999854322111 00001 15678899999999999999 88 99999999999999 899
Q ss_pred eeEcCCCCCccCCC
Q 019905 198 PRLSTFGLMKNSRD 211 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~ 211 (334)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999865433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-16 Score=131.74 Aligned_cols=133 Identities=19% Similarity=0.188 Sum_probs=100.8
Q ss_pred CC-CcCccEEEEEEeCCCCEEEEEEecCCCC-------------CChHHHHHHHHHHhcCCCCCc--cceeeeeeeC-C-
Q 019905 68 HG-EKAPNVVYKGKLENQRRIAVKRFNRMAW-------------PDPRQFLEEARSVGQLRNNRL--TNLLGCCCEG-D- 129 (334)
Q Consensus 68 lg-~G~~g~Vy~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~-~- 129 (334)
+| .|+.|+||..... +..++||.+..... .....+.+|++++..++|+++ +..+++.... .
T Consensus 39 lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~ 117 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL 117 (239)
T ss_pred eecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence 35 6777889988874 67899998853210 122457789999999998875 6666654332 2
Q ss_pred --eeeEEEecCCC-CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 130 --ERLLVAEYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 130 --~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
..++|||++++ .+|.+++. ...++.. .+.+++.+|.+||+.| |+||||||.|||++.++.++|+|||.+
T Consensus 118 ~~~~~lV~e~l~G~~~L~~~l~---~~~l~~~----~~~~i~~~l~~lH~~G-I~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 118 FYRADILIERIEGARDLVALLQ---EAPLSEE----QWQAIGQLIARFHDAG-VYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ceeeeEEEEecCCCCCHHHHHh---cCCCCHH----HHHHHHHHHHHHHHCC-CCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 23599999997 68988874 2345543 3578999999999999 999999999999998889999999987
Q ss_pred ccC
Q 019905 207 KNS 209 (334)
Q Consensus 207 ~~~ 209 (334)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1e-17 Score=159.13 Aligned_cols=248 Identities=16% Similarity=0.155 Sum_probs=187.6
Q ss_pred CCcccccccCCCcCccEEEEEEe--CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL--ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 133 (334)
...|++++.+|+|+++.|-.... .....+|.|.+.... .........|..+-..+. |.|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45577777789999999987774 335667777776543 222344556777777776 9999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT-SKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~ 211 (334)
..+|..++++.+-+........+......++.|+..++.|+| ..+ +.|+||||+|.++++.+ ..++.|||+|.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~-~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG-VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc-cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999988773223225667778889999999999999 888 99999999999999999 999999999886554
Q ss_pred -C------Ccccc-cccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccccc--CCCC
Q 019905 212 -G------KSYST-NLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL--EGQF 280 (334)
Q Consensus 212 -~------~~~~~-~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 280 (334)
. ....| ++.|+|||...+. ......|+||.|+++..+++|..|+....... ........... ....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGRFTQLP 254 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccccccCc
Confidence 2 13456 8999999999885 46678999999999999999998875432221 11111111111 1122
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
.........+++.+++..+|..|.+.+++.
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCChhhhhcccccccCCchhcccccccc
Confidence 233455788999999999999999988875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-13 Score=127.08 Aligned_cols=139 Identities=19% Similarity=0.204 Sum_probs=94.9
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh--------------------------H--------------HHHH
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP--------------------------R--------------QFLE 105 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~--------------------------~--------------~~~~ 105 (334)
..+|.|++|.||+|++++|+.||||+.++...... . .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 35699999999999999999999999875431100 0 1233
Q ss_pred HHHHHhcC----CCCCccceeeeee-eCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 019905 106 EARSVGQL----RNNRLTNLLGCCC-EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ-ALEYCTSKGR 179 (334)
Q Consensus 106 e~~~l~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~lh~~~~ 179 (334)
|...+.++ .+.+-+.+-.++. ..+..+++|||++|++|.+.... .....+ ...++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~-~~~~~~---~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL-DEAGLD---RKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH-HhcCCC---HHHHHHHHHHHHHHHHHhCC-
Confidence 44444443 2222233323332 23456899999999999887642 111222 3345555555 467889999
Q ss_pred ceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 180 i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
++|+|+||.||+++.++.++++|||++...
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999997554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-13 Score=127.39 Aligned_cols=163 Identities=15% Similarity=0.175 Sum_probs=127.1
Q ss_pred eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHH
Q 019905 81 LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160 (334)
Q Consensus 81 ~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 160 (334)
..++.+|.+..+............+-++.++.++||||+++++.+...+..|+|+|-+ ..|..++.+ +....+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHH
Confidence 4467889998887666433456778889999999999999999999999999999998 577777753 335666
Q ss_pred HHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----cccccccccCcccccCCCCCCcc
Q 019905 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----SYSTNLAFTPPEYLRTGRVTPES 236 (334)
Q Consensus 161 ~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~ 236 (334)
..-++||+.||.|||+.++++|++|.-..|+|++.|..||++|..+....... ...--..|..|+.+.... ...
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 77789999999999976669999999999999999999999998765433222 111123456666543221 457
Q ss_pred chhhhHHHHHHHHhCC
Q 019905 237 VIYSFGTLLLDLLSGK 252 (334)
Q Consensus 237 Di~slG~~l~elltg~ 252 (334)
|.|.||+++++++.|.
T Consensus 185 D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhHHHHHHHHhCcc
Confidence 9999999999999994
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.7e-14 Score=129.64 Aligned_cols=238 Identities=20% Similarity=0.234 Sum_probs=176.1
Q ss_pred ccccCCC--cCccEEEEEEe---CCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEE
Q 019905 64 IVSEHGE--KAPNVVYKGKL---ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 64 ~~~~lg~--G~~g~Vy~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 135 (334)
+...+|. |.+|.+|.+.. .++..+|+|+-+..- ......-.+|+....+++ |++.++.+..+...+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 4456688 99999999985 347788988854322 122233356777777774 999999888888888899999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCceecccCCCCeeecCC-CCeeEcCCCCCccCC
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ----ALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSR 210 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~i~H~dikp~Nili~~~-~~~kl~Dfg~a~~~~ 210 (334)
|++. .+|..+... ....++...++..+.+... ||..+|..+ ++|-|+||.||+...+ ...+++|||+.....
T Consensus 198 E~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~-~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN-IVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred cccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCc-ccccccchhheecccccceeecCCcceeEEcc
Confidence 9994 788887764 3344677788888888888 999999998 9999999999999988 889999999987665
Q ss_pred CCC---------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 211 DGK---------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 211 ~~~---------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
+.. ...+...|++||...+ .++.+.|+|++|.++.+..++..++...-...|....... ....+.
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip~e~~ 348 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IPLEFC 348 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----Cchhhh
Confidence 432 1245678999999864 5788999999999999999998776544222222111111 111222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
...+.++...+..+++.+|-.|++++.+.
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 23334566699999999999999988775
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.5e-14 Score=119.95 Aligned_cols=195 Identities=17% Similarity=0.225 Sum_probs=138.5
Q ss_pred HHHHhcCCCCCccceeeeeeeC-----CeeeEEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 019905 107 ARSVGQLRNNRLTNLLGCCCEG-----DERLLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGR 179 (334)
Q Consensus 107 ~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 179 (334)
.+.|-++.|.||++++.++.+. ....++.||+..|++..+|++. ....+......+|+.||..||.|||+..+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 4566677799999999988653 3478999999999999999753 35667788889999999999999998755
Q ss_pred -ceecccCCCCeeecCCCCeeEcCCCCCccCCC---------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHH
Q 019905 180 -ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249 (334)
Q Consensus 180 -i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 249 (334)
++|+++..+.|++..+|-+|++-- .....+. .....+-++|.+||.=.....+.++|||+||+...+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999998888887532 1111111 11223457899999877667788999999999999998
Q ss_pred hCCCCCC-chhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 250 SGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 250 tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+..-+. .+..-.........+. ......-..++.+|++..|..||++++++-
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~---------~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVII---------GLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhhhee---------eccCccccCcCcccccCCCCCCcchhhhhc
Confidence 8874322 1111111111000000 001112345788999999999999998874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=3e-13 Score=126.49 Aligned_cols=141 Identities=16% Similarity=0.166 Sum_probs=90.4
Q ss_pred CCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCC--------------------------C--------hHH-
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP--------------------------D--------PRQ- 102 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~--------------------------~--------~~~- 102 (334)
|..++. ..+|+|++|.||+|.+++ |+.||||+.++.-.. + .+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445555 567999999999999877 999999999754210 0 011
Q ss_pred -----HHHHHHHHhcCC----CCCccceeeeeee-CCeeeEEEecCCCCCHHHhhcccCCCC-----CCHHHHHHHHHHH
Q 019905 103 -----FLEEARSVGQLR----NNRLTNLLGCCCE-GDERLLVAEYMPNETLAKHLFHWETHP-----MKWAMRLRVVLHL 167 (334)
Q Consensus 103 -----~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~~i~~~i 167 (334)
+.+|...+.++. +.+.+.+-.++.+ ....++||||++|+++.+.... .... +....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHH
Confidence 223333333332 3333333333322 3446799999999999874321 1122 2233333344444
Q ss_pred HHHHHHHHhCCCceecccCCCCeeecCCC----CeeEcCCCCCccC
Q 019905 168 AQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (334)
Q Consensus 168 ~~~l~~lh~~~~i~H~dikp~Nili~~~~----~~kl~Dfg~a~~~ 209 (334)
...| ++|+|+||.||+++.++ .+++.|||++...
T Consensus 277 -------f~~G-ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 -------FRDG-FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -------HhCC-eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 3577 99999999999999887 9999999997544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.6e-13 Score=106.90 Aligned_cols=127 Identities=16% Similarity=0.095 Sum_probs=93.7
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCcc-ceeeeeeeCCeeeEEEecCCCCCHH
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT-NLLGCCCEGDERLLVAEYMPNETLA 144 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~sL~ 144 (334)
+.++.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++... ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 45688999999999875 67899999865432 223467889999888655544 444443 23457999999988775
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----ceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR----ALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 145 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~----i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
... . ....++.+++.+|+.||+.+. ++|+|++|.||+++ ++.++++||+.+.
T Consensus 80 ~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 420 1 113456789999999999871 39999999999999 6689999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.2e-12 Score=101.65 Aligned_cols=136 Identities=11% Similarity=0.158 Sum_probs=96.9
Q ss_pred ccCCCcCccEEEEEEeCC-------CCEEEEEEecCCCC---------------------CC-hHHH----HHHHHHHhc
Q 019905 66 SEHGEKAPNVVYKGKLEN-------QRRIAVKRFNRMAW---------------------PD-PRQF----LEEARSVGQ 112 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~-------~~~vaiK~~~~~~~---------------------~~-~~~~----~~e~~~l~~ 112 (334)
+.+|.|--+.||.|...+ +..+|||..+.... .+ ...+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 566899999999998542 47999998852110 01 1122 379999998
Q ss_pred CCC--CCccceeeeeeeCCeeeEEEecCCCCCHHH-hhcccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCceecccCCC
Q 019905 113 LRN--NRLTNLLGCCCEGDERLLVAEYMPNETLAK-HLFHWETHPMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAY 188 (334)
Q Consensus 113 l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~i~H~dikp~ 188 (334)
+.. -++..++++ ...++||||+.+..+.. .+ ....++......+..+++.+|..+ |+.+ ++|+|+++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g-lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN-LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHH
Confidence 853 345556654 34589999997543321 22 222345556677889999999998 8888 999999999
Q ss_pred CeeecCCCCeeEcCCCCCccCC
Q 019905 189 RILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 189 Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
||++. ++.+.++|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.8e-13 Score=121.45 Aligned_cols=243 Identities=15% Similarity=0.065 Sum_probs=173.7
Q ss_pred CcccccccCCCcCccEEEEEEe--CCCCEEEEEEecCCCCCChHH--HHHHHHHHhcC-CCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL--ENQRRIAVKRFNRMAWPDPRQ--FLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 134 (334)
.++..+.++|.|.|+.|+.... .++..+++|.+.........+ -..|+.+...+ .|.++++....+....+.++=
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 4466777889999999998874 357899999887654333322 23466666666 488888888888777778899
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-CCeeEcCCCCCccCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-~~~kl~Dfg~a~~~~~~- 212 (334)
-||+.++++..... ....+++..++.+..|++.++.++|++. .+|+|++|+||++..+ +..+++|||......-.
T Consensus 345 ~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~-~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL-FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh-hhcccccccceeeccchhhhhccccccccccceec
Confidence 99999888776553 4456778889999999999999999999 9999999999999876 78899999987643221
Q ss_pred Cccccccccc--CcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 KSYSTNLAFT--PPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 ~~~~~~~~y~--aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
......-++. ++.......+-.+.|++|||..+.+.+++........ . +... ..... ........++..
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-~-~~~i-----~~~~~--p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-Q-SLTI-----RSGDT--PNLPGLKLQLQV 492 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-c-ceee-----ecccc--cCCCchHHhhhh
Confidence 1222233444 4555556668889999999999999999985433221 1 1110 00000 111222357888
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 291 LASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
+...+...++..||.+.++....+
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhhhcCCccccchhhhhhcccch
Confidence 889999999999999988765443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.6e-11 Score=105.71 Aligned_cols=214 Identities=19% Similarity=0.168 Sum_probs=153.4
Q ss_pred ccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee----CCeeeEEEecCCC-CCHHHh
Q 019905 73 PNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLLVAEYMPN-ETLAKH 146 (334)
Q Consensus 73 ~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~sL~~~ 146 (334)
..+.|++.. -+|..+++|+++............-++.++++.|+|+|++..++.. +..+++|++|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 346788884 4688999999966554444455667899999999999999999873 4568999999985 466665
Q ss_pred hccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 147 LFHW-------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 147 l~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
.... .+...++..+|.++.|+..||.++|+.| +.-+-+.|.+|+++++.+++++..|.........
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-ceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 4321 1234567899999999999999999999 9999999999999999999999988865443322
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
. +.+. -..+-|.=.||.+++.|.+|...... ......-....+....+.++++++.
T Consensus 448 ~----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~-----------~d~~~~s~~~~I~~~yS~D~rn~v~ 503 (655)
T KOG3741|consen 448 T----------EPLE---SQQQNDLRDLGLLLLALATGTENSNR-----------TDSTQSSHLTRITTTYSTDLRNVVE 503 (655)
T ss_pred C----------cchh---HHhhhhHHHHHHHHHHHhhccccccc-----------ccchHHHHHHHhhhhhhHHHHHHHH
Confidence 0 0111 12367888999999999999632100 0000000011233455668889999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~ 312 (334)
.....++.+ -+..+++..
T Consensus 504 yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 504 YLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHhcCccc-ccHHHHHHH
Confidence 998888887 677776643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.4e-11 Score=94.09 Aligned_cols=130 Identities=19% Similarity=0.212 Sum_probs=97.7
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh--------HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP--------RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.+++|+-+.+|.+.+.+ ..+++|.-.+...... ....+|+.++.++.--.|.-..-+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 34889999999998744 3466665433322221 23557899999887556555555566677778999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
+|..|.+.+... ...++..+-.-+.-||..+ |+|+|+.++||++.+++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g-ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAG-IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC-eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888531 2567778888888999999 99999999999998665 99999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.2e-11 Score=99.96 Aligned_cols=140 Identities=18% Similarity=0.189 Sum_probs=103.0
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCC--CccceeeeeeeC---CeeeEEEecCC
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNN--RLTNLLGCCCEG---DERLLVAEYMP 139 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~ 139 (334)
+.++.|..+.||++...+|+.+++|....... .....+..|++++..+.+. .+.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 34589999999999986668899999865432 1345678999999999753 356677766553 35689999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK------------------------------------------ 177 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~------------------------------------------ 177 (334)
|.++.+.+. ...++......++.+++.+|..||+.
T Consensus 84 G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 888776542 13456666667777777777777631
Q ss_pred -------------CCceecccCCCCeeecC--CCCeeEcCCCCCcc
Q 019905 178 -------------GRALYHDLNAYRILFDE--DGNPRLSTFGLMKN 208 (334)
Q Consensus 178 -------------~~i~H~dikp~Nili~~--~~~~kl~Dfg~a~~ 208 (334)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 11699999999999998 56688999998653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-10 Score=91.30 Aligned_cols=142 Identities=15% Similarity=0.155 Sum_probs=103.7
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--------hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+..+-+|+-+.|+++.+. |+...||.-....... .....+|+.+|.++.--.|.-..-++.+...-.|.||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 344478888899999984 5677777654333222 1346679999998875566555555666666679999
Q ss_pred cCCC-CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC---eeEcCCCCCcc
Q 019905 137 YMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKN 208 (334)
Q Consensus 137 ~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~---~kl~Dfg~a~~ 208 (334)
|+++ .++.+++...............++..|-..+.-||.++ ++|+||..+||++..++. +.+.|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd-iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND-IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC-eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9975 37778776534444445555788999999999999999 999999999999975543 58999999754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.3e-10 Score=98.27 Aligned_cols=248 Identities=16% Similarity=0.162 Sum_probs=157.0
Q ss_pred cccCCCcCccEEEEEE-eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeee------eeeCC-eeeEEE
Q 019905 65 VSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGC------CCEGD-ERLLVA 135 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~~~~~-~~~lv~ 135 (334)
-+.||+|+.+.+|--- .. ..+.|+++........ +.+..|... .||-+-.=+.+ ....+ ...++|
T Consensus 16 gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhh---chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3567999999998543 32 2344777654422222 223334443 56643221111 11122 266888
Q ss_pred ecCCCCC-HHHhhc----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 136 EYMPNET-LAKHLF----HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 136 e~~~~~s-L~~~l~----~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
..+++-. ..++++ ..+....+|.-.++.++.++.+.+-||..| .+-+|++++|+|+++++.|.|.|-.......
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-CcccccCccceeeecCceEEEEcccceeecc
Confidence 8887542 222222 112345778999999999999999999999 8889999999999999999999866544433
Q ss_pred CCC---cccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhC-CCCCCch--------hhH-Hhhhccccccc
Q 019905 211 DGK---SYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSG-KHIPPSH--------ALD-LIRDRNLQMLT 272 (334)
Q Consensus 211 ~~~---~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg-~~p~~~~--------~~~-~~~~~~~~~~~ 272 (334)
++. ..+|...|++||... +..-+...|.|.||+++++++.| ++||.+- ..+ .+..+.+....
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 332 346778999999875 34467789999999999999988 5665431 111 11111111111
Q ss_pred cc------ccCCCCCchhHHHHHHHHHHhhhcC--CCCCCCHHHHHHHhcccccc
Q 019905 273 DS------CLEGQFTDDDGTELVRLASRCLQYE--PRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 273 ~~------~~~~~~~~~~~~~l~~li~~cl~~d--p~~Rps~~~~l~~L~~l~~~ 319 (334)
+. ......-.-.++++..+..+|+... +.-|||++..+..|..+.++
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11 0111112234568889999999763 56899999999888777654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.2e-12 Score=120.31 Aligned_cols=244 Identities=17% Similarity=0.133 Sum_probs=170.4
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++...+++-+-+|.++.++.+.-. .+...++|...... ..+.+....+-.++-...+|.++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455566666788889988887632 34444444433211 1112223333333333455666666555555667899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC---
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR--- 210 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~--- 210 (334)
+++|..+++|...++ +....+..........+.+++.+||... +.|+|++|.|.++..++..++.|||......
T Consensus 882 ~~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~~-r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSSL-RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccch-hhcccccccchhhcccCCcccCcccccccccccc
Confidence 999999999998886 3345666666777888899999999987 8999999999999999999999998422100
Q ss_pred -------C-------------------------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch
Q 019905 211 -------D-------------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (334)
Q Consensus 211 -------~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~ 258 (334)
. .....+|+.|.+||...+......+|.|++|+++++.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 01224678999999999999999999999999999999999988776
Q ss_pred hhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHH
Q 019905 259 ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307 (334)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 307 (334)
.-+.+.+.......... .-+...++.+.+++...+..+|.+|..+.
T Consensus 1039 tpq~~f~ni~~~~~~~p---~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWP---EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhhhccccCCCCCC---CCccccChhhhhhhhhhhccCchhccCcc
Confidence 55555433322222111 12334456889999999999999997765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.4e-10 Score=95.47 Aligned_cols=131 Identities=12% Similarity=0.133 Sum_probs=96.2
Q ss_pred EEEEEEeCCCCEEEEEEecCCCCCC-----------hHHHHHHHHHHhcCCCCCc--cceeeeeee-----CCeeeEEEe
Q 019905 75 VVYKGKLENQRRIAVKRFNRMAWPD-----------PRQFLEEARSVGQLRNNRL--TNLLGCCCE-----GDERLLVAE 136 (334)
Q Consensus 75 ~Vy~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~lv~e 136 (334)
.|.+..+ +|+.+.||......+.. ...+.+|...+.++..-+| ..+.+++.. ....++|+|
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3667666 56789999875443211 1136789888888853333 344445432 234689999
Q ss_pred cCCCC-CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-------CCCeeEcCCCCCc
Q 019905 137 YMPNE-TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-------DGNPRLSTFGLMK 207 (334)
Q Consensus 137 ~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-------~~~~kl~Dfg~a~ 207 (334)
++++. +|.+++..+...+.+......++.+++..+.-||..| ++|+|+++.|||++. +..+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G-i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG-INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc-CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 7988885433445666778899999999999999999 999999999999975 4678999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.1e-10 Score=90.62 Aligned_cols=126 Identities=17% Similarity=0.181 Sum_probs=81.2
Q ss_pred EEEEEEeCCCCEEEEEEecCCCCC----------------------C----hHHHHHHHHHHhcCCCC--Cccceeeeee
Q 019905 75 VVYKGKLENQRRIAVKRFNRMAWP----------------------D----PRQFLEEARSVGQLRNN--RLTNLLGCCC 126 (334)
Q Consensus 75 ~Vy~~~~~~~~~vaiK~~~~~~~~----------------------~----~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 126 (334)
.||.|...++..+|+|........ . .....+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888899999988532111 0 02356799999999755 455565442
Q ss_pred eCCeeeEEEecCC--CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCceecccCCCCeeecCCCCeeEcCC
Q 019905 127 EGDERLLVAEYMP--NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY-CTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (334)
Q Consensus 127 ~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~i~H~dikp~Nili~~~~~~kl~Df 203 (334)
..++||||++ |..+..... ..++......++.+++..+.. +|..| ++|+|+++.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~----~~~~~~~~~~~~~~il~~~~~~~~~~g-ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD----VDLSPEEPKELLEEILEEIIKMLHKAG-IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH----CGGGGSTHHHHHHHHHHHHHHHHHCTT-EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHh----ccccchhHHHHHHHHHHHHHHHHHhcC-ceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 555544332 111133455677777775555 57888 9999999999999987 9999999
Q ss_pred CCCccCC
Q 019905 204 GLMKNSR 210 (334)
Q Consensus 204 g~a~~~~ 210 (334)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.6e-09 Score=88.85 Aligned_cols=151 Identities=17% Similarity=0.151 Sum_probs=107.7
Q ss_pred cCHHHHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC--------------------C--hHHHH
Q 019905 47 FTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP--------------------D--PRQFL 104 (334)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~--------------------~--~~~~~ 104 (334)
++.-.|.....+-..+.+-..||-|--+.||.|...+|..+|||.=...... . .....
T Consensus 78 yD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~ 157 (304)
T COG0478 78 YDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAE 157 (304)
T ss_pred hhHHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHH
Confidence 4444555555555566667788999999999999999999999965322111 1 12356
Q ss_pred HHHHHHhcCCCC--CccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 019905 105 EEARSVGQLRNN--RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182 (334)
Q Consensus 105 ~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H 182 (334)
+|.++|.+|... .+.+.+++- ...+|||+++|..|...- ++......++..|+..+.-+-..| ++|
T Consensus 158 rEf~~L~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G-iVH 225 (304)
T COG0478 158 REFEALQRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG-IVH 225 (304)
T ss_pred HHHHHHHHhhhcCCCCCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC-ccc
Confidence 899999999644 566666653 347999999876654322 233344455566666665555777 999
Q ss_pred cccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 183 HDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 183 ~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
+|+++-||+++++|.+.++||-.+...
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccC
Confidence 999999999999999999999987543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.7e-11 Score=109.13 Aligned_cols=143 Identities=19% Similarity=0.290 Sum_probs=102.0
Q ss_pred HHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCc-------------ccccccccCcccccCCCC
Q 019905 166 HLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-------------YSTNLAFTPPEYLRTGRV 232 (334)
Q Consensus 166 ~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~~y~aPE~~~~~~~ 232 (334)
+++.|+.|+|+...+||++|.|++|.++..+..|++.|+++........ ..-...|.|||++.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 3449999999987799999999999999999999999998765444211 122468999999999888
Q ss_pred CCccchhhhHHHHHHHHhCCCC-CCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 233 TPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 233 ~~~~Di~slG~~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
+.++|+||+|+++|.+..|+.+ +......... .............+....+.++.+=+.+++..++.-||++..++
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchh--hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 9999999999999999955543 2222111111 01111111111223355667899999999999999999665544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.8e-08 Score=81.52 Aligned_cols=136 Identities=14% Similarity=0.095 Sum_probs=100.6
Q ss_pred CCcCccEEEEEEeCCCCEEEEEEecCCC------CCChHHHHHHHHHHhcCCCCC--ccceeeeee-e--C--CeeeEEE
Q 019905 69 GEKAPNVVYKGKLENQRRIAVKRFNRMA------WPDPRQFLEEARSVGQLRNNR--LTNLLGCCC-E--G--DERLLVA 135 (334)
Q Consensus 69 g~G~~g~Vy~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~-~--~--~~~~lv~ 135 (334)
|+|+.+.|+.-...+ ..+-+|+-...- .-....|.+|+..|.++..-+ +.++. ++. . + -..+||+
T Consensus 27 ~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 668888899987744 478889875211 124567999999998885333 33433 222 1 1 2367999
Q ss_pred ecCCC-CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC--eeEcCCCCCc
Q 019905 136 EYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--PRLSTFGLMK 207 (334)
Q Consensus 136 e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~--~kl~Dfg~a~ 207 (334)
|-+++ .+|.+++......+.+......++.+++.+++-||+.| +.|+|+.+.||+++.++. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G-v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN-RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 58888885433445677888899999999999999999 999999999999986666 9999998754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.7e-08 Score=80.87 Aligned_cols=158 Identities=20% Similarity=0.234 Sum_probs=112.4
Q ss_pred cccCHHHHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh-------------------H----
Q 019905 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP-------------------R---- 101 (334)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~-------------------~---- 101 (334)
-..++..+...........+.+.+..|--++||+|...++..+|+|++........ +
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 34677888888888888888888999999999999987889999999964332211 1
Q ss_pred -HHHHHHHHHhcCC--CCCccceeeeeeeCCeeeEEEecCCCCCHH-HhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 019905 102 -QFLEEARSVGQLR--NNRLTNLLGCCCEGDERLLVAEYMPNETLA-KHLFHWETHPMKWAMRLRVVLHLAQALEYCTS- 176 (334)
Q Consensus 102 -~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~-~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~- 176 (334)
-..+|+..|.++. +-.+.+.+++.. ..|||||+.....- =.| +.-++.......+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 1235777777774 334455555442 36999999533110 011 12223333567778888888888876
Q ss_pred CCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 177 KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 177 ~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
.+ +||+||+.-|||+. ++.+.++|||.|....+
T Consensus 186 a~-LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 186 AG-LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cC-cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 56 99999999999999 88999999999875543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.7e-08 Score=82.06 Aligned_cols=106 Identities=22% Similarity=0.260 Sum_probs=82.0
Q ss_pred HHHHHHHHHHhcCCCCC--ccceeeeeeeC----CeeeEEEecCCCC-CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHH
Q 019905 101 RQFLEEARSVGQLRNNR--LTNLLGCCCEG----DERLLVAEYMPNE-TLAKHLFHWETHPMKWAMRLRVVLHLAQALEY 173 (334)
Q Consensus 101 ~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~ 173 (334)
....+|...+..+..-+ ..+.+++.... ...++|+|++++. +|.+++... ...+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--EQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--cccchhhHHHHHHHHHHHHHH
Confidence 45778888877775333 45566665542 2358999999874 788888632 226667788999999999999
Q ss_pred HHhCCCceecccCCCCeeecCCC---CeeEcCCCCCccC
Q 019905 174 CTSKGRALYHDLNAYRILFDEDG---NPRLSTFGLMKNS 209 (334)
Q Consensus 174 lh~~~~i~H~dikp~Nili~~~~---~~kl~Dfg~a~~~ 209 (334)
||..| ++|+|+++.|||++.++ .+.++||+.+...
T Consensus 134 lH~~g-i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAG-IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCc-CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 99999999999999877 7999999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.3e-07 Score=85.71 Aligned_cols=138 Identities=15% Similarity=0.146 Sum_probs=89.3
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh------------------------------H----------HHHHH
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP------------------------------R----------QFLEE 106 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~------------------------------~----------~~~~e 106 (334)
-++.++-|.||+|++++|+.||||+.++.-.... + .+.+|
T Consensus 132 PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E 211 (517)
T COG0661 132 PIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE 211 (517)
T ss_pred chhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence 4478888999999999999999999875432211 0 02234
Q ss_pred HHHHhcCC-----CCCccceeeeee-eCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 019905 107 ARSVGQLR-----NNRLTNLLGCCC-EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180 (334)
Q Consensus 107 ~~~l~~l~-----h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i 180 (334)
...+.+++ .++ +.+-.++. ..+..+++|||++|..+.+.... +...++...+.....+.. +..+-..| +
T Consensus 212 A~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~ia~~~~~~f--~~q~~~dg-f 286 (517)
T COG0661 212 AANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRKELAELLVRAF--LRQLLRDG-F 286 (517)
T ss_pred HHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHHHHHHHHHHHH--HHHHHhcC-c
Confidence 44333331 222 22223332 23456899999999988887532 235566444433333322 22223356 9
Q ss_pred eecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 181 ~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
.|.|.+|-||+++.+|.+.+.|||+....
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999997544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4e-07 Score=71.87 Aligned_cols=129 Identities=17% Similarity=0.184 Sum_probs=91.9
Q ss_pred cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccc-eeeeeeeCCeeeEEEecCCCC
Q 019905 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN-LLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~ 141 (334)
++.+.|++|++|.||+|.+.+ ..+|+|.-..++ ....+..|+++|..+...++.+ ++.+.. -++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 345677999999999999955 589999887655 4568899999999998776654 333322 24669999988
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccC-CCCeeecCCCCeeEcCCCCCcc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN-AYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dik-p~Nili~~~~~~kl~Dfg~a~~ 208 (334)
.|.+.-.. .+..+ ...++..---|-..| |-|+.|+ |...++.+++.+.|+||..|..
T Consensus 98 ~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~G-I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG-----GDRKH----LLRVLEKAYKLDRLG-IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc-----ccHHH----HHHHHHHHHHHHHhc-cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88775531 12233 334444444556677 9999887 5555565566999999998874
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-06 Score=72.49 Aligned_cols=132 Identities=12% Similarity=0.115 Sum_probs=82.1
Q ss_pred cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHH---------HHHHHHHHhcCCCCC---ccceeeeeee---
Q 019905 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQ---------FLEEARSVGQLRNNR---LTNLLGCCCE--- 127 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~---iv~~~~~~~~--- 127 (334)
+.++.+-......|.+-.. +|+.+++|..........+. ..+.+..+.+++..+ ...++.+...
T Consensus 34 ~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~ 112 (229)
T PF06176_consen 34 KIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIF 112 (229)
T ss_pred eEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeec
Confidence 3333334445555666655 45889999887544222222 223444444443222 3333333221
Q ss_pred --CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 128 --GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
....+++|||++|..|.+... +++ .+...+.+++.-+|+.| +.|+|++|.|++++++ .+++.||+.
T Consensus 113 ~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G-~~HGD~hpgNFlv~~~-~i~iID~~~ 180 (229)
T PF06176_consen 113 RYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG-FYHGDPHPGNFLVSNN-GIRIIDTQG 180 (229)
T ss_pred cceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC-CccCCCCcCcEEEECC-cEEEEECcc
Confidence 234568999999988766442 222 24456777889999999 9999999999999855 499999987
Q ss_pred Cc
Q 019905 206 MK 207 (334)
Q Consensus 206 a~ 207 (334)
..
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.4e-06 Score=72.11 Aligned_cols=135 Identities=10% Similarity=0.126 Sum_probs=81.8
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--ccceeeeeeeCCeeeEEEecCCCCC-H
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLLGCCCEGDERLLVAEYMPNET-L 143 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~s-L 143 (334)
.+|.|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++....+...++|++++|.+ +
T Consensus 8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 4599999999984 24467788886533 3456788999998886433 4667777767777889999998753 2
Q ss_pred HHhh---------------------cccCCCCCCHHHHH-HHHH----------HHHHH-HHHHHh---CCCceecccCC
Q 019905 144 AKHL---------------------FHWETHPMKWAMRL-RVVL----------HLAQA-LEYCTS---KGRALYHDLNA 187 (334)
Q Consensus 144 ~~~l---------------------~~~~~~~~~~~~~~-~i~~----------~i~~~-l~~lh~---~~~i~H~dikp 187 (334)
...+ +.-........... .+.. .+... ..+|.. ...++|+|++|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 00000111111110 0100 01111 122221 11278999999
Q ss_pred CCeeecCCCCeeEcCCCCCc
Q 019905 188 YRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 188 ~Nili~~~~~~kl~Dfg~a~ 207 (334)
.||++++++ +.++||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999887 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.1e-06 Score=70.70 Aligned_cols=74 Identities=15% Similarity=0.133 Sum_probs=51.9
Q ss_pred CCcCc-cEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecCCCCCHHHh
Q 019905 69 GEKAP-NVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146 (334)
Q Consensus 69 g~G~~-g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 146 (334)
..|.. +.||+....+ ..+.+|...... ...+.+|+++++.+. +--+.+++++....+..++||++++|.++...
T Consensus 7 ~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 44444 6789987644 678888876543 345678888888874 33455677777666678999999998877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-07 Score=87.31 Aligned_cols=176 Identities=10% Similarity=-0.010 Sum_probs=127.4
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC-ccceeeeeeeCCeeeEEEecCCCC-CHH
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLVAEYMPNE-TLA 144 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-sL~ 144 (334)
.+++|+++.+++.+.-..+....+.+.. .....-++++|.+++||| .+..++.+..+...++.++++..+ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 3467788888887643334444555432 234556899999999999 777778787788899999999766 222
Q ss_pred HhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---Ccccccccc
Q 019905 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLAF 221 (334)
Q Consensus 145 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y 221 (334)
..... ....+.......+.+.-+.+++++|+.. -+|+| ||+..+ +..+++||+.+...... +...++..+
T Consensus 324 ~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~-~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~ 396 (829)
T KOG0576|consen 324 LEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY-KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEP 396 (829)
T ss_pred ccCCh-hhHhhhhhhhhhhhhhhccccccccccc-ccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCC
Confidence 11110 2223444556667778888999999875 58988 777664 68899999987765543 456788999
Q ss_pred cCcccccCCCCCCccchhhhHHHHHHHHhCCCC
Q 019905 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254 (334)
Q Consensus 222 ~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p 254 (334)
+|||+..+..+....|+|++|.-..++.-|-.|
T Consensus 397 ~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 397 LAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 999999999999999999999877777666544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.1e-06 Score=78.27 Aligned_cols=141 Identities=16% Similarity=0.117 Sum_probs=88.1
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh-------------------------------H------HHHHHHHH
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP-------------------------------R------QFLEEARS 109 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~-------------------------------~------~~~~e~~~ 109 (334)
.+|..+.|.||+|+.++|+.||||+-++.-.... + .|.+|.+.
T Consensus 168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N 247 (538)
T KOG1235|consen 168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN 247 (538)
T ss_pred hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence 4588888999999999999999999875442210 0 12234433
Q ss_pred HhcC----CCCC---ccceeeeeee-CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCce
Q 019905 110 VGQL----RNNR---LTNLLGCCCE-GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRAL 181 (334)
Q Consensus 110 l~~l----~h~~---iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~ 181 (334)
..+. .|-+ -|.+-.++.+ ....+|+|||++|..+.|.-.- ....++...+..-+.+... .-+-..| .+
T Consensus 248 ae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf~~G-ff 323 (538)
T KOG1235|consen 248 AERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIFKTG-FF 323 (538)
T ss_pred HHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHHhcC-Cc
Confidence 3332 2333 1112222222 2356899999999877764321 3345665544433333322 2223456 99
Q ss_pred ecccCCCCeeec----CCCCeeEcCCCCCccCCC
Q 019905 182 YHDLNAYRILFD----EDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 182 H~dikp~Nili~----~~~~~kl~Dfg~a~~~~~ 211 (334)
|.|-+|-||+++ .++.+.+.|||+......
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999998 367899999999765543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-05 Score=79.33 Aligned_cols=80 Identities=14% Similarity=0.258 Sum_probs=57.6
Q ss_pred ccccCCCcCccEEEEEEeCCC---CEEEEEEecCCCC-CChHHHHHHHHHHhcCC-CCCc--cceeeeeeeC---CeeeE
Q 019905 64 IVSEHGEKAPNVVYKGKLENQ---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLR-NNRL--TNLLGCCCEG---DERLL 133 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~l 133 (334)
.+..++.|.++.+|+....++ ..+++|+...... .....+.+|+.+++.+. |.++ .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 356779999999999876553 4678887654332 23456889999999995 6664 6677776553 46789
Q ss_pred EEecCCCCCH
Q 019905 134 VAEYMPNETL 143 (334)
Q Consensus 134 v~e~~~~~sL 143 (334)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.7e-06 Score=68.94 Aligned_cols=77 Identities=19% Similarity=0.272 Sum_probs=54.6
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--ccceeeeeee---CCeeeEEEecCCC
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLLGCCCE---GDERLLVAEYMPN 140 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~---~~~~~lv~e~~~~ 140 (334)
+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 455888899999999877 69999998654 23456788888888885332 4556654322 3346899999998
Q ss_pred CCHHH
Q 019905 141 ETLAK 145 (334)
Q Consensus 141 ~sL~~ 145 (334)
.++..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.8e-05 Score=62.07 Aligned_cols=126 Identities=17% Similarity=0.126 Sum_probs=87.7
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCC----------------CCChHHHHHHHHHHhcCC------CCCccceeee
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMA----------------WPDPRQFLEEARSVGQLR------NNRLTNLLGC 124 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 124 (334)
.+|.|+.-.||.- +++....||+..... .....+..+|+.....+. +.+|.+++|+
T Consensus 8 ~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 3489988888765 455668889887655 222355667776665555 7789999999
Q ss_pred eeeCCeeeEEEecCCC------CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC--CC
Q 019905 125 CCEGDERLLVAEYMPN------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE--DG 196 (334)
Q Consensus 125 ~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~--~~ 196 (334)
..++--..+|+|.+.+ .||.+++. ...++. .....+.++ ..||-+++ |+.+|++|.||++.. ++
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L~~f---~~~l~~~~-Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQALDEF---KRYLLDHH-IVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHHHHH---HHHHHHcC-CeecCCCcccEEEEecCCC
Confidence 9998888899997743 36777773 345555 434333433 45777777 999999999999963 22
Q ss_pred --CeeEcC
Q 019905 197 --NPRLST 202 (334)
Q Consensus 197 --~~kl~D 202 (334)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00011 Score=62.56 Aligned_cols=72 Identities=15% Similarity=0.129 Sum_probs=43.1
Q ss_pred cCCCcCcc-EEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCC---CccceeeeeeeC---CeeeEEEecCC
Q 019905 67 EHGEKAPN-VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN---RLTNLLGCCCEG---DERLLVAEYMP 139 (334)
Q Consensus 67 ~lg~G~~g-~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~~ 139 (334)
.++.|+.. .||+. +..+++|...... ....+.+|.+.+..+... -+.++++..... +..+++|++++
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 34655554 58875 2346778754322 345788899998877532 234444433322 23578999999
Q ss_pred CCCHH
Q 019905 140 NETLA 144 (334)
Q Consensus 140 ~~sL~ 144 (334)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.3e-05 Score=63.16 Aligned_cols=100 Identities=21% Similarity=0.285 Sum_probs=77.3
Q ss_pred HHHHHHhcCCC-CCccceeeeeeeCCeeeEEEecCCCCCHHHhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCc
Q 019905 105 EEARSVGQLRN-NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFH-WETHPMKWAMRLRVVLHLAQALEYCTSK--GRA 180 (334)
Q Consensus 105 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i 180 (334)
.|.-++..+++ +++.+++|+|-. +++.||.+.+++...... ..-...+|..+.+++.+++..+.+++.. +.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57778888865 589999999943 689999987665421100 0112468999999999999999999873 226
Q ss_pred eecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 181 LYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 181 ~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
.-.|++++|+-+++++.+|+.|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 6789999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.4e-05 Score=76.11 Aligned_cols=191 Identities=20% Similarity=0.174 Sum_probs=133.4
Q ss_pred HHHHHHHhcCCCCCccceeeeeeeCCe----eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 019905 104 LEEARSVGQLRNNRLTNLLGCCCEGDE----RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179 (334)
Q Consensus 104 ~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 179 (334)
..|...+....|+|++.++.+....-. .....+++...++...+. .-...+....+.+..++..||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 346677888899999999988765322 234567787778877775 4567788889999999999999999986
Q ss_pred ceecccCCC---CeeecCCCCeeEc--CCCCCccCCCCCc---ccccccccCcccccCCCCCC--ccchhhhHHHHHHHH
Q 019905 180 ALYHDLNAY---RILFDEDGNPRLS--TFGLMKNSRDGKS---YSTNLAFTPPEYLRTGRVTP--ESVIYSFGTLLLDLL 249 (334)
Q Consensus 180 i~H~dikp~---Nili~~~~~~kl~--Dfg~a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~--~~Di~slG~~l~ell 249 (334)
+.|.-+... +...+..+.+..+ ||+......+... ..-+..+.+||......++. ..|+|.+|.....+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 666555544 4445556666666 8888776655432 23345678888887666554 479999999999999
Q ss_pred hCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 250 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.|..+..-... +..... ........+...+|+..++++|+++.+++..
T Consensus 387 ~~~~i~~~~~~-----------~~~~l~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 387 QGEDISEKSAV-----------PVSLLD----VLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hcCcccccccc-----------hhhhhc----cccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 88754321110 111111 1111157788899999999999999999854
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00016 Score=59.07 Aligned_cols=125 Identities=18% Similarity=0.269 Sum_probs=86.5
Q ss_pred CcccccccCCCcCc-cEEEEEEeCCCCEEEEEEecCC---CC-------C-----------ChHHHHHHHHHHhcCC---
Q 019905 60 AVENIVSEHGEKAP-NVVYKGKLENQRRIAVKRFNRM---AW-------P-----------DPRQFLEEARSVGQLR--- 114 (334)
Q Consensus 60 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vaiK~~~~~---~~-------~-----------~~~~~~~e~~~l~~l~--- 114 (334)
.+++.++.||.|.. |.||+.... |..+|||.+... .. . ....|..|-....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 66777888899999 999999984 579999993211 10 0 0123667888777774
Q ss_pred CCCc--cceeeeeeeCC------------------eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHH
Q 019905 115 NNRL--TNLLGCCCEGD------------------ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYC 174 (334)
Q Consensus 115 h~~i--v~~~~~~~~~~------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l 174 (334)
+.++ ++.+|+..-.. ...||.||++... .+.... +.+|.+-+..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHH
Confidence 4445 88888874321 1356777765432 222233 45666777889
Q ss_pred HhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 175 TSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 175 h~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~g-I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG-IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC-eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999998 5588999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00025 Score=60.30 Aligned_cols=74 Identities=18% Similarity=0.120 Sum_probs=47.1
Q ss_pred ccCCCcCccEEEEEEeCC--CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC-ccceeeeeeeCCeeeEEEecCCCCC
Q 019905 66 SEHGEKAPNVVYKGKLEN--QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
+.+..|-.+.+|+....+ ++.+++|....... ..-...+|+.++..+...+ ..++++.+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 345778888999988654 57888997654321 1123347888888885333 344444332 248999999876
Q ss_pred HH
Q 019905 143 LA 144 (334)
Q Consensus 143 L~ 144 (334)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 53
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00034 Score=61.68 Aligned_cols=138 Identities=16% Similarity=0.181 Sum_probs=81.2
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--ccceeee------eeeCCeeeEEEe
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLLGC------CCEGDERLLVAE 136 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e 136 (334)
+..+..|..+.+|+....+ ..+++|.... .....+..|+.++..+.+.+ +.+++.. ....+..+.+++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4556778778899987654 4688898764 23455667787777774332 3343331 123455689999
Q ss_pred cCCCCCHHH----hh----------ccc----CC-----CCCCHHHHH----------HHHHHHHHHHHHHHh-------
Q 019905 137 YMPNETLAK----HL----------FHW----ET-----HPMKWAMRL----------RVVLHLAQALEYCTS------- 176 (334)
Q Consensus 137 ~~~~~sL~~----~l----------~~~----~~-----~~~~~~~~~----------~i~~~i~~~l~~lh~------- 176 (334)
+++|.++.. .. +.. .. ....+.... .....+..++.++.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999866532 00 000 00 001111100 011112333444442
Q ss_pred CCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 177 KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 177 ~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.+ ++|+|++|.||++++++.+.|.||+.+.
T Consensus 175 ~~-l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RG-VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred Cc-CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 34 8999999999999988777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00071 Score=60.06 Aligned_cols=158 Identities=13% Similarity=0.181 Sum_probs=88.5
Q ss_pred ccCHHHHHHHhcCCCc--ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--ccce
Q 019905 46 EFTLEQLKNATSGFAV--ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNL 121 (334)
Q Consensus 46 ~~~~~~~~~~~~~~~~--~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~ 121 (334)
..+.+++...-..|.. ...+..++.|..+.+|+...+++ .+++|...... ....+..|++++..|...+ +.++
T Consensus 6 ~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~ 82 (307)
T TIGR00938 6 SVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKP 82 (307)
T ss_pred cCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3455666555444433 33356667787788999876554 57788875422 2345556677776664222 3333
Q ss_pred eeee------eeCCeeeEEEecCCCCCHHH-----------h---hcccCC---CC----C---CHHHHH----------
Q 019905 122 LGCC------CEGDERLLVAEYMPNETLAK-----------H---LFHWET---HP----M---KWAMRL---------- 161 (334)
Q Consensus 122 ~~~~------~~~~~~~lv~e~~~~~sL~~-----------~---l~~~~~---~~----~---~~~~~~---------- 161 (334)
+... ...+..+++++|++|.++.. . ++.... .+ . .|....
T Consensus 83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l 162 (307)
T TIGR00938 83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL 162 (307)
T ss_pred ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence 3311 12456789999998754321 0 110000 00 0 011000
Q ss_pred --HHHHHHHHHHHHHHh-------CCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 162 --RVVLHLAQALEYCTS-------KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 162 --~i~~~i~~~l~~lh~-------~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.....+...+.++.. .+ ++|+|+++.|+++++++.+.|.||+.+.
T Consensus 163 ~~~~~~~l~~~~~~l~~~~~~~~~~~-l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 163 EAHMGAELDKELDYLDKFWPRDLPRG-VIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CHHHHHHHHHHHHHHHhhhhhcCCCc-cCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001122334444532 45 9999999999999988777899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00074 Score=58.25 Aligned_cols=134 Identities=13% Similarity=0.098 Sum_probs=76.0
Q ss_pred CCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-cceeeeeeeCCeeeEEEecCCCCCHHHh
Q 019905 68 HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMPNETLAKH 146 (334)
Q Consensus 68 lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~~~ 146 (334)
+..|-.+.+|+... ++..+++|........-.-...+|..+++.+...++ .+++... . -++|+||++|.++...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 35677788998874 456788887654321111135678888888864333 3344433 2 3689999998765421
Q ss_pred -----------------hccc--CCCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCceecccCCCC
Q 019905 147 -----------------LFHW--ETHPMKWA-MRLRVVLHL---------AQALEYCTS--------KGRALYHDLNAYR 189 (334)
Q Consensus 147 -----------------l~~~--~~~~~~~~-~~~~i~~~i---------~~~l~~lh~--------~~~i~H~dikp~N 189 (334)
++.. ...+++.. .+..+..++ ...+..+.. .. ++|+|+.|.|
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~H~Dl~~~N 157 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA-PLHMDVHAYN 157 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe-eecCCCCcCc
Confidence 1100 01112211 111221111 111222211 13 8999999999
Q ss_pred eeecCCCCeeEcCCCCCcc
Q 019905 190 ILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 190 ili~~~~~~kl~Dfg~a~~ 208 (334)
|++++++ +.+.||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0015 Score=59.63 Aligned_cols=76 Identities=14% Similarity=0.197 Sum_probs=52.7
Q ss_pred cccCCCcCccEEEEEEeCCC-CEEEEEEecCC------CC-CChHHHHHHHHHHhcCC---CCCccceeeeeeeCCeeeE
Q 019905 65 VSEHGEKAPNVVYKGKLENQ-RRIAVKRFNRM------AW-PDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~-~~vaiK~~~~~------~~-~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 133 (334)
++.+|.|.++.||+....+| +.++||.-.+. .+ ...+....|.+.|..+. ...+.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45779999999999998766 48999985422 11 13456677888888763 2346666665 3355789
Q ss_pred EEecCCCCC
Q 019905 134 VAEYMPNET 142 (334)
Q Consensus 134 v~e~~~~~s 142 (334)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0019 Score=57.65 Aligned_cols=158 Identities=11% Similarity=0.103 Sum_probs=84.3
Q ss_pred cccCHHHHHHHhcCCCc--ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--ccc
Q 019905 45 REFTLEQLKNATSGFAV--ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTN 120 (334)
Q Consensus 45 ~~~~~~~~~~~~~~~~~--~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~ 120 (334)
..++.+++......|.. ..-++.++.|..+.+|.....++ .+++|++.. .....+..|+..+..|...+ +.+
T Consensus 5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~ 80 (319)
T PRK05231 5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPA 80 (319)
T ss_pred ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCc
Confidence 34566666655555543 22344556777788999886555 688898752 12334444555555553112 233
Q ss_pred eee------eeeeCCeeeEEEecCCCCCHHH-----------hh---cccCC---------CCCCH-HHHHH--------
Q 019905 121 LLG------CCCEGDERLLVAEYMPNETLAK-----------HL---FHWET---------HPMKW-AMRLR-------- 162 (334)
Q Consensus 121 ~~~------~~~~~~~~~lv~e~~~~~sL~~-----------~l---~~~~~---------~~~~~-~~~~~-------- 162 (334)
++. +....+..+++++|++|..+.. .+ +.... ..+.+ .....
T Consensus 81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (319)
T PRK05231 81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD 160 (319)
T ss_pred ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence 332 1123456789999998764321 11 00000 00111 11110
Q ss_pred ----HHHH-HHHHHHHHH-------hCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 163 ----VVLH-LAQALEYCT-------SKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 163 ----i~~~-i~~~l~~lh-------~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.+.+ +...+..+. ..+ ++|+|++|.||+++++...-+.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~-liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 161 EQAALLEAELAAQLAFLASAAWPALPRG-VIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hHHHHHHHHHHHHHHhhhccccccCCcc-cCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 111122222 135 9999999999999976656899999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0017 Score=57.70 Aligned_cols=154 Identities=16% Similarity=0.158 Sum_probs=102.6
Q ss_pred HHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCC--CCC-------------------hH-----HHHH
Q 019905 52 LKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA--WPD-------------------PR-----QFLE 105 (334)
Q Consensus 52 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--~~~-------------------~~-----~~~~ 105 (334)
+....++-...++-+.|..|--+.||.+.-.+|..+|||+++-.- ..+ .+ ...+
T Consensus 136 Lfrll~RG~i~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEK 215 (520)
T KOG2270|consen 136 LFRLLNRGVIVEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEK 215 (520)
T ss_pred HHHHHhcCeeeecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHH
Confidence 444555555566677788898999999998889999999885211 000 11 1346
Q ss_pred HHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceeccc
Q 019905 106 EARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185 (334)
Q Consensus 106 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~di 185 (334)
|+..|.+++...|.-.--+... ..+|||+++. ++-+-.-. -+.-.++...+..+-.+++.-+.-|.+...+||.||
T Consensus 216 E~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlG-rdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL 291 (520)
T KOG2270|consen 216 EMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLG-RDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADL 291 (520)
T ss_pred HHHHHHHHHhcCCCCCCceeee--cceEeeeecc-CCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence 8888888876665433222222 2479999994 32211110 033456666777777888888887766545999999
Q ss_pred CCCCeeecCCCCeeEcCCCCCccCC
Q 019905 186 NAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 186 kp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
+--|+|+- +|.+.++|-+.+....
T Consensus 292 SEfN~Lyh-dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 292 SEFNLLYH-DGKLYIIDVSQSVEHD 315 (520)
T ss_pred hhhhheEE-CCEEEEEEccccccCC
Confidence 99999986 5689999988765443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0013 Score=58.19 Aligned_cols=73 Identities=21% Similarity=0.285 Sum_probs=47.0
Q ss_pred cCCCcCccEEEEEEeCC-------CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-cceeeeeeeCCeeeEEEecC
Q 019905 67 EHGEKAPNVVYKGKLEN-------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 138 (334)
.+..|-.+.+|+....+ ++.+++|...... .......+|..++..+...++ .++++.+. + .+|++|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 34567777899988654 4788999975543 222345678888887753333 34555543 2 3689999
Q ss_pred CCCCHH
Q 019905 139 PNETLA 144 (334)
Q Consensus 139 ~~~sL~ 144 (334)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00032 Score=61.11 Aligned_cols=153 Identities=14% Similarity=0.133 Sum_probs=105.5
Q ss_pred ccccCHHHHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCC--------------------CCChH--
Q 019905 44 FREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA--------------------WPDPR-- 101 (334)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--------------------~~~~~-- 101 (334)
+.-+.+-.|+...+.-..+.+..++|-|--+-||.+...+|.+.++|.-.... |-...
T Consensus 76 y~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRl 155 (465)
T KOG2268|consen 76 YAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRL 155 (465)
T ss_pred eccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHH
Confidence 34456667777777767778888999999999999999888899888543211 11111
Q ss_pred HHHHHHHHHhcCC-CCC-ccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 019905 102 QFLEEARSVGQLR-NNR-LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179 (334)
Q Consensus 102 ~~~~e~~~l~~l~-h~~-iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 179 (334)
...+|+..++.|. |.. +...+++. ..+.|||++.+-.|...-. -.+.++ +...+..-+.-|-.+|
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~-----v~d~~~---ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH-----VEDPPT---LYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee-----cCChHH---HHHHHHHHHHHHHHcC-
Confidence 2446777777774 332 44455544 3478999998877765331 122333 3344444456677888
Q ss_pred ceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 180 i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
+||+|.+-=||++++++.++++||......
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999875543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0053 Score=56.01 Aligned_cols=81 Identities=16% Similarity=0.114 Sum_probs=52.6
Q ss_pred ccccCCCcCccEEEEEEeCCCCEEEEEEecCCCC-------CChHHHHHHHHHHhcCC---CCCccceeeeeeeCCeeeE
Q 019905 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW-------PDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 133 (334)
.++.+|.|..+.||+.... +..++||.-..... -....-..|.+.|+.+. ...+.+++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3567799999999998764 45788998762211 12333445567666653 246777888776 34678
Q ss_pred EEecCCC--CCHHHhh
Q 019905 134 VAEYMPN--ETLAKHL 147 (334)
Q Consensus 134 v~e~~~~--~sL~~~l 147 (334)
+||++++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 9999975 3444443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0052 Score=55.09 Aligned_cols=72 Identities=14% Similarity=0.077 Sum_probs=46.4
Q ss_pred cCCCcCccEEEEEEeCCC-CEEEEEEecC------CC-CCChHHHHHHHHHHhcCC--CCC-ccceeeeeeeCCeeeEEE
Q 019905 67 EHGEKAPNVVYKGKLENQ-RRIAVKRFNR------MA-WPDPRQFLEEARSVGQLR--NNR-LTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~-~~vaiK~~~~------~~-~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~ 135 (334)
++|.|..+.||++..+++ +.|+||.-.+ .+ .-......-|.+.|+... .|. +.+++.+ ++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 469999999999997654 5899996542 12 122345566777777663 343 4444443 444567999
Q ss_pred ecCCC
Q 019905 136 EYMPN 140 (334)
Q Consensus 136 e~~~~ 140 (334)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0047 Score=54.88 Aligned_cols=103 Identities=17% Similarity=0.115 Sum_probs=71.8
Q ss_pred CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
.+.|++|++. |+++. .+ +.-.+.+...++++-+..++-+..+-+.-|||+.-.||||+ .|++.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3467778876 45543 22 33567889999999999888888876689999999999999 99999999999874
Q ss_pred CCCCCcccccccccCcccccCCCCCCccchhhh
Q 019905 209 SRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSF 241 (334)
Q Consensus 209 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 241 (334)
..+ .......+.--|..+.|.. +..-+||-+
T Consensus 371 ~~~-q~~isy~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 371 SYS-QGIISYNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred ccC-CceeeccccCchhhhcCcc-ceeeeHHHH
Confidence 322 2222222334455555333 666777764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0053 Score=53.56 Aligned_cols=46 Identities=13% Similarity=-0.026 Sum_probs=30.9
Q ss_pred cCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC
Q 019905 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR 114 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~ 114 (334)
..++|....|+.....+|..+++|.-.... ....+.+|..+++.+.
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~~~--~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRRPD--VSERAAAEKRVLALVR 63 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCCHH--HHHHHHHHHHHHHHHH
Confidence 335665566776655567888888875322 2456788999988885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.017 Score=51.11 Aligned_cols=153 Identities=14% Similarity=0.114 Sum_probs=84.7
Q ss_pred cCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecC--CCCCChHHHHHHHHHHhcCCCC--CccceeeeeeeCC--e
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNN--RLTNLLGCCCEGD--E 130 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~--~ 130 (334)
..+....++.....|....+|..... ++.+++. ... ..........+|..+++.+.-- -....++.|..+. .
T Consensus 22 p~~~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~ 99 (321)
T COG3173 22 PGYAGLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGT 99 (321)
T ss_pred cCcCCCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCC
Confidence 44455555656545555556665543 6778888 332 1222234456677777776421 2344566665554 6
Q ss_pred eeEEEecCCCCCHHHhhccc------------------------------CCCCCCHHHHHHHHHH--------------
Q 019905 131 RLLVAEYMPNETLAKHLFHW------------------------------ETHPMKWAMRLRVVLH-------------- 166 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~------------------------------~~~~~~~~~~~~i~~~-------------- 166 (334)
.+.||+|+.|..+.+.+... .........+..+..+
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 79999999873322211100 0000011111111111
Q ss_pred HHHHHHHHHhCCC-------ceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 167 LAQALEYCTSKGR-------ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 167 i~~~l~~lh~~~~-------i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
......+++.+.+ ++|+|+++.|++++.++-+-|.||+.+....+
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 1222345544322 89999999999999888899999999876544
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0073 Score=54.85 Aligned_cols=74 Identities=14% Similarity=0.089 Sum_probs=48.4
Q ss_pred cccCCCcCccEEEEEEeCC-CCEEEEEEecC-----CCC-CChHHHHHHHHHHhcCC--CCC-ccceeeeeeeCCeeeEE
Q 019905 65 VSEHGEKAPNVVYKGKLEN-QRRIAVKRFNR-----MAW-PDPRQFLEEARSVGQLR--NNR-LTNLLGCCCEGDERLLV 134 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~-----~~~-~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv 134 (334)
+..+|.|..+.||++...+ ++.|+||.-.+ .++ -..++..-|.++|+... .|. +.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5678999999999999743 56899986532 121 12455667788887663 443 4445443 34456788
Q ss_pred EecCCC
Q 019905 135 AEYMPN 140 (334)
Q Consensus 135 ~e~~~~ 140 (334)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998853
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.018 Score=50.78 Aligned_cols=105 Identities=10% Similarity=0.018 Sum_probs=72.6
Q ss_pred cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCC---CCccceeeeeee---CCeeeEEEe
Q 019905 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN---NRLTNLLGCCCE---GDERLLVAE 136 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e 136 (334)
.-++.+|.|..+.||.....++ .+++|..+.. .....+..|.+.++.+.. -.+.++++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3445679999999999876555 4666775431 134578899999988853 357778877653 356899999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK 177 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 177 (334)
++++.++.+ . ..+......+..+++++|+-||+.
T Consensus 94 ~i~G~~~~~-~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEA-P------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCC-C------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999887754 1 122334456667778888888874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.014 Score=52.61 Aligned_cols=136 Identities=17% Similarity=0.182 Sum_probs=78.2
Q ss_pred ccCCCcCccEEEEEEeCC-----CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-cceeeeeeeCCeeeEEEecCC
Q 019905 66 SEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~ 139 (334)
..+-.|-...+|+....+ ++.+++|....... ..-...+|..+++.+...++ .++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445567788899987532 36788898755432 21123678888888854333 3456655332 5899998
Q ss_pred CCCHHHh-h----------------cccC--C-C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 019905 140 NETLAKH-L----------------FHWE--T-H-PMKWAMRLRVVLHL-----------------AQALEYC----TS- 176 (334)
Q Consensus 140 ~~sL~~~-l----------------~~~~--~-~-~~~~~~~~~i~~~i-----------------~~~l~~l----h~- 176 (334)
+.++... + +... . . ...+..+..+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 0 0000 0 0 11123333332221 1111111 11
Q ss_pred ---CCCceecccCCCCeeecC-CCCeeEcCCCCCc
Q 019905 177 ---KGRALYHDLNAYRILFDE-DGNPRLSTFGLMK 207 (334)
Q Consensus 177 ---~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~ 207 (334)
.. ++|+|+++.||++++ ++.+.+.||..+.
T Consensus 197 ~~~~~-~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIG-FCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCce-EEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 23 799999999999986 4789999998864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.00044 Score=71.23 Aligned_cols=152 Identities=11% Similarity=-0.053 Sum_probs=106.7
Q ss_pred HHHHHHHHhcCCCCCccceeeeeee--CCeeeEEEecCCCCCHHHhhcccCC--CCCCHHHHHHHHHHH-HHHHHHHHhC
Q 019905 103 FLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVAEYMPNETLAKHLFHWET--HPMKWAMRLRVVLHL-AQALEYCTSK 177 (334)
Q Consensus 103 ~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~~i-~~~l~~lh~~ 177 (334)
...|.+.++...|+++.....=... ....+..++|+.+|.+.+.+..+.. .+++ .......+++ .....-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld-~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD-RSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch-hchHHHHHHHHHhccchhhhc
Confidence 3345556666788887765554332 2346889999999999998875332 2222 2223333443 4555555542
Q ss_pred CC----ceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----cccccccccCcccccCCCCCCccchhhhHHHHHHHH
Q 019905 178 GR----ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249 (334)
Q Consensus 178 ~~----i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 249 (334)
.. .+|+++++.|.+|..+-.++++++|+.+..++.. ...+++.|++|+....-.++.++|+|..|+.+|...
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 11 6899999999999999999999999998544443 345567788888887777888899999999999998
Q ss_pred hCCCCC
Q 019905 250 SGKHIP 255 (334)
Q Consensus 250 tg~~p~ 255 (334)
.|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888655
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.038 Score=48.98 Aligned_cols=27 Identities=15% Similarity=0.159 Sum_probs=24.0
Q ss_pred ceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 180 ALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 180 i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
++|+|+++.||+++. +.+.|.||+.+.
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 899999999999987 678999999753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.02 Score=47.54 Aligned_cols=136 Identities=14% Similarity=0.111 Sum_probs=80.4
Q ss_pred EEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHH
Q 019905 86 RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVV 164 (334)
Q Consensus 86 ~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~ 164 (334)
...+|++...... ...-+..+..++.++. .|+++..- ..-.+.++.|+|-... -.. ..++
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~~----~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------INF----SNFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cch----hHHH
Confidence 4566777654443 4456677888887765 46666632 2334668889884221 111 1122
Q ss_pred HHHHHHHHHHH-hCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccccccccCcccccCCCCCCccchhhhHH
Q 019905 165 LHLAQALEYCT-SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 243 (334)
Q Consensus 165 ~~i~~~l~~lh-~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 243 (334)
..-+.+|.-.| +.++.+|||..|+||+-|+.|.+||.|=+.... .+..|.--|+ ...+.++.+-+|=.
T Consensus 148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------~~V~~vN~~Y---~~lT~~aE~~~fv~ 216 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------NQVNMVNIEY---ESLTQEAEVKVFVK 216 (308)
T ss_pred HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh--------heeeEEeeec---cccChHHHHHHHHH
Confidence 22245677888 444599999999999999999999999764211 1111221111 12355666666655
Q ss_pred HHHHHHhC
Q 019905 244 LLLDLLSG 251 (334)
Q Consensus 244 ~l~elltg 251 (334)
.++++...
T Consensus 217 s~l~~v~~ 224 (308)
T PF07387_consen 217 SCLKLVEK 224 (308)
T ss_pred HHHHHHHH
Confidence 56665543
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.039 Score=49.48 Aligned_cols=72 Identities=15% Similarity=0.209 Sum_probs=43.7
Q ss_pred cCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-cceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
.+..|-.+.+|+....+ +..|++|....... ..-...+|..+++.+..-++ .++++++. .+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 33456667788887533 23788888754332 11223578888888854444 34565553 22 589999876
Q ss_pred CH
Q 019905 142 TL 143 (334)
Q Consensus 142 sL 143 (334)
++
T Consensus 96 ~l 97 (330)
T PLN02421 96 TL 97 (330)
T ss_pred CC
Confidence 65
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.017 Score=50.63 Aligned_cols=75 Identities=16% Similarity=0.168 Sum_probs=46.8
Q ss_pred cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC---CCCccceeeeeeeCCeeeEEEecCC
Q 019905 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
+-+..++.|.-+.+|+.. .+++.+.+|.-.. .....+..|.+-|+.|. .-.+.+++++....+..+|++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334455778888899887 5678899998762 22456778888777773 4457788888887777899999998
Q ss_pred CC
Q 019905 140 NE 141 (334)
Q Consensus 140 ~~ 141 (334)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 66
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.088 Score=47.00 Aligned_cols=145 Identities=17% Similarity=0.244 Sum_probs=82.4
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc---cc---eeeee--eeCC-
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL---TN---LLGCC--CEGD- 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i---v~---~~~~~--~~~~- 129 (334)
|........|.+ .-..+|+....+++. ++|..... ....++..|...+..|.-.++ ++ .-|-. ...+
T Consensus 25 ~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~ 100 (331)
T COG2334 25 YGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG 100 (331)
T ss_pred cCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence 333333444455 456799998877666 88888765 345667778888877732221 11 11111 1233
Q ss_pred -eeeEEEecCCCCCHHH-----hh----------c----ccC---C---CCCCHH----H---------HHHHHHHHHHH
Q 019905 130 -ERLLVAEYMPNETLAK-----HL----------F----HWE---T---HPMKWA----M---------RLRVVLHLAQA 170 (334)
Q Consensus 130 -~~~lv~e~~~~~sL~~-----~l----------~----~~~---~---~~~~~~----~---------~~~i~~~i~~~ 170 (334)
..+-+++|++|..+.. .+ + ... . ....|. . -.....++...
T Consensus 101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~ 180 (331)
T COG2334 101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA 180 (331)
T ss_pred ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence 7788999999887772 00 0 000 0 011121 0 01112233333
Q ss_pred HHHHHh------CC-C--ceecccCCCCeeecCCCC-eeEcCCCCCc
Q 019905 171 LEYCTS------KG-R--ALYHDLNAYRILFDEDGN-PRLSTFGLMK 207 (334)
Q Consensus 171 l~~lh~------~~-~--i~H~dikp~Nili~~~~~-~kl~Dfg~a~ 207 (334)
+..+.. .. . +||+|+.|.||+++.+.. ..+.||+.+.
T Consensus 181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 333332 11 1 799999999999998875 8899999763
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.12 Score=45.92 Aligned_cols=29 Identities=17% Similarity=0.179 Sum_probs=26.4
Q ss_pred ceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 180 i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
++|+|+.++|+++++++.+.+.||..+..
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 89999999999999999999999997653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.02 Score=53.26 Aligned_cols=49 Identities=18% Similarity=0.196 Sum_probs=38.1
Q ss_pred hHHHHHHHHHHhcCCCCCccceeeeeeeC-CeeeEEEecCCCCCHHHhhcc
Q 019905 100 PRQFLEEARSVGQLRNNRLTNLLGCCCEG-DERLLVAEYMPNETLAKHLFH 149 (334)
Q Consensus 100 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~ 149 (334)
..++.-..+.++.+.|+|...++++.... ....+|+|++ +.+|.+.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 34566678889999999999888877543 4578899999 5899998853
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.039 Score=49.97 Aligned_cols=59 Identities=17% Similarity=0.106 Sum_probs=41.3
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCceecccCCCCeeec
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT-SKGRALYHDLNAYRILFD 193 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~i~H~dikp~Nili~ 193 (334)
..++-+|..|.++..++ +....++.....++.-.++|+.-+- -.+ .+|.|++|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v---~~~~~pe~l~kkva~lg~~AllkMl~vDN-FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFV---KWKSQPEALVKKVAKLGVNALLKMLIVDN-FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhh---hcccChHHHHHHHHHHHHHHHHHHHHhhc-ceecccCCCcEEEE
Confidence 35677788888888888 3344455556666666666664443 334 99999999999995
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.32 Score=43.54 Aligned_cols=97 Identities=19% Similarity=0.158 Sum_probs=56.7
Q ss_pred ccccCHHHHHHHhcCCCcc--cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--cc
Q 019905 44 FREFTLEQLKNATSGFAVE--NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LT 119 (334)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~--~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv 119 (334)
+..++.+.+..+...+... ..+..++ +.-+.||+....++..+++|...... .....+..|++.+..|.... ++
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~-s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~ 85 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALN-SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV 85 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeec-cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 4556777766665444221 1222222 23457999887777889999886443 24566778888777663211 22
Q ss_pred cee---e--eeeeCCeeeEEEecCCCCC
Q 019905 120 NLL---G--CCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 120 ~~~---~--~~~~~~~~~lv~e~~~~~s 142 (334)
... | ....++..+.++++++|..
T Consensus 86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 86 APLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 211 1 1223456788999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.47 Score=49.21 Aligned_cols=148 Identities=17% Similarity=0.233 Sum_probs=80.5
Q ss_pred cCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-------CCCCcccee-ee----
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-------RNNRLTNLL-GC---- 124 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~-~~---- 124 (334)
..|.....+..|+. ....+|+....++..+++|+.+... .......|...+..| .-|.+++-. |-
T Consensus 22 ~~ygl~~~~~~L~s-~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~ 98 (1013)
T PRK06148 22 QHFGISATATPLDG-ERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLAS 98 (1013)
T ss_pred HHcCCceEEeecCC-cCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEE
Confidence 44444334456653 4577899887778889999998643 233344455555444 223333321 11
Q ss_pred eee-CC--eeeEEEecCCCCCHHHhhc---------------------ccC----CCCCCHH-----------------H
Q 019905 125 CCE-GD--ERLLVAEYMPNETLAKHLF---------------------HWE----THPMKWA-----------------M 159 (334)
Q Consensus 125 ~~~-~~--~~~lv~e~~~~~sL~~~l~---------------------~~~----~~~~~~~-----------------~ 159 (334)
... ++ ..+.+++|++|..+.+... ... ...+.|. .
T Consensus 99 v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~ 178 (1013)
T PRK06148 99 AQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPE 178 (1013)
T ss_pred eecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHH
Confidence 111 22 4677899999877765110 000 0111121 1
Q ss_pred HHHHHHHHHHHHH-----HHH--hCCCceecccCCCCeeecCCC--Cee-EcCCCCCcc
Q 019905 160 RLRVVLHLAQALE-----YCT--SKGRALYHDLNAYRILFDEDG--NPR-LSTFGLMKN 208 (334)
Q Consensus 160 ~~~i~~~i~~~l~-----~lh--~~~~i~H~dikp~Nili~~~~--~~k-l~Dfg~a~~ 208 (334)
...++.++..... .+. ..+ +||+|+++.||+++.++ .+. |.|||.+..
T Consensus 179 ~r~~l~~~~~~~~~~v~p~l~~Lp~~-vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 179 DRALVERFLARFERNVAPRLAALPAQ-VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCcc-eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1222223333222 121 135 99999999999999775 454 999998653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.14 Score=46.83 Aligned_cols=75 Identities=15% Similarity=0.193 Sum_probs=44.0
Q ss_pred cccCCCcCccEEEEEEeCCC--CE-----EEEEEecCCCCCChHHHHHHHHHHhcCCCCC-ccceeeeeeeCCeeeEEEe
Q 019905 65 VSEHGEKAPNVVYKGKLENQ--RR-----IAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 136 (334)
+..+..|-.+.+|++...++ .. |.++.. .....-.-.-.+|+++++.+...+ -.++++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 34555677788999875432 12 333332 111111112356888888886444 4456666643 59999
Q ss_pred cCCCCCHH
Q 019905 137 YMPNETLA 144 (334)
Q Consensus 137 ~~~~~sL~ 144 (334)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987764
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.19 Score=43.10 Aligned_cols=78 Identities=14% Similarity=0.089 Sum_probs=53.9
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC-CCCCHH
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM-PNETLA 144 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~sL~ 144 (334)
+.+..|..+.|+.+...+|..+++|...+......+ ......|+..+-...|++++.-.. .-.+++|.+ ++.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E--~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHE--ARGEAALRWWNGRGAVRLLAADPE--RGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhh--hhHHhHhheeCCCCceeeeccccc--cchhhhhhccCCCchh
Confidence 344678888999999888999999998754421111 112255777787788899887533 346888988 556776
Q ss_pred Hhh
Q 019905 145 KHL 147 (334)
Q Consensus 145 ~~l 147 (334)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 654
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.3 Score=40.95 Aligned_cols=59 Identities=24% Similarity=0.315 Sum_probs=43.1
Q ss_pred CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC---CCCccceeeeeeeCCeeeEEEecCCCCCHH
Q 019905 83 NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (334)
Q Consensus 83 ~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 144 (334)
+...+.+|+=.. .....|..|+.-|+.+. .-++.+++.+....++.|+|++|++-+.+.
T Consensus 38 g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 456788888532 22356778887777664 345777888888889999999999976655
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 334 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-25 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-63
Identities = 88/311 (28%), Positives = 144/311 (46%), Gaps = 30/311 (9%)
Query: 26 DVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR 85
DV A E+ E+ L + F+L +L+ A+ F+ +NI+ G VYKG+L +
Sbjct: 3 DVPAEEDPEVH----LGQLKRFSLRELQVASDNFSNKNIL---GRGGFGKVYKGRLADGT 55
Query: 86 RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144
+AVKR QF E + + L L G C ERLLV YM N ++A
Sbjct: 56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 145 KHLF--HWETHPMKWAMRLRVVLHLAQALEY--CTSKGRALYHDLNAYRILFDEDGNPRL 200
L P+ W R R+ L A+ L Y + ++ D+ A IL DE+ +
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 201 STFGLMKNSRDGKSY-STNLAFT----PPEYLRTGRVTPESVIYSFGTLLLDLLSGK--- 252
FGL K ++ +T + T PEYL TG+ + ++ ++ +G +LL+L++G+
Sbjct: 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
Query: 253 --HIPP--------SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
L++++ L+ L D L+G + D++ +L+++A C Q P E
Sbjct: 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 303 RPNPKSLVTAL 313
RP +V L
Sbjct: 296 RPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-63
Identities = 85/317 (26%), Positives = 142/317 (44%), Gaps = 42/317 (13%)
Query: 31 ENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEH---GEKAPNVVYKGKLENQRRI 87
EN + D F F+ +LKN T+ F I GE VVYKG + N +
Sbjct: 1 ENKSLEVSDT--RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-V 57
Query: 88 AVKRFNRMAWPDP----RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143
AVK+ M +QF +E + + + ++ L LLG +GD+ LV YMPN +L
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 144 AKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR------ILFDEDG 196
L + T P+ W MR ++ A + + L+ + + +R IL DE
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINF-------LHENHHIHRDIKSANILLDEAF 170
Query: 197 NPRLSTFGLMK-NSRDGKSY-STNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLS 250
++S FGL + + + ++ ++ + T PE L G +TP+S IYSFG +LL++++
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229
Query: 251 GK-----HIPPSHALD-----LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
G H P LD ++ ++ D + + +AS+CL +
Sbjct: 230 GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKK 288
Query: 301 RERPNPKSLVTALSPLQ 317
+RP+ K + L +
Sbjct: 289 NKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-60
Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 23/288 (7%)
Query: 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFL 104
L L+ AT+ F + ++ G VYKG L + ++A+KR + +F
Sbjct: 27 YRVPLVDLEEATNNFDHKFLI---GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 105 EEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF--HWETHPMKWAMRLR 162
E ++ R+ L +L+G C E +E +L+ +YM N L +HL+ T M W RL
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDGKSY-STNLA 220
+ + A+ L Y ++ D+ + IL DE+ P+++ FG+ K + +++ ST +
Sbjct: 144 ICIGAARGLHY-LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 221 FTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGK----HIPPSH-------ALDLIRD 265
T PEY GR+T +S +YSFG +L ++L + P A++ +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L+ + D L + + + A +CL +RP+ ++ L
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 51/323 (15%), Positives = 103/323 (31%), Gaps = 57/323 (17%)
Query: 43 SFREFTLEQLKNATSGFAVENIVSE--HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP 100
S + E L + + + + G V+K +L N+ +AVK F D
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGC-----VWKAQLLNEY-VAVKIFP---IQDK 60
Query: 101 RQFLEEA--RSVGQLRNNRLTNLLGCCCEGD----ERLLVAEYMPNETLAKHLFHWETHP 154
+ + E S+ +++ + +G G + L+ + +L+ L +
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NV 117
Query: 155 MKWAMRLRVVLHLAQALEYCTSKGRALY--------H-DLNAYRILFDEDGNPRLSTFGL 205
+ W + +A+ L Y L H D+ + +L + ++ FGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 206 MKNSRDGKSYSTNLAFT------PPEYLRTGRVTPESV-----IYSFGTLLLDLLSGK-- 252
GKS PE L +Y+ G +L +L S
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 253 --------------HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT-ELVRLASRCLQ 297
I +L+ +++ + L + G L C
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 298 YEPRERPNPKSLVTALSPLQKET 320
++ R + + ++ +Q+ T
Sbjct: 298 HDAEARLSAGCVGERITQMQRLT 320
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 46/258 (17%), Positives = 92/258 (35%), Gaps = 24/258 (9%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
++KG+ + I VK W R F EE + + + +LG C
Sbjct: 25 ELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 133 L--VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+ +MP +L L + + ++ L +A+ + + + + LN+
Sbjct: 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV---IYSFGTLLL 246
++ DED R+S + K S A+ PE L+ ++SF LL
Sbjct: 144 VMIDEDMTARISMADV-KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 247 DLLSGK----HIPPSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+L++ + + + L+ + + +L C+ +P
Sbjct: 203 ELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP---------HVSKLMKICMNEDPA 253
Query: 302 ERPNPKSLVTALSPLQKE 319
+RP +V L +Q +
Sbjct: 254 KRPKFDMIVPILEKMQDK 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 51/258 (19%), Positives = 107/258 (41%), Gaps = 23/258 (8%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDP--RQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V++ + +AVK + +FL E + +LR+ + +G +
Sbjct: 52 TVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 133 LVAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRI 190
+V EY+ +L + L + RL + +A+ + Y ++ + H +L + +
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLL 246
L D+ ++ FGL + S + A TP PE LR +S +YSFG +L
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 247 DLLSGK----HIPPSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+L + + ++ P+ + + + ++ + + ++ + C EP
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP---------QVAAIIEGCWTNEPW 281
Query: 302 ERPNPKSLVTALSPLQKE 319
+RP+ +++ L PL K
Sbjct: 282 KRPSFATIMDLLRPLIKS 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 28/261 (10%)
Query: 76 VYKGKLENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL- 132
VYKGK +AVK N + F E + + R+ + +G +L
Sbjct: 40 VYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLA 95
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
+V ++ +L HL H + + + A+ ++Y +K + H DL + I
Sbjct: 96 IVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIF 152
Query: 192 FDEDGNPRLSTFGL--MKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESV---IYSFG 242
ED ++ FGL K+ G L+ + PE +R P S +Y+FG
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 243 TLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+L +L++G+ +I + + R S + + + RL + CL+
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS----KVRSNCPKRMKRLMAECLKK 268
Query: 299 EPRERPNPKSLVTALSPLQKE 319
+ ERP+ ++ + L +E
Sbjct: 269 KRDERPSFPRILAEIEELARE 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 53/267 (19%), Positives = 108/267 (40%), Gaps = 31/267 (11%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV K K + +A+K+ + + F+ E R + ++ + + L G C + LV
Sbjct: 23 VVCKAKWRAKD-VAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77
Query: 135 AEYMPNETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYC-TSKGRALYH-DLNAYRIL 191
EY +L L E P A + L +Q + Y + + +AL H DL +L
Sbjct: 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 192 FDEDGN-PRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLL 246
G ++ FG + D +++ TN + PE + + ++S+G +L
Sbjct: 138 LVAGGTVLKICDFGT---ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 247 DLLSGK------HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
++++ + P + + + L + + + L +RC +P
Sbjct: 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK---------PIESLMTRCWSKDP 245
Query: 301 RERPNPKSLVTALSPLQKETEFSISPL 327
+RP+ + +V ++ L + + PL
Sbjct: 246 SQRPSMEEIVKIMTHLMRYFPGADEPL 272
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 56/332 (16%), Positives = 101/332 (30%), Gaps = 68/332 (20%)
Query: 46 EFTLEQLKNATSGFAVENIVSE--HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQF 103
E + + ++ +G VYKG L+ + +AVK F+ + + + F
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGA-----VYKGSLDERP-VAVKVFS---FANRQNF 52
Query: 104 LEEAR--SVGQLRNNRLTNLLGCCCEGD-----ERLLVAEYMPNETLAKHLFHWETHPMK 156
+ E V + ++ + + E LLV EY PN +L K+L H
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSD 109
Query: 157 WAMRLRVVLHLAQALEY-------CTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL--- 205
W R+ + + L Y A+ H DLN+ +L DG +S FGL
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 206 -----MKNSRDGKSYSTNLAFTP----PEYLR-------TGRVTPESVIYSFGTLLLDLL 249
+ + + + + T PE L + +Y+ G + ++
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 250 SGKHI-----------PPSHALDLIRDRNLQMLTDSCLEGQ-------FTDDDGT--ELV 289
M E Q + ++ L
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 290 RLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
C + R + ++ L E
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 47/277 (16%), Positives = 89/277 (32%), Gaps = 38/277 (13%)
Query: 76 VYKGKLENQRR-IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
K + +K R R FL+E + + L + + +G + +
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EY+ TL + W+ R+ +A + Y S + H DLN++ L
Sbjct: 86 TEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR 142
Query: 194 EDGNPRLSTFGL--------------MKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE 235
E+ N ++ FGL + + + P PE + +
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202
Query: 236 SVIYSFGTLLLDLLSGKHIPP-----SHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELV 289
++SFG +L +++ + P + L L +C
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP---------SFF 253
Query: 290 RLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326
+ RC +P +RP+ L L L+ +
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 49/263 (18%), Positives = 95/263 (36%), Gaps = 40/263 (15%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDP----RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY+ +AVK D +EA+ L++ + L G C +
Sbjct: 22 KVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA--LYHDLNAY 188
LV E+ L + L + + + + +A+ + Y + ++ DL +
Sbjct: 81 LCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 189 RILFDEDGNPRLST--------FGLMKNSRD-GKSYSTNLAFTP----PEYLRTGRVTPE 235
IL + + FGL +R+ ++ + A PE +R +
Sbjct: 138 NILILQKVENGDLSNKILKITDFGL---AREWHRTTKMSAAGAYAWMAPEVIRASMFSKG 194
Query: 236 SVIYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVR 290
S ++S+G LL +LL+G+ I + L + + +C E +
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE---------PFAK 245
Query: 291 LASRCLQYEPRERPNPKSLVTAL 313
L C +P RP+ +++ L
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-21
Identities = 56/269 (20%), Positives = 108/269 (40%), Gaps = 42/269 (15%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP-------RQFLEEARSVGQLRNNRLTNLLGCCC 126
+V+KG+ ++++ +A+K ++F E + L + + L G
Sbjct: 34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93
Query: 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DL 185
+V E++P L L + HP+KW+++LR++L +A +EY ++ + H DL
Sbjct: 94 NPP--RMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 186 NAYRILFDEDGNPRLST-----FGLMKNSRDGKSYSTNLAFTP----PEYL--RTGRVTP 234
+ I FGL S+ + L PE + T
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGL---SQQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 235 ESVIYSFGTLLLDLLSGK----HIPPSHA--LDLIRDRNLQM-LTDSCLEGQFTDDDGTE 287
++ YSF +L +L+G+ +++IR+ L+ + + C
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP---------R 258
Query: 288 LVRLASRCLQYEPRERPNPKSLVTALSPL 316
L + C +P++RP+ +V LS L
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 45/280 (16%), Positives = 89/280 (31%), Gaps = 45/280 (16%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDP-----RQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY G+ + +A++ + + F E + Q R+ + +G C
Sbjct: 48 QVYHGRWHGE--VAIRLID---IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
++ TL + + ++ + + + Y +KG + H DL +
Sbjct: 103 HLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSK 159
Query: 189 RILFDEDGNPRLSTFGL--MKNSRDGKSYSTNLAFTP-------PEYLRTGRVTPESV-- 237
+ +D +G ++ FGL + L PE +R E
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 238 -------IYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286
+++ GT+ +L + + P + + L+ G
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI--------GMGK 270
Query: 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326
E+ + C +E ERP L+ L L K P
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 57/264 (21%), Positives = 112/264 (42%), Gaps = 26/264 (9%)
Query: 76 VYKGKLENQR-RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VY+G + +AVK + + +FL+EA + ++++ L LLG C ++
Sbjct: 236 VYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
E+M L +L + + L + ++ A+EY K H +L A L
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG 352
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
E+ +++ FGL + + A +T PE L + + +S +++FG LL ++
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ P S +L+ +++ +M + C E ++ L C Q+ P +
Sbjct: 413 ATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE---------KVYELMRACWQWNPSD 462
Query: 303 RPNPKSLVTALSPLQKETEFSISP 326
RP+ + A + +E+ S
Sbjct: 463 RPSFAEIHQAFETMFQESSISDEV 486
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 68/267 (25%), Positives = 106/267 (39%), Gaps = 26/267 (9%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G R+A+K P FL+EA+ + +LR+ +L L E + +V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
EYM +L L ++ + + +A + Y H DL A IL E
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 315
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + A +T PE GR T +S ++SFG LL +L
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ +P LD + +R +M C E L L +C + EP ER
Sbjct: 376 TKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE---------SLHDLMCQCWRKEPEER 425
Query: 304 PNPKSLVTALSPLQKETEFSISPLCRF 330
P + L L TE P
Sbjct: 426 PTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 68/267 (25%), Positives = 106/267 (39%), Gaps = 26/267 (9%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G R+A+K P FL+EA+ + +LR+ +L L E + +V
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
EYM +L L ++ + + +A + Y H DL A IL E
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 398
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + A +T PE GR T +S ++SFG LL +L
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ +P LD + +R +M C E L L +C + EP ER
Sbjct: 459 TKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE---------SLHDLMCQCWRKEPEER 508
Query: 304 PNPKSLVTALSPLQKETEFSISPLCRF 330
P + L L TE P
Sbjct: 509 PTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-19
Identities = 57/264 (21%), Positives = 106/264 (40%), Gaps = 24/264 (9%)
Query: 75 VVYKGKLENQR-RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 28 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILF 192
+ E+M L +L + + L + ++ A+EY K H DL A L
Sbjct: 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV 144
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLD 247
E+ +++ FGL + + A +T PE L + + +S +++FG LL +
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 248 LLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ + P S +L+ + C E ++ L C Q+ P +
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSD 255
Query: 303 RPNPKSLVTALSPLQKETEFSISP 326
RP+ + A + +E+ S
Sbjct: 256 RPSFAEIHQAFETMFQESSISDEV 279
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 56/258 (21%), Positives = 104/258 (40%), Gaps = 26/258 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ ++AVK + FL EA + L++++L L + + ++
Sbjct: 204 VWMATYNKHTKVAVKT-MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 261
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
E+M +L L E + +A+ + + + H DL A IL
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSA 319
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+++ FGL + D + + A +T PE + G T +S ++SFG LL++++
Sbjct: 320 SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ IP + + +R +M ++C E EL + RC + P ER
Sbjct: 380 TYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPE---------ELYNIMMRCWKNRPEER 429
Query: 304 PNPKSLVTALSPLQKETE 321
P + + + L TE
Sbjct: 430 PTFEYIQSVLDDFYTATE 447
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 51/257 (19%), Positives = 110/257 (42%), Gaps = 26/257 (10%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK + Q +AVK + +F +EA+++ +L + +L G C + +V
Sbjct: 23 VVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EY+ N L +L ++ + L + + + + + S H DL A L D
Sbjct: 82 TEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD 138
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
D ++S FG+ + D + S+ ++ PE + + +S +++FG L+ ++
Sbjct: 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S +P S + + + ++ + + ++ C P +
Sbjct: 199 FSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASD---------TIYQIMYSCWHELPEK 248
Query: 303 RPNPKSLVTALSPLQKE 319
RP + L++++ PL+++
Sbjct: 249 RPTFQQLLSSIEPLREK 265
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 30/256 (11%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-LV 134
V G + +AVK A + FL EA + QLR++ L LLG E L +V
Sbjct: 209 VMLGDYRGNK-VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EYM +L +L + L+ L + +A+EY H DL A +L
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS 323
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLAF----TPPEYLRTGRVTPESVIYSFGTLLLDLL 249
ED ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 324 EDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 250 S-GKH----IPPSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
S G+ IP + + ++ +M D C + + C + R
Sbjct: 381 SFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPP---------AVYDVMKNCWHLDAATR 430
Query: 304 PNPKSLVTALSPLQKE 319
P L L ++
Sbjct: 431 PTFLQLREQLEHIRTH 446
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-18
Identities = 67/262 (25%), Positives = 106/262 (40%), Gaps = 31/262 (11%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-L 133
V G + +AVK A + FL EA + QLR++ L LLG E L +
Sbjct: 36 DVMLGDYRGNK-VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILF 192
V EYM +L +L + L+ L + +A+EY H DL A +L
Sbjct: 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 150
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAF----TPPEYLRTGRVTPESVIYSFGTLLLDL 248
ED ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 151 SEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 249 LS-GKH----IPPSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S G+ IP + + ++ +M D C + + C +
Sbjct: 208 YSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAM 257
Query: 303 RPNPKSLVTALSPLQKETEFSI 324
RP+ L L + K E +
Sbjct: 258 RPSFLQLREQLEHI-KTHELHL 278
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 28/259 (10%)
Query: 76 VYKGKLENQR-RIAVKRFNR-MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
V+ G+L +AVK + +FL+EAR + Q + + L+G C + +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILF 192
V E + L E ++ L++V A +EY SK H DL A L
Sbjct: 190 VMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV 246
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAF------TPPEYLRTGRVTPESVIYSFGTLLL 246
E ++S FG+ + DG ++ T PE L GR + ES ++SFG LL
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 247 DLLSGKHIP-----PSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+ S P + + ++ ++ + C + + RL +C YEP
Sbjct: 307 ETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPD---------AVFRLMEQCWAYEP 356
Query: 301 RERPNPKSLVTALSPLQKE 319
+RP+ ++ L ++K
Sbjct: 357 GQRPSFSTIYQELQSIRKR 375
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 26/258 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++AVK + + P FL EA + QL++ RL L + + ++
Sbjct: 29 VWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
EYM N +L L + L + +A+ + + + H DL A IL +
Sbjct: 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSD 144
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + A +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ IP + + +R +M+ D+C E EL +L C + P +R
Sbjct: 205 THGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDR 254
Query: 304 PNPKSLVTALSPLQKETE 321
P L + L TE
Sbjct: 255 PTFDYLRSVLEDFFTATE 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 26/257 (10%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK Q +A+K + +F+EEA+ + L + +L L G C + ++
Sbjct: 39 VVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EYM N L +L H + L + + +A+EY SK H DL A L +
Sbjct: 98 TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN 154
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+ G ++S FGL + D + S+ + ++PPE L + + +S I++FG L+ ++
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214
Query: 249 LSGKHIP-P----SHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S +P S + I + L++ E ++ + C + E
Sbjct: 215 YSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASE---------KVYTIMYSCWHEKADE 264
Query: 303 RPNPKSLVTALSPLQKE 319
RP K L++ + + E
Sbjct: 265 RPTFKILLSNILDVMDE 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 55/256 (21%), Positives = 105/256 (41%), Gaps = 26/256 (10%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
+V+ G N+ ++A+K A F+EEA + +L + +L L G C E LV
Sbjct: 23 LVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
E+M + L+ +L + L + L + + + Y + H DL A L
Sbjct: 82 TEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG 138
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
E+ ++S FG+ + D + S+ + PE R + +S ++SFG L+ ++
Sbjct: 139 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 198
Query: 249 LSGKHIP-P----SHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S IP S ++ I ++ + ++ + C + P +
Sbjct: 199 FSEGKIPYENRSNSEVVEDI-STGFRLYKPRLAST---------HVYQIMNHCWRERPED 248
Query: 303 RPNPKSLVTALSPLQK 318
RP L+ L+ + +
Sbjct: 249 RPAFSRLLRQLAEIAE 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 58/266 (21%), Positives = 103/266 (38%), Gaps = 32/266 (12%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY G+ +N+ + A+K +R+ FL E + L + + L+G +
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96
Query: 131 RLL-VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+ YM + L + + + L +A+ +EY + H DL A
Sbjct: 97 LPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAAR 153
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--------TPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + YS T E L+T R T +S ++S
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213
Query: 241 FGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
FG LL +LL+ G HI P + + C + L ++ +C
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD---------SLYQVMQQC 264
Query: 296 LQYEPRERPNPKSLVTALSPLQKETE 321
+ +P RP + LV + +
Sbjct: 265 WEADPAVRPTFRVLVGEVEQIVSALL 290
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 32/266 (12%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY G L + AVK NR+ + QFL E + + + +LLG C +
Sbjct: 41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 131 -RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
L+V YM + L + ETH + L +A+ ++Y SK H DL A
Sbjct: 101 SPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAAR 157
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--------TPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + YS + E L+T + T +S ++S
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 217
Query: 241 FGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
FG LL +L++ G + + + + C + L + +C
Sbjct: 218 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVMLKC 268
Query: 296 LQYEPRERPNPKSLVTALSPLQKETE 321
+ RP+ LV+ +S +
Sbjct: 269 WHPKAEMRPSFSELVSRISAIFSTFI 294
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 38/277 (13%)
Query: 76 VYKGKLEN------QRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VY+G + + R+A+K N A + +FL EA + + + + LLG +G
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100
Query: 129 DERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLH----LAQALEYCTSKGRA 180
L++ E M L +P+ L ++ +A + Y +
Sbjct: 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158
Query: 181 LYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRTGRVT 233
H DL A + ED ++ FG+ ++ + Y PE L+ G T
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218
Query: 234 PESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
S ++SFG +L ++ + + + L + + L D+C + L
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 269
Query: 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSIS 325
L C QY P+ RP+ +++++ + +S
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 45/282 (15%)
Query: 76 VYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + +L + ++AVK + + +A D +FL EA + + + + L+G
Sbjct: 39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98
Query: 130 ER------LLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
+ +++ +M + L + +R ++ +A +EY +S+
Sbjct: 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157
Query: 180 ALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSY---STNLAF----TPPEYLRT 229
H DL A + ED ++ FGL SR Y E L
Sbjct: 158 -FIHRDLAARNCMLAEDMTVCVADFGL---SRKIYSGDYYRQGCASKLPVKWLALESLAD 213
Query: 230 GRVTPESVIYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
T S +++FG + ++++ G+ I + + + N C+E
Sbjct: 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME------- 266
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326
E+ L +C +P++RP+ L L + +
Sbjct: 267 --EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 57/265 (21%), Positives = 100/265 (37%), Gaps = 37/265 (13%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
++KG ++ + +K ++ F E A + +L + L G C
Sbjct: 24 IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
GDE +LV E++ +L +L + + +L V LA A+ + L H ++
Sbjct: 84 GDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVC 140
Query: 187 AYRILFDEDGNPR--------LSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRV-TPESV 237
A IL + + + LS G+ + + PPE + + +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATD 200
Query: 238 IYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
+SFGT L ++ SG P L DR Q EL L
Sbjct: 201 KWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-----------HQLPAPKAAELANLI 249
Query: 293 SRCLQYEPRERPNPKSLVTALSPLQ 317
+ C+ YEP RP+ ++++ L+ L
Sbjct: 250 NNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 54/263 (20%), Positives = 95/263 (36%), Gaps = 29/263 (11%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V++G +A+K R+ FL+EA ++ Q + + L+G +
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITENP 464
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
++ E L L + A + L+ AL Y SK H D+ A
Sbjct: 465 VWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 521
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTL 244
+L + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581
Query: 245 LLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 632
Query: 300 PRERPNPKSLVTALSPLQKETEF 322
P RP L LS + +E +
Sbjct: 633 PSRRPRFTELKAQLSTILEEEKL 655
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 50/291 (17%), Positives = 98/291 (33%), Gaps = 54/291 (18%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL---GCCCEGDER- 131
V+ GK ++ +AVK F + + E + Q R N+L +G
Sbjct: 53 VWMGKWRGEK-VAVKVFF---TTEEASWFRE-TEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 132 ---LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY------CTSKGRALY 182
L+ +Y N +L +L ++ + L++ L + T A+
Sbjct: 108 TQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 183 H-DLNAYRILFDEDGNPRLSTFGL----MKNSRDGKSYSTNLAFTP----PEYLRTGRVT 233
H DL + IL ++G ++ GL + ++ + T PE L +
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLN 223
Query: 234 PESV-------IYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNLQMLTDSCLEG 278
+YSFG +L ++ P H L M C++
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 279 Q--------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
+D+ ++ +L + C + P R + L+ + + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 38/264 (14%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY G L + AVK NR+ + QFL E + + + +LLG C +
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 131 -RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
L+V YM + L + ETH + L +A+ +++ SK H DL A
Sbjct: 165 SPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAAR 221
Query: 189 RILFDEDGNPRLSTFGLMKNSRD------GKSYSTNLAF-----TPPEYLRTGRVTPESV 237
+ DE +++ FGL +RD ++ A E L+T + T +S
Sbjct: 222 NCMLDEKFTVKVADFGL---ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 238 IYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
++SFG LL +L++ G + + + + C + L +
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 329
Query: 293 SRCLQYEPRERPNPKSLVTALSPL 316
+C + RP+ LV+ +S +
Sbjct: 330 LKCWHPKAEMRPSFSELVSRISAI 353
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 53/264 (20%), Positives = 97/264 (36%), Gaps = 31/264 (11%)
Query: 75 VVYKGKLENQRR----IAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V++G + +A+K + +FL+EA ++ Q + + L+G
Sbjct: 30 DVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIG-VITE 87
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ ++ E L L + + A + L+ AL Y SK H D+ A
Sbjct: 88 NPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAA 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFG 242
+L + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 145 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 204
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
+ ++L P + + I + + +C L L ++C
Sbjct: 205 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWA 255
Query: 298 YEPRERPNPKSLVTALSPLQKETE 321
Y+P RP L LS + +E +
Sbjct: 256 YDPSRRPRFTELKAQLSTILEEEK 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 57/274 (20%), Positives = 97/274 (35%), Gaps = 35/274 (12%)
Query: 76 VYKGKLEN-----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + +AVK A P + +E + L + + GCC +
Sbjct: 47 VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
LV EY+P +L +L H + A L + + + Y ++ H DL
Sbjct: 107 AASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLA 161
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIY 239
A +L D D ++ FGL K +G Y + PE L+ + S ++
Sbjct: 162 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 221
Query: 240 SFGTLLLDLLS--GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG----------TE 287
SFG L +LL+ P + +T L + G E
Sbjct: 222 SFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL--LERGERLPRPDKCPAE 279
Query: 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ L C + E RP ++L+ L + ++ +
Sbjct: 280 VYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 47/288 (16%), Positives = 95/288 (32%), Gaps = 52/288 (18%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEAR--SVGQLRNNRLTNLLGCCCEGD---- 129
V++GK +AVK F+ + R + EA LR+ + + + +
Sbjct: 58 VWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY------CTSKGRALYH 183
+ LV++Y + +L +L + + +++ L A L + T A+ H
Sbjct: 114 QLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 184 -DLNAYRILFDEDGNPRLSTFGL----MKNSRDGKSYSTNLAFTP----PEYLRTGRVTP 234
DL + IL ++G ++ GL + + T PE L +
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD-DSINM 229
Query: 235 ESV-------IYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNLQMLTDSCLEGQ 279
+ IY+ G + ++ I P + L +M C +
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 280 --------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319
+ + + ++ C R + LS L ++
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 58/269 (21%), Positives = 102/269 (37%), Gaps = 38/269 (14%)
Query: 75 VVYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V G+L + +A+K + R FL EA +GQ + + L G G
Sbjct: 64 EVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALY-H-D 184
++V EYM N +L L TH ++ + + ++ + + Y + G Y H D
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRD 176
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESV 237
L A +L D + ++S FGL + D +T T PE + + S
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASD 236
Query: 238 IYSFGTLLLDLLSGKHIP-P----SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
++SFG ++ ++L+ P + + + C L +L
Sbjct: 237 VWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH---------ALHQLM 287
Query: 293 SRCLQYEPRERPNPKSLVTALSPLQKETE 321
C + +RP +V+ L L + E
Sbjct: 288 LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 50/276 (18%), Positives = 98/276 (35%), Gaps = 44/276 (15%)
Query: 76 VYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V +G L ++AVK + + + + +FL EA + + + LLG C E
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 130 -----ERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
+ +++ +M L + L+ ++ +A +EY +++
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167
Query: 181 LYH-DLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSY---STNLAF----TPPEYLRTG 230
H DL A + +D ++ FGL S+ Y E L
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGL---SKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224
Query: 231 RVTPESVIYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285
T +S +++FG + ++ + G + D + + + CL+
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD-------- 276
Query: 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
EL + C + +P +RP L L L +
Sbjct: 277 -ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 53/279 (18%), Positives = 97/279 (34%), Gaps = 41/279 (14%)
Query: 75 VVYKGKLENQR-----RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + + + +AVK+ R F E + L+++ + G C
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
R L+ EY+P +L +L + + L+ + + +EY +K H DL
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA 172
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIY 239
IL + + ++ FGL K K Y PE L + + S ++
Sbjct: 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV----RLA--- 292
SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 233 SFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPRPD 286
Query: 293 ----------SRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ C +RP+ + L + ++ +
Sbjct: 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 76 VYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V G+L + + +A+K + R FL EA +GQ + + L G +
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALY-H-DL 185
++V EYM N +L L H ++ + + ++ +A ++Y + G Y H DL
Sbjct: 120 PVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDL 173
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVI 238
A IL + + ++S FGL + D + T PE + + T S +
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 239 YSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
+S+G +L +++S P + + + C L +L
Sbjct: 234 WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA---------ALYQLML 284
Query: 294 RCLQYEPRERPNPKSLVTALSPL 316
C Q + RP + +V+ L L
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKL 307
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 50/267 (18%), Positives = 98/267 (36%), Gaps = 35/267 (13%)
Query: 75 VVYKGKLENQRR-----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG + +A+K P ++ L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ + MP L ++ + L + +A+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRTGRVTPESVIYSF 241
+L + +++ FGL K + + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 242 GTLLLDLLS-GKH----IPPSHALDLIRD--RNLQMLTDSCLEGQFTDDDGTELVRLASR 294
G + +L++ G IP S ++ R Q C ++ + +
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP--PICTI---------DVYMIMRK 254
Query: 295 CLQYEPRERPNPKSLVTALSPLQKETE 321
C + RP + L+ S + ++ +
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 37/268 (13%)
Query: 76 VYKGKL-----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L + + +A+K + FL EA +GQ ++ + L G +
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH-DL 185
+++ EYM N L K L ++++ + ++ +A ++Y + H DL
Sbjct: 119 KPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDL 173
Query: 186 NAYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTNLAF----TPPEYLRTGRVTPESVI 238
A IL + + ++S FGL +++ + ++ T PE + + T S +
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 239 YSFGTLLLDLLSGKHIP-P----SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
+SFG ++ ++++ P + I D C + +L
Sbjct: 234 WSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS---------AIYQLMM 284
Query: 294 RCLQYEPRERPNPKSLVTALSPLQKETE 321
+C Q E RP +V+ L L + +
Sbjct: 285 QCWQQERARRPKFADIVSILDKLIRAPD 312
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 41/276 (14%)
Query: 76 VYKGKLEN------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V+ + N + +AVK + F EA + L++ + G C +GD
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90
Query: 130 ERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--SKGRALY- 182
++V EYM + + L H + + L L+Q L + + G Y
Sbjct: 91 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV-YL 149
Query: 183 ------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS--TNLAF----TPPEYLRT 229
H DL L + ++ FG+ ++ Y + PPE +
Sbjct: 150 ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 209
Query: 230 GRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
+ T ES ++SFG +L ++ + GK + + ++ I + C +
Sbjct: 210 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK------- 262
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
E+ + C Q EP++R N K + L L K T
Sbjct: 263 --EVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 52/264 (19%), Positives = 96/264 (36%), Gaps = 30/264 (11%)
Query: 75 VVYKGKLENQRR---IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V +G +++ +A+K + D + + EA+ + QL N + L+G C+ +
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 409
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+LV E L K L + + ++ ++ ++Y K H +L A
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARN 466
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFG 242
+L ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
+ + LS P + I C EL L S C
Sbjct: 527 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWI 577
Query: 298 YEPRERPNPKSLVTALSPLQKETE 321
Y+ +RP+ ++ +
Sbjct: 578 YKWEDRPDFLTVEQRMRACYYSLA 601
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 55/264 (20%), Positives = 97/264 (36%), Gaps = 32/264 (12%)
Query: 75 VVYKGKLENQRR---IAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V KG + ++ +AVK + + L EA + QL N + ++G CE +
Sbjct: 32 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAE 90
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+LV E L K+L K + +V ++ ++Y H DL A
Sbjct: 91 SWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN--FVHRDLAAR 146
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIYSF 241
+L ++S FGL K R ++Y T+ + PE + + + +S ++SF
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206
Query: 242 GTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296
G L+ + S P S ++ C E+ L + C
Sbjct: 207 GVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCW 257
Query: 297 QYEPRERPNPKSLVTALSPLQKET 320
Y+ RP ++ L +
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDV 281
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 52/285 (18%), Positives = 99/285 (34%), Gaps = 52/285 (18%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEA--RSVGQLRNNRLTNLLGCCCEGD---- 129
V++G + + +AVK F+ D + + E + LR+ + +
Sbjct: 24 VWRGSWQGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY------CTSKGRALYH 183
+ L+ Y +L +L + + LR+VL +A L + T A+ H
Sbjct: 80 QLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 184 -DLNAYRILFDEDGNPRLSTFGL----MKNSRDGKSYSTNLAFTP----PEYLRTGRVTP 234
DL + IL ++G ++ GL +++ + T PE L +
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD-ETIQV 195
Query: 235 ESV-------IYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNLQMLTDSCLEGQ 279
+ I++FG +L ++ PP + + M C++ Q
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 280 --------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
F+D T L +L C P R + L+ +
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 56/272 (20%), Positives = 99/272 (36%), Gaps = 37/272 (13%)
Query: 75 VVYKGKL----ENQRRIAVK--RFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCE 127
VV +G+ +AVK + + ++ P+ F+ E ++ L + L L G
Sbjct: 33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVL 91
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
+V E P +L L R + +A+ + Y SK H DL
Sbjct: 92 TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLA 148
Query: 187 AYRILFDEDGNPRLSTFGLMKN-SRDGKSYSTN------LAFTPPEYLRTGRVTPESVIY 239
A +L ++ FGLM+ ++ Y A+ PE L+T + S +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 240 SFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLAS 293
FG L ++ + P S L I ++ + C + ++ +
Sbjct: 209 MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ---------DIYNVMV 259
Query: 294 RCLQYEPRERPNPKSLVTALS---PLQKETEF 322
+C ++P +RP +L L P EF
Sbjct: 260 QCWAHKPEDRPTFVALRDFLLEAQPTDMRAEF 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 45/267 (16%), Positives = 97/267 (36%), Gaps = 35/267 (13%)
Query: 75 VVYKGKLENQRR-----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V+KG + + +K + + + ++G L + + LLG C G
Sbjct: 28 TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPG 86
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
LV +Y+P +L H+ + + L + +A+ + Y G + H +L A
Sbjct: 87 SSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAA 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSF 241
+L +++ FG+ + + E + G+ T +S ++S+
Sbjct: 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203
Query: 242 GTLLLDLLS-GKH----IPPSHALDLIRD--RNLQMLTDSCLEGQFTDDDGTELVRLASR 294
G + +L++ G + + DL+ R Q C ++ + +
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP--QICTI---------DVYMVMVK 252
Query: 295 CLQYEPRERPNPKSLVTALSPLQKETE 321
C + RP K L + + ++
Sbjct: 253 CWMIDENIRPTFKELANEFTRMARDPP 279
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 56/263 (21%), Positives = 100/263 (38%), Gaps = 29/263 (11%)
Query: 75 VVYKGKLENQR----RIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY+G N + +AVK + D ++ F+ EA + L + + L+G E +
Sbjct: 27 EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEE 85
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
++ E P L +L + + + L + +A+ Y S H D+
Sbjct: 86 PTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYLESIN--CVHRDIAVR 142
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGT 243
IL +L FGL + D Y ++ + PE + R T S ++ F
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 244 LLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+ ++LS P + ++ + D C L L +RC Y
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP---------VLYTLMTRCWDY 253
Query: 299 EPRERPNPKSLVTALSPLQKETE 321
+P +RP LV +LS + + +
Sbjct: 254 DPSDRPRFTELVCSLSDVYQMEK 276
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 52/279 (18%), Positives = 98/279 (35%), Gaps = 38/279 (13%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VY+G++ ++AVK + D FL EA + + + + +G +
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105
Query: 129 DERLLVAEYMPNETLAKHL-----FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
R ++ E M L L + + L V +A +Y H
Sbjct: 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 163
Query: 184 -DLNAYRILFDEDGNPRL---STFGLMKNSRDGKSYSTNLA------FTPPEYLRTGRVT 233
D+ A L G R+ FG+ ++ Y + PPE G T
Sbjct: 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 223
Query: 234 PESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
++ +SFG LL ++ S G L+ + +C +
Sbjct: 224 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG---------PV 274
Query: 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISPL 327
R+ ++C Q++P +RPN ++ + ++ + + L
Sbjct: 275 YRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 60/284 (21%), Positives = 103/284 (36%), Gaps = 47/284 (16%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRN-NRLTNLLGCC 125
V + ++AVK A D + E + + + NLLG C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 126 CEGDERLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQAL 171
+ ++ EY L ++L + +H + + + ++ A+ +
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
EY SK H DL A +L ED +++ FGL ++ Y +TN P
Sbjct: 205 EYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQ 279
E L T +S ++SFG LL ++ + G +P L+++ + +C
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTN-- 320
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323
EL + C P +RP K LV L + T
Sbjct: 321 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 53/281 (18%), Positives = 96/281 (34%), Gaps = 45/281 (16%)
Query: 75 VVYKGKLE-----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + + +AVK+ R F E + L+++ + G C
Sbjct: 25 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH-D 184
R L+ EY+P +L +L + H + L+ + + +EY +K H D
Sbjct: 85 RRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRD 139
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESV 237
L IL + + ++ FGL K K + PE L + + S
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASD 199
Query: 238 IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV----RLA- 292
++SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 200 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPR 253
Query: 293 ------------SRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ C +RP+ + L + ++
Sbjct: 254 PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 42/280 (15%), Positives = 70/280 (25%), Gaps = 49/280 (17%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLR---NNRLTNLLGCCCE 127
VV+ + +E A+K F A + E + +L +
Sbjct: 77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 128 GD-----------------------ERLLVAEYMP--NETLAKHLFHWET--HPMKWAMR 160
D LL+ E L L
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 161 LRVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGL-MKNSRDGKSY 215
+ L + SKG L H N + DG L K G +
Sbjct: 197 HILTAQLIRLAANLQSKG--LVHGHFTPDN---LFIMPDGRLMLGDVSALWKVGTRGPAS 251
Query: 216 STNLAFTPPEYL--RTGRVTPESVIYSFGTLLLDLLSGK---HIPPSHALDLIRDRNLQM 270
S + + P E+L T T + G + + + + +L++
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
L + L R L ++ R R P +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 51/264 (19%), Positives = 95/264 (35%), Gaps = 30/264 (11%)
Query: 75 VVYKGKLENQRR---IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V +G +++ +A+K + D + + EA+ + QL N + L+G C+ +
Sbjct: 25 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 83
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+LV E L K L + + ++ ++ ++Y K H DL A
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARN 140
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIYSFG 242
+L ++S FGL K SY + + PE + + + S ++S+G
Sbjct: 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 200
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
+ + LS P + I C EL L S C
Sbjct: 201 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWI 251
Query: 298 YEPRERPNPKSLVTALSPLQKETE 321
Y+ +RP+ ++ +
Sbjct: 252 YKWEDRPDFLTVEQRMRACYYSLA 275
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 45/249 (18%), Positives = 87/249 (34%), Gaps = 25/249 (10%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCC---CEGD 129
VYKG E +A + ++F EEA + L++ + +G
Sbjct: 42 VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101
Query: 130 ERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ + LV E M + TL +L MK + + + L++ ++ + H DL
Sbjct: 102 KCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 188 YRILFD-EDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTL 244
I G+ ++ GL R + + F PE +Y+FG
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMC 218
Query: 245 LLDLLSGKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+L++ + ++ + + +T F E+ + C++
Sbjct: 219 MLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
Query: 301 RERPNPKSL 309
ER + K L
Sbjct: 272 DERYSIKDL 280
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 55/279 (19%), Positives = 100/279 (35%), Gaps = 38/279 (13%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VY+G++ ++AVK + D FL EA + + + + +G +
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 129 DERLLVAEYMPNETLAKHL---FHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH 183
R ++ E M L L + P AM L V +A +Y H
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 204
Query: 184 -DLNAYRILFDEDGNPRL---STFGLMKNSRDGKSYSTNLA------FTPPEYLRTGRVT 233
D+ A L G R+ FG+ ++ Y + PPE G T
Sbjct: 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT 264
Query: 234 PESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
++ +SFG LL ++ S G L+ + +C +
Sbjct: 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG---------PV 315
Query: 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISPL 327
R+ ++C Q++P +RPN ++ + ++ + + L
Sbjct: 316 YRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 354
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 50/267 (18%), Positives = 99/267 (37%), Gaps = 35/267 (13%)
Query: 75 VVYKGKLENQRR-----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG + +A+K P ++ L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ + MP L ++ + L + +A+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSF 241
+L + +++ FGL K + + + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 242 GTLLLDLLS-GKH----IPPSHALDLIRD--RNLQMLTDSCLEGQFTDDDGTELVRLASR 294
G + +L++ G IP S ++ R Q C ++ + +
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP--PICTI---------DVYMIMVK 254
Query: 295 CLQYEPRERPNPKSLVTALSPLQKETE 321
C + RP + L+ S + ++ +
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 40/283 (14%), Positives = 66/283 (23%), Gaps = 68/283 (24%)
Query: 75 VVYKGK-LENQRRIAVK---RFNRMAWPDPRQFLEEARSVGQLRNNR------------- 117
+ E V R +Q EE + LR +
Sbjct: 93 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152
Query: 118 ---LTNLLGCCCEGDER-------------LLVAEYMPNETLAKHLFHW--ETHPMKWAM 159
L R L +T + L +
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 160 RLRVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215
RL++ L + + L G L H L + I+ D+ G L+ F +
Sbjct: 213 RLQLTLQVIRLLASLHHYG--LVHTYLRPVD---IVLDQRGGVFLTGFEHLVRDGASAVS 267
Query: 216 STNLAFTPPEYL----------RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD 265
F PPE +T ++ G + + P+ +
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNTDDAALGG 325
Query: 266 RNLQMLTDSCLEGQFTDDDGT--ELVRLASRCLQYEPRERPNP 306
E F + L L+Y +R P
Sbjct: 326 ----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP 358
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 57/277 (20%), Positives = 97/277 (35%), Gaps = 42/277 (15%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V+ + N +AVK + + F EA + L++ + G C EG
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 130 ERLLVAEYMPNETLAKHL-------------FHWETHPMKWAMRLRVVLHLAQALEYCTS 176
L+V EYM + L + L P+ L V +A + Y
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176
Query: 177 KGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRT 229
H DL L + ++ FG+ ++ Y PPE +
Sbjct: 177 LH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234
Query: 230 GRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
+ T ES ++SFG +L ++ + GK + + A+D I +C
Sbjct: 235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPP------- 287
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E+ + C Q EP++R + K + L L +
Sbjct: 288 --EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 51/275 (18%), Positives = 97/275 (35%), Gaps = 45/275 (16%)
Query: 76 VYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + + ++AVK + +E + L + + G C E
Sbjct: 37 VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
L+ E++P+ +L ++L + + +L+ + + + ++Y S+ H DL
Sbjct: 97 GNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA 153
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIY 239
A +L + + ++ FGL K K Y + PE L + S ++
Sbjct: 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 240 SFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV----RLAS- 293
SFG L +LL+ AL L GQ T + RL
Sbjct: 214 SFGVTLHELLTYCDSDSSPMALFLKMIGPTH--------GQMTVTRLVNTLKEGKRLPCP 265
Query: 294 ------------RCLQYEPRERPNPKSLVTALSPL 316
+C +++P R + ++L+ L
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 61/277 (22%), Positives = 108/277 (38%), Gaps = 45/277 (16%)
Query: 76 VYKGKL---ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCEGDE 130
V K ++ + A+KR A D R F E + +L ++ + NLLG C
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100
Query: 131 RLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQALEYCTS 176
L EY P+ L L + + + +LH A+ ++Y +
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160
Query: 177 KGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRT 229
K H DL A IL E+ +++ FGL SR + Y T E L
Sbjct: 161 KQ--FIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWMAIESLNY 215
Query: 230 GRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
T S ++S+G LL +++S G + + + + +C +
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD------- 268
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E+ L +C + +P ERP+ ++ +L+ + +E +
Sbjct: 269 --EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 33/194 (17%), Positives = 58/194 (29%), Gaps = 34/194 (17%)
Query: 132 LLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DL--- 185
L +T + L + RL++ L + + L G L H L
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPV 235
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYL-----------RTGRVTP 234
+ I+ D+ G L+ F + S + F PPE R +T
Sbjct: 236 D---IVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292
Query: 235 ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR-LAS 293
++ G ++ + P I ++ + + VR L
Sbjct: 293 SFDAWALGLVIYWIWCAD--LP------ITKDAALGGSEWIFRS---CKNIPQPVRALLE 341
Query: 294 RCLQYEPRERPNPK 307
L+Y +R P
Sbjct: 342 GFLRYPKEDRLLPL 355
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 54/270 (20%), Positives = 95/270 (35%), Gaps = 42/270 (15%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L +A+K A R+ F EA +L++ + LLG +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84
Query: 129 DERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--SKGRALY 182
++ Y + E L H + ++ L + + G Y
Sbjct: 85 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME-Y 143
Query: 183 -------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA------FTPPEYLR 228
H DL +L + N ++S GL + Y + PE +
Sbjct: 144 LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM 203
Query: 229 TGRVTPESVIYSFGTLLLDLLSGKHIP-PSHA----LDLIRDRNLQMLTDSCLEGQFTDD 283
G+ + +S I+S+G +L ++ S P ++ +++IR+R + D C
Sbjct: 204 YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA------ 257
Query: 284 DGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+ L C P RP K + + L
Sbjct: 258 ---WVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 39/251 (15%), Positives = 77/251 (30%), Gaps = 43/251 (17%)
Query: 64 IVSEHGEKAPNVVYKG---KLENQRRIAVK--RFNRMAWPDPRQ-FLEEARSVGQLRNNR 117
++ HG P ++ L+ R++A+ + D Q L + ++
Sbjct: 35 LLIFHGGVPPLQFWQALDTALD--RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK 177
+ +L L+VAE++ +L + +T P +R + LA A +
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA-IRAMQSLAAAADAAHRA 148
Query: 178 GRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPES 236
G + + R+ DG+ L+ M P+
Sbjct: 149 G--VALSIDHPSRVRVSIDGDVVLAYPATM-----------------------PDANPQD 183
Query: 237 VIYSFGTLLLDLLSGKHIPP---SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
I G L LL + P + + D ++ +A+
Sbjct: 184 DIRGIGASLYALLVNR--WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 294 RCLQYEPRERP 304
R +Q + R
Sbjct: 242 RSVQGDGGIRS 252
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 57/279 (20%), Positives = 97/279 (34%), Gaps = 44/279 (15%)
Query: 76 VYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V + +AVK+ R F E + + L ++ + G
Sbjct: 39 VELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98
Query: 131 R--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--SKG------RA 180
+ LV EY+P+ L L R R L ++ L Y + KG R
Sbjct: 99 QSLRLVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 181 LYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRV 232
H DL A IL + + + +++ FGL K K Y PE L
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG------- 285
+ +S ++SFG +L +L + S + + +R + + ++G
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP 267
Query: 286 ---TELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E+ L C P++RP+ +L L L +
Sbjct: 268 ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 45/244 (18%), Positives = 92/244 (37%), Gaps = 19/244 (7%)
Query: 76 VYKGK-LENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
K E+ R+ +K +RM+ + + E + +++ + E
Sbjct: 40 AILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
+V +Y L K + + + L + + AL++ + + L+ D+ + I
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFL 158
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
+DG +L FG+ + + TP PE +S I++ G +L +L
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT---ELVRLASRCLQYEPRERPN 305
+ K A +++ L + G F +L L S+ + PR+RP+
Sbjct: 219 CTLK--HAFEA------GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 306 PKSL 309
S+
Sbjct: 271 VNSI 274
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 47/282 (16%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNR-LTNLLGCC 125
V + + +AVK A D + E + + ++ + NLLG C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 126 CEGDERLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQAL 171
+ ++ EY L ++L + + M + ++ A+ +
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
EY S+ H DL A +L E+ +++ FGL ++ + Y +TN P
Sbjct: 171 EYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQ 279
E L T +S ++SFG L+ ++ + G IP L+++ + +C
Sbjct: 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN-- 286
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
EL + C P +RP K LV L + T
Sbjct: 287 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 47/282 (16%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNR-LTNLLGCC 125
V + + +AVK A D + E + + ++ + NLLG C
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156
Query: 126 CEGDERLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQAL 171
+ ++ EY L ++L + + M + ++ A+ +
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
EY S+ H DL A +L E+ +++ FGL ++ + Y +TN P
Sbjct: 217 EYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQ 279
E L T +S ++SFG L+ ++ + G IP L+++ + +C
Sbjct: 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN-- 332
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
EL + C P +RP K LV L + T
Sbjct: 333 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 51/260 (19%), Positives = 85/260 (32%), Gaps = 53/260 (20%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARS-VGQLRN-NRLTNL--LGCCCEGDE 130
+VY+G +N R +AVKR + A V LR + N+ C + +
Sbjct: 40 IVYRGMFDN-RDVAVKRILP-------ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 131 RL-LVAEYMPNE----TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-D 184
+ E K H P+ ++ L + S + H D
Sbjct: 92 FQYIAIELCAATLQEYVEQKDFAHLGLEPIT------LLQQTTSGLAHLHSLN--IVHRD 143
Query: 185 LNAYRILF---DEDGNPR--LSTFGLMKNSRDGKSYSTNLAF---TP----PEYLR---T 229
L + IL + G + +S FGL K G+ + + T PE L
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 230 GRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
T I+S G + ++S P A L+ +L L +
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE-------KHE 256
Query: 285 GTELVRLASRCLQYEPRERP 304
L + + +P++RP
Sbjct: 257 DVIARELIEKMIAMDPQKRP 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 52/245 (21%), Positives = 84/245 (34%), Gaps = 26/245 (10%)
Query: 76 VYKG-KLENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDER 131
V+K E+ R AVKR D + L E S ++ + L EG
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132
Query: 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
L E +L +H W + A + AL + S+G ++ D+ I
Sbjct: 133 YLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIF 189
Query: 192 FDEDGNPRLSTFGLMKN-SRDGKSYSTNLAF--TP----PEYLRTGRVTPESVIYSFGTL 244
G +L FGL+ G P PE L+ + ++S G
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEV----QEGDPRYMAPELLQGSY-GTAADVFSLGLT 244
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
+L++ P Q L L +FT +EL + L+ +P+ R
Sbjct: 245 ILEVACNME-LPHGG------EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA 297
Query: 305 NPKSL 309
++L
Sbjct: 298 TAEAL 302
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 62/279 (22%), Positives = 104/279 (37%), Gaps = 52/279 (18%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V K +AVK A + R L E + Q+ + + L G C +
Sbjct: 39 VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98
Query: 129 DERLLVAEYMPN------------------ETLAKHLFHWETHPMKWAMRLRVVLH---- 166
LL+ EY + HP + A+ + ++
Sbjct: 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF-- 221
++Q ++Y L H DL A IL E ++S FGL ++ + SY +
Sbjct: 159 ISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPV 216
Query: 222 --TPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDS 274
E L T +S ++SFG LL ++++ G + IPP +L++ + D+
Sbjct: 217 KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDN 276
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
C E E+ RL +C + EP +RP + L
Sbjct: 277 CSE---------EMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 39/192 (20%), Positives = 75/192 (39%), Gaps = 16/192 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY + ++A+K ++F E + QL + + +++ E D
Sbjct: 26 TVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
LV EY+ TL++++ P+ + + +++ + H D+
Sbjct: 86 YYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQN 141
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF-TP----PEYLRTGRVTPESVIYSFGTL 244
IL D + ++ FG+ K + TN T PE + + IYS G +
Sbjct: 142 ILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201
Query: 245 LLDLLSGKHIPP 256
L ++L G+ PP
Sbjct: 202 LYEMLVGE--PP 211
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 55/250 (22%), Positives = 100/250 (40%), Gaps = 20/250 (8%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + M V QALE+ S ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQV-IHRDIKS 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 244 LLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+ ++++ G+ + P AL LI L + + + +RCL+ +
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---EKLSA----IFRDFLNRCLEMD 257
Query: 300 PRERPNPKSL 309
+R + K L
Sbjct: 258 VEKRGSAKEL 267
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 63/286 (22%), Positives = 102/286 (35%), Gaps = 50/286 (17%)
Query: 76 VYKGKLEN------QRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
V++ + +AVK A D + F EA + + N + LLG C G
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122
Query: 129 DERLLVAEYMPN------------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT- 175
L+ EYM T+ + + + L A+ L
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 176 -SKGRALY-------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF--- 221
+ G A Y H DL L E+ +++ FGL +N Y N A
Sbjct: 183 VAAGMA-YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 222 -TPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSC 275
PPE + R T ES ++++G +L ++ S G + + +RD N+ ++C
Sbjct: 242 WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENC 301
Query: 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
EL L C P +RP+ S+ L + + E
Sbjct: 302 PL---------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 51/270 (18%), Positives = 101/270 (37%), Gaps = 30/270 (11%)
Query: 76 VYKGK-LENQRRIAVKR---FNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VY+ L + +A+K+ F+ M ++E + QL + + E +E
Sbjct: 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 132 LLVAEYMPNETLAKHL--FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+V E L++ + F + + + + L ALE+ S+ + H D+
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPA 165
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTL 244
+ G +L GL + + + +L TP PE + +S I+S G L
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF----TDDDGTELVRLASRCLQYEP 300
L ++ + + P + NL L + + +D EL +L + C+ +P
Sbjct: 226 LYEMAALQ--SPFYG----DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279
Query: 301 RERPN-------PKSLVTALSPLQKETEFS 323
+RP+ K + + +
Sbjct: 280 EKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 50/250 (20%), Positives = 95/250 (38%), Gaps = 20/250 (8%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
GE + +V + + R++AVK + E + ++ + +
Sbjct: 54 GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
G+E ++ E++ L + + V + QAL Y ++G ++ D+ +
Sbjct: 114 GEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGV-IHRDIKS 169
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + E I+S G
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 244 LLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
++++++ G+ P A+ +RD L +S + + L R L +
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS---HKVSP----VLRDFLERMLVRD 282
Query: 300 PRERPNPKSL 309
P+ER + L
Sbjct: 283 PQERATAQEL 292
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 48/283 (16%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRN-NRLTNLLGCCCE 127
V + + +AVK A + + E + + L N + NLLG C
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98
Query: 128 GDERLLVAEYMPN------------ETLAKHLFHWETHPMKWAMRLRVVLHL----AQAL 171
G L++ EY + + A+ L +L A+ +
Sbjct: 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
+ SK H DL A IL ++ FGL ++ ++ +Y N P
Sbjct: 159 AFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNLQMLTDSCLEG 278
E + T ES ++S+G L +L S P P + +I++ + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPA- 275
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E+ + C +P +RP K +V + E+
Sbjct: 276 --------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 54/283 (19%), Positives = 92/283 (32%), Gaps = 54/283 (19%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEAR---SVGQLRNNRLTNLLGCC 125
V + + ++AVK A + + E + +GQ N + NLLG C
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN--IVNLLGAC 119
Query: 126 CEGDERLLVAEYMPN------------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY 173
G L++ EY F L +AQ + +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 174 CTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRD---GKSY--STNLAF----TP 223
SK H D+ A +L ++ FGL +RD +Y N
Sbjct: 180 LASKN--CIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMNDSNYIVKGNARLPVKWMA 234
Query: 224 PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNLQMLTDSCLE 277
PE + T +S ++S+G LL ++ S P ++ L++D +
Sbjct: 235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPK 294
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
+ + C EP RP + + + L +E
Sbjct: 295 ---------NIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 54/282 (19%), Positives = 97/282 (34%), Gaps = 47/282 (16%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCE 127
V + R +AVK A + R + E + + + ++ + NLLG C +
Sbjct: 43 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102
Query: 128 GDE-RLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLH----LAQALE 172
+++ E+ L+ +L K + L ++ +A+ +E
Sbjct: 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 162
Query: 173 YCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPE 225
+ S+ H DL A IL E ++ FGL ++ Y + PE
Sbjct: 163 FLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220
Query: 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIP------PSHALDLIRDRNLQMLTDSCLEGQ 279
+ T +S ++SFG LL ++ S P +++ D
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-- 278
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E+ + C EP +RP LV L L +
Sbjct: 279 -------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 45/249 (18%), Positives = 83/249 (33%), Gaps = 30/249 (12%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V++ K + + AVK+ + R EE + L + R+ L G EG +
Sbjct: 74 VHRMKDKQTGFQCAVKK---VRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIF 128
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E + +L + + + L + + LEY ++ L+ D+ A +L
Sbjct: 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSS 185
Query: 195 DGNP-RLSTFGLMKNSRDGKSYSTNLAF-----TP----PEYLRTGRVTPESVIYSFGTL 244
DG+ L FG + + L T PE + + I+S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 245 LLDLLSGKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+L +L+G H I ++ + + L+ EP
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIA-------SEPPPIREIPPSCAPLTAQAIQEGLRKEP 298
Query: 301 RERPNPKSL 309
R + L
Sbjct: 299 VHRASAMEL 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 52/271 (19%), Positives = 92/271 (33%), Gaps = 49/271 (18%)
Query: 75 VVYKGK-LENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VV++ K + A+K R + + E +++ +L + + E +
Sbjct: 20 VVFEAKNKVDDCNYAIKRIRLPNREL-AREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 132 L------------LVAEYMPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKG 178
+ + E L + T + ++ L + L +A+A+E+ SKG
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 179 RALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRV-TP-- 234
L H DL I F D ++ FGL+ + T L P TG+V T
Sbjct: 139 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196
Query: 235 -------------ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
+ I+S G +L +LL P S ++ +R +F
Sbjct: 197 MSPEQIHGNSYSHKVDIFSLGLILFELL----YPFSTQMERVR------TLTDVRNLKFP 246
Query: 282 DDDGT---ELVRLASRCLQYEPRERPNPKSL 309
+ L P ERP ++
Sbjct: 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 19/146 (13%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFT 222
+ A++YC K + H DL A +L D D N +++ FG G +
Sbjct: 123 IVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 223 PPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280
PE + G+ PE ++S G +L L+SG +P +NL+ L + L G++
Sbjct: 181 APELFQ-GKKYDGPEVDVWSLGVILYTLVSG-SLP-------FDGQNLKELRERVLRGKY 231
Query: 281 TDDDG--TELVRLASRCLQYEPRERP 304
T+ L R L P +R
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRG 257
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 49/268 (18%), Positives = 87/268 (32%), Gaps = 42/268 (15%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-- 132
V K + + R A+K+ R L E + L + + E +
Sbjct: 22 VVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80
Query: 133 -----------LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
+ EY N TL + + + R+ + +AL Y S+G +
Sbjct: 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQILEALSYIHSQG--I 137
Query: 182 YH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--------------TP--- 223
H DL I DE N ++ FGL KN + T
Sbjct: 138 IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV 197
Query: 224 -PEYLR-TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
E L TG + +YS G + +++ P S ++ + F
Sbjct: 198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIEFPPDFD 253
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSL 309
D+ ++ + ++P +RP ++L
Sbjct: 254 DNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 56/287 (19%), Positives = 97/287 (33%), Gaps = 51/287 (17%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCE 127
V ++AVK A + + E + + QL ++ + NLLG C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120
Query: 128 GDERLLVAEYMPN-----------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT- 175
L+ EY E ++ +E VL L +
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 176 -SKGRALY-------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF--- 221
+KG + H DL A +L ++ FGL ++ +Y N
Sbjct: 181 VAKGME-FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 239
Query: 222 -TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP------PSHALDLIRDRNLQMLTDS 274
PE L G T +S ++S+G LL ++ S P ++ LI++
Sbjct: 240 WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY 299
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E E+ + C ++ R+RP+ +L + L + E
Sbjct: 300 ATE---------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 45/254 (17%), Positives = 94/254 (37%), Gaps = 35/254 (13%)
Query: 75 VVYKGKLENQRRIAVKR--FNRMAWPDPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130
V++ E ++ A+K + E + +L+ ++++ L D+
Sbjct: 43 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 101
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+ +V E + L L ++ ++ +A+ G + H DL
Sbjct: 102 YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPA 156
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKS--YSTNLAFTP----PEYLR-----------TGR 231
L DG +L FG+ + + + T PE ++ +
Sbjct: 157 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 232 VTPESVIYSFGTLLLDLLSGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290
++P+S ++S G +L + GK P ++ I L + D E +F D +L
Sbjct: 216 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 291 LASRCLQYEPRERP 304
+ CL+ +P++R
Sbjct: 272 VLKCCLKRDPKQRI 285
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 19/160 (11%)
Query: 161 LRVVLHLAQALEYCTSKGRALYH----DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS 216
LRV+ L AL+ C + + DL + D N +L FGL + S++
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 217 TNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272
TP PE + +S I+S G LL +L + PP A + + L
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTA------FSQKELA 225
Query: 273 DSCLEGQFT---DDDGTELVRLASRCLQYEPRERPNPKSL 309
EG+F EL + +R L + RP+ + +
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 45/194 (23%), Positives = 75/194 (38%), Gaps = 22/194 (11%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNL--LGCCCEGD 129
VY+ + +R +A+K + DP + EAR+ G+L+ + + G E D
Sbjct: 50 VYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG---EID 106
Query: 130 ERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+L + + LA L P+ + +V + AL+ + G H D+
Sbjct: 107 GQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKP 162
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFG 242
IL D L FG+ + D K L + PE T + IY+
Sbjct: 163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT 222
Query: 243 TLLLDLLSGKHIPP 256
+L + L+G PP
Sbjct: 223 CVLYECLTGS--PP 234
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 46/271 (16%), Positives = 81/271 (29%), Gaps = 34/271 (12%)
Query: 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNL 121
IV K + E P + + ++ N
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 122 LGCCCEGDERLL---VAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSK 177
+G ++ + E L + + + + L + + +A+A+E+ SK
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 178 GRALYHDL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRV-T 233
G ++ DL N I F D ++ FGL+ + T L P TG+V T
Sbjct: 184 G-LMHRDLKPSN---IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 234 P---------------ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278
+ I+S G +L +LL + RNL+
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLF---- 295
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + L P ERP +
Sbjct: 296 ---TQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 63/276 (22%), Positives = 100/276 (36%), Gaps = 49/276 (17%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC 126
G A VV + ++A+KR N + L+E +++ Q + + +
Sbjct: 24 GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83
Query: 127 EGDERLLVAEYMPN---ETLAKHLFHWETHPMKW------AMRLRVVLHLAQALEYCTSK 177
DE LV + + + KH+ H A LR VL + LEY
Sbjct: 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL---EGLEYLHKN 140
Query: 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVT---- 233
G+ ++ D+ A IL EDG+ +++ FG S LA R T
Sbjct: 141 GQ-IHRDVKAGNILLGEDGSVQIADFG----------VSAFLATGGDITRNKVRKTFVGT 189
Query: 234 -----PESV-----------IYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTD 273
PE + I+SFG ++L +G PP L L + L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + G ++ S CLQ +P +RP L
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 34/176 (19%), Positives = 61/176 (34%), Gaps = 17/176 (9%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
L+ E+ P L K L + + + LA AL YC + + H D+ +L
Sbjct: 91 LMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADALHYCHERK--VIHRDIKPENLL 146
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G +++ FG ++ + + L + PPE + + ++ G L + L
Sbjct: 147 MGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT--DDDGTELVRLASRCLQYEPRER 303
G PP + + L S+ L+Y P +R
Sbjct: 207 VGM--PPFD------SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQR 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 30/201 (14%)
Query: 76 VYKGK-LENQRRIAVK----RFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLL--GCC 125
V+ + L + R +AVK R DP +F EA++ L + + + G
Sbjct: 28 VHLARDLRDHRDVAVKVLRADLAR----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83
Query: 126 CEGDERL--LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
L +V EY+ TL + PM + V+ QAL + G + H
Sbjct: 84 ETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG--IIH 139
Query: 184 -DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPE 235
D+ I+ ++ FG+ + D + T + PE R V
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 236 SVIYSFGTLLLDLLSGKHIPP 256
S +YS G +L ++L+G+ PP
Sbjct: 200 SDVYSLGCVLYEVLTGE--PP 218
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 2e-07
Identities = 43/353 (12%), Positives = 90/353 (25%), Gaps = 97/353 (27%)
Query: 13 WNSQ------FKATVL----EAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFAVE 62
N++ +L D + + T +++K+
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL---LL-- 308
Query: 63 NIVSEHGEKAPNVVYKGKLENQRRIAV----KRFNRMAWPDPRQFLEEARSVGQLRNNRL 118
+ + P V N RR+++ R W + + ++L
Sbjct: 309 KYLDCRPQDLPREVLTT---NPRRLSIIAESIRDGLATW----DNWK------HVNCDKL 355
Query: 119 TNLLGCCCEG-DERLLVAEYM-----------PNETLAKHLFHW----ETHPM------- 155
T ++ + + P L+ L W ++ M
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS--LI-WFDVIKSDVMVVVNKLH 412
Query: 156 ------KWAMRLRVVLHLAQALEYCTSKGRALYHD--LNAYRIL--FDEDGNPRLSTFGL 205
K + + + H ++ Y I FD D
Sbjct: 413 KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 206 --------MKNSRDGKSYS------TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL-LS 250
+KN + + + F + T + S L L
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS--TAWNASGSILNTLQQLKFY 530
Query: 251 GKHIPPSHALD--LIRD--RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+I + L+ L + ++ + ++TD L+R+A L E
Sbjct: 531 KPYICDNDPKYERLVNAILDFLPKIEENLICSKYTD-----LLRIA---LMAE 575
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 42/176 (23%), Positives = 66/176 (37%), Gaps = 17/176 (9%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
L+ EY P T+ + L + + LA AL YC SK + H D+ +L
Sbjct: 86 LILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHSKR--VIHRDIKPENLL 141
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G +++ FG ++ + L + PPE + + ++S G L + L
Sbjct: 142 LGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT--DDDGTELVRLASRCLQYEPRER 303
GK PP Q +FT D L SR L++ P +R
Sbjct: 202 VGK--PP------FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 249
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 45/254 (17%), Positives = 94/254 (37%), Gaps = 35/254 (13%)
Query: 75 VVYKGKLENQRRIAVKR--FNRMAWPDPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130
V++ E ++ A+K + E + +L+ ++++ L D+
Sbjct: 24 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 82
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+ +V E + L L ++ ++ +A+ G + H DL
Sbjct: 83 YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPA 137
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--TP----PEYLR-----------TGR 231
L DG +L FG+ + + + T PE ++ +
Sbjct: 138 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 232 VTPESVIYSFGTLLLDLLSGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290
++P+S ++S G +L + GK P ++ I L + D E +F D +L
Sbjct: 197 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 252
Query: 291 LASRCLQYEPRERP 304
+ CL+ +P++R
Sbjct: 253 VLKCCLKRDPKQRI 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 44/253 (17%), Positives = 91/253 (35%), Gaps = 33/253 (13%)
Query: 75 VVYKGKLENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130
V++ E ++ A+K N + E + +L+ ++++ L
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+V E + L L ++ ++ +A+ G + H DL
Sbjct: 131 IYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPAN 185
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKS--YSTNLAFTP----PEYLR-----------TGRV 232
L DG +L FG+ + + + PE ++ ++
Sbjct: 186 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 233 TPESVIYSFGTLLLDLLSGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291
+P+S ++S G +L + GK P ++ I L + D E +F D +L +
Sbjct: 245 SPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 292 ASRCLQYEPRERP 304
CL+ +P++R
Sbjct: 301 LKCCLKRDPKQRI 313
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 49/277 (17%), Positives = 90/277 (32%), Gaps = 46/277 (16%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDER-- 131
VY+ + + + R A+KR R ++E + +L + + G E
Sbjct: 44 VYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103
Query: 132 ------LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-D 184
LL+ E + + P+ L++ +A+++ + + H D
Sbjct: 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF------------TP----PEYLR 228
L +L G +L FG YS + TP PE +
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 229 TGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT---- 281
+ + I++ G +L L +H P +R + G+++
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQH--PFEDGAKLR----------IVNGKYSIPPH 271
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
D T L LQ P ER + +V L +
Sbjct: 272 DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 52/272 (19%), Positives = 87/272 (31%), Gaps = 56/272 (20%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARS-VGQLRNNRLT---NL--LGCCCEG 128
VV++G + + AVKR F + A + L N+ C
Sbjct: 31 VVFQGSFQGRPV-AVKRMLI-------DFCDIALMEIKLLT--ESDDHPNVIRYYCSETT 80
Query: 129 DERL-LVAEYMPNE----TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
D L + E +K++ K + ++ +A + + S + H
Sbjct: 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIH 138
Query: 184 -DLNAYRILFD-------------EDGNPRLSTFGLMKNSRDGKSYSTNLAFTP------ 223
DL IL E+ +S FGL K G+S P
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 224 --PEYLR-------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--LT 272
PE L R+T I+S G + +LS P R+ N+ +
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--KYSRESNIIRGIFS 256
Query: 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
++ E L S+ + ++P +RP
Sbjct: 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 32/182 (17%), Positives = 66/182 (36%), Gaps = 18/182 (9%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
+ E+ TL + + + + L + + + ++Y SK L + DL I
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF 154
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLD 247
+ ++ FGL+ + ++ + + T PE + + E +Y+ G +L +
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRTRSKG-TLRYMSPEQISSQDYGKEVDLYALGLILAE 213
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
LL D +G +D + L + L +P +RPN
Sbjct: 214 LLHVCD-TAFETSKFFTD---------LRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 308 SL 309
+
Sbjct: 264 EI 265
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 42/265 (15%), Positives = 78/265 (29%), Gaps = 43/265 (16%)
Query: 75 VVYKG-KLENQRRIAVKRFNRMAWPDP--RQFLEEARSVGQLRNNR-LTNLLGCCCEGDE 130
V+K K + A+KR + + L E + L + + E D
Sbjct: 26 SVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85
Query: 131 RLLVAEYMPNETLAKHL--FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ EY +LA + + K A ++L + + L Y S L H D+
Sbjct: 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKP 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-F--------------TP----PEYLR 228
I P ++ ++ + E L+
Sbjct: 144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ 203
Query: 229 -TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL---IRDRNLQMLTDSCLEGQFTDDD 284
P++ I++ ++ + P D IR L + +
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAE--PLPRNGDQWHEIRQGRL-----PRIPQVLSQ-- 254
Query: 285 GTELVRLASRCLQYEPRERPNPKSL 309
E L + +P RP+ +L
Sbjct: 255 --EFTELLKVMIHPDPERRPSAMAL 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 46/271 (16%), Positives = 86/271 (31%), Gaps = 39/271 (14%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDE 130
V + L + A+KR D + EA + + L+ C E
Sbjct: 45 VDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ + TL + + L ++L + + LE +KG H DL
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKP 162
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTG----------------R 231
IL ++G P L G M + S +
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222
Query: 232 VTPESVIYSFGTLLLDLLSGKH-----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286
+ + ++S G +L ++ G+ ++ L L + +
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH--------SS 274
Query: 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317
L +L + + +P +RP+ L++ L LQ
Sbjct: 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 29/266 (10%), Positives = 67/266 (25%), Gaps = 47/266 (17%)
Query: 75 VVYKGK------LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN---LLGCC 125
VY+ +N+++ +K +P +F + + +L+ +
Sbjct: 80 QVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136
Query: 126 CEGDERLLVAEYMPNETL---AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA-- 180
+ +LV E TL + M + + + + +E
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 181 --------LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEY-- 226
L + D L G S D K + FT +
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ---SIDMKLFPKGTIFTAKCETSGFQC 253
Query: 227 --LRTGRVTPESV-IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283
+ + + + + + +L G ++ +++ + + D
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-------VKNEGGECKPEGLFRRLPHLD 306
Query: 284 DGTELVRLASRCLQYEPRERPNPKSL 309
E L L
Sbjct: 307 MWNEFFH---VMLNIPDCHHLPSLDL 329
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 36/160 (22%), Positives = 58/160 (36%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
R++ + + Y + H DL +L +D N R+ FGL + K
Sbjct: 130 RIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE L G + ++S G +L LLSG PP + N +
Sbjct: 188 -KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC--PPFN------GANEYDILK 237
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+G++T + +L+R + L Y P R
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKDLIR---KMLTYVPSMRI 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
++ + + Y + H DL +L ++D ++ FGL + K
Sbjct: 140 VIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE 197
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE LR + + ++S G +L LL+G PP + Q +
Sbjct: 198 -RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY--PP------FGGQTDQEILR 247
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+G++T + +L++ + LQ++ + R
Sbjct: 248 KVEKGKYTFDSPEWKNVSEGAKDLIK---QMLQFDSQRRI 284
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 37/173 (21%), Positives = 61/173 (35%), Gaps = 41/173 (23%)
Query: 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD-EDGN 197
E ++ F + A+++C S+G + H D+ IL D G
Sbjct: 137 GEGPSRCFFG----------------QVVAAIQHCHSRG--VVHRDIKDENILIDLRRGC 178
Query: 198 PRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKH 253
+L FG D Y+ ++PPE++ + + ++S G LL D++ G
Sbjct: 179 AKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
Query: 254 IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRERP 304
P I LE + + L RCL +P RP
Sbjct: 238 --PFERDQEI------------LEAELHFPAHVSPDCCALIRRCLAPKPSSRP 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 46/275 (16%), Positives = 76/275 (27%), Gaps = 29/275 (10%)
Query: 68 HGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPR--QFLEEARSVGQLRNNRLTNLLGC 124
G + V + + V+R N A + E + +
Sbjct: 35 KGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 125 CCEGDERLLVAEYMPNETLAKHLFHWETHPMK---WAMRLRVVLHLAQALEYCTSKGRAL 181
+E +V +M + + M A L+ VL +AL+Y G
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHMGYV- 150
Query: 182 YH-DLNAYRILFDEDGNPRLSTFGL-------MKNSRDGKSYSTNLAFTP----PEYLRT 229
H + A IL DG LS + R + PE L+
Sbjct: 151 -HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 230 GRV--TPESVIYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283
+S IYS G +L +G +P + L + + L D+
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269
Query: 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
S P P + + P +
Sbjct: 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 36/148 (24%), Positives = 58/148 (39%), Gaps = 21/148 (14%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTNL--- 219
L LEY S+G + H D+ +L G ++S G+ + + T+
Sbjct: 118 LIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 220 AFTPPEYLRTGRV--TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277
AF PPE + I+S G L ++ +G P N+ L ++ +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG-LYP-------FEGDNIYKLFENIGK 227
Query: 278 GQFT--DDDGTELVRLASRCLQYEPRER 303
G + D G L L L+YEP +R
Sbjct: 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKR 255
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 40/173 (23%), Positives = 65/173 (37%), Gaps = 41/173 (23%)
Query: 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDED-GN 197
E LA+ F + +A+ +C + G + H D+ IL D + G
Sbjct: 147 QEELARSFFW----------------QVLEAVRHCHNCG--VLHRDIKDENILIDLNRGE 188
Query: 198 PRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKH 253
+L FG +D Y+ ++PPE++R R + ++S G LL D++ G
Sbjct: 189 LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
Query: 254 IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRERP 304
P + I + GQ +E L CL P +RP
Sbjct: 248 --PFEHDEEI------------IRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 29/160 (18%), Positives = 55/160 (34%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
++ + + Y + H D+ IL + N ++ FGL
Sbjct: 150 NIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE L+ + + ++S G ++ LL G PP +N Q +
Sbjct: 208 -RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY--PPFGG------QNDQDIIK 257
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+G++ D+ EL++ L Y+ +R
Sbjct: 258 KVEKGKYYFDFNDWKNISDEAKELIK---LMLTYDYNKRC 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 34/144 (23%), Positives = 54/144 (37%), Gaps = 19/144 (13%)
Query: 122 LGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSK 177
+ ++L + + M L HL + + A+ LE+ ++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHNR 311
Query: 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVT 233
+Y DL IL DE G+ R+S GL + K ++ T PE L+ G
Sbjct: 312 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAY 368
Query: 234 PESVIY-SFGTLLLDLLSGKHIPP 256
S + S G +L LL G P
Sbjct: 369 DSSADWFSLGCMLFKLLRGH--SP 390
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 7e-06
Identities = 34/179 (18%), Positives = 62/179 (34%), Gaps = 18/179 (10%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
LV E N + ++L P + + + Y S G + H DL +L
Sbjct: 88 LVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLL 144
Query: 192 FDEDGNPRLSTFGL-MKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
+ N +++ FGL + + + T + PE ES ++S G +
Sbjct: 145 LTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYT 204
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT--DDDGTELVRLASRCLQYEPRERP 304
LL G+ PP ++ + + + E L + L+ P +R
Sbjct: 205 LLIGR--PPFD------TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRL 255
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 35/214 (16%)
Query: 108 RSVGQLRNNRLTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLH 166
+ + + N+R L E + L LV M L H++H A R V +
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFY 291
Query: 167 LAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF-- 221
A+ LE + +Y DL IL D+ G+ R+S GL + +G++
Sbjct: 292 AAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RVG 347
Query: 222 TPPEYLRTGRVTPESVIY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNLQML 271
T Y+ PE V + G LL ++++G+ P + + +
Sbjct: 348 T-VGYM-----APEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRK--KKIKREEV 397
Query: 272 TDSCLEGQ--FTDDDGTELVRLASRCLQYEPRER 303
E +++ + L S+ L +P ER
Sbjct: 398 ERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 28/138 (20%), Positives = 56/138 (40%), Gaps = 20/138 (14%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRL------RVVLHLAQALEYCTSKGRALYH-DL 185
++ EYM N+++ K ++ + + ++ + + Y ++ + + H D+
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE-KNICHRDV 178
Query: 186 ---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYL--RTGRVTPESVI 238
N IL D++G +LS FG + D K + F PPE+ + + I
Sbjct: 179 KPSN---ILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 239 YSFGTLLLDLLSGKHIPP 256
+S G L + P
Sbjct: 236 WSLGICLYVMFYNV--VP 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 8e-06
Identities = 32/151 (21%), Positives = 54/151 (35%), Gaps = 17/151 (11%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL-MKNSRDGKSYSTN---LAF 221
+ +Y + H DL + +ED ++ FGL K DG+ +
Sbjct: 124 IVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
PE L + E ++S G ++ LL GK PP L+ + +++
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFE------TSCLKETYLRIKKNEYS 233
Query: 282 --DDDGTELVRLASRCLQYEPRERPNPKSLV 310
L + LQ +P RP L+
Sbjct: 234 IPKHINPVAASLIQKMLQTDPTARPTINELL 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 46/250 (18%), Positives = 95/250 (38%), Gaps = 20/250 (8%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
GE + VYK E + +A+K+ + D ++ ++E + Q + + G +
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+ +V EY +++ + + ++ + LEY + ++ D+ A
Sbjct: 96 NTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK-IHRDIKA 153
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL + +G+ +L+ FG+ D + + TP PE ++ + I+S G
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGI 213
Query: 244 LLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+++ GK I P A+ +I ++D +CL
Sbjct: 214 TAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP---ELWSD----NFTDFVKQCLVKS 266
Query: 300 PRERPNPKSL 309
P +R L
Sbjct: 267 PEQRATATQL 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 32/151 (21%), Positives = 54/151 (35%), Gaps = 17/151 (11%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL-MKNSRDGKSYST---NLAF 221
+ +Y + H DL + +ED ++ FGL K DG+ +
Sbjct: 150 IVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
PE L + E ++S G ++ LL GK PP L+ + +++
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFE------TSCLKETYLRIKKNEYS 259
Query: 282 --DDDGTELVRLASRCLQYEPRERPNPKSLV 310
L + LQ +P RP L+
Sbjct: 260 IPKHINPVAASLIQKMLQTDPTARPTINELL 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 35/165 (21%), Positives = 60/165 (36%), Gaps = 40/165 (24%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217
+++ L + + + H DL N IL D+D N +L+ FG G+
Sbjct: 128 KIMRALLEVICALHKLN--IVHRDLKPEN---ILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 218 NLAFTP----PEYLRTGRV------TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267
+ TP PE + E ++S G ++ LL+G PP R
Sbjct: 183 -VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFW------HRK 233
Query: 268 LQMLTDSCLEGQFT---------DDDGTELVRLASRCLQYEPRER 303
++ + G + D +LV R L +P++R
Sbjct: 234 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKR 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 41/160 (25%), Positives = 56/160 (35%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
R++ + A+ YC + H DL LF D +L FGL + GK T
Sbjct: 110 RIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
TP P+ L G PE +S G ++ LL G PP +
Sbjct: 168 -KVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGY--PPFS------APTDSEVML 217
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
EG FT L+R R L P++R
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAESLIR---RLLTKSPKQRI 254
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 42/198 (21%), Positives = 74/198 (37%), Gaps = 28/198 (14%)
Query: 122 LGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSK 177
L E L LV M + H+++ + + R + + AQ LE+ +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQR 308
Query: 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV 237
+Y DL +L D+DGN R+S GL + G++ + A T P ++ PE +
Sbjct: 309 N-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT-PGFM-----APELL 361
Query: 238 IY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ--FTDDDG 285
+ + G L ++++ + P A + L LE + D
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR--GPFRARG--EKVENKELKQRVLEQAVTYPDKFS 417
Query: 286 TELVRLASRCLQYEPRER 303
LQ +P +R
Sbjct: 418 PASKDFCEALLQKDPEKR 435
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 41/164 (25%), Positives = 61/164 (37%), Gaps = 34/164 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILF-DEDGNP---RLSTFGLMKNSRDGK 213
V+ + + +EY ++G H DL N IL+ DE GNP R+ FG K R
Sbjct: 120 AVLFTITKTVEYLHAQGVV--HRDLKPSN---ILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 214 SYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ 269
+T PE L I+S G LL +L+G P D +
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG--YTPFANG---PDDTPE 229
Query: 270 MLTDSCLEGQFTDDDGT---------ELVRLASRCLQYEPRERP 304
+ G+F+ G +LV + L +P +R
Sbjct: 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVS---KMLHVDPHQRL 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 55/245 (22%), Positives = 99/245 (40%), Gaps = 23/245 (9%)
Query: 75 VVYKGK-LENQRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V+KG Q+ +A+K + A + +E + Q + +T G + +
Sbjct: 37 EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96
Query: 133 LVAEYMPNETLAKHLFHWETHPMKW-AMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
++ EY+ + L A LR +L + L+Y S+ + ++ D+ A +L
Sbjct: 97 IIMEYLGGGSAL-DLLEPGPLDETQIATILREIL---KGLDYLHSEKK-IHRDIKAANVL 151
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLD 247
E G +L+ FG+ D + TP PE ++ ++ I+S G ++
Sbjct: 152 LSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDS---CLEGQFTDDDGTELVRLASRCLQYEPRERP 304
L G+ PP L ++ L ++ + LEG ++ L CL EP RP
Sbjct: 212 LARGE--PPHSELHPMK--VLFLIPKNNPPTLEGNYSK----PLKEFVEACLNKEPSFRP 263
Query: 305 NPKSL 309
K L
Sbjct: 264 TAKEL 268
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 45/248 (18%), Positives = 86/248 (34%), Gaps = 23/248 (9%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VYK K E A K + + ++ E + + + LLG + ++
Sbjct: 35 VYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E+ P + + + V + +AL + SK ++ DL A +L
Sbjct: 95 IEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI-IHRDLKAGNVLMTL 152
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PE-----YLRTGRVTPESVIYSFGTLL 245
+G+ RL+ FG+ + + TP PE ++ ++ I+S G L
Sbjct: 153 EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 246 LDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+++ + + P L I + L +++ E L P
Sbjct: 213 IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT---PSKWSV----EFRDFLKIALDKNPE 265
Query: 302 ERPNPKSL 309
RP+ L
Sbjct: 266 TRPSAAQL 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 31/159 (19%), Positives = 57/159 (35%), Gaps = 31/159 (19%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
++ + AL Y S+ + H DL ILF ++ FGL + + + +
Sbjct: 128 ELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE + VT + I+S G ++ LL+G P +L+ +
Sbjct: 186 AAG-TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC--LPFT------GTSLEEVQQ 235
Query: 274 SCLEGQFT--------DDDGTELVRLASRCLQYEPRERP 304
+ +L++ + L +P RP
Sbjct: 236 KATYKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRP 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 4e-05
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 19/145 (13%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFT 222
+ A++YC + H DL +L D N +++ FGL DG+ T + +
Sbjct: 120 ILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177
Query: 223 PPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280
PE + GR PE I+S G +L LL G +P D ++ L G F
Sbjct: 178 APEVIS-GRLYAGPEVDIWSCGVILYALLCG-TLP-------FDDEHVPTLFKKIRGGVF 228
Query: 281 T--DDDGTELVRLASRCLQYEPRER 303
+ + L LQ +P +R
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKR 253
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 38/163 (23%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILF---DEDGNPRLSTFGLMKNSRDGKS 214
R++ + + Y + H DL N IL ++D + ++ FGL +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPEN---ILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 215 YSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM 270
T PE LR G + ++S G +L LLSG PP + +N
Sbjct: 180 MKD-RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT--PPFYG------KNEYD 229
Query: 271 LTDSCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+ G++ DD +L+R + L + P R
Sbjct: 230 ILKRVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRI 269
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 35/160 (21%), Positives = 59/160 (36%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
R++ + + Y + H DL IL ++D + ++ FGL +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE LR G + ++S G +L LLSG PP + +N +
Sbjct: 183 -RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG--TPPFY------GKNEYDILK 232
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
G++ DD +L+R + L + P R
Sbjct: 233 RVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRI 269
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 46/251 (18%), Positives = 83/251 (33%), Gaps = 53/251 (21%)
Query: 75 VVYKGK--LENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDER 131
+Y N R + +K + + + E + + ++ + + + D
Sbjct: 95 WIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154
Query: 132 L-----LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL- 185
+V EY+ ++L + + A + +L + AL Y S G +Y+DL
Sbjct: 155 GDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHSIG-LVYNDLK 209
Query: 186 --NAYRILFDEDGNPRLSTFGLMKN-SRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFG 242
N I+ E+ +L G + + G Y T F PE +R T + IY+ G
Sbjct: 210 PEN---IMLTEEQ-LKLIDLGAVSRINSFGYLYGT-PGFQAPEIVR-TGPTVATDIYTVG 263
Query: 243 TLLLDLLSG---------KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
L L +P + D RL
Sbjct: 264 RTLAALTLDLPTRNGRYVDGLPEDDPVLKTYD---------------------SYGRLLR 302
Query: 294 RCLQYEPRERP 304
R + +PR+R
Sbjct: 303 RAIDPDPRQRF 313
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 40/165 (24%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217
++ L +A+ + + + H DL N IL D++ RLS FG + G+
Sbjct: 204 SIMRSLLEAVSFLHANN--IVHRDLKPEN---ILLDDNMQIRLSDFGFSCHLEPGEKLRE 258
Query: 218 NLAFTP----PEYLRTGRV------TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267
L TP PE L+ E +++ G +L LL+G PP R
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPP------FWHRR 309
Query: 268 LQMLTDSCLEGQFT---------DDDGTELVRLASRCLQYEPRER 303
++ +EGQ+ +L+ R LQ +P R
Sbjct: 310 QILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS---RLLQVDPEAR 351
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 19/142 (13%)
Query: 170 ALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPE 225
A+EYC + H DL +L D++ N +++ FGL DG T + + PE
Sbjct: 120 AIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 226 YLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT-- 281
+ G+ PE ++S G +L +L G +P D + L +
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG-RLP-------FDDEFIPNLFKKVNSCVYVMP 228
Query: 282 DDDGTELVRLASRCLQYEPRER 303
D L R + +P +R
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQR 250
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/159 (20%), Positives = 62/159 (38%), Gaps = 27/159 (16%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
++ + +A++Y S A H D+ +L+ + +L+ FG K + S +T
Sbjct: 165 EIMKSIGEAIQYLHSINIA--HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
+TP PE L + ++S G ++ LL G PP ++ +
Sbjct: 223 -PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFYSNH--GLAISPGMKT 277
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRER 303
GQ+ ++ L+R L+ EP +R
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQR 313
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 28/173 (16%)
Query: 102 QFLEEARSVGQLRNNR-LTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHWETH-PMKWA 158
F EE R V + R +T L + + L LV EY L L + P + A
Sbjct: 107 CFREE-RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 159 MRLRVVLHLAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL-MKNSRDGKS 214
+LA+ A++ G ++ D+ IL D G+ RL+ FG +K DG
Sbjct: 165 -----RFYLAEIVMAIDSVHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 215 YSTNLAFTP----PEYLRTGRVTPESVIY-------SFGTLLLDLLSGKHIPP 256
S TP PE L+ P + Y + G ++ G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TP 269
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 37/204 (18%), Positives = 67/204 (32%), Gaps = 26/204 (12%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC-------- 125
V + + ++A+K+ + P R+ + ++ N++
Sbjct: 29 YVLRWIHQDTGEQVAIKQCRQELSPKNRERWC--LEIQIMKKLNHPNVVSAREVPDGLQK 86
Query: 126 -CEGDERLLVAEYMPNETLAKHLF-HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
D LL EY L K+L +K ++ ++ AL Y + H
Sbjct: 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIH 144
Query: 184 -DLNAYRILFDEDGNPR---LSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE 235
DL I+ + G K G+ + + T PE L + T
Sbjct: 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG-TLQYLAPELLEQKKYTVT 203
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHA 259
+SFGTL + ++G P
Sbjct: 204 VDYWSFGTLAFECITGF--RPFLP 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 30/146 (20%), Positives = 56/146 (38%), Gaps = 16/146 (10%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP--- 223
L AL+Y ++ ++ D+ IL DE G+ ++ F + +T +A T
Sbjct: 124 LVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181
Query: 224 -PEYLRTGRVTPESVI---YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG- 278
PE + + S +S G +LL G+ P H + + + +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR--RPYHIRS---STSSKEIVHTFETTV 236
Query: 279 -QFTDDDGTELVRLASRCLQYEPRER 303
+ E+V L + L+ P +R
Sbjct: 237 VTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 31/149 (20%), Positives = 52/149 (34%), Gaps = 22/149 (14%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN----LAF 221
L + +EY + + H D+ +L EDG+ +++ FG+ + + +N AF
Sbjct: 146 LIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAF 203
Query: 222 TPPEYLRTGRVT---PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278
PE L R +++ G L + G P D + L
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFG-QCP-------FMDERIMCLHSKIKSQ 255
Query: 279 QFT----DDDGTELVRLASRCLQYEPRER 303
D +L L +R L P R
Sbjct: 256 ALEFPDQPDIAEDLKDLITRMLDKNPESR 284
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 48/253 (18%), Positives = 89/253 (35%), Gaps = 31/253 (12%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
+VY G+ L NQ RIA+K + EE L++ + LG E +
Sbjct: 37 IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRL--RVVLHLAQALEYCTSKGRALYH-DLNAYRI 190
E +P +L+ L + P+K + + + L+Y H D+ +
Sbjct: 97 FMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV--HRDIKGDNV 153
Query: 191 LFD-EDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRV--TPESVIYSFGT 243
L + G ++S FG K + T PE + G + I+S G
Sbjct: 154 LINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQML-----TDSC--LEGQFTDDDGTELVRLASRCL 296
++++ +GK PP + L + + + + + +C
Sbjct: 214 TIIEMATGK--PPFYEL----GEPQAAMFKVGMFKVHPEIPESMS-AEAKAFIL---KCF 263
Query: 297 QYEPRERPNPKSL 309
+ +P +R L
Sbjct: 264 EPDPDKRACANDL 276
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 39/144 (27%), Positives = 58/144 (40%), Gaps = 23/144 (15%)
Query: 170 ALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST-----NLAFTP 223
++YC + H DL +L D N +++ FGL DG+ T N A
Sbjct: 128 GVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA-- 183
Query: 224 PEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
PE + GR PE I+S G +L LL G +P D ++ L +G F
Sbjct: 184 PEVIS-GRLYAGPEVDIWSSGVILYALLCG-TLP-------FDDDHVPTLFKKICDGIFY 234
Query: 282 --DDDGTELVRLASRCLQYEPRER 303
++ L LQ +P +R
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKR 258
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 42/205 (20%)
Query: 118 LTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEY 173
LT L + +RL V EY L HL R + A+ AL+Y
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALDY 263
Query: 174 CTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDGKSYSTNLAF--TPPEYLRTG 230
S+ +Y DL ++ D+DG+ +++ FGL K +DG + T F T PEYL
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGT-PEYL--- 316
Query: 231 RVTPESVIY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG-- 278
PE + G ++ +++ G+ P +++ + L + L
Sbjct: 317 --APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LP------FYNQDHEKLFELILMEEI 366
Query: 279 QFTDDDGTELVRLASRCLQYEPRER 303
+F G E L S L+ +P++R
Sbjct: 367 RFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 44/257 (17%), Positives = 84/257 (32%), Gaps = 26/257 (10%)
Query: 79 GKLENQRRIAVKRF--NRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136
G L R F + RQ + ++ RL ++ + +
Sbjct: 112 GNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
Query: 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196
+ + + + + +A+ +E+ S+ + ++ DL A IL E
Sbjct: 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN 230
Query: 197 NPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
++ FGL ++ Y + PE + T +S ++SFG LL ++ S
Sbjct: 231 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 251 GKHIP------PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
P +++ +M D E+ + C EP +R
Sbjct: 291 LGASPYPGVKIDEEFCRRLKEGT-RMRAPDYTTP---------EMYQTMLDCWHGEPSQR 340
Query: 304 PNPKSLVTALSPLQKET 320
P LV L L +
Sbjct: 341 PTFSELVEHLGNLLQAN 357
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 40/174 (22%), Positives = 58/174 (33%), Gaps = 41/174 (23%)
Query: 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDEDGNP 198
+E LA ++F L A+ Y K + H D+ I+ ED
Sbjct: 128 DEPLASYIFR----------------QLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTI 169
Query: 199 RLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKH 253
+L FG GK + T + + PE L G PE ++S G L L+ +
Sbjct: 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEE- 227
Query: 254 IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRERPN 305
P L+ +E EL+ L S LQ P R
Sbjct: 228 -NPFCELEET------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTT 268
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.44 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.45 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.02 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.72 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.8 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.05 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.79 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.52 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=405.82 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=206.3
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.++++++.++||+|+||+||+|.+++ .||||.++...... .+.|.+|+.++++++|||||++++++.. +..++||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 45677888999999999999999754 59999997544222 3568899999999999999999998754 5689999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---- 211 (334)
||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 111 QWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKN-IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp ECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999964 3467999999999999999999999999 99999999999999999999999999975432
Q ss_pred --CCcccccccccCcccccC---CCCCCccchhhhHHHHHHHHhCCCCCCchhhH-HhhhcccccccccccCCCCCchhH
Q 019905 212 --GKSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 212 --~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
.....||+.|||||++.+ ..|+.++|||||||++|||+||+.||...... .+..........+ .....+...+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~ 267 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP-DLSKLYKNCP 267 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-CSTTSCTTSC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-Ccccccccch
Confidence 234578999999999964 35899999999999999999999998653221 1111111111111 1123445667
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
+++.+|+.+||+.||++|||+.++++.|+.++.
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 789999999999999999999999999998874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-59 Score=408.96 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=213.2
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++.+.++||+|+||.||+|.+. ++..||||+++.......+.|.+|++++++++|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667788999999999999864 367899999986554445679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcC
Q 019905 134 VAEYMPNETLAKHLFHW-----------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLST 202 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~D 202 (334)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccCHhhEEECCCCcEEECC
Confidence 99999999999999642 2357999999999999999999999999 99999999999999999999999
Q ss_pred CCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccc
Q 019905 203 FGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSC 275 (334)
Q Consensus 203 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (334)
||+++..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.......+.......
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~----- 246 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG----- 246 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT-----
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----
Confidence 9999754332 23457899999999999999999999999999999999 78888765443332221111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
.....|...++++.+|+.+||+.||++|||++++++.|+++.+..+
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 1123455667799999999999999999999999999999876554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-58 Score=408.23 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=208.3
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++.+.++||+|+||.||+|.++ ++..||||+++.......+.|.+|++++++++|||||+++++|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 44566788999999999999864 367899999986554445679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeE
Q 019905 134 VAEYMPNETLAKHLFHWE-------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl 200 (334)
||||+++|+|.+++.... ..++++..++.|+.||+.||.|||+++ |+||||||+|||+++++.+||
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHhhEEECCCCcEEE
Confidence 999999999999986421 246899999999999999999999999 999999999999999999999
Q ss_pred cCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccc
Q 019905 201 STFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTD 273 (334)
Q Consensus 201 ~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 273 (334)
+|||+++..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.......+......
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~---- 275 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ---- 275 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH----
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence 999999854332 23568899999999999999999999999999999999 7888876543333221111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
......|...++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 276 -g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 -GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 112234556677999999999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=403.76 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=210.5
Q ss_pred CCcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
+..++++++||+|+||.||+|.+. +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|..++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 455677889999999999999863 467899999975442 2356899999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~ 197 (334)
++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGC
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCccccceEECCCCC
Confidence 99999999999999996321 246899999999999999999999999 999999999999999999
Q ss_pred eeEcCCCCCccCCC------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 019905 198 PRLSTFGLMKNSRD------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (334)
+||+|||+++.... .....||+.|||||++.+..|+.++|||||||++|||+| |..||.......+......
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~- 262 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN- 262 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence 99999999875432 234568899999999999999999999999999999999 7778766543333322111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
......|...+.++.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 263 ----~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 263 ----RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111234556778999999999999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=408.79 Aligned_cols=246 Identities=17% Similarity=0.210 Sum_probs=206.1
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+.|+++++||+|+||.||+|.. .+|+.||||++....... .+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999996 468999999997654322 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++|+|.+++.......+++..++.|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 999999999997645567899999999999999999999999 999999999999999999999999999876543
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
....||+.|||||++.+..|+.++|||||||++|||++|+.||................. ...+...++++.+||
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-----PPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----CCCCTTSCHHHHHHH
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CCCCccCCHHHHHHH
Confidence 235699999999999999999999999999999999999999987654443322222111 123445677899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||++++++
T Consensus 258 ~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-58 Score=406.82 Aligned_cols=245 Identities=19% Similarity=0.255 Sum_probs=210.4
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|+++++||+|+||+||+|... +|+.||||++........+.+.+|+++++.++|||||++++++.+++.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 34888899999999999999964 68999999997666556677899999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 99999999853 56999999999999999999999999 999999999999999999999999999865432 35
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..||+.|||||++.+..|+.++|||||||++|||++|..||................ ......+...++++.+||.+
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---PPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---CCCCSCGGGSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC---CCCCCccccCCHHHHHHHHH
Confidence 679999999999999999999999999999999999999997654333322211111 11112234567799999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.||++|||+.++++
T Consensus 307 ~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 307 LLVRDPAQRATAAELLK 323 (346)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=402.63 Aligned_cols=257 Identities=18% Similarity=0.132 Sum_probs=213.1
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
...+++.++||+|+||.||+|.+. +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456777888999999999999964 589999999975432 24799999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCCC----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~~---- 212 (334)
+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+| .+||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999973 457999999999999999999999999 99999999999999887 6999999999865432
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
....||+.|||||++.+..|+.++|||||||++|||++|..||............... .......+...+++
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---PPPIREIPPSCAPL 285 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---CCGGGGSCTTSCHH
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---CCCchhcCccCCHH
Confidence 2346999999999999999999999999999999999999998754322221111111 11111345566789
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
+.+|+.+||+.||.+|||+.|+++.|.....+......|
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 999999999999999999999999998877766555544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=408.13 Aligned_cols=245 Identities=19% Similarity=0.247 Sum_probs=210.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|+++++||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++|||||+++++|..++.+|+||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 44888999999999999999964 58999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
++|+|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++...... ..
T Consensus 231 ~gG~L~~~i~---~~~l~e~~~~~~~~qil~aL~ylH~~~-IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 231 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCcHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999999985 356999999999999999999999999 999999999999999999999999999865432 35
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..||+.|||||++.+..|+.++|||||||++|||++|..||................ ..........++++.+||.+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---PPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CCCCSCTTSSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC---CCCCcccccCCHHHHHHHHH
Confidence 679999999999999999999999999999999999999997654333322211111 11112234566789999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.||.+|||+.++|+
T Consensus 384 ~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 384 LLVRDPAQRATAAELLK 400 (423)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=395.87 Aligned_cols=242 Identities=17% Similarity=0.193 Sum_probs=209.0
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC---CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
++|++++.||+|+||+||+|.. .+++.||||.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688999999999999999996 46899999999642 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999997 3467999999999999999999999999 999999999999999999999999999865322
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....||+.|||||++.+..|+.++|||||||++|+|++|..||.......+........ ..++...++++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------~~~p~~~s~~~~ 262 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------YDFPEKFFPKAR 262 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CCCCTTCCHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------CCCCcccCHHHH
Confidence 24579999999999999999999999999999999999999998765444433222211 124455677899
Q ss_pred HHHHHhhhcCCCCCCCHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l 310 (334)
+|+.+||+.||.+|||+++++
T Consensus 263 dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHHccCCHhHCcChHHHc
Confidence 999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-56 Score=384.34 Aligned_cols=243 Identities=20% Similarity=0.256 Sum_probs=195.8
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC---CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+|++++.||+|+||+||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46788999999999999999995 4689999999975432 2345789999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+ +|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIV--QRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHH--HSCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999 689999987 4567999999999999999999999999 999999999999999999999999999865443
Q ss_pred -CcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....||+.|||||++.+..+ +.++|||||||++|+|++|+.||................ ..++...++++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~ 241 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------YTLPKFLSPGAAG 241 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CCCCTTSCHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHH
Confidence 35679999999999998876 579999999999999999999998765444332221111 1234556778999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||++|||++++++
T Consensus 242 li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 242 LIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHc
Confidence 999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=384.64 Aligned_cols=242 Identities=19% Similarity=0.246 Sum_probs=195.9
Q ss_pred cccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeee----CCeeeEEE
Q 019905 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLLVA 135 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 135 (334)
++..+||+|+||+||+|.+. ++..||+|.+...... ..+.+.+|++++++++|||||+++++|.. +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567899999999999964 5889999999754322 23568899999999999999999999865 34589999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CceecccCCCCeeec-CCCCeeEcCCCCCccCCCC-
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~~~~- 212 (334)
||+++|+|.+++. ....+++..+..++.||+.||+|||+++ +|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 109 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred eCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 9999999999997 3467999999999999999999999875 399999999999998 4799999999999865443
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ..+....... ......+...++++.+
T Consensus 187 ~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG----VKPASFDKVAIPEVKE 261 (290)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT----CCCGGGGGCCCHHHHH
T ss_pred cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC----CCCCCCCccCCHHHHH
Confidence 34579999999999875 699999999999999999999999865321 1121111111 1111123334568999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||.+|||++++++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=389.27 Aligned_cols=243 Identities=19% Similarity=0.220 Sum_probs=200.0
Q ss_pred CcccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
++|++++.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999852 468999999965331 123467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-- 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~-- 211 (334)
||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999997 3467999999999999999999999999 99999999999999999999999999975432
Q ss_pred --CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 212 --GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 212 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||............... ...+|...++++.
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------KLGMPQFLSPEAQ 254 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC------CCCCCCcCCHHHH
Confidence 23567999999999999999999999999999999999999999876544433222211 1124556678999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHH
Q 019905 290 RLASRCLQYEPRERPNP-----KSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~-----~~~l~ 311 (334)
+|+.+||+.||.+|||+ +++++
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 99999999999999995 56663
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=392.92 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=211.4
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCC-CCccceeeeee
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRN-NRLTNLLGCCC 126 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h-~~iv~~~~~~~ 126 (334)
..-..+++++.+.||+|+||.||+|.+.. ++.||||.+....... .+.+.+|++++.+++| ||||+++++|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 34456789999999999999999998543 3579999997654222 3568899999999965 89999999997
Q ss_pred eC-CeeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCee
Q 019905 127 EG-DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191 (334)
Q Consensus 127 ~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nil 191 (334)
.. +..++||||+++|+|.++++... ...+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-iiHRDLK~~NIL 217 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNIL 217 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-eecCccCcccee
Confidence 64 56899999999999999996421 245889999999999999999999999 999999999999
Q ss_pred ecCCCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhh
Q 019905 192 FDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIR 264 (334)
Q Consensus 192 i~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~ 264 (334)
+++++.+||+|||+|+...... ...||+.|||||++.+..|+.++|||||||++|||+| |+.||.........
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998654322 3457889999999999999999999999999999998 78888654321111
Q ss_pred hcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 265 DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.. ..........|...++++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 298 ~~----~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 298 CR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HH----HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 10 1111112234556677999999999999999999999999999988653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=385.75 Aligned_cols=250 Identities=17% Similarity=0.249 Sum_probs=193.9
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHH--HHHHHHHhcCCCCCccceeeeeeeCC----eeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQF--LEEARSVGQLRNNRLTNLLGCCCEGD----ERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~--~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 134 (334)
++.+.++||+|+||+||+|.+ +|+.||||++.... ...+ ..|+..+.+++|||||++++++..++ ..+||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 355667889999999999998 57899999996432 3333 34566667889999999999998653 57999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK--------GRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||++ + |+||||||+|||+++++.+||+|||++
T Consensus 80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-EeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999953 5789999999999999999999986 7 999999999999999999999999998
Q ss_pred ccCCCC--------CcccccccccCcccccCC------CCCCccchhhhHHHHHHHHhCCCCCCchh-------------
Q 019905 207 KNSRDG--------KSYSTNLAFTPPEYLRTG------RVTPESVIYSFGTLLLDLLSGKHIPPSHA------------- 259 (334)
Q Consensus 207 ~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~elltg~~p~~~~~------------- 259 (334)
+..... ....||+.|||||++.+. .++.++|||||||++|||+||..|+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 754322 234689999999999764 36789999999999999999976543211
Q ss_pred --hHHhhhcccccccccccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 260 --LDLIRDRNLQMLTDSCLEGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 260 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
...... .......+..+ +...+..+.+|+.+||+.||.+|||+.++++.|+++.++..+
T Consensus 236 ~~~~~~~~----~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 236 PSVEEMRK----VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CCHHHHHH----HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred chHHHHHH----HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 011111 11111111122 223556899999999999999999999999999999876554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=373.42 Aligned_cols=241 Identities=18% Similarity=0.255 Sum_probs=186.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCC--------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-------- 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 129 (334)
.+|++++.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35788889999999999999964 5899999999754422 2356889999999999999999999987543
Q ss_pred ----eeeEEEecCCCCCHHHhhcccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCC
Q 019905 130 ----ERLLVAEYMPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (334)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg 204 (334)
..|+||||+++|+|.+++..... ...++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~-IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc-CccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999964221 23456678899999999999999999 9999999999999999999999999
Q ss_pred CCccCCCC----------------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc
Q 019905 205 LMKNSRDG----------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (334)
Q Consensus 205 ~a~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~ 268 (334)
+|+..... ....||+.|||||++.+..|+.++|||||||++|||++ ||..........
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~--- 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL--- 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH---
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH---
Confidence 99865432 12468999999999999999999999999999999996 555432111100
Q ss_pred ccccccccCCCCC---chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 QMLTDSCLEGQFT---DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 ~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.... ....+ ...++.+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 11122 223456788999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=373.58 Aligned_cols=248 Identities=16% Similarity=0.256 Sum_probs=199.4
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeC------Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 130 (334)
+.|++++.||+|+||+||+|.. .+|+.||||++....... .+.+.+|+++|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 3589999999999999999996 468999999997543221 34678899999999999999999987643 56
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.|+||||++ |+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCc-CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 78999886 5578999999999999999999999999 9999999999999999999999999997543
Q ss_pred C--------CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccc------
Q 019905 211 D--------GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC------ 275 (334)
Q Consensus 211 ~--------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 275 (334)
. .....||+.|||||++.+.. ++.++||||+||++|||++|+.||.+................+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 2 23568999999999988764 79999999999999999999999976533222211110000000
Q ss_pred ------------cCCC-------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 276 ------------LEGQ-------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 276 ------------~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.... ..+..++++.+|+.+||+.||.+|||+.++|+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 01234568999999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=366.33 Aligned_cols=243 Identities=20% Similarity=0.270 Sum_probs=194.6
Q ss_pred cccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.|+++++||+|+||+||+|..+ +++.||+|.+.... ....+.+|+++++.+ +||||+++++++...++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4888899999999999999853 46789999986543 456788999999998 6999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-CCeeEcCCCCCccCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-~~~kl~Dfg~a~~~~~~-- 212 (334)
||+++++|.+++. .+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+...+.
T Consensus 100 E~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g-IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 100 PYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG-IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp ECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred eCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC-eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999883 4899999999999999999999999 9999999999999876 79999999999754321
Q ss_pred ------------------------------CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhH
Q 019905 213 ------------------------------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALD 261 (334)
Q Consensus 213 ------------------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~ 261 (334)
....||+.|+|||++.+.. |+.++||||+||++|+|++|+.||.....+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 1246899999999998765 899999999999999999999998643211
Q ss_pred Hhhhccc-----------------c----------------------------ccc----ccccCCCCCchhHHHHHHHH
Q 019905 262 LIRDRNL-----------------Q----------------------------MLT----DSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 262 ~~~~~~~-----------------~----------------------------~~~----~~~~~~~~~~~~~~~l~~li 292 (334)
...-..+ . ... ............++++.+|+
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 1000000 0 000 00000011223456899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||++++|+
T Consensus 334 ~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHT
T ss_pred HHHCcCChhHCcCHHHHhc
Confidence 9999999999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=382.95 Aligned_cols=248 Identities=18% Similarity=0.156 Sum_probs=209.5
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|++++.||+|+||.||+|..+ +|+.||+|.+......+.+.+.+|+++|+.++||||++++++|...+..++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 46888999999999999999964 68999999997655444567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC--CCCeeEcCCCCCccCCCCC---
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~--~~~~kl~Dfg~a~~~~~~~--- 213 (334)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++.......
T Consensus 237 ~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 237 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred CCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999999864 3457999999999999999999999999 999999999999985 4899999999998766543
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...||+.|||||++.+..|+.++|||||||++|+|++|..||................. ..........++++.+||.
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW--NMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--CCCSGGGTTSCHHHHHHHH
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC--CCCcccccCCCHHHHHHHH
Confidence 45789999999999999999999999999999999999999976654433322211111 1111122345678999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.||.+|||+.++|+
T Consensus 393 ~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCSSGGGSCCHHHHHH
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=379.88 Aligned_cols=247 Identities=18% Similarity=0.163 Sum_probs=202.3
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHH---HHHHHhcCCCCCccceeeeeeeCCe
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLE---EARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
..++|++++.||+|+||.||+|... +|+.||||++.... ......+.+ ++.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3567999999999999999999964 58999999996321 122333333 4667788899999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|....
T Consensus 267 lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~g-IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999973 467999999999999999999999999 9999999999999999999999999998655
Q ss_pred CC--CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 211 DG--KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 211 ~~--~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
.. .+..||+.|||||++.+ ..|+.++|||||||++|||++|..||.......... ....... ....++...+++
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~--~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--MAVELPDSFSPE 420 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHH--CCCCCCTTSCHH
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcC--CCCCCCccCCHH
Confidence 43 45689999999999964 579999999999999999999999997643221110 0011111 112345667789
Q ss_pred HHHHHHHhhhcCCCCCCC-----HHHHH
Q 019905 288 LVRLASRCLQYEPRERPN-----PKSLV 310 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps-----~~~~l 310 (334)
+.+||.+||+.||.+|++ +++++
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 999999999999999998 67776
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=343.96 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=216.8
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..|++.+.||+|+||.||+|.+++++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 44566677799999999999988899999999987665556788999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 140 NETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 140 ~~sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
+++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC-eecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999986422 235899999999999999999999999 999999999999999999999999998754321
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-----------HhhhcccccccccccCCCC
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-----------LIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 280 (334)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........+.......
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 2335789999999998888999999999999999999999888643211 1111122233333344456
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 677888999999999999999999999999999988653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=344.61 Aligned_cols=257 Identities=18% Similarity=0.255 Sum_probs=211.8
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.+|.+.+.||+|+||+||++... +++.||+|.+........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56778888999999999999964 58899999986654444567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 213 (334)
++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 90 KGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMN-IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999999975 3567999999999999999999999999 9999999999999999999999999987543321
Q ss_pred -------------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCC
Q 019905 214 -------------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 214 -------------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (334)
...||+.|+|||++.+..++.++||||||+++|+|++|..|+............ ..........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~ 244 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---NVRGFLDRYC 244 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---CHHHHHHHTC
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---hhhccccccC
Confidence 346889999999999999999999999999999999999877543211111000 0000111122
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
+...++.+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 34445579999999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=339.40 Aligned_cols=246 Identities=20% Similarity=0.262 Sum_probs=208.5
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
...|++++.||+|+||+||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35688888999999999999995 56899999999876666677889999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 999999999953 46899999999999999999999999 999999999999999999999999998765432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...||+.|+|||.+.+..++.++||||||+++|+|++|..||............. .........+...+..+.+|+.
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSCGGGSCHHHHHHHH
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCCCccccCHHHHHHHH
Confidence 4568999999999999999999999999999999999999986543222211110 0111112234556678999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.||.+|||+.++++
T Consensus 252 ~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHccCChhHCcCHHHHhh
Confidence 999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=342.06 Aligned_cols=272 Identities=29% Similarity=0.480 Sum_probs=222.6
Q ss_pred CCccccCHHHHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccc
Q 019905 42 PSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTN 120 (334)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~ 120 (334)
...+.+++.++.....+|... +.||+|+||.||+|...+++.||+|++...... ....+.+|+++++.++||||++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNK---NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCST---TEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred CccceecHHHHHHHhhccccc---eeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 345778998988777666554 555999999999999878999999999765422 2346889999999999999999
Q ss_pred eeeeeeeCCeeeEEEecCCCCCHHHhhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCceecccCCCCeeecCC
Q 019905 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSK---GRALYHDLNAYRILFDED 195 (334)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dikp~Nili~~~ 195 (334)
+++++...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ + ++||||||+||+++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIHRDVKAANILLDEE 170 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC-EECCCCSGGGEEECTT
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeCCCchhhEEECCC
Confidence 9999999999999999999999999997532 34589999999999999999999999 8 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCC-----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH--------
Q 019905 196 GNPRLSTFGLMKNSRDG-----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-------- 262 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-------- 262 (334)
+.++|+|||++...... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999999765432 23458999999999988889999999999999999999999885321110
Q ss_pred -----hhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 263 -----IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 263 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
..........+.......+...+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 0111222333333444566777889999999999999999999999999997643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=332.04 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=214.3
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
...|++++.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35688889999999999999998888899999997654 34577899999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~ 213 (334)
++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... .
T Consensus 88 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 88 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCC-eecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999964 4456899999999999999999999999 999999999999999999999999998765432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...+..+.+++
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li 240 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQIM 240 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHH
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----ccCCCCCcCCHHHHHHH
Confidence 3445678999999998899999999999999999999 78777655433332222111 11223344567899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+||+.||.+|||+.++++.|+.+.++
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 999999999999999999999998765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=335.53 Aligned_cols=261 Identities=19% Similarity=0.234 Sum_probs=216.2
Q ss_pred cccCHHHHHHHhcCCCc-------ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCC
Q 019905 45 REFTLEQLKNATSGFAV-------ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN 116 (334)
Q Consensus 45 ~~~~~~~~~~~~~~~~~-------~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ 116 (334)
..++.++++.++..... ++....||+|+||.||+|... +|+.||||.+........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888865322 455567799999999999975 6899999999876666677899999999999999
Q ss_pred CccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC
Q 019905 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (334)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~ 196 (334)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCC
Confidence 99999999999999999999999999999984 457999999999999999999999999 99999999999999999
Q ss_pred CeeEcCCCCCccCCCC----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc
Q 019905 197 NPRLSTFGLMKNSRDG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272 (334)
Q Consensus 197 ~~kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 272 (334)
.+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~- 257 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP- 257 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-
Confidence 9999999998754432 34578999999999999899999999999999999999999987553322221111110
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
. .........++.+.+++.+||+.||.+|||+.++++.
T Consensus 258 ~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 258 P--PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp C--CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111223456789999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=336.97 Aligned_cols=262 Identities=19% Similarity=0.291 Sum_probs=208.1
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
....+..|++++.||+|+||+||+|.. ++..||+|.+....... .+.+.+|++++++++||||+++++++...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 344567888999999999999999987 56889999997654322 246789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 133 LVAEYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
+||||+++++|.+++.... ...+++..++.++.|++.||.|||+++. ++||||||+||+++.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999996321 1238999999999999999999999853 9999999999999999999999999987543
Q ss_pred CC----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 211 DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 211 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||............. ........+...++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKCKRLEIPRNLNP 266 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH----HSCCCCCCCTTSCH
T ss_pred ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcCCCCCCCccCCH
Confidence 32 34568999999999999999999999999999999999999987654333222111 11112234556677
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
++.+|+.+||+.||.+|||+.++++.|+.+.+...
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 89999999999999999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=341.34 Aligned_cols=246 Identities=20% Similarity=0.294 Sum_probs=208.9
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.....|++++.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+++++.++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456788999999999999999996 57899999999754322 23467899999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999863 357999999999999999999999999 999999999999999999999999998765433
Q ss_pred --CcccccccccCcccccCCCCC-CccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....||+.|+|||++.+..++ .++||||||+++|+|++|..||............... ....+...+.++.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 242 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------KYRIPFYMSTDCE 242 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHH
Confidence 345689999999999888765 7999999999999999999999876554443322211 1123445567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+.+||+.||.+|||++++++
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=329.31 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=211.8
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..|++++.||+|+||.||+|..+++..||+|.+.... ...+.+.+|++++.+++||||+++++++...+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 5688889999999999999998888899999997654 345778999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----c
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~ 214 (334)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+....... .
T Consensus 87 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 87 NGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQ-FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp TCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred CCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9999999864 3346899999999999999999999999 9999999999999999999999999987654432 2
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...+..+.+++.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-----HRLYRPHLASDTIYQIMY 239 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHHH
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-----CCCCCCCcChHHHHHHHH
Confidence 344667999999998889999999999999999999 88787654333222211111 111223344568999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+||+.||.+|||+.++++.|+.+.++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=339.67 Aligned_cols=255 Identities=21% Similarity=0.283 Sum_probs=209.9
Q ss_pred CcccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..|++.+.||+|+||.||+|.+. .+..||||.+...... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999974 3456999999754322 235688999999999999999999999998999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 129 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 129 TEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLG-YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999964 3457999999999999999999999999 9999999999999999999999999998654321
Q ss_pred ------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 214 ------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
...+|..|+|||++.+..++.++||||||+++|+|++ |..||............... .....+...+.
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 281 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----YRLPAPMGCPH 281 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----CCCCCCTTCCH
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----CCCCCCCCcCH
Confidence 2234668999999998889999999999999999999 88887654433332221111 11223445667
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
.+.+|+.+||+.||.+|||+.++++.|+.+.+...
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 89999999999999999999999999999986544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=328.79 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=211.1
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
...|++++.||+|+||.||++.+.++..||+|.+.... ...+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45788889999999999999999888899999997654 34577899999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~ 213 (334)
++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... .
T Consensus 102 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 102 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99999999964 2456999999999999999999999999 999999999999999999999999998765432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...++.+.+++
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li 254 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYTIM 254 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHH
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-----cCCCCCCcCCHHHHHHH
Confidence 3345678999999998889999999999999999998 88887654333222221111 11223344456899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
.+||+.||.+|||+.++++.|+++.++.
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 9999999999999999999999887653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=342.03 Aligned_cols=256 Identities=15% Similarity=0.214 Sum_probs=201.9
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC----eeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD----ERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 135 (334)
..|++++.||+|+||+||+|.+. ++.||||++.... ........|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 56888899999999999999875 6899999996533 12334566888999999999999999998744 369999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK----------GRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----------~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||+
T Consensus 102 e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 102 AFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-EEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999953 4699999999999999999999999 8 99999999999999999999999999
Q ss_pred CccCCC------CCcccccccccCcccccCC-----CCCCccchhhhHHHHHHHHhCCCCCCchhhH-------------
Q 019905 206 MKNSRD------GKSYSTNLAFTPPEYLRTG-----RVTPESVIYSFGTLLLDLLSGKHIPPSHALD------------- 261 (334)
Q Consensus 206 a~~~~~------~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~elltg~~p~~~~~~~------------- 261 (334)
+..... .....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 965432 2235689999999999873 3667899999999999999999887542110
Q ss_pred ---HhhhcccccccccccCCC-CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 262 ---LIRDRNLQMLTDSCLEGQ-FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 262 ---~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
............+..... .....+.++.+|+.+||+.||.+|||+.++++.|+++++..+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~~ 321 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN 321 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 000000000000000000 122345679999999999999999999999999999986554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=342.17 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=209.2
Q ss_pred CCcccccccCCCcCccEEEEEEeC--------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 128 (334)
...|++.+.||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356888889999999999999852 3457999999754321 235688999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC
Q 019905 129 DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~ 194 (334)
+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTE 238 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchhhEEECC
Confidence 99999999999999999987532 235789999999999999999999999 999999999999999
Q ss_pred CCCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 019905 195 DGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (334)
Q Consensus 195 ~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 267 (334)
++.+||+|||++...... ....+++.|+|||++.+..++.++||||||+++|||++ |..||............
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999998754432 22345678999999999899999999999999999999 88777654333222111
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
. .......+...+.++.+++.+||+.||.+|||+.++++.|+++..
T Consensus 319 ~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 319 K-----EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp H-----TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h-----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111223445566789999999999999999999999999998865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.05 Aligned_cols=259 Identities=17% Similarity=0.229 Sum_probs=210.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..|++++.||+|+||.||+|... ++..||+|.+....... .+.+.+|+.++..++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45888899999999999999954 58899999986544333 246788999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
||+++++|.+++.. ..++++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999963 357999999999999999999999999 999999999999999999999999998765432
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....||+.|+|||.+.+..++.++||||||+++|+|++|..||................... .....+...+..+.+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-VTTDVRKDIPQSLSN 246 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-HHHHSCTTSCHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-cchhcccCCCHHHHH
Confidence 23468999999999999999999999999999999999999987654333221111111110 011123445668999
Q ss_pred HHHHhhhcCCCCCC-CHHHHHHHhccccccCCC
Q 019905 291 LASRCLQYEPRERP-NPKSLVTALSPLQKETEF 322 (334)
Q Consensus 291 li~~cl~~dp~~Rp-s~~~~l~~L~~l~~~~~~ 322 (334)
++.+||+.||.+|| +++++.+.|+.+..+...
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 99999999999998 899999999988765544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.99 Aligned_cols=244 Identities=20% Similarity=0.245 Sum_probs=207.5
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCC---CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+|++++.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 457888899999999999999965 5899999999643 223456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC---
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--- 211 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--- 211 (334)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 999999999999863 457899999999999999999999999 99999999999999999999999999875332
Q ss_pred -CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...++++.+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKS 234 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHH
Confidence 23456899999999999989999999999999999999999998765444333222111 11244556778999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHH
Q 019905 291 LASRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
|+.+||+.||.+|| +++++++
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 99999999999999 8998874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=351.64 Aligned_cols=257 Identities=20% Similarity=0.295 Sum_probs=214.6
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
...+++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35577888999999999999999888899999998654 35678999999999999999999999986 56789999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~ 213 (334)
++|+|.+++.......+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... .
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 9999999997433346889999999999999999999999 999999999999999999999999999865432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||++.+..++.++||||||+++|||++ |..||.......+...... ......+...+.++.+|+
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~li 418 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-----GYRMPRPENCPEELYNIM 418 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-----TCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHH
Confidence 3345678999999998889999999999999999999 8888765433332221111 111223445667899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
.+||+.||.+|||++++++.|+.+.......
T Consensus 419 ~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 419 MRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 9999999999999999999999998765543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=335.82 Aligned_cols=259 Identities=19% Similarity=0.296 Sum_probs=208.0
Q ss_pred CcccccccCCCcCccEEEEEEe-----CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC--Ceee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 132 (334)
..|++++.||+|+||+||+|.+ .+++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688899999999999999984 25789999999765433346788999999999999999999998653 4589
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 90 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999999965 3345899999999999999999999999 999999999999999999999999998765432
Q ss_pred -------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhc-----------cccccccc
Q 019905 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR-----------NLQMLTDS 274 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~-----------~~~~~~~~ 274 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|..|+........... ........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 223456779999999998999999999999999999999988765432221100 00111111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
......+...+.++.+++.+||+.||.+|||+.++++.|+.+.++.
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1222345566779999999999999999999999999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=350.54 Aligned_cols=261 Identities=24% Similarity=0.328 Sum_probs=214.8
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
..+++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 4577888899999999999999887889999998654 346789999999999999999999999866 67899999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----Cc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----KS 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~~ 214 (334)
+++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++...... ..
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 999999997533456899999999999999999999999 999999999999999999999999999765432 22
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...+..+.+++.
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~li~ 415 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLMC 415 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHH
Confidence 345678999999998899999999999999999999 7877765433322221111 1122334556678999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccccccCCCCCChhh
Q 019905 294 RCLQYEPRERPNPKSLVTALSPLQKETEFSISPLC 328 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p~~ 328 (334)
+||+.||.+|||++++++.|+.+....+....|..
T Consensus 416 ~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~~ 450 (452)
T 1fmk_A 416 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450 (452)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred HHccCChhhCcCHHHHHHHHHHHhccCCccccccc
Confidence 99999999999999999999999988777666653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=348.15 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=211.6
Q ss_pred cCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC-eeeEEE
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-ERLLVA 135 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 135 (334)
-+...+++++.||+|+||.||+|.+. +..||||.++... ..+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34567888999999999999999985 6799999997644 4578999999999999999999999987654 789999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Cc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KS 214 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~ 214 (334)
||+++|+|.+++.......+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ..
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 345 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccC
Confidence 9999999999998644455799999999999999999999999 999999999999999999999999998754432 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||.+.+..++.++||||||+++|||++ |..||.......+..... .......+...++.+.+||.
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~p~~~~~~l~~li~ 420 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----KGYKMDAPDGCPPAVYDVMK 420 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-----TTCCCCCCTTCCHHHHHHHH
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCcCCHHHHHHHH
Confidence 356789999999999899999999999999999998 888876543222221111 11122345566779999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+||+.||.+|||+.++++.|+.+.+.
T Consensus 421 ~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 421 NCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=336.80 Aligned_cols=246 Identities=17% Similarity=0.186 Sum_probs=204.9
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC------ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.|++++.||+|+||.||++... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4788888999999999999965 5889999999754422 24678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC----CeeEcCCCCCccC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~----~~kl~Dfg~a~~~ 209 (334)
||||+++++|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++ .+||+|||++...
T Consensus 93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999996 4567999999999999999999999999 99999999999998776 7999999999865
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........+.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~ 247 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD--FDEEFFSQTSE 247 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSCH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCchhccCCCH
Confidence 543 3456899999999999889999999999999999999999998765443332221111000 00001123456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+.+|+.+||..||.+|||+.++++
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=346.79 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=209.5
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
...+.+.+.||+|+||.||+|.+. ++..||+|.+....... ...+.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 456778889999999999999975 68899999997543111 2357789999999999999999999999889999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 193 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 193 LVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999964 3346899999999999999999999999 9999999999999999999999999987644321
Q ss_pred ---cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 214 ---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
...++..|+|||.+.+..++.++||||||+++|||++ |..|+............. .......+...+.++.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-----KGGRLPCPELCPDAVF 345 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-----TTCCCCCCTTCCHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHH
Confidence 2234678999999998889999999999999999998 777776543332221111 1112223445567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 290 RLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+|+.+||+.||.+|||+.++++.|+.+.++
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=334.59 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=208.2
Q ss_pred CcccccccCCCcCccEEEEEEeCC-C-------CEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-Q-------RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
.+|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467888899999999999998543 3 47999999765545567899999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC--------eeEcCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--------PRLSTF 203 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~--------~kl~Df 203 (334)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++. ++|+||
T Consensus 88 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENT-LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhCC-eECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999999975 3345899999999999999999999999 999999999999998876 999999
Q ss_pred CCCccCCCCCcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 204 GLMKNSRDGKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 204 g~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
|.+..........++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+............... ....+.
T Consensus 166 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~------~~~~~~ 239 (289)
T 4fvq_A 166 GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQLPA 239 (289)
T ss_dssp CSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------TCCCCC
T ss_pred cccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc------cCCCCC
Confidence 99987766666678899999999987 56899999999999999999977666543222111111110 111223
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
..+.++.+++.+||+.||.+|||+.++++.|+.+...+..+
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 33457999999999999999999999999999998755443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=322.77 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=213.6
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+...|++++.||+|+||.||++...++..||+|.+.... ...+.+.+|+++++.++||||+++++++..++..+++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 346788889999999999999998888899999997654 2457789999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 85 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999965 3457899999999999999999999999 999999999999999999999999998765432
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...+..+.++
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQI 237 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHH
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-----CcCCCCccCcHHHHHH
Confidence 23455678999999998889999999999999999999 77777654333222211111 1112334456789999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.+||+.||.+|||+.++++.|+.+.++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=351.74 Aligned_cols=256 Identities=20% Similarity=0.332 Sum_probs=215.3
Q ss_pred CCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
...+++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567788899999999999999764 7899999997654 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 213 (334)
+++++|.+++.......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 99999999997655567999999999999999999999999 9999999999999999999999999988654322
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
...++..|+|||++.+..++.++||||||+++|||++ |..||.......+... .........+...+..+.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----HHTTCCCCCCTTCCHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHHHH
Confidence 2334678999999998889999999999999999999 7777765433222211 11112223445566789999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
+.+||+.||.+|||+.++++.|+.+..+..
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 999999999999999999999999875543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=337.43 Aligned_cols=251 Identities=18% Similarity=0.133 Sum_probs=195.9
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.....|++++.||+|+||+||++... +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 34567899999999999999999965 688999999976542 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC--eeEcCCCCCccCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--PRLSTFGLMKNSRD-- 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~--~kl~Dfg~a~~~~~-- 211 (334)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++.....
T Consensus 96 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~-ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 96 EYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999863 456999999999999999999999999 999999999999987665 99999999874322
Q ss_pred -CCcccccccccCcccccCCCCCCc-cchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGRVTPE-SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
.....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.............................++++.
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 234578999999999988887665 899999999999999999986532211111111111111111111223457899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+.+||+.||.+|||+.++++
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHh
Confidence 9999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=329.64 Aligned_cols=245 Identities=18% Similarity=0.231 Sum_probs=208.2
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
...+|++++.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3467888999999999999999964 68999999996432 2345678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp EECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 999999999999997 3457899999999999999999999999 999999999999999999999999999865443
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++.+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------ELRFPPFFNEDVKDLL 234 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------CCCCCTTSCHHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHHHH
Confidence 3467899999999999999999999999999999999999998765433332221111 1123455667899999
Q ss_pred HHhhhcCCCCCC-----CHHHHHH
Q 019905 293 SRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
.+||+.||.+|| +++++++
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhccCHHHcCCCcCCCHHHHhc
Confidence 999999999999 8888883
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=329.10 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=199.6
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
...|++++.||+|+||+||+|...+++.||+|++....... ...+.+|++++++++||||+++++++..+...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999998889999999997543222 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|++ ++|.+.+.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 100 FME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp CCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 997 588887764 4456999999999999999999999999 999999999999999999999999999765422
Q ss_pred CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc-----------------
Q 019905 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS----------------- 274 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----------------- 274 (334)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...................
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 34467899999999976 458999999999999999999999886542221111110000000
Q ss_pred -------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 -------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..........++++.+|+.+||+.||.+|||++++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000011234568999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=324.77 Aligned_cols=271 Identities=30% Similarity=0.487 Sum_probs=220.1
Q ss_pred ccccCHHHHHHHhcCCCcccc---cccCCCcCccEEEEEEeCCCCEEEEEEecCCCC----CChHHHHHHHHHHhcCCCC
Q 019905 44 FREFTLEQLKNATSGFAVENI---VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW----PDPRQFLEEARSVGQLRNN 116 (334)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~---~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~ 116 (334)
...+++.++.+.+.+|+...+ .+.||+|+||.||+|.. ++..||+|.+..... ...+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 467999999999999987522 25679999999999987 578999999975321 1245788999999999999
Q ss_pred CccceeeeeeeCCeeeEEEecCCCCCHHHhhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
||+++++++...+..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH-HIHRDIKSANILLDEA 169 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTT
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEcCC
Confidence 9999999999999999999999999999998642 2456899999999999999999999999 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH----hhh
Q 019905 196 GNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----IRD 265 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~----~~~ 265 (334)
+.++|+|||++...... ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||....... +..
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence 99999999998754432 23467899999998875 48899999999999999999998886532211 100
Q ss_pred c------ccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 266 R------NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 266 ~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
. ......+... ...+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 249 EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred Hhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 0 0011111111 23455677889999999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=325.62 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=211.6
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
...|++++.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 35688889999999999999998888899999997644 34678899999999999999999999886 45689999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-----
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 213 (334)
++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||++++++.++|+|||.+.......
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 9999999996432336899999999999999999999999 9999999999999999999999999987654322
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...+.++.+++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----GYRMVRPDNCPEELYQLM 243 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHH
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-----ccCCCCcccccHHHHHHH
Confidence 2345678999999988889999999999999999999 7777765433322211111 111223445567899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
.+||+.||.+|||+.++++.|+.+........+|
T Consensus 244 ~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHC------
T ss_pred HHHhccChhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence 9999999999999999999999998776655554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=341.40 Aligned_cols=258 Identities=20% Similarity=0.310 Sum_probs=209.7
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..|++++.||+|+||.||+|.+. ++..||||.+...... ....+.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 55788899999999999999953 3568999999654322 2346888999999999999999999999988999
Q ss_pred EEEecCCCCCHHHhhcccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC---CeeEcCCC
Q 019905 133 LVAEYMPNETLAKHLFHWE-----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLSTFG 204 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~---~~kl~Dfg 204 (334)
+||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEEecCCCCceEEECCCc
Confidence 9999999999999997532 245889999999999999999999999 99999999999999554 59999999
Q ss_pred CCccC------CCCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccC
Q 019905 205 LMKNS------RDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 205 ~a~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
++... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||............... ..
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~-----~~ 304 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-----GR 304 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-----CC
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CC
Confidence 98632 22334567889999999998899999999999999999998 88787665433332221111 11
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
...+...+..+.+|+.+||+.||.+|||+.++++.|+.+....+..
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 2234455668999999999999999999999999999887754433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=325.54 Aligned_cols=245 Identities=18% Similarity=0.200 Sum_probs=197.6
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--------------------------ChHHHHHHHHHHh
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--------------------------DPRQFLEEARSVG 111 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~ 111 (334)
...|++++.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467888899999999999999964 5789999999654311 1246789999999
Q ss_pred cCCCCCccceeeeeee--CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCC
Q 019905 112 QLRNNRLTNLLGCCCE--GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189 (334)
Q Consensus 112 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~N 189 (334)
+++||||+++++++.. .+..++||||+++++|.+++ ....+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQK-IIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHH
Confidence 9999999999999986 56789999999999998876 4567999999999999999999999999 9999999999
Q ss_pred eeecCCCCeeEcCCCCCccCCCC----CcccccccccCcccccCCC---CCCccchhhhHHHHHHHHhCCCCCCchhhHH
Q 019905 190 ILFDEDGNPRLSTFGLMKNSRDG----KSYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDL 262 (334)
Q Consensus 190 ili~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~elltg~~p~~~~~~~~ 262 (334)
|+++.++.+||+|||++...... ....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 99999999999999998765433 2456899999999998765 4778999999999999999999987654333
Q ss_pred hhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......... .........+.++.+++.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 LHSKIKSQA----LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHCC----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhccc----CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 322111111 111112345568999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=321.72 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=198.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC----ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP----DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
++..|++.+.||+|+||.||+|.+. +..||+|.+...... ..+.+.+|+++++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4567888899999999999999975 789999998754322 24678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CceecccCCCCeeecC--------CCCeeEcCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG--RALYHDLNAYRILFDE--------DGNPRLSTF 203 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dikp~Nili~~--------~~~~kl~Df 203 (334)
||||+++++|.+++ ....+++..++.++.|++.||.|||+++ +++||||||+||+++. ++.++|+||
T Consensus 84 v~e~~~~~~L~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 84 VMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEECCTTEEHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEcCCCCCHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998 4568999999999999999999999986 2779999999999985 778999999
Q ss_pred CCCccCCCC--CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 204 GLMKNSRDG--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 204 g~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
|.+...... ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.............. .......+
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~ 236 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM----NKLALPIP 236 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT----SCCCCCCC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc----CCCCCCCC
Confidence 998754432 345688999999999988899999999999999999999999876433322211111 11122334
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 55567899999999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=332.70 Aligned_cols=248 Identities=15% Similarity=0.185 Sum_probs=205.3
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+..|++++.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 356888899999999999999965 57899999987433 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC--CCCeeEcCCCCCccCCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~--~~~~kl~Dfg~a~~~~~~~-- 213 (334)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g-ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999999964 3357999999999999999999999999 999999999999996 7899999999998765433
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...+|+.|+|||++.+..++.++||||||+++|+|++|..||................... ........+.++.+|+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--DEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CHHHHTTSCHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC--ChhhhccCCHHHHHHH
Confidence 3467899999999998889999999999999999999999987654433322221111100 0000123456899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||+.++++
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=334.51 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=213.1
Q ss_pred HHHhcCCCcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeee
Q 019905 53 KNATSGFAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCC 125 (334)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~ 125 (334)
....-....|++++.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 334445567888899999999999999964 34789999997543222 35688999999999999999999999
Q ss_pred eeCCeeeEEEecCCCCCHHHhhcccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceec
Q 019905 126 CEGDERLLVAEYMPNETLAKHLFHWE----------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183 (334)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~ 183 (334)
...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH~ 198 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHR 198 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCS
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecC
Confidence 99999999999999999999987522 257899999999999999999999999 9999
Q ss_pred ccCCCCeeecCCCCeeEcCCCCCccCCC------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCC
Q 019905 184 DLNAYRILFDEDGNPRLSTFGLMKNSRD------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPP 256 (334)
Q Consensus 184 dikp~Nili~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~ 256 (334)
||||+||+++.++.+||+|||++..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999864322 233456789999999998889999999999999999999 888886
Q ss_pred chhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 257 SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
.............. .....+...+.++.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 279 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEVIYYVRDG-----NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHHHHHHhCC-----CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 55433332211111 1112344566789999999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=336.21 Aligned_cols=249 Identities=19% Similarity=0.180 Sum_probs=206.4
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+..|++++.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 356888899999999999999964 5889999999765433445788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec--CCCCeeEcCCCCCccCCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~--~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++ ..+.+||+|||++.......
T Consensus 130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999999864 3347899999999999999999999999 99999999999997 45789999999998765432
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...+|+.|+|||++.+..++.++||||||+++|+|++|..||............... ............+.++.+|+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--DWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--CCCCCSSTTTTSCHHHHHHH
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccccccCCHHHHHHH
Confidence 346899999999999988999999999999999999999998765433222111111 00111122334567899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||+.++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHT
T ss_pred HHHcCCChhHCcCHHHHhh
Confidence 9999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=329.92 Aligned_cols=249 Identities=18% Similarity=0.258 Sum_probs=196.2
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhc--CCCCCccceeeeeee----CCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQ--LRNNRLTNLLGCCCE----GDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~~l 133 (334)
..|++++.||+|+||+||+|.. +++.||+|++... ....+..|.+++.. ++||||+++++++.. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4578888899999999999998 6789999999643 34556667776665 799999999998754 245899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--------SKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
||||+++++|.+++ ....+++..++.++.|++.||.||| +++ ++||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHH---TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHH---hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-eecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999999 4467999999999999999999999 888 99999999999999999999999999
Q ss_pred CccCCCC--------CcccccccccCcccccCC------CCCCccchhhhHHHHHHHHhC----------CCCCCchh--
Q 019905 206 MKNSRDG--------KSYSTNLAFTPPEYLRTG------RVTPESVIYSFGTLLLDLLSG----------KHIPPSHA-- 259 (334)
Q Consensus 206 a~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~elltg----------~~p~~~~~-- 259 (334)
+...... ....||+.|+|||++.+. .++.++||||||+++|+|++| ..||....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 8643322 234789999999999876 355799999999999999999 66664321
Q ss_pred ---hHHhhhcccc-cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 260 ---LDLIRDRNLQ-MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 260 ---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
.......... ...........+...+.++.+|+.+||+.||.+|||+.++++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111111100 00001111112334678899999999999999999999999999876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=329.08 Aligned_cols=246 Identities=16% Similarity=0.159 Sum_probs=203.9
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC------ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.|++.+.||+|+||.||++... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3777888899999999999965 5889999999754322 35678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC----CeeEcCCCCCccC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~----~~kl~Dfg~a~~~ 209 (334)
||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 92 ILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCC-eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999996 4567999999999999999999999999 99999999999999877 8999999999765
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||................. ..........+.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 246 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY--EFEDEYFSNTSA 246 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC--CCCHHHHTTSCH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC--CcCccccccCCH
Confidence 432 345689999999999988899999999999999999999999876543322211111000 000011123456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+.+|+.+||+.||.+|||+.++++
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 8999999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=340.82 Aligned_cols=247 Identities=17% Similarity=0.185 Sum_probs=203.6
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|++++.||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 3578888899999999999985 46889999999754422 23467899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec---CCCCeeEcCCCCCccCCCC-
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~---~~~~~kl~Dfg~a~~~~~~- 212 (334)
|+++++|.+.+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 91 ~~~gg~L~~~i~--~~~~~~e~~~~~i~~qil~aL~~lH~~g-ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999887 3467999999999999999999999999 99999999999998 5678999999999765543
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....||+.|+|||++.+..++.++||||||+++|+|++|..||................... ........++++.
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~ 245 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF--PSPEWDTVTPEAK 245 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CTTTTTTSCHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--CccccccCCHHHH
Confidence 23578999999999999899999999999999999999999987665443332221111111 1111234567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+.+||+.||.+|||+.++++
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=323.02 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=199.5
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|++++.||+|+||+||+|... +++.||+|.+....... ...+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 56888899999999999999964 58899999997554322 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----C
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----G 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~ 212 (334)
|++ +++.+.+.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~-~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~-ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCD-QDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCC-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 997 566666543 4567999999999999999999999999 99999999999999999999999999976542 2
Q ss_pred CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhH-Hhhhccccc--------------ccc---
Q 019905 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQM--------------LTD--- 273 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~--------------~~~--- 273 (334)
....+|..|+|||++.+.. ++.++||||||+++|+|++|+.|+...... ......... ..+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 3456789999999998766 899999999999999999998886443211 111100000 000
Q ss_pred ------cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 ------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 ------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...........+.++.+|+.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001122345678999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=339.04 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=199.6
Q ss_pred CcccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..|++.+.||+|+||.||+|... ++..||||.+...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 45777788899999999999864 4678999999764321 235688999999999999999999999998999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 125 ~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999964 3457899999999999999999999999 9999999999999999999999999987654321
Q ss_pred ------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 214 ------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
...++..|+|||++.+..++.++||||||+++|||++ |..||............... .....+...+.
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~ 277 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-----YRLPPPMDCPA 277 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-----EECCCCTTCBH
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCccccH
Confidence 1223568999999998899999999999999999998 88887654333322211111 11223345567
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+.+++.+||+.||.+||++.++++.|+++.+.
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999988754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.61 Aligned_cols=249 Identities=17% Similarity=0.225 Sum_probs=205.0
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.++..|++++.||+|+||.||++... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34678899999999999999999964 57899999986422 234567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 92 lv~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999997 4567999999999999999999999999 999999999999999999999999999865432
Q ss_pred ---CcccccccccCcccccC---CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 ---KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||............ ..... ....++...+.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-~~~~~--~~~~~p~~~s~ 245 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-HTFET--TVVTYPSAWSQ 245 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-HHHHH--CCCCCCTTSCH
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-HHHhh--cccCCCCcCCH
Confidence 35678999999999964 45899999999999999999999998643211111000 00000 11234555677
Q ss_pred HHHHHHHHhhhcCCCCCCC-HHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPN-PKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps-~~~~l~ 311 (334)
++.+|+.+||+.||.+||+ ++++++
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 9999999999999999999 666653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=336.74 Aligned_cols=257 Identities=22% Similarity=0.286 Sum_probs=211.8
Q ss_pred CCcccccccCCCcCccEEEEEEeC--------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 128 (334)
...|.+.+.||+|+||.||+|... .+..||+|++...... ....+.+|+++++.+ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 356788889999999999999852 2357999999765322 135688999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC
Q 019905 129 DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~ 194 (334)
+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTE 226 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCcceEEEcC
Confidence 99999999999999999997532 245899999999999999999999999 999999999999999
Q ss_pred CCCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 019905 195 DGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (334)
Q Consensus 195 ~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 267 (334)
++.+||+|||++...... ....++..|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~ 306 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999765432 23445788999999999899999999999999999999 88887655433332221
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
.. ......+...+.++.+|+.+||+.||.+|||+.++++.|+++.....
T Consensus 307 ~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 307 KE-----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HT-----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred Hc-----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11 11222344566789999999999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=336.69 Aligned_cols=245 Identities=19% Similarity=0.259 Sum_probs=203.1
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
...+|++++.||+|+||.||+|... +++.||+|.+.... ......+.+|..++..+ +||||+++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3567888899999999999999965 58899999996431 22345678899999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 101 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999973 467999999999999999999999999 99999999999999999999999999875332
Q ss_pred ---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~ 251 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLHEDA 251 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHH
Confidence 23456899999999999888999999999999999999999999776544433222211 112344566789
Q ss_pred HHHHHHhhhcCCCCCCCH------HHHHH
Q 019905 289 VRLASRCLQYEPRERPNP------KSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~------~~~l~ 311 (334)
.+|+.+||+.||.+||++ +++++
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 999999999999999998 66663
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=331.64 Aligned_cols=248 Identities=19% Similarity=0.167 Sum_probs=201.1
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+..|++++.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999965 6889999999654322 23568899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----- 211 (334)
|+++++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999986 4557999999999999999999999999 99999999999999999999999999875432
Q ss_pred -CCcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
.....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........... ...............+..+.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHH
Confidence 124568999999999987775 7789999999999999999999865322111100 00000111111234566899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
+|+.+||+.||.+|||+.++++.
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhhCcCHHHHhhC
Confidence 99999999999999999999853
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=321.26 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=209.5
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 133 (334)
.+..|++++.||+|+||.||+|.++ +..||+|.+....... .+.+.+|+.++++++||||+++++++... ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 4567888999999999999999985 7899999997654322 34688999999999999999999999876 77899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+|||+++++|.+++.......+++..++.++.|++.||.|||+++. ++||||||+||+++.++.++++|||++.... .
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-S 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-C
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-c
Confidence 9999999999999975444468999999999999999999998642 8999999999999999999999888765432 2
Q ss_pred CcccccccccCcccccCCCCCC---ccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTP---ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....+|+.|+|||.+.+..++. ++||||||+++|+|++|..||.............. .......+...+.++.
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 241 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL----EGLRPTIPPGISPHVS 241 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH----SCCCCCCCTTCCHHHH
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh----cCCCCCCCCCCCHHHH
Confidence 3456789999999998765444 79999999999999999999876543332221111 1122234455667899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 290 RLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
+++.+||+.||.+|||+.++++.|+++.+
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 242 KLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999998864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=320.15 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=205.1
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCCh-------HHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDP-------RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
-..|++.+.||+|+||.||+|.. .+++.||+|.+........ +.+.+|++++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35688889999999999999996 4688999999975443322 56889999999999999999999986654
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecccCCCCeeecCCCC-----eeEcCCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGN-----PRLSTFG 204 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dikp~Nili~~~~~-----~kl~Dfg 204 (334)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++. ++||||||+||+++.++. ++|+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 699999999999998864 45679999999999999999999999854 999999999999987776 9999999
Q ss_pred CCccCCCC-CcccccccccCccccc--CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 205 LMKNSRDG-KSYSTNLAFTPPEYLR--TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 205 ~a~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
++...... ....+++.|+|||.+. ...++.++||||||+++|+|++|..||.......... .............+
T Consensus 175 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~ 252 (287)
T 4f0f_A 175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLRPTIP 252 (287)
T ss_dssp TCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCCCCCC
T ss_pred ccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCCCCCC
Confidence 98765443 3456899999999994 4457899999999999999999999986543222110 01111112222345
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
...++++.+++.+||+.||.+|||+.++++.|+++
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 56677899999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.53 Aligned_cols=245 Identities=16% Similarity=0.176 Sum_probs=208.6
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
....|++++.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3567889999999999999999965 58999999986432 2345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999999973 356999999999999999999999999 999999999999999999999999999865543
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++.+++
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKDLL 269 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTCCHHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHH
Confidence 3467899999999999989999999999999999999999998765443333222111 1123455667899999
Q ss_pred HHhhhcCCCCCCC-----HHHHHH
Q 019905 293 SRCLQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps-----~~~~l~ 311 (334)
.+||+.||.+||+ ++++++
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhcCHHhccCCccCCHHHHHh
Confidence 9999999999998 888874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.23 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=209.4
Q ss_pred CcccccccCCCcCccEEEEEEe-----CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeee--eCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC--EGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 132 (334)
..|++++.||+|+||.||++.+ .++..||+|.+........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4588889999999999999984 357899999997655334456899999999999999999999886 345689
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 103 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSRR-CVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999999864 2346899999999999999999999999 999999999999999999999999998765432
Q ss_pred -------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhc----------ccccccccc
Q 019905 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR----------NLQMLTDSC 275 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~----------~~~~~~~~~ 275 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|..||........... .........
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 233467789999999988899999999999999999999988765443322111 001111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
.....+...++.+.+|+.+||+.||.+|||+.++++.|+.+..+.
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 222345566778999999999999999999999999999887643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=322.52 Aligned_cols=249 Identities=19% Similarity=0.265 Sum_probs=199.5
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|...+++.||+|++..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999988899999999965432 2246788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~ 213 (334)
++ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... ..
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LD-QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CS-EEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 97 589888864 3467899999999999999999999999 99999999999999999999999999875432 22
Q ss_pred cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc----------------ccc--
Q 019905 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML----------------TDS-- 274 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------------~~~-- 274 (334)
...+|+.|+|||++.+. .++.++||||||+++|+|++|..||................ .+.
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 34678999999999765 48999999999999999999999887543222111110000 000
Q ss_pred -----ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 -----CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..........++++.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000112345678999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=351.14 Aligned_cols=261 Identities=24% Similarity=0.327 Sum_probs=217.1
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
...+++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|++++++++|+||+++++++.. +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34577888899999999999999888889999998654 346789999999999999999999999866 6789999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~ 213 (334)
++++|.+++.......+++..++.++.||+.||.|||+++ ++||||||+|||+++++.+||+|||++...... .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 9999999997533456899999999999999999999999 999999999999999999999999999765432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...++..|+|||++.+..++.++||||||+++|||++ |..||.......+...... ......+...+..+.+||
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~li 497 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLM 497 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHH
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHH
Confidence 3345678999999998889999999999999999999 7877765433322221111 111223445667899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccccCCCCCChh
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKETEFSISPL 327 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p~ 327 (334)
.+||+.||.+|||++++++.|+.+.........|.
T Consensus 498 ~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~ 532 (535)
T 2h8h_A 498 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532 (535)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC-
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHhhccCcccCcc
Confidence 99999999999999999999999988776665554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=332.13 Aligned_cols=246 Identities=18% Similarity=0.218 Sum_probs=203.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|++++.||+|+||.||+|... ++..||+|.+....... .+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 4788888899999999999964 58899999997654322 34678999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC---CCeeEcCCCCCccCCCCC-
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~---~~~kl~Dfg~a~~~~~~~- 213 (334)
+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.......
T Consensus 110 ~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 110 VTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred CCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999886 4567899999999999999999999999 9999999999999854 459999999998665432
Q ss_pred --cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 214 --SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
...||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........+.++.+|
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTGGGGSCHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHHH
Confidence 357899999999999989999999999999999999999998765433332221111110 0011113456789999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+||+.||.+|||+.++++
T Consensus 265 i~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=328.35 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=209.7
Q ss_pred CCcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
...|.+.+.||+|+||.||+|.. .++..||+|.+...... ..+.+.+|+++++.++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 35677888899999999999985 23578999999754321 235688999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWET----------------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~N 189 (334)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dikp~N 180 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-LVHRDLAARN 180 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-Ccccccchhe
Confidence 999999999999999975321 34889999999999999999999999 9999999999
Q ss_pred eeecCCCCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHH
Q 019905 190 ILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDL 262 (334)
Q Consensus 190 ili~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~ 262 (334)
|+++.++.++|+|||++...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998765432 23345678999999998889999999999999999999 888876544332
Q ss_pred hhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
....... ......+...++++.+++.+||+.||.+|||+.++++.|+++..+
T Consensus 261 ~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 LFNLLKT-----GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHT-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHhhc-----CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 2211111 112233455667899999999999999999999999999988754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.86 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=195.8
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++.+.||+|+||.||+|...+ .||+|.+....... .+.+.+|+.++++++||||+++++++ .....++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 457788888999999999998644 59999997654322 35688999999999999999999965 45668999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC------
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD------ 211 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~------ 211 (334)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 101 CEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred cCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999999864 4567899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcccccccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-hhhcccccccccccCCCCCchhHHH
Q 019905 212 GKSYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
.....+|..|+|||.+. +..++.++||||||+++|+|++|..||....... ............ .........+..
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 257 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-DLSKVRSNCPKR 257 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-CTTSSCTTSCHH
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-chhhccccCCHH
Confidence 12346789999999986 5568889999999999999999999886532211 111111111111 111223455678
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.+|+.+||+.||.+|||+.++++.|+++.++
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 99999999999999999999999999988753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=331.80 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=204.5
Q ss_pred CCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
....|.+++.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 356788999999999999999996 568899999986421 2234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+ +|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 6899988863 457999999999999999999999999 999999999999999999999999998765443
Q ss_pred --CcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||............ ... ....+...++++.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----~~~--~~~~p~~~s~~~~ 236 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----NSC--VYVMPDFLSPGAQ 236 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----CSS--CCCCCTTSCHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----HcC--CCCCcccCCHHHH
Confidence 34568999999999988775 78999999999999999999998654332221111 111 1123455677899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+.+||+.||.+|||++++++
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHHcCCChhHCcCHHHHHh
Confidence 9999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=326.48 Aligned_cols=255 Identities=18% Similarity=0.296 Sum_probs=205.2
Q ss_pred cccccccCCCcCccEEEEEEe-----CCCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeC--Ceee
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 132 (334)
.|++++.||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 377888899999999999984 357899999997543 23457789999999999999999999999876 5689
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 102 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcCC-cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999999999864 3456999999999999999999999999 999999999999999999999999998765432
Q ss_pred -------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh----------hcccccccccc
Q 019905 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNLQMLTDSC 275 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~ 275 (334)
....+|..|+|||.+.+..++.++||||||+++|+|++|..|+......... ...........
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2345677899999999888999999999999999999999765332111100 00001111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
.....+...++.+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222345566779999999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=329.58 Aligned_cols=259 Identities=18% Similarity=0.256 Sum_probs=195.3
Q ss_pred CcccccccCCCcCccEEEEEEeCCC----CEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCee--
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQ----RRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER-- 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 131 (334)
..|++++.||+|+||.||+|....+ ..||+|.+...... ..+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 4577888889999999999996543 27999999765322 246788999999999999999999999876554
Q ss_pred ----eEEEecCCCCCHHHhhcccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCC
Q 019905 132 ----LLVAEYMPNETLAKHLFHWE----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (334)
Q Consensus 132 ----~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Df 203 (334)
+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-FIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-cccCCCCcceEEEcCCCCEEEeec
Confidence 89999999999999886321 226899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccccccccc
Q 019905 204 GLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 204 g~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
|++...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||............... .
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----~ 256 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-----N 256 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----C
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC-----C
Confidence 998765332 23345678999999999899999999999999999999 77777654332222111111 1
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSI 324 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~ 324 (334)
....+...+.++.+++.+||+.||.+|||+.++++.|+++........
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 122344556789999999999999999999999999999987655444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=323.83 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=214.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
....|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34567888899999999999999754 7889999997543 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC---
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
|+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT-CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC-ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 999999999997655677999999999999999999999999 9999999999999999999999999987655432
Q ss_pred --cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 214 --SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 214 --~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...++.+.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DYRMERPEGCPEKVYE 243 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----TCCCCCCTTCCHHHHH
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----cCCCCCCCCCCHHHHH
Confidence 2345678999999998899999999999999999999 7777765433322221111 1122334556678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 291 LASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
++.+||+.||.+|||+.++++.|+.+..+..
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999998876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=323.67 Aligned_cols=257 Identities=15% Similarity=0.136 Sum_probs=208.1
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+.... ....+.+|+.++..+ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4578888889999999999995 568899999986543 334678899999999 799999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC-----eeEcCCCCCccCCCC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN-----PRLSTFGLMKNSRDG 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~-----~kl~Dfg~a~~~~~~ 212 (334)
+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++. ++|+|||++......
T Consensus 88 ~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 88 L-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred c-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9 8999999974 3456999999999999999999999999 999999999999987765 999999998754332
Q ss_pred -----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh---HHhhhcccccccccccCC
Q 019905 213 -----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL---DLIRDRNLQMLTDSCLEG 278 (334)
Q Consensus 213 -----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 278 (334)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............... ..
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-HH
Confidence 344688999999999998899999999999999999999999865211 111000000000000 00
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
......++++.+++.+||+.||.+|||+.++++.|+++.++...
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 11223456899999999999999999999999999999876554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=324.56 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=201.6
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
++..|++.+.||+|+||.||++.+. ++.||+|.+... ...+.+.+|++++++++||||+++++++.. ..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 4567888899999999999999985 688999999643 235678899999999999999999998873 47899999
Q ss_pred CCCCCHHHhhcccCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCceecccCCCCeeecCCCC-eeEcCCCCCccCCC-
Q 019905 138 MPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTS---KGRALYHDLNAYRILFDEDGN-PRLSTFGLMKNSRD- 211 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dikp~Nili~~~~~-~kl~Dfg~a~~~~~- 211 (334)
+++++|.+++..... ..++...++.++.|++.||.|||+ ++ ++||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~-ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC-CCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC-eecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999974222 247889999999999999999999 77 999999999999998887 79999999875543
Q ss_pred CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||............ . .........+...+..+.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--A-VHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--H-HHTTCCCCCBTTCCHHHHHH
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--H-HhcCCCCCcccccCHHHHHH
Confidence 23456899999999999989999999999999999999999988643211111000 0 00011112234456689999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
+.+||+.||.+|||+.++++.|+.+.+..+..
T Consensus 237 i~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 99999999999999999999999887655433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=336.48 Aligned_cols=244 Identities=18% Similarity=0.259 Sum_probs=199.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
...+|++++.||+|+||.||++... +++.||+|++...... ....+.+|..++.++ +||||+++++++...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4567889999999999999999965 4789999999754322 234578899999877 8999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999873 457999999999999999999999999 99999999999999999999999999875322
Q ss_pred ---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHh-----hhcccccccccccCCCCCch
Q 019905 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI-----RDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 283 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||........ .......+... ...++..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~ 284 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRS 284 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--CCCCCTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--ccCCCCc
Confidence 2356789999999999999999999999999999999999999853211100 00001111111 1234556
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCH
Q 019905 284 DGTELVRLASRCLQYEPRERPNP 306 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~ 306 (334)
.+.++.+|+.+||+.||.+||++
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCHHHHHHHHHHhcCCHhHcCCC
Confidence 67789999999999999999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=328.95 Aligned_cols=254 Identities=16% Similarity=0.139 Sum_probs=205.7
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|.. .+++.||||.+.... ....+.+|+.+++.+ +||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4577888899999999999995 568899999987543 234678999999999 899999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC-----eeEcCCCCCccCCCC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN-----PRLSTFGLMKNSRDG 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~-----~kl~Dfg~a~~~~~~ 212 (334)
+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++. ++|+|||++......
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 87 L-GPSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHSKN-LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred C-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 9 8999999874 3568999999999999999999999999 999999999999998877 999999999754321
Q ss_pred -----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh---hcccccccccccCC
Q 019905 213 -----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR---DRNLQMLTDSCLEG 278 (334)
Q Consensus 213 -----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~ 278 (334)
....||+.|+|||++.+..++.++||||||+++|+|++|..||......... ......... ....
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CCHH
Confidence 3456899999999999999999999999999999999999998753211111 000000000 0000
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
......+ ++.+++..||+.||.+||++.++++.|+++.+..
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0111233 8999999999999999999999999998887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=332.37 Aligned_cols=244 Identities=18% Similarity=0.244 Sum_probs=204.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
...+|++++.||+|+||.||+|..+ +++.||+|.+.... ......+..|..++..+ +||||+++++++...+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4567888888999999999999975 57899999996532 23456678899999876 8999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999963 357899999999999999999999999 99999999999999999999999999875422
Q ss_pred ---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 245 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEA 245 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CCCCCcccCHHH
Confidence 23457899999999999989999999999999999999999998765443333222111 112344566789
Q ss_pred HHHHHHhhhcCCCCCCCHH-HHH
Q 019905 289 VRLASRCLQYEPRERPNPK-SLV 310 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~-~~l 310 (334)
.+|+.+||+.||.+||++. +++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHH
Confidence 9999999999999999997 654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=323.98 Aligned_cols=261 Identities=18% Similarity=0.222 Sum_probs=204.0
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
....+..|++++.||+|+||.||++... +++.||+|.+....... .+.+.+|+.++++++||||+++++++..++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 4455788999999999999999999965 57899999997544333 2568899999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAG-ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc-CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999999873 357899999999999999999999999 9999999999999999999999999987554
Q ss_pred CC-----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 211 DG-----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 211 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|..||.................. ....+...+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 262 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPR---PSTVRPGIP 262 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCC---GGGTSTTCC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCC---ccccCCCCC
Confidence 32 2346789999999999888999999999999999999999998766544332211111111 112234455
Q ss_pred HHHHHHHHHhhhcCCCCCC-CHHHHHHHhccccccCC
Q 019905 286 TELVRLASRCLQYEPRERP-NPKSLVTALSPLQKETE 321 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rp-s~~~~l~~L~~l~~~~~ 321 (334)
.++.+++.+||+.||.+|| |++++++.|+++.....
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 6899999999999999999 99999999998876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=329.63 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=208.9
Q ss_pred ccccccCCCcCccEEEEEEeC-----CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeC--CeeeE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 133 (334)
+++++.||+|+||+||++.+. +++.||+|++...... ..+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478889999999999998743 5789999999764321 235688999999999999999999999874 57899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999953 45999999999999999999999999 999999999999999999999999998865443
Q ss_pred ------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh----------hccccccccccc
Q 019905 213 ------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNLQMLTDSCL 276 (334)
Q Consensus 213 ------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~~ 276 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ............
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 2334677899999999888999999999999999999999887654322111 001111112222
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
....+...+.++.+|+.+||+.||.+|||+.++++.|+.+.++...
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 2334556677999999999999999999999999999998765543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=326.42 Aligned_cols=244 Identities=18% Similarity=0.243 Sum_probs=197.4
Q ss_pred CCcccccccCCCcCccEEEEEEe----CCCCEEEEEEecCCCC----CChHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMAW----PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
...|++++.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45688889999999999999986 4689999999975431 223457789999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999863 456899999999999999999999999 9999999999999999999999999987533
Q ss_pred C----CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 211 D----GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 211 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
. .....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~ 246 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC------KLNLPPYLTQ 246 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------CCCCCTTSCH
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCH
Confidence 2 23456899999999999888999999999999999999999998765443332221111 1123445667
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
++.+++.+||+.||.+|| ++.++++
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 899999999999999999 7778774
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=328.07 Aligned_cols=247 Identities=17% Similarity=0.185 Sum_probs=201.4
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCC-----CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM-----AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.|++++.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4788889999999999999964 5899999998532 122457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC---eeEcCCCCCccC
Q 019905 135 AEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNS 209 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~---~kl~Dfg~a~~~ 209 (334)
|||+++++|.+.+... ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++. +||+|||++...
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999998877532 2346899999999999999999999999 999999999999986554 999999999765
Q ss_pred CCC----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 210 RDG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 210 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||................ .. ........+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~-~~--~~~~~~~~s 260 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY-KM--NPRQWSHIS 260 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCC-CC--CHHHHTTSC
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCC-CC--CccccccCC
Confidence 543 23568999999999999899999999999999999999999987654322221110000 00 000012345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.+|+.+||+.||.+|||+.++++
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 68999999999999999999999984
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=323.85 Aligned_cols=257 Identities=14% Similarity=0.154 Sum_probs=206.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCC--eeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 135 (334)
..|.+++.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 45888899999999999999965 48999999997543 234567889999999999999999999987654 679999
Q ss_pred ecCCCCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee----cCCCCeeEcCCCCCccCC
Q 019905 136 EYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili----~~~~~~kl~Dfg~a~~~~ 210 (334)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999999997432 234899999999999999999999999 9999999999999 777889999999998654
Q ss_pred CCC---cccccccccCccccc--------CCCCCCccchhhhHHHHHHHHhCCCCCCchhh----HHhhhccccccc---
Q 019905 211 DGK---SYSTNLAFTPPEYLR--------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNLQMLT--- 272 (334)
Q Consensus 211 ~~~---~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~elltg~~p~~~~~~----~~~~~~~~~~~~--- 272 (334)
... ...+|..|+|||++. +..++.++||||||+++|+|++|..||..... ...........+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 432 456889999999986 46789999999999999999999998853211 111100000000
Q ss_pred ----------------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 273 ----------------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 273 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
........+...+..+.+++.+||+.||.+|||+.++++-..+-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111122345667889999999999999999999999998876544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=329.54 Aligned_cols=245 Identities=19% Similarity=0.258 Sum_probs=205.5
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCC---CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
...+|++++.||+|+||.||++.... ++.||+|.+.... ....+.+..|..++..+ +||+|+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45678888999999999999999754 7899999996431 23456788899999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999963 356999999999999999999999999 99999999999999999999999999875322
Q ss_pred ---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...+.++
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 248 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------NVAYPKSMSKEA 248 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHH
Confidence 23457899999999999999999999999999999999999998765444333222211 112445667799
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHH
Q 019905 289 VRLASRCLQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps-----~~~~l~ 311 (334)
.+|+.+||+.||.+||+ ++++++
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999999999995 466653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=334.42 Aligned_cols=259 Identities=17% Similarity=0.181 Sum_probs=204.0
Q ss_pred CCCcccccccCCCc--CccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEK--APNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
+-..|++++.||+| +||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34568888999999 99999999975 68999999997544222 346778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC--
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-- 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~-- 210 (334)
+||||+++++|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999997655577999999999999999999999999 9999999999999999999999999875321
Q ss_pred ---------CCCcccccccccCcccccC--CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc----c--
Q 019905 211 ---------DGKSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT----D-- 273 (334)
Q Consensus 211 ---------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~----~-- 273 (334)
......+|..|+|||++.+ ..++.++|||||||++|+|++|..||................. +
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1223467889999999987 5699999999999999999999999865322111110000000 0
Q ss_pred ----------------------------------cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hcccc
Q 019905 274 ----------------------------------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA--LSPLQ 317 (334)
Q Consensus 274 ----------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--L~~l~ 317 (334)
.......+...++++.+|+.+||+.||.+|||+.++++- ++.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000011233456789999999999999999999999853 44443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=329.18 Aligned_cols=244 Identities=20% Similarity=0.232 Sum_probs=202.6
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|++++.||+|+||.||+|.. .+++.||||++....... .+.+.+|++++++++||||+++++++..++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 67778889999999999995 568899999997544322 24578999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 217 (334)
++ |+|.+.+.. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..........|
T Consensus 136 ~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~g 212 (348)
T 1u5q_A 136 CL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG 212 (348)
T ss_dssp CS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred CC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccC
Confidence 97 788887754 3467999999999999999999999999 99999999999999999999999999988777677789
Q ss_pred cccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 218 NLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 218 ~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
|+.|+|||++. +..++.++||||||+++|+|++|..||.............. .......+...+..+.+|+.+
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCCCTTSCHHHHHHHHH
T ss_pred CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCCCCCCHHHHHHHHH
Confidence 99999999985 45689999999999999999999998865432221111111 111111233456689999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~ 312 (334)
||+.||.+|||++++++.
T Consensus 289 ~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HTCSSGGGSCCHHHHTTC
T ss_pred HcccChhhCcCHHHHhhC
Confidence 999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=328.97 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=201.2
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCC----EEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
..|++++.||+|+||+||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45778888899999999999954 333 36888886433 234567899999999999999999999998754 789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
+++|+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 94 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999999975 4567999999999999999999999999 999999999999999999999999998754322
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....+|..|+|||.+.+..++.++||||||+++|+|++ |..||............ ........+...+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-----EKGERLPQPPICTI 246 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----HTTCCCCCCTTBCH
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-----HcCCCCCCCccCCH
Confidence 12345778999999999999999999999999999999 88887654333222111 11112233455667
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 89999999999999999999999999988764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=323.45 Aligned_cols=250 Identities=19% Similarity=0.264 Sum_probs=188.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 46788888999999999999954 589999999975442 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhccc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--
Q 019905 138 MPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-- 211 (334)
Q Consensus 138 ~~~~sL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~-- 211 (334)
++ ++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 97 6999888642 1246899999999999999999999999 99999999999999999999999999876542
Q ss_pred --CCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc--------------cc-
Q 019905 212 --GKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------------TD- 273 (334)
Q Consensus 212 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------------~~- 273 (334)
.....+|+.|+|||++.+. .++.++||||||+++|+|++|..||................ ..
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 2345678999999999764 58999999999999999999999987653322211110000 00
Q ss_pred -ccc------------CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 -SCL------------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 -~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... ........+.++.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 00111234568999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=332.45 Aligned_cols=258 Identities=15% Similarity=0.152 Sum_probs=202.7
Q ss_pred CcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCCCh-----------HHHHHHHHHHhcCCCCCcccee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPDP-----------RQFLEEARSVGQLRNNRLTNLL 122 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~ 122 (334)
..|++++.||+|+||.||+|.+.. ++.||+|.+........ ..+..|+..+..++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 468888999999999999999754 47899999865431110 1223455667788899999999
Q ss_pred eeeeeC----CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec--CCC
Q 019905 123 GCCCEG----DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDG 196 (334)
Q Consensus 123 ~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~--~~~ 196 (334)
+++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~-iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHE-YVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEESSCTT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eEEecCCHHHEEEecCCCC
Confidence 998764 4589999999 8999999975 4467999999999999999999999999 99999999999999 889
Q ss_pred CeeEcCCCCCccCCCC-----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh-
Q 019905 197 NPRLSTFGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR- 264 (334)
Q Consensus 197 ~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~- 264 (334)
.+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999654321 2334899999999999989999999999999999999999998753211110
Q ss_pred -------hcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 265 -------DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 265 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
......+.+.++. ....+.++.+++..||+.||.+||++.++++.|+++.++....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 0111112222211 1334568999999999999999999999999999888765443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=337.73 Aligned_cols=255 Identities=17% Similarity=0.173 Sum_probs=209.1
Q ss_pred HHHHHhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeee
Q 019905 51 QLKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCC 126 (334)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 126 (334)
.+........+|++++.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34455556678999999999999999999965 57899999986421 123345788999999999999999999999
Q ss_pred eCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
.....++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999853 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCC-----CcccccccccCcccccCCC----CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC
Q 019905 207 KNSRDG-----KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 207 ~~~~~~-----~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
...... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||................... .
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~ 293 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--T 293 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--C
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--c
Confidence 765543 2567899999999997655 7899999999999999999999997665443332222111111 1
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRE--RPNPKSLVT 311 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~~l~ 311 (334)
.......+.++.+|+.+||+.+|.+ ||+++++++
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1112245678999999999999988 999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=321.51 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=197.1
Q ss_pred CcccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..|++.+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+.++++++||||+++++++. ++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 567888899999999999998643 457999998754322 2356889999999999999999999984 5678999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 94 MELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999999964 3457899999999999999999999999 9999999999999999999999999987654322
Q ss_pred ----cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 214 ----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...++.+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-----GERLPMPPNCPPTL 246 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----TCCCCCCTTCCHHH
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-----CCCCCCCCCCCHHH
Confidence 2345678999999998889999999999999999997 7777765432222111111 11122345566789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=321.58 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=203.1
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC-CeeeEEEe
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-DERLLVAE 136 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 136 (334)
+...|++++.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4567888999999999999999874 7899999997543 456789999999999999999999987554 47899999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Ccc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~ 215 (334)
|+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ...
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 999999999997533334889999999999999999999999 999999999999999999999999998755433 234
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...++.+.+++.+
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----TCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCcccCCHHHHHHHHH
Confidence 56789999999998889999999999999999998 8887765433222211111 11223345566789999999
Q ss_pred hhhcCCCCCCCHHHHHHHhcccccc
Q 019905 295 CLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
||+.||.+|||+.++++.|+.+...
T Consensus 250 ~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999988754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=329.09 Aligned_cols=244 Identities=21% Similarity=0.249 Sum_probs=188.9
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 3777888899999999999975 47899999997543 34567889999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccCCCC---C
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDG---K 213 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~~~~---~ 213 (334)
+++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++...... .
T Consensus 132 ~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 132 GGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENG-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp SCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999986 4466899999999999999999999999 999999999999975 889999999998765432 3
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-hhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...||+.|+|||++.+..++.++||||||+++|+|++|..||....... .......... ..........+.++.+|+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY--YFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC--CCCTTTTTTSCHHHHHHH
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC--ccCCchhhhCCHHHHHHH
Confidence 4568999999999999889999999999999999999999986543322 1111111000 011112234567899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||+.++++
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=325.99 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=209.6
Q ss_pred CcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 131 (334)
..|++.+.||+|+||.||+|.+ .++..||+|.+...... ..+.+.+|+.++.++ +||||+++++++..++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5678888899999999999984 34678999999754421 235688999999999 899999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 132 LLVAEYMPNETLAKHLFHWET----------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHG 181 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEcCC
Confidence 999999999999999875322 25899999999999999999999999 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccc
Q 019905 196 GNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 268 (334)
+.+||+|||++....... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 999999999987654432 2345678999999998899999999999999999999 887775432211111111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
........+...+..+.+++.+||+.||.+|||+.++++.|+++..+..
T Consensus 262 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 262 ----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp ----HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ----ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1111122334556789999999999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=320.75 Aligned_cols=259 Identities=20% Similarity=0.248 Sum_probs=211.6
Q ss_pred Ccccccc-cCCCcCccEEEEEEeC---CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
..+.+++ .||+|+||.||+|... ++..||+|.+...... ..+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4456666 7899999999999853 5778999999765321 245688999999999999999999999 55678999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999864 4456999999999999999999999999 999999999999999999999999998765432
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~~~ 240 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-----GKRMECPPECPP 240 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-----TCCCCCCTTCCH
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-----CCcCCCCCCcCH
Confidence 22345788999999988889999999999999999998 8888865433222211111 111234456677
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
++.+++.+||+.||.+|||+.++++.|+.+..+......+
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 9999999999999999999999999999998876665543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=328.50 Aligned_cols=251 Identities=17% Similarity=0.265 Sum_probs=202.2
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCE----EEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRR----IAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
..|++++.||+|+||.||+|.+. ++.. ||+|.+.... ......+.+|+.+++.++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46888899999999999999964 3443 8888886443 223356778999999999999999999886 456889
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHG-MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHTT-CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhCC-CCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999864 3457889999999999999999999999 999999999999999999999999999865432
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 244 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-----GERLAQPQICTI 244 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-----TCBCCCCTTBCT
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-----CCCCCCCCcCcH
Confidence 23346779999999998899999999999999999999 8888865433322211111 111122333455
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
++.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999999988865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=333.25 Aligned_cols=245 Identities=19% Similarity=0.160 Sum_probs=196.9
Q ss_pred cccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 63 NIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3355689999999999996 458899999998655444567899999999999999999999999999999999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee--cCCCCeeEcCCCCCccCCCC---Cccc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF--DEDGNPRLSTFGLMKNSRDG---KSYS 216 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili--~~~~~~kl~Dfg~a~~~~~~---~~~~ 216 (334)
+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...... ....
T Consensus 172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 249 (373)
T 2x4f_A 172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249 (373)
T ss_dssp EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence 99998864 3456899999999999999999999999 9999999999999 56788999999999865543 2346
Q ss_pred ccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhh
Q 019905 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (334)
Q Consensus 217 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (334)
||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........++++.+|+.+||
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~~~L 327 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--LEDEEFQDISEEAKEFISKLL 327 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--SCSGGGTTSCHHHHHHHHTTS
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CChhhhccCCHHHHHHHHHHc
Confidence 899999999999888999999999999999999999998765433322221111110 001111234568999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 019905 297 QYEPRERPNPKSLVT 311 (334)
Q Consensus 297 ~~dp~~Rps~~~~l~ 311 (334)
+.||.+|||+.++++
T Consensus 328 ~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 328 IKEKSWRISASEALK 342 (373)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhhCCCHHHHhc
Confidence 999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=327.81 Aligned_cols=243 Identities=18% Similarity=0.255 Sum_probs=199.4
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 133 (334)
..+|++++.||+|+||.||++... +++.||+|.+....... .+.+.+|..++.++ +||||+++++++...+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 466888899999999999999965 57899999997654333 24577899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-- 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~-- 211 (334)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999999863 357999999999999999999999999 99999999999999999999999999875322
Q ss_pred --CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-----hhhcccccccccccCCCCCchh
Q 019905 212 --GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 212 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ........+... ...++...
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~ 242 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSL 242 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTTS
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCCC
Confidence 234578999999999999899999999999999999999999985421100 000000111111 12345566
Q ss_pred HHHHHHHHHHhhhcCCCCCCCH
Q 019905 285 GTELVRLASRCLQYEPRERPNP 306 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~ 306 (334)
+.++.+|+.+||+.||.+||++
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTC
T ss_pred CHHHHHHHHHHhcCCHhHCCCC
Confidence 7789999999999999999996
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=334.14 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=206.6
Q ss_pred cCCCcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeeeC
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 128 (334)
-....|++.+.||+|+||.||+|.+ .+++.||||.+....... .+.+.+|++++.++ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 3446788888999999999999973 235789999997543221 34688999999999 799999999998875
Q ss_pred C-eeeEEEecCCCCCHHHhhcccCC-------------------------------------------------------
Q 019905 129 D-ERLLVAEYMPNETLAKHLFHWET------------------------------------------------------- 152 (334)
Q Consensus 129 ~-~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------------- 152 (334)
+ ..++||||+++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 48999999999999999874221
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC------Ccccc
Q 019905 153 ---------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------KSYST 217 (334)
Q Consensus 153 ---------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~------~~~~~ 217 (334)
..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ....+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 12889999999999999999999999 999999999999999999999999998754332 23456
Q ss_pred cccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhh
Q 019905 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (334)
Q Consensus 218 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (334)
|..|+|||++.+..++.++||||||+++|+|++ |..||.............. .......+...++++.+++.+||
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTMLDCW 333 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----HTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH----cCCCCCCCCCCCHHHHHHHHHHc
Confidence 788999999998899999999999999999998 8888765432211111111 11112234455678999999999
Q ss_pred hcCCCCCCCHHHHHHHhcccccc
Q 019905 297 QYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 297 ~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.||.+|||+.++++.|+.+.+.
T Consensus 334 ~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 334 HGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999988753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=329.91 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=205.5
Q ss_pred CCcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCC-CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 130 (334)
...|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 45678888899999999999995 235689999997543 22346788999999999 89999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWET---------------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~N 189 (334)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~N 202 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARN 202 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGGG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChhh
Confidence 9999999999999999974221 23789999999999999999999999 9999999999
Q ss_pred eeecCCCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHH
Q 019905 190 ILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDL 262 (334)
Q Consensus 190 ili~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~ 262 (334)
|+++.++.++|+|||++....... ...+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 999999999999999987543321 2345678999999998899999999999999999998 888876543221
Q ss_pred hhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
..... .........+...+.++.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 283 ~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 283 NFYKL----IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHH----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHH----HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 11111 11111222344556789999999999999999999999999999876544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=341.25 Aligned_cols=245 Identities=22% Similarity=0.254 Sum_probs=199.3
Q ss_pred CCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC---CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
....|++++.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346788999999999999999995 45889999999743 22234567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++.....
T Consensus 226 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~g-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTC-CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCC-EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999999863 4578999999999999999999998 88 99999999999999999999999999875332
Q ss_pred ---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...++++
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~ 376 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLGPEA 376 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHH
Confidence 23457899999999999999999999999999999999999999766544333222111 112345566789
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHH
Q 019905 289 VRLASRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
.+|+.+||+.||.+|| +++++++
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 9999999999999999 9999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=325.30 Aligned_cols=251 Identities=18% Similarity=0.268 Sum_probs=199.6
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC--CCCCccceeeeeeeC----CeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL--RNNRLTNLLGCCCEG----DERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~l 133 (334)
..|++++.||+|+||.||+|... ++.||+|++.... ......|.+++..+ +||||+++++++... ...++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 35778888899999999999985 7899999986432 34555666666655 899999999999876 67899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK--------GRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+
T Consensus 113 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-EEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999999999953 4699999999999999999999998 8 99999999999999999999999999
Q ss_pred CccCCCC--------CcccccccccCcccccCCCCCCc------cchhhhHHHHHHHHhC----------CCCCCchh--
Q 019905 206 MKNSRDG--------KSYSTNLAFTPPEYLRTGRVTPE------SVIYSFGTLLLDLLSG----------KHIPPSHA-- 259 (334)
Q Consensus 206 a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~~l~elltg----------~~p~~~~~-- 259 (334)
+...... ....||+.|+|||++.+..++.. +||||||+++|+|++| ..|+....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 8654332 23468999999999987776655 9999999999999999 44443211
Q ss_pred ---hHHhhhcccccccccccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 260 ---LDLIRDRNLQMLTDSCLEGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 260 ---~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
......... ........ ....+.++.+++.+||+.||.+|||+.++++.|+++.++.++
T Consensus 269 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 269 DPSYEDMREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp SCCHHHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred CCchhhhHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 111111100 01111112 235678899999999999999999999999999999877654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=337.65 Aligned_cols=244 Identities=19% Similarity=0.264 Sum_probs=206.8
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
...|.+.+.||+|+||.||+|... +|+.||||.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356888899999999999999965 68999999996432 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+++++|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999996 4567999999999999999999999999 999999999999999999999999999865443
Q ss_pred -CcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||................ ...+...++++.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~ 245 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------FYTPQYLNPSVIS 245 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------CCCCTTCCHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------cCCCccCCHHHHH
Confidence 34568999999999998775 679999999999999999999987654433322221111 1223445678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||.+|||+.++++
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCchhCcCHHHHHh
Confidence 999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.89 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=203.8
Q ss_pred ccccccCCCcCccEEEEEEeC-CC---CEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCee-eEEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQ---RRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER-LLVA 135 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~ 135 (334)
+++.+.||+|+||+||+|.+. ++ ..+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+.. +++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 444577899999999999853 22 37999999754321 235688999999999999999999999876554 9999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---- 211 (334)
||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 103 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 103 PYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK-FVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred ecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 99999999999964 4567899999999999999999999999 99999999999999999999999999875432
Q ss_pred ----CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 212 ----GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 212 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+............ .........+...+..
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF----LAQGRRLPQPEYCPDS 256 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH----HHTTCCCCCCTTCCHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH----hhcCCCCCCCccchHH
Confidence 23345678999999999989999999999999999999977766543221111111 1111112234445678
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
+.+++.+||+.||.+|||+.++++.|+++.++..
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999887543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=324.67 Aligned_cols=244 Identities=17% Similarity=0.253 Sum_probs=193.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCC--------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-------- 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 129 (334)
..|++++.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45778888999999999999975 6899999999754433 3467899999999999999999999986543
Q ss_pred -------------------------------------------------eeeEEEecCCCCCHHHhhcccC-CCCCCHHH
Q 019905 130 -------------------------------------------------ERLLVAEYMPNETLAKHLFHWE-THPMKWAM 159 (334)
Q Consensus 130 -------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~ 159 (334)
..+++|||+++++|.+++.... ....++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999997422 13355667
Q ss_pred HHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----------------CcccccccccC
Q 019905 160 RLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----------------KSYSTNLAFTP 223 (334)
Q Consensus 160 ~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~y~a 223 (334)
++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... ....||+.|+|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHhCC-eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 8999999999999999999 999999999999999999999999998765432 23468999999
Q ss_pred cccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCC
Q 019905 224 PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303 (334)
Q Consensus 224 PE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 303 (334)
||.+.+..++.++||||||+++|+|++|..|+.... ......... .........++++.+++.+||+.||.+|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-RIITDVRNL------KFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-HHHHHHHTT------CCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-HHHHHhhcc------CCCcccccCChhHHHHHHHHccCCCCcC
Confidence 999999899999999999999999999875432211 111100000 0000112334578999999999999999
Q ss_pred CCHHHHHH
Q 019905 304 PNPKSLVT 311 (334)
Q Consensus 304 ps~~~~l~ 311 (334)
||+.++++
T Consensus 318 ps~~~~l~ 325 (332)
T 3qd2_B 318 PEATDIIE 325 (332)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhh
Confidence 99999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=318.04 Aligned_cols=250 Identities=16% Similarity=0.193 Sum_probs=198.7
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-----CChHHHHHHHHHHhcCC---CCCccceeeeeeeCC-
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-----PDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGD- 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~- 129 (334)
..|++++.||+|+||+||+|.. .+++.||+|.+..... .....+.+|+.+++.++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 4678888889999999999995 5689999999964321 12346778888877764 999999999998754
Q ss_pred ----eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 130 ----ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
..+++|||+. ++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 4789999996 79999997544455999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc---cccccC--
Q 019905 206 MKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML---TDSCLE-- 277 (334)
Q Consensus 206 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~-- 277 (334)
+...... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||................ ....+.
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 9765433 34567999999999999899999999999999999999999987654332221111100 000000
Q ss_pred ---------C-------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 278 ---------G-------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 278 ---------~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 011234578999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.33 Aligned_cols=264 Identities=18% Similarity=0.227 Sum_probs=203.0
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..+..|++++.||+|+||.||+|.. .++..||+|.+......+ ...+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 3456788899999999999999996 468999999997644333 346788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 133 LVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999988632 3567899999999999999999999999 9999999999999999999999999987544
Q ss_pred CC----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 211 DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 211 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|..||........... ................+.
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC--KKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH--HHHHTTCSCCCCTTTSCH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH--HHhhcccCCCCcccccCH
Confidence 32 234678999999999988899999999999999999999998865432211100 000111111112234566
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
++.+++.+||+.||.+|||+.++++.|+++......+
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 8999999999999999999999999999998654443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=320.13 Aligned_cols=256 Identities=24% Similarity=0.295 Sum_probs=203.5
Q ss_pred CCcccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeee-eCCeee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCC-EGDERL 132 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 132 (334)
...|++.+.||+|+||+||+|...+ ...+|+|.+...... ..+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3457788889999999999998543 235899998753321 2356889999999999999999999864 456789
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
++|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999964 4567899999999999999999999999 999999999999999999999999998754332
Q ss_pred --------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh-hHHhhhcccccccccccCCCCCch
Q 019905 213 --------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 213 --------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.... .......... ......+..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 256 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-----GRRLLQPEY 256 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-----TCCCCCCTT
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-----CCCCCCCcc
Confidence 23345678999999998899999999999999999999665554321 1111111111 111122344
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
.+..+.+++.+||+.||.+|||+.++++.|+.+..+..
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 55689999999999999999999999999999876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=323.71 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=209.3
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCE--EEEEEecCCC-CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRR--IAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 133 (334)
+..|++.+.||+|+||.||+|... ++.. +|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 456778888899999999999954 4554 4999987533 22345788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCee
Q 019905 134 VAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~k 199 (334)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCccceEEEcCCCeEE
Confidence 999999999999986421 247899999999999999999999999 99999999999999999999
Q ss_pred EcCCCCCccCCC---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccc
Q 019905 200 LSTFGLMKNSRD---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSC 275 (334)
Q Consensus 200 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (334)
|+|||++..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...............
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~----- 257 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 257 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-----
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-----
Confidence 999999874332 223455788999999988889999999999999999998 88888665433332221111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCC
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSI 324 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~ 324 (334)
.....+...+.++.+++.+||+.||.+|||+.++++.|+++..+.....
T Consensus 258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 1122344566789999999999999999999999999999887655433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=325.18 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=208.6
Q ss_pred CCcccccccCCCcCccEEEEEEeC--------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 128 (334)
...|++.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 366888889999999999999863 4678999999754321 235688999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC
Q 019905 129 DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~ 194 (334)
+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTE 192 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCccceEEEcC
Confidence 99999999999999999997432 124889999999999999999999999 999999999999999
Q ss_pred CCCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 019905 195 DGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (334)
Q Consensus 195 ~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 267 (334)
++.+||+|||++...... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 272 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence 999999999998765432 23345678999999988889999999999999999999 88887655433332211
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
... .....+...+.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 273 ~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 273 KEG-----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcC-----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111 11223445567899999999999999999999999999998763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=326.69 Aligned_cols=258 Identities=19% Similarity=0.301 Sum_probs=208.3
Q ss_pred CcccccccCCCcCccEEEEEEe-----CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC--eee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 132 (334)
..|++++.||+|+||.||++.+ .+++.||+|.+........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4578889999999999999984 357899999998755444567899999999999999999999987643 689
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 121 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999999975 3456899999999999999999999999 999999999999999999999999998865433
Q ss_pred C-------cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhh-----------ccccccccc
Q 019905 213 K-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD-----------RNLQMLTDS 274 (334)
Q Consensus 213 ~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~ 274 (334)
. ...++..|+|||.+.+..++.++||||||+++|+|++|..|+.......... .........
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 2 2345678999999998889999999999999999999997765432111110 000011111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
......+...+.++.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 279 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 112223455677899999999999999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.10 Aligned_cols=251 Identities=18% Similarity=0.253 Sum_probs=201.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCC----EEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
..|++++.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.+++.++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888899999999999999954 344 35888876433 334678899999999999999999999998754 789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
+++|+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 94 v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCC-CcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999999875 4567999999999999999999999999 999999999999999999999999999765332
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ........+...+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-----EKGERLPQPPICTI 246 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----HTTCCCCCCTTBCH
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----HcCCCCCCCccCCH
Confidence 22345678999999999999999999999999999999 88887654333222111 11112223455667
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
++.+++.+||+.||.+|||+.++++.|+++..
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999998874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=321.37 Aligned_cols=246 Identities=17% Similarity=0.192 Sum_probs=204.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC------ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4778888899999999999965 5889999999754322 25678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC----CeeEcCCCCCccC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~----~~kl~Dfg~a~~~ 209 (334)
||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~-ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 93 ILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999996 4567899999999999999999999999 99999999999999887 7999999998765
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
... ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.................. .........+.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 247 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--FDEEFFSHTSE 247 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--cChhhhcccCH
Confidence 443 3456899999999999889999999999999999999999998765433322211111000 00001123456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+.+++.+||+.||.+|||+.++++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 8999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=328.17 Aligned_cols=255 Identities=18% Similarity=0.157 Sum_probs=196.8
Q ss_pred CcccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCCC-----------hHHHHHHHHHHhcCCCCCccceeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPD-----------PRQFLEEARSVGQLRNNRLTNLLGC 124 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~ 124 (334)
..|++++.||+|+||.||+|... ++..+|+|.+....... ...+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999975 57899999997543211 1235578888999999999999999
Q ss_pred eee----CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC--Ce
Q 019905 125 CCE----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG--NP 198 (334)
Q Consensus 125 ~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~--~~ 198 (334)
+.. ....++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHENE-YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCcCHHHEEEccCCCCcE
Confidence 987 67899999999 8999999974 337999999999999999999999999 99999999999999777 99
Q ss_pred eEcCCCCCccCCCC-----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-----
Q 019905 199 RLSTFGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----- 262 (334)
Q Consensus 199 kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~----- 262 (334)
||+|||++...... ....+|..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999754321 23468899999999999889999999999999999999999985421111
Q ss_pred hhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
......................+.++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111100000111455689999999999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=317.51 Aligned_cols=248 Identities=18% Similarity=0.290 Sum_probs=204.5
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee------------
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE------------ 127 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------ 127 (334)
.|++++.||+|+||.||+|... +++.||+|.+.... ..+.+|+++++.++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 4677788899999999999975 68999999997533 456789999999999999999998854
Q ss_pred ----CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCC
Q 019905 128 ----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (334)
Q Consensus 128 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Df 203 (334)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHEEEcCCCCEEECcc
Confidence 345799999999999999997545567999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCC
Q 019905 204 GLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 204 g~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (334)
|++...... ....+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ... ... ....
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~~~-----~~~----~~~~ 236 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-FFT-----DLR----DGII 236 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-HHH-----HHH----TTCC
T ss_pred hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-HHH-----Hhh----cccc
Confidence 998765442 345688999999999988899999999999999999999977643211 111 011 1122
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.....
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 3344568999999999999999999999999999988765543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=321.67 Aligned_cols=239 Identities=20% Similarity=0.217 Sum_probs=192.7
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCCh--HHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDP--RQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|+++++||+|+||+||+|... +++.||||++........ .....|+..+..+ +|+||+++++++...+..++|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 4778888899999999999975 689999999865442222 2344555555554 89999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---C
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---K 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---~ 213 (334)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 138 ~~-~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 138 LC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp CC-CCBHHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred cc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 99 6899998865 3457999999999999999999999999 999999999999999999999999998765432 3
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...||+.|+|||++.+ .++.++||||||+++|+|++|..+|..... ..+..... ....+...+.++.+++
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--------PPEFTAGLSSELRSVL 285 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCC--------CHHHHTTSCHHHHHHH
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCC--------CcccccCCCHHHHHHH
Confidence 4568999999999886 789999999999999999999876654322 22221111 1111233456899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||+.++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHT
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=336.33 Aligned_cols=253 Identities=18% Similarity=0.168 Sum_probs=205.2
Q ss_pred hcCCCcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
.....+|++++.||+|+||.||+|.... ++.||+|++.... ......+.+|+.++..++||||+++++++...+..
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 3445678888889999999999999754 7899999996421 12233478899999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999999999964 3467999999999999999999999999 99999999999999999999999999976543
Q ss_pred C-----CcccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 212 G-----KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 212 ~-----~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||..................... ....
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~ 306 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF-PTQV 306 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC-CSSC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC-Cccc
Confidence 2 2357899999999997 456899999999999999999999999776544333222111111111 1112
Q ss_pred chhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 019905 282 DDDGTELVRLASRCLQYEPRE--RPNPKSLVT 311 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~--Rps~~~~l~ 311 (334)
...++++.+||.+||..+|++ ||+++++++
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 335678999999999888887 999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=324.91 Aligned_cols=254 Identities=18% Similarity=0.237 Sum_probs=198.2
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCCe----e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDE----R 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~ 131 (334)
..|++++.||+|+||.||++.. .+++.||+|.+........ ..+.+|+.++.+++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4588888999999999999996 5688999999986554443 357889999999999999999999876543 4
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999963 357899999999999999999999999 99999999999999999999999999875433
Q ss_pred C-------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 212 G-------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 212 ~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
. ....||+.|+|||++.+..++.++||||||+++|+|++|..||................... ........
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 246 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGL 246 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--HHHHSTTC
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--cccccCCC
Confidence 2 23457999999999999899999999999999999999999987654333221111110000 00112234
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHH-HHHhccccc
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSL-VTALSPLQK 318 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~-l~~L~~l~~ 318 (334)
+.++.+++.+||+.||.+||++.++ .+.+.+...
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 5689999999999999999976555 455655543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.91 Aligned_cols=247 Identities=16% Similarity=0.191 Sum_probs=202.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|.+++.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 35778888899999999999964 68999999998655444567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee---cCCCCeeEcCCCCCccCCCC--C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG--K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili---~~~~~~kl~Dfg~a~~~~~~--~ 213 (334)
++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||++ ++++.++|+|||++...... .
T Consensus 89 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 89 SGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENG-IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp CSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred CCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 99999998863 356899999999999999999999999 9999999999999 78899999999998765432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||................. ..........+.++.+++.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY--EFESPFWDDISESAKDFIC 243 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC--CCCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCccccccCCHHHHHHHH
Confidence 34578999999999998899999999999999999999999876543333222111111 1111223455678999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.||.+|||+.++++
T Consensus 244 ~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 244 HLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHCSSTTTSCCHHHHHT
T ss_pred HHcCCChhHCcCHHHHhc
Confidence 999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=330.25 Aligned_cols=242 Identities=20% Similarity=0.210 Sum_probs=195.6
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC---ChHHHHHHHHH-HhcCCCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARS-VGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
...+|++++.||+|+||.||++..+ +++.||+|.+...... ....+.+|..+ ++.++||||+++++++...+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467888999999999999999965 4789999999754322 23345667766 57789999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC--
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-- 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~-- 210 (334)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 116 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999863 457899999999999999999999999 9999999999999999999999999987532
Q ss_pred --CCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 211 --DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 211 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
......||+.|+|||++.+..++.++||||||+++|||++|..||............... ...++...+.++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~ 266 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSA 266 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------CCCCCSSSCHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------ccCCCCCCCHHH
Confidence 233567899999999999999999999999999999999999999765544333222211 112344566789
Q ss_pred HHHHHHhhhcCCCCCCCHHH
Q 019905 289 VRLASRCLQYEPRERPNPKS 308 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~ 308 (334)
.+|+.+||+.||.+||++.+
T Consensus 267 ~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHHcccCHHhCCCCCC
Confidence 99999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=322.48 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=202.9
Q ss_pred CcccccccCCCcCccEEEEEEeCC-----CCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
..|.+.+.||+|+||.||+|.... +..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456777888999999999998643 235999999754322 13467899999999999999999999999899999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999999865 4467999999999999999999999999 9999999999999999999999999987654321
Q ss_pred -------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 214 -------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 214 -------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||............... .....+...+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~ 276 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----FRLPTPMDCP 276 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTCB
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-----CcCCCcccCC
Confidence 2234678999999998889999999999999999999 88888654333222211111 1112334556
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 7899999999999999999999999999888753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=315.35 Aligned_cols=247 Identities=18% Similarity=0.215 Sum_probs=204.4
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|++++.||+|+||.||+|... ++..||+|.+....... .+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 55888899999999999999964 58899999997544322 3567889999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC---eeEcCCCCCccCCCCC
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNSRDGK 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~---~kl~Dfg~a~~~~~~~ 213 (334)
|+++++|.+.+.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++. ++|+|||.+.......
T Consensus 86 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 86 LVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred cCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999988863 356899999999999999999999999 999999999999986555 9999999987655433
Q ss_pred ---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 214 ---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||................... ........++++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY--PSPEWDTVTPEAKS 240 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTTTTTSCHHHHH
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC--CchhhcccCHHHHH
Confidence 3568899999999999999999999999999999999999987654443332221111111 11112345668999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||+.||.+|||+.++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=332.75 Aligned_cols=247 Identities=14% Similarity=0.130 Sum_probs=190.8
Q ss_pred Cccccc-ccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHh-cCCCCCccceeeeeee----CCeee
Q 019905 60 AVENIV-SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVG-QLRNNRLTNLLGCCCE----GDERL 132 (334)
Q Consensus 60 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~~ 132 (334)
..|.++ +.||+|+||+||++... +++.||||.+.. ...+.+|++++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 445565 56899999999999964 588999999953 356778888874 4589999999999875 56789
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNS 209 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~ 209 (334)
+||||+++|+|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 9999999999999997544457999999999999999999999999 999999999999997 789999999999865
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccc--cCCCCCchh
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC--LEGQFTDDD 284 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 284 (334)
... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||...............+.... .........
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 294 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294 (400)
T ss_dssp C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence 432 345678999999999988999999999999999999999999865422111000000000000 011111345
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
+.++.+|+.+||+.||.+|||+.++++-
T Consensus 295 s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 295 SEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 6789999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=316.39 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=203.7
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.+.+|++++.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567888899999999999999865 46799999985422 1234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT-CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999863 356899999999999999999999999 999999999999999999999999988654432
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.............. .....+...+..+.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDL 237 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCCCTTSCHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh------CCCCCCCcCCHHHHHH
Confidence 345688999999999998899999999999999999999999876544333222111 1112344456789999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+||+.||.+|||+.++++
T Consensus 238 i~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHhh
Confidence 99999999999999999995
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=326.09 Aligned_cols=245 Identities=20% Similarity=0.281 Sum_probs=197.6
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCC--CCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRN--NRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 134 (334)
-..|++++.||+|+||.||++...++..||+|.+....... .+.+.+|+.++..++| +||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35688889999999999999998889999999997554322 2568899999999976 9999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
||+. +++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 88 ~e~~-~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 88 MECG-NIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp ECCC-SEEHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EeCC-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 9955 789999997 3467899999999999999999999999 99999999999997 578999999999765432
Q ss_pred ----CcccccccccCcccccC-----------CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC
Q 019905 213 ----KSYSTNLAFTPPEYLRT-----------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... ..........
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~ 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHE 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHCTTSC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH---HHHHhcCCcc
Confidence 24568999999999865 56889999999999999999999988653211111 1111222222
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...+...+.++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 3344455568999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.98 Aligned_cols=248 Identities=17% Similarity=0.211 Sum_probs=187.4
Q ss_pred hcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
...+..|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 34567788999999999999999996 468999999996432 22346788999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999864 3467899999999999999999999999 99999999999999999999999999876543
Q ss_pred C----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 212 G----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 212 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
. ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.............. . ....+...+.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~--~~~~~~~~~~~ 238 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----A--DYEMPSFLSIE 238 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----S--CCCCCTTSCHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----c--ccCCccccCHH
Confidence 2 235678999999999988899999999999999999999998865432222111110 0 11234455678
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcccCHhhCCCHHHHhc
Confidence 999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=320.31 Aligned_cols=260 Identities=18% Similarity=0.259 Sum_probs=201.3
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
.+..|++.+.||+|+||.||+|...+ .+|+|.+..... ...+.+.+|+.++++++||||+++++++...+..+++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 46778899999999999999999754 499999975432 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~---- 211 (334)
||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++ ++.++|+|||++.....
T Consensus 109 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKG-ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp BCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred ecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999999964 3456899999999999999999999999 99999999999998 67999999998764321
Q ss_pred -----CCcccccccccCcccccC---------CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC
Q 019905 212 -----GKSYSTNLAFTPPEYLRT---------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 212 -----~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..................
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 261 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP---- 261 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC----
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC----
Confidence 123457899999999874 34788999999999999999999998765443332221111111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
.......+.++.+++.+||+.||.+|||+.++++.|+.+.+.......|
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~ 310 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence 1112234457999999999999999999999999999999877666554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=320.68 Aligned_cols=256 Identities=18% Similarity=0.230 Sum_probs=203.4
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee----CCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 133 (334)
...|++++.||+|+||.||++.. .+++.||+|.+........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35688888999999999999996 5689999999866443345678899999999999999999999873 346899
Q ss_pred EEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 134 VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+.....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-YAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999988642 3467999999999999999999999999 99999999999999999999999998875432
Q ss_pred C-------------CcccccccccCcccccCCC---CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccc
Q 019905 212 G-------------KSYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275 (334)
Q Consensus 212 ~-------------~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 275 (334)
. ....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||....... ..........
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~ 263 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVALAVQNQ 263 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHHHHHCC
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhHHhhcc
Confidence 1 1224588999999997654 6889999999999999999998874321100 0000000001
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
.....+...+.++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1112233456789999999999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=312.63 Aligned_cols=246 Identities=17% Similarity=0.182 Sum_probs=203.4
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|++.+.||+|+||.||+|.... +..+|+|.+........+.+.+|++++++++||||+++++++......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 347788888999999999999654 6799999998766667788999999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee---cCCCCeeEcCCCCCccCCCC---
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili---~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 89 TGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLN-VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99999998863 456899999999999999999999999 9999999999999 78899999999998765433
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
....+|+.|+|||.+.+. ++.++||||||+++|+|++|..||.................... .......++.+.+++
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP--EKDWLNVSPQAESLI 242 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--HHHHTTSCHHHHHHH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--chhhhcCCHHHHHHH
Confidence 345688999999998754 89999999999999999999999876543332221111100000 000013456899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||+.++++
T Consensus 243 ~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999984
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=322.54 Aligned_cols=250 Identities=20% Similarity=0.201 Sum_probs=205.4
Q ss_pred CHHHHHHHhcCC-CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--------ChHHHHHHHHHHhcCCCCC
Q 019905 48 TLEQLKNATSGF-AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--------DPRQFLEEARSVGQLRNNR 117 (334)
Q Consensus 48 ~~~~~~~~~~~~-~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~ 117 (334)
.++.+......+ ..|++++.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++++++|||
T Consensus 11 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (335)
T 3dls_A 11 ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90 (335)
T ss_dssp ECCHHHHHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTT
T ss_pred cccccccCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCC
Confidence 333444343333 4588889999999999999995 45789999999765421 2235678999999999999
Q ss_pred ccceeeeeeeCCeeeEEEecCCCC-CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC
Q 019905 118 LTNLLGCCCEGDERLLVAEYMPNE-TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (334)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~ 196 (334)
|+++++++...+..++||||+.+| +|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 91 Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKD-IIHRDIKDENIVIAEDF 167 (335)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTS
T ss_pred EeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEeccCHHHEEEcCCC
Confidence 999999999999999999999766 9999886 4557999999999999999999999999 99999999999999999
Q ss_pred CeeEcCCCCCccCCCCC---cccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc
Q 019905 197 NPRLSTFGLMKNSRDGK---SYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272 (334)
Q Consensus 197 ~~kl~Dfg~a~~~~~~~---~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 272 (334)
.+||+|||++....... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... .
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~--------- 237 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-V--------- 237 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-T---------
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-H---------
Confidence 99999999998655432 4568999999999988876 78999999999999999999988642211 0
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.. ....+...+.++.+|+.+||+.||.+|||+.++++-
T Consensus 238 ~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 EA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 111233456689999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=314.11 Aligned_cols=242 Identities=17% Similarity=0.198 Sum_probs=201.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..|++++.||+|+||.||+|... +++.||+|.+....... ...+.+|+..+..+ +||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 34778888899999999999975 68999999997654333 35678899999999 8999999999999999999999
Q ss_pred ecCCCCCHHHhhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC------------------
Q 019905 136 EYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED------------------ 195 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~------------------ 195 (334)
||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEC--------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-EeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999986421 267899999999999999999999999 9999999999999844
Q ss_pred -CCeeEcCCCCCccCCCCCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhccccccc
Q 019905 196 -GNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLT 272 (334)
Q Consensus 196 -~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~ 272 (334)
..++|+|||.+..........++..|+|||.+.+. .++.++||||||+++|+|++|..++..... ..+....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----- 244 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR----- 244 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTC-----
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCC-----
Confidence 47999999999887777777899999999999876 467899999999999999999876544321 1111111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
....+...+.++.+++.+||+.||.+|||+.++++
T Consensus 245 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 245 ----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11234455678999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=329.15 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=195.3
Q ss_pred CcccccccCCCcCccEEEEEEeC--C--CCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeee-CCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE--N--QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 133 (334)
..|++.+.||+|+||.||+|.+. + ...||+|.+..... ...+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34666788899999999999853 2 24689999875432 224578899999999999999999998754 567899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999964 4456889999999999999999999999 999999999999999999999999998754322
Q ss_pred -------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCC-CCchhhHHhhhcccccccccccCCCCCchh
Q 019905 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 213 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
....++..|+|||.+.+..++.++||||||+++|+|++|+.| |.............. ......+...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~-----~~~~~~p~~~ 321 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-----GRRLLQPEYC 321 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-----TCCCCCCTTC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-----CCCCCCCCCC
Confidence 223456789999999998999999999999999999995544 433211111111000 0111223445
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 6789999999999999999999999999998876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=329.69 Aligned_cols=257 Identities=15% Similarity=0.132 Sum_probs=205.3
Q ss_pred CcccccccCCCcCccEEEEEEeCC---------CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccc----------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN---------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN---------- 120 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------- 120 (334)
..|++++.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 568888899999999999999653 789999999643 45789999999999999887
Q ss_pred -----eeeeeee-CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC
Q 019905 121 -----LLGCCCE-GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (334)
Q Consensus 121 -----~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~ 194 (334)
+++++.. ....++||||+ +++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE-YVHGNVTAENIFVDP 194 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCGGGEEEET
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEEcC
Confidence 5666665 67889999999 899999997543468999999999999999999999999 999999999999999
Q ss_pred CC--CeeEcCCCCCccCCCC-----------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh--
Q 019905 195 DG--NPRLSTFGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-- 259 (334)
Q Consensus 195 ~~--~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~-- 259 (334)
++ .++|+|||++...... ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 88 8999999998754321 23468899999999999899999999999999999999999886542
Q ss_pred hHHhhhcc---cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 260 LDLIRDRN---LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 260 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
........ .................+.++.+|+.+||+.||.+|||+.++++.|+++.++....
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 11111110 00000000000111234578999999999999999999999999999998876554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=319.33 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=198.6
Q ss_pred CCcccccccCCCcCccEEEEEEeC----CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCC---
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD--- 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 129 (334)
...|.+.+.||+|+||.||+|... ++..||+|.+....... .+.+.+|+.++++++||||+++++++...+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 356778888899999999999853 24589999997654322 346889999999999999999999987654
Q ss_pred --eeeEEEecCCCCCHHHhhcc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCC
Q 019905 130 --ERLLVAEYMPNETLAKHLFH----WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (334)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Df 203 (334)
..+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-FLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCSGGGEEECTTSCEEECSC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEEeec
Confidence 35999999999999998842 13467999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccccccccc
Q 019905 204 GLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 204 g~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
|++...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||............... .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~ 266 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-----H 266 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----C
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC-----C
Confidence 998765332 23345778999999999889999999999999999999 66666544332222111111 1
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
....+...+..+.+++.+||+.||.+|||+.++++.|+++.++.
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 12234455678999999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.08 Aligned_cols=248 Identities=20% Similarity=0.250 Sum_probs=203.3
Q ss_pred cCCCcCccEEEEEEeC---CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCC
Q 019905 67 EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (334)
+||+|+||.||+|.+. ++..||||.++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6899999999999863 456799999986532 346789999999999999999999999876 56899999999999
Q ss_pred HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-------cc
Q 019905 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-------SY 215 (334)
Q Consensus 143 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-------~~ 215 (334)
|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++....... ..
T Consensus 422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 9999964 3567999999999999999999999999 9999999999999999999999999998654321 12
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
.+++.|+|||++.+..++.++||||||+++|||++ |..||.......+..... .......+...+.++.+||.+
T Consensus 500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-----~~~~~~~p~~~~~~l~~li~~ 574 (613)
T 2ozo_A 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-----QGKRMECPPECPPELYALMSD 574 (613)
T ss_dssp --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-----TTCCCCCCTTCCHHHHHHHHH
T ss_pred CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCcCCHHHHHHHHH
Confidence 34578999999998899999999999999999998 888886543332221111 111223455667799999999
Q ss_pred hhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 295 CLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
||+.||.+|||+.++++.|+.+......
T Consensus 575 cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 575 CWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp TTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 9999999999999999999988665433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=314.85 Aligned_cols=248 Identities=19% Similarity=0.244 Sum_probs=207.3
Q ss_pred HhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 55 ATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
..-....|++++.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++||||+++++++...+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 3344567889999999999999999965 46789999986421 2234678899999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERK-VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999999874 356899999999999999999999999 9999999999999999999999999986544
Q ss_pred C--CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 211 D--GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 211 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||............... ...++...+.++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 239 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DLKFPPFLSDGS 239 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCCCCTTSCHHH
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------ccCCCCcCCHHH
Confidence 3 23456889999999999988999999999999999999999988754433222211111 112344556789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 019905 289 VRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+++.+||+.||.+|||+.++++
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhhcCHhhCCCHHHHhh
Confidence 99999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=321.41 Aligned_cols=246 Identities=18% Similarity=0.183 Sum_probs=195.2
Q ss_pred ccccc-ccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIV-SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|+++ +.||+|+||.||+|.. .+++.||||.+..........+.+|++++.++ +||||+++++++...+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 46665 5689999999999995 46899999999876655677899999999885 799999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC---eeEcCCCCCccCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~---~kl~Dfg~a~~~~~~-- 212 (334)
+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++......
T Consensus 93 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 93 MRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999974 357899999999999999999999999 999999999999997765 999999998754311
Q ss_pred ---------CcccccccccCcccccC-----CCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-----------hhhcc
Q 019905 213 ---------KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-----------IRDRN 267 (334)
Q Consensus 213 ---------~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-----------~~~~~ 267 (334)
....||..|+|||++.+ ..++.++||||||+++|+|++|..||....... .....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 13358899999999975 458899999999999999999999886532100 00000
Q ss_pred cccccccccCCCCC----chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 268 LQMLTDSCLEGQFT----DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 268 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...+.... ...+ ...+.++.+|+.+||+.||.+|||+.++++
T Consensus 250 ~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000000 0111 124568999999999999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=343.15 Aligned_cols=252 Identities=18% Similarity=0.252 Sum_probs=207.9
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.....|++++.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34456888889999999999999964 68999999996421 234566889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+||||+++|+|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g-IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999987544456999999999999999999999999 999999999999999999999999999866543
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....||+.|+|||++.+..++.++||||||+++|+|++|..||...............+.. ....++...+.++.
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQAR 417 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCccCCHHHH
Confidence 2457899999999999888999999999999999999999998754211000000011111 11234455677999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHH
Q 019905 290 RLASRCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rp-----s~~~~l~ 311 (334)
+|+.+||+.||.+|| +++++++
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 999999999999999 7788874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=323.87 Aligned_cols=249 Identities=19% Similarity=0.302 Sum_probs=194.7
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|.+++.||+|+||+||+|... +++.||+|.+....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56888899999999999999965 68899999997543221 12345799999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
++ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 97 689888865 4567899999999999999999999999 999999999999999999999999998754422 2
Q ss_pred cccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc---ccCC-----------
Q 019905 214 SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS---CLEG----------- 278 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~----------- 278 (334)
...+|..|+|||++.+ ..++.++||||||+++|+|++|+.||..................+ .+..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 3467899999999976 458999999999999999999999987654332221111100000 0000
Q ss_pred ----------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 279 ----------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 279 ----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+.++.+|+.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 011234568899999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=321.92 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=206.2
Q ss_pred CcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..|++.+.||+|+||.||+|.+. ++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 45778888899999999999854 3678999999754321 2345789999999999999999999999989999
Q ss_pred EEEecCCCCCHHHhhcccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCC
Q 019905 133 LVAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg 204 (334)
+||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-CccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999986421 246789999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccC
Q 019905 205 LMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 205 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
++...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||................ .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----~ 258 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-----L 258 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-----C
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-----c
Confidence 98754332 22345778999999998889999999999999999999 677765543333222111110 1
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
...+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 12334556789999999999999999999999999988754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=323.71 Aligned_cols=240 Identities=18% Similarity=0.230 Sum_probs=178.0
Q ss_pred ccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
+.||+|+||.||+|... +++.||+|.+... ....+.+|+.+++.+. ||||+++++++......++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67899999999999965 5889999999643 3467789999999997 99999999999999999999999999999
Q ss_pred HHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC---CeeEcCCCCCccCCCC----Cccc
Q 019905 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLSTFGLMKNSRDG----KSYS 216 (334)
Q Consensus 144 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~---~~kl~Dfg~a~~~~~~----~~~~ 216 (334)
.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||++...... ....
T Consensus 94 ~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 94 FERIK--KKKHFSETEASYIMRKLVSAVSHMHDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp HHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99997 3467999999999999999999999999 99999999999998665 7999999999755432 3445
Q ss_pred ccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhh---cccccccccccC--CCCCchhHHHHHHH
Q 019905 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD---RNLQMLTDSCLE--GQFTDDDGTELVRL 291 (334)
Q Consensus 217 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~l~~l 291 (334)
+|+.|+|||++.+..++.++||||||+++|+|++|..||.......... .....+...... .......++++.+|
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 7899999999999899999999999999999999999986532211000 000011111100 00012346789999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+||+.||.+|||+.++++
T Consensus 251 i~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 251 IQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHCCCChhHCCCHHHHhc
Confidence 99999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=312.52 Aligned_cols=247 Identities=16% Similarity=0.178 Sum_probs=199.4
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|.+.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 34778888899999999999964 58899999997644 33457889999999999999999999999999999999999
Q ss_pred CCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee---cCCCCeeEcCCCCCccCCCC
Q 019905 138 MPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili---~~~~~~kl~Dfg~a~~~~~~ 212 (334)
+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9999999988532 3467999999999999999999999999 9999999999999 45678999999999764432
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....++..|+|||.+. ..++.++||||||+++|+|++|..||.................... ......++++.
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 256 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA---VECRPLTPQAV 256 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---C--CCCCHHHH
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc---cccCcCCHHHH
Confidence 3456889999999986 4688999999999999999999999876654443322211111111 11122456899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+.+||+.||.+|||+.++++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=332.83 Aligned_cols=255 Identities=19% Similarity=0.161 Sum_probs=204.4
Q ss_pred HHHhcCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeC
Q 019905 53 KNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128 (334)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 128 (334)
.+......+|++++.||+|+||.||++..+ +++.||+|++.... ......+.+|..++..++||||+++++++...
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 334455677888889999999999999974 68999999996421 11123477899999999999999999999999
Q ss_pred CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccCHHHeeecCCCCEEEeechhhee
Confidence 999999999999999999964 2357999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCC-----CcccccccccCccccc-------CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccccc
Q 019905 209 SRDG-----KSYSTNLAFTPPEYLR-------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 209 ~~~~-----~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
.... ....||+.|+|||++. +..++.++||||||+++|||++|..||....................
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~- 290 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS- 290 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC-
Confidence 5443 2357899999999997 34589999999999999999999999976644433222211100000
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRER---PNPKSLVT 311 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~~l~ 311 (334)
....+...+.++.+||.+||. +|.+| |+++++++
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 011123456789999999999 99998 58999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=316.16 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=205.0
Q ss_pred Ccccccc-cCCCcCccEEEEEEe---CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVS-EHGEKAPNVVYKGKL---ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
..|++.+ .||+|+||.||+|.+ .+++.||+|.+....... .+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4577777 889999999999964 246889999997654322 45688999999999999999999999 5667899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 95 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCC-eEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999999973 456899999999999999999999999 9999999999999999999999999987654332
Q ss_pred -------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 214 -------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 214 -------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......+...+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 246 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-----GERMGCPAGCP 246 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTCC
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCC
Confidence 2234678999999988889999999999999999999 8888865443332221111 11123345566
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
..+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999887643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=316.03 Aligned_cols=252 Identities=22% Similarity=0.272 Sum_probs=203.3
Q ss_pred CCcccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
...|.+.+.||+|+||.||+|.+.+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3567788888999999999998543 23699999976432 224568899999999999999999999865 45789
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESIN-CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999999964 3456899999999999999999999999 999999999999999999999999998765432
Q ss_pred ----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.............. ......+...++.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-----GDRLPKPDLCPPV 242 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-----TCCCCCCTTCCHH
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-----CCCCCCCCCCCHH
Confidence 23345778999999998889999999999999999998 8888864332222111111 0111233445678
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999988764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=318.61 Aligned_cols=249 Identities=20% Similarity=0.224 Sum_probs=196.8
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|++++.||+|+||+||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888899999999999999975 48999999987654222 3457789999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHN-CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 999999988876 4567999999999999999999999999 999999999999999999999999999765432
Q ss_pred CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc--------------------c
Q 019905 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------------------L 271 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------------------~ 271 (334)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 24467899999999976 55899999999999999999999988654322211100000 0
Q ss_pred cccccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 TDSCLEGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 ~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
........ .....+.++.+|+.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 01234567999999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=317.34 Aligned_cols=254 Identities=16% Similarity=0.179 Sum_probs=205.6
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeee-eeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC-CEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+.... ....+.+|+.+++.++|++++..+..+ ......+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4577888889999999999996 568899999987544 234688999999999988877666655 556778999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee---cCCCCeeEcCCCCCccCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili---~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++......
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9 8999999864 3567999999999999999999999999 9999999999999 48889999999998754332
Q ss_pred ---------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-------HHhhhccccccccccc
Q 019905 213 ---------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNLQMLTDSCL 276 (334)
Q Consensus 213 ---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 276 (334)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+.........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch----
Confidence 345688999999999998999999999999999999999998864211 111111110000
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
.......++++.+++.+||+.||.+|||+.++++.|+++..+...+
T Consensus 240 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 240 -EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp -HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 0011334568999999999999999999999999999998876654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=322.69 Aligned_cols=249 Identities=18% Similarity=0.181 Sum_probs=198.8
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-----CCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----NNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~l 133 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++.+. ||||+++++++...+..++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 4577888889999999999996 468899999996422 22345778999999886 9999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-------------------
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE------------------- 194 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~------------------- 194 (334)
||||+ +++|.+++.......+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS-LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCcccEEEccccccccccchhcccccccc
Confidence 99999 899999997655567999999999999999999999999 999999999999975
Q ss_pred ------CCCeeEcCCCCCccCCC-CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc
Q 019905 195 ------DGNPRLSTFGLMKNSRD-GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267 (334)
Q Consensus 195 ------~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~ 267 (334)
++.+||+|||++..... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 271 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 78999999999986544 34567899999999999999999999999999999999999988654222111000
Q ss_pred cc---ccc---------------------ccccCCCCC----------------chhHHHHHHHHHHhhhcCCCCCCCHH
Q 019905 268 LQ---MLT---------------------DSCLEGQFT----------------DDDGTELVRLASRCLQYEPRERPNPK 307 (334)
Q Consensus 268 ~~---~~~---------------------~~~~~~~~~----------------~~~~~~l~~li~~cl~~dp~~Rps~~ 307 (334)
.. ... ...+..... ....+.+.+|+.+||+.||.+|||+.
T Consensus 272 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~ 351 (360)
T 3llt_A 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPA 351 (360)
T ss_dssp HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHH
Confidence 00 000 000000000 01125788999999999999999999
Q ss_pred HHHH
Q 019905 308 SLVT 311 (334)
Q Consensus 308 ~~l~ 311 (334)
++++
T Consensus 352 elL~ 355 (360)
T 3llt_A 352 ELLK 355 (360)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=328.88 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=188.3
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCC-CCCccceeeeeeeCC--eeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGD--ERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~l 133 (334)
..|++++.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++..+. ||||+++++++...+ ..++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 4678888999999999999995 46899999999653322 2345778999999997 999999999997544 6899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC--
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-- 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~-- 211 (334)
||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 89 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG-LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999997 789998853 57899999999999999999999999 99999999999999999999999999875422
Q ss_pred -----------------------CCcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc
Q 019905 212 -----------------------GKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267 (334)
Q Consensus 212 -----------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~ 267 (334)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 123468899999999987 56899999999999999999999998765332221111
Q ss_pred cccccc-----------------------------cccCC------------CCCchhHHHHHHHHHHhhhcCCCCCCCH
Q 019905 268 LQMLTD-----------------------------SCLEG------------QFTDDDGTELVRLASRCLQYEPRERPNP 306 (334)
Q Consensus 268 ~~~~~~-----------------------------~~~~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~ 306 (334)
...+.. ..... ......++++.+|+.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 100000 00000 0011345689999999999999999999
Q ss_pred HHHHHH
Q 019905 307 KSLVTA 312 (334)
Q Consensus 307 ~~~l~~ 312 (334)
+++++-
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=327.48 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=196.6
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCC--CCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLR--NNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..|++++.||+|+||.||++...++..||||.+....... .+.+.+|+.++..++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588889999999999999998778999999997544322 356889999999996 599999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
|+ .+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 136 E~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 EC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred ec-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 95 57899999874 457889999999999999999999999 99999999999996 589999999999865432
Q ss_pred ---CcccccccccCcccccC-----------CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCC
Q 019905 213 ---KSYSTNLAFTPPEYLRT-----------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (334)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ...........
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~~~~~~~~~~~ 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHEI 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHCTTSCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH---HHHHhCccccC
Confidence 24568999999999865 35889999999999999999999988653211100 11111222222
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+...+.++.+|+.+||+.||.+|||+.++++
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 233444568999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=318.51 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=196.8
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeee--------
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE-------- 127 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 127 (334)
...|++++.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46789999999999999999996 56899999998654422 24567899999999999999999999877
Q ss_pred CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.+..++||||++ ++|.+.+.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccC-CCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 346899999997 577777754 3457999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCC--------CCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc---ccccc
Q 019905 208 NSRD--------GKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM---LTDSC 275 (334)
Q Consensus 208 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~---~~~~~ 275 (334)
.... .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||............... .....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 5432 1234678999999999764 4899999999999999999999988765332221111000 00000
Q ss_pred cC----------------CCCC--c-----hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 276 LE----------------GQFT--D-----DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 276 ~~----------------~~~~--~-----~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+. .... . ..++.+.+|+.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 0000 0 01456889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=331.96 Aligned_cols=248 Identities=17% Similarity=0.236 Sum_probs=181.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeC-----Cee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 131 (334)
..|++++.||+|+||+||+|... +++.||||++...... ..+.+.+|+.+++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 46889999999999999999854 6899999999654322 235688999999999999999999998543 468
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||+ +++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAG-ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 489999886 4567999999999999999999999999 99999999999999999999999999976432
Q ss_pred C-------------------------------CcccccccccCcccc-cCCCCCCccchhhhHHHHHHHHh---------
Q 019905 212 G-------------------------------KSYSTNLAFTPPEYL-RTGRVTPESVIYSFGTLLLDLLS--------- 250 (334)
Q Consensus 212 ~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ellt--------- 250 (334)
. ....||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 1 234568999999986 45569999999999999999998
Q ss_pred --CCCCCCchhh---------------------HHhhhc----------------------cccccccc--ccCCCCCch
Q 019905 251 --GKHIPPSHAL---------------------DLIRDR----------------------NLQMLTDS--CLEGQFTDD 283 (334)
Q Consensus 251 --g~~p~~~~~~---------------------~~~~~~----------------------~~~~~~~~--~~~~~~~~~ 283 (334)
|+.+|++... +..... ........ .......+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 4544443210 000000 00000000 000001123
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++++.+|+.+||+.||.+|||++++++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 4678999999999999999999999996
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=335.71 Aligned_cols=246 Identities=16% Similarity=0.218 Sum_probs=190.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCC------e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 130 (334)
..|++++.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 56888899999999999999854 588999999975421 12456789999999999999999999996543 4
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 142 ~~lv~E~~~-~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 142 VYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEECCS-EEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEEeCCC-CCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 699999997 55666664 24899999999999999999999999 9999999999999999999999999998655
Q ss_pred CC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc--------------
Q 019905 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-------------- 273 (334)
Q Consensus 211 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------------- 273 (334)
.. ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.............+..
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 43 3467899999999999999999999999999999999999998764322111111000000
Q ss_pred ----cc-------cCCCCC-----------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 ----SC-------LEGQFT-----------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 ----~~-------~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. ....++ ...++++.+|+.+||+.||.+|||++++++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000 112668999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=322.61 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=195.8
Q ss_pred hcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHH--HhcCCCCCccceeeeeee-----C
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARS--VGQLRNNRLTNLLGCCCE-----G 128 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~ 128 (334)
.-+...|++++.||+|+||.||+|.. +++.||+|++.... ...+..|.++ +..++|+||+++++.+.. .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 34567899999999999999999987 57899999996432 3444455554 445899999999986542 2
Q ss_pred CeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCceecccCCCCeeecCCCCee
Q 019905 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK---------GRALYHDLNAYRILFDEDGNPR 199 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------~~i~H~dikp~Nili~~~~~~k 199 (334)
...++||||+++++|.+++.. ...++..++.++.|++.||.|||+. + ++||||||+|||++.++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA-ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC-EECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccc-eeecccccceEEEcCCCcEE
Confidence 357899999999999999953 4568899999999999999999999 8 99999999999999999999
Q ss_pred EcCCCCCccCCCC------------CcccccccccCcccccC-------CCCCCccchhhhHHHHHHHHhCCCCCCchhh
Q 019905 200 LSTFGLMKNSRDG------------KSYSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260 (334)
Q Consensus 200 l~Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~elltg~~p~~~~~~ 260 (334)
|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9999999754321 13458999999999987 3466789999999999999999876643211
Q ss_pred HH------------------hhhcccccccccccCC--CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 261 DL------------------IRDRNLQMLTDSCLEG--QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 261 ~~------------------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
.. ................ ......+.++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 00 0000000000000111 1123356789999999999999999999999999988875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=323.24 Aligned_cols=248 Identities=20% Similarity=0.159 Sum_probs=195.0
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC-----CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM-----AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.|++++.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 466777889999999999996 45789999998643 223356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 019905 135 AEYMPNETLAKHLFHWE--------------------------------------THPMKWAMRLRVVLHLAQALEYCTS 176 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~ 176 (334)
|||+++++|.+++.... ...+++..++.++.|++.||.|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999885210 1123567788999999999999999
Q ss_pred CCCceecccCCCCeeecCCC--CeeEcCCCCCccCCC--------CCcccccccccCcccccC--CCCCCccchhhhHHH
Q 019905 177 KGRALYHDLNAYRILFDEDG--NPRLSTFGLMKNSRD--------GKSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTL 244 (334)
Q Consensus 177 ~~~i~H~dikp~Nili~~~~--~~kl~Dfg~a~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~ 244 (334)
++ ++||||||+||+++.++ .+||+|||++..... .....+|+.|+|||.+.+ ..++.++||||||++
T Consensus 187 ~~-ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 187 QG-ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp TT-EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred CC-ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99 99999999999998766 899999999874322 234568899999999975 568999999999999
Q ss_pred HHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 245 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+|++|..||.................. .........++++.+|+.+||+.||.+|||+.++++
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC--TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccc--cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999998765433322211111110 011111234678999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=324.92 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=206.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC------CCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeCC
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 129 (334)
....|++.+.||+|+||.||+|.... ...||+|.+...... ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34668888889999999999999643 247999999764422 235688999999999 8999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWE------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~ 197 (334)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-CIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGCEEEGGGE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCcccceEEECCCCe
Confidence 9999999999999999986421 346889999999999999999999999 999999999999999999
Q ss_pred eeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 019905 198 PRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (334)
Q Consensus 198 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (334)
++|+|||++...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---- 278 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK---- 278 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH----
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH----
Confidence 999999998754322 22345678999999998889999999999999999999 7777754322111111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
..........+...+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111111223344566899999999999999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.95 Aligned_cols=246 Identities=16% Similarity=0.205 Sum_probs=200.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
...|++++.||+|+||.||+|... +++.||+|.+.... ....+.+|+.++..++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 356888888999999999999965 48999999997643 456789999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+...... .
T Consensus 106 ~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 106 CGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR-KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp CTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 999999999863 3567899999999999999999999999 999999999999999999999999998754432 3
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...++..|+|||.+.+..++.++||||||+++|+|++|..||.............. ........+...+..+.+++.
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT---NPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSCHHHHHHHH
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---CCCcccCCcccCCHHHHHHHH
Confidence 45678999999999998899999999999999999999998865432211110000 001111223445678999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.||.+|||+.++++
T Consensus 261 ~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHTCSCTTTSCCHHHHTT
T ss_pred HHccCChhhCcCHHHHHh
Confidence 999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=323.81 Aligned_cols=252 Identities=18% Similarity=0.267 Sum_probs=196.2
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCC------e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 130 (334)
..|++++.||+|+||.||+|.. .+++.||||++....... .+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4578888899999999999996 468999999996543222 346789999999999999999999997653 4
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 105 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 59999999 7999999853 57899999999999999999999999 9999999999999999999999999998655
Q ss_pred CC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (334)
.. ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 43 34578999999999987 5699999999999999999999999875432211111000
Q ss_pred ----c---ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhcccc
Q 019905 270 ----M---LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQ 317 (334)
Q Consensus 270 ----~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~ 317 (334)
. ...... .......++++.+|+.+||+.||.+|||+.++++ .++.+.
T Consensus 260 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 260 NYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 000000 1122345678999999999999999999999987 454443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.05 Aligned_cols=246 Identities=19% Similarity=0.175 Sum_probs=201.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45778888999999999999965 6889999999754432 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC------
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD------ 211 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~------ 211 (334)
+++++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+.....
T Consensus 87 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999986 4467899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 212 GKSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.....++..|+|||.+.+..+ +.++||||||+++|+|++|..||............ ..............+..+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHHHH
Confidence 234567899999999987765 77999999999999999999988653221110000 00000111112345668999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||+.||.+|||+.++++
T Consensus 241 li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHCCCCchhCCCHHHHhc
Confidence 999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=313.66 Aligned_cols=255 Identities=16% Similarity=0.175 Sum_probs=202.6
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeee-eeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC-CEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+.... ....+.+|+.+++.++|++++..+..+ ......+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3577778889999999999995 568899999876543 223578899999999988877766655 566778999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee---cCCCCeeEcCCCCCccCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili---~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++......
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9 8999999864 3567999999999999999999999999 9999999999999 78899999999998754332
Q ss_pred ---------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-------Hhhhccccccccccc
Q 019905 213 ---------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-------LIRDRNLQMLTDSCL 276 (334)
Q Consensus 213 ---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~ 276 (334)
....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ........... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-- 240 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E-- 240 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H--
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-h--
Confidence 2456889999999999999999999999999999999999998652111 11110000000 0
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSI 324 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~ 324 (334)
......+.++.+++.+||+.||.+|||+.++++.|+++..+...+.
T Consensus 241 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 241 --VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp --HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred --hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 0112335689999999999999999999999999999988766543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=311.62 Aligned_cols=252 Identities=15% Similarity=0.197 Sum_probs=203.7
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC------ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.|++++.||+|+||.||++... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 4778888899999999999975 5899999998754322 35678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC----CeeEcCCCCCccC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~----~~kl~Dfg~a~~~ 209 (334)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .++|+|||.+...
T Consensus 86 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999963 457899999999999999999999999 99999999999998777 8999999998765
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
... ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.................. .........+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 240 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--FDEEYFSNTSE 240 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--CcchhcccCCH
Confidence 432 2346789999999999888999999999999999999999998765433222211111000 00001123456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH--Hhcccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT--ALSPLQ 317 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~ 317 (334)
.+.+++.+||+.||.+|||+.++++ .++.+.
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 8999999999999999999999986 444443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=337.69 Aligned_cols=251 Identities=17% Similarity=0.229 Sum_probs=205.7
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
.....|++++.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++......+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34567888888999999999999974 58999999996432 233567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 133 LVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC-CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999986422 456999999999999999999999999 9999999999999999999999999998654
Q ss_pred CC----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 211 DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 211 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||...............+... ...++...+.
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccCH
Confidence 33 23478999999999999899999999999999999999999987542110000011111111 1234556677
Q ss_pred HHHHHHHHhhhcCCCCCCCH-----HHHH
Q 019905 287 ELVRLASRCLQYEPRERPNP-----KSLV 310 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~-----~~~l 310 (334)
++.+|+.+||+.||.+||++ ++++
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 99999999999999999975 5665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=333.43 Aligned_cols=246 Identities=20% Similarity=0.201 Sum_probs=202.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|++++.||+|+||+||+|... +++.||+|++.... ......+.+|++++++++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 35888899999999999999965 68899999985322 2346778999999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec---CCCCeeEcCCCCCccCCCC-
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~---~~~~~kl~Dfg~a~~~~~~- 212 (334)
|+++++|.+.+.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 102 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999998863 357999999999999999999999999 99999999999995 4567999999998765433
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||................... ........+.++.+
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD 255 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--CSGGGGGSCHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCcccCCCCHHHHH
Confidence 34568999999999976 58999999999999999999999987654433322211111100 00111345678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||.+|||+.++++
T Consensus 256 li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhc
Confidence 999999999999999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.71 Aligned_cols=243 Identities=18% Similarity=0.267 Sum_probs=204.5
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.|++++.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 377788889999999999985 4588999999975542 34577899999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Cc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~ 214 (334)
++++|.+++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+...... ..
T Consensus 103 ~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 103 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp TTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999999984 467999999999999999999999999 999999999999999999999999998765432 34
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..++..|+|||.+.+..++.++||||||+++|+|++|..|+.............. ......+...+..+.+++.+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-----NNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----SCCCCCCSSCCHHHHHHHHH
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-----CCCCCCccccCHHHHHHHHH
Confidence 5678999999999998999999999999999999999988865432222111111 11122344556789999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~ 312 (334)
||+.||.+|||+.++++.
T Consensus 254 ~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HCCSSGGGSCCHHHHTTC
T ss_pred HcCCChhhCcCHHHHhhC
Confidence 999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=311.69 Aligned_cols=247 Identities=17% Similarity=0.228 Sum_probs=198.7
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.+.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 344444669999999999996 4578999999987655556778999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCccCCC----CC
Q 019905 140 NETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 140 ~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~~~~~----~~ 213 (334)
+++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||.+..... ..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC-EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 999999987532 235678899999999999999999999 999999999999987 89999999999876543 23
Q ss_pred cccccccccCcccccCCC--CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
...++..|+|||++.+.. ++.++||||||+++|+|++|..||............ ..........+...+.++.++
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHHHCCCCCCCTTSCHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hccccccccccccCCHHHHHH
Confidence 456889999999997654 788999999999999999999888543211111000 000011223445566789999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+||+.||.+|||+.++++
T Consensus 259 i~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHccCChhhCCCHHHHhc
Confidence 99999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.72 Aligned_cols=250 Identities=19% Similarity=0.223 Sum_probs=201.7
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
...|++++.||+|+||.||++... ++..||+|.+....... .+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356888999999999999999965 58899999997643221 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCCCeeEcCCCCCccCC--CCC
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR--DGK 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~--~~~ 213 (334)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. + ++||||||+||+++.++.++|+|||++.... ...
T Consensus 112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCC-EEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999999963 35689999999999999999999996 8 9999999999999999999999999986432 223
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc-------------------------
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL------------------------- 268 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~------------------------- 268 (334)
...+|+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 4578999999999999899999999999999999999999986543322111000
Q ss_pred -------------ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 -------------QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 -------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
................+.++.+|+.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000001111112234668999999999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=320.40 Aligned_cols=252 Identities=18% Similarity=0.225 Sum_probs=193.4
Q ss_pred hcCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 56 TSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
......|++++.||+|+||+||+|.. .+++.||+|++....... ...+.+|+.++++++||||+++++++......+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34456789999999999999999985 468899999997544222 345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-----CCCCeeEcCCCCCc
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-----EDGNPRLSTFGLMK 207 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-----~~~~~kl~Dfg~a~ 207 (334)
+||||++ ++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+||+++ +.+.+||+|||++.
T Consensus 110 lv~e~~~-~~L~~~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRR-CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEECCS-EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEecCC-CCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999997 69999986 3456999999999999999999999999 99999999999994 45559999999987
Q ss_pred cCCC----CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc--------
Q 019905 208 NSRD----GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS-------- 274 (334)
Q Consensus 208 ~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 274 (334)
.... .....+|..|+|||++.+.. ++.++||||||+++|+|++|..||...................
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 5432 23446789999999998754 8999999999999999999999887653322211111000000
Q ss_pred ----ccCCC------------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 ----CLEGQ------------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 ----~~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+... .+...+.++.+|+.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 01124568999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=321.20 Aligned_cols=251 Identities=18% Similarity=0.293 Sum_probs=198.6
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.+..|++++.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4567889999999999999999965 48899999986544222 24577899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 103 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCC-EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999888888765 4567999999999999999999999999 999999999999999999999999998754332
Q ss_pred --CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc--------------------c
Q 019905 213 --KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL--------------------Q 269 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~--------------------~ 269 (334)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||............. .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 345678999999999876 58999999999999999999999886543221111000 0
Q ss_pred cccccccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 MLTDSCLEGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
....+..... .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 11234678999999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=315.92 Aligned_cols=247 Identities=18% Similarity=0.221 Sum_probs=198.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|++++.||+|+||.||+|... ++..||+|.+........+.+.+|++++..++||||+++++++...+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 45788888999999999999975 48899999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC----CCCCc
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS----RDGKS 214 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~----~~~~~ 214 (334)
++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++... .....
T Consensus 99 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 99 PGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999998864 3467999999999999999999999999 999999999999999999999999986432 12234
Q ss_pred ccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 215 YSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 215 ~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
..++..|+|||.+. +..++.++||||||+++|+|++|..|+............... .......+...+..+.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---DPPTLLTPSKWSVEFR 253 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSSGGGSCHHHH
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---CCcccCCccccCHHHH
Confidence 56889999999983 566899999999999999999999988654332221111111 0111122345567899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+++.+||+.||.+|||+.++++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHcccChhhCCCHHHHhc
Confidence 9999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=321.08 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=203.7
Q ss_pred CcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 132 (334)
..|++++.||+|+||.||+|.+ .++..||+|.+..... .....+.+|+.++++++||||+++++++......+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 5677888899999999999984 2467899999974432 12346888999999999999999999999998999
Q ss_pred EEEecCCCCCHHHhhcccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCC
Q 019905 133 LVAEYMPNETLAKHLFHWET-----HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFG 204 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg 204 (334)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++. +..++|+|||
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999999999999975321 45889999999999999999999999 999999999999994 4569999999
Q ss_pred CCccCC------CCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccC
Q 019905 205 LMKNSR------DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 205 ~a~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
++.... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||............... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-----~~ 263 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-----GR 263 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-----CC
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC-----CC
Confidence 876322 1233456889999999998889999999999999999998 77777654333222211111 11
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1234455678999999999999999999999999998887644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=334.57 Aligned_cols=245 Identities=18% Similarity=0.167 Sum_probs=203.8
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.|++++.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4788888999999999999965 68999999996543 2346778999999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee---cCCCCeeEcCCCCCccCCCCC
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili---~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
|+.+++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++.......
T Consensus 107 ~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 107 VYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp CCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred cCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999999886 4567999999999999999999999999 9999999999999 467899999999987655432
Q ss_pred ---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 214 ---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
...||+.|+|||++.+ .++.++||||||+++|+|++|..||.................. .........++++.+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--FELPQWKKVSESAKD 260 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCSGGGGGSCHHHHH
T ss_pred ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCCcccccCCHHHHH
Confidence 3468999999999976 6899999999999999999999998765443332221111110 000112345678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||.+|||+.++++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhh
Confidence 999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.10 Aligned_cols=244 Identities=19% Similarity=0.255 Sum_probs=207.0
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCC---CCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
...+|++++.||+|+||.||+|... +++.||||.+... .....+.+..|..++..+ +||+|+++++++...+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567889999999999999999965 5789999999642 223456778899999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g-IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTS-EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999974 357999999999999999999999999 99999999999999999999999999875322
Q ss_pred ---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
.....||+.|+|||++.+..++.++||||||+++|||++|..||............... ...++...+.++
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 569 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------NVAYPKSMSKEA 569 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS------CCCCCTTSCHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHH
Confidence 23467899999999999999999999999999999999999999876544433322221 123455677899
Q ss_pred HHHHHHhhhcCCCCCCCH-----HHHH
Q 019905 289 VRLASRCLQYEPRERPNP-----KSLV 310 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~-----~~~l 310 (334)
.+||.+||+.||.+||++ ++|+
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 999999999999999997 6665
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=322.11 Aligned_cols=243 Identities=19% Similarity=0.243 Sum_probs=196.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||++..+ +++.||+|.+...... ..+|++++.++ +||||+++++++..+...++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 34888899999999999999965 5789999999764422 34688888887 799999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC----CCeeEcCCCCCccCCCC-
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED----GNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~----~~~kl~Dfg~a~~~~~~- 212 (334)
+++++|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+||++... +.+||+|||++......
T Consensus 98 ~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~g-ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 98 MKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999986 4567999999999999999999999999 9999999999998533 34999999999865432
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh---hHHhhhcccccccccccCCCCCchhHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....+|+.|+|||++.+..++.++||||||+++|+|++|..||.... ...+........ ...........+.
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--FSLSGGYWNSVSD 252 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC--CCCCSTTTTTSCH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC--cccCccccccCCH
Confidence 24567899999999988779999999999999999999999986421 111111111100 0111122345667
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+|+.+||+.||.+|||+.++++
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999984
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=319.40 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=205.9
Q ss_pred CCCcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcC-CCCCccceeeeeeeCC
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 129 (334)
....|++++.||+|+||.||+|.+ .+++.||+|.+...... ..+.+.+|+.++.++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 346788888999999999999984 24688999999764422 134688999999999 7999999999987754
Q ss_pred -eeeEEEecCCCCCHHHhhcccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC
Q 019905 130 -ERLLVAEYMPNETLAKHLFHWET--------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (334)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~ 194 (334)
..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSE 183 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECC
Confidence 58999999999999999974221 12789999999999999999999999 999999999999999
Q ss_pred CCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 019905 195 DGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (334)
Q Consensus 195 ~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 267 (334)
++.+||+|||++....... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||............
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 9999999999987654322 2345778999999998899999999999999999998 88777543221111000
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.. .......+...++.+.+++.+||+.||.+|||+.++++.|+.+.++
T Consensus 264 ~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 264 LK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hc----cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 00 0111223344567899999999999999999999999999988754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=314.70 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=197.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC--CCC--EEEEEEecCCCCC---ChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE--NQR--RIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
...|++++.||+|+||+||+|.+. ++. .||+|.+...... ..+.+.+|+++++.++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356888899999999999999853 233 6899999754322 2456889999999999999999999997754 8
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++++||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 96 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeEecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 899999999999999864 2356899999999999999999999999 99999999999999999999999999876543
Q ss_pred CC-------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 212 GK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 212 ~~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. .......+..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~ 249 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----EGERLPRPED 249 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----SCCCCCCCTT
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc----cCCCCCCCcC
Confidence 22 2345678999999988889999999999999999999 8888865443332221111 1111123345
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+.++.+++.+||+.||.+|||+.++++.|++++..
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 567899999999999999999999999999988743
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.89 Aligned_cols=244 Identities=19% Similarity=0.248 Sum_probs=198.2
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
...|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 456888899999999999999975 68999999986432 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHC-SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999863 356899999999999999999999999 999999999999999999999999998765443
Q ss_pred -CcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||............... ....+...+..+.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------VFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------cccCchhcCHHHHH
Confidence 23467889999999987765 68999999999999999999988765433332211111 01223445668999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||+.||.+|||+.++++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHh
Confidence 999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=320.17 Aligned_cols=252 Identities=19% Similarity=0.223 Sum_probs=194.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-----hHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-----PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
....|++++.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3456788888899999999999964 58999999997533211 24678999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFME-TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCS-EEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCC-CCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999997 588888864 3456888999999999999999999999 99999999999999999999999999876543
Q ss_pred C----CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc---ccccC------
Q 019905 212 G----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT---DSCLE------ 277 (334)
Q Consensus 212 ~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~------ 277 (334)
. ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||................. ...+.
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 345678999999999765 488999999999999999999988765433222111111000 00000
Q ss_pred -----CC--------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 278 -----GQ--------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 278 -----~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.. .....+.++.+|+.+||+.||.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 013345789999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=320.60 Aligned_cols=250 Identities=16% Similarity=0.237 Sum_probs=200.8
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhc--CCCCCccceeeeeeeCC----eeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQ--LRNNRLTNLLGCCCEGD----ERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv 134 (334)
.|++.+.||+|+||.||+|.. +++.||+|.+... ....+.+|++++.. ++||||+++++++.... ..++|
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 466777779999999999998 4789999999643 34567788888877 78999999999998765 78999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--------SKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
|||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.+||+|||++
T Consensus 119 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp ECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999999953 46899999999999999999999 888 999999999999999999999999998
Q ss_pred ccCCCC--------CcccccccccCcccccCCC------CCCccchhhhHHHHHHHHhC----------CCCCCchh---
Q 019905 207 KNSRDG--------KSYSTNLAFTPPEYLRTGR------VTPESVIYSFGTLLLDLLSG----------KHIPPSHA--- 259 (334)
Q Consensus 207 ~~~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~elltg----------~~p~~~~~--- 259 (334)
...... ....+|+.|+|||.+.+.. ++.++||||||+++|+|++| ..||....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 754332 3346889999999998753 33689999999999999999 55664321
Q ss_pred --hHHhhhcccccccccccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 260 --LDLIRDRNLQMLTDSCLEGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 260 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
...+.... ......... ....+..+.+|+.+||+.||.+|||+.++++.|+++.++...
T Consensus 275 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 275 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred ccHHHHHHHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 11111111 111111112 235567899999999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.40 Aligned_cols=245 Identities=16% Similarity=0.187 Sum_probs=197.5
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.|++++.||+|+||+||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 4888899999999999999965 57899999997543 23356788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~~~~-- 212 (334)
+++++|.+.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 118 ~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 118 YKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHN-IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 999999998863 357899999999999999999999999 999999999999975 455999999998765433
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
....||+.|+|||++. ..++.++||||||+++|+|++|..||................... ........++.+.+|
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--DSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CSGGGTTSCHHHHHH
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CchhcccCCHHHHHH
Confidence 3456899999999986 469999999999999999999999987654443332221111110 000112345689999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 019905 292 ASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+||+.||.+|||+.++++
T Consensus 272 i~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCChhhCccHHHHhc
Confidence 99999999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=310.49 Aligned_cols=244 Identities=16% Similarity=0.138 Sum_probs=204.8
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
...|.+.+.||+|+||.||++... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 456888889999999999999965 47899999987543222 34678899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC---
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--- 211 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--- 211 (334)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+.....
T Consensus 94 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999998863 357899999999999999999999999 99999999999999999999999999876432
Q ss_pred -CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||............... ....+...+..+.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 244 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EYSIPKHINPVAAS 244 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCCCCTTSCHHHHH
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc------cCCCccccCHHHHH
Confidence 23356789999999999888999999999999999999999988765433222111111 11234455678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||+.||.+|||+.++++
T Consensus 245 li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHcccChhhCcCHHHHhh
Confidence 999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=328.68 Aligned_cols=259 Identities=14% Similarity=0.151 Sum_probs=207.1
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCC--eeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 135 (334)
..|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 45888899999999999999965 48999999997543 233567889999999999999999999988754 679999
Q ss_pred ecCCCCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee----cCCCCeeEcCCCCCccCC
Q 019905 136 EYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili----~~~~~~kl~Dfg~a~~~~ 210 (334)
||+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC-EEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999999996432 234899999999999999999999999 9999999999999 777789999999997655
Q ss_pred CC---CcccccccccCcccccC--------CCCCCccchhhhHHHHHHHHhCCCCCCchhh----HHhhhccccccc---
Q 019905 211 DG---KSYSTNLAFTPPEYLRT--------GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNLQMLT--- 272 (334)
Q Consensus 211 ~~---~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~elltg~~p~~~~~~----~~~~~~~~~~~~--- 272 (334)
.. ....||..|+|||++.+ ..++.++||||||+++|+|++|+.||..... ...........+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 43 24568999999999865 4578899999999999999999998853211 001000000000
Q ss_pred ----------------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 273 ----------------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 273 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
............+..+.+++.+||+.||.+|||+.++++.++.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 01111234466788999999999999999999999999999887653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.59 Aligned_cols=248 Identities=12% Similarity=0.130 Sum_probs=203.8
Q ss_pred CCcccccccCCCcCccEEEEEE------eCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC---CCCccceeeeeeeCC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGK------LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGD 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~ 129 (334)
-..|.+.+.||+|+||+||+|. ..+++.||+|.+... ....+..|++++..++ |+||+.+++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3567888889999999999994 446889999999753 4567888888888886 999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhccc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-----------C
Q 019905 130 ERLLVAEYMPNETLAKHLFHW---ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-----------D 195 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-----------~ 195 (334)
..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++. +
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-IIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECGGGTCC------C
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999642 3467999999999999999999999999 999999999999998 8
Q ss_pred CCeeEcCCCCCccCC---C---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc
Q 019905 196 GNPRLSTFGLMKNSR---D---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ 269 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~---~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 269 (334)
+.+||+|||++.... . .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----- 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----- 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence 999999999996432 1 13456899999999999999999999999999999999999888544221111
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhhhcCCCCC-CCHHHHHHHhccccccC
Q 019905 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER-PNPKSLVTALSPLQKET 320 (334)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~~l~~L~~l~~~~ 320 (334)
...... .. .....+.+++..|++.+|.+| |+++++.+.|+++..+.
T Consensus 295 --~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 --PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 111111 11 235678899999999999999 77888888888877654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=317.30 Aligned_cols=244 Identities=16% Similarity=0.138 Sum_probs=204.8
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
...|.+++.||+|+||.||++... +++.||+|.+....... .+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 456888889999999999999965 47899999987543222 35678899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC---
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--- 211 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--- 211 (334)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999998863 357899999999999999999999999 99999999999999999999999999876542
Q ss_pred -CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.....++..|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+..+.+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 270 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EYSIPKHINPVAAS 270 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCCCTTSCHHHHH
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------CCCCCccCCHHHHH
Confidence 23456789999999999888999999999999999999999998765433222111110 11233455668999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||.+|||+.++++
T Consensus 271 li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=344.62 Aligned_cols=243 Identities=21% Similarity=0.259 Sum_probs=200.0
Q ss_pred cCCCcCccEEEEEEe---CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKL---ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~---~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
+||+|+||.||+|.+ .+++.||||.++..... ..+.+.+|++++++++||||+++++++.. +..++||||++++
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g 454 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 454 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCC
Confidence 689999999999965 24678999999764322 24678999999999999999999999864 5588999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-------Cc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-------KS 214 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-------~~ 214 (334)
+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 455 ~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~-iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9999996 4567999999999999999999999999 999999999999999999999999998755432 12
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..++..|+|||++.+..++.++||||||+++|||++ |..||.......+...... ......+...+.++.+||.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-----~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-----GERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHHH
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHH
Confidence 345678999999999899999999999999999998 8888876543333222111 1122344556779999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
+||+.||.+|||+.++++.|+++..
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999988753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=318.61 Aligned_cols=255 Identities=18% Similarity=0.197 Sum_probs=189.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeee--------eCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCC--------EGD 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~~ 129 (334)
..|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 35788888999999999999964 68899999986554334567889999999995 999999999984 334
Q ss_pred eeeEEEecCCCCCHHHhhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 130 ERLLVAEYMPNETLAKHLFH-WETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
..+++|||++ |+|.+++.. .....+++..++.++.|++.||.|||+++ +++||||||+||+++.++.+||+|||++.
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 5799999996 799888753 23457999999999999999999999974 39999999999999999999999999987
Q ss_pred cCCCCC----------------cccccccccCcccc---cCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc
Q 019905 208 NSRDGK----------------SYSTNLAFTPPEYL---RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (334)
Q Consensus 208 ~~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~ 268 (334)
...... ...+|+.|+|||++ .+..++.++||||||+++|+|++|..||............
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~- 265 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK- 265 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc-
Confidence 654321 33478899999998 5566899999999999999999999998654332222111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCC
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFS 323 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~ 323 (334)
.........+..+.+|+.+||+.||.+|||+.++++.|+.+....+..
T Consensus 266 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 266 -------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred -------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 111112233346889999999999999999999999999988755443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=314.21 Aligned_cols=247 Identities=13% Similarity=0.192 Sum_probs=196.9
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeee------CCe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCE------GDE 130 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~ 130 (334)
...|++++.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++++ +||||+++++++.. .+.
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 45577888889999999999996 468899999997544 3457788999999999 79999999999976 467
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 899999999999999997544567999999999999999999999999 9999999999999999999999999987644
Q ss_pred CC----CcccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 211 DG----KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 211 ~~----~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
.. ....++..|+|||++. +..++.++||||||+++|+|++|..||............ .........+
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~ 256 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPAPRLKS 256 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCSC
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----hcCccccCCc
Confidence 32 3456889999999997 456899999999999999999999988654322211111 1111111223
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...+..+.+++.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 345668999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.10 Aligned_cols=246 Identities=15% Similarity=0.163 Sum_probs=199.4
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-------------CChHHHHHHHHHHhcCCCCCccceeeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-------------PDPRQFLEEARSVGQLRNNRLTNLLGCC 125 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 125 (334)
..|.+++.||+|+||+||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45888899999999999999965 578999999975432 2245788999999999999999999999
Q ss_pred eeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC---CeeEcC
Q 019905 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLST 202 (334)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~---~~kl~D 202 (334)
......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHN-IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999998863 457999999999999999999999999 99999999999998765 699999
Q ss_pred CCCCccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCC
Q 019905 203 FGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (334)
Q Consensus 203 fg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (334)
||++...... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||..................... .
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--~ 269 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF--N 269 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH--H
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--c
Confidence 9999765443 34568999999999874 6899999999999999999999999765444333222111100000 0
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.....+.++.+|+.+||+.||.+|||++++++
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 01234568999999999999999999999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=319.69 Aligned_cols=251 Identities=18% Similarity=0.196 Sum_probs=203.0
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCCh-----------------HHHHHHHHHHhcCCCCCccce
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP-----------------RQFLEEARSVGQLRNNRLTNL 121 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~~iv~~ 121 (334)
...|++++.||+|+||.||+|.. +++.||+|.+........ +.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35688888999999999999999 889999999964321111 778999999999999999999
Q ss_pred eeeeeeCCeeeEEEecCCCCCHHHh------hcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecC
Q 019905 122 LGCCCEGDERLLVAEYMPNETLAKH------LFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDE 194 (334)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~ 194 (334)
++++...+..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ ++ ++||||||+||+++.
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC-EECCCCCGGGEEECT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC-EeecCCChHhEEEcC
Confidence 9999999999999999999999998 653336789999999999999999999999 88 999999999999999
Q ss_pred CCCeeEcCCCCCccCCCC--CcccccccccCcccccCC-CCCC-ccchhhhHHHHHHHHhCCCCCCchhh-HHhhhcccc
Q 019905 195 DGNPRLSTFGLMKNSRDG--KSYSTNLAFTPPEYLRTG-RVTP-ESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQ 269 (334)
Q Consensus 195 ~~~~kl~Dfg~a~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~ 269 (334)
++.++|+|||.+...... ....++..|+|||.+.+. .++. ++||||||+++|+|++|..||..... .........
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 999999999998764332 345688999999999887 5666 99999999999999999998865432 111111111
Q ss_pred ccccccc-------------CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 MLTDSCL-------------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
....... ........+.++.+|+.+||+.||.+|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 00011445678999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=314.04 Aligned_cols=254 Identities=19% Similarity=0.284 Sum_probs=186.5
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
-....|++++.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3456788889999999999999985 467899999986543 22345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHhhccc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCcc
Q 019905 135 AEYMPNETLAKHLFHW------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~ 208 (334)
|||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999988631 2456899999999999999999999999 99999999999999999999999998765
Q ss_pred CCCC---------CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc----ccccccc
Q 019905 209 SRDG---------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN----LQMLTDS 274 (334)
Q Consensus 209 ~~~~---------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~----~~~~~~~ 274 (334)
.... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||............ .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 4321 23467899999999975 45899999999999999999999988654322211111 1111111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..........+.++.+++.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111223445678999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=327.71 Aligned_cols=242 Identities=15% Similarity=0.191 Sum_probs=188.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--------CChHHHHHHHHHHhcCCCCCccceeeeeeeCCe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--------PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 130 (334)
..|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 45778888899999999999964 578999999864321 112247899999999999999999999754 55
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC---CCeeEcCCCCCc
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMK 207 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~---~~~kl~Dfg~a~ 207 (334)
.++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.+ +.+||+|||++.
T Consensus 214 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 799999999999999886 4567999999999999999999999999 9999999999999754 459999999998
Q ss_pred cCCCC---CcccccccccCcccccC---CCCCCccchhhhHHHHHHHHhCCCCCCchhhH-----Hhhhccccccccccc
Q 019905 208 NSRDG---KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNLQMLTDSCL 276 (334)
Q Consensus 208 ~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 276 (334)
..... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .+....... ..
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~-~~--- 366 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-IP--- 366 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC-CH---
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC-Cc---
Confidence 75543 34568999999999864 55888999999999999999999988653211 111111000 00
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+..+.+|+.+||+.||.+|||+.++++
T Consensus 367 --~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 367 --EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 001234568999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=324.62 Aligned_cols=249 Identities=18% Similarity=0.231 Sum_probs=200.7
Q ss_pred CCcccccccCCCcCccEEEEEEe----CCCCEEEEEEecCCC----CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 129 (334)
...|++++.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 45788889999999999999996 368999999986432 12345567899999999 6999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999974 356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCC-----CcccccccccCcccccCC--CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 210 RDG-----KSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 210 ~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
... ....||+.|+|||++.+. .++.++||||||+++|+|++|..||.................. ....++.
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~ 287 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ 287 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCc
Confidence 322 234689999999999864 3789999999999999999999988643211111000011111 1123445
Q ss_pred hhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 019905 283 DDGTELVRLASRCLQYEPRERP-----NPKSLVTA 312 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~~l~~ 312 (334)
..+..+.+|+.+||+.||.+|| |+.++++.
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 5667899999999999999999 99999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=315.88 Aligned_cols=247 Identities=15% Similarity=0.144 Sum_probs=200.8
Q ss_pred cccc-ccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--CChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEe
Q 019905 62 ENIV-SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 62 ~~~~-~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
|.++ +.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..+ +||||+++++++...+..++|||
T Consensus 30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e 109 (327)
T 3lm5_A 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 109 (327)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEE
Confidence 4455 66899999999999965 589999999975432 2356788999999999 47999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccCCCC-
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~~~~- 212 (334)
|+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++......
T Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g-ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 999999999986545578999999999999999999999999 999999999999997 789999999999865443
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....+++.|+|||++.+..++.++||||||+++|+|++|..||................. ..........+..+.+
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~ 266 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV--DYSEETFSSVSQLATD 266 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTTTTTSCHHHHH
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc--ccCchhhcccCHHHHH
Confidence 345689999999999999999999999999999999999999876543332221111111 1112223445678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||+.||.+|||++++++
T Consensus 267 li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 267 FIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCChhhCcCHHHHhC
Confidence 999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=313.01 Aligned_cols=243 Identities=16% Similarity=0.212 Sum_probs=196.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeee--CCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCE--GDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~ 135 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+.. ...+.+.+|+.+++.++ ||||+++++++.. ....+++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999985 5689999999964 34678899999999997 9999999999987 56789999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCCC--
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~~-- 212 (334)
||+++++|.+++. .+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .++|+|||++......
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999999999884 3889999999999999999999999 99999999999999766 8999999999765432
Q ss_pred -CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHH--hh----------------hcc-----
Q 019905 213 -KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL--IR----------------DRN----- 267 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~--~~----------------~~~----- 267 (334)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... .. ...
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 34567889999999987 568999999999999999999999884321110 00 000
Q ss_pred ---------cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 268 ---------LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 268 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.............+...+.++.+|+.+||+.||.+|||++++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000001111122335678999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.88 Aligned_cols=249 Identities=16% Similarity=0.212 Sum_probs=198.2
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcC------CCCCccceeeeeeeCCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL------RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~ 132 (334)
..|++++.||+|+||.||+|... +++.||||.+.... .....+.+|+.+++.+ +|+||+++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 34788889999999999999864 57899999996532 1234567788887766 5779999999999999999
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC--eeEcCCCCCccCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--PRLSTFGLMKNSR 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~--~kl~Dfg~a~~~~ 210 (334)
++|||+. ++|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT-EECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 9999996 79999987655567999999999999999999999999 999999999999998887 9999999987654
Q ss_pred CC-CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc-----------------cc
Q 019905 211 DG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM-----------------LT 272 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~-----------------~~ 272 (334)
.. ....+|+.|+|||++.+..++.++|||||||++|+|++|..||............... ..
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~ 333 (429)
T 3kvw_A 254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333 (429)
T ss_dssp CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHB
T ss_pred CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhcc
Confidence 43 3567899999999999989999999999999999999999888654322111000000 00
Q ss_pred cc------------------------------------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 DS------------------------------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ~~------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+. .+....+...++++.+|+.+||+.||.+|||+.++++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp CTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 00 0000011123567999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=326.80 Aligned_cols=247 Identities=13% Similarity=0.049 Sum_probs=181.6
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---hHHHHHHH---HHHhcCCCCCcccee-------eeee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEA---RSVGQLRNNRLTNLL-------GCCC 126 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~ 126 (334)
.|++++.||+|+||.||+|.+. +++.||+|++....... .+.+.+|+ ..++. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 4778888999999999999964 68899999998755322 23566774 45555 799988755 3443
Q ss_pred eC-----------------CeeeEEEecCCCCCHHHhhcccCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCceec
Q 019905 127 EG-----------------DERLLVAEYMPNETLAKHLFHWETHPMKWAMR------LRVVLHLAQALEYCTSKGRALYH 183 (334)
Q Consensus 127 ~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~~lh~~~~i~H~ 183 (334)
.. ...++||||++ ++|.+++... ...+.+..+ ..++.||+.||.|||+++ |+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-CccC
Confidence 32 33799999998 8999999752 233455555 677899999999999999 9999
Q ss_pred ccCCCCeeecCCCCeeEcCCCCCccCCCCC-cccccccccCcccccC--CCCCCccchhhhHHHHHHHHhCCCCCCchhh
Q 019905 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGK-SYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260 (334)
Q Consensus 184 dikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~elltg~~p~~~~~~ 260 (334)
||||+|||++.++.+||+|||++....... ...+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776544 5567799999999987 5699999999999999999999998876532
Q ss_pred HHhhhccc---ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 261 DLIRDRNL---QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 261 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
........ ................++.+.+|+.+||+.||.+|||+.++++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 21111000 1111111111222356779999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.04 Aligned_cols=191 Identities=20% Similarity=0.245 Sum_probs=162.7
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeC-----Cee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 131 (334)
..|++++.||+|+||.||+|... +++.||||++...... ..+.+.+|+.+++.++|+||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 46888888999999999999964 5789999999754322 235688999999999999999999999765 568
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||++ ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESG-IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999996 79999986 4567999999999999999999999999 99999999999999999999999999976432
Q ss_pred C--------------------------CcccccccccCcccc-cCCCCCCccchhhhHHHHHHHHhCCCC
Q 019905 212 G--------------------------KSYSTNLAFTPPEYL-RTGRVTPESVIYSFGTLLLDLLSGKHI 254 (334)
Q Consensus 212 ~--------------------------~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~elltg~~p 254 (334)
. ....||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 1 345678999999986 455699999999999999999985433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=331.54 Aligned_cols=239 Identities=15% Similarity=0.120 Sum_probs=187.0
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHH---HHHhcCCCCCcccee-------eee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEA---RSVGQLRNNRLTNLL-------GCC 125 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~ 125 (334)
..|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+ +.++.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5578889999999999999995 568999999997432 22346788999 455566899999998 555
Q ss_pred eeCC-----------------eeeEEEecCCCCCHHHhhcccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCceec
Q 019905 126 CEGD-----------------ERLLVAEYMPNETLAKHLFHWE-----THPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183 (334)
Q Consensus 126 ~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~ 183 (334)
...+ ..+++|||+ +|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHr 230 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVHT 230 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-EECS
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecC
Confidence 4442 278999999 589999987421 112335788899999999999999999 9999
Q ss_pred ccCCCCeeecCCCCeeEcCCCCCccCCCC-CcccccccccCcccccCC-----------CCCCccchhhhHHHHHHHHhC
Q 019905 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTG-----------RVTPESVIYSFGTLLLDLLSG 251 (334)
Q Consensus 184 dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~elltg 251 (334)
||||+|||++.++.+||+|||++...... ....| +.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999865443 23456 999999999887 799999999999999999999
Q ss_pred CCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 252 KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 252 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.||.......... .... .....++++.+|+.+||+.||.+|||+.++++
T Consensus 310 ~~Pf~~~~~~~~~~----~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 310 DLPITKDAALGGSE----WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp SCCC------CCSG----GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCCCcccccccchh----hhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99886543221111 1111 11334568999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=317.33 Aligned_cols=247 Identities=19% Similarity=0.192 Sum_probs=199.7
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--------hHHHHHHHHHHhcC-CCCCccceeeeeeeCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 129 (334)
..|++.+.||+|+||.||+|... +|+.||||++....... .+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 34777788899999999999975 68999999997544221 23567899999999 7999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||.||+++.++.++|+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g-i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANN-IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999863 357899999999999999999999999 999999999999999999999999998765
Q ss_pred CCC---CcccccccccCcccccC------CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCC
Q 019905 210 RDG---KSYSTNLAFTPPEYLRT------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (334)
... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..................... ..
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~ 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS--PE 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH--HH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--cc
Confidence 443 34568999999999863 35889999999999999999999998664332222111110000000 00
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
....+..+.+++.+||+.||.+|||+.++++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0123457999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=321.53 Aligned_cols=246 Identities=20% Similarity=0.240 Sum_probs=194.4
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC----------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG---------- 128 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------- 128 (334)
..|++++.||+|+||.||+|.. .+++.||+|++.... ....+|+++++.++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4678888889999999999985 568999999996543 2234799999999999999999998543
Q ss_pred ----------------------------CeeeEEEecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019905 129 ----------------------------DERLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKG 178 (334)
Q Consensus 129 ----------------------------~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 178 (334)
...++||||++ ++|.+.+.. .....+++..+..++.|++.||.|||+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 34789999997 687776653 24578999999999999999999999999
Q ss_pred CceecccCCCCeeec-CCCCeeEcCCCCCccCCC---CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCC
Q 019905 179 RALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRD---GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKH 253 (334)
Q Consensus 179 ~i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~ 253 (334)
++||||||+||+++ .++.+||+|||++..... .....+|..|+|||.+.+.. ++.++||||||+++|+|++|+.
T Consensus 162 -i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 162 -ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 99999999999998 688999999999986433 23456789999999998755 8999999999999999999999
Q ss_pred CCCchhhHHhhhcccc-----------------------cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 254 IPPSHALDLIRDRNLQ-----------------------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 254 p~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
||.............. ......+...++...+.++.+|+.+||+.||.+|||+.+++
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 9876432221111100 00011111123444667899999999999999999999998
Q ss_pred H
Q 019905 311 T 311 (334)
Q Consensus 311 ~ 311 (334)
+
T Consensus 321 ~ 321 (383)
T 3eb0_A 321 A 321 (383)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=310.50 Aligned_cols=255 Identities=17% Similarity=0.219 Sum_probs=205.0
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeee--CCee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE--GDER 131 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 131 (334)
.....|++++.||+|+||.||++... +++.||+|.+....... .+.+.+|+.++++++||||+++++++.. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34567888999999999999999965 68999999997654322 3468899999999999999999998754 5678
Q ss_pred eEEEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----ceecccCCCCeeecCCCCeeEcCCCC
Q 019905 132 LLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGR----ALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~----i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+. ++||||||+||+++.++.++|+|||.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999998642 23458999999999999999999998752 99999999999999999999999999
Q ss_pred CccCCCCC----cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC
Q 019905 206 MKNSRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (334)
Q Consensus 206 a~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (334)
+....... ...++..|+|||.+.+..++.++||||||+++|+|++|..||............... .....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~ 237 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIP 237 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCCCCC
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----ccccCC
Confidence 87654432 345789999999999888999999999999999999999988765433222211111 111234
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccc
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
...+.++.+++.+||+.||.+|||+.++++.+...
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 45667899999999999999999999999876443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.17 Aligned_cols=245 Identities=19% Similarity=0.242 Sum_probs=196.4
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeee----CCeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 132 (334)
..|++.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677788899999999999964 5789999999754322 23568899999999999999999999865 35589
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CceecccCCCCeeec-CCCCeeEcCCCCCccCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD-EDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~~ 210 (334)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ +++||||||+||+++ .++.++|+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999963 367899999999999999999999974 399999999999998 88999999999987554
Q ss_pred CC--CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-HhhhcccccccccccCCCCCchhHHH
Q 019905 211 DG--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 211 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
.. ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... .......... .....+...+++
T Consensus 184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 258 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----KPASFDKVAIPE 258 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC----CCGGGGGCCCHH
T ss_pred ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC----CccccCCCCCHH
Confidence 43 24568899999998874 5899999999999999999999988653221 1111111111 111122333468
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.+++.+||+.||.+|||+.++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCCCHHHHhh
Confidence 999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=307.80 Aligned_cols=245 Identities=19% Similarity=0.189 Sum_probs=198.4
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC----CCChHHHHHHHHHHhcCCCCCccceeeeee--eCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQLRNNRLTNLLGCCC--EGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 131 (334)
...|++++.||+|+||.||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 35688888899999999999996 457899999996432 223467889999999999999999999984 44578
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||++++ |.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999855 777776545678999999999999999999999999 99999999999999999999999999876542
Q ss_pred C------CcccccccccCcccccCCC--CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 212 G------KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 212 ~------~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
. ....++..|+|||++.+.. ++.++||||||+++|+|++|..||............... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~~~~~~~ 235 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------SYAIPGD 235 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------CCCCCSS
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------CCCCCCc
Confidence 1 2345789999999997654 477999999999999999999998765433332211111 1123445
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+..+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 5678999999999999999999999995
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=318.51 Aligned_cols=246 Identities=15% Similarity=0.203 Sum_probs=189.2
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCC------e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 130 (334)
..|++++.||+|+||.||+|... +++.||||++....... ...+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 56888888999999999999864 57899999997543221 346788999999999999999999997654 6
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 105 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 799999997 67888774 35889999999999999999999999 9999999999999999999999999997654
Q ss_pred CC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc-------------
Q 019905 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS------------- 274 (334)
Q Consensus 211 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 274 (334)
.. ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||..................+
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 32 34568899999999999889999999999999999999999987643222111111100000
Q ss_pred -----ccC------------CCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 -----CLE------------GQF------TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 -----~~~------------~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... ... ....+.++.+|+.+||+.||.+|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 000 0123678999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.26 Aligned_cols=251 Identities=17% Similarity=0.198 Sum_probs=202.6
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCC-CccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN-RLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 137 (334)
..|++++.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.++|+ ++..+..++......++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4588889999999999999995 5689999998865442 34578899999999864 555666666777889999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee---cCCCCeeEcCCCCCccCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili---~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9 8999999864 3567999999999999999999999999 9999999999999 58899999999998754432
Q ss_pred ---------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-------HHhhhccccccccccc
Q 019905 213 ---------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNLQMLTDSCL 276 (334)
Q Consensus 213 ---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 276 (334)
....||..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+..........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--- 238 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE--- 238 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH---
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH---
Confidence 245689999999999999999999999999999999999999865321 1111111111000
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
......+.++.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 239 --~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 --ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp --HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 011233468999999999999999999999999999886543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=320.40 Aligned_cols=247 Identities=18% Similarity=0.236 Sum_probs=180.7
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeC------Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 130 (334)
..|++++.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4578888899999999999985 46889999999754322 235678999999999999999999998654 45
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++++++ +++|.+++. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 109 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 689998884 367999999999999999999999999 9999999999999999999999999987654
Q ss_pred CC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc----------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT---------------- 272 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~---------------- 272 (334)
.. ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.................
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 33 34578999999999987 5689999999999999999999999876432211111000000
Q ss_pred ---cc---ccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 ---DS---CLEG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ---~~---~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. .... ......++.+.+|+.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 0000 001233568999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=311.12 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=201.0
Q ss_pred CcccccccCCCcCccEEEEEEe--CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcC---CCCCccceeeeee-----e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL--ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQL---RNNRLTNLLGCCC-----E 127 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 127 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4578888899999999999997 45789999998643321 233566777777666 8999999999987 4
Q ss_pred CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
....++||||++ ++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g-i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 567899999997 79999987645566999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc--------c----
Q 019905 208 NSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------T---- 272 (334)
Q Consensus 208 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~---- 272 (334)
..... ....++..|+|||++.+..++.++||||||+++|+|++|..||................ .
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 65432 24567899999999998889999999999999999999999887543222111110000 0
Q ss_pred ---------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhcccc
Q 019905 273 ---------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQ 317 (334)
Q Consensus 273 ---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~ 317 (334)
............+..+.+|+.+||+.||.+|||+.++++ .+..+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000001123445678999999999999999999999994 344443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=317.55 Aligned_cols=249 Identities=15% Similarity=0.207 Sum_probs=191.2
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC-----------hHHHHHHHHHHhcCCCCCccceeeeeee-
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD-----------PRQFLEEARSVGQLRNNRLTNLLGCCCE- 127 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 127 (334)
..|++++.||+|+||.||+|...++..||||++....... .+.+.+|++++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 4466677779999999999998889999999996543222 1578899999999999999999999854
Q ss_pred ----CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCC
Q 019905 128 ----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (334)
Q Consensus 128 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Df 203 (334)
....++||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAG-VVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCT
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCc-CEecCCChHHEEEcCCCCEEEEec
Confidence 235799999997 788888864 4457999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCC---CCcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc--------
Q 019905 204 GLMKNSRD---GKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML-------- 271 (334)
Q Consensus 204 g~a~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~-------- 271 (334)
|++..... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||................
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 99875433 234567889999999987 568999999999999999999999987643222111110000
Q ss_pred -----------cccccC-------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 -----------TDSCLE-------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 -----------~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...... .......++.+.+|+.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 000000 0012234567999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=312.65 Aligned_cols=249 Identities=17% Similarity=0.179 Sum_probs=200.1
Q ss_pred CcccccccCCCcCccEEEEEEe--CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCC------CccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL--ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN------RLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~ 131 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+++++.++|+ +++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4688889999999999999986 357899999996432 2235678899999888655 499999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-----------------
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE----------------- 194 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~----------------- 194 (334)
++||||+ +++|.+++......++++..+..++.|++.||.|||+++ ++||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999999 799999997645557899999999999999999999999 999999999999987
Q ss_pred --CCCeeEcCCCCCccCCCC-CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc---
Q 019905 195 --DGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL--- 268 (334)
Q Consensus 195 --~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~--- 268 (334)
++.++|+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 250 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 678999999998865443 45578999999999999899999999999999999999999887543221111000
Q ss_pred cccc-----------------------------------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 QMLT-----------------------------------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 ~~~~-----------------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.... ............++++.+|+.+||+.||.+|||+.++++
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0000 000001123345678999999999999999999999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=321.36 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=194.8
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCC------eeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~l 133 (334)
..|.+++.||+|+||+||+|....+..+|+|++..... ...+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 45888888999999999999987777799998865332 2247999999999999999999986543 3789
Q ss_pred EEecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCCCCCccCC
Q 019905 134 VAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~~ 210 (334)
||||++++ +...+.. .....+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99999854 4443321 13567999999999999999999999999 99999999999999 79999999999997643
Q ss_pred C---CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-----------------
Q 019905 211 D---GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ----------------- 269 (334)
Q Consensus 211 ~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~----------------- 269 (334)
. .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||..............
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 3 33567789999999997654 89999999999999999999999876532211111000
Q ss_pred ------cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhcccc
Q 019905 270 ------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQ 317 (334)
Q Consensus 270 ------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~ 317 (334)
......+...++...++++.+|+.+||+.||.+|||+.++++ .++.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000000111123345678999999999999999999999985 344443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.56 Aligned_cols=249 Identities=14% Similarity=0.180 Sum_probs=196.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC--------CCCccceeeeee----
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR--------NNRLTNLLGCCC---- 126 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~---- 126 (334)
..|++++.||+|+||+||+|.. .+++.||+|++.... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 5688889999999999999985 457899999996432 22456788999999885 788999999987
Q ss_pred eCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCC---------
Q 019905 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDG--------- 196 (334)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~--------- 196 (334)
.....++||||+ +++|.+.+.......+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g-ivHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHeeEeccchhhhhhhhh
Confidence 456789999999 57777777654456799999999999999999999998 8 99999999999999775
Q ss_pred ----------------------------------------CeeEcCCCCCccCCCC-CcccccccccCcccccCCCCCCc
Q 019905 197 ----------------------------------------NPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPE 235 (334)
Q Consensus 197 ----------------------------------------~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~ 235 (334)
.+||+|||.+...... ....+|..|+|||++.+..++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 273 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcH
Confidence 8999999998765433 34578999999999999899999
Q ss_pred cchhhhHHHHHHHHhCCCCCCchhhHH-------hhh--cccccc--------------ccc------------------
Q 019905 236 SVIYSFGTLLLDLLSGKHIPPSHALDL-------IRD--RNLQML--------------TDS------------------ 274 (334)
Q Consensus 236 ~Di~slG~~l~elltg~~p~~~~~~~~-------~~~--~~~~~~--------------~~~------------------ 274 (334)
+||||||+++|+|++|..||....... ... ...... ...
T Consensus 274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (397)
T 1wak_A 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353 (397)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence 999999999999999999886432100 000 000000 000
Q ss_pred -ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 275 -CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 275 -~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001234566778999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=307.99 Aligned_cols=250 Identities=17% Similarity=0.160 Sum_probs=203.1
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC---------hHHHHHHHHHHhcCC-CCCccceeeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---------PRQFLEEARSVGQLR-NNRLTNLLGCC 125 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~iv~~~~~~ 125 (334)
.-+..|++++.||+|+||.||+|... +++.||+|.+....... .+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34567888999999999999999975 57899999997543211 245678999999995 99999999999
Q ss_pred eeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
...+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999999973 357899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCC---CcccccccccCccccc------CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccccc
Q 019905 206 MKNSRDG---KSYSTNLAFTPPEYLR------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 206 a~~~~~~---~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
+...... ....++..|+|||++. ...++.++||||||+++|+|++|..||.................. .
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~ 248 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--F 248 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--C
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc--c
Confidence 8765433 2346789999999985 445889999999999999999999988655433222211111110 0
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
........+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11112345678999999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=308.57 Aligned_cols=248 Identities=19% Similarity=0.221 Sum_probs=186.6
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC-h-HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD-P-RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
...|++++.||+|+||.||++.. .+++.||+|.+....... . +.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45688889999999999999996 468899999997543221 1 22344555688889999999999999999999999
Q ss_pred ecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 136 EYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
||++ ++|.+++.. .....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++......
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC-CCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-eecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 9997 688777643 1456799999999999999999999998 8 999999999999999999999999998765432
Q ss_pred ---CcccccccccCcccc----cCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 213 ---KSYSTNLAFTPPEYL----RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
....+++.|+|||.+ .+..++.++||||||+++|+|++|..||........... ...............+
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK---QVVEEPSPQLPADKFS 240 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH---HHHHSCCCCCCTTTSC
T ss_pred ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH---HHhccCCCCcccccCC
Confidence 234688999999996 455689999999999999999999998864321111110 0111111112233456
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.+++.+||+.||.+|||+.++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 78999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=319.04 Aligned_cols=246 Identities=19% Similarity=0.265 Sum_probs=195.3
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeC-----CeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 133 (334)
.|++++.||+|+||.||+|... ++..||+|++....... ...+.+|++++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 5888888899999999999964 57889999997533211 25678999999999999999999998764 35899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+. ++|.+++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 108 v~e~~~-~~L~~~l~---~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCS-EEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccC-cCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999997 69999885 356999999999999999999999999 999999999999999999999999998755432
Q ss_pred ------CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc-------------
Q 019905 213 ------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT------------- 272 (334)
Q Consensus 213 ------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~------------- 272 (334)
....+|+.|+|||++.+. .++.++||||||+++|+|++|..||.................
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 234689999999987654 489999999999999999999998865432221111100000
Q ss_pred -------ccccCC-----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 -------DSCLEG-----QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 -------~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...... ......+.++.+|+.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 011234568999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=307.07 Aligned_cols=243 Identities=19% Similarity=0.271 Sum_probs=191.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee------------
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE------------ 127 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------ 127 (334)
.|++++.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4777888899999999999964 68999999996422 224568899999999999999999998764
Q ss_pred -CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 128 -GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQG-IIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCC-eecccCCHHhEEEcCCCCEEEeeCcch
Confidence 3568999999999999999974 3456788999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCC------------------CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhH-Hhhhc
Q 019905 207 KNSRDG------------------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDR 266 (334)
Q Consensus 207 ~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~ 266 (334)
...... ....++..|+|||.+.+. .++.++||||||+++|+|++ |+...... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 754321 234578899999999865 58999999999999999998 44332111 11111
Q ss_pred ccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... ........++...+..+.+++.+||+.||.+|||+.++++
T Consensus 241 ~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 241 LRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHS--TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc--cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 100 1111222344556678999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=311.41 Aligned_cols=247 Identities=18% Similarity=0.243 Sum_probs=190.2
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeee------------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC------------ 126 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------------ 126 (334)
..|++++.||+|+||.||+|.... ++.||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 458888999999999999999754 8899999997654333467889999999999999999999873
Q ss_pred --eCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCC
Q 019905 127 --EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTF 203 (334)
Q Consensus 127 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Df 203 (334)
.....++||||++ ++|.+++ ....+++..++.++.|++.||.|||+++ ++||||||+||+++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVL---EQGPLLEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHh---hcCCccHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999997 7999998 4467899999999999999999999999 99999999999997 5678999999
Q ss_pred CCCccCCCC-------CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc---
Q 019905 204 GLMKNSRDG-------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT--- 272 (334)
Q Consensus 204 g~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~--- 272 (334)
|++...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 998765321 23456788999999865 5689999999999999999999998875432221111100000
Q ss_pred ---------------ccccC-C-----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 273 ---------------DSCLE-G-----QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 273 ---------------~~~~~-~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..... . ......+.++.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 0 011234678999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=321.93 Aligned_cols=245 Identities=22% Similarity=0.251 Sum_probs=191.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC------CeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l 133 (334)
.|++++.||+|+||.||+|.+. +++.||||++.... ....+|+++++.++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4778888899999999999975 58999999996533 2234799999999999999999998542 23679
Q ss_pred EEecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-CCeeEcCCCCCccCC
Q 019905 134 VAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSR 210 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-~~~kl~Dfg~a~~~~ 210 (334)
||||++ +++.+.+.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++....
T Consensus 131 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 999997 566665542 24567999999999999999999999999 9999999999999955 568999999998643
Q ss_pred C---CCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc----------------
Q 019905 211 D---GKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM---------------- 270 (334)
Q Consensus 211 ~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~---------------- 270 (334)
. .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 3 2345789999999999765 6899999999999999999999998764322111110000
Q ss_pred -------ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 271 -------LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 271 -------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.....+...++...+.++.+|+.+||+.||.+|||+.++++
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000111123345678999999999999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=313.05 Aligned_cols=241 Identities=16% Similarity=0.196 Sum_probs=192.1
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC--------CChHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--------PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
.|.+++.||+|+||.||+|... +++.||||.+..... .....+.+|+++++.++||||+++++++..+. .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 5778888899999999999964 578999999965321 11234788999999999999999999987654 8
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC---eeEcCCCCCcc
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKN 208 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~---~kl~Dfg~a~~ 208 (334)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 99999999999999886 4567999999999999999999999999 999999999999986654 99999999987
Q ss_pred CCCCC---cccccccccCccccc---CCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-----HhhhcccccccccccC
Q 019905 209 SRDGK---SYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNLQMLTDSCLE 277 (334)
Q Consensus 209 ~~~~~---~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~ 277 (334)
..... ...++..|+|||++. ...++.++||||||+++|+|++|..||...... .+....... ..
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~---- 241 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-IP---- 241 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-CH----
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-Cc----
Confidence 65442 345789999999974 456899999999999999999999988653221 111111000 00
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......+..+.+++.+||+.||.+|||+.++++
T Consensus 242 -~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 242 -EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 001234568999999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=337.40 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=204.9
Q ss_pred CCcccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
...|++.+.||+|+||.||+|.+.. +..||+|.+....... .+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 3567888889999999999998643 4579999987543222 356889999999999999999999985 456899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 213 (334)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 468 v~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 468 IMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999964 3456899999999999999999999999 9999999999999999999999999998654432
Q ss_pred -----cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 214 -----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
...+++.|+|||.+.+..++.++||||||+++|||++ |..||.............. ......+...++.
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-----GERLPMPPNCPPT 620 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-----TCCCCCCTTCCHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccccHH
Confidence 2345678999999998889999999999999999997 7777765433322211111 1112234556678
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999988654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=311.74 Aligned_cols=247 Identities=14% Similarity=0.160 Sum_probs=173.3
Q ss_pred Cccccccc-CCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee----CCeeeE
Q 019905 60 AVENIVSE-HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLL 133 (334)
Q Consensus 60 ~~~~~~~~-lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 133 (334)
..|.++++ ||+|+||.||+|... +++.||+|.+... .....+....++.+.||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 34666554 799999999999975 5899999999642 2222333345677799999999999876 445899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccCC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSR 210 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~~ 210 (334)
||||+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.++|+|||++....
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 999999999999997644567999999999999999999999999 999999999999985 4559999999987654
Q ss_pred CC--CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccccc--ccCCCCCchhHH
Q 019905 211 DG--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS--CLEGQFTDDDGT 286 (334)
Q Consensus 211 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 286 (334)
.. ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||................... ..........+.
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 32 34567899999999988889999999999999999999999986554332211111111111 111111234567
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+|+.+||+.||.+|||+.++++
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999996
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.66 Aligned_cols=251 Identities=18% Similarity=0.202 Sum_probs=178.7
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-hHHHHHHHH-HHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
...|++++.||+|+||.||+|... +++.||+|.+....... ...+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 466888889999999999999974 68899999997543211 234555655 777889999999999999999999999
Q ss_pred ecCCCCCHHHhhcc---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 136 EYMPNETLAKHLFH---WETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 136 e~~~~~sL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
||++ ++|.+++.. .....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-CCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-EeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9997 588777642 1356789999999999999999999998 8 99999999999999999999999999876543
Q ss_pred C---CcccccccccCcccc----cCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 212 G---KSYSTNLAFTPPEYL----RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 212 ~---~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
. ....++..|+|||.+ .+..++.++||||||+++|+|++|..||.............................
T Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3aln_A 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCC
T ss_pred ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccC
Confidence 2 233688999999999 455689999999999999999999998865321111000000000011111122345
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+..+.+|+.+||+.||.+|||+.++++
T Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 678999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=318.34 Aligned_cols=246 Identities=16% Similarity=0.242 Sum_probs=179.3
Q ss_pred ccccc-cCCCcCccEEEEEEeC---CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee--CCeeeEEE
Q 019905 62 ENIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVA 135 (334)
Q Consensus 62 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 135 (334)
|++.+ +||+|+||+||+|... +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 55544 6899999999999965 47899999997543 34578899999999999999999999954 66799999
Q ss_pred ecCCCCCHHHhhccc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee----cCCCCeeEcCCC
Q 019905 136 EYMPNETLAKHLFHW-------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFG 204 (334)
Q Consensus 136 e~~~~~sL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili----~~~~~~kl~Dfg 204 (334)
||+. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-EeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 9996 6888777521 1235899999999999999999999999 9999999999999 677899999999
Q ss_pred CCccCCCC-------CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHh---------hhcc
Q 019905 205 LMKNSRDG-------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLI---------RDRN 267 (334)
Q Consensus 205 ~a~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~---------~~~~ 267 (334)
++...... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ....
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99765432 2456789999999998754 89999999999999999999998854321100 0000
Q ss_pred ccc------------------------ccccccCC--------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 268 LQM------------------------LTDSCLEG--------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 268 ~~~------------------------~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
... ........ ......+..+.+|+.+||+.||.+|||++++++
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000000 000111457889999999999999999999996
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=301.60 Aligned_cols=246 Identities=19% Similarity=0.190 Sum_probs=200.2
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|++++.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..+++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 45788888899999999999975 68899999986433 2346778999999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC---CCeeEcCCCCCccCCCCC
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMKNSRDGK 213 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~---~~~kl~Dfg~a~~~~~~~ 213 (334)
|+++++|.+.+.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.++|+|||++.......
T Consensus 102 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999998863 356899999999999999999999999 9999999999999754 469999999987654432
Q ss_pred ---cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 214 ---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
...++..|+|||.+.+ .++.++||||||+++|+|++|..||................... ........+.++.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD 255 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CSGGGTTSCHHHHH
T ss_pred ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CchhhhhcCHHHHH
Confidence 3457889999999876 48999999999999999999999987654333222111111000 00011234568999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||+.||.+|||+.++++
T Consensus 256 li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhc
Confidence 999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=312.40 Aligned_cols=253 Identities=15% Similarity=0.224 Sum_probs=197.7
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeC-----Ceee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 132 (334)
..|++++.||+|+||.||+|... +++.||||.+...... ....+.+|+.+++.++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 45788888899999999999965 5889999999653321 134577899999999999999999987654 5689
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~ 212 (334)
++|||+. ++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 91 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999997 799998853 57999999999999999999999999 999999999999999999999999998754421
Q ss_pred --------------CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccccc-----
Q 019905 213 --------------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT----- 272 (334)
Q Consensus 213 --------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~----- 272 (334)
....||..|+|||++.+ ..++.++||||||+++|+|++|..||.................
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 12357899999998865 6689999999999999999999998876532221110000000
Q ss_pred ---------------cccc---C---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhcccc
Q 019905 273 ---------------DSCL---E---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQ 317 (334)
Q Consensus 273 ---------------~~~~---~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~ 317 (334)
.... . .......+.++.+|+.+||+.||.+|||+.++++ .++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 0 0011245678999999999999999999999986 444443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.54 Aligned_cols=246 Identities=17% Similarity=0.230 Sum_probs=193.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCee-----
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER----- 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----- 131 (334)
..|.+++.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 35777788899999999999964 58899999997644222 35678999999999999999999999876654
Q ss_pred -eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 132 -LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 132 -~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
++||||+. ++|.+.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 78888773 34899999999999999999999999 9999999999999999999999999997654
Q ss_pred CC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc-----------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML----------------- 271 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------------- 271 (334)
.. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||................
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 43 34577999999999987 668999999999999999999999987643222111110000
Q ss_pred --cc---cccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 --TD---SCLEG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 --~~---~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. ..... ......++++.+|+.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 00000 012234678999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.38 Aligned_cols=246 Identities=19% Similarity=0.275 Sum_probs=195.7
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCC--CCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 134 (334)
-..|++++.||+|+||.||++...+++.||+|.+...... ....+.+|+.++.+++ |+||+++++++...+..+++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 3558888889999999999999888999999999754422 2356889999999997 59999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
||+ .+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||++++ +.+||+|||++......
T Consensus 107 ~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 107 MEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp ECC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred Eec-CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 995 47899999973 457899999999999999999999999 999999999999974 89999999998765432
Q ss_pred ----CcccccccccCcccccC-----------CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC
Q 019905 213 ----KSYSTNLAFTPPEYLRT-----------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (334)
....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......... ..........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~ 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHE 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHCTTSC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH---HHHHHhcccc
Confidence 23467899999999875 46888999999999999999999988653221111 1111112222
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
...+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 23344445689999999999999999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=310.03 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=185.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCe-------
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE------- 130 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------- 130 (334)
+..|++++.||+|+||.||+|... +++.||||++.... .......++++.+..++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 356778888899999999999964 58899999986543 233456778888899999999999999876433
Q ss_pred eeEEEecCCCCCHHHhhcc--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCceecccCCCCeeecC-CCCeeEcCCCC
Q 019905 131 RLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCT--SKGRALYHDLNAYRILFDE-DGNPRLSTFGL 205 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~ 205 (334)
.++||||+++ +|...+.. .....+++..+..++.|++.||.||| +++ ++||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-CBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-eecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 7899999975 55544432 24567889999999999999999999 998 999999999999996 89999999999
Q ss_pred CccCCCC---CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc--------
Q 019905 206 MKNSRDG---KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-------- 273 (334)
Q Consensus 206 a~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 273 (334)
+...... ....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||..................
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 9865543 3456789999999997655 899999999999999999999998764332221111100000
Q ss_pred ------------------cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 274 ------------------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 274 ------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...........+.++.+|+.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00001122335778999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=311.60 Aligned_cols=197 Identities=17% Similarity=0.152 Sum_probs=168.2
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CC-----CccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NN-----RLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~ 131 (334)
...|++++.||+|+||.||+|... +++.||||++.... .....+..|+.+++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 356888888899999999999965 57899999996432 12345677888888875 55 499999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCceecccCCCCeeec--CCCCeeEcCCCCCc
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS--KGRALYHDLNAYRILFD--EDGNPRLSTFGLMK 207 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dikp~Nili~--~~~~~kl~Dfg~a~ 207 (334)
++||||++ ++|.+++.......+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+||+|||++.
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~-ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC-EECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC-EEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 699999976555679999999999999999999994 57 99999999999995 57889999999998
Q ss_pred cCCCC-CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch
Q 019905 208 NSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (334)
Q Consensus 208 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~ 258 (334)
..... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 210 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 210 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 66543 4567899999999999999999999999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.01 Aligned_cols=246 Identities=17% Similarity=0.222 Sum_probs=193.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCe------
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE------ 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 130 (334)
..|.+.+.||+|+||.||+|... +|+.||||.+....... ...+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 35777788899999999999964 58899999997643222 3467889999999999999999999987654
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.+++|||++ ++|.+++. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 78887773 35899999999999999999999999 9999999999999999999999999987654
Q ss_pred CC-CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (334)
.. ....+|..|+|||.+.+ ..++.++||||||+++|+|++|..||..............
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 33 34567899999999987 5689999999999999999999998865432211110000
Q ss_pred ----ccccc--ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 ----MLTDS--CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ----~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..... ..........+.++.+|+.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0001223455778999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=312.71 Aligned_cols=255 Identities=18% Similarity=0.213 Sum_probs=199.8
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-----------CCCccceeeeeee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----------NNRLTNLLGCCCE 127 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 127 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688889999999999999996 468899999996432 12456788999988886 8899999999886
Q ss_pred CC----eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeec------CCC
Q 019905 128 GD----ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFD------EDG 196 (334)
Q Consensus 128 ~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~------~~~ 196 (334)
.+ ..+++|||+ +++|.+++.......+++..+..++.||+.||.|||++ + ++||||||+|||++ ..+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~-ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC-EEecCCChHHeEEeccCCCcCcc
Confidence 54 689999999 89999999765556799999999999999999999998 8 99999999999994 344
Q ss_pred CeeEcCCCCCccCCCC-CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh------hccc-
Q 019905 197 NPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR------DRNL- 268 (334)
Q Consensus 197 ~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~------~~~~- 268 (334)
.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||......... ....
T Consensus 176 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 7999999998765443 3457899999999999989999999999999999999999988643211000 0000
Q ss_pred --cccc--------------------cc-------------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--
Q 019905 269 --QMLT--------------------DS-------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT-- 311 (334)
Q Consensus 269 --~~~~--------------------~~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~-- 311 (334)
.... .. .....++...+.++.+|+.+||+.||.+|||+.++++
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 0000 00 0011345667889999999999999999999999986
Q ss_pred Hhcccc
Q 019905 312 ALSPLQ 317 (334)
Q Consensus 312 ~L~~l~ 317 (334)
.+....
T Consensus 336 ~f~~~~ 341 (373)
T 1q8y_A 336 WLKDTL 341 (373)
T ss_dssp GGTTCT
T ss_pred hhhccc
Confidence 444443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=307.03 Aligned_cols=249 Identities=14% Similarity=0.133 Sum_probs=197.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CC-CEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC------ccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQ-RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR------LTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~ 131 (334)
..|++++.||+|+||.||+|... ++ ..||+|.+.... ...+.+.+|+.+++.++|++ ++.+.+++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 46888889999999999999964 34 689999996432 22456778999999887655 88999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee-------------------
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF------------------- 192 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili------------------- 192 (334)
++||||+ ++++.+++.......+++..++.++.||+.||.|||+++ ++||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEecccccccccccccccccc
Confidence 9999999 577777776544567999999999999999999999999 9999999999999
Q ss_pred cCCCCeeEcCCCCCccCCCC-CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccc---
Q 019905 193 DEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL--- 268 (334)
Q Consensus 193 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~--- 268 (334)
+.++.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 56789999999999865443 45678999999999999899999999999999999999999987543221110000
Q ss_pred cccc-----------------------------------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 269 QMLT-----------------------------------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 269 ~~~~-----------------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...+ ............+.++.+|+.+||+.||.+|||+.++++
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 000001122334668999999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=306.74 Aligned_cols=240 Identities=20% Similarity=0.288 Sum_probs=199.6
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC------hHHHHHHHHHHhcCC--CCCccceeeeeee
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD------PRQFLEEARSVGQLR--NNRLTNLLGCCCE 127 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 127 (334)
.-...|++++.||+|+||.||+|.. .+++.||+|.+....... ...+.+|+.++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3346688899999999999999985 467899999997544222 245668999999996 5999999999999
Q ss_pred CCeeeEEEecCCC-CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCCCC
Q 019905 128 GDERLLVAEYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGL 205 (334)
Q Consensus 128 ~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Dfg~ 205 (334)
.+..++++|++.+ ++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++ +++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999976 899999863 457899999999999999999999999 99999999999999 788999999999
Q ss_pred CccCCCC--CcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 206 MKNSRDG--KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 206 a~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
+...... ....+|..|+|||++.+..+ +.++||||||+++|+|++|..||...... .. . ....+.
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~-~----------~~~~~~ 264 (320)
T 3a99_A 197 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-IR-G----------QVFFRQ 264 (320)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-HH-C----------CCCCSS
T ss_pred ccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-hc-c----------cccccc
Confidence 8765543 34568899999999987765 67899999999999999999988654321 11 1 011233
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 283 DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
..+.++.+|+.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 45568999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.09 Aligned_cols=237 Identities=20% Similarity=0.304 Sum_probs=191.4
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC------hHHHHHHHHHHhcC----CCCCccceeeeeeeC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD------PRQFLEEARSVGQL----RNNRLTNLLGCCCEG 128 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~ 128 (334)
..|++++.||+|+||.||+|.. .+++.||+|.+....... ...+.+|+.++.++ +|+||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 4577888889999999999985 467899999997544221 22355788888888 899999999999988
Q ss_pred CeeeEEEec-CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec-CCCCeeEcCCCCC
Q 019905 129 DERLLVAEY-MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLM 206 (334)
Q Consensus 129 ~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~-~~~~~kl~Dfg~a 206 (334)
+..++++|+ +.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRG-VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT-EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 899999999 788999999974 456899999999999999999999999 99999999999999 8899999999998
Q ss_pred ccCCCC--CcccccccccCcccccCCCCC-CccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 207 KNSRDG--KSYSTNLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 207 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
...... ....++..|+|||++.+..+. .++||||||+++|+|++|+.||..... .... ....+..
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~----------~~~~~~~ 255 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--ILEA----------ELHFPAH 255 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHT----------CCCCCTT
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hhhh----------ccCCccc
Confidence 765443 345678999999999877654 589999999999999999988865421 1110 1123345
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.+..+.+++.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 5678999999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=314.71 Aligned_cols=241 Identities=18% Similarity=0.132 Sum_probs=182.2
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCCCCCH
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++..+...++||||++ ++|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 45679999999987766678999999986532 45678899999876 89999999999999999999999996 799
Q ss_pred HHhhcccCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC-------------CCeeEcCCCC
Q 019905 144 AKHLFHWETHP-----MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-------------GNPRLSTFGL 205 (334)
Q Consensus 144 ~~~l~~~~~~~-----~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~-------------~~~kl~Dfg~ 205 (334)
.+++....... ..+..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~ 174 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence 99996422111 122345789999999999999999 9999999999999754 4799999999
Q ss_pred CccCCCCC--------cccccccccCcccccC-------CCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 019905 206 MKNSRDGK--------SYSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQ 269 (334)
Q Consensus 206 a~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 269 (334)
+....... ...||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......... ....
T Consensus 175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-i~~~ 253 (434)
T 2rio_A 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN-IIRG 253 (434)
T ss_dssp CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH-HHHT
T ss_pred ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH-HhcC
Confidence 98654422 3468999999999976 568999999999999999999 77777543221110 0000
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...............+.++.+++.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 000111111223456789999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=298.18 Aligned_cols=248 Identities=19% Similarity=0.244 Sum_probs=179.9
Q ss_pred CCCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-h-HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-P-RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.+..|++++.||+|+||.||+|... +++.||+|.+....... . +.+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3567888899999999999999975 68999999997644221 1 2234445578888999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
|||+ ++.+...... ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC-CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC-EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 4555555432 356799999999999999999999995 8 999999999999999999999999998754432
Q ss_pred --CcccccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-HhhhcccccccccccCCCCCchh
Q 019905 213 --KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
....+++.|+|||.+. +..++.++||||||+++|+|++|..||...... ........... .........
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP---PLLPGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC---CCCCSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC---CCCCccCCC
Confidence 2346789999999995 455889999999999999999999888652211 11111111000 000111234
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+.++.+++.+||+.||.+|||+.++++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 568999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=311.66 Aligned_cols=241 Identities=16% Similarity=0.122 Sum_probs=183.8
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|++.+.||+|+||+||.....+++.||||++.... ...+.+|+++++.+ +||||+++++++......++||||++
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 466667789999999765555678999999996533 23456899999999 79999999999999999999999996
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-----CCCeeEcCCCCCccCCCC--
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-----DGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-----~~~~kl~Dfg~a~~~~~~-- 212 (334)
++|.+++.. ....+....++.++.||+.||.|||+++ |+||||||+|||++. ...++|+|||++......
T Consensus 102 -g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 -ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLN-IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp -EEHHHHHHS-SSCCCCSSCHHHHHHHHHHHHHHHHHTT-CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred -CCHHHHHHh-cCCCccchhHHHHHHHHHHHHHHHHHCc-CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 799999864 2334455566789999999999999999 999999999999953 235789999998765432
Q ss_pred -----CcccccccccCcccccC---CCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 213 -----KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.......... ....... ........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~--~~~~~~~~ 255 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSL--DCLHPEKH 255 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCC--TTSCTTCH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCc--cccCcccc
Confidence 23568999999999974 457889999999999999999 666664332221111 1110000 01112334
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
.+..+.+|+.+||+.||.+|||+.+++
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 566789999999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=325.08 Aligned_cols=261 Identities=16% Similarity=0.195 Sum_probs=199.2
Q ss_pred cCCCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeee------C
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCE------G 128 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 128 (334)
..+..|++++.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3456788999999999999999986 4588999999875431 123568889999999999999999998765 5
Q ss_pred CeeeEEEecCCCCCHHHhhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCC---eeEcCCC
Q 019905 129 DERLLVAEYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFG 204 (334)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~---~kl~Dfg 204 (334)
+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++|+|||
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g-IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT-BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 67899999999999999997422 236889999999999999999999999 999999999999997665 8999999
Q ss_pred CCccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHh-hhc---------c----
Q 019905 205 LMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI-RDR---------N---- 267 (334)
Q Consensus 205 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~-~~~---------~---- 267 (334)
.+...... ....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ... .
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 99865443 345788999999999998999999999999999999999999865321110 000 0
Q ss_pred ----cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHH-----HHHHhccccc
Q 019905 268 ----LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS-----LVTALSPLQK 318 (334)
Q Consensus 268 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~-----~l~~L~~l~~ 318 (334)
.................+..+.+++.+||+.||.+|||+.+ ..+.++.+..
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000001122345567889999999999999999999977 3345544443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.81 Aligned_cols=232 Identities=15% Similarity=0.148 Sum_probs=184.6
Q ss_pred CcccccccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
..|++++.||+|+||.||+|.... ++.||+|.+......+. +.+.+|+.++.+++||||+++++++..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 458888899999999999999754 88999999986654332 56889999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 215 (334)
||+++++|.+++.. . .....+..++.|++.||.|||+++ ++||||||+||+++.++.++|++++.
T Consensus 111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~g-ivH~Dikp~NIll~~~g~~kl~~~~~---------- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSIDGDVVLAYPAT---------- 175 (286)
T ss_dssp ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEETTSCEEECSCCC----------
T ss_pred EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCC-CccCCCCcccEEEcCCCCEEEEeccc----------
Confidence 99999999999842 2 356678899999999999999999 99999999999999999999985543
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc-cccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-SCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 294 (334)
++ .++.++||||||+++|+|++|+.||.................. ...........+.++.+++.+
T Consensus 176 ------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (286)
T 3uqc_A 176 ------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242 (286)
T ss_dssp ------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred ------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence 33 3688999999999999999999998754321100000000000 000001223456689999999
Q ss_pred hhhcCCCCCCCHHHHHHHhccccccC
Q 019905 295 CLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
||+.||.+| |+.++++.|+++....
T Consensus 243 ~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 243 SVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999 9999999998877543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=290.82 Aligned_cols=226 Identities=15% Similarity=0.151 Sum_probs=179.8
Q ss_pred Cccccc-ccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHH-hcCCCCCccceeeeeee----CCeee
Q 019905 60 AVENIV-SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCE----GDERL 132 (334)
Q Consensus 60 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~ 132 (334)
..|.++ +.||+|+||.||++.. .+++.||+|.+.. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 446666 5589999999999996 4688999999953 35677889887 56689999999999876 66789
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNS 209 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~ 209 (334)
+||||+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999999999997655567999999999999999999999999 999999999999997 788999999997543
Q ss_pred CCCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCC----chhH
Q 019905 210 RDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT----DDDG 285 (334)
Q Consensus 210 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 285 (334)
. +..++.++||||||+++|+|++|..||..................... ..+ ...+
T Consensus 171 ~------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 230 (299)
T 3m2w_A 171 T------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--EFPNPEWSEVS 230 (299)
T ss_dssp T------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC--SSCHHHHTTSC
T ss_pred c------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc--cCCchhcccCC
Confidence 2 234788999999999999999999998654332222111111111111 111 2356
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 78999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=326.59 Aligned_cols=239 Identities=19% Similarity=0.247 Sum_probs=193.3
Q ss_pred CcccccccCCCcCccEEEEEEeC--CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCe-----e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE-----R 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~ 131 (334)
..|++++.||+|+||.||+|.+. +++.||||.+...... ....+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 56888889999999999999975 5789999998654321 23467889999999999999999999987655 6
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||+++++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ .+||+|||++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~g-iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIG-LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC-CeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 99999999999988774 27999999999999999999999999 9999999999999975 999999999988777
Q ss_pred CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
.....||+.|+|||++.+.. +.++||||||+++|+|++|..|+...... .+. ........+..+.++
T Consensus 234 ~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~----~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 234 FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLP----EDDPVLKTYDSYGRL 300 (681)
T ss_dssp CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCC----TTCHHHHHCHHHHHH
T ss_pred CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------ccc----ccccccccCHHHHHH
Confidence 77778999999999997654 88999999999999999998665432110 000 011111234579999
Q ss_pred HHHhhhcCCCCCCC-HHHHHHHhcccc
Q 019905 292 ASRCLQYEPRERPN-PKSLVTALSPLQ 317 (334)
Q Consensus 292 i~~cl~~dp~~Rps-~~~~l~~L~~l~ 317 (334)
+.+||+.||.+||+ ++++.+.|..+.
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999995 666667766554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.42 Aligned_cols=240 Identities=13% Similarity=0.069 Sum_probs=183.1
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCC--------CChHHHHHHHHHHhcCC---------CCCccce
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--------PDPRQFLEEARSVGQLR---------NNRLTNL 121 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~~iv~~ 121 (334)
...|++++.||+|+||.||+|.. +++.||||++..... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35577888999999999999998 679999999976532 12367889999988886 6565555
Q ss_pred eee-----------------eee-------------CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHH
Q 019905 122 LGC-----------------CCE-------------GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQAL 171 (334)
Q Consensus 122 ~~~-----------------~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l 171 (334)
.++ +.. .+..++||||+++|++.+.+. ...+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHH
Confidence 554 333 678999999999998777773 36789999999999999999
Q ss_pred HHHH-hCCCceecccCCCCeeecCCC--------------------CeeEcCCCCCccCCCCCcccccccccCcccccCC
Q 019905 172 EYCT-SKGRALYHDLNAYRILFDEDG--------------------NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTG 230 (334)
Q Consensus 172 ~~lh-~~~~i~H~dikp~Nili~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~ 230 (334)
.||| +++ |+||||||+|||++.++ .+||+|||++...... ...||+.|+|||++.+.
T Consensus 175 ~~lH~~~~-ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 175 AVAEASLR-FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHHHC-CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCC
T ss_pred HHHHHhCC-EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCC
Confidence 9999 898 99999999999999877 8999999999865543 45789999999999876
Q ss_pred CCCCccchhhhHHH-HHHHHhCCCCCCchhhHH-hhhccccc-ccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHH
Q 019905 231 RVTPESVIYSFGTL-LLDLLSGKHIPPSHALDL-IRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307 (334)
Q Consensus 231 ~~~~~~Di~slG~~-l~elltg~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 307 (334)
. +.++|||||+++ .+++++|..||....+.. ........ ..........+...++++.+|+.+||+.| |++
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 6 889999998777 777888887775432111 11111100 01111111123457889999999999977 899
Q ss_pred HHH
Q 019905 308 SLV 310 (334)
Q Consensus 308 ~~l 310 (334)
+++
T Consensus 327 e~l 329 (336)
T 2vuw_A 327 DLL 329 (336)
T ss_dssp HHH
T ss_pred HHH
Confidence 888
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=298.83 Aligned_cols=237 Identities=16% Similarity=0.112 Sum_probs=177.9
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---hHHHHHHHHHHhcCCC-CCccce---------eee--
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRN-NRLTNL---------LGC-- 124 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h-~~iv~~---------~~~-- 124 (334)
.+...+.||+|+||+||+|.+ .+++.||||++....... .+.+.+|+.+++.++| .|.... ...
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 455667789999999999995 468999999997433222 5678899999999987 321111 111
Q ss_pred ----------eee-----CCeeeEEEecCCCCCHHHhhc-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecc
Q 019905 125 ----------CCE-----GDERLLVAEYMPNETLAKHLF-----HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184 (334)
Q Consensus 125 ----------~~~-----~~~~~lv~e~~~~~sL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 184 (334)
+.. ....+++|++. +++|.+++. ......+++..++.++.|++.||.|||+++ |+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-iiHrD 236 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVHTY 236 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-EECSC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCC
Confidence 111 12356777776 589998884 112455778889999999999999999999 99999
Q ss_pred cCCCCeeecCCCCeeEcCCCCCccCCCC-CcccccccccCcccc----------cCCCCCCccchhhhHHHHHHHHhCCC
Q 019905 185 LNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYL----------RTGRVTPESVIYSFGTLLLDLLSGKH 253 (334)
Q Consensus 185 ikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~elltg~~ 253 (334)
|||+|||++.++.+||+|||++...... ....| +.|+|||++ .+..++.++||||||+++|+|++|+.
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999998765443 33456 999999999 44558899999999999999999999
Q ss_pred CCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 019905 254 IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 254 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 310 (334)
||............ ... ....++++.+|+.+||+.||.+|||+.+++
T Consensus 316 Pf~~~~~~~~~~~~----~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 316 PNTDDAALGGSEWI----FRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp CCCTTGGGSCSGGG----GSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCcchhhhHHHH----Hhh------cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 98765432221111 110 113346899999999999999999976664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=259.60 Aligned_cols=177 Identities=14% Similarity=0.094 Sum_probs=125.9
Q ss_pred CCcCccEEEEEE-eCCCCEEEEEEecCCCCCC----------hHHHHHHHHHHhcC-CCCCccceeeeeeeCCeeeEEEe
Q 019905 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD----------PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 69 g~G~~g~Vy~~~-~~~~~~vaiK~~~~~~~~~----------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+.|+.|.+..+. .-.|+.+++|.+....... .+++.+|+++|+++ .|+||+++++++.+++..|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 455555444433 2247889999997543221 24588999999999 69999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|++|++|.+++. ...+++.. .|+.||+.||.|+|++| |+||||||+|||++++|.+||+|||+|+.....
T Consensus 323 yv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~G-IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 323 KLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQG-FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp CCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHTT-CEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred cCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHCC-ceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999997 44567654 47899999999999999 999999999999999999999999999865443
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCC
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK 252 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~ 252 (334)
....||+.|||||++.+. +..++|+|++|++++++.++.
T Consensus 397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 245689999999999764 567899999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=229.79 Aligned_cols=176 Identities=13% Similarity=0.110 Sum_probs=142.4
Q ss_pred ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCC--------hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+.||+|+||.||+|.. .+..+++|......... .+.+.+|++++++++||||+++..++...+..++||||
T Consensus 342 ~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 342 HLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp ------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4569999999999964 56889999876533222 13478999999999999999777776677788999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----- 212 (334)
+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g-IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKND-VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT-EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc-CccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999852 5689999999999999999 999999999999998 9999999999877653
Q ss_pred ------CcccccccccCcccccC--CCCCCccchhhhHHHHHHHHhCCCCC
Q 019905 213 ------KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIP 255 (334)
Q Consensus 213 ------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~elltg~~p~ 255 (334)
....||+.|||||++.+ ..|+..+|+|+..+-..+-+.++.++
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 24568999999999987 45888899999988887777665433
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-25 Score=193.25 Aligned_cols=154 Identities=16% Similarity=0.089 Sum_probs=121.7
Q ss_pred HHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC------------------ChHHHHHHHHHHhc
Q 019905 51 QLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP------------------DPRQFLEEARSVGQ 112 (334)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~ 112 (334)
.+.....+-..|.+.+.||+|+||.||+|...+++.||+|.+...... ....+.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 344455555666667889999999999999977899999999643211 13457899999999
Q ss_pred CCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeee
Q 019905 113 LRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (334)
Q Consensus 113 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili 192 (334)
++ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+.+ ++||||||+|||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g-iiHrDlkp~NILl 226 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLV 226 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEE
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC-CEeCCCCHHHEEE
Confidence 99 5 677775543 56799999999999988 421 224579999999999999999 9999999999999
Q ss_pred cCCCCeeEcCCCCCccCCCCCcccccccccCccccc
Q 019905 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLR 228 (334)
Q Consensus 193 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~ 228 (334)
+ ++.++|+|||++.. +..++|||.+.
T Consensus 227 ~-~~~vkl~DFG~a~~---------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------CCCCCHHHHHH
Confidence 9 99999999999863 34568888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3e-21 Score=165.78 Aligned_cols=149 Identities=13% Similarity=0.075 Sum_probs=112.6
Q ss_pred HHHHHHHhcCCCcccccccCCCcCccEEEEEEe-CCCCE--EEEEEecCCCCCC------------------------hH
Q 019905 49 LEQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRR--IAVKRFNRMAWPD------------------------PR 101 (334)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vaiK~~~~~~~~~------------------------~~ 101 (334)
...+.....+-..|++.+.||+|+||.||+|.. .+|.. ||||.+....... ..
T Consensus 36 ~~~l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (258)
T 1zth_A 36 LKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFI 115 (258)
T ss_dssp HHHHHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHH
T ss_pred HHHHHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHH
Confidence 344455555556677888899999999999997 67888 9999976432110 12
Q ss_pred HHHHHHHHHhcCCCCCc--cceeeeeeeCCeeeEEEecCCC-C----CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHH
Q 019905 102 QFLEEARSVGQLRNNRL--TNLLGCCCEGDERLLVAEYMPN-E----TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYC 174 (334)
Q Consensus 102 ~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l 174 (334)
.+.+|+.++.++.|+++ ..+++. +..++||||+.+ | +|.+.... .++..+..++.|++.+|.||
T Consensus 116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHH
Confidence 57789999999988764 333332 356899999942 3 67665532 22446778999999999999
Q ss_pred H-hCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 175 T-SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 175 h-~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
| +.+ ++||||||.|||++. .++|+|||++...
T Consensus 187 H~~~g-ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEAE-LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTSC-EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHCC-EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 888 999999999999998 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.7e-19 Score=157.51 Aligned_cols=151 Identities=13% Similarity=0.067 Sum_probs=108.6
Q ss_pred HHHHHHHhcCCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC--------------ChHH--------HHHH
Q 019905 49 LEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP--------------DPRQ--------FLEE 106 (334)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~--------------~~~~--------~~~e 106 (334)
+-.+....+.-..|.+.+.||.|++|.||+|...+|+.||||.++..... .... ..+|
T Consensus 84 ~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE 163 (397)
T 4gyi_A 84 YLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKE 163 (397)
T ss_dssp HHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHH
Confidence 33456666777789999999999999999999888999999987632110 0011 2346
Q ss_pred HHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccC
Q 019905 107 ARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN 186 (334)
Q Consensus 107 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dik 186 (334)
...|.++.+.++.-..-+.. ...++||||+++++|..... . .....++.|++.+|.+||+.+ +||||||
T Consensus 164 ~~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~g-IVHrDLK 232 (397)
T 4gyi_A 164 FAFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHG-LIHGDFN 232 (397)
T ss_dssp HHHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTT-EECSCCS
T ss_pred HHHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCC-CcCCCCC
Confidence 66666665444322111111 22479999999888865442 1 124567899999999999999 9999999
Q ss_pred CCCeeecCCCC----------eeEcCCCCCccCC
Q 019905 187 AYRILFDEDGN----------PRLSTFGLMKNSR 210 (334)
Q Consensus 187 p~Nili~~~~~----------~kl~Dfg~a~~~~ 210 (334)
|.|||+++++. +.++||+.+....
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999987763 8899999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=4.3e-13 Score=115.02 Aligned_cols=137 Identities=12% Similarity=0.004 Sum_probs=106.9
Q ss_pred cccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|.+....+.|+.+.||+.... +..+++|............+.+|+.+++.+. +..+.++++++...+..++||||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 3556666688888999999754 6899999987532223446888999998884 6678889999888888999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS------------------------------------------- 176 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~------------------------------------------- 176 (334)
|.+|.+.+. +......++.+++.+|..||+
T Consensus 94 G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 94 GVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999887642 112234678899999999998
Q ss_pred ----------------CCCceecccCCCCeeecCCCCeeEcCCCCC
Q 019905 177 ----------------KGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (334)
Q Consensus 177 ----------------~~~i~H~dikp~Nili~~~~~~kl~Dfg~a 206 (334)
.. ++|+|++|.||+++++..+.|+||+.+
T Consensus 167 ~~~l~~~l~~~~~~~~~~-l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELV-FSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHHHCCCCCCEE-EECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHHhcCCCCCce-EECCCCCcCcEEEECCcEEEEEEchhc
Confidence 33 899999999999987656679999975
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=105.54 Aligned_cols=126 Identities=13% Similarity=0.083 Sum_probs=93.5
Q ss_pred CCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--ccceeeeeeeCCeeeEEEecCCCCCHHHh
Q 019905 69 GEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLLGCCCEGDERLLVAEYMPNETLAKH 146 (334)
Q Consensus 69 g~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 146 (334)
+.|..+.||+....+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456668999998767788999998654 2345778999988885444 556888887777889999999988874
Q ss_pred hcccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 019905 147 LFHWETHPMKWAMRLRVVLHLAQALEYCTSKG------------------------------------------------ 178 (334)
Q Consensus 147 l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------------------ 178 (334)
.. . .+ ...++.+++..|..||+..
T Consensus 104 ~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 21 1 11 1245667777777777532
Q ss_pred ---------CceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 179 ---------RALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 179 ---------~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.++|+|++|.||++++++.+.|+||+.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 18999999999999877667799999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=7.3e-11 Score=105.84 Aligned_cols=144 Identities=12% Similarity=0.125 Sum_probs=105.6
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEec--CCC-CCChHHHHHHHHHHhcCCC--CCccceeeeeeeC---Cee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFN--RMA-WPDPRQFLEEARSVGQLRN--NRLTNLLGCCCEG---DER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~ 131 (334)
.....++.++.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+.. ..+.+++.++... +..
T Consensus 38 ~~~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 38 AGPLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCCCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CCCceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 333446677999999999998754 678889876 332 1223467789999998863 4577888887665 458
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK---------------------------------- 177 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------------------------------- 177 (334)
++||||++|.++.+.. ...++......++.+++..|+.||+.
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 8999999987774422 23467888889999999999999972
Q ss_pred -----------------------CCceecccCCCCeeecCCCC--eeEcCCCCCcc
Q 019905 178 -----------------------GRALYHDLNAYRILFDEDGN--PRLSTFGLMKN 208 (334)
Q Consensus 178 -----------------------~~i~H~dikp~Nili~~~~~--~kl~Dfg~a~~ 208 (334)
..++|+|++|.||+++.++. +.|.||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 12899999999999997653 58999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=9.6e-11 Score=102.60 Aligned_cols=184 Identities=13% Similarity=0.107 Sum_probs=117.7
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCC--ccceeeeeeeCC---eeeEEEecC
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNR--LTNLLGCCCEGD---ERLLVAEYM 138 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~ 138 (334)
+..++.|..+.||+.. ..+++|..... .....+.+|..+++.+. +.. +.+++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3456888888888863 46888986532 12456888999998873 333 334444433322 357899999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS------------------------------------------ 176 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~------------------------------------------ 176 (334)
+|.++.+... ..++......++.+++..|+.||+
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9888865332 245666777778888888888775
Q ss_pred ----------------CCCceecccCCCCeeecC--CCCeeEcCCCCCccCCCCCcccccccc---cCcccccC----C-
Q 019905 177 ----------------KGRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRDGKSYSTNLAF---TPPEYLRT----G- 230 (334)
Q Consensus 177 ----------------~~~i~H~dikp~Nili~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~y---~aPE~~~~----~- 230 (334)
.. ++|+|++|.||++++ ...+.+.||+.+....+..-......+ ..|+.... .
T Consensus 175 ~~~~~~l~~~~~~~~~~~-~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPC-LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCE-EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCce-eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 12 799999999999997 456789999987654332111111111 12221110 0
Q ss_pred C---------CCCccchhhhHHHHHHHHhCCCCCCchh
Q 019905 231 R---------VTPESVIYSFGTLLLDLLSGKHIPPSHA 259 (334)
Q Consensus 231 ~---------~~~~~Di~slG~~l~elltg~~p~~~~~ 259 (334)
. ...-.+.|+++.++|.+.+|..++....
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g 291 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEG 291 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHH
Confidence 0 1122588999999999999986554433
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=3.3e-07 Score=80.11 Aligned_cols=134 Identities=13% Similarity=0.056 Sum_probs=87.2
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCC---Cccceeeeee-eCCeeeEEEecCCC
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN---RLTNLLGCCC-EGDERLLVAEYMPN 140 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~ 140 (334)
+..++.|..+.||+. +..+++|..... .....+.+|..+++.+.+. .+.+++.++. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 345578888889987 466888885321 1235688999999998643 2455666653 34567899999998
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG------------------------------------------ 178 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------------ 178 (334)
.++.+... ..++......++.++...|..||+..
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88765321 12233334444444444444444211
Q ss_pred -----------------CceecccCCCCeeecC---CCCe-eEcCCCCCcc
Q 019905 179 -----------------RALYHDLNAYRILFDE---DGNP-RLSTFGLMKN 208 (334)
Q Consensus 179 -----------------~i~H~dikp~Nili~~---~~~~-kl~Dfg~a~~ 208 (334)
.++|+|++|.||+++. ++.+ .|.||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1699999999999987 4554 7999998643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.5e-06 Score=74.31 Aligned_cols=125 Identities=17% Similarity=0.065 Sum_probs=84.9
Q ss_pred cEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccC
Q 019905 74 NVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWE 151 (334)
Q Consensus 74 g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 151 (334)
+.||+.... ++..+++|.-... ....+.+|...|+.+. +--+.++++++..++..++||++++|.++.+....
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-- 113 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-- 113 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--
T ss_pred CeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC--
Confidence 368887754 4567889987542 2456788999888774 32366788888888899999999998887664421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------------CC--
Q 019905 152 THPMKWAMRLRVVLHLAQALEYCTS---------------------------------------------------KG-- 178 (334)
Q Consensus 152 ~~~~~~~~~~~i~~~i~~~l~~lh~---------------------------------------------------~~-- 178 (334)
.......+..++...|.-||. ..
T Consensus 114 ----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 114 ----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp ----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred ----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 011122233344444444442 10
Q ss_pred ----CceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 179 ----RALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 179 ----~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.++|+|+++.||+++.++.+-|.||+.+.
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987777799999863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.7e-07 Score=81.45 Aligned_cols=80 Identities=5% Similarity=-0.048 Sum_probs=53.7
Q ss_pred cccC-CCcCccEEEEEEeC-------CCCEEEEEEecCCC---CCChHHHHHHHHHHhcCC-C--CCccceeeeeeeC--
Q 019905 65 VSEH-GEKAPNVVYKGKLE-------NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLR-N--NRLTNLLGCCCEG-- 128 (334)
Q Consensus 65 ~~~l-g~G~~g~Vy~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~-- 128 (334)
++.+ +.|..+.+|+.... ++..+++|...... ......+.+|+.+++.+. + -.+.+++.++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4556 77888899988754 25678888875432 111245678888888774 2 2466677776554
Q ss_pred -CeeeEEEecCCCCCHH
Q 019905 129 -DERLLVAEYMPNETLA 144 (334)
Q Consensus 129 -~~~~lv~e~~~~~sL~ 144 (334)
+..++|||+++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999986654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=7.6e-06 Score=74.06 Aligned_cols=75 Identities=13% Similarity=0.092 Sum_probs=48.6
Q ss_pred cccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-------CChHHHHHHHHHHhcCCC--CC-ccceeeeeeeCCeeeE
Q 019905 65 VSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-------PDPRQFLEEARSVGQLRN--NR-LTNLLGCCCEGDERLL 133 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~l 133 (334)
++.+|.|..+.||++... +++.+++|....... .....+..|.++++.+.. +. +.+++.+ ..+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 456799999999999754 467899998653221 123456778888887732 33 3345543 3445689
Q ss_pred EEecCCCC
Q 019905 134 VAEYMPNE 141 (334)
Q Consensus 134 v~e~~~~~ 141 (334)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.9e-05 Score=68.41 Aligned_cols=74 Identities=14% Similarity=0.209 Sum_probs=42.3
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCC--CCccceee------eeeeCCeeeEEEe
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN--NRLTNLLG------CCCEGDERLLVAE 136 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e 136 (334)
+..++.|..+.||+....++ .+++|.... ....+..|..+++.+.. -.+.+++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34456677889999987554 588999865 23444455555555421 12333332 1234567889999
Q ss_pred cCCCCCH
Q 019905 137 YMPNETL 143 (334)
Q Consensus 137 ~~~~~sL 143 (334)
|++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9997644
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00012 Score=59.49 Aligned_cols=143 Identities=12% Similarity=0.029 Sum_probs=95.4
Q ss_pred CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccccc
Q 019905 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNL 219 (334)
Q Consensus 141 ~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 219 (334)
-+|.+.|.. ...++++.++|.++.|.+.+|.-+-. +. -..+=+.|..|++..+|.|-..+ +.+ .....
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s--------~~~~~ 101 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AAD--------DAGEP 101 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-ccc--------ccccc
Confidence 478888865 56799999999999999999877632 22 22334457889999999987764 111 11233
Q ss_pred cccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHhhhc-
Q 019905 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY- 298 (334)
Q Consensus 220 ~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~- 298 (334)
.+.|||... ...+.+.-|||||+++|.-+..+.+... ....++.|.+||..|...
T Consensus 102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e-----------------------E~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE-----------------------ERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE-----------------------EECCCHHHHHHHHHHTTCC
T ss_pred CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc-----------------------chhhCHHHHHHHHHHHhcc
Confidence 567888763 3356788899999999999987754322 223445788888888755
Q ss_pred ------------------------CCCCCCCHHHHHHHhccccc
Q 019905 299 ------------------------EPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 299 ------------------------dp~~Rps~~~~l~~L~~l~~ 318 (334)
.+..|++.++|++.=+.-.+
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence 24678999999988766553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.6e-05 Score=65.13 Aligned_cols=76 Identities=22% Similarity=0.269 Sum_probs=55.2
Q ss_pred cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCC---CccceeeeeeeCCeeeEEEecCC
Q 019905 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN---RLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.-+..+|.|..+.||+....+|+.+++|+...........+..|...|+.+... -+.+++++ +..+++|||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeec
Confidence 345667999999999999989999999988765544456788899988887422 23444443 23478999998
Q ss_pred CCC
Q 019905 140 NET 142 (334)
Q Consensus 140 ~~s 142 (334)
++.
T Consensus 94 ~~~ 96 (288)
T 3f7w_A 94 ERP 96 (288)
T ss_dssp CCC
T ss_pred ccC
Confidence 654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00018 Score=62.60 Aligned_cols=75 Identities=15% Similarity=0.068 Sum_probs=58.2
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC---CCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
+..++.|..+.+|+... ++..+++|..... ....+..|...|+.+. ...+.+++.+....+..++|||++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45668999999999886 4578888987643 2566888988888873 245778888887778899999999987
Q ss_pred CH
Q 019905 142 TL 143 (334)
Q Consensus 142 sL 143 (334)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00022 Score=62.25 Aligned_cols=159 Identities=12% Similarity=0.123 Sum_probs=87.6
Q ss_pred cccCHHHHHHHhcCCCcc--cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--ccc
Q 019905 45 REFTLEQLKNATSGFAVE--NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTN 120 (334)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~--~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~ 120 (334)
..++.+++......|... .-++.++.|..+.+|+....++ .+++|...... ....+..|+.++..+...+ +.+
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 346667777666666542 2345567788889999987655 67889886531 2335566777776663212 233
Q ss_pred eeee------eeeCCeeeEEEecCCCCCHHH--------------hhccc--C-CCC----CC---HHHHHH--------
Q 019905 121 LLGC------CCEGDERLLVAEYMPNETLAK--------------HLFHW--E-THP----MK---WAMRLR-------- 162 (334)
Q Consensus 121 ~~~~------~~~~~~~~lv~e~~~~~sL~~--------------~l~~~--~-~~~----~~---~~~~~~-------- 162 (334)
++.. ....+..++++++++|.++.. .++.. . ..+ .. |.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 123456789999998754321 01110 0 000 11 111000
Q ss_pred ----HHHHHHHHHHHHHh-------CCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 163 ----VVLHLAQALEYCTS-------KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 163 ----i~~~i~~~l~~lh~-------~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
+...+...+..+.. .+ ++|+|+++.||++++++.+.+.||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~-liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAG-VIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEE-EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcc-cCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113344455542 23 8999999999999977666899999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00029 Score=64.10 Aligned_cols=74 Identities=15% Similarity=0.073 Sum_probs=43.9
Q ss_pred hCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcc---cc--cccccCcccccCC---CCCCccchhhhHHHHHH
Q 019905 176 SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY---ST--NLAFTPPEYLRTG---RVTPESVIYSFGTLLLD 247 (334)
Q Consensus 176 ~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---~~--~~~y~aPE~~~~~---~~~~~~Di~slG~~l~e 247 (334)
... ++|+|++|.||+++.++ +.+.||+.+....+..-. .. ...|.+|+..... .-....++.+....+|+
T Consensus 231 ~~~-liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQA-LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCE-EECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCe-EEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 344 99999999999999776 999999987643321100 00 1234555444211 11122444566667777
Q ss_pred HHhC
Q 019905 248 LLSG 251 (334)
Q Consensus 248 lltg 251 (334)
.+.+
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0014 Score=57.31 Aligned_cols=98 Identities=18% Similarity=0.169 Sum_probs=60.2
Q ss_pred ccccCHHHHHHHhcCCCcc--cccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC--cc
Q 019905 44 FREFTLEQLKNATSGFAVE--NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LT 119 (334)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~--~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv 119 (334)
+..++.+.+......+... ..+..++ |..+.||+....+|+.+++|...... .....+..|..+++.+...+ +.
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence 4456666666555444321 1233445 77788998877667789999987443 24566777888877764222 33
Q ss_pred ceeee-----eeeCCeeeEEEecCCCCCH
Q 019905 120 NLLGC-----CCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 120 ~~~~~-----~~~~~~~~lv~e~~~~~sL 143 (334)
+++.. ....+..+++|++++|.++
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence 34332 1234566889999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00022 Score=61.74 Aligned_cols=71 Identities=13% Similarity=0.127 Sum_probs=42.7
Q ss_pred cccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-cceeeeeeeCCeeeEEEecC-CCCC
Q 019905 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYM-PNET 142 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~s 142 (334)
+..++.|..+.+|+. ..+++|........ .-...+|+.+++.+...++ .++++.. .+.-+++++|+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 455578888899998 45888888653211 1123467777776642233 3455443 33357899999 6654
Q ss_pred H
Q 019905 143 L 143 (334)
Q Consensus 143 L 143 (334)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00063 Score=59.71 Aligned_cols=30 Identities=17% Similarity=0.172 Sum_probs=26.0
Q ss_pred ceecccCCCCeeecCC----CCeeEcCCCCCccC
Q 019905 180 ALYHDLNAYRILFDED----GNPRLSTFGLMKNS 209 (334)
Q Consensus 180 i~H~dikp~Nili~~~----~~~kl~Dfg~a~~~ 209 (334)
++|||+++.||+++.+ +.+.+.||+.+...
T Consensus 185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 8999999999999874 67899999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00057 Score=61.15 Aligned_cols=137 Identities=15% Similarity=0.171 Sum_probs=79.7
Q ss_pred ccCCCcCccEEEEEEeC--------CCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEe
Q 019905 66 SEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..+..|-.+.+|+.... ++..+++|+.-. .........+|..+++.+. +.-..++++.+.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45566777889998864 247889988633 2234556678998888874 3323556665543 39999
Q ss_pred cCCCCCHHHh-h----------------ccc---CCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 019905 137 YMPNETLAKH-L----------------FHW---ETHPMK--WAMRLRVVLHLAQ-------------------ALEYC- 174 (334)
Q Consensus 137 ~~~~~sL~~~-l----------------~~~---~~~~~~--~~~~~~i~~~i~~-------------------~l~~l- 174 (334)
|++|.+|... + +.. ..+... +..+.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9997655321 0 000 011222 3445555544322 12222
Q ss_pred ---HhCC---CceecccCCCCeeecCC----CCeeEcCCCCCc
Q 019905 175 ---TSKG---RALYHDLNAYRILFDED----GNPRLSTFGLMK 207 (334)
Q Consensus 175 ---h~~~---~i~H~dikp~Nili~~~----~~~kl~Dfg~a~ 207 (334)
...+ .++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 18999999999999876 789999999864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00079 Score=61.42 Aligned_cols=73 Identities=16% Similarity=0.303 Sum_probs=48.6
Q ss_pred cccCCCcCccEEEEEEeCC--------CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-cceeeeeeeCCeeeEEE
Q 019905 65 VSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVA 135 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 135 (334)
+..++.|..+.+|+....+ +..+++|+.... .....+..|..+++.+...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3456778888999998653 478999988432 122556678888888753333 556665432 3899
Q ss_pred ecCCCCCH
Q 019905 136 EYMPNETL 143 (334)
Q Consensus 136 e~~~~~sL 143 (334)
+|++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0085 Score=52.67 Aligned_cols=68 Identities=7% Similarity=-0.004 Sum_probs=42.5
Q ss_pred CCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC---CCCccceeee------eeeCCeeeEEEecCC
Q 019905 69 GEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGC------CCEGDERLLVAEYMP 139 (334)
Q Consensus 69 g~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~------~~~~~~~~lv~e~~~ 139 (334)
|.|..+.||+....++ .+++|+...... ..|+..++.|. -+++.+++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444688999987666 899998765442 24555554442 2223444322 233567899999999
Q ss_pred CCCH
Q 019905 140 NETL 143 (334)
Q Consensus 140 ~~sL 143 (334)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.001 Score=59.25 Aligned_cols=74 Identities=12% Similarity=0.179 Sum_probs=42.8
Q ss_pred cccCCCcCccEEEEEEeCC---------CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC-ccceeeeeeeCCeeeEE
Q 019905 65 VSEHGEKAPNVVYKGKLEN---------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLV 134 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 134 (334)
+..++.|..+.+|+....+ +..+++|....... .......|..+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3456788888999998654 26788888754221 1112356777777774333 34555543 2 3689
Q ss_pred EecCCCCCH
Q 019905 135 AEYMPNETL 143 (334)
Q Consensus 135 ~e~~~~~sL 143 (334)
|+|++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.016 Score=53.14 Aligned_cols=73 Identities=14% Similarity=0.104 Sum_probs=45.8
Q ss_pred ccCCCcCccEEEEEEeCC-CCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-cceeeeeeeCCeeeEEEecCCCCCH
Q 019905 66 SEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMPNETL 143 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL 143 (334)
..++.|..+.+|+....+ +..+++|...... ...-...+|..+++.|...++ .++++.+. + .+|++|++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 456778888999998765 4678888874432 111112578888888864444 45666652 2 369999987554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.032 Score=50.56 Aligned_cols=74 Identities=16% Similarity=0.124 Sum_probs=46.9
Q ss_pred cccCCCcCccEEEEEEeCC--------CCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEE
Q 019905 65 VSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 135 (334)
+..+..|-.+.+|+....+ +..++++...... ...-...+|..+++.+. +.-..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4556778888999998753 5788988864432 11112357788777774 22234455433 2 26899
Q ss_pred ecCCCCCH
Q 019905 136 EYMPNETL 143 (334)
Q Consensus 136 e~~~~~sL 143 (334)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.05 E-value=0.19 Score=45.02 Aligned_cols=28 Identities=21% Similarity=0.156 Sum_probs=24.1
Q ss_pred ceecccCCCCeee------cCCCCeeEcCCCCCc
Q 019905 180 ALYHDLNAYRILF------DEDGNPRLSTFGLMK 207 (334)
Q Consensus 180 i~H~dikp~Nili------~~~~~~kl~Dfg~a~ 207 (334)
++|+|+.+.||++ +++..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999999874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.79 E-value=2.1 Score=34.68 Aligned_cols=83 Identities=13% Similarity=0.139 Sum_probs=57.4
Q ss_pred CCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCceecccCCCCeee
Q 019905 114 RNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALE-YCTSKGRALYHDLNAYRILF 192 (334)
Q Consensus 114 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~i~H~dikp~Nili 192 (334)
.||++ -..+-.+.+.+.+.++.-+++.-...+ +..+...+++++.+|+.... +++ . -+|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~--~-r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA--R-RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS--S-SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh--C-ceeEEEeCceEEE
Confidence 56776 444445666666666665333222233 35788899999999877555 333 2 5788999999999
Q ss_pred cCCCCeeEcCCCCC
Q 019905 193 DEDGNPRLSTFGLM 206 (334)
Q Consensus 193 ~~~~~~kl~Dfg~a 206 (334)
+.++.+++.-.|+.
T Consensus 118 ~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 118 NRALEPFFLHVGVK 131 (219)
T ss_dssp CTTCCEEESCCEET
T ss_pred eCCCcEEEEEcCCc
Confidence 99999999977763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.35 E-value=0.25 Score=45.24 Aligned_cols=62 Identities=5% Similarity=-0.029 Sum_probs=18.7
Q ss_pred cccccCCCcCccEEEEEEeCC-CCEEEE------EEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeee
Q 019905 63 NIVSEHGEKAPNVVYKGKLEN-QRRIAV------KRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE 127 (334)
Q Consensus 63 ~~~~~lg~G~~g~Vy~~~~~~-~~~vai------K~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 127 (334)
.+.+++| ||.||+|.+.. ...||+ |........ ....+.+|..+...++|+|+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4566666 99999999754 367888 766543311 22356778888888999999998887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.52 E-value=2.5 Score=34.05 Aligned_cols=115 Identities=15% Similarity=0.129 Sum_probs=72.0
Q ss_pred CCCCccceeeeeeeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec
Q 019905 114 RNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (334)
Q Consensus 114 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~ 193 (334)
.||+++.. .+-...+.+.+.++.-+ +..++- .-+..+...+++++.+|+....+++. -+|--++|+|++++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~---~ik~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD---NIKSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG---GGGGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH---HHHhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEEc
Confidence 57777755 44455565555555443 222222 22457888999999999887644432 46889999999999
Q ss_pred CCCCeeEcCCCCCccCCCCCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCC
Q 019905 194 EDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP 255 (334)
Q Consensus 194 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~ 255 (334)
.++.+++.-.|+... ++|.. .+...=.-.+=+++..+++++..|
T Consensus 114 ~~~~p~i~~RGik~~-------------l~P~~-----~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 114 RDGLPIAKTRGLQNV-------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp TTSCEEESCCEETTT-------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred CCCCEEEEEccCccC-------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999997775322 22211 122222334556788888887544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 334 | ||||
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-40 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-07 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-43
Identities = 52/249 (20%), Positives = 105/249 (42%), Gaps = 12/249 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
+V+ G N+ ++A+K A + F+EEA + +L + +L L G C E LV
Sbjct: 20 LVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E+M + L+ + + L + L + + + Y ++ DL A L E
Sbjct: 79 FEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGE 136
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ ++S FG+ + D + S+ + + PE R + +S ++SFG L+ ++
Sbjct: 137 NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
S IP + + + + T + ++ + C + P +RP L
Sbjct: 197 SEGKIPYEN----RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252
Query: 310 VTALSPLQK 318
+ L+ + +
Sbjct: 253 LRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-42
Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 12/244 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK Q +A+K + + +F+EEA+ + L + +L L G C + ++
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM N L +L H + L + + +A+EY SK L+ DL A L ++
Sbjct: 78 TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF-LHRDLAARNCLVND 135
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G ++S FGL + D + S+ + ++PPE L + + +S I++FG L+ ++
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
S +P + L ++ + C + ERP K L
Sbjct: 196 SLGKMPYER----FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
Query: 310 VTAL 313
++ +
Sbjct: 252 LSNI 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-41
Identities = 59/257 (22%), Positives = 107/257 (41%), Gaps = 22/257 (8%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V+ G ++AVK + + P FL EA + QL++ RL L + + ++
Sbjct: 28 EVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM N +L L + L + +A+ + + + ++ DL A IL +
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-IHRDLRAANILVSD 144
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + + +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
+ IP + + + D+C E EL +L C + P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255
Query: 305 NPKSLVTALSPLQKETE 321
L + L TE
Sbjct: 256 TFDYLRSVLEDFFTATE 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-41
Identities = 61/257 (23%), Positives = 104/257 (40%), Gaps = 12/257 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V+ G R+A+K P FL+EA+ + +LR+ +L L E + +V
Sbjct: 32 EVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM +L L ++ + + +A + Y ++ DL A IL E
Sbjct: 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGE 148
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + + +T PE GR T +S ++SFG LL +L
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ +P + +R + + + L L +C + EP ERP + L
Sbjct: 209 TKGRVPYPG----MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264
Query: 310 VTALSPLQKETEFSISP 326
L TE P
Sbjct: 265 QAFLEDYFTSTEPQYQP 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-41
Identities = 62/251 (24%), Positives = 100/251 (39%), Gaps = 20/251 (7%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-L 133
V G ++AVK A + FL EA + QLR++ L LLG E L +
Sbjct: 22 DVMLGDYRG-NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
V EYM +L +L + L+ L + +A+EY ++ DL A +L
Sbjct: 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-VHRDLAARNVLVS 137
Query: 194 EDGNPRLSTFGLMKN-SRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK 252
ED ++S FGL K S + + +T PE LR + + +S ++SFG LL ++ S
Sbjct: 138 EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 253 HIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
+P + + D C + + C + RP+
Sbjct: 198 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFL 248
Query: 308 SLVTALSPLQK 318
L L ++
Sbjct: 249 QLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 2e-40
Identities = 54/255 (21%), Positives = 108/255 (42%), Gaps = 12/255 (4%)
Query: 75 VVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 32 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
+ E+M L +L + + L + ++ A+EY K ++ DL A L
Sbjct: 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVG 149
Query: 194 EDGNPRLSTFGLMKNSRDGKSYST-----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
E+ +++ FGL + + + +T PE L + + +S +++FG LL ++
Sbjct: 150 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
+ P +DL + L + + + ++ L C Q+ P +RP+
Sbjct: 210 ATYGM-SPYPGIDL---SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 265
Query: 309 LVTALSPLQKETEFS 323
+ A + +E+ S
Sbjct: 266 IHQAFETMFQESSIS 280
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 9e-40
Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 26/292 (8%)
Query: 47 FTLEQLKNATSGFAVENIVSEH------GEKAPNVVYKGKL----ENQRRIAVKRFNRMA 96
FT E A FA E +S G V G L + + +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 97 WPDP-RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPM 155
R FL EA +GQ + + +L G + +++ E+M N +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 156 KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215
+ ++ +A ++Y ++ DL A IL + + ++S FGL + D S
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNY-VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 216 STN---------LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR 266
T + +T PE ++ + T S ++S+G ++ +++S P + ++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----MTNQ 240
Query: 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
++ + D + L +L C Q + RP +V L + +
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-39
Identities = 51/258 (19%), Positives = 102/258 (39%), Gaps = 20/258 (7%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VYKGK + + + F E + + R+ + +G + +V
Sbjct: 23 TVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 81
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
++ +L HL ET + + + AQ ++Y +K ++ DL + I E
Sbjct: 82 TQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSI-IHRDLKSNNIFLHE 139
Query: 195 DGNPRLSTFGL--MKNSRDGKSYSTNLAFTP----PEYLRT---GRVTPESVIYSFGTLL 245
D ++ FGL +K+ G L+ + PE +R + +S +Y+FG +L
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 246 LDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+L++G+ +I + + R S + + RL + CL+ +
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK----AMKRLMAECLKKKRD 255
Query: 302 ERPNPKSLVTALSPLQKE 319
ERP ++ ++ L +
Sbjct: 256 ERPLFPQILASIELLARS 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-38
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 25/272 (9%)
Query: 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDP--- 100
R++ LE + I G+ VY + +++ +A+K +
Sbjct: 1 RQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 50
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
Q E LR+ + L G + L+ EY P T+ + L
Sbjct: 51 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRT 108
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-- 218
+ LA AL YC SK ++ D+ +L G +++ FG ++ + +
Sbjct: 109 ATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 167
Query: 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278
L + PPE + + ++S G L + L GK ++ R + +E
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEF 221
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
F D L SR L++ P +RP + ++
Sbjct: 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-37
Identities = 60/282 (21%), Positives = 112/282 (39%), Gaps = 40/282 (14%)
Query: 75 VVYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
+VY+G E + R+A+K N A + +FL EA + + + + LLG +
Sbjct: 35 MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94
Query: 128 GDERLLVAEYMPNETLAKHLFHW--------ETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
G L++ E M L +L P + +++ +A + Y +
Sbjct: 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF 154
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVT 233
++ DL A + ED ++ FG+ ++ + Y + + PE L+ G T
Sbjct: 155 -VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213
Query: 234 PESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
S ++SFG +L ++ + P L + + L D+C + L
Sbjct: 214 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 264
Query: 289 VRLASRCLQYEPRERPNPKSLVTALS----PLQKETEFSISP 326
L C QY P+ RP+ +++++ P +E F S
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 306
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-36
Identities = 54/263 (20%), Positives = 99/263 (37%), Gaps = 30/263 (11%)
Query: 75 VVYKGKLENQ---RRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V KG + + + +AVK A + L EA + QL N + ++G C E +
Sbjct: 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 80
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
+LV E L K+L + +K + +V ++ ++Y ++ DL A
Sbjct: 81 SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF-VHRDLAARN 137
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFG 242
+L ++S FGL K R ++Y + + PE + + + +S ++SFG
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
L+ + S P S ++ C E+ L + C
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCWT 248
Query: 298 YEPRERPNPKSLVTALSPLQKET 320
Y+ RP ++ L +
Sbjct: 249 YDVENRPGFAAVELRLRNYYYDV 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (327), Expect = 5e-36
Identities = 48/243 (19%), Positives = 85/243 (34%), Gaps = 14/243 (5%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY + + N +A+K+ + + ++E R + +LR+ GC
Sbjct: 30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
LV EY H P++ V Q L Y S ++ D+ A I
Sbjct: 90 AWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNM-IHRDVKAGNI 146
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLD 247
L E G +L FG S+ + PE + G+ + ++S G ++
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
L K + Q + + G +++ CLQ P++RP +
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE----YFRNFVDSCLQKIPQDRPTSE 262
Query: 308 SLV 310
L+
Sbjct: 263 VLL 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 52/277 (18%), Positives = 98/277 (35%), Gaps = 44/277 (15%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
VV+K + +A K + P Q + E + + + + + G E
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
+ E+M +L + L + + + +V + + + L Y K + ++ D+ IL
Sbjct: 81 ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
+ G +L FG+ D + S ++ PE L+ + +S I+S G L+++
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 251 GKH-IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT----------------------- 286
G++ IPP A +L Q+ D+ G
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 287 --------------ELVRLASRCLQYEPRERPNPKSL 309
E ++CL P ER + K L
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 9e-36
Identities = 47/255 (18%), Positives = 88/255 (34%), Gaps = 28/255 (10%)
Query: 75 VVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
K + + + + K + M + + + E + +L++ + +
Sbjct: 19 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 132 LL--VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH---- 183
L V EY LA + E + LRV+ L AL+ C + +
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIY 239
DL + D N +L FGL + S++ TP PE + +S I+
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 198
Query: 240 SFGTLLLDLLSGKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
S G LL +L + IR+ + + + EL + +R
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD---------ELNEIITRM 249
Query: 296 LQYEPRERPNPKSLV 310
L + RP+ + ++
Sbjct: 250 LNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-35
Identities = 63/262 (24%), Positives = 112/262 (42%), Gaps = 26/262 (9%)
Query: 75 VVYKGKLENQRR----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY G L + AVK NR+ + QFL E + + + +LLG C +
Sbjct: 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101
Query: 130 ER-LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L+V YM + L ++ ETH + L +A+ +++ SK ++ DL A
Sbjct: 102 GSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF-VHRDLAAR 159
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------LAFTPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + S + + + E L+T + T +S ++S
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ---FTDDDGTELVRLASRCLQ 297
FG LL +L++ P D N +T L+G+ + L + +C
Sbjct: 220 FGVLLWELMTRGAPPYP-------DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWH 272
Query: 298 YEPRERPNPKSLVTALSPLQKE 319
+ RP+ LV+ +S +
Sbjct: 273 PKAEMRPSFSELVSRISAIFST 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-35
Identities = 45/256 (17%), Positives = 88/256 (34%), Gaps = 15/256 (5%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122
I+ E G+ A VYK + E A K + + + ++ E + + + LL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 123 GCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182
+ ++ E+ + + E P+ + V AL Y ++
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK-IIH 133
Query: 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST----NLAFTPPEYLRT-----GRVT 233
DL A ILF DG+ +L+ FG+ + + PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 234 PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
++ ++S G L+++ + PP H L+ + L++ +
Sbjct: 194 YKADVWSLGITLIEMAEIE--PPHHELNPM-RVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 294 RCLQYEPRERPNPKSL 309
+CL+ R L
Sbjct: 251 KCLEKNVDARWTTSQL 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (321), Expect = 3e-35
Identities = 61/284 (21%), Positives = 105/284 (36%), Gaps = 50/284 (17%)
Query: 75 VVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCE 127
V++ + E +AVK A D F EA + + N + LLG C
Sbjct: 28 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87
Query: 128 GDERLLVAEYMPNETLAKHLFHWETH----------------------PMKWAMRLRVVL 165
G L+ EYM L + L H P+ A +L +
Sbjct: 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 147
Query: 166 HLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------L 219
+A + Y + + ++ DL L E+ +++ FGL +N Y + +
Sbjct: 148 QVAAGMAYLSERKF-VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDS 274
+ PPE + R T ES ++++G +L ++ S P + +RD N+ ++
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN 266
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
C EL L C P +RP+ S+ L + +
Sbjct: 267 CPL---------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 8e-35
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 28/255 (10%)
Query: 75 VVYKGKL---ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V +G + Q +A+K + D + + EA+ + QL N + L+G C + +
Sbjct: 24 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 82
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
+LV E L K L + + ++ ++ ++Y K ++ DL A +
Sbjct: 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF-VHRDLAARNV 140
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFGT 243
L ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200
Query: 244 LLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+ + LS P + I C EL L S C Y
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWIY 251
Query: 299 EPRERPNPKSLVTAL 313
+ +RP+ ++ +
Sbjct: 252 KWEDRPDFLTVEQRM 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-34
Identities = 60/272 (22%), Positives = 110/272 (40%), Gaps = 15/272 (5%)
Query: 46 EFTLEQLKNATSGFAVEN---IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPR 101
E LE+L++ S + + G+ A VY + + +A+++ N P
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 102 QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRL 161
+ E + + +N + N L GDE +V EY+ +L + M
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIA 119
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF 221
V QALE+ S ++ D+ + IL DG+ +L+ FG +S + +
Sbjct: 120 AVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 222 TP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277
TP PE + P+ I+S G + ++++ G+ PP + +R + T+ E
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENPLRALY-LIATNGTPE 235
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
Q + +RCL + +R + K L
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-34
Identities = 56/277 (20%), Positives = 108/277 (38%), Gaps = 33/277 (11%)
Query: 75 VVYKGKLEN---QRRIAVKRFNRMAWPDP-RQFLEEARSVGQLRNNR-LTNLLGCCCEGD 129
V K +++ + A+KR A D R F E + +L ++ + NLLG C
Sbjct: 25 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84
Query: 130 ERLLVAEYMPNETLAKHL--------------FHWETHPMKWAMRLRVVLHLAQALEYCT 175
L EY P+ L L + + L +A+ ++Y +
Sbjct: 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144
Query: 176 SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRV 232
K ++ DL A IL E+ +++ FGL + + + + E L
Sbjct: 145 QKQF-IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203
Query: 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG---QFTDDDGTELV 289
T S ++S+G LL +++S P L + +G + + E+
Sbjct: 204 TTNSDVWSYGVLLWEIVSLGGTPY-------CGMTCAELYEKLPQGYRLEKPLNCDDEVY 256
Query: 290 RLASRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326
L +C + +P ERP+ ++ +L+ + +E + ++
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-34
Identities = 54/275 (19%), Positives = 98/275 (35%), Gaps = 41/275 (14%)
Query: 75 VVYKGKLENQRR------IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNR-LTNLLGCCC 126
V + +AVK A R+ + E + + QL ++ + NLLG C
Sbjct: 52 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111
Query: 127 EGDERLLVAEYMPNETLAKHLF---------------------HWETHPMKWAMRLRVVL 165
L+ EY L +L + + + + L
Sbjct: 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 166 HLAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------ 218
+A+ +E+ K H DL A +L ++ FGL ++ +Y
Sbjct: 172 QVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229
Query: 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278
+ + PE L G T +S ++S+G LL ++ S P + D N L + +
Sbjct: 230 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP---GIPVDANFYKLIQNGFKM 286
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
E+ + C ++ R+RP+ +L + L
Sbjct: 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-33
Identities = 44/259 (16%), Positives = 97/259 (37%), Gaps = 19/259 (7%)
Query: 75 VVYKGKL-----ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG + + +A+K P ++ L+EA + + N + LLG C
Sbjct: 24 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
+L+ + MP L + + L + +A+ + Y + ++ DL A
Sbjct: 84 TVQLIT-QLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL-VHRDLAAR 140
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFG 242
+L + +++ FGL K + + + E + T +S ++S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200
Query: 243 TLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ +L++ P D I + + + ++ + +C +
Sbjct: 201 VTVWELMTFGSKPY----DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 303 RPNPKSLVTALSPLQKETE 321
RP + L+ S + ++ +
Sbjct: 257 RPKFRELIIEFSKMARDPQ 275
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-33
Identities = 51/260 (19%), Positives = 102/260 (39%), Gaps = 19/260 (7%)
Query: 75 VVYKGKLEN-----QRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L+ + +A+K R FL EA +GQ ++ + L G +
Sbjct: 22 EVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
+++ EYM N + + ++ +A ++Y + + DL A
Sbjct: 82 KPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV-HRDLAAR 139
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSF 241
IL + + ++S FGL + D + + +T PE + + T S ++SF
Sbjct: 140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 199
Query: 242 GTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
G ++ ++++ P + + + + D + + +L +C Q E
Sbjct: 200 GIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 255
Query: 302 ERPNPKSLVTALSPLQKETE 321
RP +V+ L L + +
Sbjct: 256 RRPKFADIVSILDKLIRAPD 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-33
Identities = 53/276 (19%), Positives = 96/276 (34%), Gaps = 34/276 (12%)
Query: 75 VVYKGKL------ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNR-LTNLLGCCC 126
V + + +AVK A R+ + E + + L N+ + NLLG C
Sbjct: 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 127 EGDERLLVAEYMPNETLAKHLFHW----------------ETHPMKWAMRLRVVLHLAQA 170
G L++ EY L L + + L +A+
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 171 LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPP 224
+ + SK ++ DL A IL ++ FGL ++ ++ +Y + + P
Sbjct: 158 MAFLASKNC-IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
E + T ES ++S+G L +L S P + D + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---MPVDSKFYKMIKEGFRMLSPEHA 273
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
E+ + C +P +RP K +V + E+
Sbjct: 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-32
Identities = 46/247 (18%), Positives = 92/247 (37%), Gaps = 17/247 (6%)
Query: 75 VVYKGKL-ENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VYKG E +A ++ + ++F EEA + L++ + +
Sbjct: 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 132 ----LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
+LV E M + TL +L MK + + + L++ ++ + H DL
Sbjct: 84 KKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 141
Query: 187 AYRILF-DEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGT 243
I G+ ++ GL R + + F PE + +Y+FG
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGM 200
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+L++ + ++ P S + + + +T F E+ + C++ ER
Sbjct: 201 CMLEMATSEY-PYSECQN--AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
Query: 304 PNPKSLV 310
+ K L+
Sbjct: 258 YSIKDLL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (303), Expect = 3e-32
Identities = 43/241 (17%), Positives = 79/241 (32%), Gaps = 10/241 (4%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VV++ A K D +E +++ LR+ L NL + +E ++
Sbjct: 41 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF- 192
+ E+M L + + E + M + + + + L + ++ DL I+F
Sbjct: 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFT 158
Query: 193 -DEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+L FGL + +S F PE V + ++S G L L
Sbjct: 159 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
LSG P + D ++ + + L +P R
Sbjct: 219 LSGL--SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 309 L 309
Sbjct: 277 A 277
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 8e-32
Identities = 43/288 (14%), Positives = 90/288 (31%), Gaps = 50/288 (17%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEA--RSVGQLRNNRLTNLLGCCCEGD--- 129
V++GK +AVK F+ + R + EA LR+ + + + +
Sbjct: 18 EVWRGKWRG-EEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73
Query: 130 -ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH----- 183
+ LV++Y + +L +L + + +++ L A L + +
Sbjct: 74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 184 --DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY----STNLAFTP----PEYLRT---- 229
DL + IL ++G ++ GL + T PE L
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 230 --GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----------------DLIRDRNLQML 271
+ IY+ G + ++ I H ++ + Q L
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319
+ + + + ++ C R + LS L ++
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-31
Identities = 52/262 (19%), Positives = 99/262 (37%), Gaps = 27/262 (10%)
Query: 75 VVYKGKLENQRR----IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGD 129
V++G + +A+K R+ FL+EA ++ Q + + L+G E +
Sbjct: 22 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 80
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
++ E L + + + A + L+ AL Y SK ++ D+ A
Sbjct: 81 PVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF-VHRDIAARN 138
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEY-----LRTGRVTPESVIYSFGTL 244
+L + +L FGL + D Y + P ++ + R T S ++ FG
Sbjct: 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198
Query: 245 LLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 249
Query: 300 PRERPNPKSLVTALSPLQKETE 321
P RP L LS + +E +
Sbjct: 250 PSRRPRFTELKAQLSTILEEEK 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-31
Identities = 50/257 (19%), Positives = 90/257 (35%), Gaps = 20/257 (7%)
Query: 75 VVYKGKLE----NQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCE 127
VV +G+ + +AVK P F+ E ++ L + L L G
Sbjct: 23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+ +V E P +L R + +A+ + Y SK ++ DL A
Sbjct: 83 PPMK-MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-IHRDLAA 139
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYS 240
+L ++ FGLM+ + A+ PE L+T + S +
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FG L ++ + P L + L + +D ++ + +C ++P
Sbjct: 200 FGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 256
Query: 301 RERPNPKSLVTALSPLQ 317
+RP +L L Q
Sbjct: 257 EDRPTFVALRDFLLEAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-31
Identities = 46/244 (18%), Positives = 76/244 (31%), Gaps = 15/244 (6%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V + +AVK + D P +E L + + G EG+ +
Sbjct: 20 EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
L EY L + M R L + Y G + D+ +L
Sbjct: 80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGI-THRDIKPENLLL 136
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESV-IYSFGTLL 245
DE N ++S FGL R L + PE L+ E V ++S G +L
Sbjct: 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196
Query: 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+L+G+ + + + + D L+ + L P R
Sbjct: 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARIT 253
Query: 306 PKSL 309
+
Sbjct: 254 IPDI 257
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 9e-31
Identities = 45/241 (18%), Positives = 81/241 (33%), Gaps = 10/241 (4%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VV++ R K N D E + QL + +L NL + E +L
Sbjct: 44 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
+ E++ L + E + M A + + + L++ ++ D+ I+ +
Sbjct: 104 ILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHEHSI-VHLDIKPENIMCE 161
Query: 194 --EDGNPRLSTFGLMKNSRDGKS---YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+ + ++ FGL + + F PE + V + +++ G L L
Sbjct: 162 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
LSG P D + D + E LQ EPR+R
Sbjct: 222 LSGL--SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279
Query: 309 L 309
Sbjct: 280 A 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 3e-30
Identities = 45/264 (17%), Positives = 85/264 (32%), Gaps = 16/264 (6%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V + Q+ +A+K + A E + ++++ + L G
Sbjct: 24 EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA--LYHDLNAYRI 190
L+ + + L + E R++ + A++Y G N
Sbjct: 84 LIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
DED +S FGL K G ST + PE L + +S G +
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
LL G PP + + + + + + + DD ++ +P +R +
Sbjct: 202 LLCGY--PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259
Query: 308 SL-----VTALSPLQKETEFSISP 326
+ + L K S+S
Sbjct: 260 QALQHPWIAGDTALDKNIHQSVSE 283
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 7e-30
Identities = 38/252 (15%), Positives = 92/252 (36%), Gaps = 11/252 (4%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122
I + G +V++ +++ K ++ D +E + R+ + +L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 123 GCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182
+E +++ E++ + + + + + + V + +AL++ S +
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHNIG-H 125
Query: 183 HDLNAYRILFDEDGNPR--LSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESV 237
D+ I++ + + FG + + G ++ + PE + V+ +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 238 IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
++S GTL+ LLSG P A + M + + + + E + R L
Sbjct: 186 MWSLGTLVYVLLSGI--NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243
Query: 298 YEPRERPNPKSL 309
E + R
Sbjct: 244 KERKSRMTASEA 255
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-29
Identities = 41/253 (16%), Positives = 81/253 (32%), Gaps = 19/253 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V + L R A+K + E + +L + L + ++
Sbjct: 23 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
Y N L K++ + ALEY K ++ DL I
Sbjct: 83 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENI 139
Query: 191 LFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTL 244
L +ED + +++ FG K S+ + PE L S +++ G +
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 199
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
+ L++G + LI + +++ E F + + L + L + +R
Sbjct: 200 IYQLVAGLPPFRAGNEYLIFQKIIKL------EYDFPEKFFPKARDLVEKLLVLDATKRL 253
Query: 305 NPKSLVTALSPLQ 317
+ +
Sbjct: 254 GCEEMEGYGPLKA 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (277), Expect = 4e-29
Identities = 49/245 (20%), Positives = 86/245 (35%), Gaps = 20/245 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCE--- 127
V+ + L R +AVK DP +F EA++ L + + +
Sbjct: 22 EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81
Query: 128 -GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN 186
G +V EY+ TL + PM + V+ QAL + G ++ D+
Sbjct: 82 AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG-IIHRDVK 138
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNL-------AFTPPEYLRTGRVTPESVIY 239
I+ ++ FG+ + D + T + PE R V S +Y
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
S G +L ++L+G+ PP + + D + +L + + L
Sbjct: 199 SLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256
Query: 300 PRERP 304
P R
Sbjct: 257 PENRY 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-28
Identities = 54/271 (19%), Positives = 95/271 (35%), Gaps = 33/271 (12%)
Query: 75 VVYKG------KLENQRRIAVKRFNR-MAWPDPRQFLEEARSVGQLRN-NRLTNLLGCCC 126
V + K R +AVK + R + E + + + + + NLLG C
Sbjct: 28 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87
Query: 127 E-GDERLLVAEYMPNETLAKHLFHWETH--------------PMKWAMRLRVVLHLAQAL 171
+ G +++ E+ L+ +L + + +A+ +
Sbjct: 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPE 225
E+ S+ ++ DL A IL E ++ FGL ++ Y L + PE
Sbjct: 148 EFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206
Query: 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285
+ T +S ++SFG LL ++ S P + D + D
Sbjct: 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEFCRRLKEGTRMRAPDYTT 263
Query: 286 TELVRLASRCLQYEPRERPNPKSLVTALSPL 316
E+ + C EP +RP LV L L
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (269), Expect = 5e-28
Identities = 45/255 (17%), Positives = 82/255 (32%), Gaps = 25/255 (9%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---------RQFLEEARSVGQLRNNRLT-NLLG 123
VV + + AVK + L+E + ++ + L
Sbjct: 18 VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77
Query: 124 CCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
LV + M L +L E + +++ L + + +
Sbjct: 78 TYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKLNIV-HR 134
Query: 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRV------TP 234
DL IL D+D N +L+ FG G+ ++ PE +
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 235 ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294
E ++S G ++ LL+G PP + + M + DD + L SR
Sbjct: 195 EVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 295 CLQYEPRERPNPKSL 309
L +P++R +
Sbjct: 253 FLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 108 bits (270), Expect = 2e-27
Identities = 47/240 (19%), Positives = 80/240 (33%), Gaps = 16/240 (6%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTN---LLGCCCE 127
VY + + + A+K ++ L E + + +
Sbjct: 19 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
D+ + + M L HL A + LE+ ++ +Y DL
Sbjct: 79 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFV-VYRDLKP 135
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN--LAFTPPEYLRTGR-VTPESVIYSFGTL 244
IL DE G+ R+S GL + K +++ + PE L+ G + +S G +
Sbjct: 136 ANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
L LL G H + + LT + + D EL L LQ + R
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (268), Expect = 2e-27
Identities = 43/237 (18%), Positives = 86/237 (36%), Gaps = 18/237 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ---FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V+ + N R A+K + +Q +E + + + + + G + +
Sbjct: 19 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 78
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
++ +Y+ L ++ + + ALEY SK +Y DL I
Sbjct: 79 IFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENI 135
Query: 191 LFDEDGNPRLSTFGLMKNSRD-GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
L D++G+ +++ FG K D + + PE + T +SFG L+ ++L
Sbjct: 136 LLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT--ELVRLASRCLQYEPRERP 304
+G D N + L + ++ L SR + + +R
Sbjct: 196 AGYTPFY--------DSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-27
Identities = 46/242 (19%), Positives = 84/242 (34%), Gaps = 22/242 (9%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP----RQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V+ + + + A+K + +E+ + LT++ +
Sbjct: 17 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
V EY+ L H+ H + + L++ SKG +Y DL
Sbjct: 77 NLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKGI-VYRDLKLDN 133
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT----PPEYLRTGRVTPESVIYSFGTLL 245
IL D+DG+ +++ FG+ K + G + + T PE L + +SFG LL
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193
Query: 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRER 303
++L G+ ++ + L S E L + EP +R
Sbjct: 194 YEMLIGQSPFH--------GQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245
Query: 304 PN 305
Sbjct: 246 LG 247
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 54/272 (19%), Positives = 94/272 (34%), Gaps = 35/272 (12%)
Query: 75 VVYKGKL--------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNR-LTNLLGC 124
V + ++AVK A D + E + + ++ + NLLG
Sbjct: 28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87
Query: 125 CCEGDERLLVAEYMPNETLAKHLFHWETHP--------------MKWAMRLRVVLHLAQA 170
C + ++ EY L ++L + + +A+
Sbjct: 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 147
Query: 171 LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPP 224
+EY SK ++ DL A +L ED +++ FGL ++ Y + + P
Sbjct: 148 MEYLASKKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
E L T +S ++SFG LL ++ + P + L L +
Sbjct: 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGHRMDKPSNC 262
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
EL + C P +RP K LV L +
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-26
Identities = 38/249 (15%), Positives = 77/249 (30%), Gaps = 19/249 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ------FLEEARSVGQLRNNRLTNLLGCCCE 127
VV K + + A K + R+ E + ++++ + L
Sbjct: 25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+ +L+ E + L E + + + + Y S A + DL
Sbjct: 85 KTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQIA-HFDLKP 141
Query: 188 YRILFDEDGNPR----LSTFGLMKNSRDGKSYSTNL---AFTPPEYLRTGRVTPESVIYS 240
I+ + P+ + FGL G + F PE + + E+ ++S
Sbjct: 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
G + LLSG + + E ++ + R L +P
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAV--NYEFEDEYFSNTSALAKDFIRRLLVKDP 259
Query: 301 RERPNPKSL 309
++R +
Sbjct: 260 KKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 2e-25
Identities = 50/248 (20%), Positives = 93/248 (37%), Gaps = 27/248 (10%)
Query: 75 VVYKGK-LENQRRIAVKRFNR------MAWPDPRQFLEEARSVGQLRNN--RLTNLLGCC 125
VY G + + +A+K + P+ + E + ++ + + LL
Sbjct: 19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78
Query: 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185
D +L+ E E ++ + + +A+ +C + G L+ D+
Sbjct: 79 ERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGV-LHRDI 136
Query: 186 NAYRILFDED-GNPRLSTFGLMKNSRDG--KSYSTNLAFTPPEYLRTGRVTPESV-IYSF 241
IL D + G +L FG +D + ++PPE++R R S ++S
Sbjct: 137 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196
Query: 242 GTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
G LL D++ G P H ++IR + F +E L CL P
Sbjct: 197 GILLYDMVCGDI-PFEHDEEIIRGQVF-----------FRQRVSSECQHLIRWCLALRPS 244
Query: 302 ERPNPKSL 309
+RP + +
Sbjct: 245 DRPTFEEI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (251), Expect = 2e-25
Identities = 40/290 (13%), Positives = 82/290 (28%), Gaps = 32/290 (11%)
Query: 63 NIVSEH-------GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR 114
N+V H GE + V+++G L N +++A+K R + D Q +E R+ L
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA 58
Query: 115 N-NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY 173
+ N+ EG +LV + + L + ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 174 CTSKGRALYHDLNAYRILFDE-----DGNPRLSTFGLMKNSRDGKSYSTN---------- 218
K +Y D+ L + FG++K RD +
Sbjct: 117 IHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 219 -LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT--DSC 275
+ + + + G + + L G + + ++ S
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSIS 325
+ E + P+ L S + + +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 6e-25
Identities = 41/267 (15%), Positives = 79/267 (29%), Gaps = 23/267 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN-NRLTNLLGCCCEGDERL 132
+Y G + +A+K Q E++ ++ + + C EGD +
Sbjct: 22 DIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
+V E + LF++ + L + + +EY SK ++ D+ L
Sbjct: 80 MVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF-IHRDVKPDNFLM 136
Query: 193 DEDGNPRL---STFGLMKNSRDGKSYSTN-----------LAFTPPEYLRTGRVTPESVI 238
L FGL K RD +++ + + +
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196
Query: 239 YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD--SCLEGQFTDDDGTELVRLASRCL 296
S G +L+ G R + ++ S +E + C
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 256
Query: 297 QYEPRERPNPKSLVTALSPLQKETEFS 323
++P+ L L FS
Sbjct: 257 SLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 3e-24
Identities = 39/271 (14%), Positives = 94/271 (34%), Gaps = 37/271 (13%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
+V N+ R+A+K+ + ++ L E + + + R+ + +
Sbjct: 23 MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82
Query: 133 LVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
+ Y+ + L+ +T + + + + L+Y S L+ DL +L
Sbjct: 83 MKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV-LHRDLKPSNLL 141
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYST-------NLAFTPPEYLRTGRVTPESV-IYSFGT 243
+ + ++ FGL + + ++ + PE + + +S+ I+S G
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE-------------------------G 278
+L ++LS + I P + L +L E
Sbjct: 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + ++ + L + L + P +R +
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 97.3 bits (241), Expect = 5e-24
Identities = 44/276 (15%), Positives = 95/276 (34%), Gaps = 33/276 (11%)
Query: 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNL 121
+ + GE VVYK + A+K+ + P + E + +L+++ + L
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
+LV E++ + L ++ +L L + YC + L
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR-VL 122
Query: 182 YHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP-----PEYLRTGRVTPES 236
+ DL +L + +G +++ FGL + T+ T + + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 237 VIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG------------------ 278
I+S G + ++++G + P + R ++L +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 279 -----QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
F + L S+ L+ +P +R K
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 5e-24
Identities = 46/268 (17%), Positives = 82/268 (30%), Gaps = 36/268 (13%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPD-----PRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYK + + +A+K+ + R L E + + +L + + LL
Sbjct: 13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
LV ++M + + + + + +L Q LEY + DL
Sbjct: 73 SNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL-HRDLKPN 129
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT-----PPEYLRTGRVTPESVIYSFGT 243
+L DE+G +L+ FGL K+ T+ T P +++ G
Sbjct: 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE----------------------GQFT 281
+L +LL P + R + L E
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSL 309
G +L+ L + P R
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 6e-23
Identities = 39/249 (15%), Positives = 77/249 (30%), Gaps = 20/249 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCC----CEG 128
V + Q + A+K D + E + + ++
Sbjct: 27 KVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L+V E + L + ++ + +A++Y S A + D+
Sbjct: 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA-HRDVKPE 140
Query: 189 RILFD---EDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESVIYSFG 242
+L+ + +L+ FG K + S +T + PE L + ++S G
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200
Query: 243 TLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEP 300
++ LL G S+ I + E + E+ L L+ EP
Sbjct: 201 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 260
Query: 301 RERPNPKSL 309
+R
Sbjct: 261 TQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 8e-23
Identities = 48/242 (19%), Positives = 87/242 (35%), Gaps = 17/242 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNR---MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V + R A+K + +A + + E+R + R+ LT L D
Sbjct: 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
V EY L HL + A + ALEY S+ +Y D+ +
Sbjct: 80 LCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHSRDV-VYRDIKLENL 136
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLL 246
+ D+DG+ +++ FGL K + TP PE L + G ++
Sbjct: 137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 247 DLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306
+++ G+ + + + + L E +F E L + L+ +P++R
Sbjct: 197 EMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
Query: 307 KS 308
Sbjct: 251 GP 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 2e-22
Identities = 53/272 (19%), Positives = 89/272 (32%), Gaps = 43/272 (15%)
Query: 75 VVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER-- 131
VVY+ KL ++ +A+K+ + D R E + + +L + + L E+
Sbjct: 35 VVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90
Query: 132 ----LLVAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSKGRALYH-DL 185
LV +Y+P + + + L ++L Y S G + H D+
Sbjct: 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDI 148
Query: 186 NAYRILFDEDGNP-RLSTFGLMKNSRDGKSYSTNLAFT----PPEYLRTGRVTPESVIYS 240
+L D D +L FG K G+ + + P T ++S
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWS 208
Query: 241 FGTLLLDLLSGKHI----PPSHALDLI-------------------RDRNLQMLTDSCLE 277
G +L +LL G+ I L I + +
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 268
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
F E + L SR L+Y P R P
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 2e-22
Identities = 52/266 (19%), Positives = 99/266 (37%), Gaps = 33/266 (12%)
Query: 75 VVYKGK-LENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VVYK + +A+K R + P + E + +L + + LL ++
Sbjct: 17 VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
LV E++ ++ L K + + + + L Q L +C S R L+ DL +L
Sbjct: 77 YLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLL 134
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT-----PPEYLRTGRVTPESVIYSFGTLLL 246
+ +G +L+ FGL + T+ T P L + I+S G +
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFA 194
Query: 247 DLLSGKHI-PPSHALDLIRD--RNLQMLTDSCLEGQFTDDD------------------- 284
++++ + + P +D + R L + G + D
Sbjct: 195 EMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254
Query: 285 -GTELVRLASRCLQYEPRERPNPKSL 309
+ L S+ L Y+P +R + K+
Sbjct: 255 LDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 6e-22
Identities = 47/281 (16%), Positives = 88/281 (31%), Gaps = 36/281 (12%)
Query: 64 IVSEHGEKAPNVVYKGK--LENQRRIAVKRFNRMAWPD--PRQFLEEA---RSVGQLRNN 116
V+E GE A V+K + R +A+KR + P + E R + +
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 117 RLTNLLGCCCEGDERLLVAEYMPNETLA----KHLFHWETHPMKWAMRLRVVLHLAQALE 172
+ L C + E + +L + ++ L + L+
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 173 YCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRT 229
+ S ++ DL IL G +L+ FGL + + ++ L + PE L
Sbjct: 131 FLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 230 GRVTPESVIYSFGTLLLDLLSGKHI---------------------PPSHALDLIRDRNL 268
++S G + ++ K + D+ R
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ +F D L +CL + P +R + S
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 1e-21
Identities = 36/267 (13%), Positives = 82/267 (30%), Gaps = 33/267 (12%)
Query: 75 VVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
V ++A+K+ R + ++ E R + +R+ + LL +
Sbjct: 33 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 132 LLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
++ + + +V + + L Y + G + DL
Sbjct: 93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII-HRDLKPGN 151
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--TPPEYLRTGRVTPESVIYSFGTLLLD 247
+ +ED ++ FGL + + + + P L R T I+S G ++ +
Sbjct: 152 LAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211
Query: 248 LLSGKHI-------------------PPSHALDLIRDRNLQMLTDSCLE------GQFTD 282
+++GK + PP+ + ++ + E
Sbjct: 212 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271
Query: 283 DDGTELVRLASRCLQYEPRERPNPKSL 309
+ V L + L + +R
Sbjct: 272 NASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 3e-20
Identities = 40/267 (14%), Positives = 78/267 (29%), Gaps = 35/267 (13%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
V+K K E +A+KR + P L E + +L++ + L +
Sbjct: 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76
Query: 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
LV E+ + F + + + L + L +C S+ L+ DL +L
Sbjct: 77 TLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV-LHRDLKPQNLL 133
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT-----PPEYLRTGRVTPESVIYSFGTLLL 246
+ +G +L+ FGL + + T P + ++S G +
Sbjct: 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 247 DLLSGKHIP------------------------PSHALDLIRDRNLQMLTDSCLEGQFTD 282
+L + L + M +
Sbjct: 194 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253
Query: 283 DDGTELVRLASRCLQYEPRERPNPKSL 309
L L+ P +R + +
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.2 bits (215), Expect = 5e-20
Identities = 43/236 (18%), Positives = 78/236 (33%), Gaps = 14/236 (5%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ---FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V K E+ A+K ++ +Q L E R + + L L +
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
+V EY+ + HL + EY S +Y DL +
Sbjct: 116 LYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENL 172
Query: 191 LFDEDGNPRLSTFGLMKNSRD-GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
L D+ G +++ FG K + + PE + + ++ G L+ ++
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+G PP A I+ + +F ++L L LQ + +R
Sbjct: 233 AGY--PPFFADQPIQ----IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 8e-20
Identities = 47/292 (16%), Positives = 94/292 (32%), Gaps = 49/292 (16%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTN 120
+++ G+ V+K + + +++A+K+ P L E + + L++ + N
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 121 LLGCCCEGDER--------LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALE 172
L+ C LV ++ ++ + RV+ L L
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLNGLY 131
Query: 173 YCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------LAFTPP 224
Y L+ D+ A +L DG +L+ FGL + K+ N L + PP
Sbjct: 132 YIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 225 EYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283
E L R P ++ G ++ ++ + I + Q+ E D
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 284 DGT--------------------------ELVRLASRCLQYEPRERPNPKSL 309
+ + L + L +P +R +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 1e-17
Identities = 43/246 (17%), Positives = 79/246 (32%), Gaps = 21/246 (8%)
Query: 75 VVYKGKL----ENQRRIAVKRFNRMAWPD----PRQFLEEARSVGQLRNNRLTNLLGCCC 126
V+ + + + A+K + E + + +R + L
Sbjct: 39 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98
Query: 127 EGDERLLVA-EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185
+ + +L + +Y+ L HL E V + ALE+ G +Y D+
Sbjct: 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--YVGEIVLALEHLHKLG-IIYRDI 155
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT-------GRVTPESVI 238
IL D +G+ L+ FGL K ++ EY+
Sbjct: 156 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 215
Query: 239 YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+S G L+ +LL+G P + E + + L R L
Sbjct: 216 WSLGVLMYELLTGA--SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 299 EPRERP 304
+P++R
Sbjct: 274 DPKKRL 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.5 bits (187), Expect = 3e-16
Identities = 41/278 (14%), Positives = 83/278 (29%), Gaps = 33/278 (11%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTN 120
+S G A V + R+AVK+ +R + ++ E R + +++ +
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKG 178
LL + L + + + ++ + + L+Y S
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 179 RALYHDLNAYRILFDEDGNPRLSTFGL--MKNSRDGKSYSTNLAFTPPEYLRTGRVTPES 236
+ DL + +ED ++ FGL + +T P L
Sbjct: 142 II-HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 237 VIYSFGTLLLDLLSGKH-------------------IPPSHALDLIRDRNLQMLTDSCLE 277
I+S G ++ +LL+G+ P + L I + + S +
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 278 ------GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
V L + L + +R
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 74.1 bits (181), Expect = 1e-15
Identities = 39/276 (14%), Positives = 88/276 (31%), Gaps = 50/276 (18%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERL 132
V++ + N ++ VK + ++ E + + LR + L + R
Sbjct: 50 EVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106
Query: 133 --LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
LV E++ N + + + + +AL+YC S G + D+ + +
Sbjct: 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIM-HRDVKPHNV 160
Query: 191 LFDEDGNP-RLSTFGLMKNSRDGKSYS----TNLAFTPPEYLRTGRVTPESVIYSFGTLL 245
+ D + RL +GL + G+ Y+ + P + ++S G +L
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 246 LDLLSGKH--------------------------------IPPSHALDLIRDRNLQMLTD 273
++ K I + I R+ + +
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + E + + L+Y+ + R +
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 70.4 bits (171), Expect = 3e-14
Identities = 39/299 (13%), Positives = 84/299 (28%), Gaps = 65/299 (21%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
V+ K + N +A+K R +E + + ++ + T +LL
Sbjct: 28 TVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86
Query: 134 VAEYMPNETLAKHLFHWETHPMKW--------------AMRLRVVLHLAQALEYCTSKGR 179
+ +E ++ L L+Y +
Sbjct: 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 146
Query: 180 ALYHDLNAYRILFDEDGNP------RLSTFGLMKNSRDGKSYS-TNLAFTPPEYLRTGRV 232
++ D+ +L + +P +++ G + + S + PE L
Sbjct: 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPW 206
Query: 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG-------------- 278
+ I+S L+ +L++G + + + L G
Sbjct: 207 GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266
Query: 279 ----------------------------QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+F+ D+ E+ S LQ +PR+R + L
Sbjct: 267 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.7 bits (164), Expect = 2e-13
Identities = 39/294 (13%), Positives = 88/294 (29%), Gaps = 54/294 (18%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTN 120
+ G A +V R +A+K+ +R ++ E + + + + +
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 121 LLGCCC------EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYC 174
LL E + LV E M + ++ + +++
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKHL 135
Query: 175 TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGR 231
S G ++ DL I+ D ++ FGL + + + + PE +
Sbjct: 136 HSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 232 VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE-------------- 277
I+S G ++ +++ K + P ++ ++ L C E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 278 ----------------------GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ ++ L S+ L +P +R +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 47.1 bits (111), Expect = 5e-07
Identities = 17/147 (11%), Positives = 37/147 (25%), Gaps = 25/147 (17%)
Query: 75 VVYKGKLENQRRIAVKRFN----------RMAWPDPRQFLEEARSVGQLRNNRLTNLLGC 124
V+ E VK F A + L L G
Sbjct: 15 AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74
Query: 125 CC----EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
+ ++ E + E + ++ V+ + + + +
Sbjct: 75 AVPKVYAWEGNAVLMELI---------DAKELYRVRVENPDEVLDMILEEVAKFYHR-GI 124
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMK 207
++ DL+ Y +L + + F
Sbjct: 125 VHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.78 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=388.41 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=205.9
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
++|++++.||+|+||+||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5678888999999999999999888899999997644 456789999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----Cc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----KS 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~~ 214 (334)
+|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 84 ~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 84 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccc-eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999998864 4467889999999999999999999999 999999999999999999999999998765432 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch-hhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..||+.|+|||++.+..++.++||||||+++|||+|++.|+... ....+..... .......+...++++.+|+.
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-----~~~~~~~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-----TGFRLYKPRLASTHVYQIMN 236 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-----HTCCCCCCTTSCHHHHHHHH
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----hcCCCCCccccCHHHHHHHH
Confidence 46788999999999999999999999999999999976555433 2222221111 11222334555678999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+||+.||++|||++++++.|+++.++
T Consensus 237 ~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=386.68 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=204.9
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
.+.|++.+.||+|+||.||+|.+++ .||||+++.... ...+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4667888899999999999998754 599999975432 234678899999999999999999998754 56899999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 y~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~-ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 84 WCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred cCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999864 4457999999999999999999999999 999999999999999999999999998764321
Q ss_pred --CcccccccccCcccccCC---CCCCccchhhhHHHHHHHHhCCCCCCchhhHH-hhhcccccccccccCCCCCchhHH
Q 019905 213 --KSYSTNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....||+.|||||++.+. .|+.++|||||||++|||+||+.||....... ...........+. ....+...++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~ 240 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-LSKVRSNCPK 240 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-GGGSCTTCCH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-chhccccchH
Confidence 245689999999999643 48999999999999999999999986532221 1111111111111 1123445567
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
++.+|+.+||+.||.+|||+.++++.|+.+.++.
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 8999999999999999999999999999987643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-56 Score=390.22 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=217.0
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.++|++.++||+|+||+||+|.+. +++.||||++.... ...+++.+|++++++++||||+++++++..++..+++|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 456788889999999999999975 47899999997654 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC----
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 213 (334)
+++|+|.+++.......+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC-cccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 99999999997656678999999999999999999999999 9999999999999999999999999998755432
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchh-hHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
...+++.|+|||++.+..++.++||||||+++|||++|+.||.... ...+.. ..........+...++++.+|
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~-----~i~~~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKDYRMERPEGCPEKVYEL 248 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-----HHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH-----HHhcCCCCCCCccchHHHHHH
Confidence 2346789999999999999999999999999999999887765432 221111 111122233455667799999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhccccccCC
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l~~~~~ 321 (334)
+.+||+.||.+|||+.++++.|+.+.++..
T Consensus 249 i~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence 999999999999999999999998876654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=385.08 Aligned_cols=244 Identities=20% Similarity=0.265 Sum_probs=208.9
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|+++++||+|+||+||+|.. .+|+.||||.+........+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 588899999999999999995 4689999999986665667789999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----Ccc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~ 215 (334)
+|+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 101 gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp TCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9999998853 57999999999999999999999999 999999999999999999999999999865432 345
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (334)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ........+...+.++.+|+.+|
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHHHH
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHHHH
Confidence 689999999999999999999999999999999999999875433222111111 11111223455677899999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 019905 296 LQYEPRERPNPKSLVT 311 (334)
Q Consensus 296 l~~dp~~Rps~~~~l~ 311 (334)
|+.||.+|||+.++++
T Consensus 254 L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQ 269 (293)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=385.89 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=212.1
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+..|++++.||+|+||.||+|.++++..||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46788889999999999999999888899999997644 456789999999999999999999998754 5679999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~ 213 (334)
++|+|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~-ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 9999999886544456999999999999999999999999 999999999999999999999999999865443 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhH-HhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...+|+.|+|||++.+..++.++||||||+++|||+||+.|+...... ...... ........+...++++.+|+
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----ERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-----HTTCCCCCCTTCCHHHHHHH
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HhcCCCCCcccChHHHHHHH
Confidence 346788999999999888999999999999999999987766543221 111111 11112233455667899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccccC
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKET 320 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~~ 320 (334)
.+||+.||++|||++++++.|+++..++
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 9999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=380.63 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=209.1
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCC---CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
++|++++.||+|+||+||+|..+ +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999974 5889999998632 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--C
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--K 213 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 213 (334)
||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 9999999999987 3457999999999999999999999999 999999999999999999999999999866543 3
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...++...++++.+|+.
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EFTFPDFVTEGARDLIS 236 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCCCCTTSCHHHHHHHH
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCccCCHHHHHHHH
Confidence 457899999999999999999999999999999999999999765444333221111 11244556779999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.||.+|||++++++
T Consensus 237 ~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHHc
Confidence 999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-56 Score=388.88 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=201.7
Q ss_pred CcccccccCCCcCccEEEEEEeCC-C---CEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLEN-Q---RRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
+.|++.+.||+|+||+||+|.++. + ..||||.+...... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777889999999999999643 2 36899998754422 235689999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCC-
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 213 (334)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC-CccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999999999998864 4457999999999999999999999999 9999999999999999999999999998654321
Q ss_pred --------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 214 --------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 214 --------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
...+|+.|+|||.+.+..++.++|||||||++|||+| |..||.......+...... ......+...
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-----~~~~~~~~~~ 258 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-----DYRLPPPMDC 258 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----TCCCCCCTTC
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCccc
Confidence 2346789999999999999999999999999999998 7777765443333221111 1122344556
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.++.+|+.+||+.||.+|||+.++++.|+++.++
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 77899999999999999999999999999988753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=373.57 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=212.0
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
++++++++||+|+||+||+|.++++..||||.++... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5677889999999999999999888899999998655 356789999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----Cc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----KS 214 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~~ 214 (334)
+|+|..++.. ....+++..+..++.|+++||.|||+++ |+||||||+||++++++.+||+|||++...... ..
T Consensus 83 ~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~-iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 83 NGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp TEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT-BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcC-cccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9999998764 4457889999999999999999999999 999999999999999999999999999754432 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..+|..|+|||.+.+..++.++||||||+++|||+| |+.||.......+...... ......|...++.+.+|+.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-----~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-----GLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-----TCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-----CCCCCCcccccHHHHHHHH
Confidence 457889999999999999999999999999999998 6777765444333322111 1222345566678999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPL 316 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l 316 (334)
+||+.||++|||++++++.|.++
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-56 Score=381.21 Aligned_cols=246 Identities=19% Similarity=0.177 Sum_probs=201.7
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCC-CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
++|++++.||+|+||+||+|... +++.||||.+..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46889999999999999999964 589999999975432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC------
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD------ 211 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~------ 211 (334)
+++|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|.....
T Consensus 85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~-IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC-CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999986 4567999999999999999999999999 99999999999999999999999999985432
Q ss_pred CCcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 212 GKSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.....||+.|||||++.+..+ +.++|||||||++|+|++|+.||............ ..............++++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHH
Confidence 234578999999999988776 57899999999999999999998654221111000 01111111122345678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||.+|||++++++
T Consensus 239 li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=383.22 Aligned_cols=246 Identities=16% Similarity=0.197 Sum_probs=206.8
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (334)
.|++++.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 4788899999999999999964 688999999987665556788999999999999999999999999999999999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CCcc
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSY 215 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~ 215 (334)
+|+|.+++.. ..+++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 93 ~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~~-ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 93 GGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp TEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 9999998764 3467999999999999999999999999 99999999999999999999999999875432 2356
Q ss_pred cccccccCccccc-----CCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 216 STNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 216 ~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.||+.|+|||++. +..|+.++|||||||++|+|++|+.||............... .......+...++++.+
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHHHH
Confidence 7899999999984 445899999999999999999999998664332222111111 11112234556779999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 019905 291 LASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~~~l~ 311 (334)
|+.+||+.||.+|||+.++++
T Consensus 248 li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-55 Score=382.27 Aligned_cols=243 Identities=20% Similarity=0.233 Sum_probs=205.2
Q ss_pred ccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|+.+++||+|+||+||+|.. .+++.||||.+........ +.+.+|++++++++||||+++++++..++..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 77888999999999999995 4678999999976543332 4578899999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCCCcccc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 217 (334)
+++|+|..++. ...++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........|
T Consensus 97 ~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~G 173 (309)
T d1u5ra_ 97 CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG 173 (309)
T ss_dssp CSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred cCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEECCCCCEEEeecccccccCCCCcccc
Confidence 99998876665 4567999999999999999999999999 99999999999999999999999999998877778899
Q ss_pred cccccCcccccC---CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 218 NLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 218 ~~~y~aPE~~~~---~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
|+.|||||++.+ ..|+.++|||||||++|+|++|..||.............. .......+...++++.+|+.+
T Consensus 174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSCTTSCHHHHHHHHH
T ss_pred CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCCCHHHHHHHHH
Confidence 999999999964 3589999999999999999999999875433222211111 111112233456789999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 019905 295 CLQYEPRERPNPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~ 311 (334)
||+.||.+|||++++++
T Consensus 250 ~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HTCSSGGGSCCHHHHTT
T ss_pred HCcCChhHCcCHHHHHh
Confidence 99999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=376.61 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=213.9
Q ss_pred CCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
+.++++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++||||+++++++.. +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46788899999999999999999888899999997554 456789999999999999999999999854 5689999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-----C
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-----~ 213 (334)
++|+|..++.......+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh-eecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 9999999887545567999999999999999999999999 999999999999999999999999999765432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHH-hhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...+|+.|+|||++....++.++||||||+++|||++|+.|+....... ....... ......+...++++.+|+
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLM 247 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----TCCCCCCTTSCHHHHHHH
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----cCCCCCCcccCHHHHHHH
Confidence 3457899999999999999999999999999999999877765432221 1111111 112234556677899999
Q ss_pred HHhhhcCCCCCCCHHHHHHHhccccccCCCCCCh
Q 019905 293 SRCLQYEPRERPNPKSLVTALSPLQKETEFSISP 326 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~p 326 (334)
.+||+.||++|||+++|++.|+....+...+.+|
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 9999999999999999999999988776655554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=385.60 Aligned_cols=249 Identities=19% Similarity=0.236 Sum_probs=202.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
++|+++++||+|+||+||+|... +++.||+|+++...... ...+.+|+.++++++||||++++++|..++..++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46888899999999999999964 68899999997654333 45788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCceecccCCCCeeecCCCCeeEcCCCCCccCCC--CCc
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKS 214 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~ 214 (334)
+++|+|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|....+ ...
T Consensus 86 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 86 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred CCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC-EEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 999999999973 45799999999999999999999974 7 99999999999999999999999999985432 345
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------------
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------------- 269 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~------------------------- 269 (334)
..||+.|+|||++.+..|+.++||||+||++|||++|+.||..............
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 6899999999999999999999999999999999999999865422211000000
Q ss_pred -------------cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 -------------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...............+.++.+|+.+||+.||.+|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000111224578999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-54 Score=377.74 Aligned_cols=246 Identities=17% Similarity=0.206 Sum_probs=193.9
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.|++++.||+|+||+||+|... +++.||||.+...... ....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3788899999999999999964 5889999999754422 2346778999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec---CCCCeeEcCCCCCccCCCC---
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~---~~~~~kl~Dfg~a~~~~~~--- 212 (334)
++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+||++. +++.+||+|||++......
T Consensus 90 ~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 90 SGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhce-eeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999996 4568999999999999999999999999 99999999999995 5789999999999865443
Q ss_pred CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
....||+.|+|||++.+..|+.++|||||||++|+|++|..||................. ..........++++.+|+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--EFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC--CCCTTTTTTSCHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--CCCCccccCCCHHHHHHH
Confidence 345789999999999999999999999999999999999999976644433322221111 111223345677899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||++++++
T Consensus 245 ~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHccCCHhHCcCHHHHhc
Confidence 9999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=375.61 Aligned_cols=248 Identities=17% Similarity=0.234 Sum_probs=197.2
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeee--CCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 133 (334)
.++|++++.||+|+||.||+|.. .+|+.||+|.+....... .+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 46788999999999999999996 468899999997654332 3458899999999999999999999864 456899
Q ss_pred EEecCCCCCHHHhhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC----CceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 134 VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKG----RALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~----~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ .|+||||||+|||++.++.+||+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988632 3567999999999999999999999853 29999999999999999999999999988
Q ss_pred cCCCC----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 208 NSRDG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 208 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .. ....+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~----~~-~~~~~~~ 237 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GK-FRRIPYR 237 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----TC-CCCCCTT
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc----CC-CCCCCcc
Confidence 65432 345789999999999999999999999999999999999999876544433322111 11 1123455
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.++++.+|+.+||+.||.+|||+.++++
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 6778999999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=372.83 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=202.2
Q ss_pred cccccccCCCcCccEEEEEEeCCC-----CEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLENQ-----RRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.++..+.||+|+||.||+|.++++ ..||||++....... ...+.+|++++++++||||+++++++...+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 355556679999999999996542 379999997544222 34688999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+.++++.+.+.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~-iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 88 TEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccc-cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999988764 4567999999999999999999999999 999999999999999999999999999764332
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ..+... .........+...+.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-----i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----INDGFRLPTPMDCPS 240 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----HHTTCCCCCCTTCBH
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-----HhccCCCCCchhhHH
Confidence 123568899999999999999999999999999999998776654322 111111 111122234555667
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 899999999999999999999999999988753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=376.15 Aligned_cols=242 Identities=18% Similarity=0.199 Sum_probs=206.4
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCC---CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
++|++++.||+|+||+||+|.. .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688999999999999999996 468999999986421 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC---
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 212 (334)
||+++|+|.+++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhcccc-EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999886 4467999999999999999999999999 999999999999999999999999999865422
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....||+.|+|||++.+..++.++|||||||++|+|++|..||............... ...++...++++.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------EYDFPEKFFPKAR 238 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------CCCCCTTCCHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC------CCCCCccCCHHHH
Confidence 2356899999999999999999999999999999999999999765444333222111 1124455677899
Q ss_pred HHHHHhhhcCCCCCCCHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLV 310 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l 310 (334)
+||.+||+.||.+|||++|++
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGT
T ss_pred HHHHHHccCCHhHCcCHHHHc
Confidence 999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-54 Score=383.04 Aligned_cols=249 Identities=18% Similarity=0.167 Sum_probs=210.5
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
++.|++++.||+|+||.||+|.. .+|+.||||++......+...+.+|+.++++++||||+++++++..++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45689999999999999999996 46899999999765433455788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec--CCCCeeEcCCCCCccCCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~--~~~~~kl~Dfg~a~~~~~~~-- 213 (334)
+++|+|.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 999999988753 3457999999999999999999999999 99999999999998 67899999999998766543
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...+|+.|+|||++.+..++.++|||||||++|+|++|..||................ ...........++++.+||
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--WEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--CCCCSSTTTTSCHHHHHHH
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCcccccCCCHHHHHHH
Confidence 3578999999999999999999999999999999999999997654433322211111 1112223345677899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||+.++++
T Consensus 264 ~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=372.39 Aligned_cols=249 Identities=20% Similarity=0.254 Sum_probs=203.4
Q ss_pred ccccc-cCCCcCccEEEEEEeC---CCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 62 ENIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 62 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
+.+.. +||+|+||.||+|.++ ++..||||.+...... ..+.+.+|++++++++||||+++++++.. +..++|||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 33444 4799999999999864 3457999999754422 24578899999999999999999999865 46899999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
|+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 89 MAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred eCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999998754 4467999999999999999999999999 999999999999999999999999999865432
Q ss_pred ---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 213 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
....+|+.|+|||++.+..++.++||||||+++|||+| |..||.......+..... .......+...++++
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-----~~~~~~~p~~~~~~l 241 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-----QGKRMECPPECPPEL 241 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-----TTCCCCCCTTCCHHH
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCcCCHHH
Confidence 23457889999999998899999999999999999998 788876543332221111 111223455667899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 289 VRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
.+|+.+||+.||++|||+.++++.|+....
T Consensus 242 ~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999876553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=369.88 Aligned_cols=242 Identities=21% Similarity=0.266 Sum_probs=197.6
Q ss_pred cCCCcCccEEEEEEeCC---CCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecCCCC
Q 019905 67 EHGEKAPNVVYKGKLEN---QRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (334)
Q Consensus 67 ~lg~G~~g~Vy~~~~~~---~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (334)
+||+|+||.||+|.+++ ++.||||+++...... .+.+.+|++++++++||||+++++++.. +..++||||+++|
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g 92 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 92 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCC
Confidence 58999999999998643 4689999997543222 3568999999999999999999999865 4578999999999
Q ss_pred CHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-------Cc
Q 019905 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-------KS 214 (334)
Q Consensus 142 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-------~~ 214 (334)
+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 93 ~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~~-iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhCC-cccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 9999987 4567999999999999999999999999 999999999999999999999999999865432 23
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
..||+.|+|||.+.+..++.++||||||+++|||++ |+.||.......+..... .......+...+.++.+|+.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-----~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----KGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCcccCHHHHHHHH
Confidence 457889999999999899999999999999999998 788876543332221111 11122345566779999999
Q ss_pred HhhhcCCCCCCCHHHHHHHhcccc
Q 019905 294 RCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
+||+.||.+|||++++++.|+...
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHH
Confidence 999999999999999999887653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=368.16 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=202.0
Q ss_pred CCCcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeee-CCeeeEEEe
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAE 136 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 136 (334)
+.+++++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3456788889999999999999985 6789999996533 45779999999999999999999999865 456899999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Ccc
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~ 215 (334)
|+++|+|.+++.......+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+|++|||++...... ...
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc-eeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 999999999997544456899999999999999999999998 999999999999999999999999999865443 345
Q ss_pred cccccccCcccccCCCCCCccchhhhHHHHHHHHhC-CCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 216 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
.++..|+|||++.+..++.++||||||+++|||+|+ ..|+.......+..... .......+...++++.+|+.+
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----KGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-----TTCCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----cCCCCCCCccCCHHHHHHHHH
Confidence 678899999999999999999999999999999995 55554433222222111 112233455667799999999
Q ss_pred hhhcCCCCCCCHHHHHHHhccccc
Q 019905 295 CLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 295 cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
||+.||.+|||+.++++.|+++++
T Consensus 236 cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-53 Score=380.53 Aligned_cols=248 Identities=18% Similarity=0.156 Sum_probs=208.3
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEecC
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
..|++++.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688889999999999999996 468899999997655444567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec--CCCCeeEcCCCCCccCCCCC---
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGK--- 213 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~--~~~~~kl~Dfg~a~~~~~~~--- 213 (334)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.......
T Consensus 106 ~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 106 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999854 3457999999999999999999999999 99999999999996 46789999999998765433
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...||+.|||||++.+..++.++|||||||++|+|++|..||................. ..........++++.+|+.
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW--NMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CSCCGGGGGCCHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCCCHHHHHHHH
Confidence 45789999999999999999999999999999999999999876543333222111110 1111222345678999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 019905 294 RCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rps~~~~l~ 311 (334)
+||+.||.+|||++++++
T Consensus 262 ~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHCCSSGGGSCCHHHHHH
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=366.15 Aligned_cols=243 Identities=19% Similarity=0.241 Sum_probs=196.1
Q ss_pred ccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeee----CCeeeEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLLV 134 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 134 (334)
++...+||+|+||+||+|... ++..||+|.+...... ..+.+.+|++++++++||||+++++++.. +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 355567899999999999964 5789999998754322 23568899999999999999999999865 3457999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecccCCCCeeec-CCCCeeEcCCCCCccCCCC
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDG 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dikp~Nili~-~~~~~kl~Dfg~a~~~~~~ 212 (334)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+++. |+||||||+|||++ +++.+||+|||++......
T Consensus 91 mE~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EeCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999996 34679999999999999999999998743 99999999999997 5789999999999865443
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhh-HHhhhcccccccccccCCCCCchhHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (334)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .......... ......+...++++.
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG----VKPASFDKVAIPEVK 243 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT----CCCGGGGGCCCHHHH
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC----CCCcccCccCCHHHH
Confidence 34678999999999875 599999999999999999999999864321 1121111111 111112333456899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 019905 290 RLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 290 ~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+|+.+||+.||++|||++++++
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHhC
Confidence 9999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=378.06 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=203.3
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC-C-----CEEEEEEecCCC-CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCC
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN-Q-----RRIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 129 (334)
+.+++++.+.||+|+||+||+|.+.. + ..||+|.+.... ......+.+|+.++.++ +|||||++++++...+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678888999999999999998643 2 369999986543 23346788999999998 8999999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWE---------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~ 188 (334)
..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-IiHRDlKp~ 193 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAAR 193 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCchh
Confidence 9999999999999999996422 135889999999999999999999999 999999999
Q ss_pred CeeecCCCCeeEcCCCCCccCCCCC------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhH
Q 019905 189 RILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALD 261 (334)
Q Consensus 189 Nili~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~ 261 (334)
||+++.++.+||+|||+|+...... ...+|+.|||||++.+..++.++|||||||++|||+| |..||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999997644322 3456889999999999999999999999999999998 78777653322
Q ss_pred HhhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhc
Q 019905 262 LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (334)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~ 314 (334)
.... ...........+...++++.+||.+||+.||++|||+++|++.|.
T Consensus 274 ~~~~----~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFY----KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHH----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH----HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1111 111111222345566779999999999999999999999999884
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=372.34 Aligned_cols=244 Identities=20% Similarity=0.245 Sum_probs=209.9
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC---CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.++|++++.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 45788999999999999999996 46899999999642 223457788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 212 (334)
|||+++|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++++|.+||+|||+++.....
T Consensus 84 ~ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhcC-ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999987 4467899999999999999999999999 999999999999999999999999999865432
Q ss_pred --CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 213 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
....||+.|+|||++.+..|+.++|||||||++|||++|..||............... ...+|...++++.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKS 234 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------CCCCCccCCHHHHH
Confidence 2457899999999999999999999999999999999999999876554443322221 12345566778999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHH
Q 019905 291 LASRCLQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 291 li~~cl~~dp~~Rps-----~~~~l~ 311 (334)
||.+||+.||.+||+ ++++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHhhccCCchhhcccccccHHHHHc
Confidence 999999999999995 778775
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=368.25 Aligned_cols=246 Identities=15% Similarity=0.161 Sum_probs=205.1
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC------ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.|++++.||+|+||+||+|.. .+|+.||||.+...... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 488899999999999999996 46899999999643321 24678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC----CeeEcCCCCCccC
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~----~~kl~Dfg~a~~~ 209 (334)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+|++|||++...
T Consensus 91 v~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~-ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcc-eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999873 357999999999999999999999999 99999999999998766 5999999999865
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.................. .....+...+.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~ 245 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEYFSNTSA 245 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSCH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCchhcCCCCH
Confidence 443 3457889999999999989999999999999999999999998765443332221111000 01111233456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
++.+||.+||+.||.+|||++++++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-52 Score=368.02 Aligned_cols=243 Identities=19% Similarity=0.230 Sum_probs=209.3
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC---CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 135 (334)
++|++++.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688999999999999999996 45899999999632 2334577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-Cc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KS 214 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~ 214 (334)
||+++|+|..++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccCc-EEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 9999999999887 4567889999999999999999999999 999999999999999999999999999876543 35
Q ss_pred ccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHHH
Q 019905 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (334)
Q Consensus 215 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (334)
..||+.|+|||++.+..|+.++|||||||++|+|++|+.||............... ...++...++++.+++.+
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------ELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------CCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHH
Confidence 67999999999999999999999999999999999999999776544333222211 113445567789999999
Q ss_pred hhhcCCCCCC-----CHHHHHH
Q 019905 295 CLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 295 cl~~dp~~Rp-----s~~~~l~ 311 (334)
||+.||.+|+ |++++++
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHT
T ss_pred HhhhCHHhccccchhhHHHHHc
Confidence 9999999996 8999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=363.06 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=197.4
Q ss_pred CCcccccccCCCcCccEEEEEEeCC--C--CEEEEEEecCCCCCC---hHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN--Q--RRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
..+|++++.||+|+||.||+|.++. + ..||||.+....... .+.+.+|+.++++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4668899999999999999998532 2 378999987543222 3578999999999999999999999965 467
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||++++++.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred heeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhCC-EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 899999999999998764 3456999999999999999999999999 99999999999999999999999999986543
Q ss_pred CC-------cccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCch
Q 019905 212 GK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (334)
Q Consensus 212 ~~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (334)
.. ...++..|+|||++.+..++.++||||||+++|||+| |..||.............. .......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~ 239 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----EGERLPRPED 239 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----SCCCCCCCTT
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh----CCCCCCCccc
Confidence 22 2346789999999999999999999999999999998 7888765544333222111 1112233455
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 284 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
.+.++.+|+.+||+.||++|||+.+|++.|++.+
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 6678999999999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=362.43 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=199.3
Q ss_pred CCcccccccCCCcCccEEEEEEeCC----CCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.++|++.+.||+|+||.||+|.+.. +..||||.+....... .+.+.+|++++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3568888999999999999998643 3468999986544222 356889999999999999999999985 467899
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccC-eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998764 4567899999999999999999999999 999999999999999999999999999764432
Q ss_pred ----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHHH
Q 019905 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (334)
Q Consensus 213 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (334)
....+|+.|+|||++.+..++.++||||||+++|||++ |..|+.......+...... ......+...++.
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-----GERLPMPPNCPPT 237 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----TCCCCCCTTCCHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHH
Confidence 23456889999999999999999999999999999998 6666654433322211111 1112345566779
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 288 l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.+||.+||+.||.+|||+.++++.|+.+.++
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999887653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=365.66 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=209.6
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC-CC--EEEEEEecCCC-CCChHHHHHHHHHHhcC-CCCCccceeeeeeeCCeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QR--RIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 132 (334)
+|+++++.+.||+|+||.||+|.+++ +. .||||++.... ....+.+.+|++++.++ +||||+++++++..++..+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 45678888889999999999999654 33 57889886433 33456789999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHhhccc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCe
Q 019905 133 LVAEYMPNETLAKHLFHW--------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~ 198 (334)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-ccccccccceEEEcCCCce
Confidence 999999999999998642 2467899999999999999999999999 9999999999999999999
Q ss_pred eEcCCCCCccCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCC-CchhhHHhhhccccccccc
Q 019905 199 RLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-PSHALDLIRDRNLQMLTDS 274 (334)
Q Consensus 199 kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~-~~~~~~~~~~~~~~~~~~~ 274 (334)
||+|||++...... ....+|..|+|||.+.+..++.++||||||+++|||++|..|| .......+......
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~----- 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----- 241 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-----
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-----
Confidence 99999998765432 2446789999999999999999999999999999999987654 33332222221111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
......+...++++.+||.+||+.||++|||++++++.|+++.++...
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 112234556678999999999999999999999999999998875543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-52 Score=360.04 Aligned_cols=253 Identities=18% Similarity=0.232 Sum_probs=203.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCCh---HHHHHHHHHHhcCCCCCccceeeeeeeCC----ee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGD----ER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 131 (334)
+.|++++.||+|+||+||+|.. .+++.||||.+......+. ..+.+|+++++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 3488889999999999999996 4688999999986554443 35889999999999999999999987643 37
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
|+||||+++++|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++..+++|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~-iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999886 3467999999999999999999999999 99999999999999999999999998764322
Q ss_pred -------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchh
Q 019905 212 -------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (334)
Q Consensus 212 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||................. ..........
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--IPPSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--CCGGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC--CCCchhccCC
Confidence 2345689999999999999999999999999999999999999876543333222111111 1111223445
Q ss_pred HHHHHHHHHHhhhcCCCCCC-CHHHHHHHhcccc
Q 019905 285 GTELVRLASRCLQYEPRERP-NPKSLVTALSPLQ 317 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rp-s~~~~l~~L~~l~ 317 (334)
++++.+++.+||+.||.+|| |++++++.|.++.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 67899999999999999999 8999999988764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=366.90 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=202.3
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCC----EEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 133 (334)
.+|++++.||+|+||+||+|.+. +|+ .||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888899999999999999864 333 68999986543 33467899999999999999999999999765 5678
Q ss_pred EEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-
Q 019905 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (334)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~- 212 (334)
+++|+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~-iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcC-cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 8899999999998865 5678999999999999999999999999 999999999999999999999999998865432
Q ss_pred -----CcccccccccCcccccCCCCCCccchhhhHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccCCCCCchhHH
Q 019905 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (334)
Q Consensus 213 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (334)
....||+.|+|||++.+..++.++||||||+++|||+| |..||.......+.... ........+...++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-----~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-----EKGERLPQPPICTI 240 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-----HHTCCCCCCTTBCH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----HcCCCCCCCcccCH
Confidence 22357899999999999999999999999999999999 55555543322222111 11112234556677
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 287 ~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
++.+|+.+||+.||.+|||+.++++.|+++.+
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999887653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-52 Score=363.22 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=206.9
Q ss_pred CCcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
.++|+++++||+|+||+||+|+++ +++.||||++....... .+.+.+|++++++++||||+++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 356888899999999999999864 35789999997544222 35689999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWE----------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~N 189 (334)
+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-ivHrDlKp~N 170 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRN 170 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-eEeeEEcccc
Confidence 99999999999999885321 234788999999999999999999999 9999999999
Q ss_pred eeecCCCCeeEcCCCCCccCCC------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCC-CCchhhHH
Q 019905 190 ILFDEDGNPRLSTFGLMKNSRD------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDL 262 (334)
Q Consensus 190 ili~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p-~~~~~~~~ 262 (334)
||++.++.+||+|||+++...+ .....+++.|+|||.+.+..++.++||||||+++|||++|..| |.......
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 9999999999999999874332 2234677899999999999999999999999999999999755 44332222
Q ss_pred hhhcccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccc
Q 019905 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (334)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~ 317 (334)
...... .. .....+...++++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 251 ~~~~v~----~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIYYVR----DG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHH----TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHH----cC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 221111 11 112345566678999999999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-51 Score=368.46 Aligned_cols=244 Identities=16% Similarity=0.177 Sum_probs=209.3
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCC---CCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
.++|++++.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 35789999999999999999996 46899999998632 223456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-C
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-K 213 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~-~ 213 (334)
|||+.+|+|..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 120 ~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999999999863 457999999999999999999999999 999999999999999999999999999876543 4
Q ss_pred cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHHH
Q 019905 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
...||+.|||||++.+..++.++|||||||++|+|++|..||................ ...+...++++.+|+.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------VRFPSHFSSDLKDLLR 270 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTCCHHHHHHHH
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC------CCCCccCCHHHHHHHH
Confidence 5678999999999999999999999999999999999999997664443332222111 1234556778999999
Q ss_pred HhhhcCCCCCC-----CHHHHHH
Q 019905 294 RCLQYEPRERP-----NPKSLVT 311 (334)
Q Consensus 294 ~cl~~dp~~Rp-----s~~~~l~ 311 (334)
+||+.||.+|+ |++++++
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccccccHHHHHc
Confidence 99999999994 8999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-52 Score=357.62 Aligned_cols=248 Identities=17% Similarity=0.160 Sum_probs=206.6
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC---------hHHHHHHHHHHhcCC-CCCccceeeeeee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---------PRQFLEEARSVGQLR-NNRLTNLLGCCCE 127 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 127 (334)
+.+|++++.||+|+||+||+|+. .+++.||||++....... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46788999999999999999996 468899999997544222 124778999999997 9999999999999
Q ss_pred CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
++..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999973 457999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCC---CcccccccccCcccccC------CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCC
Q 019905 208 NSRDG---KSYSTNLAFTPPEYLRT------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (334)
Q Consensus 208 ~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (334)
..... ....||..|+|||.+.+ ..++.++||||+||++|+|++|+.||................. ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~--~~~~ 236 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY--QFGS 236 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC--CCCC
Confidence 65542 34568999999999853 3478899999999999999999999987654433322221111 1112
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
......++++.+|+.+||+.||.+|||++++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 233456789999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=365.36 Aligned_cols=248 Identities=15% Similarity=0.192 Sum_probs=206.4
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
|+.|++++.||+|+||+||+|... +++.||+|.+.... .+...+.+|+++|+.++||||+++++++..++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 678999999999999999999964 67899999997543 2234678999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC--CCCeeEcCCCCCccCCCCC--
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRDGK-- 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~--~~~~kl~Dfg~a~~~~~~~-- 213 (334)
+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ...+||+|||++.......
T Consensus 83 ~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~-iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-CCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 999999999964 3347999999999999999999999999 999999999999984 4589999999998765433
Q ss_pred -cccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHHH
Q 019905 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (334)
Q Consensus 214 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (334)
...+++.|+|||.+.+..++.++|||||||++|+|++|..||.................. .........++++.+|+
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHHHTTSCHHHHHHH
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CChhhccCCCHHHHHHH
Confidence 346789999999999999999999999999999999999999776544333222111100 00001123456899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 019905 293 SRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 293 ~~cl~~dp~~Rps~~~~l~ 311 (334)
.+||+.||.+|||+.++++
T Consensus 239 ~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=365.34 Aligned_cols=246 Identities=15% Similarity=0.143 Sum_probs=198.0
Q ss_pred Cccccccc-CCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhc-CCCCCccceeeeeee----CCeee
Q 019905 60 AVENIVSE-HGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQ-LRNNRLTNLLGCCCE----GDERL 132 (334)
Q Consensus 60 ~~~~~~~~-lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~ 132 (334)
+.|+++++ ||+|+||+||+|.. .+++.||||++.. ...+.+|++++.+ .+||||++++++|.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46778765 89999999999996 5689999999853 4567889998655 589999999999865 45689
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC---CCCeeEcCCCCCccC
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNS 209 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~---~~~~kl~Dfg~a~~~ 209 (334)
+||||++||+|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||+++ .+.+||+|||++...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~-iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC-Cccccccccccccccccccccccccccceeeec
Confidence 9999999999999997544567999999999999999999999999 999999999999985 567999999999865
Q ss_pred CCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccC--CCCCchh
Q 019905 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE--GQFTDDD 284 (334)
Q Consensus 210 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 284 (334)
... ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||...................... .......
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 432 35678999999999999899999999999999999999999987653222221111111111111 1111245
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 285 ~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
++++.+|+.+||+.||++|||+.++++
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 678999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=358.04 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=204.8
Q ss_pred CCCcccccccCCCcCccEEEEEEeCC--------CCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeee
Q 019905 58 GFAVENIVSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCE 127 (334)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 127 (334)
+.+.|++.+.||+|+||.||+|.... +..||||++....... ...+.+|+..+.++ +||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34678889999999999999998532 2479999997654222 35677888888888 79999999999999
Q ss_pred CCeeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec
Q 019905 128 GDERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (334)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~ 193 (334)
++..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ ++||||||+|||++
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVT 169 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEC
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-EEeeeecccceeec
Confidence 999999999999999999996432 245899999999999999999999999 99999999999999
Q ss_pred CCCCeeEcCCCCCccCCC------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhC-CCCCCchhhHHhhhc
Q 019905 194 EDGNPRLSTFGLMKNSRD------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDR 266 (334)
Q Consensus 194 ~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg-~~p~~~~~~~~~~~~ 266 (334)
.++.+||+|||++..... .....+++.|+|||.+.+..|+.++||||||+++|||+++ ..||.......+...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999875432 2335678899999999999999999999999999999985 555554433332221
Q ss_pred ccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
.........+...++++.+|+.+||+.||.+|||+.++++.|+++..-
T Consensus 250 -----i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 250 -----LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -----HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111222234556677899999999999999999999999999988653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-51 Score=367.35 Aligned_cols=247 Identities=18% Similarity=0.173 Sum_probs=200.5
Q ss_pred CCcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHH---HHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLE---EARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
.++|++++.||+|+||.||+|... +|+.||||++.... ......+.+ ++.+++.++||||+++++++..++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 457888899999999999999964 58999999985321 112233333 46778888999999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC
Q 019905 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~ 211 (334)
++||||+++|+|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 83 ~ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~-iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHHCC-ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999997 3467889999999999999999999999 99999999999999999999999999986554
Q ss_pred C--CcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHH
Q 019905 212 G--KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (334)
Q Consensus 212 ~--~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (334)
. ....||+.|+|||++.. ..|+.++|||||||++|+|++|..||............ .... ......+...++++
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~--~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL--TMAVELPDSFSPEL 236 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSS--SCCCCCCSSSCHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hhcc--cCCCCCCCCCCHHH
Confidence 3 34679999999999975 45899999999999999999999998754322111100 0000 11123345567799
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHH
Q 019905 289 VRLASRCLQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 289 ~~li~~cl~~dp~~Rps-----~~~~l~ 311 (334)
.+||.+||+.||.+||| ++++++
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 99999999999999999 688874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=357.85 Aligned_cols=245 Identities=20% Similarity=0.223 Sum_probs=192.7
Q ss_pred ccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC-----hHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 64 IVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD-----PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
.++.||+|+||+||+|.. .+|+.||||++....... .+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 356679999999999996 458999999996543221 24688999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----C
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~ 213 (334)
+.++++..... ....+++..+..++.||+.||.|||+++ ++||||||+|||+++++.+||+|||++...... .
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc-eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 98777666554 4567899999999999999999999999 999999999999999999999999999765432 2
Q ss_pred cccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc--------c------ccccCC
Q 019905 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------T------DSCLEG 278 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~------~~~~~~ 278 (334)
...+|+.|+|||++.+. .|+.++|||||||++|+|++|..||................ . ......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45689999999998755 58999999999999999999998886543322211110000 0 000000
Q ss_pred C--------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 279 Q--------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 279 ~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
. .....++++.+|+.+||+.||++|||++|+|+
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 01234578999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=361.78 Aligned_cols=258 Identities=21% Similarity=0.255 Sum_probs=196.3
Q ss_pred cCCCcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeeeC
Q 019905 57 SGFAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (334)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 128 (334)
-..++|++++.||+|+||.||+|.+. +++.||||.+....... .+.+.+|...+.++ +|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34567889999999999999999853 24689999997543222 34577788877776 688999999988664
Q ss_pred -CeeeEEEecCCCCCHHHhhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec
Q 019905 129 -DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (334)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~ 193 (334)
...++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-ivHrDlKp~NILl~ 168 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLS 168 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-CcCCcCCccceeEC
Confidence 46899999999999999986421 235889999999999999999999999 99999999999999
Q ss_pred CCCCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCC-CCchhhHHhhhc
Q 019905 194 EDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDR 266 (334)
Q Consensus 194 ~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p-~~~~~~~~~~~~ 266 (334)
+++.+||+|||+++..... ....||+.|+|||++.+..++.++|||||||++|||++|..+ |...........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999754322 234688999999999999999999999999999999998754 433221111100
Q ss_pred ccccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
..........+...++++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 249 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 249 ----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp ----HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111112234455667899999999999999999999999999988643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=361.66 Aligned_cols=242 Identities=19% Similarity=0.249 Sum_probs=203.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCC---CCChHHHHHHHHHHh-cCCCCCccceeeeeeeCCeeeEE
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVG-QLRNNRLTNLLGCCCEGDERLLV 134 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 134 (334)
++|++++.||+|+||+||+|... +++.||||++.... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888899999999999999964 68999999996421 234456667777665 68999999999999999999999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC---
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--- 211 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--- 211 (334)
|||+++|+|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+|||+++++.+||+|||++.....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~~-iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999997 4457899999999999999999999999 99999999999999999999999999975433
Q ss_pred -CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHH
Q 019905 212 -GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (334)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...++...++++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d 232 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEAKD 232 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCccCCHHHHH
Confidence 23457899999999999999999999999999999999999999876544443322111 11344556778999
Q ss_pred HHHHhhhcCCCCCCCHH-HHH
Q 019905 291 LASRCLQYEPRERPNPK-SLV 310 (334)
Q Consensus 291 li~~cl~~dp~~Rps~~-~~l 310 (334)
|+.+||+.||.+|||+. +++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHhcccCCCCCcCHHHHHH
Confidence 99999999999999996 675
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=356.50 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=200.3
Q ss_pred ccCCCcCccEEEEEEeCCC----CEEEEEEecCCC-CCChHHHHHHHHHHhcCCCCCccceeeeeee-CCeeeEEEecCC
Q 019905 66 SEHGEKAPNVVYKGKLENQ----RRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAEYMP 139 (334)
Q Consensus 66 ~~lg~G~~g~Vy~~~~~~~----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 139 (334)
+.||+|+||+||+|.+.++ ..||||++.... ....+.+.+|++++++++||||++++|++.. ++..++||||++
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 4579999999999996432 358999997433 2223578999999999999999999999875 467899999999
Q ss_pred CCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC-------
Q 019905 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------- 212 (334)
Q Consensus 140 ~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~------- 212 (334)
+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 113 ~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~-iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 113 HGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp TCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred cCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC-cccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 9999998864 4556778899999999999999999999 999999999999999999999999998754332
Q ss_pred -CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhHHHHHHH
Q 019905 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (334)
Q Consensus 213 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (334)
....||..|+|||.+.+..++.++||||||+++|||++|+.||......... ...+.. ..+...+...++++.+|
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---~~~i~~-g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQ-GRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C---HHHHHT-TCCCCCCTTCCHHHHHH
T ss_pred cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc-CCCCCCcccCcHHHHHH
Confidence 2345788999999999999999999999999999999988887654322110 011111 11222344556789999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 292 ASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 292 i~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
+.+||+.||++|||+.++++.|+.+.+.
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=351.03 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=202.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
++|++++.||+|+||+||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4688889999999999999996 5689999999965432 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----C
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----G 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~ 212 (334)
|+. +.+.+.+.......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+..... .
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~-IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC-EEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 996 55555554445678999999999999999999999999 99999999999999999999999999875433 2
Q ss_pred CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc--------------cccccc--
Q 019905 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--------------MLTDSC-- 275 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~--------------~~~~~~-- 275 (334)
....||+.|+|||.+.... ++.++||||||+++|+|++|+.||.............. ......
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 3457899999999987766 57899999999999999999999875432211100000 000000
Q ss_pred cCCC-------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCCCCC
Q 019905 276 LEGQ-------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEFSIS 325 (334)
Q Consensus 276 ~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~~~~ 325 (334)
.... .....++++.+|+.+||+.||.+|||+.++++- ...++.+-|+|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~~~p~p 294 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKPVP 294 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTCCCCCC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccCCCCCC
Confidence 0000 012345689999999999999999999999873 23333344444
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=358.33 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=207.8
Q ss_pred CcccccccCCCcCccEEEEEEe------CCCCEEEEEEecCCCCCC-hHHHHHHHHHHhcC-CCCCccceeeeeeeCCee
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 131 (334)
.++++.+.||+|+||.||+|.+ .+++.||||+++...... ...+.+|+.++.++ +||||+++++++..+...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677888899999999999985 235789999997654222 34688999999999 699999999999999999
Q ss_pred eEEEecCCCCCHHHhhcccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCC
Q 019905 132 LLVAEYMPNETLAKHLFHWE----------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~ 195 (334)
+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ ++||||||+||+++.+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHG 181 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccccccccccccc
Confidence 99999999999999986422 236889999999999999999999999 9999999999999999
Q ss_pred CCeeEcCCCCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCch-hhHHhhhccc
Q 019905 196 GNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNL 268 (334)
Q Consensus 196 ~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~-~~~~~~~~~~ 268 (334)
+.++++|||.++..... ....+|+.|+|||.+.+..++.++||||||+++|||+|++.|+... ......
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~---- 257 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF---- 257 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH----
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence 99999999998865432 2345689999999999999999999999999999999966555432 111110
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
............+...+..+.+||.+||+.||.+|||+.++++.|++..++
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111111222233455667899999999999999999999999999887655
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=353.23 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=207.2
Q ss_pred CCcccccccCCCcCccEEEEEEeC------CCCEEEEEEecCCCCCC-hHHHHHHHHHHhcCCCCCccceeeeeeeCCee
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 131 (334)
.+++++.+.||+|+||+||+|.++ ++..||||++....... ...+.+|++++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 366788889999999999999863 25789999997543221 23588999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHhhccc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCC
Q 019905 132 LLVAEYMPNETLAKHLFHW--------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (334)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Df 203 (334)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++++||+||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeeceEcCCceeecCCceEEEeec
Confidence 9999999999999988632 2245788999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCC------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCC-CCchhhHHhhhccccccccccc
Q 019905 204 GLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRNLQMLTDSCL 276 (334)
Q Consensus 204 g~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~ 276 (334)
|+++..... ....+|+.|+|||.+.+..++.++||||||+++|||+||..+ +.......+..... +. .
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~----~~-~ 252 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM----EG-G 252 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH----TT-C
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----hC-C
Confidence 999754332 233578999999999999999999999999999999999654 43333222222111 11 1
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccc
Q 019905 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (334)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~ 318 (334)
....+...++.+.+++.+||+.||.+|||++++++.|++...
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 122345566789999999999999999999999999987753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-50 Score=349.00 Aligned_cols=249 Identities=18% Similarity=0.240 Sum_probs=199.9
Q ss_pred CcccccccCCCcCccEEEEEEeCCCCEEEEEEecCCC--CCChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEec
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 137 (334)
+.|+++++||+|+||+||+|..++|+.||||++.... ......+.+|+.++++++||||+++++++..++..+++|+|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4688999999999999999999889999999996543 22256789999999999999999999999999999999999
Q ss_pred CCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC----CC
Q 019905 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GK 213 (334)
Q Consensus 138 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~----~~ 213 (334)
+.++.+..+.. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||.+..... ..
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~-IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc-EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 98766666554 5678999999999999999999999999 99999999999999999999999999876443 23
Q ss_pred cccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccc--------------cc-------
Q 019905 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--------------ML------- 271 (334)
Q Consensus 214 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~--------------~~------- 271 (334)
...+++.|+|||.+.+.. ++.++||||||+++|||++|+.||.............. ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 446788999999997654 78999999999999999999999865422211111000 00
Q ss_pred --cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 272 --TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 272 --~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.............++++.+|+.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001123345678999999999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=353.30 Aligned_cols=253 Identities=16% Similarity=0.210 Sum_probs=194.1
Q ss_pred ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHH--HHHHHhcCCCCCccceeeeeeeCC----eeeEEE
Q 019905 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLE--EARSVGQLRNNRLTNLLGCCCEGD----ERLLVA 135 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~--e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 135 (334)
+.+.+.||+|+||.||+|++ +|+.||||++.... ...+.+ |+..+..++||||+++++++...+ ..++||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 45567789999999999997 56899999996432 334444 455556789999999999998653 578999
Q ss_pred ecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS--------KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 136 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--------~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
||+++|+|.+++.. ..+++..++.++.+++.||+|+|+ ++ |+||||||+|||++.++.+||+|||++.
T Consensus 81 Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~-IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-eeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999963 468999999999999999999996 46 9999999999999999999999999987
Q ss_pred cCCC--------CCcccccccccCcccccCCC------CCCccchhhhHHHHHHHHhCCCCCCchhh-------------
Q 019905 208 NSRD--------GKSYSTNLAFTPPEYLRTGR------VTPESVIYSFGTLLLDLLSGKHIPPSHAL------------- 260 (334)
Q Consensus 208 ~~~~--------~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~elltg~~p~~~~~~------------- 260 (334)
.... .....||+.|+|||++.+.. ++.++|||||||++|||+||..|+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 5432 22456899999999987643 56789999999999999999876532110
Q ss_pred --HHhhhccccccccccc-CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 261 --DLIRDRNLQMLTDSCL-EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 261 --~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
.............+.. ....+......+.+|+.+||+.||.+|||+.++++.|+++..+.++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 0011110010111110 0111223456799999999999999999999999999999877654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=348.19 Aligned_cols=237 Identities=20% Similarity=0.297 Sum_probs=196.9
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC------hHHHHHHHHHHhcCC--CCCccceeeeeeeCCe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD------PRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 130 (334)
+.|++.+.||+|+||+||+|.. .+++.||||.+....... ...+.+|+.++++++ ||||+++++++..++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 3588888899999999999996 468999999997543222 234668999999986 8999999999999999
Q ss_pred eeEEEecCCC-CCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-CCCeeEcCCCCCcc
Q 019905 131 RLLVAEYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKN 208 (334)
Q Consensus 131 ~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-~~~~kl~Dfg~a~~ 208 (334)
.++||||+.+ +++.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999975 57777776 3467999999999999999999999999 999999999999985 57899999999986
Q ss_pred CCCC--CcccccccccCcccccCCCC-CCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCchhH
Q 019905 209 SRDG--KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (334)
Q Consensus 209 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (334)
.... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +... ...++...+
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--i~~~----------~~~~~~~~s 228 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRG----------QVFFRQRVS 228 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHC----------CCCCSSCCC
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--Hhhc----------ccCCCCCCC
Confidence 5443 35678999999999987775 5679999999999999999998865421 1111 112334456
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 286 ~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
+++.+|+.+||+.||.+|||++++++
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 78999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=349.02 Aligned_cols=255 Identities=20% Similarity=0.226 Sum_probs=197.9
Q ss_pred CcccccccCCCcCccEEEEEEeC-C-CCEEEEEEecCCCC--CChHHHHHHHHHHhcC---CCCCccceeeeeee-----
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-N-QRRIAVKRFNRMAW--PDPRQFLEEARSVGQL---RNNRLTNLLGCCCE----- 127 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~----- 127 (334)
.+|+++++||+|+||+||+|... + ++.||||++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 56899999999999999999963 4 56799999864332 2234566788777665 79999999999853
Q ss_pred CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
....+++|||++++.+..... .....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346899999998766554433 25677899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCC---CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccc-------------
Q 019905 208 NSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML------------- 271 (334)
Q Consensus 208 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~------------- 271 (334)
..... ....||+.|+|||++.+..|+.++||||+||++|||++|..||................
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 65432 35678999999999999999999999999999999999999987653222111110000
Q ss_pred --------cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhccc
Q 019905 272 --------TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPL 316 (334)
Q Consensus 272 --------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l 316 (334)
.............++.+.+|+.+||+.||.+|||+.++++ .|+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0000011123445678999999999999999999999985 34444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=344.38 Aligned_cols=248 Identities=18% Similarity=0.235 Sum_probs=191.3
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC-ChHHHHHHHHHHhcCCCCCccceeeeeeeCC----eeeEE
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD----ERLLV 134 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 134 (334)
.|+++++||+|+||+||+|.. .+++.||||++...... ..+.+.+|+++|+.++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 488999999999999999985 57899999999754321 1346789999999999999999999987643 23455
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC---
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--- 211 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~--- 211 (334)
++|+.+++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++.....
T Consensus 89 ~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~-iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 666778999999953 47999999999999999999999999 99999999999999999999999999875432
Q ss_pred ----CCcccccccccCcccccC-CCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc-------------
Q 019905 212 ----GKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD------------- 273 (334)
Q Consensus 212 ----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 273 (334)
.....||+.|+|||++.. ..++.++||||+|+++|+|++|..||..................
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 234568899999999854 45789999999999999999999998654322111110000000
Q ss_pred ------cccC------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 019905 274 ------SCLE------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (334)
Q Consensus 274 ------~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 312 (334)
.... .......+.++.+|+.+||+.||.+|||++++|+-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00112345679999999999999999999999963
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=337.96 Aligned_cols=250 Identities=17% Similarity=0.201 Sum_probs=193.4
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCC--CChHHHHHHHHHHhcCCCCCccceeeeeee--------
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCE-------- 127 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 127 (334)
.+.|+++++||+|+||+||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46789999999999999999996 4689999999865432 234678899999999999999999998855
Q ss_pred CCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.+..+++|||+.++.+..... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~-ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC-EEecCcCchheeecCCCcEEeeecceee
Confidence 345789999998776655443 5567899999999999999999999999 9999999999999999999999999986
Q ss_pred cCCC--------CCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc---cc
Q 019905 208 NSRD--------GKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD---SC 275 (334)
Q Consensus 208 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~---~~ 275 (334)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.................. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 5432 2335689999999999766 5899999999999999999999888654322221111000000 00
Q ss_pred cC--------------CCCC---------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 276 LE--------------GQFT---------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 276 ~~--------------~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. .... ...++++.+|+.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0000 012356789999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=343.66 Aligned_cols=252 Identities=18% Similarity=0.261 Sum_probs=195.1
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeCC------e
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 130 (334)
..|+++++||+|+||+||+|.. .+|+.||||++....... .+.+.+|+++|+.++||||++++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4588899999999999999996 458999999997543222 346789999999999999999999997654 4
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.++||||+ +.+|...+. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||.+....
T Consensus 98 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~-IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCcchhhcccccccccccccceeccC
Confidence 69999999 577877773 457999999999999999999999999 9999999999999999999999999998765
Q ss_pred CC-CcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc---------------------
Q 019905 211 DG-KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN--------------------- 267 (334)
Q Consensus 211 ~~-~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~--------------------- 267 (334)
.. ....+|+.|+|||++.+. .++.++||||+||++|+|++|+.||............
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 43 346789999999999765 4789999999999999999999988654221111000
Q ss_pred -----cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hcccc
Q 019905 268 -----LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA--LSPLQ 317 (334)
Q Consensus 268 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--L~~l~ 317 (334)
........+ .......++++.+|+.+||+.||.+|||+.++|+- |+.+.
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 253 NYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000 11223446789999999999999999999999963 55543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=332.94 Aligned_cols=249 Identities=17% Similarity=0.193 Sum_probs=201.5
Q ss_pred CcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCC--ChHHHHHHHHHHhcCCCCCccceeeeeeeCCeeeEEEe
Q 019905 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 136 (334)
..|+++++||+|+||+||+|+. .+++.||||+++..... ....+.+|+.+++.++||||+++++++......+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688999999999999999996 46889999999654422 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCCC----
Q 019905 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (334)
Q Consensus 137 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~~---- 212 (334)
++.++++..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~-IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC-EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999888887775 5678899999999999999999999999 999999999999999999999999999865432
Q ss_pred CcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHH-hhhcc-----------------------
Q 019905 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRN----------------------- 267 (334)
Q Consensus 213 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~-~~~~~----------------------- 267 (334)
....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||....... .....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 2345678899999987665 6899999999999999999999875321111 00000
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.................++.+.+|+.+||+.||.+|||++|+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001111233445678999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=341.29 Aligned_cols=251 Identities=21% Similarity=0.216 Sum_probs=193.6
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccceeeeeeeC------CeeeE
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DERLL 133 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l 133 (334)
.|+.++.||+|+||+||+|... +++.||||++..... ...+|++++++++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677778899999999999964 689999999975432 234799999999999999999998643 34789
Q ss_pred EEecCCCCCHHHhhc-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCC
Q 019905 134 VAEYMPNETLAKHLF-HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD 211 (334)
Q Consensus 134 v~e~~~~~sL~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~ 211 (334)
||||++++.+..... ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999998654333322 124567999999999999999999999999 99999999999999765 899999999876543
Q ss_pred ---CCcccccccccCcccccCC-CCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc--------------------
Q 019905 212 ---GKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-------------------- 267 (334)
Q Consensus 212 ---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~-------------------- 267 (334)
.....|+..|+|||.+.+. .++.++||||+||++|||++|..||............
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 2345789999999998764 5899999999999999999999988654322211110
Q ss_pred ---cccccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhccc
Q 019905 268 ---LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPL 316 (334)
Q Consensus 268 ---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l 316 (334)
........+........++++.+|+.+||+.||.+|||+.|+++ .++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00000111111223345678999999999999999999999995 34444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=336.21 Aligned_cols=253 Identities=15% Similarity=0.144 Sum_probs=196.7
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCccc-eeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN-LLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~ 138 (334)
.|++++.||+|+||.||+|.+ .+++.||||.+.... ....+..|+++++.++|++++. +.+++..++..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 488889999999999999996 458899999987543 2345788999999998776555 555567778899999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeec---CCCCeeEcCCCCCccCCCC---
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG--- 212 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~---~~~~~kl~Dfg~a~~~~~~--- 212 (334)
++++.+.+.. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..++|+|||+++.....
T Consensus 86 -~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 -GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp -CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred -CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 4677776654 5568999999999999999999999999 99999999999986 4557999999999864332
Q ss_pred --------CcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcc---cccccccccCCCCC
Q 019905 213 --------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---LQMLTDSCLEGQFT 281 (334)
Q Consensus 213 --------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 281 (334)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||............ ....... ......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 241 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEVLC 241 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHHHHT
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-ChhHhc
Confidence 2446899999999999999999999999999999999999998653222111100 0000000 001112
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhcccccc
Q 019905 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (334)
Q Consensus 282 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~ 319 (334)
...++++.+++.+||+.||.+||++.++.+.|+.+..+
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 34456899999999999999999999999988877543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=338.41 Aligned_cols=244 Identities=16% Similarity=0.203 Sum_probs=195.7
Q ss_pred CCcccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeC--CeeeEE
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEG--DERLLV 134 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 134 (334)
.++|+++++||+|+||+||+|.. .+++.||||++... ..+.+.+|+++++.+. ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 45799999999999999999996 46899999999643 3677899999999995 99999999998753 568999
Q ss_pred EecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCC-CeeEcCCCCCccCCC--
Q 019905 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD-- 211 (334)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~-~~kl~Dfg~a~~~~~-- 211 (334)
|||+++++|.... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .++|+|||++.....
T Consensus 111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g-IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc-cccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999987754 46999999999999999999999999 99999999999998655 589999999986544
Q ss_pred -CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhh------------------hcccc--
Q 019905 212 -GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR------------------DRNLQ-- 269 (334)
Q Consensus 212 -~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~------------------~~~~~-- 269 (334)
.....+|+.|+|||.+.+.. ++.++||||+||++|++++|+.||......... .....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 33556789999999987765 799999999999999999999988643211100 00000
Q ss_pred ------------cccccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 270 ------------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 270 ------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
...............++++.+||.+||+.||.+|||++++|+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000111122335678999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-47 Score=332.49 Aligned_cols=257 Identities=15% Similarity=0.147 Sum_probs=204.0
Q ss_pred cccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCChHHHHHHHHHHhcCCC-CCccceeeeeeeCCeeeEEEecC
Q 019905 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN-NRLTNLLGCCCEGDERLLVAEYM 138 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~ 138 (334)
.|++++.||+|+||+||+|.+. +|+.||||.+.... +...+.+|++.+..++| +|++.+++++..+...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5778888999999999999964 58899999986543 33457789999999965 89999999999999999999999
Q ss_pred CCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecC-----CCCeeEcCCCCCccCCC--
Q 019905 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-----DGNPRLSTFGLMKNSRD-- 211 (334)
Q Consensus 139 ~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~-----~~~~kl~Dfg~a~~~~~-- 211 (334)
+++|.+++.. ....++...+..++.|++.||.|||+++ |+||||||+||+++. ++.++|+|||+++....
T Consensus 84 -~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g-iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 -GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp -CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred -CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC-ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 6899998864 4567999999999999999999999999 999999999999974 57899999999975432
Q ss_pred ---------CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhc--ccccccccccCCCC
Q 019905 212 ---------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR--NLQMLTDSCLEGQF 280 (334)
Q Consensus 212 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~ 280 (334)
.....||+.|||||++.+..++.++||||||+++|||++|..||........... ..............
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 2245689999999999999999999999999999999999999864321110000 00000000000111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhccccccCCC
Q 019905 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEF 322 (334)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~L~~l~~~~~~ 322 (334)
....++++.+++..||+.+|++||+++.+.+.|+++.++...
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 233456899999999999999999999999988887655443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=340.18 Aligned_cols=248 Identities=18% Similarity=0.236 Sum_probs=200.9
Q ss_pred CCcccccccCCCcCccEEEEEEe----CCCCEEEEEEecCCC----CCChHHHHHHHHHHhcCCC-CCccceeeeeeeCC
Q 019905 59 FAVENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQLRN-NRLTNLLGCCCEGD 129 (334)
Q Consensus 59 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 129 (334)
.++|++++.||+|+||+||+|.. .+|+.||||.+.... ....+.+.+|++++++++| |||+++++++....
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 46688999999999999999984 247899999986432 2234567899999999976 89999999999999
Q ss_pred eeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccC
Q 019905 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (334)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~ 209 (334)
..+++|||+.+++|.+++. ..+.+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcCC-EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999987 3456788999999999999999999999 999999999999999999999999998755
Q ss_pred CCC-----CcccccccccCcccccCCC--CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccccccCCCCCc
Q 019905 210 RDG-----KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (334)
Q Consensus 210 ~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
... ....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.................. ....++.
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--~~~~~~~ 257 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ 257 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--CCCCCcc
Confidence 432 3456789999999997654 788999999999999999999998654322211111111111 1123445
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 019905 283 DDGTELVRLASRCLQYEPRERPN-----PKSLVT 311 (334)
Q Consensus 283 ~~~~~l~~li~~cl~~dp~~Rps-----~~~~l~ 311 (334)
..++++.+|+.+||++||.+||| ++++++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 67789999999999999999994 788885
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=336.04 Aligned_cols=253 Identities=16% Similarity=0.193 Sum_probs=195.7
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeC-----Ceee
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 132 (334)
.|+++++||+|+||+||+|.. .+|+.||||++....... .+.+.+|++++++++||||+++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 588899999999999999995 568999999997544222 34678999999999999999999998643 3346
Q ss_pred EEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCCC-
Q 019905 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (334)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~~- 211 (334)
++++|+.+++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||.+.....
T Consensus 99 ~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~g-iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp EEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred EEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCCccccccccccccccccchhcccCcc
Confidence 7777888999999984 467999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcccccccccCcccccCCC-CCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhcccccccc-----------------
Q 019905 212 GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD----------------- 273 (334)
Q Consensus 212 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------------- 273 (334)
.....|+..|+|||.+.+.. ++.++|||||||++|+|++|..||..................
T Consensus 175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 34567889999999987765 688999999999999999999998754322111110000000
Q ss_pred -----cccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hhcccc
Q 019905 274 -----SCLEG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--ALSPLQ 317 (334)
Q Consensus 274 -----~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L~~l~ 317 (334)
..... ......++++.+||.+||+.||.+|||++++|+ .+.++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000 001234568999999999999999999999996 455443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=333.09 Aligned_cols=246 Identities=16% Similarity=0.218 Sum_probs=186.6
Q ss_pred CcccccccCCCcCccEEEEEEeC-CCCEEEEEEecCCCCCC--hHHHHHHHHHHhcCCCCCccceeeeeeeC------Ce
Q 019905 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (334)
Q Consensus 60 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 130 (334)
..|+++++||+|+||+||+|.+. +|+.||||++....... ...+.+|+.++++++||||++++++|... .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 36889999999999999999965 58999999997544221 34578999999999999999999999643 57
Q ss_pred eeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCCCccCC
Q 019905 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (334)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~~~~ 210 (334)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++++|||++....
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g-iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc-cccccCCccccccccccceeeechhhhhccc
Confidence 89999999755 444442 45899999999999999999999999 9999999999999999999999999877544
Q ss_pred C---CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhhhccccc-----------------
Q 019905 211 D---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM----------------- 270 (334)
Q Consensus 211 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~~~~~~~----------------- 270 (334)
. .....+|+.|+|||++.+..++.++||||+||++++|++|+.||...............
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 3 23456889999999999999999999999999999999999888654222111100000
Q ss_pred ----------------cc-ccccC--CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 019905 271 ----------------LT-DSCLE--GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (334)
Q Consensus 271 ----------------~~-~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 311 (334)
.. ..... .......++++.+|+.+||+.||++|||++|+|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000 0011234678999999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-40 Score=299.69 Aligned_cols=263 Identities=16% Similarity=0.178 Sum_probs=191.9
Q ss_pred cccccccCCCcCccEEEEEEe-CCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-----------CCCccceeeeeeeC
Q 019905 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----------NNRLTNLLGCCCEG 128 (334)
Q Consensus 61 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~ 128 (334)
.|+++++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 489999999999999999996 4689999999975331 2356778898888775 57899999888653
Q ss_pred --CeeeEEEecCCCCC-HHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecccCCCCeeecCCCC------e
Q 019905 129 --DERLLVAEYMPNET-LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGN------P 198 (334)
Q Consensus 129 --~~~~lv~e~~~~~s-L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dikp~Nili~~~~~------~ 198 (334)
...++++.+...+. ............+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++. +
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~-IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC-cccccCChhHeeeeccCccccccee
Confidence 44556666654443 3333333356788999999999999999999998 77 999999999999986553 8
Q ss_pred eEcCCCCCccCCC-CCcccccccccCcccccCCCCCCccchhhhHHHHHHHHhCCCCCCchhhHHhh-------------
Q 019905 199 RLSTFGLMKNSRD-GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR------------- 264 (334)
Q Consensus 199 kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~elltg~~p~~~~~~~~~~------------- 264 (334)
+++|||.+..... .....+|+.|+|||++.+..++.++||||+|+++++|++|+.||.........
T Consensus 172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~l 251 (362)
T d1q8ya_ 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251 (362)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred eEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHh
Confidence 9999999875543 34567899999999999999999999999999999999999987543111000
Q ss_pred ---------hcc-------ccccccc-------------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--Hh
Q 019905 265 ---------DRN-------LQMLTDS-------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT--AL 313 (334)
Q Consensus 265 ---------~~~-------~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~L 313 (334)
... ....... ..........++++.+|+.+||+.||.+|||++++|+ .+
T Consensus 252 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f 331 (362)
T d1q8ya_ 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331 (362)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGG
T ss_pred CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 000 0000000 0011234556789999999999999999999999986 35
Q ss_pred ccccccCCCCCC
Q 019905 314 SPLQKETEFSIS 325 (334)
Q Consensus 314 ~~l~~~~~~~~~ 325 (334)
+......+...+
T Consensus 332 ~~~~~~~~~~~p 343 (362)
T d1q8ya_ 332 KDTLGMEEIRVP 343 (362)
T ss_dssp TTCTTCTTCCCT
T ss_pred CCCCCcccCCCC
Confidence 444333333333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=9.6e-25 Score=177.16 Aligned_cols=161 Identities=16% Similarity=0.114 Sum_probs=116.7
Q ss_pred ccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCC-----C-------------hHHHHHHHHHHhcCCCCCccceeeee
Q 019905 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-----D-------------PRQFLEEARSVGQLRNNRLTNLLGCC 125 (334)
Q Consensus 64 ~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~-----~-------------~~~~~~e~~~l~~l~h~~iv~~~~~~ 125 (334)
+-++||+|+||+||+|...+|+.||||.++..... . .....+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45678999999999999888999999987642211 0 01234678889999999998877653
Q ss_pred eeCCeeeEEEecCCCCCHHHhhcccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCceecccCCCCeeecCCCCeeEcCCCC
Q 019905 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (334)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 205 (334)
..+++|||+++..+.. ++......++.|++.+|.|||+++ ++||||||+|||++++ .++|+|||.
T Consensus 84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g-iiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEETT-EEEECCCTT
T ss_pred ----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC-EEEccCChhheeeeCC-CEEEEECCC
Confidence 2379999998765433 233445678999999999999999 9999999999999965 489999999
Q ss_pred CccCCCCCcccccccccCc------ccccCCCCCCccchhhhHHH
Q 019905 206 MKNSRDGKSYSTNLAFTPP------EYLRTGRVTPESVIYSFGTL 244 (334)
Q Consensus 206 a~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~Di~slG~~ 244 (334)
|......... .|... +. ....|+.++|+||+.--
T Consensus 149 a~~~~~~~~~----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 149 SVEVGEEGWR----EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CEETTSTTHH----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred cccCCCCCcH----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 8765433211 11110 11 12457889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.63 E-value=1.2e-07 Score=78.74 Aligned_cols=85 Identities=12% Similarity=-0.017 Sum_probs=58.8
Q ss_pred ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEEecCCC
Q 019905 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPN 140 (334)
Q Consensus 62 ~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (334)
+++++..+.++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+...++..++||++++|
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G 94 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccc
Confidence 34555444455578998875 45667888886554344455778888877764 33356778888888889999999998
Q ss_pred CCHHHhh
Q 019905 141 ETLAKHL 147 (334)
Q Consensus 141 ~sL~~~l 147 (334)
.++.+..
T Consensus 95 ~~~~~~~ 101 (263)
T d1j7la_ 95 VLCSEEY 101 (263)
T ss_dssp EEHHHHT
T ss_pred ccccccc
Confidence 8776543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=7.5e-05 Score=60.83 Aligned_cols=68 Identities=18% Similarity=0.197 Sum_probs=49.6
Q ss_pred cEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCC--CccceeeeeeeCCeeeEEEecCCCCCHH
Q 019905 74 NVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN--RLTNLLGCCCEGDERLLVAEYMPNETLA 144 (334)
Q Consensus 74 g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 144 (334)
+.||+...+++..+++|....... ..+..|...++.+... .+.+++.+...++..++||++++|.++.
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 578999887788889998765442 3456777777766422 3566777777778889999999876653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.95 E-value=2.1e-05 Score=68.89 Aligned_cols=76 Identities=13% Similarity=0.145 Sum_probs=47.8
Q ss_pred cccCCCcCccEEEEEEeC-CCCEEEEEEecC------CCC-CChHHHHHHHHHHhcCC-C-C-CccceeeeeeeCCeeeE
Q 019905 65 VSEHGEKAPNVVYKGKLE-NQRRIAVKRFNR------MAW-PDPRQFLEEARSVGQLR-N-N-RLTNLLGCCCEGDERLL 133 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~-~~~~vaiK~~~~------~~~-~~~~~~~~e~~~l~~l~-h-~-~iv~~~~~~~~~~~~~l 133 (334)
++.+|.|..+.||+.... +++.+++|.-.+ ..+ ........|.+.|+.+. + | .+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346799999999999854 467899996543 111 12344566888877662 2 2 34445543 4456689
Q ss_pred EEecCCCCC
Q 019905 134 VAEYMPNET 142 (334)
Q Consensus 134 v~e~~~~~s 142 (334)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.58 E-value=0.00019 Score=60.93 Aligned_cols=97 Identities=20% Similarity=0.238 Sum_probs=59.5
Q ss_pred CccccCHHHHHHHhcCCCc---ccccccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCCc-
Q 019905 43 SFREFTLEQLKNATSGFAV---ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL- 118 (334)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i- 118 (334)
++..++++.+..+..++.- ..+. .|+ +--..||+...++|..+++|...+... ..+++..|...+..|...++
T Consensus 4 ~f~~L~pd~i~~al~~~g~~~~~~~~-~L~-s~EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gip 80 (325)
T d1zyla1 4 TFQTLHPDTIMDALFEHGIRVDSGLT-PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVP 80 (325)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCE-EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCS
T ss_pred CccccCHHHHHHHHHHcCCCCCcCcc-ccc-cccceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCC
Confidence 3456677777655543321 1121 222 234689999998899999999876553 45778888888877742222
Q ss_pred -ccee-----eeeeeCCeeeEEEecCCCCC
Q 019905 119 -TNLL-----GCCCEGDERLLVAEYMPNET 142 (334)
Q Consensus 119 -v~~~-----~~~~~~~~~~lv~e~~~~~s 142 (334)
+... ..+...+..+.++++++|..
T Consensus 81 v~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 81 VAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp BCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 1111 12334566788999997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.88 E-value=0.0013 Score=57.14 Aligned_cols=73 Identities=15% Similarity=0.254 Sum_probs=48.2
Q ss_pred cccCCCcCccEEEEEEeCC--------CCEEEEEEecCCCCCChHHHHHHHHHHhcCC-CCCccceeeeeeeCCeeeEEE
Q 019905 65 VSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVA 135 (334)
Q Consensus 65 ~~~lg~G~~g~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 135 (334)
++.++.|-...+|+....+ .+.|.++..- .. ...-...+|..+++.+. +.-..++++++.. ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4566888889999998643 3456666654 22 33445667888888874 4334567776643 5899
Q ss_pred ecCCCCCH
Q 019905 136 EYMPNETL 143 (334)
Q Consensus 136 e~~~~~sL 143 (334)
+|+++.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99986544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.78 E-value=0.0012 Score=55.43 Aligned_cols=157 Identities=12% Similarity=0.062 Sum_probs=81.1
Q ss_pred cCHHHHHHHhcCCCccccc--ccCCCcCccEEEEEEeCCCCEEEEEEecCCCCCChHHHHHHHHHHhcCCCCC-----cc
Q 019905 47 FTLEQLKNATSGFAVENIV--SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-----LT 119 (334)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-----iv 119 (334)
++.+++.....+|..-++. ..+..|--.+.|+...++| .+++|.+.... ....+..|++++..|...+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 5667777777776543333 3345676678899987665 47889886532 2345556676666663222 11
Q ss_pred cee-e--eeeeCCeeeEEEecCCCCCHHH--------------hhccc-C----C--CCCCHH-----------------
Q 019905 120 NLL-G--CCCEGDERLLVAEYMPNETLAK--------------HLFHW-E----T--HPMKWA----------------- 158 (334)
Q Consensus 120 ~~~-~--~~~~~~~~~lv~e~~~~~sL~~--------------~l~~~-~----~--~~~~~~----------------- 158 (334)
... | +....+....++.++.+..... .++.. . . ......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 1 1122344566666665432211 00000 0 0 000000
Q ss_pred -HHHHHHHHHHHHHHHHHh----CCCceecccCCCCeeecCCCCeeEcCCCCCc
Q 019905 159 -MRLRVVLHLAQALEYCTS----KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (334)
Q Consensus 159 -~~~~i~~~i~~~l~~lh~----~~~i~H~dikp~Nili~~~~~~kl~Dfg~a~ 207 (334)
.....+......+.-.+. .+ ++|+|+.++||+++++...-+.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~g-iIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAG-VIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEE-EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccc-cccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222221 34 8999999999999988777899999863
|